data_1e0a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e0a _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 69.44 140.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.27 144.68 46.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.1 pt -119.87 114.57 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.11 100.05 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -77.93 130.21 36.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' CG1' HG23 ' A' ' 75' ' ' THR . 2.1 m -96.67 150.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.433 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 17.9 t -125.63 154.29 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.362 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 59' ' ' ALA . 7.2 p -149.64 121.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' CD2' ' A' ' 97' ' ' TRP . . . 130.6 -179.52 16.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.93 -179.53 5.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.48 77.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.379 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 81' ' ' CYS . . . 53.41 84.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -109.23 4.26 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.286 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 19' ' ' LEU . . . 97.09 -18.19 57.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.281 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' CG ' HG21 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.92 -74.19 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.773 0.321 . . . . 0.0 111.515 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.62 -25.88 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 19' ' ' LEU . 2.1 p -65.61 -48.11 73.38 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.705 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 23' ' ' TYR . 4.3 mt -61.26 -73.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.349 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.476 HD11 ' CD2' ' A' ' 40' ' ' TYR . 11.2 mt -40.8 -43.42 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.981 0.419 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -48.71 -69.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.806 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 1.8 t -93.79 -55.39 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CZ ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -51.96 -19.25 1.7 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.498 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 43.2 m -123.94 -86.23 0.64 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.232 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 4.7 t -65.83 -14.21 60.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' ILE . 36.0 t30 79.03 -56.28 0.44 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.908 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HD3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -47.74 145.74 2.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.996 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -88.48 167.01 20.32 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.7 Cg_endo -45.82 165.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.993 2.462 . . . . 0.0 112.688 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.8 t -119.56 -76.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.98 113.94 25.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.643 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.28 109.3 4.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 111.056 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' THR . 67.2 t -157.52 138.03 9.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.478 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 84.3 Cg_exo -43.81 92.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.314 2.009 . . . . 0.0 111.617 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.43 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 56.8 m -51.98 87.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' B' ' 96' ' ' PHE . 20.9 t -79.54 -28.23 12.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 109.762 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.483 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 3.7 t80 -146.62 -68.76 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 1.2 m-20 60.47 131.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.389 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 5.6 t-20 -108.0 159.81 16.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.476 ' CD2' HD11 ' A' ' 20' ' ' LEU . 3.7 m-85 -152.18 157.44 41.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -115.29 137.94 51.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.176 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 3.2 m -162.2 164.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.8 m -155.94 99.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.483 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.54 117.15 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.806 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.5 mtm -91.37 102.12 14.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.21 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 1.7 mp -87.3 107.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 20.84 77.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.39 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -141.67 100.47 6.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.949 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.38 155.95 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.501 2.134 . . . . 0.0 112.196 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -154.16 169.63 23.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 111.327 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 97.22 4.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.321 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -105.04 161.26 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 111.375 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -160.27 127.3 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.057 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 20' ' ' LEU . 1.8 mm? -75.93 103.23 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.9 103.0 12.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.022 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.43 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 m-20 -78.19 142.57 37.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 57' ' ' ASP . 2.2 p -167.72 178.68 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 64' ' ' TYR . . . -127.17 -66.71 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . 104.06 54.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.757 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 170.48 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.324 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 22.7 mt-10 -85.79 89.96 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.186 0.517 . . . . 0.0 111.886 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 61.71 13.66 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.02 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.482 ' CE2' ' HB1' ' A' ' 59' ' ' ALA . 93.7 m-85 -102.62 -29.07 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -49.21 -27.37 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -93.49 -31.54 14.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.699 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.532 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -94.02 24.16 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -85.31 -46.31 0.63 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.205 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.7 Cg_exo -50.16 -23.15 9.14 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.487 HD11 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -76.24 -26.05 55.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.339 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.447 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 2.3 m -92.62 -23.42 19.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.487 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 2.0 p90 46.29 102.7 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.501 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.81 -34.28 8.29 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.657 2.238 . . . . 0.0 112.663 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.83 -10.66 50.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.563 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.487 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 8.3 t -38.42 -51.66 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 167.97 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.942 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 p -58.44 162.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -99.5 135.46 40.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 55' ' ' LEU . 12.6 tp -109.95 115.78 30.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.059 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.1 t -131.23 145.86 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.411 ' HB3' ' CA ' ' A' ' 14' ' ' VAL . 11.4 t -139.17 158.66 43.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 7.6 p90 -152.37 149.52 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -51.36 160.77 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG22 ' CA ' ' A' ' 115' ' ' THR . 73.0 t -109.09 -69.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.0 t -52.03 -73.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.88 106.16 0.61 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.3 -25.76 13.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.528 2.152 . . . . 0.0 112.551 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.69 -24.16 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -96.15 -30.69 13.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.158 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.95 -69.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.125 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -50.47 -48.29 56.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.5 m-80 -53.2 -69.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 82' ' ' PHE . 61.5 t -40.45 -30.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.925 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.61 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.38 8.42 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.953 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 92' ' ' ASN . 21.8 mmtm -113.3 -44.79 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.492 ' CD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 m95 -95.55 -36.79 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 94.1 t -52.5 -44.74 95.2 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.511 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 52.9 Cg_exo -52.51 -28.47 36.35 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.288 1.992 . . . . 0.0 112.288 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -22.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.6 mm -49.17 -31.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -85.01 -24.87 28.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 60' ' ' GLY . 9.9 t60 -65.78 -37.22 85.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -103.71 -19.66 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.256 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 12.2 m -152.88 74.49 7.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.761 0.315 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -12.57 33.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.617 2.211 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.57 21.16 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.255 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 135.67 25.04 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.85 159.63 4.87 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.498 2.132 . . . . 0.0 112.148 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 16.5 p90 -135.76 134.93 39.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.85 122.03 46.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.875 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.49 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 12.4 mt -91.15 162.94 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' PHE . 49.0 t -152.79 141.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.1 104.45 0.35 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.392 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.435 ' HB ' ' CA ' ' A' ' 158' ' ' SER . 71.1 p -137.84 137.56 38.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 177.32 71.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 pt -98.69 -22.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.7 -24.41 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.15 -27.91 59.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -50.22 139.66 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.65 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.023 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -54.16 120.94 27.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.2 -41.42 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t -49.53 -31.67 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.7 m -56.83 -58.98 5.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -51.38 -45.34 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -42.53 61.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -37.27 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -50.71 -25.51 4.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.496 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.62 -20.46 53.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.21 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -81.3 -27.03 35.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.8 -8.36 57.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.454 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 62.89 26.45 15.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -100.84 -26.33 13.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.77 168.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.27 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.6 mt -51.52 135.37 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.438 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -132.31 177.75 2.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -53.35 -21.15 16.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.64 -42.34 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.7 m -50.88 -46.75 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.27 -40.43 58.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -43.87 97.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -51.55 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.799 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.78 -44.42 77.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . . . -60.47 -31.38 70.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.86 -44.11 86.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.53 -50.64 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 4.3 pp -68.14 -27.32 66.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.59 108.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -148.82 -162.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.429 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 57.3 t -67.34 -11.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.678 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 73.87 139.77 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.703 0.287 . . . . 0.0 110.86 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 112' ' ' LEU . 24.6 p90 -153.11 162.64 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.9 m -158.32 124.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.624 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -171.06 166.37 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 18.2 p -113.82 -173.13 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.435 ' CA ' ' HB ' ' A' ' 115' ' ' THR . 8.4 t -87.61 166.81 14.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.898 0.38 . . . . 0.0 111.029 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 22' ' ' SER . . . -52.16 -174.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.412 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.403 HD23 ' CB ' ' A' ' 159' ' ' ALA . 1.4 mm? 67.72 -64.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 166.14 11.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.01 122.94 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -105.07 -37.33 6.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 165.44 79.87 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.486 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 4.0 mt -83.89 -25.14 30.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 111.029 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -52.78 -31.46 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.416 ' N ' ' HD3' ' A' ' 166' ' ' LYS . 12.1 m-80 -65.28 -65.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.74 -27.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.936 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -74.3 -35.13 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.272 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.437 ' CB ' HG13 ' B' ' 75' ' ' ILE . 5.1 t70 -63.26 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.516 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 -25.6 25.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.769 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.99 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.054 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 46' ' ' ILE . 31.6 mm -94.8 -23.71 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.8 tt -72.5 -45.96 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.87 71.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.63 -19.67 23.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.437 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -47.47 -41.54 20.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.151 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.06 -83.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.437 HG13 ' CB ' ' A' ' 170' ' ' ASP . 8.4 mm -91.67 140.03 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m -128.38 139.58 52.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -75.88 138.73 69.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.431 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 65.6 Cg_exo -51.3 146.85 22.98 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.461 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 30.8 t -108.41 -51.3 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -77.49 167.88 20.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.501 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 6.5 t80 171.41 124.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -153.19 132.38 12.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 111.382 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -68.91 95.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.43 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -74.51 -62.86 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.576 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.43 ' N ' ' OG1' ' B' ' 84' ' ' THR . 1.1 mp -116.87 113.94 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.888 0.375 . . . . 0.0 111.499 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.08 96.91 7.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.198 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 39.4 t -79.31 137.77 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.445 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.14 177.56 18.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -77.26 136.48 38.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 95' ' ' GLU . 10.0 t0 -124.21 110.1 14.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.11 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -40.98 -48.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.848 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.4 p -155.48 50.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 47.73 33.42 9.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.421 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' B' ' 90' ' ' ASP . 11.8 pt-20 -118.31 -178.01 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.325 . . . . 0.0 110.79 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.479 ' CD2' HG13 ' A' ' 36' ' ' VAL . 2.3 m-85 -101.95 164.23 11.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -109.78 168.86 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 48.71 27.58 6.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.432 ' HE2' ' CD2' ' A' ' 67' ' ' LEU . 2.7 mtp -52.64 131.11 46.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.593 0.235 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.469 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 81.3 Cg_exo -49.5 145.74 15.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.554 2.17 . . . . 0.0 112.19 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -45.59 -39.93 8.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -78.57 -51.12 10.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.525 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.532 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 2.6 m0 -53.76 -55.43 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 109.622 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.64 -62.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.841 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 15.9 ptt85 -55.95 -36.31 67.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.301 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -46.83 -63.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.414 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -96.2 -69.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.193 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.449 ' O ' ' CB ' ' B' ' 109' ' ' THR . 0.4 OUTLIER -80.4 -105.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.071 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 0.5 OUTLIER 159.34 -24.14 0.0 OUTLIER 'General case' 0 C--N 1.351 0.653 0 C-N-CA 122.43 0.292 . . . . 0.0 111.361 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.432 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.0 OUTLIER -109.5 107.9 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.332 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.415 ' N ' ' OD1' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -43.43 -50.81 6.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 110.847 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -103.15 132.43 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.49 153.22 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.4 pt -158.04 121.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.981 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 112.88 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -91.86 128.73 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 71' ' ' SER . 59.1 t -107.24 159.06 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.994 0.426 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 4.9 m -126.79 163.24 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.469 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 3.5 t -153.68 123.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.212 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 147.7 168.97 14.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.735 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -60.0 -152.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -40.73 141.48 0.92 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.89 62.48 2.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.182 0.515 . . . . 0.0 109.701 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 9' ' ' VAL . 2.9 t -54.68 -19.62 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 132.6 -36.04 2.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' N ' HG13 ' A' ' 8' ' ' VAL . 7.5 mmtt -95.91 -73.71 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.237 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.414 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 4.7 t -36.09 -53.06 0.79 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 p -63.8 -48.6 76.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.785 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 HD21 ' CG ' ' A' ' 23' ' ' TYR . 12.5 mt -55.71 -72.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 40' ' ' TYR . 8.6 mt -38.09 -43.05 0.71 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.588 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -49.4 -69.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.459 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -93.47 -54.16 3.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.157 0.503 . . . . 0.0 111.452 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CE1' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -51.31 -21.82 2.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.411 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 77.2 m -120.63 -88.07 0.63 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.832 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.502 HG22 ' CZ ' ' B' ' 81' ' ' PHE . 5.0 t -54.89 -30.46 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.219 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.6 OUTLIER 76.64 51.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 25' ' ' THR . 0.2 OUTLIER -158.83 116.28 2.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.768 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -45.85 168.39 0.11 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.884 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 61.7 Cg_exo -53.05 158.32 6.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.743 2.295 . . . . 0.0 112.981 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.1 t -107.44 -76.25 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.779 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.45 108.04 19.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.377 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.8 100.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.45 . . . . 0.0 111.161 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 96.5 t -151.51 139.51 12.85 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.207 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' VAL . 98.1 Cg_exo -41.58 91.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.385 2.056 . . . . 0.0 112.04 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' VAL . 93.0 m -54.25 87.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' PRO . 59.5 t -85.99 -24.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.398 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CD2' ' HG3' ' B' ' 100' ' ' PRO . 2.6 t80 -142.39 -66.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 6.1 m-20 53.71 107.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 41.7 t30 -107.6 153.08 23.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.794 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -149.47 168.82 22.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.71 115.62 28.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' HB ' ' CG ' ' B' ' 78' ' ' PRO . 12.3 m -134.38 137.68 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.1 m -136.7 108.59 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 m -98.24 117.29 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.052 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.2 mtm -79.4 100.98 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mm -87.95 91.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.077 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.43 16.04 74.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.709 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.09 25.8 10.9 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.736 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -124.65 131.26 24.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.554 0.216 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 159.07 28.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.466 2.111 . . . . 0.0 112.271 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.51 41.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -136.44 97.42 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.531 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.34 131.76 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.266 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.17 134.24 11.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.252 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -113.19 103.1 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.945 0.402 . . . . 0.0 110.905 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 4.1 m-85 -102.11 111.28 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD2' ' CG2' ' A' ' 17' ' ' THR . 4.5 t70 -88.01 171.4 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 8' ' ' VAL . 8.4 p -139.56 -175.7 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.715 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.02 -23.44 14.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . . . 74.71 51.78 7.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.359 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.0 174.89 11.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.88 30.77 2.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.1 28.81 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CD2' ' CE1' ' A' ' 104' ' ' HIS . 1.8 m-85 -101.14 -11.74 19.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -43.06 -28.51 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.675 0.274 . . . . 0.0 111.592 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 3.5 mtt85 -45.02 -62.82 1.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' CD2' ' CG ' ' B' ' 103' ' ' TRP . 1.3 mp -72.33 173.5 8.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 5.2 tpp180 -101.0 -72.66 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.5 Cg_endo -71.4 -58.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.036 1.824 . . . . 0.0 113.06 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.494 HD21 ' CZ2' ' B' ' 103' ' ' TRP . 63.4 mt 50.1 25.65 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.479 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.7 OUTLIER 164.17 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.02 175.25 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 111.072 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 72' ' ' TYR . 34.3 Cg_exo -61.9 -24.41 77.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.645 2.23 . . . . 0.0 112.17 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -68.06 -10.12 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.608 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -36.94 -32.15 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t0 51.62 -151.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.537 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.56 156.2 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.692 0.282 . . . . 0.0 110.478 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -113.34 134.51 54.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.93 122.22 44.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.08 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 3.2 t -130.35 101.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.0 t -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -137.34 124.68 21.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.008 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 p -52.96 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' CG ' ' A' ' 116' ' ' GLN . 4.1 m -62.2 86.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 30.3 m -122.92 75.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.79 148.48 0.12 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 132' ' ' ASN . 51.9 Cg_exo -54.6 -19.34 17.88 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.749 2.299 . . . . 0.0 112.591 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 t -46.59 -73.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.39 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 74.3 m -61.28 -24.57 66.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.32 -58.96 4.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.035 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -49.65 -60.72 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -53.32 -63.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 89' ' ' SER . 72.9 t -41.14 -29.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.959 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 6.9 tttt -74.84 -69.51 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.664 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.73 7.98 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.39 -43.34 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.648 0.261 . . . . 0.0 111.553 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.471 ' CZ3' ' O ' ' A' ' 60' ' ' GLY . 16.1 m95 -95.3 -40.12 9.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.5 t -52.65 -44.2 94.64 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.512 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.4 Cg_exo -59.79 -28.82 88.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.278 1.985 . . . . 0.0 112.235 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -24.29 60.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.7 mt -49.48 -27.81 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -76.87 -28.15 55.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -70.81 -44.8 65.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CE1' ' CD2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -89.02 -33.72 17.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 2.7 m -107.6 129.63 23.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.654 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.61 -83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.444 2.096 . . . . 0.0 112.64 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -153.52 83.68 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.48 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -151.59 163.92 22.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 59.4 Cg_exo -52.09 130.24 34.27 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.451 2.101 . . . . 0.0 112.037 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -102.6 125.77 49.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.69 121.4 44.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -114.1 162.59 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.087 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -146.84 166.3 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -161.12 101.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.529 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.2 p -158.48 142.23 15.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.431 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.457 ' NE2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -174.79 40.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.453 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.1 mt -37.83 -37.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.59 -43.82 96.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.457 ' CB ' ' NE2' ' A' ' 116' ' ' GLN . 2.0 mt -86.99 -45.55 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 5.1 tmm_? -48.93 -26.24 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.9 46.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.23 156.09 38.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.05 -49.89 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.17 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -50.05 -47.71 53.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -31.76 30.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.218 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.56 -54.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.66 -40.91 13.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -84.86 -37.84 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -49.58 -32.73 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.337 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.01 65.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.103 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -24.02 19.67 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.314 . . . . 0.0 110.867 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.421 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 18.7 m120 -95.98 30.19 2.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 26.65 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 49.19 -166.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.58 86.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.448 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 74.0 Cg_exo -48.38 169.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.575 2.184 . . . . 0.0 112.317 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.1 mt -94.13 130.27 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.9 p -110.75 168.42 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.962 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.58 -17.74 23.37 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.714 2.276 . . . . 0.0 112.562 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -82.55 -32.93 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.194 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.3 m -56.69 -62.78 1.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.971 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.95 -50.58 26.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.38 -39.86 70.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.753 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -53.66 -54.73 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -37.15 65.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . . . -57.23 -46.78 82.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -57.76 -44.68 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.626 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -22.29 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.037 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 151' ' ' ALA . 2.9 pp -121.38 21.27 11.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 43.9 tttm 56.16 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 59.07 174.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.044 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 60.9 t -59.49 -17.76 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.46 135.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.647 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' HG ' ' A' ' 112' ' ' LEU . 13.6 p90 -152.9 154.82 35.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.363 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 35.0 m -155.07 123.67 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.23 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 2.6 pt-20 -170.88 -178.68 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 111.111 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.8 p -127.91 -170.37 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.018 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.7 t -85.35 174.52 9.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.755 0.312 . . . . 0.0 110.288 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.432 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -34.36 -85.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.05 -171.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.499 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 162' ' ' GLN . 4.3 p 64.72 -67.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.836 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER 54.53 94.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 110.783 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -105.18 -67.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.1 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.96 77.84 0.38 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.793 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -93.7 -29.05 15.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -54.62 -60.25 3.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -43.31 -37.06 2.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 156' ' ' GLU . 23.9 t -59.37 -62.28 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.755 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 66.2 m-85 -52.08 -28.94 19.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 1.9 m-20 -63.07 -41.8 99.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -45.55 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 110.908 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.7 70.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 50.0 mm -86.35 -52.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.4 tm? -55.05 -39.65 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.64 -47.4 70.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.87 35.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.7 tp -50.85 -44.83 59.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.037 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -44.38 96.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 7.2 tt -143.98 151.94 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.7 154.72 51.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.025 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.492 ' CD2' ' CE1' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -89.09 137.45 29.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.438 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 50.7 Cg_exo -55.25 -63.6 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.45 2.1 . . . . 0.0 111.793 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.88 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.164 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.79 88.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -118.79 -173.12 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.02 128.97 10.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.6 85.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.433 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -53.87 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.73 154.18 24.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 96.75 4.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 86.0 t -80.18 121.65 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.439 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -125.87 177.27 17.16 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.127 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.3 138.52 39.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 111.004 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -139.0 112.94 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.16 60.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.646 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 12.7 p -41.22 -33.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.606 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.8 t -140.09 -37.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.445 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.96 20.96 1.59 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.71 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.34 -158.63 0.9 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.6 0.238 . . . . 0.0 110.394 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.402 ' HB3' HG11 ' B' ' 87' ' ' VAL . 1.0 OUTLIER -103.41 164.53 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.803 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 11.5 p -95.73 162.53 13.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.1 46.18 33.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.568 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.432 ' HB2' ' CB ' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -61.53 124.36 80.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.561 0.219 . . . . 0.0 110.862 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.507 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 63.7 Cg_exo -50.62 159.66 2.1 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.366 2.044 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.01 -57.26 3.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.276 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -72.51 -56.09 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.508 ' CG ' ' CD2' ' A' ' 67' ' ' LEU . 8.6 m0 -46.24 -55.34 7.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' B' ' 99' ' ' MET . . . -54.76 -45.94 74.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.109 0.481 . . . . 0.0 110.447 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 55.0 mtp85 -58.52 -41.41 85.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.88 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -50.3 -55.88 13.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.253 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.32 -69.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' B' ' 109' ' ' THR . 8.8 tp60 -79.14 -100.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.2 p -168.17 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 120.872 0.367 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.403 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.4 OUTLIER -150.95 174.25 13.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.217 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.58 72.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.621 0.725 . . . . 0.0 111.608 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.824 0.345 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.1 124.08 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.21 141.03 28.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.402 ' CG2' ' OD2' ' A' ' 76' ' ' ASP . 3.9 mt -146.7 129.34 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -131.65 95.35 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.568 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 t -77.35 100.44 5.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 94.0 t -84.4 113.25 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.656 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 16' ' ' LYS . 27.4 m -85.04 140.0 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.549 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 104' ' ' HIS . 11.8 p -126.49 154.88 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.679 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . 147.6 -169.19 28.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.666 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.94 29.6 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -125.12 -41.57 0.36 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 85.64 -23.68 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 81' ' ' CYS . 28.7 m -48.7 -23.83 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -120.56 -33.78 0.99 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.603 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 44.3 mtmt -63.82 -76.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 111.406 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 17.4 p -98.24 -43.9 6.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.253 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 58.2 m -52.61 -23.82 7.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.757 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' A' ' 23' ' ' TYR . 18.8 tp -61.8 -71.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' A' ' 40' ' ' TYR . 14.2 mt -44.12 -29.13 0.57 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 6.8 mm -65.79 -45.12 92.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.369 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' LEU . 78.5 p -94.93 -13.15 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.81 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 165' ' ' LEU . 2.9 m-30 -95.93 -67.45 0.85 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.437 ' CG2' ' HB2' ' B' ' 81' ' ' PHE . 58.6 m -82.74 -81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.647 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.504 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -47.23 -40.44 16.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.274 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t30 64.79 41.38 5.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.1 OUTLIER -126.84 -159.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.38 155.66 76.21 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 65.1 Cg_exo -36.79 132.47 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.017 2.478 . . . . 0.0 113.118 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m -97.91 -82.83 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.556 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.78 108.77 20.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.45 109.29 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.294 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.4 p -160.63 133.23 4.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.383 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 36' ' ' VAL . 90.5 Cg_exo -41.26 93.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.353 2.035 . . . . 0.0 111.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 17' ' ' THR . 23.8 m -53.07 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.328 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.48 HG13 ' CD2' ' B' ' 96' ' ' PHE . 2.2 t -77.48 -24.6 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -150.56 -75.49 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.699 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.43 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 5.7 m-20 60.27 117.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.778 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 16.0 t-20 -107.13 156.66 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.557 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CD1' HD11 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.06 168.97 22.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.258 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.31 138.76 53.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' B' ' 78' ' ' PRO . 11.0 m -147.04 131.45 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.2 m -116.66 103.12 10.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' B' ' 75' ' ' ILE . 40.6 t -98.91 121.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.041 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.3 mtm -87.05 100.09 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 51' ' ' TYR . 14.1 mt -98.3 93.82 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 17.34 79.93 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.364 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 35.52 5.43 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -141.19 128.33 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.483 0.182 . . . . 0.0 110.928 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 168.7 3.24 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.05 . . . . 0.0 112.232 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 46' ' ' ILE . 2.4 m-85 -147.96 156.08 42.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 p -130.52 99.93 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 10.4 tt -133.53 160.56 37.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -153.4 149.27 20.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 20' ' ' LEU . 16.3 mt -99.14 104.11 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 111.214 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 5.5 m-85 -83.39 112.66 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.437 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 7.2 t70 -66.93 134.09 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 111.237 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.471 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -145.12 155.33 43.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.765 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.46 -176.37 4.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.212 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -110.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tp 50.29 -161.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.366 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -132.52 40.0 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -131.69 21.04 4.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 58' ' ' THR . 2.7 m-85 -111.34 -27.99 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.74 -41.28 22.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -69.06 -36.7 77.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.404 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.9 OUTLIER -98.0 29.05 3.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.576 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 2.6 tpt180 -88.73 -66.12 0.16 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 87.5 Cg_exo -37.27 -31.28 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.844 2.363 . . . . 0.0 112.827 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -51.99 -31.53 29.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.483 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -91.8 -25.47 19.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.9 OUTLIER 50.47 170.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.748 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.2 Cg_exo -68.67 -20.78 40.04 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.075 2.517 . . . . 0.0 112.666 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.52 -10.95 39.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.512 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.42 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.5 t -48.71 -23.82 1.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 111.639 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 75' ' ' THR . 4.2 m-20 77.25 -152.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.67 148.85 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 7' ' ' VAL . 4.6 m-85 -100.39 131.92 46.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD2' HG13 ' A' ' 8' ' ' VAL . 48.9 tp -103.74 115.97 31.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.137 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.38 150.76 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 111.799 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.452 ' SG ' ' CZ3' ' A' ' 97' ' ' TRP . 31.4 p -92.75 170.73 9.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -161.86 101.34 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.385 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.464 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 41.9 t -68.33 129.92 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 115' ' ' THR . 27.4 m -121.51 49.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -115.68 -69.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -100.2 103.44 23.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.733 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.411 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 80.2 Cg_exo -44.8 -27.61 2.5 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.584 2.189 . . . . 0.0 112.504 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -64.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 4.8 m -58.33 -34.95 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -45.61 -41.35 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.263 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.77 -61.26 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.735 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.4 m-20 -59.63 -38.68 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' ' CE3' ' A' ' 97' ' ' TRP . 92.5 t -47.5 -52.75 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 11.2 tttm -65.16 -47.83 75.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.479 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -82.36 8.17 12.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.36 -37.41 2.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.67 0.271 . . . . 0.0 111.558 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.49 ' CE3' ' CG1' ' A' ' 93' ' ' VAL . 22.6 m0 -92.28 -28.93 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.67 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.496 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 33.1 t -74.47 -44.09 5.62 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 27.0 Cg_exo -62.34 -23.11 74.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.321 2.014 . . . . 0.0 112.345 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.9 -14.9 27.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.618 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -46.62 -33.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.388 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 p -81.06 -34.19 32.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -61.9 -27.29 68.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.406 ' CD2' HG22 ' A' ' 9' ' ' VAL . 98.1 m-70 -113.44 -24.58 9.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.44 ' SG ' ' CG ' ' A' ' 78' ' ' PHE . 2.1 m -120.62 92.02 47.5 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 55.9 Cg_endo -70.18 99.33 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.634 2.223 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 44.29 41.55 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.4 m -117.64 142.2 30.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.28 133.86 30.58 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.433 ' CB ' HD13 ' A' ' 101' ' ' ILE . 6.8 p90 -115.45 149.54 37.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.996 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 148.03 46.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 tp -116.03 142.26 47.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.628 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 79' ' ' LEU . 1.4 m -153.54 176.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.32 138.13 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.4 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.439 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -158.35 153.13 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 28.5 mm-40 -151.84 98.42 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.652 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.418 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 mt -90.44 -46.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -25.81 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.439 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -77.22 -43.09 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 117' ' ' ILE . 0.6 OUTLIER -52.2 -29.03 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.17 47.01 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.982 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 140.93 29.1 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.793 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.75 -36.56 33.38 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -82.63 -30.43 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.1 m -56.03 -63.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -50.53 -39.16 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.1 -55.87 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.711 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.76 45.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.57 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.33 -26.28 4.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 110.368 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.69 -24.13 63.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.802 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -84.15 -22.76 30.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 9.1 m-80 -93.92 30.05 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt 70.58 28.21 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -160.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.44 82.57 0.17 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 54.1 Cg_exo -52.46 166.69 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.435 HG22 ' CG2' ' A' ' 141' ' ' THR . 4.8 mt -101.59 122.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.433 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.1 p -112.98 176.51 1.46 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.433 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.6 Cg_exo -54.56 -20.37 20.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.607 2.205 . . . . 0.0 112.371 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.72 -47.94 15.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.435 ' CG2' HG22 ' A' ' 137' ' ' ILE . 96.9 m -51.18 -49.83 60.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.01 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.33 -35.63 77.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.809 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -59.09 4.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.8 tp -61.82 -27.29 68.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -73.2 -31.89 64.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.47 -45.51 65.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -23.07 25.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.049 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.472 ' CD1' ' CB ' ' A' ' 151' ' ' ALA . 4.5 pp -108.48 -16.55 14.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt 75.12 -69.73 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 -172.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.432 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 62.1 t -68.29 -8.95 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.748 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.49 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.977 0.417 . . . . 0.0 111.003 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 112' ' ' LEU . 2.8 p90 -153.47 154.54 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 2.6 m -158.2 124.47 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.769 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -171.18 166.65 7.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.412 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 16.7 p -123.48 -173.63 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.22 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 116' ' ' GLN . 3.6 p -88.2 162.86 16.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.443 ' CB ' HD23 ' A' ' 160' ' ' LEU . . . -52.91 -173.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.443 HD23 ' CB ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER 52.14 30.14 7.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.02 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 -68.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.82 105.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -102.3 -64.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.13 88.82 0.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.604 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 23' ' ' TYR . 2.4 mt -93.95 -10.86 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.553 0.216 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.13 81.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -57.8 -50.97 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 55.6 t -52.33 -66.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.179 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -40.73 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -50.14 -55.49 14.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -48.81 66.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.83 -28.97 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.096 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.453 ' CG2' ' CD1' ' A' ' 46' ' ' ILE . 26.0 mm -93.57 -27.67 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -26.4 62.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.12 5.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.29 52.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -48.97 -26.32 2.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.68 -85.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.428 ' CD1' HG13 ' A' ' 44' ' ' VAL . 8.3 tt -135.12 151.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.088 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 40.1 t -134.78 148.72 50.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.17 88.44 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.635 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.431 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . 9.4 Cg_endo -52.42 -172.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.61 2.207 . . . . 0.0 112.004 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.406 ' O ' ' N ' ' B' ' 81' ' ' PHE . 34.4 p -165.93 -40.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.204 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 71.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.504 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.2 t80 -93.35 139.58 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -153.37 129.26 10.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 78.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 110.372 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -52.69 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.542 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.16 101.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.561 0.219 . . . . 0.0 111.395 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . 0.456 ' O ' ' CD2' ' B' ' 86' ' ' HIS . 13.5 p-80 -85.4 96.78 9.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 88.0 t -78.43 158.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.243 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.43 ' N ' HG13 ' B' ' 87' ' ' VAL . . . -143.18 171.18 25.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.099 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.37 116.04 28.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.903 0.383 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.438 ' CB ' HG21 ' B' ' 97' ' ' THR . 49.9 t0 -136.51 124.06 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.23 0.72 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.976 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.404 ' CG1' HG21 ' B' ' 93' ' ' THR . 7.2 p -43.66 -29.09 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.861 0.362 . . . . 0.0 111.368 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.404 HG21 ' CG1' ' B' ' 92' ' ' VAL . 1.4 p -155.4 25.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.803 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.38 20.68 65.73 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.29 -163.25 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.48 ' CD2' HG13 ' A' ' 36' ' ' VAL . 1.1 m-85 -105.04 164.57 11.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.438 HG21 ' CB ' ' B' ' 90' ' ' ASP . 1.3 p -98.72 144.11 28.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.51 45.18 24.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.313 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.471 ' CG ' ' CB ' ' B' ' 104' ' ' ALA . 2.4 tpt -49.95 105.67 0.54 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.619 0.247 . . . . 0.0 110.998 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' B' ' 104' ' ' ALA . 74.2 Cg_exo -48.88 144.32 15.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.481 2.12 . . . . 0.0 112.22 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -46.87 -47.29 21.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.176 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.53 -65.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.509 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 4.0 m0 -49.51 -53.51 22.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.599 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.471 ' CB ' ' CG ' ' B' ' 99' ' ' MET . . . -52.62 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.166 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 2.8 mtt-85 -51.24 -32.79 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.812 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -49.79 -57.64 6.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -72.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.952 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' B' ' 109' ' ' THR . 2.8 pt20 -81.98 -113.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.229 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 0.5 OUTLIER 158.75 65.78 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.499 0.32 . . . . 0.0 111.071 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER 170.07 125.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 111.345 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.4 OUTLIER -84.98 75.34 10.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.332 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.445 HD11 ' N ' ' B' ' 112' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.25 121.31 15.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.26 151.83 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -144.55 120.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 143.18 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.1 m -136.04 155.3 50.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.795 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.462 ' CG1' ' CG2' ' A' ' 58' ' ' THR . 41.9 t -138.19 158.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 58' ' ' THR . 7.7 p -110.95 160.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.175 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' N ' HG23 ' A' ' 8' ' ' VAL . 7.4 p -151.53 133.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.57 177.25 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -76.98 117.82 18.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.56 178.69 16.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.342 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' CB ' ' CB ' ' A' ' 18' ' ' CYS . . . -131.57 0.41 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG13 ' CG2' ' A' ' 113' ' ' VAL . 3.8 t -54.81 -20.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -56.9 -109.3 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.452 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 3.9 mptp? -98.86 -53.88 3.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HB ' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -43.85 -77.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.487 ' CB ' ' CB ' ' A' ' 13' ' ' ALA . 40.0 t -66.19 -24.72 66.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.953 0.406 . . . . 0.0 111.351 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD12 ' CD2' ' A' ' 23' ' ' TYR . 15.4 tp -63.08 -72.78 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.357 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 1.3 mm? -41.59 -38.26 1.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -49.37 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.64 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -93.76 -50.21 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 112.001 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.496 ' CD2' HD12 ' A' ' 19' ' ' LEU . 2.6 t80 -53.75 -31.66 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 94.5 m -108.91 -87.7 0.5 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.551 -0.459 . . . . 0.0 112.119 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.488 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.8 t -55.09 -24.75 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.558 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' SER . 17.6 t-20 72.21 51.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.806 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD3' ' CE1' ' B' ' 81' ' ' PHE . 8.6 pttt -135.15 -167.48 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.512 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.482 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -124.72 154.33 70.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.794 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 88.0 Cg_exo -41.5 146.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.848 2.365 . . . . 0.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -103.01 -81.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.779 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.67 114.94 26.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.746 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.2 t80 -67.88 107.81 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 ' CG1' ' HD2' ' A' ' 34' ' ' PRO . 97.2 t -158.7 140.12 9.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.281 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' CG1' ' A' ' 33' ' ' VAL . 80.1 Cg_exo -43.51 91.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.381 2.054 . . . . 0.0 111.898 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.3 m -52.5 89.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.271 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' B' ' 87' ' ' VAL . 25.2 t -95.6 22.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.416 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 2.2 t80 168.04 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.178 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.54 109.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.728 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.4 t30 -107.42 168.38 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD2' ' CE2' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -153.12 168.91 24.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.423 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.64 124.09 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.725 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.15 138.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.387 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.0 m -136.92 108.21 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.05 116.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 100.36 13.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.767 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.9 mm -72.81 90.7 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.6 77.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 35.34 4.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.33 93.28 36.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.12 121.15 6.41 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -117.34 162.62 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 t -112.88 97.24 6.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.572 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.72 160.1 15.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.12 100.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.442 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 1.4 mm? -78.17 126.98 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 3.4 m-85 -108.7 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.607 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -74.27 -163.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.933 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.462 ' CG2' ' CG1' ' A' ' 7' ' ' VAL . 69.4 p -159.48 169.02 24.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.98 65.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 27.02 22.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -137.59 23.53 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 0.0 111.026 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 48.56 27.85 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.04 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -98.76 26.74 5.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD1' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -88.76 -22.26 23.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -43.94 -28.88 0.5 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -49.55 -60.48 2.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.848 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.493 HD23 ' CE3' ' B' ' 103' ' ' TRP . 1.9 mp -65.84 -176.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.383 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -100.85 -63.67 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 59.3 Cg_endo -95.42 -59.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.338 2.025 . . . . 0.0 113.001 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.498 HD21 ' CH2' ' B' ' 103' ' ' TRP . 23.3 mt 62.52 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 120.838 0.351 . . . . 0.0 110.761 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 25.6 p -90.98 -14.38 31.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.037 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 49.34 173.31 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.56 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.3 Cg_exo -68.0 -23.3 40.64 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.839 2.359 . . . . 0.0 112.282 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -11.95 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.1 t -47.49 -25.7 1.16 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.613 0.244 . . . . 0.0 111.506 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 47.33 -91.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.035 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' THR . 44.9 t -95.37 161.23 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.553 0.216 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 9.4 m-85 -122.77 147.07 46.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' CD1' ' CG1' ' A' ' 113' ' ' VAL . 1.9 mm? -103.91 147.15 27.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.065 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.32 97.18 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.09 100.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' C ' ' A' ' 113' ' ' VAL . 38.6 p90 -116.84 144.02 45.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.14 164.4 24.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 115' ' ' THR . 32.2 m -131.63 42.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.993 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.45 72.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.417 ' CB ' HD13 ' A' ' 129' ' ' LEU . 1.0 OUTLIER 74.99 153.65 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.045 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HA ' ' CB ' ' A' ' 90' ' ' PHE . 27.5 Cg_exo -61.51 -13.72 31.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.681 2.254 . . . . 0.0 112.58 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.6 t -43.41 -71.79 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 45.9 m -80.77 -26.91 36.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.546 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.409 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 1.7 t80 -47.67 -61.4 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.049 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -50.23 -54.44 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -54.26 -45.67 72.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 89' ' ' SER . 98.4 t -47.59 -50.04 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.414 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 1.3 mtmt -78.26 -44.42 25.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.422 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -77.84 5.32 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.48 -36.97 2.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.613 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -95.31 -41.96 8.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.517 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 46.1 t -49.87 -44.49 78.41 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.359 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_exo -55.05 -31.08 73.26 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.284 1.989 . . . . 0.0 111.957 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.7 -17.33 26.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -45.33 -31.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.861 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.433 ' N ' HG21 ' A' ' 101' ' ' ILE . 68.2 p -71.13 -42.91 68.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.444 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -52.21 -36.15 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.329 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.472 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m80 -89.95 -36.68 14.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 17.3 t -98.02 115.61 65.74 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.36 -63.78 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.428 2.086 . . . . 0.0 112.475 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.7 34.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.421 HG21 ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -109.4 160.17 28.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.421 ' CD ' HG21 ' A' ' 108' ' ' THR . 50.0 Cg_exo -53.46 169.55 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.539 2.16 . . . . 0.0 112.392 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -127.39 143.28 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 124.29 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.32 162.56 14.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.712 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG2' HG13 ' A' ' 14' ' ' VAL . 15.1 m -155.6 121.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.196 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.54 168.43 13.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.346 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 12.8 t -172.51 -165.4 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.433 ' HG2' ' CD1' ' A' ' 119' ' ' LEU . 0.0 OUTLIER 66.73 94.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.61 -40.26 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.059 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.85 -27.84 66.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.433 ' CD1' ' HG2' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -62.22 -58.62 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.423 ' NH1' HG23 ' A' ' 138' ' ' THR . 1.7 ptm180 -53.55 161.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.4 27.0 5.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.86 160.02 59.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.22 -38.37 61.17 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.535 2.157 . . . . 0.0 112.328 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -87.75 -29.76 20.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.0 m -53.17 -61.19 2.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.71 -37.66 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -58.42 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -33.87 62.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.562 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.48 -26.21 4.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.39 -24.01 66.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.798 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -94.1 -17.97 22.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -92.56 22.29 4.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.744 0.307 . . . . 0.0 111.093 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 10.7 mmmm 69.29 39.54 1.65 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.852 0.358 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 12.7 pt20 47.38 -163.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.088 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 64.65 84.56 0.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.426 ' CB ' HD23 ' A' ' 129' ' ' LEU . 52.5 Cg_endo -69.52 -177.62 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.637 2.225 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 3.9 mm -94.81 105.3 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.423 HG23 ' NH1' ' A' ' 120' ' ' ARG . 1.6 p -99.04 167.89 10.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.77 -27.6 27.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.739 2.292 . . . . 0.0 112.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -91.15 -28.68 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.2 m -49.15 -48.63 44.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.14 -59.82 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.47 -36.05 31.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -51.04 67.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.522 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.5 tp -58.08 -34.22 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.491 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.487 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -58.06 -58.0 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -51.79 -41.23 61.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -51.26 -29.88 15.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.1 pp -126.69 21.92 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.75 -86.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 57.36 -178.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 38.9 t -70.37 -7.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 77.03 151.02 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.853 0.358 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' HB1' ' A' ' 146' ' ' ALA . 8.2 p90 -152.63 148.49 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -158.08 124.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.289 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.31 172.3 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.57 -173.54 3.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -87.76 158.75 18.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 111.038 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -53.57 -172.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 67.14 -66.76 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.744 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 159' ' ' ALA . 10.0 p -76.13 -79.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.842 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 68.28 116.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -99.07 -67.96 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.71 96.04 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.455 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.494 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -92.83 -10.77 35.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -54.88 -40.9 70.22 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.423 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 42.5 m-80 -55.51 -65.95 0.5 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 169' ' ' PHE . 7.4 p -51.41 -39.24 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CD2' ' HG ' ' B' ' 77' ' ' LEU . 0.1 OUTLIER -54.22 -43.27 70.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.492 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 22.9 t0 -62.56 -45.98 90.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -59.03 -26.07 64.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.33 -61.28 2.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 173' ' ' ILE . 1.3 mp -67.65 -56.92 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.533 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 4.6 tp -50.92 -25.83 5.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.01 -60.91 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.92 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.9 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.4 m 63.73 -75.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' B' ' 73' ' ' GLY . 6.2 tt -142.8 151.55 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 7.3 t -125.61 140.08 53.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.486 ' HG ' ' CD2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -72.63 134.56 81.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -50.56 148.01 16.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.393 2.062 . . . . 0.0 112.169 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 4.3 t -112.29 -34.73 5.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -77.21 164.66 25.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.503 ' CE2' ' CD2' ' A' ' 40' ' ' TYR . 8.0 t80 175.69 118.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.475 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -149.32 133.69 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.055 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.422 ' NE2' ' HB3' ' B' ' 86' ' ' HIS . 1.4 t-160 -68.98 86.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' B' ' 85' ' ' ILE . 38.9 p -69.39 -74.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.409 ' N ' ' OG1' ' B' ' 84' ' ' THR . 0.9 OUTLIER -115.97 111.51 35.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . 0.422 ' HB3' ' NE2' ' B' ' 83' ' ' HIS . 5.2 p80 -98.92 96.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.865 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 22.1 t -83.39 132.5 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -132.69 177.91 18.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.487 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -76.82 115.89 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' CG2' ' B' ' 92' ' ' VAL . 24.5 t0 -107.41 117.64 34.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -10.37 59.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.411 ' CG2' ' OD1' ' B' ' 90' ' ' ASP . 58.5 t -45.73 -50.02 3.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.598 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 14.2 t -154.06 56.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.11 27.31 5.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -118.75 -177.66 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.419 ' HB3' HG11 ' B' ' 87' ' ' VAL . 6.2 m-85 -97.24 164.79 12.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.21 156.8 16.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.754 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.94 52.32 26.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.503 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' B' ' 107' ' ' LEU . 0.0 OUTLIER -63.52 121.37 69.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' B' ' 103' ' ' TRP . 79.4 Cg_exo -46.07 162.34 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.175 1.917 . . . . 0.0 111.794 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -42.7 -64.2 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -45.77 64.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.498 ' CH2' HD21 ' A' ' 70' ' ' LEU . 11.6 m0 -52.86 -46.49 67.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.35 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.444 ' HB1' ' CA ' ' B' ' 110' ' ' SER . . . -61.48 -63.18 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.952 0.406 . . . . 0.0 110.666 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.6 mtp180 -51.24 -34.51 32.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.472 ' CD2' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -50.05 -58.12 6.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.873 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.28 -69.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.429 ' OE1' ' CG1' ' B' ' 112' ' ' ILE . 5.1 tt0 -79.03 -98.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 23.5 p -160.53 -35.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.444 ' CA ' ' HB1' ' B' ' 104' ' ' ALA . 0.5 OUTLIER -166.33 169.04 14.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 111.703 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' B' ' 99' ' ' MET . 8.0 p30 -68.2 67.89 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.646 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.488 HD11 ' N ' ' B' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.869 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.71 158.26 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.792 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 m -136.3 118.15 15.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' A' ' 76' ' ' ASP . 1.3 mp -126.41 149.39 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' THR . 12.1 mmtp -135.81 95.42 3.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.568 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.0 m -77.45 154.57 32.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.429 ' CA ' ' HE3' ' A' ' 16' ' ' LYS . 53.0 t -136.43 159.22 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.048 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 57' ' ' ASP . 12.5 p -100.86 159.12 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.53 129.04 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.035 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.74 139.86 4.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.448 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.4 m-20 -69.98 71.72 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 81' ' ' CYS . . . -156.73 -148.24 5.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.774 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -148.91 -35.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 20.3 t -47.7 -23.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -52.08 -105.22 0.01 OUTLIER Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.586 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE3' ' CA ' ' A' ' 7' ' ' VAL . 41.5 mttm -95.61 -56.05 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -44.26 -75.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.972 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 35.4 t -55.74 -39.68 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' ' CG ' ' A' ' 23' ' ' TYR . 5.1 tp -54.16 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.15 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD11 ' CD1' ' A' ' 40' ' ' TYR . 74.9 mt -39.89 -38.16 0.65 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.431 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -54.05 -69.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.149 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.418 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -91.31 -34.05 15.08 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CG ' ' CD1' ' A' ' 19' ' ' LEU . 4.2 t80 -72.6 -45.75 57.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.435 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 97.5 m -89.81 -85.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' B' ' 81' ' ' PHE . 3.3 t -54.56 -28.35 45.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.832 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 77.75 52.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 9.3 pttt -137.71 -166.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.537 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -127.72 170.54 10.06 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.577 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 81.9 Cg_exo -40.33 140.59 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.801 2.334 . . . . 0.0 112.706 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.61 -84.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE1' ' CG ' ' B' ' 86' ' ' HIS . 13.2 pt-20 -96.31 119.43 34.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.19 109.26 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.167 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -159.84 139.0 8.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' VAL . 95.4 Cg_exo -41.73 96.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.43 2.087 . . . . 0.0 111.904 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.431 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 3.1 m -47.1 89.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.273 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 HG12 ' CG ' ' B' ' 96' ' ' PHE . 58.2 t -95.18 -47.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.487 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 49.2 t80 -162.5 82.19 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.232 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 19.8 m-20 -83.01 124.91 30.86 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' CB ' HD11 ' B' ' 85' ' ' ILE . 44.7 t30 -107.89 154.28 21.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.845 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.38 168.91 23.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.225 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.21 115.28 29.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.51 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.441 ' HB ' ' CG ' ' B' ' 78' ' ' PRO . 1.4 m -139.8 130.04 30.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.303 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.5 m -125.79 112.4 15.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.078 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.66 116.94 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.07 0.462 . . . . 0.0 110.333 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.8 mtm -89.48 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.275 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.03 133.39 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.23 63.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.388 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 -24.35 26.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.648 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.6 151.9 59.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.56 169.71 18.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.651 2.234 . . . . 0.0 112.297 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.06 168.47 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.9 97.12 4.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tt -134.06 158.7 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.62 136.44 5.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.594 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 mp -93.42 103.02 15.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.83 0.348 . . . . 0.0 110.814 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 2.6 m-85 -84.62 128.34 34.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.435 ' HA ' ' CG1' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -91.22 174.43 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 111.222 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -162.39 146.45 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -27.62 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.64 -22.49 33.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.4 174.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -103.51 25.39 9.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.79 22.41 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 -4.95 59.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.345 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.11 -30.41 0.75 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -42.25 42.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.381 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -93.53 21.79 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.799 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -83.73 -45.65 0.79 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.298 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 78.4 Cg_exo -46.91 -25.98 4.38 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.372 2.048 . . . . 0.0 112.115 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.521 ' CD1' ' CD1' ' B' ' 103' ' ' TRP . 2.6 mt -75.03 -28.43 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 3.6 p -86.77 -29.83 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.764 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CG ' ' O ' ' A' ' 71' ' ' SER . 2.4 p90 51.3 161.55 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.946 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.39 -22.53 29.08 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.125 . . . . 0.0 112.158 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -10.65 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.454 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' LYS . 12.1 t -44.68 -26.74 0.41 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.78 0.324 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 75.43 -154.08 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.593 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.64 156.71 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 1.1 p90 -129.39 161.57 30.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.42 ' CD1' HG12 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -103.97 160.4 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.329 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' LEU . 3.7 t -128.55 150.7 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.453 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 1.8 m -111.77 142.96 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.383 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 82' ' ' PHE . 51.1 p90 178.12 112.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.849 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.7 p -57.23 165.77 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.83 29.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.316 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 96.4 t -89.49 -78.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.05 117.83 67.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 52.3 Cg_exo -54.35 -21.93 25.04 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.449 2.099 . . . . 0.0 112.475 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.16 -35.19 16.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 11.7 t -80.26 -35.68 35.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.164 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -45.89 -43.7 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.86 -61.43 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.4 m-80 -63.86 -42.06 97.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.483 HG12 ' CZ3' ' A' ' 97' ' ' TRP . 97.9 t -41.38 -48.2 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.903 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 1.2 tppt? -83.59 -52.33 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 8.02 5.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.9 tttp -128.26 -39.39 1.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.483 ' CZ3' HG12 ' A' ' 93' ' ' VAL . 52.2 m0 -94.92 -28.61 15.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.7 t -65.47 -44.44 66.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.728 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.4 Cg_exo -49.82 -35.11 38.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.153 1.902 . . . . 0.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -11.9 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 16.7 tt -45.74 -31.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.746 0.307 . . . . 0.0 111.548 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 p -81.77 -27.44 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -64.41 -37.72 88.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -51.09 9.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 15.9 p -82.93 141.6 43.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.16 -45.83 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.629 2.219 . . . . 0.0 112.214 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 172.61 56.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.09 163.78 47.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.469 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 52.1 Cg_exo -52.33 164.22 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.609 2.206 . . . . 0.0 112.326 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 14.1 p90 -132.37 137.23 47.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 80' ' ' VAL . 4.9 mt -110.23 121.39 45.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -106.41 128.93 54.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.3 m -128.05 147.71 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.116 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . -167.21 122.58 1.06 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.275 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.429 ' HB ' ' CA ' ' A' ' 158' ' ' SER . 78.1 p -157.66 153.53 26.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 111.439 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.441 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER 178.16 99.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.67 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.424 ' CG1' ' OG ' ' A' ' 158' ' ' SER . 33.1 mt -99.99 -29.79 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.13 -30.28 34.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.441 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -92.16 -46.04 7.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 111.562 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 34.4 ptt180 -45.65 -34.0 3.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 111.164 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.75 55.98 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 156.16 38.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.07 -56.25 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 m -64.03 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 94.8 m -49.15 -62.25 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.043 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -50.4 -41.25 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.37 -62.59 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -34.52 76.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 136' ' ' PRO . 0.5 OUTLIER -50.82 -26.0 5.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.358 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.6 59.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.867 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -78.76 -23.19 45.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 4.5 m120 -94.08 30.08 1.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 70.53 19.41 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.242 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.87 112.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 83.6 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.408 ' N ' HD22 ' A' ' 129' ' ' LEU . 28.4 Cg_endo -62.71 96.26 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.592 2.195 . . . . 0.0 112.12 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 5.6 mt -47.74 122.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.404 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -104.21 171.02 5.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.07 -22.45 39.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.725 2.283 . . . . 0.0 112.514 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -91.0 -28.65 17.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 137' ' ' ILE . 25.3 m -49.49 -59.39 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.054 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.18 -46.9 46.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.14 79.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -54.4 -46.71 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.29 -49.24 78.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . . . -64.86 -29.58 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -73.58 -40.54 63.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.94 -37.69 86.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 4.5 pp -82.12 -21.16 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 68.6 126.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.728 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 179.59 -159.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.138 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 12.1 p -44.36 -45.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 111.443 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.42 142.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.673 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 40.3 p90 -153.07 160.74 42.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.372 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -158.01 123.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.686 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.68 153.01 3.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.406 ' CB ' ' HD2' ' A' ' 163' ' ' LYS . 10.2 p -101.86 -173.83 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.968 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 1.6 p -88.44 174.4 8.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -47.94 178.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.907 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.416 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 mm? 59.01 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.967 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 159' ' ' ALA . 6.7 p -56.03 176.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -163.22 103.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.036 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 157' ' ' CYS . 1.8 mtpp -95.35 -24.69 16.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.49 79.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.532 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 12.9 mt -71.06 -41.68 70.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.432 ' NZ ' ' HA ' ' B' ' 76' ' ' SER . 0.1 OUTLIER -45.43 -27.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.543 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -60.64 -72.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.474 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 23' ' ' TYR . 13.2 p -47.49 -35.13 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.734 0.302 . . . . 0.0 111.087 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -73.23 -38.93 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -54.01 -42.05 68.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.208 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -80.46 -34.49 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.463 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.85 82.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.798 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.12 -27.24 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.914 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.65 -49.03 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.578 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.16 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.8 -21.92 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.1 41.67 1.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -51.43 -36.26 43.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.963 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 23.1 mm -144.1 142.59 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 166' ' ' LYS . 0.5 OUTLIER -138.45 134.52 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 133.67 76.25 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.618 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.441 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 49.3 Cg_exo -55.46 -53.06 6.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.447 2.098 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 45.3 m 59.71 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.026 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -56.13 108.67 0.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.689 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -141.84 -175.84 4.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.346 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -153.28 138.25 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.64 99.28 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.344 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -69.73 -77.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.485 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.436 ' CG2' ' HD3' ' B' ' 100' ' ' PRO . 1.2 mp -122.25 128.58 75.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . 0.446 ' CG ' ' OE1' ' A' ' 31' ' ' GLU . 3.0 p-80 -105.26 96.14 6.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' B' ' 99' ' ' MET . 24.6 t -84.59 149.45 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.674 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.07 24.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.165 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -108.7 129.14 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 41.6 t0 -140.29 130.84 25.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.85 20.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.015 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -45.87 -27.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.352 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -152.11 -39.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.41 7.64 2.15 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.291 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.58 -170.99 2.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.013 0.406 . . . . 0.0 110.688 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 2.9 m-85 -86.8 162.4 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 3.1 p -109.93 153.99 23.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.68 27.59 13.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.375 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.461 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.0 OUTLIER -77.15 141.36 66.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.295 . . . . 0.0 111.452 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.436 ' HD3' ' CG2' ' B' ' 85' ' ' ILE . 81.5 Cg_exo -39.56 138.46 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.848 2.365 . . . . 0.0 112.693 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.22 -60.38 2.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.161 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.93 -50.29 27.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.521 ' CD1' ' CD1' ' A' ' 70' ' ' LEU . 1.7 m0 -55.22 -55.21 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.223 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -55.7 -55.01 37.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.321 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 7.9 mtt-85 -49.61 -45.0 47.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.043 0.449 . . . . 0.0 110.649 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -54.99 16.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.97 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.433 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.62 -69.26 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.347 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' B' ' 110' ' ' SER . 0.0 OUTLIER -78.61 -94.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.383 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.435 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 17.6 p -160.78 -45.84 0.04 OUTLIER 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER -159.27 166.92 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.94 0.4 . . . . 0.0 111.876 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' B' ' 99' ' ' MET . 27.4 t-20 -63.79 75.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -89.12 140.63 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -107.14 128.81 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mm -120.14 118.0 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.2 mmtt -116.67 96.03 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.518 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.45 108.45 10.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 71' ' ' SER . 3.3 t -84.44 158.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.663 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.443 HG13 ' CB ' ' A' ' 16' ' ' LYS . 29.7 t -136.51 141.58 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.979 0.418 . . . . 0.0 111.828 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 ' N ' HG11 ' A' ' 8' ' ' VAL . 22.0 t -144.69 121.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.76 42.41 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.866 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -89.14 -48.36 7.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -160.23 1.71 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.176 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . . . -136.57 4.63 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 ' N ' ' HB3' ' A' ' 81' ' ' CYS . 61.9 t -47.76 -23.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -115.55 -61.59 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.753 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' CB ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -51.25 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -96.56 -68.98 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 8.2 m -48.02 -21.0 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 tm? -56.88 -74.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.651 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 19' ' ' LEU . 27.7 mt -63.49 -26.6 68.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.618 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -66.28 -44.34 91.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.865 179.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 m -94.81 -11.82 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.862 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 19' ' ' LEU . 3.9 m-30 -95.54 -67.67 0.84 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 112.112 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' B' ' 79' ' ' SER . 46.5 m -83.85 -81.22 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.22 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -48.84 -35.63 15.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.184 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 10.0 t-20 51.31 65.21 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.254 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' CE ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -147.95 -175.35 4.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.464 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -102.78 157.98 32.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.644 0.259 . . . . 0.0 110.609 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 79.2 Cg_exo -39.55 145.82 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.732 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -99.57 -82.27 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' ' CE1' ' B' ' 86' ' ' HIS . 8.0 pt-20 -102.06 118.29 36.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.4 t80 -70.05 110.49 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 92.0 t -158.96 138.34 8.35 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 36' ' ' VAL . 85.1 Cg_exo -44.85 91.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.307 2.005 . . . . 0.0 111.684 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' VAL . 88.2 m -51.92 87.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.505 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' B' ' 96' ' ' PHE . 45.8 t -82.32 -28.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 1.8 t80 -141.87 -64.37 0.43 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 37' ' ' PHE . 11.3 t0 52.75 104.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.17 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 25.0 t30 -107.21 156.59 18.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.452 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 0.1 OUTLIER -151.04 169.01 22.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.746 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.03 141.96 46.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -160.82 126.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -109.44 110.95 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 169' ' ' PHE . 24.5 t -98.6 119.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 39.6 mtm -84.96 99.79 11.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 51' ' ' TYR . 4.8 mt -103.17 89.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.703 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.74 17.01 55.62 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.212 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.94 35.07 8.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -136.22 137.84 25.69 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.81 157.7 60.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.545 2.163 . . . . 0.0 112.336 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -147.05 167.1 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.176 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -129.2 97.24 4.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.375 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 28.6 tp -112.87 155.98 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.333 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -158.34 121.65 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.312 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD11 ' CG2' ' A' ' 8' ' ' VAL . 3.7 mm? -75.94 105.63 7.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.881 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 7.4 m-85 -84.11 103.23 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -72.35 120.9 18.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.702 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.455 HG21 ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -136.66 170.39 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.414 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -124.1 -40.51 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.73 47.94 88.47 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.501 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -40.13 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 165.78 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.546 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 66' ' ' ARG . 52.6 p30 -86.99 -22.59 25.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CD1' HG21 ' A' ' 58' ' ' THR . 28.3 m-85 -67.02 -21.37 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.168 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -48.02 -26.05 1.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.244 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 3.6 ptp180 -93.98 -27.87 16.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -103.21 18.1 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -93.05 -30.21 0.3 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -55.62 -20.81 28.82 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.53 1.487 . . . . 0.0 111.899 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' B' ' 103' ' ' TRP . 0.8 OUTLIER -72.81 -25.98 61.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 18.8 m -101.58 -21.46 14.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 55.31 104.87 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.51 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 34.1 Cg_endo -64.69 -23.66 63.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -88.0 -9.92 51.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.345 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -37.53 -53.69 1.17 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -169.92 -88.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 111' ' ' LEU . 9.9 p -128.21 163.72 31.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.683 0.278 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 5.6 m-85 -111.85 138.52 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.03 143.17 33.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.522 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 111' ' ' LEU . 2.9 t -132.3 153.05 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.797 0.332 . . . . 0.0 111.268 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.464 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -144.4 132.57 21.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.427 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.28 164.89 36.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.806 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -62.83 180.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 ' CA ' HG23 ' A' ' 137' ' ' ILE . 4.9 m -156.35 43.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.288 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 ' CG1' ' CB ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -154.13 -86.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -52.64 110.13 1.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.57 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.49 -15.95 44.5 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.024 . . . . 0.0 112.476 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.7 p -64.8 -23.65 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 p -95.95 -42.94 8.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -39.69 21.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 1.1 mm-40 -58.63 -55.56 33.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.8 m-20 -64.9 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 63.4 t -48.3 -67.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.69 -37.43 76.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.419 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 91' ' ' GLU . 28.7 mm-40 -74.05 -2.53 24.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -127.98 -35.02 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.412 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 60.4 m95 -88.7 -36.73 16.02 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 58.6 t -57.8 -46.3 99.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 85.9 Cg_endo -79.49 -21.5 8.73 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.558 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.58 -36.57 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.407 HD12 ' CG ' ' A' ' 110' ' ' PHE . 15.7 tt -50.62 -28.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.813 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -73.61 -38.46 65.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.573 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -56.63 -44.04 80.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 68' ' ' ARG . 1.7 t60 -88.87 -32.32 17.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.447 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 3.3 m -111.7 87.94 8.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.604 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 -78.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.46 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -126.78 48.1 2.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.85 139.51 35.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.748 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.61 165.26 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CE1' HD12 ' A' ' 149' ' ' LEU . 6.7 p90 -148.29 151.23 35.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.061 0.458 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD2' ' CD1' ' A' ' 154' ' ' TYR . 1.1 mp -125.6 119.73 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' CB ' ' HB ' ' A' ' 80' ' ' VAL . 1.4 pt? -135.14 119.58 17.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.645 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' CE2' ' A' ' 154' ' ' TYR . 10.1 p -156.57 111.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.885 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.47 169.12 40.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.668 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.9 t -174.82 137.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.863 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.432 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -166.72 84.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.741 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mt -77.39 -32.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -87.0 -23.68 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -95.86 -0.79 50.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.682 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' CB ' ' CG1' ' A' ' 85' ' ' VAL . 1.3 ptt85 -94.56 26.02 3.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.919 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.6 41.19 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.981 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.54 127.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.07 -44.18 49.37 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -57.45 -27.91 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -57.86 -68.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -49.42 -37.43 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.69 -66.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -34.16 72.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mt -50.15 -26.17 4.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.449 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.03 61.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.921 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -18.65 36.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.214 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.83 30.1 1.91 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.179 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt 73.77 29.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 58.93 -161.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.48 90.14 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.32 118.57 5.76 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.587 2.191 . . . . 0.0 112.312 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.434 HG23 ' CA ' ' A' ' 84' ' ' VAL . 7.2 mt -49.85 123.78 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.423 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -118.91 176.44 1.7 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.0 Cg_exo -54.17 -22.01 24.24 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.201 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -84.42 -36.27 22.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.7 m -51.51 -61.81 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -48.63 -45.72 38.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.433 ' HG3' ' CG1' ' A' ' 155' ' ' VAL . 2.4 tm-20 -57.39 -40.48 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.562 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -58.9 -34.34 71.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.536 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.84 -32.23 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.738 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.65 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -83.96 -35.22 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 43.0 m-20 -54.5 -61.51 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.479 HD12 ' CE1' ' A' ' 110' ' ' PHE . 3.4 pp -58.89 -18.1 30.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.304 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.91 80.84 0.07 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.939 0.4 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 149' ' ' LEU . . . -134.39 -173.72 3.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 88.9 t -47.54 -29.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 58.33 124.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.243 0.544 . . . . 0.0 111.686 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.536 ' CE2' ' CG1' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -153.79 126.09 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 19.8 m -97.23 131.88 43.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.766 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.477 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 2.5 pm0 -162.73 138.68 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.794 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 6.7 m -102.3 -174.59 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 p -88.47 165.29 15.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.012 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.53 -159.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.073 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.57 25.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -173.28 -72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.63 115.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.771 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -103.49 -68.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.09 96.08 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.512 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -93.61 -10.65 33.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.527 0.203 . . . . 0.0 111.371 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -34.29 54.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 110.065 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -66.44 -33.09 74.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 66.7 t -64.81 -63.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CZ ' ' CG ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -51.35 -32.29 25.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.9 -52.39 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.12 -28.31 4.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 169' ' ' PHE . 16.4 mm -94.78 -38.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.757 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.6 tt -54.96 -34.24 63.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.43 59.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.065 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mp -94.5 46.51 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.887 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.6 m -64.44 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.329 . . . . 0.0 110.802 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 tt -104.01 148.83 8.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -138.2 138.72 38.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 126.81 84.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.622 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.527 ' CG ' ' CZ ' ' A' ' 169' ' ' PHE . 9.0 Cg_endo -51.9 171.26 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 24' ' ' THR . 41.9 t -136.65 -67.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -51.49 95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.524 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.4 t80 -114.3 141.22 47.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.43 131.86 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 91.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.192 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.65 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.02 120.17 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . 0.443 ' CE1' ' O ' ' A' ' 31' ' ' GLU . 3.5 t-160 -103.98 96.56 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 44.6 t -79.86 155.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.04 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.437 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -146.48 178.26 24.27 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.236 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -85.97 112.76 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -103.76 98.24 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -0.08 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.029 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.47 -47.89 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.99 -21.81 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.433 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.25 12.73 6.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.554 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.83 -175.94 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.8 0.333 . . . . 0.0 110.815 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.53 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 4.1 m-85 -82.05 164.6 21.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.14 150.87 19.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.66 28.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.457 ' HE3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -57.77 125.6 73.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.549 0.214 . . . . 0.0 110.974 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' B' ' 103' ' ' TRP . 69.6 Cg_exo -49.85 152.95 6.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.04 1.826 . . . . 0.0 111.595 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 8.4 pt-20 -43.32 -48.46 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 111.517 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -78.95 -52.95 7.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.548 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 4.9 m0 -50.12 -51.06 46.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.419 0.628 . . . . 0.0 110.052 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -61.93 -55.57 28.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.78 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 76.0 mtt180 -53.76 -44.44 70.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.428 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -48.85 -57.5 6.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -95.23 -68.86 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.295 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.457 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.9 tp60 -77.71 -101.6 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.353 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 4.1 p -168.16 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.684 0.278 . . . . 0.0 111.447 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.51 174.2 11.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.129 0.49 . . . . 0.0 111.836 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -68.56 84.98 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.096 -179.488 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.24 126.8 54.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.752 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -94.1 150.9 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 pt -155.87 147.07 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.048 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.83 115.38 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.09 154.36 31.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.31 144.95 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.421 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 57' ' ' ASP . 7.2 p -118.78 136.02 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -127.08 122.88 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.95 168.81 12.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.86 129.89 55.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' CA ' ' HB2' ' A' ' 81' ' ' CYS . . . 163.89 -27.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . 84.76 -41.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 16.0 t -48.42 -23.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.67 0.271 . . . . 0.0 111.667 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -56.71 -114.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.11 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -96.15 -65.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -34.2 -73.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -52.67 -36.56 57.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.39 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' HG ' ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -49.7 -70.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 40' ' ' TYR . 1.3 mm? -40.61 -37.21 0.69 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' HG21 ' A' ' 25' ' ' THR . 6.6 mm -52.37 -69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 159' ' ' ALA . 5.7 t -88.33 -50.71 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.471 0.653 . . . . 0.0 110.448 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CD2' ' CD1' ' A' ' 165' ' ' LEU . 21.9 t80 -46.13 -49.86 16.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.548 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.436 ' CG2' ' CG1' ' A' ' 42' ' ' VAL . 52.3 m -96.71 -89.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.6 OUTLIER -55.28 -26.16 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.2 t-20 70.59 58.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 10.1 pttt -134.84 -161.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.435 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -132.57 148.83 71.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.286 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 75.4 Cg_exo -39.34 133.72 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.758 2.306 . . . . 0.0 112.72 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -84.88 0.51 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.64 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.316 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.49 97.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.158 0.504 . . . . 0.0 111.041 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.5 p -154.33 137.34 10.22 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.815 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 36' ' ' VAL . 62.6 Cg_exo -36.55 89.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.876 2.384 . . . . 0.0 112.645 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 33' ' ' VAL . 58.4 m -53.54 89.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.013 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG13 ' CG ' ' B' ' 96' ' ' PHE . 3.3 t -79.14 -25.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 5.1 t80 -149.14 -70.85 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.7 m-20 63.28 130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.47 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 6.6 t-20 -108.01 157.77 17.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.104 0.478 . . . . 0.0 111.359 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 m-85 -152.78 160.31 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.078 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.22 126.67 50.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.49 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' CG1' ' CB ' ' B' ' 78' ' ' PRO . 1.5 m -148.94 140.05 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.101 0.477 . . . . 0.0 111.895 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.2 m -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.894 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.21 123.13 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.212 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.418 ' HE1' ' CB ' ' B' ' 76' ' ' SER . 12.6 mtm -90.7 100.08 12.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.17 105.27 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.93 15.11 76.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 38.41 4.82 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.775 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -141.69 124.2 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.496 0.189 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.96 161.54 15.44 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.624 2.216 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.23 165.15 30.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.6 112.56 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.423 ' CD2' ' HG ' ' A' ' 55' ' ' LEU . 4.6 tt -119.86 138.46 53.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -126.33 102.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.214 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -83.98 149.69 26.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.411 . . . . 0.0 111.4 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 15.3 m-85 -138.93 116.79 11.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.679 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 4.2 t70 -69.91 152.75 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.474 HG23 ' CE1' ' A' ' 104' ' ' HIS . 1.6 m -157.54 128.85 6.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.33 33.84 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.409 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . 48.18 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.27 -169.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.894 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.88 -25.77 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.15 -23.4 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 68' ' ' ARG . 4.3 m-85 -64.47 -12.6 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -40.3 -44.97 2.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.788 0.328 . . . . 0.0 111.586 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' B' ' 107' ' ' LEU . 0.0 OUTLIER -73.41 -35.56 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.498 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD2' ' CZ3' ' B' ' 103' ' ' TRP . 11.1 tp -90.38 10.53 24.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.117 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 1.6 tmt_? -82.93 -63.82 0.26 Allowed Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 68' ' ' ARG . 4.2 Cg_endo -46.59 -26.73 4.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.412 2.075 . . . . 0.0 111.756 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.511 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 8.5 mp -54.28 -39.51 66.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.581 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.466 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 88.3 p -92.49 -15.28 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 61.26 139.93 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.696 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.66 -45.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -10.27 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.549 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 76' ' ' ASP . 10.3 t -40.4 -48.45 2.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER 171.51 -167.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.784 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 111' ' ' LEU . 11.9 p -58.26 162.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.517 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' SG ' ' A' ' 105' ' ' CYS . 16.4 m-85 -112.01 143.2 43.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -103.5 145.88 29.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.101 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 113' ' ' VAL . 3.9 t -131.65 151.35 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.944 0.402 . . . . 0.0 111.482 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.474 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -121.28 103.55 9.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.697 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 112' ' ' LEU . 25.0 p90 -128.87 123.01 31.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.443 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.462 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -130.73 -74.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.268 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' CG1' ' CG2' ' A' ' 125' ' ' THR . 22.6 t -50.5 -70.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.02 100.86 0.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.954 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.6 -21.74 65.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.642 2.228 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -48.15 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 p -77.84 -37.45 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 84' ' ' VAL . 2.3 t80 -50.97 -66.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -41.52 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -60.99 -65.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.442 ' CG1' ' CB ' ' A' ' 82' ' ' PHE . 93.0 t -40.68 -41.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.906 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -60.78 -69.69 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.48 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -80.9 8.34 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.59 -43.03 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -95.41 -37.1 11.09 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.2 t -50.02 -58.3 9.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 21.1 Cg_endo -60.67 -22.04 71.49 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.171 1.914 . . . . 0.0 112.031 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -32.05 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.454 HG23 ' CG ' ' A' ' 110' ' ' PHE . 22.1 mt -49.84 -26.51 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 p -74.55 -36.87 63.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -63.74 -38.42 91.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.776 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.474 ' CE1' HG23 ' A' ' 58' ' ' THR . 6.5 m-70 -95.76 -24.38 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 2.9 m -121.53 97.77 46.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.749 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.49 -61.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.585 2.19 . . . . 0.0 112.414 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.24 32.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 161.31 26.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.87 129.35 24.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.53 2.153 . . . . 0.0 112.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CG ' HG23 ' A' ' 101' ' ' ILE . 12.8 p90 -118.1 124.74 48.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.431 ' CD1' ' HB ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -96.85 119.5 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.447 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.495 ' HG ' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp -97.94 102.05 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' HA3' ' A' ' 15' ' ' GLY . 26.8 m -106.77 139.1 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 111.271 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -165.31 144.08 8.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 173.17 151.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -167.76 94.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.81 -27.4 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.724 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' CB ' HD11 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -96.36 -48.07 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 111.45 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.28 -59.33 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.084 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.439 ' HB3' ' CG2' ' A' ' 85' ' ' VAL . 33.5 mmt180 -66.97 -174.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 5.7 m-20 81.9 39.49 0.05 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -96.58 169.68 8.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.716 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.71 -19.41 24.25 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.5 t -84.38 -46.69 11.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.444 ' CG2' ' CG1' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -48.83 -60.84 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.031 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -50.83 -40.62 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.15 -46.03 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -83.76 -35.98 23.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.95 -26.51 4.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.51 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.52 65.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -78.41 -47.39 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.52 -26.33 68.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.99 52.37 9.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 1.4 tt0 -128.55 -86.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 134' ' ' GLN . 2.5 mtmt 166.72 161.34 0.11 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.686 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.33 100.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.468 2.112 . . . . 0.0 112.159 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 5.8 mt -48.67 119.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -111.08 177.08 1.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -55.13 -20.52 24.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.434 2.089 . . . . 0.0 112.219 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -80.06 -45.4 18.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.424 ' CG2' HG22 ' A' ' 137' ' ' ILE . 97.8 m -53.38 -45.54 69.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.93 -42.68 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.61 -37.22 86.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.724 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -53.98 47.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.96 -42.38 84.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.43 -41.96 66.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.092 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -45.43 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.99 -42.48 99.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.3 pp -80.09 -26.48 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 0.8 OUTLIER 67.04 118.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.984 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -160.03 -161.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 15.7 t -70.62 -7.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.19 140.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 110.791 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 146' ' ' ALA . 3.0 p90 -152.71 148.29 27.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 111.454 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -158.47 124.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.832 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.87 149.62 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 2.6 p -108.27 -174.58 2.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -86.16 159.6 19.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' O ' ' CD1' ' A' ' 160' ' ' LEU . . . -55.21 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.474 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 68.78 -62.67 0.38 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.126 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.47 -68.83 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.277 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.87 118.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.711 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -105.53 -68.27 0.88 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.075 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.08 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -86.44 -10.19 54.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.643 0.259 . . . . 0.0 111.196 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -45.63 30.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.735 0.302 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -58.8 -62.88 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 165' ' ' LEU . 7.4 p -47.75 -26.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.19 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -50.43 13.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.372 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -49.96 -29.28 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.15 -39.76 22.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.048 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.72 -22.31 43.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.96 -30.17 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.175 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.74 -26.09 37.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.69 65.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.89 -27.2 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.63 -30.66 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -50.73 63.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.96 151.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.418 ' CB ' ' HE1' ' A' ' 45' ' ' MET . 16.1 t -135.09 137.62 43.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.414 ' CD2' ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -67.48 141.5 95.59 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.806 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.472 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 Cg_exo -51.64 166.41 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.177 . . . . 0.0 112.28 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 81' ' ' PHE . 0.4 OUTLIER -139.56 -66.57 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.68 86.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.523 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 9.1 t80 -108.61 134.26 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.66 111.98 3.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.486 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 83' ' ' HIS . 27.2 p-80 -68.37 109.4 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.059 0.457 . . . . 0.0 109.943 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 1.5 p -77.17 -62.57 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.786 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -121.9 143.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.764 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.65 96.57 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 25.1 t -78.21 149.08 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 87' ' ' VAL . . . -146.24 177.63 24.47 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.352 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.22 129.62 47.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.439 ' CB ' HG22 ' B' ' 97' ' ' THR . 68.3 t0 -137.89 132.19 32.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 1.37 19.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.142 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -45.44 -27.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 120.912 0.387 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 13.2 t -153.41 -42.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.58 34.26 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.418 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.28 175.44 10.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 110.46 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.474 ' CG ' HG13 ' A' ' 36' ' ' VAL . 2.2 m-85 -71.98 160.48 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.561 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.439 HG22 ' CB ' ' B' ' 90' ' ' ASP . 16.9 p -104.76 156.27 18.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.166 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.53 39.57 74.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 123.34 19.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.537 0.208 . . . . 0.0 110.675 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.438 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 84.7 Cg_exo -46.75 154.54 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.275 1.983 . . . . 0.0 112.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -45.57 -48.27 14.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.282 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.39 -55.7 5.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.535 ' CZ3' ' CD2' ' A' ' 67' ' ' LEU . 2.2 m0 -48.54 -53.36 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -57.68 -61.93 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.239 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 43.4 mtt85 -48.04 -45.23 31.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HG ' ' HG ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -48.33 -57.88 5.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -94.81 -67.73 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.107 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.436 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.9 tp60 -77.39 -99.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 2.9 p -166.58 -40.22 0.02 OUTLIER 'General case' 0 C--N 1.338 0.084 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.66 176.51 11.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.993 0.425 . . . . 0.0 111.473 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.73 72.73 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.81 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 111.178 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 68.68 129.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.09 149.63 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 76' ' ' ASP . 21.5 mt -140.48 153.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -129.56 96.22 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 37.4 t -81.36 107.96 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 58' ' ' THR . 58.2 t -84.27 154.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 16' ' ' LYS . 2.4 t -140.5 139.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 104' ' ' HIS . 3.0 m -133.02 156.12 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.068 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . 147.63 178.54 22.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.647 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -25.46 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.71 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.01 -24.13 49.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.355 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.404 ' C ' ' HB2' ' A' ' 18' ' ' CYS . . . 70.02 7.58 6.29 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' N ' ' HB3' ' A' ' 81' ' ' CYS . 16.1 t -49.04 -24.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 111.251 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -107.77 -43.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.541 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -67.35 -74.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.776 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.432 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -97.68 -52.94 3.58 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.424 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -55.29 -25.59 35.09 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 1.6 tm? -56.47 -73.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.423 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 HD13 ' CD2' ' A' ' 40' ' ' TYR . 18.7 mt -63.24 -25.36 68.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 110.553 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 1.1 mp -62.9 -47.29 93.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.858 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 82.8 p -94.13 -17.32 22.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.558 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 3.7 m-30 -88.22 -66.8 0.88 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.002 0.429 . . . . 0.0 112.047 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -89.04 -83.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.182 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.512 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -42.77 -44.32 4.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.448 ' N ' HG21 ' A' ' 25' ' ' THR . 16.6 t-20 64.42 41.65 5.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HD2' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -131.99 141.42 49.27 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.475 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -63.63 164.33 16.47 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 70.9 Cg_exo -38.21 150.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.952 2.434 . . . . 0.0 113.078 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 t -108.96 -83.1 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.24 114.59 26.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.637 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.33 107.88 5.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 6.5 p -160.63 139.44 7.65 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.29 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' VAL . 80.8 Cg_exo -39.45 93.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.568 2.179 . . . . 0.0 111.874 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 m -48.09 87.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.781 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.475 HG12 ' CG ' ' B' ' 96' ' ' PHE . 92.2 t -89.77 -35.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 60.8 t80 -170.86 119.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.777 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 3.2 m-20 -119.44 138.27 53.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.425 ' C ' ' CG ' ' A' ' 40' ' ' TYR . 8.7 t-20 -106.65 157.6 17.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.173 0.511 . . . . 0.0 111.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.472 ' CD2' HD13 ' A' ' 20' ' ' LEU . 1.2 m-85 -152.89 161.9 41.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.64 117.75 30.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.48 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HB ' ' CG ' ' B' ' 78' ' ' PRO . 23.8 m -136.6 167.75 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.393 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.8 m -156.39 85.98 1.0 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.874 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.1 m -98.6 176.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -140.46 157.34 45.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.183 0.516 . . . . 0.0 111.565 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -129.82 88.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.139 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.4 74.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.483 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.93 -34.37 3.29 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.025 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.88 133.28 76.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.662 0.231 . . . . 0.0 111.202 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 174.57 4.87 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.594 2.196 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.469 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -153.5 155.06 35.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.6 97.06 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.4 pp -134.17 161.03 36.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -140.66 138.06 8.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.307 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 19' ' ' LEU . 3.8 mp -75.7 107.18 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.09 102.99 12.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -73.4 144.11 46.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.302 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.482 HG23 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.51 179.42 9.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.32 163.36 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 43.7 1.62 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.72 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.622 0.249 . . . . 0.0 110.843 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 174.48 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.791 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.66 42.82 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.482 ' CD2' HG23 ' A' ' 58' ' ' THR . 4.4 m-85 -106.42 -24.62 12.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.673 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -45.76 -34.39 3.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.048 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -51.94 -36.05 47.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.988 0.423 . . . . 0.0 110.483 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.536 ' CD1' ' CE3' ' B' ' 103' ' ' TRP . 2.5 mt -96.01 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.386 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.3 mtt180 -56.76 -71.15 0.28 Allowed Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.563 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 33.9 Cg_endo -64.18 -29.42 64.74 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.059 1.839 . . . . 0.0 110.649 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 9.8 mp -52.43 -24.79 8.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -155.72 33.18 0.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.455 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -35.23 151.03 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.985 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -75.67 -32.01 4.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.895 2.397 . . . . 0.0 112.606 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -57.6 -17.84 16.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.701 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -46.74 -52.89 12.95 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.592 0.234 . . . . 0.0 111.396 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.0 OUTLIER 176.99 -159.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.062 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.98 163.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.619 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 6.0 m-85 -115.62 132.69 56.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 0.0 110.863 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 13.3 tp -103.66 143.54 32.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.115 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 113' ' ' VAL . 2.6 t -133.75 150.66 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.438 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -125.06 153.38 42.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -162.24 158.72 24.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.93 164.26 25.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG11 ' CG2' ' A' ' 137' ' ' ILE . 60.6 t -147.08 55.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 120' ' ' ARG . 68.9 t -151.9 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.426 ' N ' HG11 ' A' ' 85' ' ' VAL . 5.8 m -66.77 150.16 97.83 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 0.0 110.73 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 72.1 Cg_endo -77.39 -36.63 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.588 2.192 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 p -53.13 -38.9 63.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 -24.92 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CD1' HD11 ' A' ' 137' ' ' ILE . 2.2 t80 -69.91 -61.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -26.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.2 m-20 -75.58 -60.96 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.501 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 12.7 m -47.55 -27.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.669 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 23.3 tttt -78.47 -61.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 8.37 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.995 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 6.7 ttpt -114.37 -37.82 4.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.635 0.255 . . . . 0.0 111.34 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 19.0 m95 -95.3 -42.12 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.604 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.5 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.2 t -53.57 -43.63 96.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.8 Cg_exo -73.88 -31.4 8.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 112.499 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.11 -33.07 24.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 12.9 tt -48.61 -29.31 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.43 ' N ' HG21 ' A' ' 101' ' ' ILE . 7.7 p -66.62 -42.69 86.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.652 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -63.18 -33.0 74.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.472 ' CD2' HG12 ' A' ' 9' ' ' VAL . 12.4 m80 -79.76 -31.33 40.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 108' ' ' THR . 18.6 p -130.68 122.39 19.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 48.0 Cg_exo -55.63 -64.92 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.489 2.126 . . . . 0.0 112.351 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -156.7 31.46 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 105' ' ' CYS . 1.8 t -97.25 150.03 36.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.05 144.65 27.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.802 2.335 . . . . 0.0 112.14 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -121.92 157.33 31.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' VAL . 8.1 mt -127.66 145.25 50.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.474 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 5.7 mt -120.34 159.4 25.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.512 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 80' ' ' VAL . 10.8 m -156.11 106.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.909 0.385 . . . . 0.0 111.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.5 128.15 6.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.39 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.421 ' HB ' ' N ' ' A' ' 158' ' ' SER . 48.3 p -153.79 142.91 21.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 111.192 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.412 ' HG2' ' CD1' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -178.84 36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.868 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.441 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 5.4 pt -56.24 -21.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.266 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' CB ' HD11 ' A' ' 160' ' ' LEU . 9.9 t0 -96.09 -26.04 15.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' CD1' ' HG2' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -65.72 -56.53 11.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' CB ' HG12 ' A' ' 85' ' ' VAL . 7.0 tmm_? -46.68 100.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.84 -44.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.86 132.12 66.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.07 -36.57 96.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.422 2.082 . . . . 0.0 112.231 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.9 m -49.24 -45.04 44.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.987 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -53.77 -59.86 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.4 mp -60.16 -40.61 84.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.958 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.58 -61.67 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 2.0 ttpp -73.05 -36.01 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 136' ' ' PRO . 10.5 mt -50.29 -25.92 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.88 -20.75 57.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -91.22 -37.08 13.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.0 -27.66 66.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -78.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 179.14 -46.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 150.15 65.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 50.7 Cg_exo -53.58 174.38 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.615 2.21 . . . . 0.0 112.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.453 HD11 ' CD1' ' A' ' 90' ' ' PHE . 5.9 mt -92.5 122.62 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.2 p -110.81 167.71 8.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 81.9 Cg_exo -47.84 -25.44 6.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -46.72 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 m -52.16 -51.35 58.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.02 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.022 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.7 -35.29 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.73 94.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.12 -45.52 84.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -25.59 66.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.37 -64.04 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD13 ' N ' ' A' ' 150' ' ' LYS . 3.9 pp -51.32 -25.19 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.411 ' N ' HD13 ' A' ' 149' ' ' LEU . 11.0 mttp 65.59 108.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 149' ' ' LEU . . . -145.64 -161.01 1.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 92.8 t -60.93 -20.11 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.316 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 78.25 137.99 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.166 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 50.0 p90 -153.2 166.27 33.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.25 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 154' ' ' TYR . 28.2 m -158.36 124.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.818 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.77 152.52 3.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.8 p -111.18 -173.64 2.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.441 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 11.1 t -87.79 156.49 19.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.73 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.207 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.41 HD11 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 53.36 25.09 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.95 -65.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.469 ' NE2' ' CD1' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 64.74 122.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.35 -67.96 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 100.17 0.16 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.396 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.469 ' CD1' ' NE2' ' A' ' 162' ' ' GLN . 4.8 mt -93.68 -10.68 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.542 0.211 . . . . 0.0 111.539 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.44 -28.05 1.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.383 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -78.4 -60.9 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.045 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 169' ' ' PHE . 7.7 p -50.01 -41.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -69.49 -40.84 76.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -50.27 -53.03 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.07 -51.54 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.05 -30.69 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.237 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.48 HD13 ' CD1' ' A' ' 169' ' ' PHE . 5.9 mt -91.76 -24.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.9 tp -80.33 -52.58 7.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -31.29 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.306 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.26 66.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.271 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.414 ' CD1' HG13 ' A' ' 46' ' ' ILE . 2.2 mp -90.34 48.28 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -117.6 -53.91 2.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mm -104.02 144.23 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.69 153.08 48.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.202 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.91 135.79 28.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.639 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.434 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 52.5 Cg_exo -54.21 -172.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.562 2.174 . . . . 0.0 112.205 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 60.4 p -162.56 -53.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.548 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.5 62.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.403 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.512 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.0 t80 -81.32 131.02 35.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -153.59 120.06 5.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.18 102.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.425 ' OG1' ' CD1' ' B' ' 85' ' ' ILE . 0.6 OUTLIER -77.53 -60.77 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.592 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.425 ' CD1' ' OG1' ' B' ' 84' ' ' THR . 1.0 OUTLIER -120.69 134.61 63.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.934 0.397 . . . . 0.0 111.971 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -120.88 96.5 5.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.623 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 47.1 t -79.95 148.05 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.752 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.412 ' N ' HG11 ' B' ' 87' ' ' VAL . . . -144.77 177.76 23.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -95.94 131.93 41.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.41 120.18 13.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.32 -0.66 26.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.72 -26.51 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.282 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.9 t -149.05 -41.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.082 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.97 25.98 0.87 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.672 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.76 -162.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.74 0.305 . . . . 0.0 110.546 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CG ' HG12 ' A' ' 36' ' ' VAL . 1.2 m-85 -100.25 164.2 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.22 167.12 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.11 33.61 22.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.441 ' CB ' ' HB3' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -47.21 109.04 0.98 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.501 0.191 . . . . 0.0 110.709 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 97.0 Cg_exo -40.19 153.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.7 2.266 . . . . 0.0 112.811 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -45.34 -57.9 3.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.194 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.49 -54.19 36.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.536 ' CE3' ' CD1' ' A' ' 67' ' ' LEU . 4.7 m0 -49.21 -63.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 0.0 110.788 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' B' ' 110' ' ' SER . . . -47.49 -70.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.765 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 3.9 mtp180 -44.62 -37.07 3.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.436 ' CD1' HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -50.37 -56.18 12.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.134 179.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.464 ' CD1' ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.42 -70.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.43 ' O ' ' CG2' ' B' ' 109' ' ' THR . 4.8 tt0 -79.98 -99.06 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 29.9 p -160.35 -35.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.442 ' N ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -161.66 -173.42 3.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.018 0.437 . . . . 0.0 111.951 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' B' ' 100' ' ' PRO . 0.3 OUTLIER -84.79 81.86 8.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.83 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 121.614 0.721 . . . . 0.0 111.349 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.824 0.345 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 63.31 117.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.42 169.34 8.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.405 ' CG2' ' OD2' ' A' ' 76' ' ' ASP . 2.5 pt -160.23 134.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.41 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mptt -125.53 147.79 49.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -133.48 134.48 43.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -115.21 151.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 58' ' ' THR . 9.2 p -93.24 160.87 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 104' ' ' HIS . 7.3 p -152.61 129.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 174.21 17.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.78 84.66 2.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 81' ' ' CYS . . . -171.9 -147.21 5.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 18' ' ' CYS . . . -178.95 32.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.492 ' CG1' ' HB2' ' A' ' 81' ' ' CYS . 3.3 p -81.32 4.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -84.04 -103.89 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.286 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HE2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 ttpm? -97.38 -13.2 21.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.32 -74.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -74.16 -34.88 63.98 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.089 -0.382 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.551 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.11 -74.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.584 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.471 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 18.2 mt -47.93 -42.27 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.876 0.37 . . . . 0.0 111.067 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.479 HD12 ' CE2' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -49.13 -68.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.42 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -93.18 -56.99 2.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.551 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 4.1 t80 -50.12 -26.8 4.85 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 84.9 m -113.82 -91.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.925 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 4.1 t -51.87 -24.22 5.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.964 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.94 52.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -132.5 -166.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.647 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -130.78 147.08 64.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.04 151.97 5.31 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.752 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 t -105.81 -80.54 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.7 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.51 105.95 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.4 p -160.55 138.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 36' ' ' VAL . 72.3 Cg_exo -39.21 92.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.689 2.26 . . . . 0.0 112.272 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' VAL . 1.4 m -50.25 91.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.197 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' B' ' 87' ' ' VAL . 1.9 t -81.86 -26.35 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CD2' ' CG ' ' B' ' 100' ' ' PRO . 9.3 t80 -148.63 -77.01 0.16 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.804 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 40' ' ' TYR . 59.0 t0 58.27 112.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 16.4 t-20 -106.33 159.62 15.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.005 0.431 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.487 ' CD1' ' HE2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -152.12 168.85 23.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.063 -178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.97 133.14 50.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' B' ' 78' ' ' PRO . 1.2 m -162.51 133.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.479 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.0 m -131.34 116.27 17.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' TYR . 4.0 m -98.08 117.19 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.052 0.453 . . . . 0.0 110.581 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -91.31 102.0 14.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' B' ' 74' ' ' SER . 9.7 mm -82.34 121.22 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.186 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.79 25.38 61.34 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.62 19.62 67.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.62 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -115.82 151.31 46.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.662 0.268 . . . . 0.0 110.795 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.56 139.55 64.64 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.584 2.189 . . . . 0.0 112.357 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.424 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -151.58 174.52 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.657 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.78 111.32 9.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.235 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.31 129.7 38.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.39 103.41 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.005 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.437 ' CD1' HD22 ' A' ' 20' ' ' LEU . 23.6 mt -125.83 154.46 42.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -144.56 125.94 14.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 15.0 t0 -67.66 161.83 24.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -168.73 157.73 8.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.79 -175.26 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.46 -145.72 4.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 mt 51.77 -162.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.91 52.4 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.18 28.25 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.34 -19.33 17.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -44.05 -29.21 0.57 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.789 0.328 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -56.72 -46.64 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.584 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' CD1' ' CZ3' ' B' ' 103' ' ' TRP . 40.5 mt -94.25 23.31 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 tmt_? -57.02 -57.86 21.75 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.99 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.8 Cg_endo -47.95 -22.3 3.32 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.641 2.227 . . . . 0.0 113.053 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -88.68 -15.02 35.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 17.3 m -108.04 -31.37 7.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 47.76 94.35 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 73.7 Cg_exo -49.51 -36.8 40.81 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.668 2.245 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.36 59.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.592 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 76' ' ' ASP . 14.7 t -41.32 -50.65 3.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.7 0.286 . . . . 0.0 111.629 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 75' ' ' THR . 0.6 OUTLIER 171.72 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.685 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.0 154.84 2.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 105' ' ' CYS . 0.7 OUTLIER -104.26 163.69 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.156 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -114.48 139.01 49.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 4.1 t -131.09 134.44 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.492 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 42.3 t -134.49 154.63 51.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 112.05 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 2.8 p90 -124.03 108.33 12.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.589 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.2 p -37.39 102.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.177 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.6 t 56.86 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.386 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -162.04 -81.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.562 0.22 . . . . 0.0 111.511 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m 54.27 102.25 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.516 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.18 -30.25 64.79 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.393 2.062 . . . . 0.0 112.322 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 p -71.72 -23.6 61.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.11 -22.6 19.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.448 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -48.92 -69.81 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.353 . . . . 0.0 111.032 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -51.74 -36.84 48.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 51.0 m-20 -64.04 -63.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.1 t -43.06 -32.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.717 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.43 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.0 -69.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.847 0.356 . . . . 0.0 111.417 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -80.25 8.04 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 15.3 tttt -115.09 -45.3 2.96 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -95.42 -38.46 10.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.2 t -51.64 -44.51 90.24 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.631 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.6 Cg_exo -55.92 -21.6 34.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 112.256 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.92 -31.18 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.125 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 98' ' ' VAL . 56.0 mt -48.14 -31.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.3 p -64.05 -34.84 78.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.633 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -72.78 -33.18 66.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.468 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 1.3 m-70 -79.17 -43.87 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 17.8 p -103.64 134.01 19.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_endo -83.86 72.91 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.386 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.0 26.38 15.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -107.85 142.15 24.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -51.46 172.23 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 6.7 p90 -148.57 138.7 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -95.26 119.51 33.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -97.9 121.84 40.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.436 HG21 ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.4 137.36 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.405 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.513 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -174.67 156.45 22.94 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.759 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 116' ' ' GLN . 1.4 t 173.45 177.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.113 0.482 . . . . 0.0 111.297 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.427 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -174.59 52.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.292 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 mt -37.11 -31.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.966 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -58.49 -64.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.614 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.409 ' N ' HD21 ' A' ' 119' ' ' LEU . 3.7 mm? -95.97 -23.97 16.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.688 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 7.3 tmm_? -41.9 -30.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.447 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 61.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.04 157.6 36.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.979 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.5 -34.79 34.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.679 2.253 . . . . 0.0 112.272 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.7 m -69.79 -45.82 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -57.05 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -61.19 -32.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -69.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 mt -50.34 -25.98 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.92 57.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.226 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 4.5 mmtp -87.1 -28.4 22.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.883 0.373 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.4 -18.2 57.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.236 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER 63.15 26.73 15.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.79 122.45 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -50.25 153.07 2.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.66 136.75 27.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 90' ' ' PHE . 5.2 mp -72.42 99.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.031 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.464 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -90.27 179.79 1.41 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.711 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 51.7 Cg_exo -53.11 -21.6 16.97 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.487 2.125 . . . . 0.0 112.326 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -38.09 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 19.3 m -52.35 -48.81 65.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.98 -60.07 3.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -52.53 -27.4 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.29 13.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.731 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 tp -54.77 -36.89 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.49 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -64.68 -39.74 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -58.74 -42.8 89.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -23.98 66.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.794 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' ALA . 3.7 pp -119.08 19.18 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.74 -85.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 59.79 179.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 43.0 t -67.83 -14.87 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.17 141.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.719 0.295 . . . . 0.0 110.492 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 146' ' ' ALA . 7.9 p90 -152.8 157.42 40.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 168' ' ' VAL . 1.2 m -158.1 122.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.476 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -172.42 150.65 2.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.4 ' SG ' ' CD ' ' A' ' 163' ' ' LYS . 72.1 m -102.15 -173.46 2.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.864 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 16.1 t -87.85 174.14 8.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 111.35 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -61.64 -175.87 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 65.03 -71.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' ALA . 35.8 p -69.11 -83.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 69.77 113.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.489 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.4 ' CD ' ' SG ' ' A' ' 157' ' ' CYS . 5.7 mttp -101.4 -67.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 111.222 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.77 88.18 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.527 ' CB ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -93.84 -15.24 25.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.546 0.212 . . . . 0.0 111.288 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -42.78 73.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.867 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -52.77 -64.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.9 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 155' ' ' VAL . 7.6 p -49.32 -29.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 173' ' ' ILE . 0.1 OUTLIER -59.01 -44.86 91.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.801 179.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 36.3 t0 -61.18 -37.5 83.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.019 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 0.2 OUTLIER -71.15 -22.27 62.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.576 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.44 -54.05 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.064 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 10.4 mt -63.46 -39.12 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 13.1 tp -76.5 -36.08 58.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.05 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -53.61 -46.46 70.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.24 57.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.069 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -53.97 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.022 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.799 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.431 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 2.8 m -50.53 -44.72 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 170' ' ' ASP . 0.7 OUTLIER -144.16 133.64 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.03 142.79 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -70.53 136.77 85.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 51.0 Cg_exo -54.43 154.4 19.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.516 2.144 . . . . 0.0 112.019 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.7 m -116.88 -83.29 0.64 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.394 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.79 99.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.49 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 13.8 t80 -123.19 129.46 51.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.23 142.31 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.0 102.51 1.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.613 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -86.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.438 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.432 HD11 ' CB ' ' A' ' 39' ' ' ASN . 1.1 mp -104.35 127.47 58.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 111.191 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -105.79 99.18 8.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 74.1 t -85.56 151.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.403 ' CA ' HG23 ' A' ' 33' ' ' VAL . . . -146.33 165.58 28.23 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.054 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.63 106.75 18.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.412 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 16.0 t0 -124.08 118.24 26.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.71 21.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.34 -27.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-O 121.027 0.441 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 95' ' ' GLU . 0.1 OUTLIER -152.11 20.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.981 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.92 68.45 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.038 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 10.2 pt-20 -132.41 164.89 25.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.079 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' A' ' 67' ' ' LEU . 7.4 m-85 -79.11 154.65 29.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.811 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 19.1 p -93.5 169.47 10.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.21 23.54 8.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.418 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.437 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -49.82 106.16 0.6 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.492 0.186 . . . . 0.0 110.959 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 67.2 Cg_exo -36.0 152.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 112.906 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -66.69 0.28 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.716 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.28 -52.0 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.075 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.515 ' CZ3' ' CD1' ' A' ' 67' ' ' LEU . 3.5 m0 -48.27 -62.5 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.127 0.489 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' B' ' 99' ' ' MET . . . -47.57 -69.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.546 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 0.6 OUTLIER -46.64 -38.5 9.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.421 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.424 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -49.48 -57.11 7.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.37 . . . . 0.0 110.568 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.3 -69.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.452 ' O ' ' CG2' ' B' ' 109' ' ' THR . 8.3 tp60 -79.18 -100.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.785 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.3 p -168.62 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.034 0.445 . . . . 0.0 110.736 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 170.58 15.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.212 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 99' ' ' MET . 10.9 m120 -54.31 -63.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.557 0.694 . . . . 0.0 109.37 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.8 91.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -89.86 159.51 16.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.25 136.96 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.262 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 4.4 mptt -118.91 96.41 5.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.22 97.36 4.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 12.7 t -84.45 111.26 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.77 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 10.7 m -105.43 129.57 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.39 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.49 138.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.98 120.52 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.649 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.86 -31.23 70.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.029 0.442 . . . . 0.0 110.488 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.12 83.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' CG2' ' A' ' 17' ' ' THR . . . 54.01 23.49 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.889 0.376 . . . . 0.0 111.032 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CG1' ' OG1' ' A' ' 115' ' ' THR . 45.3 t -91.19 -17.89 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.488 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . -130.2 -8.82 3.18 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.263 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' CG ' ' N ' ' A' ' 17' ' ' THR . 1.8 pttt -94.9 -57.59 2.4 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 5.2 t -96.59 -41.8 8.36 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.013 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 2.8 m -64.28 -25.93 68.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -42.75 -72.74 0.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.585 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 40' ' ' TYR . 16.4 mt -63.45 -33.81 76.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.152 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 25' ' ' THR . 0.8 OUTLIER -55.29 -43.72 72.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.146 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 -26.68 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.523 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 3.7 m-30 -80.73 -67.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' B' ' 81' ' ' PHE . 55.0 m -79.65 -83.03 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.487 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.525 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -50.53 -24.86 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.187 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.28 38.71 2.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.7 OUTLIER -114.24 -165.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.981 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -122.37 141.84 35.68 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.953 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 51.7 Cg_exo -34.86 136.44 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.209 2.606 . . . . 0.0 113.267 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -105.78 -84.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.442 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.73 95.34 5.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.203 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.48 105.91 1.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.229 0.537 . . . . 0.0 111.378 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.6 p -160.63 134.06 4.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.541 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.22 89.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.435 2.09 . . . . 0.0 112.221 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -72.98 86.65 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.113 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.485 ' CG2' ' CG1' ' B' ' 87' ' ' VAL . 22.9 m -68.09 -22.54 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.244 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 2.9 t80 -129.21 -76.2 0.55 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.569 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' OD1' ' CE1' ' A' ' 40' ' ' TYR . 32.8 t0 61.39 118.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.599 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.0 t-20 -107.49 148.98 28.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.576 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.471 ' CE1' ' OD1' ' A' ' 38' ' ' ASP . 1.2 m-85 -141.49 143.1 33.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.213 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.99 131.54 40.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.592 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' CG1' ' CB ' ' B' ' 78' ' ' PRO . 3.2 m -150.53 163.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.122 0.487 . . . . 0.0 111.618 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.3 m -155.73 101.41 2.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.001 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' B' ' 76' ' ' SER . 11.9 t -98.41 130.96 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.211 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 19.5 mtm -91.06 99.92 12.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.912 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -101.48 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.67 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.01 12.94 72.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.355 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.21 34.22 6.85 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.706 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -141.78 134.81 14.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.582 0.23 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.35 167.96 10.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.113 . . . . 0.0 112.287 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.81 168.49 26.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.8 p -135.24 97.4 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.505 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 9.8 tt -115.82 160.92 19.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -161.11 120.81 0.97 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 19' ' ' LEU . 10.0 mp -77.04 102.82 6.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.918 0.39 . . . . 0.0 110.927 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 9.8 m-85 -84.1 104.95 14.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' CG2' ' A' ' 58' ' ' THR . 40.0 m-20 -66.84 175.85 2.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.716 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.422 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 23.1 p -161.43 128.95 4.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 170.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.51 66.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.35 150.45 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.314 . . . . 0.0 110.918 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 34.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -116.7 20.54 13.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -78.38 -10.48 59.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.382 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -42.54 -30.64 0.37 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -79.55 -45.56 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 1.4 mp -95.18 25.27 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.448 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -98.02 -49.61 0.22 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.675 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 60.1 Cg_exo -51.41 -43.1 51.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 121.965 1.776 . . . . 0.0 111.838 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' B' ' 103' ' ' TRP . 1.0 OUTLIER -49.08 -24.57 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.246 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.482 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p -104.52 -20.65 13.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.336 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 60.38 139.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.895 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -47.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.584 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -69.23 -10.69 58.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.537 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.437 HG23 ' CG2' ' A' ' 7' ' ' VAL . 6.2 t -40.89 -52.21 3.09 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.17 -167.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.4 162.41 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 105' ' ' CYS . 15.0 m-85 -110.48 134.61 52.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER -104.31 120.33 40.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.16 153.76 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.488 ' HB2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -144.64 175.89 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 111.672 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -167.21 -176.05 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.703 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 115' ' ' THR . 24.9 t -135.07 44.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG12 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 177.38 -70.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -44.48 100.6 0.23 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.194 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.91 -36.4 83.53 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.667 2.245 . . . . 0.0 112.296 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 t -49.95 -32.37 14.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -96.0 -33.08 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CE1' HG12 ' A' ' 137' ' ' ILE . 1.4 t80 -55.76 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -48.86 -26.13 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' CA ' ' HG3' ' A' ' 96' ' ' LYS . 17.9 m-20 -73.2 -65.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.083 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.1 t -41.71 -33.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.829 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 9.2 ttpt -79.09 -62.38 1.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.17 7.79 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG3' ' CA ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -117.8 -41.57 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.821 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -95.23 -39.58 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.507 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 98.1 t -47.57 -43.31 49.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.632 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.8 Cg_exo -67.76 -31.85 31.25 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.525 2.15 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -93.13 -22.76 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.437 HD12 ' CG ' ' A' ' 110' ' ' PHE . 10.2 tt -47.05 -27.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 p -74.94 -40.14 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.25 -39.12 81.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 110.407 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 7.2 m-70 -93.73 -26.18 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -123.86 66.54 39.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.44 111.56 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.66 2.24 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.96 48.7 22.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.014 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 69.9 m -140.89 140.59 21.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.833 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.419 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 19.5 Cg_endo -58.4 169.98 2.7 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 0.0 111.914 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.437 ' CG ' HD12 ' A' ' 101' ' ' ILE . 3.1 p90 -159.84 137.72 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.411 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 mp -100.96 124.29 46.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.154 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.484 ' HG ' ' CZ ' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -134.71 102.12 5.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 154' ' ' TYR . 4.0 p -145.3 108.0 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 155.47 42.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.437 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 1.2 p -148.16 115.76 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -169.97 72.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 157' ' ' CYS . 24.9 mt -64.87 -62.52 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -50.93 -60.0 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.64 -48.37 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.439 ' CG ' HG12 ' A' ' 85' ' ' VAL . 22.0 ttp85 -50.34 -28.23 7.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.61 -15.46 61.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.485 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.84 143.83 38.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.757 0.313 . . . . 0.0 110.967 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.74 -45.02 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.0 m -49.25 -40.2 33.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -53.6 -63.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -50.97 -39.51 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.92 -63.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.09 -34.6 66.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 136' ' ' PRO . 1.2 mt -50.15 -26.28 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.959 0.409 . . . . 0.0 110.459 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.42 61.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.908 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.54 -16.66 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -93.63 29.59 1.98 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.16 33.64 2.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 50.04 -163.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.28 75.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 57.2 Cg_endo -70.69 169.14 20.83 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.697 2.265 . . . . 0.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 90' ' ' PHE . 4.0 mp -97.95 131.9 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.117 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.478 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -129.57 -179.24 0.96 Allowed Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.266 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 61.2 Cg_exo -52.14 -21.26 12.41 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.442 2.095 . . . . 0.0 112.496 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.0 -40.79 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.437 ' CG2' HG22 ' A' ' 137' ' ' ILE . 96.8 m -48.37 -47.24 37.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.184 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.89 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -32.0 73.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.414 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -55.43 -49.61 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.481 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.12 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.501 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.533 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -68.53 -49.07 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -63.46 -35.14 79.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -31.01 71.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.735 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.66 -20.12 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 146' ' ' ALA . 5.4 mmtm 63.13 93.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.55 -173.43 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 9.2 p -41.72 -45.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.606 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 112.81 139.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.589 1.18 . . . . 0.0 109.959 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -153.65 140.57 19.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.687 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 154' ' ' TYR . 34.7 m -158.47 125.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.666 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.429 ' CG ' HG12 ' A' ' 113' ' ' VAL . 3.4 pt-20 -161.02 174.15 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.652 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 16.9 p -135.23 -170.73 2.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.995 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 164.44 17.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.815 0.34 . . . . 0.0 110.506 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -40.72 -90.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.067 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.07 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.699 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 170.04 -66.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.647 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 43.73 96.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.604 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.84 -49.47 3.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.74 68.52 0.35 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.973 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.52 ' CD2' ' CD1' ' A' ' 23' ' ' TYR . 2.6 tp -93.02 -22.27 19.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 111.408 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -41.93 75.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.01 -65.21 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.67 -49.1 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.466 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 39.8 t80 -55.09 -43.79 74.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.639 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -53.09 -43.16 66.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 -44.82 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.818 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.83 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.925 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.458 HG13 ' CE2' ' A' ' 169' ' ' PHE . 19.6 mm -94.95 -30.2 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.36 -46.18 80.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.87 -26.24 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.216 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.56 63.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.69 65.96 6.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 60.23 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' B' ' 73' ' ' GLY . 8.5 tt -127.13 145.87 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.423 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.39 132.19 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 145.32 83.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.491 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 73.9 Cg_exo -50.49 -175.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.733 2.288 . . . . 0.0 112.545 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 73.4 m -153.72 -63.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.525 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.2 t80 -98.44 139.71 33.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.81 124.76 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.783 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.453 ' CD2' ' OD1' ' A' ' 38' ' ' ASP . 2.9 t-160 -68.21 78.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -50.51 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.98 -179.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -119.33 110.34 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -91.22 96.54 10.62 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.485 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 60.3 t -78.1 137.27 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.562 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.61 177.74 17.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.191 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -78.11 123.86 27.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 111.034 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -114.95 97.87 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.08 -18.68 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.585 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 p -45.37 -46.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 111.493 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -121.94 -10.74 8.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.687 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.58 18.92 21.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.309 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -124.47 -160.73 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.648 0.261 . . . . 0.0 110.708 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -98.34 164.32 12.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.46 167.94 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 47.84 33.83 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.373 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.447 ' HE3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.99 117.86 5.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.46 0.171 . . . . 0.0 111.179 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.438 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 92.4 Cg_exo -42.88 155.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.054 . . . . 0.0 112.294 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -47.77 -54.05 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -55.85 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.548 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 6.0 m0 -47.83 -57.54 5.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.73 -65.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.346 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' B' ' 109' ' ' THR . 3.7 mtt-85 -49.11 -44.52 42.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.43 -61.24 1.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -94.75 -68.79 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.273 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' B' ' 109' ' ' THR . 0.1 OUTLIER -78.45 -97.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.89 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 22.5 p -160.48 -55.06 0.05 Allowed 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -151.63 172.44 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 112.121 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' B' ' 99' ' ' MET . 7.2 p30 -64.37 75.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.537 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.483 0.658 . . . . 0.0 111.004 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.819 0.342 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.9 -171.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 135.63 36.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.982 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 pt -149.63 111.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -134.26 99.73 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.404 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 6.0 m -77.27 152.4 34.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.418 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 17.4 t -136.9 143.9 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.285 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 9' ' ' VAL . 6.5 p -85.01 160.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' N ' HG23 ' A' ' 8' ' ' VAL . 3.9 m -138.09 121.18 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.22 173.9 31.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.22 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -89.54 110.42 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.0 110.769 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -161.15 -39.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 83.45 -47.99 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 81' ' ' CYS . 18.5 m -47.07 -25.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 8' ' ' VAL . . . -56.33 -94.44 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.477 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' HE2' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -96.83 -71.57 0.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 18' ' ' CYS . 1.1 t -36.0 -58.42 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 17' ' ' THR . 10.9 m -68.94 -26.86 65.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.964 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 23' ' ' TYR . 3.0 tp -58.38 -76.85 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.819 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD13 ' CD1' ' A' ' 40' ' ' TYR . 12.9 mt -48.91 -33.35 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.856 -0.528 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD11 ' N ' ' A' ' 21' ' ' ILE . 1.2 mp -51.16 -68.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 t -93.33 -57.19 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.571 ' CE1' ' CD1' ' A' ' 169' ' ' PHE . 10.4 t80 -39.28 -39.89 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 62.7 m -104.72 -75.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.6 OUTLIER -71.22 -15.33 62.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 9.5 t-20 65.59 36.92 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 111.165 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tttp 176.6 164.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -134.22 60.97 47.64 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.69 0.281 . . . . 0.0 111.748 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 80.9 Cg_endo -91.63 126.56 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.064 2.51 . . . . 0.0 112.516 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.7 p 171.82 -88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.991 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.96 153.04 13.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.0 t80 -91.02 111.92 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 110.835 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.0 t -158.67 140.38 9.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.0 Cg_exo -46.61 91.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.262 1.975 . . . . 0.0 111.446 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' VAL . 54.5 m -52.9 87.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.544 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' PRO . 37.2 t -75.4 -25.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 109.898 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -148.29 -68.82 0.23 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.247 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 3.0 m-20 57.97 111.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.331 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 11.2 t-20 -107.96 148.82 29.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.08 142.15 25.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.599 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.22 152.17 25.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 24' ' ' THR . 1.2 m -162.43 148.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -132.09 104.81 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.31 117.23 41.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.5 . . . . 0.0 110.58 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.422 ' HE1' ' CB ' ' B' ' 76' ' ' SER . 3.8 mtm -100.23 100.01 10.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.947 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.3 tt -109.85 109.54 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.982 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.25 15.81 61.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.545 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.68 -43.01 1.94 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.616 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.61 142.91 66.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.293 . . . . 0.0 111.057 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.81 173.98 11.85 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.322 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -153.28 146.46 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -99.72 97.42 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' A' ' 173' ' ' ILE . 7.9 tt -112.33 156.5 22.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.994 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -151.99 112.33 0.53 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.354 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.407 ' CD1' HD22 ' A' ' 53' ' ' LEU . 3.6 mp -85.5 103.34 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 6.4 m-85 -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.35 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.17 166.36 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.7 m -169.32 128.59 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.544 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 64' ' ' TYR . . . -77.94 -73.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.69 -137.67 6.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 mt 71.73 -174.23 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -96.08 -16.89 21.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.393 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -76.34 -19.27 58.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.4 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.461 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -70.33 -16.79 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.542 0.21 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -48.04 -25.73 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -91.99 -40.95 10.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' CD2' ' CZ3' ' B' ' 103' ' ' TRP . 27.3 tp -86.78 1.13 53.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.51 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.01 -47.28 0.39 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.838 -0.164 . . . . 0.0 111.282 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 76.3 Cg_exo -49.08 -25.21 8.78 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.19 1.927 . . . . 0.0 111.411 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.502 ' HB2' ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -65.02 -28.15 69.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.497 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 22.5 m -100.15 -14.89 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.262 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 54.58 141.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 123.252 0.621 . . . . 0.0 112.03 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.99 -34.51 2.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -10.71 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.322 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 9.0 t -40.6 -47.88 2.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.572 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 1.3 m-20 169.06 -168.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 111' ' ' LEU . 12.2 p -58.29 141.97 14.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.448 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 105' ' ' CYS . 10.3 m-85 -92.9 143.7 26.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -103.68 115.94 31.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.219 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 110' ' ' PHE . 2.7 t -89.26 93.69 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.962 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.439 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 28.1 p -67.62 110.38 3.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.744 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' CD2' HG13 ' A' ' 93' ' ' VAL . 2.6 t80 -131.92 105.8 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.42 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -50.66 156.83 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 ' CG1' ' CG2' ' A' ' 137' ' ' ILE . 63.0 t -83.49 -75.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' CG1' ' HD3' ' A' ' 87' ' ' PRO . 97.9 t -69.26 -101.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.7 m 33.72 57.59 1.76 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD3' ' CG1' ' A' ' 85' ' ' VAL . 2.7 Cg_endo -46.06 -25.65 3.04 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.9 2.4 . . . . 0.0 112.362 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.39 -26.04 26.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 16.1 m -96.28 -38.78 9.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.254 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -45.17 -66.99 0.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.238 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 -55.55 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -54.17 -64.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.914 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' A' ' 82' ' ' PHE . 48.0 t -41.37 -36.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.813 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 25.1 tptp -63.2 -69.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.78 8.62 11.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tptp -117.43 -44.93 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -95.12 -28.19 15.2 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 24.5 t -70.03 -44.56 21.5 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.704 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.5 Cg_exo -51.06 -29.31 27.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.23 1.953 . . . . 0.0 112.57 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -93.11 -17.51 23.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.666 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 9.6 tt -47.5 -35.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.805 0.336 . . . . 0.0 111.29 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 p -65.62 -38.33 89.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -61.67 -29.46 70.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.179 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -87.06 -48.96 7.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 28.9 p -104.04 96.55 9.66 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 111.005 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.56 100.45 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.573 2.182 . . . . 0.0 112.334 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.82 5.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 m -117.32 131.17 24.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.55 175.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.483 2.122 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CE1' ' CD1' ' A' ' 149' ' ' LEU . 3.9 p90 -163.15 159.42 22.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 77' ' ' VAL . 8.7 mp -111.96 120.08 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.847 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 1.3 tm? -95.19 102.49 14.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.69 160.39 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.373 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.45 137.3 6.51 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.364 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.431 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 6.5 p -130.26 -155.62 0.71 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.1 tp60 82.4 77.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.4 HG13 ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -100.12 -34.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -78.04 -51.72 9.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.268 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -40.37 59.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' HG22 ' A' ' 85' ' ' VAL . 7.6 ptt85 -72.44 61.93 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -137.72 46.7 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.022 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.32 145.89 34.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.62 -45.21 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.317 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -49.96 -45.93 51.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.79 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -29.62 20.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.8 mm -66.09 -57.35 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.054 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -48.43 -38.19 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.056 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -39.09 17.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.976 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 mt -51.18 -25.54 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.409 . . . . 0.0 110.436 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.82 -19.18 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -31.9 33.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -67.62 -19.46 65.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.13 46.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.49 133.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.5 168.18 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.54 129.22 32.73 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.468 ' CG2' ' CG1' ' A' ' 84' ' ' VAL . 8.5 mt -60.41 129.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.471 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -128.09 179.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.948 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 73.0 Cg_exo -51.75 -21.67 11.9 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.674 2.25 . . . . 0.0 112.508 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.58 -53.37 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.4 m -46.21 -47.52 17.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.133 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.34 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -33.79 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.577 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -58.51 -56.62 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.9 tp -59.09 -52.94 63.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -57.91 -41.01 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.408 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.402 ' HA ' ' OH ' ' A' ' 154' ' ' TYR . 48.4 ttt-85 -50.16 -41.56 49.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.44 -21.74 64.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.522 ' CD1' ' CE1' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -74.84 -28.47 60.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 tttt 66.83 58.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.648 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -107.28 -177.97 3.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.412 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 66.3 t -48.86 -64.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 178.97 160.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.756 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -154.34 111.23 3.35 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 23.6 m -158.27 120.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.859 0.362 . . . . 0.0 110.412 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -173.18 -178.63 1.79 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.61 -173.42 4.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.89 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.4 ' OG ' HG13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -87.2 155.94 19.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.267 0.556 . . . . 0.0 111.301 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 22' ' ' SER . . . -57.18 -158.85 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER 47.86 26.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.802 179.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.62 121.46 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -105.42 -68.28 0.87 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.178 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.86 85.19 0.11 Allowed Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.549 ' CB ' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -94.05 -10.11 34.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.728 0.299 . . . . 0.0 111.669 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -43.74 -29.44 0.52 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.925 0.393 . . . . 0.0 111.135 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 155' ' ' VAL . 16.1 m-20 -64.37 -47.4 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.557 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 86.1 t -54.45 -47.62 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.571 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -69.97 -38.76 76.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.746 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.37 -42.34 66.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.269 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.43 ' CB ' ' HG2' ' A' ' 153' ' ' LYS . 1.6 tp10 -90.03 -41.53 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.72 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -60.48 -35.73 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 29.6 mm -86.11 -44.65 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.37 -41.13 85.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -52.3 -40.03 61.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.56 -23.83 29.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 tp -48.91 -64.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.22 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.35 142.61 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.058 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.422 ' CB ' ' HE1' ' A' ' 45' ' ' MET . 0.7 OUTLIER -129.48 144.89 51.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -72.53 129.29 87.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.72 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.459 ' CD ' ' CE2' ' A' ' 169' ' ' PHE . 9.2 Cg_endo -51.91 149.64 19.88 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.4 ' O ' ' N ' ' B' ' 81' ' ' PHE . 75.4 m -120.37 -64.07 1.29 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -47.53 93.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.548 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.3 t80 -119.75 135.87 54.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.89 131.24 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.487 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.22 88.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.474 . . . . 0.0 110.397 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -76.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.661 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.431 HD11 ' CB ' ' A' ' 39' ' ' ASN . 1.1 mp -121.4 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.931 0.396 . . . . 0.0 111.788 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -105.31 97.48 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.907 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 41.5 t -77.62 145.38 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.707 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.415 ' CA ' HG13 ' A' ' 33' ' ' VAL . . . -146.31 167.49 27.94 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.227 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -92.19 126.82 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 37.1 t0 -135.82 135.14 39.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.758 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.42 1.72 18.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.009 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 m -45.5 -27.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -153.41 -44.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.837 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.57 35.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.367 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -144.66 -160.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.752 0.311 . . . . 0.0 110.598 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.56 147.3 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.437 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -90.71 178.49 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.74 32.28 32.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.473 ' CG ' ' CB ' ' B' ' 104' ' ' ALA . 1.8 tpt -44.1 101.92 0.27 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 0.0 111.423 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.431 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 82.7 Cg_exo -45.51 151.95 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.114 1.876 . . . . 0.0 112.077 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -43.97 -63.84 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.929 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -64.7 -61.29 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.747 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.543 ' CZ3' ' CD2' ' A' ' 67' ' ' LEU . 3.1 m0 -46.39 -50.62 16.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.473 ' CB ' ' CG ' ' B' ' 99' ' ' MET . . . -61.14 -66.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.0 ptm180 -47.35 -27.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.915 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' CD1' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -63.05 -62.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.331 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -59.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.679 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' B' ' 109' ' ' THR . 6.8 tp60 -77.82 -99.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.2 p -166.74 -52.17 0.03 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.891 0.377 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.1 -176.5 5.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.434 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' B' ' 99' ' ' MET . 26.7 t-20 -82.41 80.48 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.845 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.492 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.701 0.762 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.41 141.59 43.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 t -119.98 111.8 18.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -115.88 151.98 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 96.26 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.7 104.8 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.418 ' CG2' ' OG1' ' A' ' 75' ' ' THR . 25.7 t -84.71 158.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 34.4 m -140.76 150.71 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.405 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' CA ' HG22 ' A' ' 14' ' ' VAL . 2.8 m -145.12 135.2 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.335 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.72 146.08 4.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.69 152.58 39.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.58 0.228 . . . . 0.0 110.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.76 96.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.976 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' CYS . . . 67.61 64.13 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.141 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 HG22 ' CA ' ' A' ' 9' ' ' VAL . 7.6 p -48.56 -24.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.2 -32.84 2.6 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.14 -73.45 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.637 0.256 . . . . 0.0 111.56 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.0 p -39.52 -61.31 0.82 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.775 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . 6.1 p -46.43 -37.3 7.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 23' ' ' TYR . 5.9 tp -67.94 -71.46 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 mm? -38.18 -41.37 0.59 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.753 0.311 . . . . 0.0 111.604 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 4.4 mm -61.04 -45.05 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' LEU . 90.8 p -94.2 -64.02 1.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' B' ' 77' ' ' LEU . 27.1 t80 -49.38 -47.88 47.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.197 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.435 ' HA ' ' CD2' ' B' ' 77' ' ' LEU . 94.5 m -97.45 -95.76 0.21 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.501 ' HB ' ' CE2' ' B' ' 81' ' ' PHE . 5.0 t -41.23 -29.38 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 t30 68.13 24.25 7.74 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' CE ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -112.41 -160.02 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.196 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.01 156.61 74.01 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 63.2 Cg_exo -36.68 142.33 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.071 2.514 . . . . 0.0 113.133 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.95 -83.32 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.537 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.94 97.31 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.377 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.38 106.45 1.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.098 0.475 . . . . 0.0 110.97 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.424 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 4.4 p -160.6 139.64 7.79 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.179 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 36' ' ' VAL . 62.4 Cg_exo -37.66 100.2 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.764 2.31 . . . . 0.0 112.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 m -47.0 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.257 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG12 ' CG ' ' B' ' 96' ' ' PHE . 91.2 t -91.21 -43.67 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 84.0 t80 -172.57 106.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.746 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 30.0 m-20 -107.52 127.36 53.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 31.4 t-20 -107.48 147.01 31.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.113 0.482 . . . . 0.0 111.309 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.27 161.11 43.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.187 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.82 116.75 29.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.182 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 55' ' ' LEU . 1.3 m -124.92 124.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 0.0 111.76 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -122.27 95.94 4.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.459 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 76' ' ' SER . 10.7 p -97.34 116.78 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.8 mtm -89.04 114.99 26.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.047 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' B' ' 74' ' ' SER . 9.0 mt -115.8 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 73' ' ' GLY . . . 85.79 18.73 59.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.21 33.45 44.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.544 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -139.15 147.33 52.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.66 162.9 35.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.491 2.127 . . . . 0.0 112.207 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.34 167.53 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.37 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.5 m -131.87 97.04 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.214 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.75 158.94 16.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.29 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.92 103.72 0.26 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.054 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -78.39 103.32 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -83.71 102.95 12.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.172 179.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -71.38 -178.07 2.0 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.985 0.421 . . . . 0.0 111.111 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.522 ' CG2' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -170.53 172.81 5.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.701 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.39 -61.45 1.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.253 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.51 18.46 9.04 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 mt -94.33 -173.83 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.801 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.67 39.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -135.64 12.33 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.346 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.522 ' CE2' ' CG2' ' A' ' 58' ' ' THR . 1.3 m-85 -86.69 2.68 47.73 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.525 0.202 . . . . 0.0 111.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -49.43 -25.63 2.7 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -39.07 12.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.84 26.32 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.538 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.568 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.49 -26.57 0.3 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 72.5 Cg_endo -76.72 -22.91 11.51 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.455 1.437 . . . . 0.0 111.667 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 7.4 mt -60.19 -18.27 47.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -94.38 -27.24 16.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.04 168.47 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.976 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 72' ' ' TYR . 14.1 Cg_endo -57.4 -17.62 27.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.422 2.081 . . . . 0.0 112.198 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -10.76 38.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.2 t -38.3 -30.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.03 -154.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 78' ' ' PHE . 41.4 t -57.84 161.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -111.94 122.08 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.945 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.434 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 1.9 tp -103.83 121.51 43.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.291 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.484 HG13 ' CZ3' ' A' ' 97' ' ' TRP . 2.3 t -131.06 138.12 54.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.95 152.99 48.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 26.9 p90 -138.65 176.13 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.429 ' HA ' ' NE2' ' A' ' 116' ' ' GLN . 91.5 p -89.69 120.03 30.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 116' ' ' GLN . 32.3 m -93.06 40.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 120' ' ' ARG . 19.4 m -95.46 -45.77 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 2.0 p -139.46 139.35 22.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.74 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' HG2' ' CB ' ' A' ' 132' ' ' ASN . 42.6 Cg_endo -68.53 -17.81 43.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.579 2.186 . . . . 0.0 112.469 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -51.68 -23.73 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -93.32 -29.91 15.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.169 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 2.7 m-85 -46.44 -44.93 17.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.193 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.65 -58.26 8.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -63.17 -36.71 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG11 ' CE3' ' A' ' 97' ' ' TRP . 72.7 t -48.63 -65.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.435 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 13.0 mtmm -73.33 -37.25 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.71 -12.39 61.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.9 tttm -119.03 -25.88 6.11 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ3' HG13 ' A' ' 80' ' ' VAL . 31.2 m0 -93.29 -49.03 6.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.625 0.25 . . . . 0.0 111.313 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.507 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.8 t -47.6 -43.93 52.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.1 Cg_exo -67.38 -26.53 41.09 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.53 2.154 . . . . 0.0 112.589 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.05 -35.21 15.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.439 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -47.67 -27.58 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.367 . . . . 0.0 111.294 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.419 ' N ' HG21 ' A' ' 101' ' ' ILE . 38.3 p -89.13 -33.23 17.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -51.92 -44.68 63.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 -46.59 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -97.34 104.23 19.12 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.746 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -41.65 -51.12 4.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.554 2.17 . . . . 0.0 112.565 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -173.79 48.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 56.6 m -103.97 142.79 25.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 78.7 Cg_exo -39.79 129.08 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.547 2.165 . . . . 0.0 112.086 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.473 ' CE1' ' HB1' ' A' ' 151' ' ' ALA . 8.6 p90 -102.53 173.75 6.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.164 0.507 . . . . 0.0 111.48 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.52 ' CD2' ' CE2' ' A' ' 154' ' ' TYR . 3.0 mt -151.74 126.25 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.876 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 tt -143.63 125.64 15.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.675 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.525 ' CG1' ' CD2' ' A' ' 154' ' ' TYR . 7.1 p -157.05 134.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.326 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.471 ' HA2' ' CE1' ' A' ' 82' ' ' PHE . . . -105.94 158.62 15.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.555 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.0 t -168.87 144.36 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.733 0.302 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 2.3 mt-30 172.06 55.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.45 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 158' ' ' SER . 38.3 mt -52.88 -24.46 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 28.0 t70 -82.26 -55.22 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.231 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -63.29 -40.76 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' CB ' ' HA ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -66.25 71.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -174.97 53.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.45 161.24 25.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.12 -26.17 15.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.832 2.355 . . . . 0.0 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -28.71 16.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.98 -68.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.088 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -45.36 -39.69 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.445 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -61.29 2.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.14 -35.38 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -49.7 -27.74 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 110.686 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.95 -20.36 62.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.404 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -89.92 -21.56 22.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.19 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 1.3 t-20 -88.21 -26.67 22.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.172 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 166.78 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 87.18 -175.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 1.4 tmmt? 63.22 129.03 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.5 140.18 62.0 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.429 2.086 . . . . 0.0 112.458 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.9 mt -70.2 118.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.969 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.81 156.9 34.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.334 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.07 -29.46 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.293 2.662 . . . . 0.0 112.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.31 -43.74 73.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.412 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.58 -66.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.32 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 114' ' ' GLY . . . -47.41 -47.69 26.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.246 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.435 ' CG ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -56.39 -44.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -39.97 75.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.0 -52.34 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.599 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.45 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -81.37 -35.52 30.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.9 -52.13 8.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.254 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -94.34 30.82 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.242 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.03 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 110' ' ' PHE . . . 51.65 -176.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.156 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 42.5 t -71.46 -8.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.81 152.1 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.52 0.328 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.525 ' CD2' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -153.16 151.8 30.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.088 0.471 . . . . 0.0 111.884 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.435 ' HA ' ' CG ' ' A' ' 143' ' ' GLU . 33.2 m -158.75 124.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.447 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.89 -178.46 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.349 0.595 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.7 p -141.77 -168.21 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.431 ' HB2' ' HB ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -82.92 161.22 21.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 109.976 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' HB3' ' CB ' ' A' ' 22' ' ' SER . . . -45.54 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.959 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.436 ' CD2' ' HB2' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -37.04 -42.72 0.43 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.057 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.6 p -86.77 171.71 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.154 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -163.39 89.01 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 -68.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.951 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.37 77.02 0.39 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -94.02 -32.81 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.138 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -65.66 -43.67 88.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.401 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 47.0 m-20 -51.72 -66.02 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 154' ' ' TYR . 2.1 p -42.92 -56.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.562 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CD2' HG13 ' A' ' 173' ' ' ILE . 1.0 OUTLIER -52.12 -33.2 38.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 5.0 t0 -70.0 -31.14 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -88.99 -26.24 21.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.16 -24.53 21.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.988 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.494 HG13 ' CD2' ' A' ' 169' ' ' PHE . 15.8 mm -94.98 -57.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.1 tp -53.53 -24.67 14.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.77 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.62 -23.66 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.73 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -60.85 -68.81 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 tt -144.03 151.43 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 10.8 t -136.03 130.12 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.516 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -47.17 139.47 7.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 67.6 Cg_exo -50.68 142.47 31.79 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.345 2.03 . . . . 0.0 112.189 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 166.78 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.724 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.51 110.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 20' ' ' LEU . 4.5 p90 -81.08 172.73 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.305 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -130.04 135.98 48.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.9 95.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.181 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -72.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 0.9 OUTLIER -125.24 138.88 52.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.024 0.44 . . . . 0.0 111.936 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.16 98.03 5.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.715 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 61.2 t -77.65 152.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.881 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.39 177.88 24.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.152 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -77.16 124.59 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 110.788 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' B' ' 97' ' ' THR . 11.0 t0 -114.86 108.33 16.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.132 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.1 -19.35 62.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.2 -57.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.016 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -146.05 53.04 1.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.06 30.08 7.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -118.21 -176.75 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 0.3 OUTLIER -99.27 164.15 12.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.644 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.433 HG22 ' CB ' ' B' ' 90' ' ' ASP . 10.3 p -104.29 166.8 10.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 46.73 26.87 2.9 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.433 ' O ' ' CB ' ' B' ' 111' ' ' ASN . 1.2 mtp -48.5 137.55 12.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.598 0.237 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.475 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 52.7 Cg_exo -53.8 151.39 26.15 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.238 1.959 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 2.7 mt-10 -44.63 -55.46 5.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.599 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 1.4 tm0? -70.84 -46.56 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.535 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m0 -51.1 -57.91 7.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' B' ' 110' ' ' SER . . . -53.1 -67.37 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.098 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' B' ' 102' ' ' GLN . 10.8 ptt85 -44.66 -40.98 6.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.397 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.97 -55.08 19.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.83 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.46 -69.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.191 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' B' ' 110' ' ' SER . 7.3 tt0 -79.47 -96.3 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 16.8 p -164.07 -56.62 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.539 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -125.85 173.46 9.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.608 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' B' ' 99' ' ' MET . 0.8 OUTLIER -59.58 -55.76 30.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.752 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.787 0.327 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.43 122.18 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.65 147.23 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.741 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.443 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 10.5 mt -131.46 104.18 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.274 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.415 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -102.72 96.48 6.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.744 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -80.81 122.07 26.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.477 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 71.8 t -97.69 154.05 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 2.5 t -120.17 166.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.389 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG21 ' CE1' ' A' ' 104' ' ' HIS . 7.4 p -157.51 121.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.45 169.28 27.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.289 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 4.0 m-20 -87.3 134.11 33.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 -45.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . 77.31 -66.13 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 82' ' ' PHE . 23.4 m -48.07 -24.67 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.747 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 81' ' ' CYS . . . -55.25 -91.09 0.01 OUTLIER Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.162 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 57' ' ' ASP . 2.1 ttpm? -96.07 -72.84 0.62 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -40.51 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' SG ' ' CB ' ' A' ' 13' ' ' ALA . 69.6 m -49.52 -29.82 7.4 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.22 0.533 . . . . 0.0 110.833 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.0 -73.99 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.03 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 1.5 mt -48.46 -29.45 4.1 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 25' ' ' THR . 6.4 mm -53.69 -65.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.245 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -95.71 -17.96 20.85 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -179.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CE1' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -97.24 -40.92 8.53 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.501 ' CB ' ' HA ' ' A' ' 20' ' ' LEU . 41.2 m -94.56 20.95 7.8 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.083 -0.386 . . . . 0.0 111.668 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.48 HG22 ' CD1' ' B' ' 81' ' ' PHE . 3.3 t -177.13 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.211 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 25' ' ' THR . 9.8 m-80 81.2 51.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -133.93 -178.78 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.177 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -123.56 146.55 50.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.0 Cg_exo -35.62 146.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.661 2.908 . . . . 0.0 112.975 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -76.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.828 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.77 114.29 25.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.661 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 1.7 t80 -66.84 111.28 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.072 0.463 . . . . 0.0 111.121 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 87.8 t -159.51 131.3 4.1 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.2 Cg_exo -44.79 92.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.183 1.922 . . . . 0.0 111.451 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' VAL . 97.8 m -50.72 88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.684 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' PRO . 2.4 t -79.79 -42.84 22.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.504 ' CD2' ' HG3' ' B' ' 100' ' ' PRO . 2.8 t80 -124.76 -68.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.084 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 2.1 m-20 54.62 111.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.811 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.4 t-20 -106.99 160.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.038 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.524 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -148.29 162.36 39.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -178.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.09 148.06 30.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' HG ' ' A' ' 53' ' ' LEU . 19.9 m -151.61 158.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.259 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -154.93 87.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 51' ' ' TYR . 33.2 m -99.49 168.22 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.416 ' CE ' ' CB ' ' B' ' 76' ' ' SER . 19.1 mtm -121.44 101.53 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 51' ' ' TYR . 6.8 mm -93.32 90.1 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.41 20.35 60.49 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.38 34.43 8.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.558 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -138.62 138.65 22.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.65 165.37 2.51 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.53 2.153 . . . . 0.0 112.297 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.476 ' CD2' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -152.91 136.93 16.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.6 m -135.4 97.82 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HG ' ' CG2' ' A' ' 42' ' ' VAL . 1.5 pp -133.67 160.53 37.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -140.76 123.94 2.47 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 20' ' ' LEU . 33.8 mt -75.73 117.49 17.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 3.6 m-85 -95.16 116.96 29.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 5.2 t70 -75.96 162.21 28.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.521 ' CG2' ' CD2' ' A' ' 64' ' ' TYR . 21.9 m -168.08 147.79 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.434 ' N ' HG21 ' A' ' 58' ' ' THR . . . -179.76 -83.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.079 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.51 19.3 26.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.449 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 63.73 51.93 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 63.47 28.43 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.17 22.38 7.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CD2' ' CG2' ' A' ' 58' ' ' THR . 0.2 OUTLIER -86.68 -2.55 58.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.525 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.59 -28.92 0.65 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 110.639 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -73.97 -45.36 50.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.489 HD12 ' CE2' ' B' ' 96' ' ' PHE . 52.4 mt -89.92 16.5 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -69.36 -59.36 5.03 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.473 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 10.5 Cg_endo -53.84 -19.64 15.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.466 2.11 . . . . 0.0 112.424 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -79.66 -27.44 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.455 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -103.83 -9.65 18.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.511 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 41.77 91.95 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.296 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 47.9 Cg_exo -55.85 -42.21 69.42 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -69.05 -10.91 59.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.59 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 72' ' ' TYR . 12.2 t -45.02 -48.47 11.59 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.666 0.27 . . . . 0.0 111.565 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' N ' ' CG2' ' A' ' 75' ' ' THR . 0.6 OUTLIER -170.74 -159.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.431 ' CG2' HD13 ' A' ' 111' ' ' LEU . 10.1 p -58.25 162.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 104' ' ' HIS . 0.4 OUTLIER -111.2 133.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.301 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' CD1' ' OH ' ' A' ' 154' ' ' TYR . 1.3 tp -104.21 116.07 31.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 58.9 t -103.34 154.59 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.416 . . . . 0.0 111.79 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 15' ' ' GLY . 23.8 p -115.2 117.69 31.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.811 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CB ' ' O ' ' A' ' 113' ' ' VAL . 9.9 t80 -99.12 165.71 11.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.608 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -83.26 136.85 34.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.473 0.654 . . . . 0.0 111.489 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 116' ' ' GLN . 98.8 t -51.68 -81.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.272 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -121.54 -96.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.734 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 7.1 t 39.91 93.29 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HG3' ' CD1' ' A' ' 129' ' ' LEU . 84.4 Cg_exo -45.47 -26.78 2.94 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.553 2.168 . . . . 0.0 112.462 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -57.79 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.424 ' CB ' ' HB3' ' A' ' 86' ' ' SER . 0.3 OUTLIER -47.49 -43.05 24.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.459 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 1.5 t80 -48.13 -67.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.94 -42.43 65.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.112 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -61.39 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 97' ' ' TRP . 28.4 m -47.47 -26.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.666 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.95 -59.7 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.357 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 7.88 8.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -113.36 -41.01 3.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.629 0.252 . . . . 0.0 111.525 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.475 ' CZ2' ' HB2' ' A' ' 11' ' ' ASP . 4.4 m95 -95.54 -43.34 8.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 91.1 t -45.14 -58.23 6.01 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 13.9 Cg_endo -57.16 -17.93 27.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.437 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 -28.07 16.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.483 HD13 ' CD2' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -49.66 -35.6 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.3 -31.56 67.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.56 -43.3 93.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.64 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 12.1 m80 -76.25 -64.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.207 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 24.4 p -68.32 112.73 11.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.701 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 34.0 Cg_exo -61.07 -66.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.584 2.189 . . . . 0.0 112.341 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -145.93 23.78 1.36 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.8 146.15 33.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.57 173.47 6.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.475 2.117 . . . . 0.0 111.894 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 4.8 p90 -150.28 -179.04 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 2.2 mp -137.16 142.99 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.217 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 154' ' ' TYR . 1.3 tp -112.86 125.98 54.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 111.473 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.543 ' CG2' ' CE2' ' A' ' 154' ' ' TYR . 3.5 t -106.31 135.71 43.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.413 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.04 143.55 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 5.2 t -161.05 -169.79 2.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.677 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.453 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 172.49 72.57 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.773 0.32 . . . . 0.0 111.368 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 157' ' ' CYS . 14.8 mt -98.75 -67.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.941 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -42.18 18.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -44.94 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -19.94 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.37 -28.09 0.8 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.309 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.21 116.2 10.0 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.59 -56.17 3.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.512 2.141 . . . . 0.0 112.639 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -43.82 -39.17 3.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -57.98 -64.01 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.27 -40.54 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -48.92 -38.55 23.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -89.94 -37.37 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.274 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.419 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 8.6 tp -48.95 -30.69 6.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.302 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.34 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.635 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -82.39 -25.77 33.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.53 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 7.3 m120 -85.1 -25.22 27.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.976 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 161.41 -23.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.567 0.542 . . . . 0.0 111.304 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 89.67 -43.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.978 0.511 . . . . 0.0 110.553 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.67 50.02 4.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.353 179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 73.2 Cg_endo -76.68 -47.37 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.622 2.214 . . . . 0.0 112.769 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.484 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 2.2 mm -106.82 136.67 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 111.211 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 17.2 p -159.74 155.37 22.51 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.47 -25.29 4.97 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.708 2.272 . . . . 0.0 112.197 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 -35.36 14.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.27 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -50.21 74.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.007 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.58 11.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.43 ' HG3' ' CG1' ' A' ' 155' ' ' VAL . 1.4 tt0 -62.76 -39.04 92.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -58.93 -49.16 78.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.662 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.44 -36.1 70.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.622 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.43 -23.98 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.73 -41.57 37.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -51.34 -47.3 62.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.69 -9.85 58.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.384 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.91 116.55 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.64 -176.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' A' ' 111' ' ' LEU . 63.3 t -64.25 -14.51 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.571 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 78.78 160.1 0.19 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 111.076 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.543 ' CE2' ' CG2' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -152.57 110.88 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.003 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.43 ' CG1' ' HG3' ' A' ' 143' ' ' GLU . 2.2 m -118.07 123.5 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' OE2' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -172.05 -178.33 2.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -130.5 166.97 19.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.251 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 115' ' ' THR . 0.1 OUTLIER -88.6 99.94 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.517 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.431 ' CB ' HD23 ' A' ' 160' ' ' LEU . . . 46.22 -175.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.538 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 41.24 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.119 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 75.5 p 40.47 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.984 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 76.45 79.99 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.821 0.343 . . . . 0.0 110.991 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.67 -68.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.34 57.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.73 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HG ' ' CD2' ' A' ' 23' ' ' TYR . 1.6 tp -93.74 -29.0 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -72.44 -57.4 4.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.417 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 72.4 m-80 -44.09 -56.71 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 111.12 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 155' ' ' VAL . 2.4 p -55.07 -39.9 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.41 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.26 -25.62 59.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.739 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 4.4 t70 -85.14 -28.61 25.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.38 -39.58 58.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.89 -44.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.437 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 169' ' ' PHE . 28.7 mm -70.68 -62.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.362 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -54.67 -21.55 11.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.263 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.52 92.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 111.265 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -75.34 -24.02 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.324 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.43 -29.08 5.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.966 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.5 -63.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tt -138.62 151.21 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.416 ' CB ' ' CE ' ' A' ' 45' ' ' MET . 1.1 t -130.52 167.55 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.769 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -103.7 136.97 19.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.83 178.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.434 2.089 . . . . 0.0 112.1 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -150.75 -48.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.271 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -49.26 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.48 ' CD1' HG22 ' A' ' 25' ' ' THR . 21.6 t80 59.5 119.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 111.04 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -153.23 127.52 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 92.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.282 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 70.1 p -77.22 -85.75 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 0.9 OUTLIER -92.94 109.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.745 -179.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -98.11 96.86 8.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.924 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 59.3 t -83.18 143.23 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.652 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.437 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -146.57 177.82 24.65 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.069 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -99.2 125.31 44.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.441 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 38.3 t0 -137.55 131.58 31.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.809 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 2.28 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.043 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.89 -28.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 120.892 0.377 . . . . 0.0 111.404 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -150.27 -44.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.851 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.36 34.44 0.28 Allowed Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.448 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.22 -166.6 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.285 . . . . 0.0 110.473 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE2' HD12 ' A' ' 67' ' ' LEU . 9.0 m-85 -87.63 162.24 17.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 7.7 p -103.33 163.98 11.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 49.43 27.16 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.171 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.4 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -47.65 134.16 10.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.886 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.504 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 59.1 Cg_exo -53.32 142.64 56.62 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.367 2.045 . . . . 0.0 112.205 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.14 -47.89 12.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.919 0.39 . . . . 0.0 110.807 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -54.39 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.51 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.498 ' CD1' ' HB3' ' A' ' 70' ' ' LEU . 18.7 m0 -53.15 -61.47 2.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' B' ' 110' ' ' SER . . . -43.13 -67.69 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.594 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 17.4 mtt85 -48.1 -41.76 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.034 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.71 -56.68 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.422 ' CD1' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.78 -70.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.252 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.45 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.2 tt0 -79.05 -96.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.684 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 9.3 p -165.68 -55.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 15.8 m -126.02 -179.32 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' B' ' 99' ' ' MET . 0.7 OUTLIER -66.77 -59.66 3.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.698 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.554 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.805 0.336 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -124.81 125.55 44.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 111.68 23.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -129.22 132.23 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.265 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -113.57 157.46 22.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.397 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -128.74 112.97 14.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 73' ' ' PRO . 10.7 t -87.04 98.67 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 16' ' ' LYS . 22.5 m -114.4 145.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.597 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 104' ' ' HIS . 32.8 m -137.94 121.34 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.54 167.41 38.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.852 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.09 -62.48 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.057 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.69 -137.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.597 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . . . -173.27 30.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 2.8 t -65.14 -12.52 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . -120.25 -24.84 2.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.644 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.21 -74.36 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.423 0.612 . . . . 0.0 112.159 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -77.92 -63.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.706 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 13.0 m -49.09 -45.5 43.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.079 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm? -39.73 -72.65 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.213 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 40' ' ' TYR . 16.8 mt -61.99 -19.27 62.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.602 0.239 . . . . 0.0 111.205 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.452 ' HA ' HG21 ' A' ' 25' ' ' THR . 1.0 OUTLIER -67.97 -48.22 75.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.357 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 m -93.28 -20.54 20.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.662 0.268 . . . . 0.0 111.239 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 4.4 m-30 -84.0 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.83 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -87.75 -83.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.238 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.518 ' HB ' ' CD1' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -49.12 -26.98 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.257 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 p-10 47.19 41.97 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 110.821 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -132.51 134.89 45.56 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -59.49 154.36 44.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 57.9 Cg_exo -34.9 145.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.18 2.587 . . . . 0.0 113.221 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.02 -83.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -100.93 115.67 30.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.92 103.5 4.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' THR . 66.1 t -152.98 139.43 12.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 33' ' ' VAL . 98.6 Cg_exo -42.02 92.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.5 2.133 . . . . 0.0 111.737 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' VAL . 72.7 m -52.97 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.552 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' B' ' 96' ' ' PHE . 23.8 t -74.99 -32.74 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 3.2 t80 -144.96 -66.28 0.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.729 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 37' ' ' PHE . 4.4 m-20 55.18 108.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.391 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 46.9 t-20 -107.63 157.21 18.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.008 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.479 ' HB3' ' CE1' ' B' ' 81' ' ' PHE . 0.1 OUTLIER -150.93 167.71 26.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.952 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -123.12 156.98 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 15.6 m -160.71 147.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.087 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.3 m -124.08 101.41 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.543 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 173' ' ' ILE . 15.8 m -98.61 141.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 21.5 mtm -105.18 100.19 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.482 HD11 ' CD1' ' A' ' 51' ' ' TYR . 5.1 mp -104.77 92.78 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.73 16.69 61.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.395 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.98 38.8 6.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.603 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -141.64 139.17 18.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.656 0.265 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.1 168.07 14.79 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.642 2.228 . . . . 0.0 112.387 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CD1' HD11 ' A' ' 46' ' ' ILE . 4.9 m-85 -152.08 160.75 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.289 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -136.06 97.4 3.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.233 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 7.7 tt -132.59 160.55 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.207 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.42 139.88 6.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.34 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 79' ' ' LEU . 1.1 mt -79.33 104.13 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.057 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 5' ' ' LYS . 4.2 m-85 -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 4.8 t0 -71.38 -169.46 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.746 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.484 HG21 ' CG ' ' A' ' 64' ' ' TYR . 4.0 m -166.99 163.57 15.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' CB ' HD23 ' A' ' 61' ' ' LEU . . . -92.79 -74.69 0.51 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.74 61.57 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.851 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -132.31 -168.57 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.98 86.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 3.4 t0 76.03 43.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.041 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 5.0 t80 50.63 35.72 12.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.1 -152.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 18.8 mmt180 -87.52 -1.39 57.91 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.132 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.541 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 4.1 mp -81.97 58.28 3.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -63.59 -70.06 0.51 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.7 Cg_endo -68.23 -22.5 40.27 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.026 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.508 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 3.9 mt -57.48 -20.65 32.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.022 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.415 ' OG ' ' CE2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -112.08 -34.12 6.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.095 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.513 ' CG ' ' HB ' ' A' ' 75' ' ' THR . 1.0 OUTLIER 66.04 76.33 0.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.673 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 77.8 Cg_exo -50.58 -55.18 4.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.854 2.369 . . . . 0.0 112.974 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -67.46 -8.04 30.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.513 ' HB ' ' CG ' ' A' ' 72' ' ' TYR . 8.8 t -33.05 -53.94 0.37 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 -161.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.802 0.335 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 109' ' ' PRO . 66.2 t -58.98 150.28 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 39.1 p90 -139.93 128.74 23.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.901 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 55' ' ' LEU . 1.8 pt? -103.77 116.23 31.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' LEU . 10.1 t -94.24 154.53 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.482 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.423 ' N ' HG11 ' A' ' 80' ' ' VAL . 7.7 p -67.08 171.84 5.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -163.78 105.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.81 0.338 . . . . 0.0 111.335 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -58.63 111.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG1' HG23 ' A' ' 137' ' ' ILE . 90.8 t -103.02 87.21 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 111.164 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 86' ' ' SER . 0.5 OUTLIER 169.12 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.481 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.476 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 68.2 m -46.99 103.59 0.37 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 111.025 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.62 -40.12 80.46 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.48 2.12 . . . . 0.0 112.363 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.8 t -53.6 -25.33 17.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.029 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 -36.7 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.025 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -60.13 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.86 -31.9 73.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.6 m-20 -69.29 -61.9 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.476 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 29.9 m -48.73 -36.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.313 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.438 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -61.31 -63.07 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -82.68 8.01 13.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.895 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.9 tttt -117.23 -36.53 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.674 0.274 . . . . 0.0 111.338 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.476 ' CZ2' ' CG1' ' A' ' 93' ' ' VAL . 28.5 m0 -93.38 -41.55 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.261 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.4 t -48.91 -57.96 9.86 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.3 Cg_endo -59.11 -18.04 41.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 112.305 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -84.76 -51.24 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.851 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 7.6 pt -51.29 -24.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.1 p -74.78 -28.99 60.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.362 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -70.87 -35.14 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.529 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 9' ' ' VAL . 8.4 m-70 -107.71 -2.43 20.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.739 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 3.5 m -149.62 58.03 3.09 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.63 55.9 5.07 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.747 2.298 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt 176.9 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.364 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 t -73.17 146.07 86.6 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.472 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 20.0 Cg_endo -60.29 178.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.644 2.229 . . . . 0.0 111.961 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 33.6 p90 -137.31 158.79 43.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -135.14 127.53 30.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.475 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -104.31 101.38 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.064 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -107.43 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . -168.74 159.13 32.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.805 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -167.89 -64.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 0.0 110.756 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.414 ' NE2' HD11 ' A' ' 119' ' ' LEU . 0.8 OUTLIER 48.86 60.43 3.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.007 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.1 mt -65.71 -31.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.428 ' CB ' HD22 ' A' ' 160' ' ' LEU . 11.9 p-10 -81.75 -49.15 10.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.414 HD11 ' NE2' ' A' ' 116' ' ' GLN . 9.3 tt -49.65 -49.19 48.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -57.74 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.789 179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.0 t0 75.96 31.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -93.73 157.32 38.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.35 -39.75 5.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -25.75 59.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.9 m -56.21 -68.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -46.81 -40.86 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.415 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -62.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.12 -34.83 68.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -50.3 -25.86 4.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.418 . . . . 0.0 110.706 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.76 46.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.39 26.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.082 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -93.02 -30.0 15.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 169.02 146.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 129' ' ' LEU . 5.8 mmmt 60.61 145.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 140.97 70.57 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 141' ' ' THR . 4.3 mt -50.71 126.3 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -98.75 167.3 11.61 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.338 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.39 -22.98 22.57 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.827 2.351 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.22 -35.67 14.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.488 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 22.9 m -46.45 -42.5 15.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.057 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -51.29 56.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -54.57 -38.79 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -52.12 -55.87 18.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.287 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.33 -32.67 57.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -63.51 -49.75 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.664 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.606 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -25.43 58.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 151' ' ' ALA . 3.0 pp -122.65 19.89 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.21 -83.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 58.78 176.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 78.7 t -76.02 -7.35 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.78 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 82.85 141.35 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.694 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.488 ' CE2' ' HB3' ' A' ' 146' ' ' ALA . 5.8 p90 -153.21 153.4 32.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.799 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 m -158.56 123.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.413 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.75 157.97 14.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.993 0.425 . . . . 0.0 111.482 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.402 ' HA ' ' CG2' ' A' ' 115' ' ' THR . 1.8 m -119.01 -173.51 2.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.172 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.29 152.68 22.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.507 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -40.48 -76.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.567 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -36.05 -33.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.652 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -82.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.476 ' NE2' ' CD2' ' A' ' 165' ' ' LEU . 0.9 OUTLIER 63.41 97.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -65.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.06 75.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.685 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 4.5 pp -93.13 -10.15 36.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.771 0.32 . . . . 0.0 111.377 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 -26.33 3.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.851 0.358 . . . . 0.0 110.179 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.99 -51.28 68.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 98.6 t -53.7 -49.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.31 -33.36 73.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.314 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -68.85 -36.94 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.76 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -44.83 27.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.59 62.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.462 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 16.7 mt -82.62 -43.76 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.2 -52.78 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.46 -33.14 29.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.019 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.83 -26.96 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -49.94 -51.25 42.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 62.9 m -50.29 -80.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 tt -119.6 151.95 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.194 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -134.14 165.64 24.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -87.87 137.93 31.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' CG1' ' A' ' 44' ' ' VAL . 38.4 Cg_endo -66.68 -167.46 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.613 2.209 . . . . 0.0 112.131 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.421 ' O ' ' N ' ' B' ' 81' ' ' PHE . 81.1 p -168.34 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.43 78.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.518 ' CD1' ' HB ' ' A' ' 25' ' ' THR . 86.2 t80 -74.66 152.01 39.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -153.62 96.3 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.606 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -68.96 69.75 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.161 0.505 . . . . 0.0 109.662 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -43.79 -85.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.59 130.79 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -111.63 97.15 6.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.387 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 16.6 t -77.84 157.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 112.047 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.27 177.89 24.32 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -112.16 123.01 49.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.482 ' CB ' ' CG2' ' B' ' 97' ' ' THR . 14.8 t0 -140.26 127.84 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.733 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.59 -5.8 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.793 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.59 -29.09 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-O 120.802 0.334 . . . . 0.0 111.656 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.5 p -153.89 24.3 0.5 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.069 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.55 37.22 74.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.83 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.82 179.8 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.722 0.296 . . . . 0.0 110.878 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.473 ' CD2' HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -74.76 164.13 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.482 ' CG2' ' CB ' ' B' ' 90' ' ' ASP . 27.1 p -126.6 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.163 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.72 29.67 26.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.58 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.415 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -74.4 164.77 58.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.081 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.78 142.23 63.11 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.707 2.272 . . . . 0.0 112.343 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -45.71 -60.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -50.34 72.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.61 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.541 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 6.2 m0 -46.8 -63.38 1.04 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 110.411 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -51.01 -60.06 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 31.2 mtt-85 -48.77 -41.04 31.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.136 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.02 -56.73 8.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.47 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.462 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -95.06 -68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.062 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.0 tp60 -77.87 -101.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.338 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.0 p -167.08 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.337 0.061 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' B' ' 104' ' ' ALA . 5.0 m -140.42 172.77 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.421 ' N ' ' OD1' ' B' ' 111' ' ' ASN . 0.7 OUTLIER -56.96 -67.21 0.34 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -71.2 132.65 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 m -94.24 112.81 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.92 133.09 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 104.34 7.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m -77.33 99.06 5.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.665 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.526 ' CG1' ' CE1' ' A' ' 104' ' ' HIS . 10.8 t -84.61 159.45 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.465 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 58.4 t -130.47 148.73 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 80' ' ' VAL . 12.6 p -138.41 132.64 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.92 146.11 17.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.631 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.505 ' CB ' ' CZ2' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -72.05 126.22 29.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.89 -42.16 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.603 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 18' ' ' CYS . . . 47.8 38.9 9.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.443 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 1.9 t -109.27 -14.01 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.77 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -135.67 -55.3 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -43.11 -66.26 0.39 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.171 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.7 m -95.15 -50.53 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -50.5 -44.39 56.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.326 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 18.1 tp -50.09 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.003 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.476 HD13 ' CD1' ' A' ' 40' ' ' TYR . 3.9 mt -51.14 -29.95 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 120.653 0.263 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -55.71 -69.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.353 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.434 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -90.79 -10.49 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 7.7 t80 -95.37 -59.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.48 ' CG2' ' CG1' ' A' ' 42' ' ' VAL . 63.5 m -73.67 -45.61 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.333 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.488 ' HB ' ' CD1' ' B' ' 81' ' ' PHE . 0.6 OUTLIER -113.97 3.83 15.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 p30 43.38 58.06 3.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 111.741 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 10.8 pttt -134.0 -164.74 1.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.511 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -134.21 166.45 29.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 46.5 Cg_exo -36.02 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.147 2.565 . . . . 0.0 113.47 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.64 -85.22 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.368 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.709 0.29 . . . . 0.0 110.286 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.1 t80 -80.91 106.39 12.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 111.623 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' THR . 12.7 m -158.99 145.3 12.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.093 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 36' ' ' VAL . 81.2 Cg_exo -44.73 88.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 66.0 m -55.19 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.386 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' B' ' 96' ' ' PHE . 3.6 t -84.34 -21.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.651 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.578 ' CE1' ' CE2' ' A' ' 56' ' ' PHE . 2.2 t80 -147.96 -65.36 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.627 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 37' ' ' PHE . 7.4 m-20 54.33 109.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.271 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 28.0 t-20 -106.88 147.99 29.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.12 0.486 . . . . 0.0 110.968 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.476 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -139.07 169.2 18.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.785 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.81 141.55 45.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.306 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' CG1' ' CG2' ' A' ' 24' ' ' THR . 2.4 m -162.83 159.57 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.35 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.8 m -145.37 104.41 3.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.175 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.438 ' CG1' HD12 ' A' ' 173' ' ' ILE . 42.2 t -98.27 117.51 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 21.6 mtm -76.68 99.96 5.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.011 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 66.0 mt -92.96 89.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.0 70.12 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.572 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.53 -17.82 30.51 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.859 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.29 138.85 25.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.66 0.267 . . . . 0.0 111.112 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -68.73 166.49 25.95 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.625 2.217 . . . . 0.0 112.341 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 46' ' ' ILE . 23.1 m-85 -153.94 173.73 15.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 97.26 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 9.6 tt -101.68 161.31 13.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.82 118.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.425 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 20' ' ' LEU . 5.5 mp -75.88 105.62 7.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.362 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -83.23 103.46 12.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.036 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -75.67 172.68 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 HG21 ' CE1' ' A' ' 64' ' ' TYR . 2.2 m -167.05 171.37 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.48 -161.07 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 61' ' ' LEU . . . -60.18 -16.08 39.98 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.75 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 1.5 tp 80.17 132.58 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 0.0 111.228 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 169.86 -34.91 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.593 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -116.21 -12.41 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.712 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -48.83 -33.96 11.54 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -47.49 -28.07 2.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.053 0.454 . . . . 0.0 110.424 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -82.04 -46.77 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.234 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' B' ' 103' ' ' TRP . 1.4 mp -92.49 49.56 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -99.65 -31.17 0.23 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 28.0 Cg_exo -37.14 -49.8 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.486 2.124 . . . . 0.0 114.025 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.545 ' CD2' ' CD1' ' B' ' 103' ' ' TRP . 0.1 OUTLIER -94.8 32.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 72' ' ' TYR . 4.4 p -134.04 -52.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.6 OUTLIER 41.56 98.89 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.805 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -45.62 -34.63 11.62 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.523 2.149 . . . . 0.0 112.579 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.93 -10.37 52.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.591 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.486 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 13.7 t -37.66 -49.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 75' ' ' THR . 0.2 OUTLIER 165.79 -165.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.678 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 10.9 p -64.84 125.69 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.766 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CD1' ' CB ' ' A' ' 105' ' ' CYS . 42.4 p90 -96.54 133.81 40.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.587 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 2.2 pp -103.59 116.05 31.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' LEU . 5.1 t -94.99 154.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.423 ' HB3' ' N ' ' A' ' 15' ' ' GLY . 5.8 p -111.5 160.0 17.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 111.385 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 40.7 p90 -152.66 103.9 2.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 14' ' ' VAL . 22.8 t -54.5 118.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.001 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -88.74 81.86 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.223 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' CG1' HD23 ' A' ' 119' ' ' LEU . 1.6 m -131.68 79.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.5 m 71.23 151.08 0.14 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.793 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.15 -22.03 14.18 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.541 2.161 . . . . 0.0 112.419 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -52.49 -32.43 40.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -91.09 -30.83 16.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.016 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.454 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -47.55 -65.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.17 -28.43 67.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 23.2 m-20 -69.84 -84.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.476 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 2.3 m -43.75 -29.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.693 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 12.6 tttt -70.57 -69.39 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -81.44 7.63 11.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.064 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.1 -42.59 3.92 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.413 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ2' ' CB ' ' A' ' 11' ' ' ASP . 12.7 m95 -95.27 -43.36 8.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 68.7 t -48.41 -44.36 64.23 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.57 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 48.0 Cg_exo -55.68 -23.43 40.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.017 1.811 . . . . 0.0 112.166 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -93.53 -30.01 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.854 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -49.43 -26.41 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.138 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.422 ' N ' HG13 ' A' ' 101' ' ' ILE . 19.6 p -77.4 -32.13 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -64.54 -49.6 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.526 ' CE1' ' CG1' ' A' ' 7' ' ' VAL . 55.4 t-80 -65.54 -66.94 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.53 ' CB ' ' CD1' ' A' ' 78' ' ' PHE . 1.2 m -104.5 90.83 3.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.92 118.04 5.33 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.675 2.25 . . . . 0.0 112.572 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.3 51.99 15.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.235 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.87 144.09 51.41 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 99.2 Cg_exo -42.0 147.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.512 2.141 . . . . 0.0 112.102 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.7 p90 -139.41 139.38 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -126.93 119.81 27.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.42 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 1.8 mt -90.34 102.12 14.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.72 96.75 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . -117.61 -119.42 2.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 157' ' ' CYS . 20.2 m 69.11 167.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 111.438 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 176.43 112.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.484 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 159' ' ' ALA . 54.4 mt -91.82 -22.61 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.411 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.83 -44.23 7.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.469 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.433 HD23 ' CG1' ' A' ' 85' ' ' VAL . 1.9 tt -74.7 -47.87 29.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -48.99 -29.39 4.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.107 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.96 51.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -114.23 142.06 27.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.39 -21.64 18.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.552 2.168 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -43.17 57.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 p -56.36 -62.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -48.54 -46.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.41 -58.78 3.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.24 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -36.12 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.906 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -26.43 3.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.39 64.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -85.32 -41.5 15.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -61.39 -23.37 65.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.99 64.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.19 -171.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 167.6 9.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.15 120.93 6.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.538 2.158 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.61 121.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.235 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -117.96 164.8 18.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.833 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HG3' ' CG2' ' A' ' 115' ' ' THR . 75.3 Cg_exo -49.16 -26.21 10.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.568 2.179 . . . . 0.0 112.311 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.78 -51.05 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.6 m -54.87 -55.79 26.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 82' ' ' PHE . . . -50.11 -49.18 52.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.61 -42.09 70.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -46.85 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.689 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -55.98 -48.72 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.867 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.81 68.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -70.36 -43.59 69.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.769 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -59.44 -26.25 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.6 pp -103.15 -23.26 13.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.999 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.4 tptt 60.25 116.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -162.08 -161.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.299 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.451 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 9.2 p -44.93 -43.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.494 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 89.95 145.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.452 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 112' ' ' LEU . 48.8 p90 -153.05 150.97 29.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.885 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 m -158.36 122.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.434 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.464 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -172.04 124.74 0.53 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.553 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 115' ' ' THR . 0.6 OUTLIER -128.51 119.52 25.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -156.99 175.19 14.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.386 0.612 . . . . 0.0 112.497 -177.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 158' ' ' SER . . . 136.15 88.93 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.899 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 58.73 26.01 14.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 p -147.85 -72.08 0.21 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.466 ' NE2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 75.51 114.12 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.248 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 3.4 tttt -105.9 -45.12 4.45 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.11 71.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.621 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 158' ' ' SER . 0.1 OUTLIER -95.05 -16.91 22.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.973 0.416 . . . . 0.0 111.25 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -24.92 2.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 18.4 m-80 -71.79 -61.38 1.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.478 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 169' ' ' PHE . 11.4 p -45.52 -32.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CD2' HD13 ' A' ' 173' ' ' ILE . 1.1 t80 -77.04 -35.28 56.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 167' ' ' ASN . 3.8 t70 -58.25 -35.52 71.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.357 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.14 -44.5 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.777 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.98 64.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.989 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.489 HD13 ' CD2' ' A' ' 169' ' ' PHE . 5.1 mt -93.63 -54.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -59.8 -29.73 68.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.72 62.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.95 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -80.23 -23.51 40.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.68 42.04 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 75' ' ' ILE . 5.2 p 69.7 -62.19 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.429 HG21 ' N ' ' B' ' 76' ' ' SER . 8.6 mt -144.1 137.21 23.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.429 ' N ' HG21 ' B' ' 75' ' ' ILE . 1.4 m -131.59 152.48 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.99 145.92 99.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.745 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.41 ' HB2' HG22 ' A' ' 24' ' ' THR . 61.0 Cg_exo -52.65 -167.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.552 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 84.3 p -149.67 -79.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.85 119.7 12.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.488 ' CD1' ' HB ' ' A' ' 25' ' ' THR . 12.8 t80 -132.78 130.23 39.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.658 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.33 136.45 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 90.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -57.41 -81.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.59 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.59 110.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.78 0.324 . . . . 0.0 111.717 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . 0.405 ' O ' ' ND1' ' B' ' 86' ' ' HIS . 8.7 p80 -85.4 96.84 9.69 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 41.0 t -87.83 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.225 0.536 . . . . 0.0 112.304 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 96' ' ' PHE . . . -142.61 177.8 21.49 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.362 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -101.05 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.3 0.55 . . . . 0.0 111.141 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 9.0 t0 -140.47 114.48 9.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.622 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.73 -5.17 31.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.973 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 p -45.74 -28.24 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.859 0.362 . . . . 0.0 111.176 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' B' ' 95' ' ' GLU . 0.0 OUTLIER -149.25 18.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.08 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.59 17.44 64.61 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.901 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 18.6 pt-20 -128.62 -163.28 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.719 0.295 . . . . 0.0 110.708 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 67' ' ' LEU . 6.6 m-30 -96.04 164.62 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -95.69 136.39 36.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' B' ' 111' ' ' ASN . . . 49.12 36.91 22.46 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.995 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.514 ' CE ' ' HB3' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -77.56 165.63 49.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.243 0.544 . . . . 0.0 112.31 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 51.5 Cg_exo -54.69 141.6 75.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.116 2.544 . . . . 0.0 112.26 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -56.02 -22.25 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 110.399 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.42 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.77 -64.73 0.81 Allowed 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.545 ' CD1' ' CD2' ' A' ' 70' ' ' LEU . 4.7 m0 -51.44 -60.09 3.52 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.437 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -40.51 -65.25 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 21.7 mtp85 -62.68 -35.48 79.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.768 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' B' ' 102' ' ' GLN . 0.9 OUTLIER -49.64 -55.49 13.5 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -72.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.138 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' B' ' 109' ' ' THR . 9.0 tp60 -82.67 -105.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.565 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 1.4 t 156.03 58.77 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.194 0.598 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.02 126.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.972 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.41 ' HB3' ' HA3' ' B' ' 98' ' ' GLY . 15.0 m120 -50.49 -70.49 0.08 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.15 121.35 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.81 120.47 40.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.61 130.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.42 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -135.83 96.61 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.965 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.417 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 8.2 m -80.35 147.01 31.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 4.4 t -122.16 159.88 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.431 . . . . 0.0 111.669 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' CG1' ' HA2' ' A' ' 15' ' ' GLY . 6.5 m -123.0 169.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.795 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -157.51 120.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.014 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 145.17 -161.78 28.15 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.702 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -118.25 169.26 9.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.733 0.301 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 90.54 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.223 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 81' ' ' CYS . . . 53.47 71.7 0.48 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.742 0.306 . . . . 0.0 110.244 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 8' ' ' VAL . 1.6 m -47.07 -25.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' HA2' ' CG1' ' A' ' 8' ' ' VAL . . . 140.85 -40.45 1.36 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.577 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -97.46 -74.23 0.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.1 t -35.37 -51.81 0.61 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.687 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.26 -45.99 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.726 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -59.36 -68.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.48 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.515 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 17.7 mt -40.71 -45.38 2.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.159 0.504 . . . . 0.0 111.148 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -46.26 -70.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.547 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 14.5 t -95.2 -60.76 1.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.243 0.544 . . . . 0.0 111.564 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CE1' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -44.43 -26.63 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.929 -178.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 99.1 m -109.16 -89.92 0.47 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.195 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.498 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 1.4 t -64.14 -19.91 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.697 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.7 t30 70.41 32.75 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.355 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HB3' ' CG2' ' A' ' 25' ' ' THR . 4.9 ttpt -127.9 138.04 52.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -81.67 149.29 63.88 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.736 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.11 153.89 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.788 2.326 . . . . 0.0 112.723 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -108.06 -71.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.67 109.76 17.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.608 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.83 92.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 73.3 t -138.1 131.29 16.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.426 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 36' ' ' VAL . 97.9 Cg_exo -42.26 93.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 111.837 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' VAL . 81.5 m -51.48 87.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.38 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 34' ' ' PRO . 93.8 t -77.05 -37.43 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 2.7 t80 -136.38 -63.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.745 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 35' ' ' THR . 11.5 t0 56.25 114.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.5 t-20 -108.11 153.09 23.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.379 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -144.33 169.25 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 0.0 111.343 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.07 138.08 46.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 24' ' ' THR . 2.3 m -162.37 139.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.302 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 51' ' ' TYR . 51.6 m -132.71 110.85 10.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.188 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.07 117.07 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mtm -94.42 100.28 12.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.129 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.6 mt -93.13 114.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 17.94 78.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.02 29.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.524 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.09 130.41 63.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.504 0.192 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.11 160.38 42.78 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.595 2.197 . . . . 0.0 112.405 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' THR . 36.2 m-85 -146.74 165.19 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.157 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -121.11 97.67 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.497 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 7.2 tt -113.79 157.23 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -151.9 113.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 2.3 mt -90.32 117.19 28.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.389 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -89.27 144.53 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.063 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -104.44 -163.69 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.904 0.383 . . . . 0.0 111.536 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.49 HG21 ' CD1' ' A' ' 64' ' ' TYR . 89.2 m -153.53 161.04 42.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.93 74.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.45 -22.85 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.366 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.55 176.37 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.784 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -81.94 67.75 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.08 19.4 4.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.367 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.49 ' CD1' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -89.61 -10.37 46.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.253 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.15 -31.02 0.86 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.834 0.35 . . . . 0.0 111.022 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -71.9 -39.76 69.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.476 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 103' ' ' TRP . 23.5 mt -90.09 6.54 42.01 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.299 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -47.74 -43.02 49.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_exo -60.5 -19.0 57.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.209 1.939 . . . . 0.0 112.021 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD12 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -106.5 -48.22 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.817 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 33.75 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -41.04 153.73 0.23 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.463 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.74 -25.27 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.743 2.295 . . . . 0.0 112.774 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -65.51 -11.19 41.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.739 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 2.5 t -42.99 -54.18 4.39 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.45 -152.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.42 158.22 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.681 0.277 . . . . 0.0 110.676 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 7' ' ' VAL . 1.4 m-85 -115.47 145.79 42.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' CB ' ' CG1' ' A' ' 8' ' ' VAL . 2.2 mm? -104.05 135.7 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.846 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 112' ' ' LEU . 3.0 t -115.56 153.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.981 0.419 . . . . 0.0 111.729 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 23.0 p -110.05 155.28 22.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 30.9 p90 -178.9 109.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -54.28 -170.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.563 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.06 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.429 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -47.18 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.474 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.6 m -68.43 110.72 6.27 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.498 0.19 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.79 -21.87 50.45 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.527 2.152 . . . . 0.0 112.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -30.62 46.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.162 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 m -92.98 -26.99 17.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.441 ' CZ ' HD12 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -48.73 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.197 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.62 -43.64 36.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -54.87 -69.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.429 HG13 ' CB ' ' A' ' 82' ' ' PHE . 93.2 t -39.66 -44.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.933 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -58.74 -69.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.673 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.74 8.23 8.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -116.76 -43.72 2.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.715 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 13.8 m95 -95.64 -39.09 10.08 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.5 t -51.63 -45.47 91.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.489 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.3 Cg_exo -46.45 -38.44 21.04 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.359 2.039 . . . . 0.0 112.359 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.977 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.6 mm -49.28 -26.66 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 p -90.34 -22.4 21.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -69.14 -37.31 78.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.673 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -103.71 -70.6 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.662 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.78 108.73 1.51 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.43 -65.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.25 28.42 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.842 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.61 148.16 34.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.448 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . 53.1 Cg_exo -53.71 161.61 4.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.523 2.148 . . . . 0.0 112.157 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.0 126.14 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 111.073 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.08 120.57 41.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.8 mt -90.68 149.31 22.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 ' CG2' ' HA3' ' A' ' 15' ' ' GLY . 29.2 m -156.82 173.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.951 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 115' ' ' THR . . . 138.36 -125.94 3.33 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.634 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 114' ' ' GLY . 0.6 OUTLIER 77.59 148.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.308 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HB3' ' CB ' ' A' ' 119' ' ' LEU . 16.7 mp0 -137.38 128.49 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.0 mt -98.65 -38.38 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.13 -23.46 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.444 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 1.3 tt -73.02 -15.31 61.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.474 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -69.3 -163.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.727 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 22.95 13.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.127 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.84 141.89 33.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.799 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.71 -46.97 29.79 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -69.06 -33.34 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.6 m -52.59 -66.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -57.97 -38.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.014 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.73 -61.52 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -35.77 77.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.675 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.2 -26.21 4.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.488 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.02 -23.08 63.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -85.15 -24.6 27.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -95.1 29.27 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.6 34.8 2.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 52.33 -162.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt 65.88 89.23 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.35 143.63 75.68 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.576 2.184 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.441 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 6.0 mt -56.49 121.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -106.07 172.39 3.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.62 -19.95 25.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.696 2.264 . . . . 0.0 112.318 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -85.53 -31.62 22.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.435 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.6 m -59.93 -48.49 81.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.946 0.403 . . . . 0.0 110.676 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.6 -47.97 58.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.42 -41.73 73.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.304 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -47.22 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.56 -35.83 75.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.441 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.523 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -65.18 -30.63 71.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.083 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -75.1 -51.25 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -52.42 -48.01 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.86 -26.88 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 65.19 122.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.975 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -165.03 -160.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 17.3 t -61.37 -16.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.546 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.31 144.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.567 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CE2' ' CB ' ' A' ' 146' ' ' ALA . 37.5 p90 -152.15 144.09 23.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 124.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' CB ' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -171.03 -178.69 2.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 14.6 p -133.09 -173.18 3.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.36 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 t -87.48 159.66 18.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.787 0.327 . . . . 0.0 110.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 22' ' ' SER . . . -56.32 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 159' ' ' ALA . 0.6 OUTLIER 51.6 33.89 11.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.253 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 160' ' ' LEU . 1.4 p -167.82 -84.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.197 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.431 ' NE2' HD23 ' A' ' 165' ' ' LEU . 0.8 OUTLIER 73.43 104.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.019 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 -68.53 0.86 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.963 0.411 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.53 77.5 0.39 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.928 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' A' ' 23' ' ' TYR . 1.7 tp -92.19 -36.94 12.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.0 111.569 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -26.31 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.332 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -66.33 -73.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.0 p -44.59 -37.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.5 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.3 -44.2 97.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 0.0 110.653 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -59.28 -40.0 84.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.436 ' HG2' ' CE ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -77.82 -47.38 19.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.24 66.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.3 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.7 mm -82.21 -57.0 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.04 -29.02 11.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.089 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.63 63.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.02 -14.53 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.495 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 tp -91.88 21.23 5.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.258 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.882 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.18 -64.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.8 tt -140.75 151.88 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 2.2 m -130.77 133.35 45.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.19 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.49 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -62.1 136.99 95.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 169' ' ' PHE . 77.3 Cg_exo -48.68 144.05 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.401 2.067 . . . . 0.0 112.372 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -104.39 -54.71 2.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -67.56 162.43 23.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.498 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 6.1 t80 174.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.52 139.71 18.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.27 70.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.28 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.696 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.428 HG22 ' N ' ' B' ' 100' ' ' PRO . 1.3 mp -109.65 108.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 111.654 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -87.79 96.87 10.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.052 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 17.2 t -81.13 145.26 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.553 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -145.08 174.7 25.03 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.232 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -108.98 117.64 34.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.411 ' CB ' HG22 ' B' ' 97' ' ' THR . 42.2 t0 -123.89 136.18 54.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.972 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.41 0.77 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.894 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.421 HG11 ' CG2' ' B' ' 93' ' ' THR . 7.7 p -48.22 -25.96 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.885 0.374 . . . . 0.0 111.304 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.421 ' CG2' HG11 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -155.79 -39.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.325 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.84 11.91 2.53 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.406 ' CG ' HG22 ' B' ' 93' ' ' THR . 0.7 OUTLIER -122.85 172.11 8.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.889 0.344 . . . . 0.0 110.553 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.44 ' CG ' HG13 ' A' ' 36' ' ' VAL . 1.8 m-85 -67.73 158.06 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.365 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.411 HG22 ' CB ' ' B' ' 90' ' ' ASP . 29.2 p -119.71 165.88 13.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.91 27.62 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.909 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.411 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -77.33 163.1 66.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.933 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.428 ' N ' HG22 ' B' ' 85' ' ' ILE . 72.1 Cg_exo -48.52 136.21 26.46 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.246 . . . . 0.0 112.409 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.18 -39.75 14.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.028 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -47.62 34.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 67' ' ' LEU . 4.8 m0 -49.3 -59.97 3.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.546 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' B' ' 110' ' ' SER . . . -52.49 -59.57 4.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.033 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.7 mtt180 -48.46 -42.18 31.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.871 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.439 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.14 -54.63 19.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.63 -69.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' B' ' 110' ' ' SER . 6.2 tt0 -79.53 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.586 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 4.7 p -166.03 -46.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.444 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.2 OUTLIER -131.59 167.21 19.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.965 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -56.28 -54.85 40.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.879 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.88 171.42 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.62 139.19 54.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp -125.72 139.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.21 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -114.98 138.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.675 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.53 110.76 22.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 16.4 t -87.59 145.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.649 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 19.6 m -137.79 167.07 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.665 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' CG1' HG23 ' A' ' 101' ' ' ILE . 9.1 p -163.76 136.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 97' ' ' TRP . . . 139.44 148.93 5.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.821 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 160.68 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.638 0.256 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.84 86.28 0.01 OUTLIER Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.991 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' CB ' ' SG ' ' A' ' 18' ' ' CYS . . . 72.8 67.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.178 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 8' ' ' VAL . 3.7 p -48.7 -24.99 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . 125.18 -27.9 5.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.393 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.448 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -96.91 -73.46 0.6 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 111.443 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 3.3 p -45.82 -66.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.711 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' SG ' ' CB ' ' A' ' 13' ' ' ALA . 11.7 p -41.49 -48.12 3.83 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.792 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.9 -69.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.705 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 83.6 mt -40.53 -59.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' N ' HD11 ' A' ' 21' ' ' ILE . 1.1 mp -36.33 -55.65 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 1.2 t -93.72 -67.1 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.381 0.61 . . . . 0.0 110.672 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 165' ' ' LEU . 24.5 t80 -40.13 -66.68 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.835 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.3 m -85.95 -80.23 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 111.648 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -36.04 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.296 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.41 55.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.468 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HE3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -173.93 -174.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -101.13 166.46 12.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 80.0 Cg_exo -44.45 146.67 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.505 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.4 m -102.51 -82.25 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.709 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.54 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.519 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.38 92.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 92.7 t -136.31 138.74 27.84 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 36' ' ' VAL . 86.4 Cg_exo -42.93 106.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.352 2.035 . . . . 0.0 111.504 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 39.7 m -47.07 88.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 34' ' ' PRO . 89.7 t -98.03 -51.64 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.504 ' HB2' ' CZ3' ' B' ' 103' ' ' TRP . 60.0 t80 -163.35 95.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.751 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 25.9 m-20 -96.99 123.02 40.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.1 t-20 -108.07 150.25 27.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.832 0.349 . . . . 0.0 110.636 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.36 169.18 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.201 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.1 140.57 39.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.643 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 ' CB ' ' HB3' ' B' ' 78' ' ' PRO . 3.6 m -159.14 157.57 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.032 0.444 . . . . 0.0 111.908 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 51' ' ' TYR . 53.8 m -155.95 108.33 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 m -98.35 119.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.415 ' HE1' ' CB ' ' B' ' 76' ' ' SER . 30.3 mtm -74.95 104.91 5.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.884 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mm -94.78 111.44 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 20.67 71.35 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.561 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 41.57 8.18 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -140.59 147.82 50.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.792 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.9 153.09 77.77 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.565 2.177 . . . . 0.0 112.274 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' O ' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -147.98 162.04 40.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -135.31 97.39 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.573 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 7.4 tt -124.69 159.6 30.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -154.7 123.56 1.39 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 6.2 mp -75.87 119.65 20.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 6.9 m-85 -108.18 120.52 42.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' N ' ' HE3' ' A' ' 16' ' ' LYS . 1.4 t70 -67.77 174.74 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.338 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 64' ' ' TYR . 15.4 m -169.97 166.13 9.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.422 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 104' ' ' HIS . . . -136.28 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.472 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -78.32 -128.95 0.51 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.708 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.416 ' CD2' ' OD2' ' A' ' 65' ' ' ASP . 3.4 mm? 62.33 152.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.494 ' HA ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 mp0 -45.97 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.319 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 7.0 m-20 -90.69 57.04 3.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 1.5 t80 47.12 43.61 14.48 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' OD2' ' CD2' ' A' ' 61' ' ' LEU . 1.0 OUTLIER 71.22 -140.65 0.05 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -95.32 -1.93 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.192 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.527 ' CD1' ' CZ3' ' B' ' 103' ' ' TRP . 68.1 mt -88.0 51.73 2.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.369 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -94.06 -43.48 0.3 Allowed Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 13.1 Cg_exo -69.8 -42.74 3.1 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.19 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.486 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -86.51 11.91 11.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.631 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' ' CZ2' ' B' ' 103' ' ' TRP . 3.3 t -166.21 32.04 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.57 0.224 . . . . 0.0 111.043 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.484 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 7.6 p90 -33.34 122.36 0.45 Allowed Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.068 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 104' ' ' HIS . 26.7 Cg_exo -62.48 -27.3 76.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.536 2.157 . . . . 0.0 112.587 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.98 -10.03 45.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.86 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 72' ' ' TYR . 3.5 t -36.01 -55.01 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -158.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.497 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.93 163.24 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.298 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 9.0 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.426 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.3 tp -130.16 123.82 31.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.21 147.14 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.056 0.455 . . . . 0.0 111.943 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.409 ' HB2' ' HA3' ' A' ' 15' ' ' GLY . 17.8 m -139.63 155.27 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.408 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' HG13 ' A' ' 93' ' ' VAL . 6.7 p90 -162.21 164.17 27.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.78 157.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 116' ' ' GLN . 59.0 t -111.76 -75.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.09 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -81.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.42 105.13 0.47 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.871 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 -17.04 48.69 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.47 2.113 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t -48.91 -27.3 3.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.411 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 23.2 t -96.12 -37.59 10.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.456 ' CD2' HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -49.78 -62.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -50.23 -57.34 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.032 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 5.6 m-20 -51.34 -59.64 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.48 HG13 ' CD2' ' A' ' 82' ' ' PHE . 61.3 t -44.33 -38.95 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.671 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.9 -62.28 1.48 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.02 7.99 5.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -121.3 -43.89 2.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.492 ' CE2' ' HA3' ' A' ' 10' ' ' GLY . 20.0 m95 -95.59 -34.12 12.13 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 94.7 t -49.58 -47.28 78.66 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.2 Cg_endo -74.94 -11.56 21.59 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.051 1.834 . . . . 0.0 112.459 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.61 -43.48 9.61 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.09 0.472 . . . . 0.0 110.68 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HG23 ' CG1' ' A' ' 9' ' ' VAL . 11.7 pt -51.11 -34.97 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.484 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.6 p -52.87 -47.6 67.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.326 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.494 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 15.6 t60 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.183 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 66.5 m-70 -79.96 -31.47 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 28.1 p -111.88 94.52 24.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.953 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -51.73 -55.19 4.18 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.568 2.179 . . . . 0.0 112.412 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 31.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 139.94 24.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 152' ' ' VAL . 75.7 Cg_exo -51.27 -172.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.629 2.219 . . . . 0.0 112.259 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 15.3 p90 -161.3 129.65 4.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.29 129.94 44.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.474 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 1.2 pt? -131.8 133.38 44.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.561 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 154' ' ' TYR . 2.7 m -141.16 176.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.375 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.8 142.92 14.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.143 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.0 p -128.91 108.71 10.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 111.238 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 1.2 mt-30 170.7 66.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.426 HG12 ' CB ' ' A' ' 158' ' ' SER . 4.9 pt -98.64 -23.41 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.64 -36.99 11.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.73 -18.74 34.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.302 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -51.23 -23.79 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 111.15 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -44.73 -28.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 125' ' ' THR . 28.2 p-10 -66.53 116.72 37.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.23 -22.58 41.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.42 2.08 . . . . 0.0 112.275 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -56.07 -43.93 78.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 122' ' ' ASP . 10.1 t -50.95 -33.02 22.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mp -81.23 -42.76 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -49.48 -48.68 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -36.94 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.983 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.89 -26.63 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.18 63.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -94.22 -37.5 11.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -56.14 -24.42 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.17 53.33 0.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.13 170.36 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.425 ' HD3' ' CD ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -76.91 154.99 83.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.425 ' CD ' ' HD3' ' A' ' 135' ' ' LYS . 76.6 Cg_exo -49.98 122.1 8.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.231 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' A' ' 90' ' ' PHE . 6.4 mt -50.98 125.19 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -130.89 -179.8 1.14 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.551 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 76.9 Cg_exo -51.14 -22.69 11.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.438 2.092 . . . . 0.0 112.221 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.33 -42.5 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.428 ' CG2' HG22 ' A' ' 137' ' ' ILE . 57.2 m -49.92 -56.35 10.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.41 -38.09 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.85 -48.43 81.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.08 62.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -38.05 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.243 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.05 -45.27 83.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.768 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -58.1 -45.71 86.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -56.89 13.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.808 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.474 ' CD1' ' CB ' ' A' ' 151' ' ' ALA . 3.5 pp -62.17 -27.29 68.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 72.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.094 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 149' ' ' LEU . . . -109.07 -179.6 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 68.9 t -46.74 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 159.14 136.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.43 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 146' ' ' ALA . 11.1 p90 -153.15 141.84 20.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 111.544 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.06 124.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.854 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.65 -178.81 2.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.733 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.19 -173.32 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.64 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.426 ' CB ' HG12 ' A' ' 117' ' ' ILE . 5.0 p -87.2 156.0 19.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.349 . . . . 0.0 110.527 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 22' ' ' SER . . . -51.78 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.294 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.403 ' O ' ' CG2' ' A' ' 161' ' ' THR . 0.2 OUTLIER 55.0 24.03 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.422 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 169.9 128.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -126.31 121.73 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -101.2 -43.63 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.85 85.67 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 7.0 mt -85.3 -37.25 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -52.99 -24.84 10.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -63.45 -69.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.123 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 169' ' ' PHE . 7.6 p -47.27 -41.98 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.479 ' CD1' ' OH ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -67.59 -49.08 64.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -47.14 -45.37 22.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.428 ' HG3' ' CG ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -84.29 -47.68 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -53.95 -33.21 56.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 23.3 mm -87.84 -33.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.17 -56.75 13.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.72 -32.49 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.03 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.0 tp -54.3 -25.41 23.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -51.33 -76.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.96 0.41 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 tt -115.69 151.74 17.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.415 ' CB ' ' HE1' ' A' ' 45' ' ' MET . 0.5 OUTLIER -135.93 135.15 39.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.379 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.47 136.33 70.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.527 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.47 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 71.7 Cg_exo -50.7 143.69 28.34 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.479 2.12 . . . . 0.0 112.411 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.1 -70.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -58.08 88.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.509 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 9.5 t80 -113.25 136.28 52.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.34 130.0 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.386 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 96.95 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.926 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 1.1 mp -101.53 139.72 22.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.994 0.426 . . . . 0.0 111.979 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' B' ' 86' ' ' HIS . 52.1 p-80 -120.38 96.55 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.335 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 46.9 t -83.47 152.54 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.86 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.455 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -146.42 177.85 24.49 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.503 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.53 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 1.2 m-20 -132.68 134.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 1.11 20.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.909 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.412 HG11 ' N ' ' B' ' 93' ' ' THR . 7.3 p -46.08 -27.84 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.412 ' N ' HG11 ' B' ' 92' ' ' VAL . 6.2 t -148.58 -42.02 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.044 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.79 29.67 0.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.467 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -138.18 -159.47 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.704 0.288 . . . . 0.0 110.457 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 67' ' ' LEU . 3.5 m-85 -98.99 164.24 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.758 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -109.41 171.76 7.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 44.26 28.12 1.32 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.773 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.83 129.46 21.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.562 0.22 . . . . 0.0 110.883 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.423 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 50.3 Cg_exo -53.92 140.4 68.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.375 2.05 . . . . 0.0 111.884 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -42.67 -45.88 4.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.252 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -56.78 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.797 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.527 ' CZ3' ' CD1' ' A' ' 67' ' ' LEU . 3.6 m0 -52.36 -58.74 5.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.143 0.496 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' B' ' 108' ' ' GLN . . . -45.58 -70.32 0.11 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.136 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -47.32 -38.56 13.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.041 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -43.82 -64.88 0.58 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.859 0.361 . . . . 0.0 110.12 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.432 HD12 ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.09 -70.25 0.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' B' ' 110' ' ' SER . 0.6 OUTLIER -80.71 -160.39 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -154.23 57.43 0.71 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.26 -0.275 . . . . 0.0 111.042 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.435 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.4 OUTLIER 167.74 124.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.157 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -48.1 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.874 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.54 136.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -102.31 142.25 33.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.23 138.76 52.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.216 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.52 96.33 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.566 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.48 107.93 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 3.0 t -84.58 150.48 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 7.5 p -135.34 146.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.75 121.03 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.955 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' CD2' ' A' ' 97' ' ' TRP . . . 147.97 -174.32 27.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.68 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.68 155.4 49.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.367 . . . . 0.0 111.178 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 88.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.94 53.78 12.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' CG1' ' HD3' ' A' ' 16' ' ' LYS . 10.0 p -80.54 2.68 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.345 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 109.87 -29.62 9.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.663 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 57' ' ' ASP . 9.5 pttt -51.42 -67.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.773 -0.251 . . . . 0.0 111.635 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.81 -26.37 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 t -61.24 -58.42 8.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.424 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' TYR . 14.5 mt -50.99 -73.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.393 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' ' CG ' ' A' ' 40' ' ' TYR . 15.1 mt -39.35 -40.34 0.78 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -51.96 -67.35 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.8 t -93.27 -53.36 4.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.24 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 169' ' ' PHE . 13.9 t80 -44.51 -30.03 0.81 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.061 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 93.7 m -125.33 -101.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.492 HG22 ' CZ ' ' B' ' 81' ' ' PHE . 4.7 t -40.37 -34.8 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 75.65 47.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -151.4 136.91 17.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.438 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -58.42 166.7 2.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 28' ' ' PHE . 11.8 Cg_endo -55.69 171.81 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.945 2.43 . . . . 0.0 112.858 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 t -116.24 -75.38 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.099 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 129.06 39.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -90.66 104.32 16.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.198 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 35' ' ' THR . 5.2 p -160.78 140.51 8.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.915 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 55.7 Cg_exo -35.38 91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.933 2.422 . . . . 0.0 112.291 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' VAL . 98.8 m -51.32 87.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.15 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' B' ' 87' ' ' VAL . 88.6 t -84.9 -33.74 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 16.9 t80 -173.61 128.81 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.877 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 m-20 -127.86 148.98 50.49 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.778 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.435 ' CB ' ' OG1' ' B' ' 84' ' ' THR . 2.8 t-20 -107.07 157.27 17.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 0.0 110.69 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' CD1' ' A' ' 20' ' ' LEU . 4.2 m-85 -152.82 169.29 23.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.237 0.542 . . . . 0.0 112.006 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.6 115.56 18.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.642 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -141.13 155.53 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.438 . . . . 0.0 111.557 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.2 m -156.33 95.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.099 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' CG1' ' HD3' ' B' ' 78' ' ' PRO . 27.4 m -98.42 178.35 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.427 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 2.7 mtt -115.07 157.26 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 51' ' ' TYR . 18.0 mt -158.24 89.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.585 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.17 3.02 79.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.77 26.91 5.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.63 138.82 17.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.638 0.256 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.44 174.38 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.578 2.185 . . . . 0.0 112.198 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.87 171.2 17.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.002 0.43 . . . . 0.0 111.155 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -136.3 97.02 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.337 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 11.3 tp -98.22 157.71 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.954 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -163.22 103.01 0.21 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.426 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 20' ' ' LEU . 3.4 mm? -75.78 105.05 6.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.763 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.26 107.48 15.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.178 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -67.84 130.4 42.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.323 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.455 HG23 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.45 163.74 32.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . . . -103.34 -53.62 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.411 . . . . 0.0 111.004 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.23 -45.64 1.1 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.268 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -151.76 17.91 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 13.2 mt-10 -103.43 83.59 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.139 0.495 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 78.28 -3.49 2.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.604 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 24.2 m-85 -85.26 -13.7 48.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.747 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -39.49 -47.13 1.81 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.013 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -54.06 37.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 2.3 mp -78.59 82.24 4.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.19 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 24.1 ptt180 -88.2 -35.02 0.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 2.5 Cg_endo -82.68 7.95 4.86 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.081 . . . . 0.0 112.73 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.527 HD21 ' CE2' ' B' ' 103' ' ' TRP . 39.0 mt -51.54 111.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.485 0.659 . . . . 0.0 111.471 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 70.18 4.78 5.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.433 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 59.97 154.7 0.1 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.466 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.93 -52.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.947 2.432 . . . . 0.0 112.932 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -69.86 -8.2 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.986 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.444 ' CG2' HG22 ' A' ' 7' ' ' VAL . 1.1 t -32.79 -73.52 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.56 -155.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.86 162.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -98.5 127.34 44.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.467 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 13.5 tp -103.69 115.47 30.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.274 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' CG2' ' A' ' 14' ' ' VAL . 2.5 t -131.9 153.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.446 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 14' ' ' VAL . 62.6 m -142.65 172.02 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.511 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 50.8 p90 -164.41 151.72 11.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.105 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.47 136.8 42.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 ' CG1' ' HA2' ' A' ' 114' ' ' GLY . 5.3 m -107.15 68.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.12 -85.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.13 163.8 55.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.803 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 132' ' ' ASN . 51.7 Cg_endo -69.17 -22.53 34.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.58 2.187 . . . . 0.0 112.287 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 p -70.18 -33.83 72.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.2 p -51.89 -46.25 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -51.92 -69.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.067 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.93 -29.22 55.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.002 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.5 m-20 -62.47 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.446 HG12 ' CG ' ' A' ' 82' ' ' PHE . 7.2 p -41.38 -31.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.14 -70.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.842 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.57 8.11 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 27.3 tttm -113.68 -40.62 3.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CD2' ' HA3' ' A' ' 10' ' ' GLY . 11.0 m95 -95.96 -13.58 23.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 2.5 m -53.02 -32.57 10.37 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.5 Cg_exo -68.78 -41.87 5.26 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.782 1.654 . . . . 0.0 112.217 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' CG ' HD11 ' A' ' 61' ' ' LEU . 19.0 mp0 -58.56 -43.67 89.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.481 ' CG2' ' CD2' ' A' ' 110' ' ' PHE . 71.3 mt -48.58 -26.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -84.67 -37.16 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.58 -34.56 51.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -102.94 -61.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 8.4 m -109.29 85.61 3.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.2 -11.66 29.1 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.632 2.221 . . . . 0.0 112.794 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -152.78 40.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 111.419 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 139.88 36.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.853 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.18 143.96 17.82 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.542 2.161 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.6 p90 -131.39 130.52 42.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' CD1' ' HB ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -101.28 136.09 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.394 179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 154' ' ' TYR . 2.2 pp -146.78 114.19 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 154' ' ' TYR . 10.0 p -129.1 152.3 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.382 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -73.16 -176.92 32.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.305 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -174.14 172.36 3.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 111.426 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.413 ' N ' ' OG1' ' A' ' 115' ' ' THR . 14.1 mt-30 72.53 108.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.455 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 41.7 mt -98.48 -59.83 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 119' ' ' LEU . 24.9 p30 -55.02 -22.51 15.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.42 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 7.3 tp -61.93 -48.11 81.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 1.6 ptt180 -58.91 -22.89 60.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.72 -23.8 7.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -54.22 135.6 59.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.58 -42.55 64.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.522 2.148 . . . . 0.0 112.397 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -38.69 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 126' ' ' ILE . 19.7 p -59.05 -64.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.412 ' N ' ' OG1' ' A' ' 125' ' ' THR . 4.6 mp -48.65 -43.68 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.069 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 -32.93 68.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mt -50.81 -26.23 5.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.928 0.394 . . . . 0.0 110.295 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.35 -22.44 60.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.928 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.48 -22.51 37.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 87' ' ' PRO . 25.6 t30 -94.04 30.59 1.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.957 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 34.69 0.37 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.788 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.71 -160.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.45 95.65 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.773 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.56 141.8 56.69 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.608 2.205 . . . . 0.0 112.363 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.1 mt -67.47 125.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.442 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -124.43 177.73 1.68 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 51.1 Cg_exo -54.23 -24.7 35.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.691 2.26 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -86.36 -39.02 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.027 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.8 m -49.97 -48.29 52.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -49.91 61.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.04 -47.93 68.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.52 -40.62 59.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.593 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.477 HD11 ' CE2' ' A' ' 90' ' ' PHE . 8.5 tt -61.38 -41.69 97.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.524 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -53.33 -54.93 29.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -55.05 -38.83 68.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -51.49 -32.67 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.6 pp -125.39 21.86 7.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.142 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 58.1 -84.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.993 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 58.07 175.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 6.1 t -61.52 -15.99 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.484 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.45 140.84 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 110.466 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CE1' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -153.39 151.57 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 168' ' ' VAL . 14.9 m -157.93 123.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.579 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.36 152.21 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 83.3 m -101.82 -177.53 3.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.455 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 30.8 t -86.77 156.6 19.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.049 0.452 . . . . 0.0 111.594 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 160' ' ' LEU . . . -55.04 -169.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.029 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 50.87 24.89 1.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.549 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -174.17 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 57.66 115.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.338 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -64.07 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.28 92.98 0.11 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.419 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -93.79 -10.37 34.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.477 0.18 . . . . 0.0 111.455 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.16 -43.32 3.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.336 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.94 -67.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.732 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 155' ' ' VAL . 7.3 p -50.27 -28.78 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.78 -51.26 70.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.146 179.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 2.5 p30 -63.13 -32.24 73.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.4 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 24.6 tp10 -70.14 -30.68 67.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.98 -29.36 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 44.5 mm -94.95 -66.36 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -49.94 -45.76 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.979 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -55.34 -25.56 35.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.33 -29.23 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.057 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -92.7 44.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 28.5 m -55.34 -42.56 74.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.6 149.19 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.22 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 176.1 8.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -94.88 140.37 22.49 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' CG1' ' A' ' 44' ' ' VAL . 52.9 Cg_exo -54.61 -164.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.437 2.091 . . . . 0.0 112.103 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -167.79 -65.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.59 95.59 2.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.985 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.492 ' CZ ' HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -129.02 148.93 51.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.141 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -153.22 140.45 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.93 0.395 . . . . 0.0 111.758 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -75.48 95.34 3.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.051 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -77.02 -42.49 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 2.0 mt -129.07 147.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 111.558 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -141.12 97.16 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 63.3 t -78.25 125.07 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 111.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 172.92 15.91 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.869 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -98.62 111.23 23.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.29 128.78 43.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.36 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.15 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.918 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . 0.413 HG11 ' N ' ' B' ' 93' ' ' THR . 7.5 p -41.5 -30.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 111.591 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.47 ' CG2' ' CG ' ' B' ' 95' ' ' GLU . 1.1 t -151.61 21.1 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.151 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.96 25.27 67.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.47 ' CG ' ' CG2' ' B' ' 93' ' ' THR . 8.3 pt-20 -145.71 171.84 14.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -70.54 164.75 24.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.421 . . . . 0.0 110.745 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -110.45 176.68 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 43.05 28.54 0.76 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.87 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.447 ' HE2' ' CD2' ' A' ' 67' ' ' LEU . 3.0 mtp -57.74 124.63 69.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.252 . . . . 0.0 110.956 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.491 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 49.2 Cg_exo -38.86 152.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.792 2.328 . . . . 0.0 112.692 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' B' ' 105' ' ' ARG . 2.8 mt-10 -47.58 -43.24 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.065 0.459 . . . . 0.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -72.56 -57.67 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.246 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.527 ' CE2' HD21 ' A' ' 70' ' ' LEU . 13.1 m0 -48.31 -60.26 2.8 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.601 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' B' ' 99' ' ' MET . . . -47.47 -67.99 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 10.2 mtp85 -52.23 -34.4 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.032 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -45.75 -65.64 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.434 HD13 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -63.22 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.56 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' B' ' 110' ' ' SER . 0.4 OUTLIER -78.8 -100.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.677 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 11.7 p -164.94 -57.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.226 0 CA-C-O 120.788 0.327 . . . . 0.0 111.851 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.456 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -127.7 158.89 36.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.382 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' B' ' 111' ' ' ASN . 0.6 OUTLIER -45.15 -57.44 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.055 0.455 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.85 0.357 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -94.6 120.93 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.8 t -99.73 147.15 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.415 ' CD1' ' OH ' ' A' ' 51' ' ' TYR . 65.8 mt -135.66 103.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.426 ' O ' ' CG2' ' A' ' 75' ' ' THR . 5.6 mmtp -95.67 98.31 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -77.77 112.35 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.113 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 59.6 t -91.09 150.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 16' ' ' LYS . 7.3 p -139.51 147.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.063 0.458 . . . . 0.0 111.529 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 60' ' ' GLY . 7.1 p -138.27 120.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.534 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.62 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.769 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -20.87 15.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.782 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.431 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . -78.37 -45.17 10.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.69 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 18' ' ' CYS . . . 73.47 3.0 4.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 5.4 t -57.78 -17.93 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.242 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -81.25 -124.32 0.65 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.422 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -34.06 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -50.91 -71.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 51.7 t -48.03 -46.45 33.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.126 0.489 . . . . 0.0 110.985 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 69.4 tp -46.14 -59.78 2.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.537 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 21.8 mt -44.69 -49.15 10.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.708 0.29 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 27' ' ' LYS . 3.4 mm -42.58 -49.19 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.491 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -93.68 -61.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.453 0.644 . . . . 0.0 110.256 178.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 165' ' ' LEU . 1.2 t80 -39.8 -66.85 0.26 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.249 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' B' ' 78' ' ' PRO . 50.6 m -96.57 -77.54 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.366 0.603 . . . . 0.0 111.151 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.537 ' CG2' ' CZ ' ' B' ' 81' ' ' PHE . 0.2 OUTLIER -36.29 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.225 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t30 47.72 65.08 1.37 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 110.616 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.16 -169.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.316 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.485 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -111.91 157.89 38.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -51.2 143.05 34.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.669 2.246 . . . . 0.0 112.438 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 p -95.12 -80.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.22 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.89 109.33 21.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.02 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.11 107.73 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.103 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG13 ' CA ' ' B' ' 88' ' ' GLY . 59.2 t -157.89 131.89 5.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' VAL . 94.7 Cg_exo -41.86 92.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.379 2.053 . . . . 0.0 111.969 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.423 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 40.4 m -53.11 87.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.268 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' PRO . 12.2 t -73.41 -27.04 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 110.058 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 15.8 t80 -146.85 -79.78 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.312 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER 60.69 118.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.119 -179.089 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 t-20 -107.7 156.86 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -152.49 144.89 24.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.005 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.11 140.2 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.139 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 ' CG1' HG22 ' A' ' 24' ' ' THR . 25.6 m -154.81 132.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.4 m -125.39 95.31 4.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.13 123.75 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -72.8 100.18 2.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG2' HD23 ' A' ' 177' ' ' LEU . 24.7 mm -90.48 89.37 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.44 12.74 55.62 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 4.7 58.96 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.125 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.13 150.61 43.23 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.03 0.415 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.29 162.44 7.74 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.679 2.252 . . . . 0.0 112.126 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.415 ' OH ' ' CD1' ' A' ' 4' ' ' ILE . 7.0 t80 -154.11 153.28 31.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.952 0.406 . . . . 0.0 111.459 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 p -136.31 97.43 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.223 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 tt -112.51 144.89 41.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -127.5 112.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.183 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 5.6 mp -77.96 102.93 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.308 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 1.3 m-85 -88.86 103.01 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.01 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -73.57 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.94 0.4 . . . . 0.0 111.246 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.05 -171.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -156.69 149.27 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 9' ' ' VAL . . . -109.01 99.49 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.36 -65.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 170.02 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.736 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -111.14 27.29 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -91.42 -23.05 20.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -27.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' B' ' 107' ' ' LEU . 22.1 mtt180 -48.67 -40.27 27.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.877 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.522 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -92.12 40.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.638 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tpt180 -81.59 -66.46 0.23 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.499 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 19.3 Cg_endo -58.91 -15.16 25.73 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.56 2.173 . . . . 0.0 112.626 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.41 -13.0 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.108 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 1.3 t -111.6 -19.49 12.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.319 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 39.01 95.86 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.801 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 37.9 Cg_endo -66.2 -45.58 5.42 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.609 2.206 . . . . 0.0 112.183 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -12.08 47.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 6.6 t -40.56 -46.8 2.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.414 ' OD2' ' CG2' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -172.64 -160.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.749 0.309 . . . . 0.0 111.058 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -58.17 154.18 2.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.731 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -106.76 138.79 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.27 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -104.11 122.61 45.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.093 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.9 153.77 8.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.065 0.46 . . . . 0.0 111.919 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.27 155.66 18.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CZ ' HG22 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -166.07 121.66 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.968 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.88 164.4 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 115' ' ' THR . 34.5 t -147.67 66.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.318 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 70.8 t -151.27 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.76 137.71 43.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HG3' ' CB ' ' A' ' 132' ' ' ASN . 57.9 Cg_endo -72.06 -19.47 26.42 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.556 2.171 . . . . 0.0 112.325 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.8 p -56.91 -52.23 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.81 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -29.82 63.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -45.86 54.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -47.54 85.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -61.1 -66.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 82' ' ' PHE . 28.7 m -43.53 -40.84 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.664 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 19.2 tttm -57.44 -68.03 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.53 8.4 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.138 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.02 -38.69 3.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.404 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CE3' ' HB ' ' A' ' 93' ' ' VAL . 49.9 m0 -95.23 -40.89 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.511 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.51 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 60.7 t -55.85 -44.09 99.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 39.5 Cg_exo -60.22 -19.65 58.31 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.33 2.02 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.71 -30.8 56.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 8.4 tp -49.16 -31.4 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.198 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -77.71 -44.04 29.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -51.86 -37.76 53.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 5.3 m-70 -97.2 -61.72 1.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 4.7 t -74.42 108.89 5.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.501 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.49 -60.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.392 2.062 . . . . 0.0 112.419 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -154.68 36.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.29 153.98 40.83 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.89 145.68 97.67 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.606 2.204 . . . . 0.0 111.97 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 20.1 p90 -123.1 127.48 48.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.314 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' CD1' HG13 ' A' ' 152' ' ' VAL . 6.8 tt -109.14 119.29 39.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.045 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 mp -90.99 155.14 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.229 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG1' HD11 ' A' ' 19' ' ' LEU . 3.0 t -148.78 165.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . 143.41 154.63 6.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.433 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -176.78 164.48 2.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.408 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -172.25 93.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.815 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -25.72 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.855 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -95.26 -30.91 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.795 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -78.41 -44.72 24.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.449 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -53.14 -23.49 8.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 55.89 2.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.3 m-20 -111.11 150.04 41.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 -57.95 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.716 2.277 . . . . 0.0 112.374 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -34.57 75.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 54.2 m -55.49 -72.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 122' ' ' ASP . 3.7 mp -52.03 -39.1 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -32.08 30.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.048 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.67 -39.34 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.524 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.6 mt -49.9 -26.14 3.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.457 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.43 67.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -25.35 22.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.427 ' CB ' ' HG3' ' A' ' 87' ' ' PRO . 9.6 m120 -115.95 30.23 7.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 103.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.973 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -42.69 150.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 10.1 mttt 47.94 48.43 5.88 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 73.8 Cg_endo -75.88 -46.15 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.561 2.174 . . . . 0.0 112.562 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.427 HG23 ' CG1' ' A' ' 84' ' ' VAL . 5.7 mm -99.85 129.94 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -148.86 164.5 21.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.76 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.78 -23.31 8.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.546 2.164 . . . . 0.0 112.315 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -90.64 -41.23 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.1 m -49.02 -57.69 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.89 -49.56 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.65 -38.11 80.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -50.36 73.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.1 tp -57.25 -37.93 73.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . . . -71.57 -26.53 62.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ttt-85 -73.43 -40.7 64.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.21 -44.7 94.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 4.4 pp -71.77 -26.39 62.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.412 ' N ' HD13 ' A' ' 149' ' ' LEU . 9.0 tptt 69.05 109.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 149' ' ' LEU . . . -150.62 -161.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 91.2 t -56.82 -20.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.305 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 75.07 139.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.197 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 112' ' ' LEU . 39.6 p90 -152.8 162.09 41.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.7 m -158.13 124.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.695 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.62 167.55 7.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 17.4 p -118.9 -173.24 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -87.68 165.04 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.973 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' CB ' HD23 ' A' ' 160' ' ' LEU . . . -51.43 -175.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.435 HD23 ' CB ' ' A' ' 159' ' ' ALA . 1.7 mm? 66.23 -69.29 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.276 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.93 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.409 ' NE2' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 68.61 108.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.667 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -68.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.35 96.57 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 23' ' ' TYR . 19.2 mt -93.24 -17.62 23.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.68 0.276 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -62.92 -49.96 72.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.455 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 166' ' ' LYS . 23.1 m-80 -48.8 -71.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.42 ' CG1' ' OH ' ' A' ' 23' ' ' TYR . 3.5 p -47.62 -30.06 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -64.42 -38.21 90.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.779 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.442 ' CB ' HG13 ' B' ' 75' ' ' ILE . 17.4 t0 -63.63 -35.54 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.127 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -81.79 -24.63 35.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.851 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.73 41.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 21.2 mt -88.71 -48.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.204 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.46 -27.77 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.82 -37.14 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.52 -20.58 19.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.432 HD23 ' CG2' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -82.99 -24.58 32.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.017 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.876 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.3 p -99.36 -39.55 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.442 HG13 ' CB ' ' A' ' 170' ' ' ASP . 6.7 mm -140.33 139.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 3.5 p -138.69 141.85 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.24 131.67 88.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.439 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 53.1 Cg_exo -54.63 154.29 20.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.399 2.066 . . . . 0.0 112.273 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.86 -43.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.87 61.63 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.976 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 23.7 t80 -74.39 149.8 40.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.65 101.72 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -72.34 69.31 0.81 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' B' ' 85' ' ' ILE . 44.8 p -52.43 -85.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.245 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.435 ' N ' ' OG1' ' B' ' 84' ' ' THR . 0.5 OUTLIER -96.95 145.32 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.096 0.474 . . . . 0.0 112.092 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.95 96.89 4.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.519 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 29.7 t -78.03 157.29 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.969 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.433 ' CA ' HG13 ' A' ' 33' ' ' VAL . . . -146.43 177.92 24.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -84.52 119.08 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.425 ' CB ' HG22 ' B' ' 97' ' ' THR . 13.8 t0 -111.01 98.32 7.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.23 61.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 p -46.92 -33.47 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.308 . . . . 0.0 111.436 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' B' ' 95' ' ' GLU . 7.8 t -148.16 23.72 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.17 25.39 72.25 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.622 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 17.4 pt-20 -119.84 -166.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.732 0.301 . . . . 0.0 110.791 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 m-85 -103.9 163.74 12.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.425 HG22 ' CB ' ' B' ' 90' ' ' ASP . 1.6 p -104.64 150.05 25.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.576 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.415 ' HA3' ' ND2' ' B' ' 111' ' ' ASN . . . 69.5 43.93 66.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.473 ' CG ' ' CB ' ' B' ' 104' ' ' ALA . 2.7 tpt -47.28 103.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.551 0.215 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.493 ' HG2' ' CD2' ' A' ' 37' ' ' PHE . 77.5 Cg_exo -50.3 147.44 16.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.487 2.125 . . . . 0.0 111.915 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -66.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -65.7 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.417 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.522 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -46.71 -56.85 5.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.201 0.524 . . . . 0.0 110.552 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.473 ' CB ' ' CG ' ' B' ' 99' ' ' MET . . . -55.26 -60.91 2.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.653 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 6.1 mtt-85 -42.42 -36.23 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.368 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -60.81 -60.72 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.32 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.18 -64.36 1.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.481 ' O ' ' CG2' ' B' ' 109' ' ' THR . 5.5 tp60 -76.93 -79.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.236 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 6.0 p 96.78 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.366 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 171.26 93.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.958 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' HA3' ' B' ' 98' ' ' GLY . 1.7 t30 -49.78 92.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.611 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' B' ' 110' ' ' SER . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.187 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.769 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.58 167.57 11.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -91.83 132.63 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.25 133.41 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.422 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -123.27 149.44 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.722 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.97 96.05 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 78' ' ' PHE . 56.4 t -100.79 128.01 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' CG2' ' HG2' ' A' ' 16' ' ' LYS . 18.5 m -106.73 169.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.28 121.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.98 -140.58 5.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HB2' ' CE2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -126.5 -78.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' VAL . . . -60.36 -147.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' CB ' ' SG ' ' A' ' 18' ' ' CYS . . . -60.81 78.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 110.78 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.487 ' HA ' ' N ' ' A' ' 81' ' ' CYS . 2.5 t -73.81 -1.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.142 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . 95.62 -24.74 28.08 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HG2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.32 -64.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.431 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -96.09 -34.35 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 13' ' ' ALA . 3.3 p -66.39 -45.19 80.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HG ' ' CD1' ' A' ' 23' ' ' TYR . 8.1 tp -61.29 -73.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.959 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -43.86 -48.45 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.397 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -47.74 -69.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.01 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 2.1 t -93.2 -60.89 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.462 . . . . 0.0 111.971 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.543 ' CE2' ' CB ' ' A' ' 165' ' ' LEU . 8.2 t80 -47.6 -24.96 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.6 m -111.36 -96.25 0.42 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.562 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.508 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.6 t -60.07 -21.76 61.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 27.9 t-20 72.1 30.38 2.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.9 OUTLIER -125.78 134.75 51.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -69.21 160.12 80.17 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.042 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.2 Cg_endo -50.64 169.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.965 2.444 . . . . 0.0 112.409 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -74.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 134.11 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.21 110.06 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.424 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -154.78 138.85 11.27 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.497 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 36' ' ' VAL . 93.8 Cg_exo -41.18 109.07 0.1 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.46 2.107 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.437 HG23 ' CE ' ' A' ' 16' ' ' LYS . 18.1 m -47.16 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.297 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' CG ' ' B' ' 96' ' ' PHE . 61.3 t -103.78 -53.77 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.886 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.493 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 45.8 t80 -159.0 78.46 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 12.2 m-20 -80.59 121.52 25.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 26.6 t-20 -107.07 151.2 25.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.037 0.446 . . . . 0.0 111.272 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.2 160.03 43.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.216 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.25 116.97 29.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.906 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.452 ' CG1' ' CB ' ' B' ' 78' ' ' PRO . 1.4 m -146.08 132.07 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.059 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.0 m -127.49 112.19 14.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.838 0.352 . . . . 0.0 110.215 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.485 HG23 ' CD2' ' A' ' 169' ' ' PHE . 92.6 t -97.73 117.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.215 0.531 . . . . 0.0 110.143 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -93.42 106.09 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.294 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.418 HG21 ' CD1' ' B' ' 75' ' ' ILE . 7.2 mt -85.82 100.97 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.845 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.25 19.86 56.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.361 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.33 -46.31 1.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.595 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.72 139.69 97.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.663 0.268 . . . . 0.0 111.031 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.0 158.71 49.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.13 150.03 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.4 p -86.63 97.8 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.718 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.429 ' HG ' ' CD1' ' A' ' 173' ' ' ILE . 1.0 OUTLIER -133.76 137.31 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.409 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -162.25 145.4 10.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.551 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.431 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 3.1 mm? -75.88 114.34 14.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.636 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.2 103.72 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.062 0.458 . . . . 0.0 109.843 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 1.5 m-20 -67.51 137.12 55.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.424 ' CG2' ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -176.07 135.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.806 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -76.52 -61.97 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.221 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.99 89.56 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -118.63 -38.5 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 166.81 -30.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.22 -24.21 27.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 18.7 m-85 -56.6 -20.19 19.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -41.77 -30.26 0.23 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.768 0.318 . . . . 0.0 111.446 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -70.01 -48.66 57.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -88.56 49.55 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.552 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -99.45 -43.39 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.0 Cg_exo -58.12 -14.63 19.93 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.63 2.22 . . . . 0.0 112.979 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -104.07 -15.6 15.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.103 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -132.9 22.07 4.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.494 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 15.1 p90 -46.61 114.33 2.67 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.106 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 37.8 Cg_endo -65.72 -21.42 58.61 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.562 2.175 . . . . 0.0 112.32 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -65.92 -11.79 49.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.231 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.494 ' HB ' ' CD1' ' A' ' 72' ' ' TYR . 8.9 t -41.47 -48.55 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 111.47 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 2.6 m-20 -164.54 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 24.9 t -132.14 156.7 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 110' ' ' PHE . 36.2 p90 -144.57 140.96 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 111.462 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.429 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.65 150.0 24.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 111' ' ' LEU . 2.5 t -131.34 154.62 40.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.186 0.517 . . . . 0.0 111.913 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.487 ' N ' ' HA ' ' A' ' 14' ' ' VAL . 10.1 p -68.15 172.93 5.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.815 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CZ ' ' CD2' ' A' ' 145' ' ' LEU . 0.9 OUTLIER 179.44 100.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.62 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 m -58.57 91.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 ' CA ' HG22 ' A' ' 137' ' ' ILE . 10.4 m -83.52 54.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' CG2' ' N ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -150.6 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.531 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.481 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 4.2 t -57.5 135.76 82.04 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.618 0.247 . . . . 0.0 110.64 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.25 -39.42 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.548 2.165 . . . . 0.0 112.478 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.24 -24.02 6.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.18 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 70.5 m -88.68 -40.34 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -42.32 -53.04 4.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.686 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -48.34 -55.41 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.364 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.0 m-20 -70.78 -37.89 73.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.189 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.478 HG11 ' CE3' ' A' ' 97' ' ' TRP . 98.6 t -44.09 -45.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.639 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -85.69 -47.79 9.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.38 7.67 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -128.56 -38.09 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.478 ' CE3' HG11 ' A' ' 93' ' ' VAL . 46.1 m0 -95.13 -26.54 15.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.516 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 59.7 t -67.35 -44.1 45.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.563 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 41.6 Cg_exo -56.87 -34.98 98.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.324 2.016 . . . . 0.0 112.308 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.16 -33.29 74.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.6 mt -49.17 -40.25 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.5 p -77.3 -21.44 53.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.328 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.45 -37.2 77.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.86 0.362 . . . . 0.0 110.678 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 73' ' ' PRO . 22.1 m-70 -106.51 -39.75 5.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.813 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 3.9 m -99.25 102.74 16.9 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -42.99 -62.29 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.479 2.119 . . . . 0.0 112.403 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -171.67 40.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 155.76 41.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.646 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.91 118.21 2.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.457 2.104 . . . . 0.0 112.179 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.2 p90 -104.89 141.99 35.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.431 ' CD1' ' HB ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.319 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 3.5 mt -129.49 158.11 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.989 0.423 . . . . 0.0 111.244 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.56 155.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.44 39.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.415 ' HB ' ' CB ' ' A' ' 158' ' ' SER . 73.0 p -146.29 160.04 42.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.699 0.285 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.42 35.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.406 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 20.0 mt -97.04 -61.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.987 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.66 -35.88 11.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.79 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.52 -32.21 69.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.423 ' CG ' HG22 ' A' ' 85' ' ' VAL . 7.0 ttm180 -76.63 59.38 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -129.21 37.29 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.87 141.64 22.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.44 -49.57 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.556 2.171 . . . . 0.0 112.265 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m -57.77 -22.98 49.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -48.83 -66.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -57.69 -45.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.154 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -50.19 52.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.37 -35.09 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.91 -25.56 4.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.495 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.26 -21.41 56.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.081 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -83.38 -20.05 34.93 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.98 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.89 30.55 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 77.79 32.95 0.38 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.39 -161.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.14 93.25 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 124.85 13.12 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.548 2.165 . . . . 0.0 112.064 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.469 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 3.7 mt -50.55 120.29 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -118.12 158.41 46.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 3.7 Cg_exo -40.3 -29.42 0.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.071 2.514 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -36.75 21.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' THR . 93.5 m -48.05 -47.61 33.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.31 -46.58 46.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -42.95 84.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.42 -53.47 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 14.8 tp -57.26 -31.95 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.467 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -66.66 -31.59 72.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -70.34 -47.64 60.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -23.14 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.4 pp -106.3 -24.26 12.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 1.2 tttt 62.16 120.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.845 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -159.7 -161.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 5.1 t -67.37 -15.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.574 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.32 146.02 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 112' ' ' LEU . 24.3 p90 -152.79 126.25 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.186 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 3.1 t -138.12 123.39 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -170.73 -179.63 2.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 17.6 p -130.62 -173.22 3.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.415 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 8.7 t -87.15 163.2 17.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.702 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 22' ' ' SER . . . -52.25 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.058 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 69.73 -63.25 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.64 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.2 p -89.51 -169.62 2.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -172.56 109.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -100.39 -38.75 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.44 88.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.304 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.543 ' CB ' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -91.98 -11.54 35.8 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -34.22 37.36 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -57.09 -45.43 83.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.283 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 31.1 t -54.76 -52.96 37.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.472 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 44' ' ' VAL . 1.4 m-30 -70.15 -28.25 65.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -53.93 -52.12 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.775 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.9 -33.9 16.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -66.14 -38.38 88.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.429 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 42.3 mm -86.66 -44.17 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.4 tm? -64.43 -31.94 73.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.75 -29.29 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.98 66.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.18 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.71 38.3 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.286 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -27.49 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.339 . . . . 0.0 110.898 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.418 ' CD1' HG21 ' A' ' 46' ' ' ILE . 19.9 mm -144.03 137.41 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.65 133.54 32.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.2 143.23 69.28 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.59 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.452 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 51.3 Cg_exo -54.12 152.36 24.84 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.352 2.035 . . . . 0.0 112.062 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -117.19 -37.07 3.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.89 163.05 27.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.508 ' CD2' ' HB ' ' A' ' 25' ' ' THR . 27.6 t80 -167.46 130.35 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.624 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -153.42 116.67 4.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 69.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.414 ' N ' ' O ' ' B' ' 82' ' ' GLU . 8.2 p -57.9 -77.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.247 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.434 ' CG2' ' HG3' ' B' ' 100' ' ' PRO . 1.1 mp -103.76 139.44 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.499 . . . . 0.0 112.279 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -123.11 96.21 4.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.101 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.491 ' CG1' ' CG1' ' A' ' 36' ' ' VAL . 57.7 t -88.08 144.51 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.891 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.36 176.85 20.05 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.989 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -77.35 113.42 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.99 108.05 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.66 -17.2 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.307 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 10.2 p -43.01 -35.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.643 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -157.79 45.33 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.54 27.39 5.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.62 -168.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.719 0.295 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.531 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -106.0 164.49 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.829 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 1.9 p -99.45 165.31 11.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.09 51.73 24.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.762 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.423 ' HE3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -60.48 119.33 42.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.441 ' HG2' ' CD2' ' A' ' 37' ' ' PHE . 58.4 Cg_exo -49.56 156.46 2.9 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.291 1.994 . . . . 0.0 112.146 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.67 -57.1 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.455 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -69.94 -52.52 23.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.225 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.539 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -50.1 -57.77 6.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.725 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.204 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 77.5 mtt180 -54.76 -34.29 62.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.242 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.432 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.05 -61.04 2.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.925 0.393 . . . . 0.0 109.978 179.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.41 -70.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.15 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' B' ' 109' ' ' THR . 4.0 pt20 -80.74 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.203 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 0.5 OUTLIER 159.05 62.58 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.459 0.304 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 168.41 108.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.384 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' B' ' 111' ' ' ASN . 0.8 OUTLIER -65.39 74.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . 0.441 HD11 ' N ' ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 121.196 0.522 . . . . 0.0 111.311 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 69.44 140.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.27 144.68 46.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.1 pt -119.87 114.57 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.11 100.05 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -77.93 130.21 36.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' CG1' HG23 ' A' ' 75' ' ' THR . 2.1 m -96.67 150.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.433 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 17.9 t -125.63 154.29 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.362 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 59' ' ' ALA . 7.2 p -149.64 121.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' CD2' ' A' ' 97' ' ' TRP . . . 130.6 -179.52 16.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.93 -179.53 5.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.48 77.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.379 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 81' ' ' CYS . . . 53.41 84.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -109.23 4.26 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.286 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 19' ' ' LEU . . . 97.09 -18.19 57.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.281 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' CG ' HG21 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.92 -74.19 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.773 0.321 . . . . 0.0 111.515 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.62 -25.88 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' SG ' ' C8 ' ' A' ' 185' ' ' GNP . 2.1 p -65.61 -48.11 73.38 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.705 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 23' ' ' TYR . 4.3 mt -61.26 -73.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.349 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.476 HD11 ' CD2' ' A' ' 40' ' ' TYR . 11.2 mt -40.8 -43.42 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.981 0.419 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -48.71 -69.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.806 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 1.8 t -93.79 -55.39 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CZ ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -51.96 -19.25 1.7 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.498 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 43.2 m -123.94 -86.23 0.64 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.232 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 4.7 t -65.83 -14.21 60.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' ILE . 36.0 t30 79.03 -56.28 0.44 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.908 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HD3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -47.74 145.74 2.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.996 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -88.48 167.01 20.32 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.7 Cg_endo -45.82 165.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.993 2.462 . . . . 0.0 112.688 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.8 t -119.56 -76.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.98 113.94 25.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.643 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.28 109.3 4.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 111.056 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' THR . 67.2 t -157.52 138.03 9.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.478 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 84.3 Cg_exo -43.81 92.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.314 2.009 . . . . 0.0 111.617 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.43 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 56.8 m -51.98 87.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' B' ' 96' ' ' PHE . 20.9 t -79.54 -28.23 12.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 109.762 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.483 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 3.7 t80 -146.62 -68.76 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 1.2 m-20 60.47 131.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.389 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 5.6 t-20 -108.0 159.81 16.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.476 ' CD2' HD11 ' A' ' 20' ' ' LEU . 3.7 m-85 -152.18 157.44 41.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -115.29 137.94 51.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.176 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 3.2 m -162.2 164.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.8 m -155.94 99.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.483 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.54 117.15 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.806 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.5 mtm -91.37 102.12 14.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.21 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 1.7 mp -87.3 107.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 20.84 77.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.39 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -141.67 100.47 6.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.949 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.38 155.95 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.501 2.134 . . . . 0.0 112.196 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -154.16 169.63 23.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 111.327 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 97.22 4.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.321 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -105.04 161.26 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 111.375 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -160.27 127.3 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.057 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 20' ' ' LEU . 1.8 mm? -75.93 103.23 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.9 103.0 12.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.022 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 m-20 -78.19 142.57 37.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 57' ' ' ASP . 2.2 p -167.72 178.68 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 64' ' ' TYR . . . -127.17 -66.71 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . 104.06 54.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.757 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 170.48 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.324 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 22.7 mt-10 -85.79 89.96 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.186 0.517 . . . . 0.0 111.886 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 61.71 13.66 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.02 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' CE2' ' HB1' ' A' ' 59' ' ' ALA . 93.7 m-85 -102.62 -29.07 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -49.21 -27.37 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -93.49 -31.54 14.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.699 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.532 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -94.02 24.16 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -85.31 -46.31 0.63 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.205 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.7 Cg_exo -50.16 -23.15 9.14 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.487 HD11 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -76.24 -26.05 55.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.339 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.447 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 2.3 m -92.62 -23.42 19.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.487 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 2.0 p90 46.29 102.7 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.501 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.81 -34.28 8.29 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.657 2.238 . . . . 0.0 112.663 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.83 -10.66 50.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.563 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.487 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 8.3 t -38.42 -51.66 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 167.97 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.942 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 p -58.44 162.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -99.5 135.46 40.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 55' ' ' LEU . 12.6 tp -109.95 115.78 30.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.059 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.1 t -131.23 145.86 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.411 ' HB3' ' CA ' ' A' ' 14' ' ' VAL . 11.4 t -139.17 158.66 43.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 7.6 p90 -152.37 149.52 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -51.36 160.77 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG22 ' CA ' ' A' ' 115' ' ' THR . 73.0 t -109.09 -69.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.0 t -52.03 -73.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.88 106.16 0.61 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.3 -25.76 13.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.528 2.152 . . . . 0.0 112.551 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.69 -24.16 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.8 m -96.15 -30.69 13.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.158 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.95 -69.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.125 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -50.47 -48.29 56.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.5 m-80 -53.2 -69.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 82' ' ' PHE . 61.5 t -40.45 -30.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.925 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.61 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.38 8.42 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.953 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 92' ' ' ASN . 21.8 mmtm -113.3 -44.79 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.492 ' CD2' ' HA3' ' A' ' 10' ' ' GLY . 10.4 m95 -95.55 -36.79 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 94.1 t -52.5 -44.74 95.2 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.511 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 52.9 Cg_exo -52.51 -28.47 36.35 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.288 1.992 . . . . 0.0 112.288 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.94 -22.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.6 mm -49.17 -31.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -85.01 -24.87 28.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 60' ' ' GLY . 9.9 t60 -65.78 -37.22 85.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -103.71 -19.66 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.256 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 12.2 m -152.88 74.49 7.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.761 0.315 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -12.57 33.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.617 2.211 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.57 21.16 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.255 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 135.67 25.04 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.85 159.63 4.87 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.498 2.132 . . . . 0.0 112.148 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 16.5 p90 -135.76 134.93 39.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.85 122.03 46.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.875 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.49 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 12.4 mt -91.15 162.94 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' PHE . 49.0 t -152.79 141.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.1 104.45 0.35 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.392 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.435 ' HB ' ' CA ' ' A' ' 158' ' ' SER . 71.1 p -137.84 137.56 38.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 177.32 71.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 pt -98.69 -22.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.7 -24.41 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.15 -27.91 59.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -50.22 139.66 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.65 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.023 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -54.16 120.94 27.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.2 -41.42 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t -49.53 -31.67 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 85.7 m -56.83 -58.98 5.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -51.38 -45.34 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -42.53 61.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -37.27 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -50.71 -25.51 4.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.496 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.62 -20.46 53.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.21 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -81.3 -27.03 35.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.8 -8.36 57.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.454 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 62.89 26.45 15.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -100.84 -26.33 13.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.77 168.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.27 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.6 mt -51.52 135.37 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.224 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.438 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -132.31 177.75 2.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -53.35 -21.15 16.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.64 -42.34 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.7 m -50.88 -46.75 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.27 -40.43 58.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -43.87 97.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -51.55 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.799 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.78 -44.42 77.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . . . -60.47 -31.38 70.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.86 -44.11 86.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.53 -50.64 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 4.3 pp -68.14 -27.32 66.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.59 108.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -148.82 -162.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.429 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 57.3 t -67.34 -11.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.678 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 73.87 139.77 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.703 0.287 . . . . 0.0 110.86 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' A' ' 112' ' ' LEU . 24.6 p90 -153.11 162.64 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.9 m -158.32 124.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.624 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -171.06 166.37 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.41 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 18.2 p -113.82 -173.13 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.435 ' CA ' ' HB ' ' A' ' 115' ' ' THR . 8.4 t -87.61 166.81 14.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.898 0.38 . . . . 0.0 111.029 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 22' ' ' SER . . . -52.16 -174.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.412 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.403 HD23 ' CB ' ' A' ' 159' ' ' ALA . 1.4 mm? 67.72 -64.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 166.14 11.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.01 122.94 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -105.07 -37.33 6.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 165.44 79.87 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.486 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 4.0 mt -83.89 -25.14 30.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 111.029 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -52.78 -31.46 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.416 ' N ' ' HD3' ' A' ' 166' ' ' LYS . 12.1 m-80 -65.28 -65.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.74 -27.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.936 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -74.3 -35.13 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.272 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.437 ' CB ' HG13 ' B' ' 75' ' ' ILE . 5.1 t70 -63.26 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.516 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 -25.6 25.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.769 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.99 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.054 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 46' ' ' ILE . 31.6 mm -94.8 -23.71 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.8 tt -72.5 -45.96 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.87 71.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.63 -19.67 23.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.437 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -47.47 -41.54 20.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.151 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 50.51 81.83 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.84 102.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.73 135.75 71.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.588 2.192 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.08 145.86 31.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 74.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.557 2.171 . . . . 0.0 112.257 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.26 129.53 54.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.881 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.06 -83.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.437 HG13 ' CB ' ' A' ' 170' ' ' ASP . 8.4 mm -91.67 140.03 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 70.9 m -128.38 139.58 52.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -75.88 138.73 69.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.431 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 65.6 Cg_exo -51.3 146.85 22.98 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.461 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 30.8 t -108.41 -51.3 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -77.49 167.88 20.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.501 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 6.5 t80 171.41 124.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -153.19 132.38 12.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 111.382 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -68.91 95.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.43 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -74.51 -62.86 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.576 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.43 ' N ' ' OG1' ' B' ' 84' ' ' THR . 1.1 mp -116.87 113.94 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.888 0.375 . . . . 0.0 111.499 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.08 96.91 7.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.198 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 39.4 t -79.31 137.77 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.445 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.14 177.56 18.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -77.26 136.48 38.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 95' ' ' GLU . 10.0 t0 -124.21 110.1 14.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.11 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -40.98 -48.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.848 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.4 p -155.48 50.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 47.73 33.42 9.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.421 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' B' ' 90' ' ' ASP . 11.8 pt-20 -118.31 -178.01 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.325 . . . . 0.0 110.79 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.479 ' CD2' HG13 ' A' ' 36' ' ' VAL . 2.3 m-85 -101.95 164.23 11.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 19.4 p -109.78 168.86 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 48.71 27.58 6.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.432 ' HE2' ' CD2' ' A' ' 67' ' ' LEU . 2.7 mtp -52.64 131.11 46.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.593 0.235 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.469 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 81.3 Cg_exo -49.5 145.74 15.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.554 2.17 . . . . 0.0 112.19 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -45.59 -39.93 8.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -78.57 -51.12 10.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.525 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.532 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 2.6 m0 -53.76 -55.43 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 109.622 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.64 -62.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.841 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 15.9 ptt85 -55.95 -36.31 67.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.301 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -46.83 -63.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.414 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -96.2 -69.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.193 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.449 ' O ' ' CB ' ' B' ' 109' ' ' THR . 0.4 OUTLIER -80.4 -105.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.071 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 0.5 OUTLIER 159.34 -24.14 0.0 OUTLIER 'General case' 0 C--N 1.351 0.653 0 C-N-CA 122.43 0.292 . . . . 0.0 111.361 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.432 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.0 OUTLIER -109.5 107.9 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.332 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.415 ' N ' ' OD1' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -43.43 -50.81 6.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 110.847 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.4 87.09 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 7.0 m 68.99 -63.52 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.064 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' B' ' 116' ' ' GLU . 9.4 mtpt -132.05 39.67 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.985 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m 60.8 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 114' ' ' LYS . 0.6 OUTLIER -177.89 153.98 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -93.34 97.93 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.876 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.448 HN21 HD12 ' A' ' 165' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -103.15 132.43 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.49 153.22 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.4 pt -158.04 121.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.981 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 112.88 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -91.86 128.73 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 71' ' ' SER . 59.1 t -107.24 159.06 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.994 0.426 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 4.9 m -126.79 163.24 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.469 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 3.5 t -153.68 123.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.212 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 147.7 168.97 14.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.735 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -60.0 -152.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -40.73 141.48 0.92 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.89 62.48 2.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.182 0.515 . . . . 0.0 109.701 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 9' ' ' VAL . 2.9 t -54.68 -19.62 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 132.6 -36.04 2.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' N ' HG13 ' A' ' 8' ' ' VAL . 7.5 mmtt -95.91 -73.71 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.237 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.414 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 4.7 t -36.09 -53.06 0.79 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.4 p -63.8 -48.6 76.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.785 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 HD21 ' CG ' ' A' ' 23' ' ' TYR . 12.5 mt -55.71 -72.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 40' ' ' TYR . 8.6 mt -38.09 -43.05 0.71 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.588 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -49.4 -69.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.459 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -93.47 -54.16 3.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.157 0.503 . . . . 0.0 111.452 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CE1' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -51.31 -21.82 2.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.411 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 77.2 m -120.63 -88.07 0.63 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.832 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.502 HG22 ' CZ ' ' B' ' 81' ' ' PHE . 5.0 t -54.89 -30.46 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.219 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.6 OUTLIER 76.64 51.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 25' ' ' THR . 0.2 OUTLIER -158.83 116.28 2.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.768 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -45.85 168.39 0.11 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.884 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 61.7 Cg_exo -53.05 158.32 6.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.743 2.295 . . . . 0.0 112.981 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.1 t -107.44 -76.25 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.779 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.45 108.04 19.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.377 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.8 100.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.45 . . . . 0.0 111.161 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 96.5 t -151.51 139.51 12.85 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.207 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' VAL . 98.1 Cg_exo -41.58 91.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.385 2.056 . . . . 0.0 112.04 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' VAL . 93.0 m -54.25 87.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' PRO . 59.5 t -85.99 -24.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.398 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CD2' ' HG3' ' B' ' 100' ' ' PRO . 2.6 t80 -142.39 -66.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 6.1 m-20 53.71 107.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 41.7 t30 -107.6 153.08 23.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.794 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -149.47 168.82 22.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.71 115.62 28.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' HB ' ' CG ' ' B' ' 78' ' ' PRO . 12.3 m -134.38 137.68 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.1 m -136.7 108.59 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 m -98.24 117.29 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.052 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.2 mtm -79.4 100.98 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mm -87.95 91.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.077 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.43 16.04 74.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.709 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.09 25.8 10.9 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.736 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -124.65 131.26 24.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.554 0.216 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 159.07 28.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.466 2.111 . . . . 0.0 112.271 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.51 41.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -136.44 97.42 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.531 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -107.34 131.76 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.266 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.17 134.24 11.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.252 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -113.19 103.1 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.945 0.402 . . . . 0.0 110.905 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 4.1 m-85 -102.11 111.28 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD2' ' CG2' ' A' ' 17' ' ' THR . 4.5 t70 -88.01 171.4 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 8' ' ' VAL . 8.4 p -139.56 -175.7 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.715 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.02 -23.44 14.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.071 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . . . 74.71 51.78 7.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.359 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.0 174.89 11.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.88 30.77 2.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.1 28.81 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CD2' ' CE1' ' A' ' 104' ' ' HIS . 1.8 m-85 -101.14 -11.74 19.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -43.06 -28.51 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.675 0.274 . . . . 0.0 111.592 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 3.5 mtt85 -45.02 -62.82 1.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' CD2' ' CG ' ' B' ' 103' ' ' TRP . 1.3 mp -72.33 173.5 8.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 5.2 tpp180 -101.0 -72.66 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.5 Cg_endo -71.4 -58.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.036 1.824 . . . . 0.0 113.06 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.494 HD21 ' CZ2' ' B' ' 103' ' ' TRP . 63.4 mt 50.1 25.65 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.479 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.7 OUTLIER 164.17 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.02 175.25 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 111.072 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 72' ' ' TYR . 34.3 Cg_exo -61.9 -24.41 77.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.645 2.23 . . . . 0.0 112.17 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -68.06 -10.12 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.608 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -36.94 -32.15 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t0 51.62 -151.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.537 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -57.56 156.2 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.692 0.282 . . . . 0.0 110.478 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -113.34 134.51 54.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.93 122.22 44.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.08 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 3.2 t -130.35 101.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.0 t -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -137.34 124.68 21.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.008 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 p -52.96 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' CG ' ' A' ' 116' ' ' GLN . 4.1 m -62.2 86.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 85' ' ' VAL . 30.3 m -122.92 75.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.79 148.48 0.12 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 132' ' ' ASN . 51.9 Cg_exo -54.6 -19.34 17.88 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.749 2.299 . . . . 0.0 112.591 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 t -46.59 -73.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.39 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 74.3 m -61.28 -24.57 66.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.32 -58.96 4.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.035 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -49.65 -60.72 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -53.32 -63.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 89' ' ' SER . 72.9 t -41.14 -29.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.959 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 6.9 tttt -74.84 -69.51 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.664 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.73 7.98 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.39 -43.34 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.648 0.261 . . . . 0.0 111.553 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.471 ' CZ3' ' O ' ' A' ' 60' ' ' GLY . 16.1 m95 -95.3 -40.12 9.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.5 t -52.65 -44.2 94.64 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.512 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.4 Cg_exo -59.79 -28.82 88.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.278 1.985 . . . . 0.0 112.235 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -24.29 60.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.7 mt -49.48 -27.81 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -76.87 -28.15 55.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -70.81 -44.8 65.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CE1' ' CD2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -89.02 -33.72 17.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 2.7 m -107.6 129.63 23.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.654 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.61 -83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.444 2.096 . . . . 0.0 112.64 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -153.52 83.68 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.48 ' O ' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -151.59 163.92 22.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 59.4 Cg_exo -52.09 130.24 34.27 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.451 2.101 . . . . 0.0 112.037 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -102.6 125.77 49.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.69 121.4 44.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -114.1 162.59 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.087 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -146.84 166.3 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -161.12 101.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.529 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.2 p -158.48 142.23 15.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.431 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.457 ' NE2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -174.79 40.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.453 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.1 mt -37.83 -37.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.59 -43.82 96.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.457 ' CB ' ' NE2' ' A' ' 116' ' ' GLN . 2.0 mt -86.99 -45.55 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 5.1 tmm_? -48.93 -26.24 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.9 46.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.23 156.09 38.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.05 -49.89 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.17 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -50.05 -47.71 53.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -31.76 30.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.218 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.56 -54.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.66 -40.91 13.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -84.86 -37.84 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -49.58 -32.73 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.337 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.01 65.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.103 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -24.02 19.67 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.314 . . . . 0.0 110.867 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 18.7 m120 -95.98 30.19 2.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 26.65 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 49.19 -166.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.58 86.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.448 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 74.0 Cg_exo -48.38 169.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.575 2.184 . . . . 0.0 112.317 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.1 mt -94.13 130.27 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.9 p -110.75 168.42 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.962 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.58 -17.74 23.37 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.714 2.276 . . . . 0.0 112.562 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -82.55 -32.93 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.194 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.3 m -56.69 -62.78 1.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.971 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.95 -50.58 26.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.38 -39.86 70.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.753 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -53.66 -54.73 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -37.15 65.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . . . -57.23 -46.78 82.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -57.76 -44.68 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.626 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -22.29 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.037 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 151' ' ' ALA . 2.9 pp -121.38 21.27 11.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 43.9 tttm 56.16 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 59.07 174.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.044 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 60.9 t -59.49 -17.76 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.46 135.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.647 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' HG ' ' A' ' 112' ' ' LEU . 13.6 p90 -152.9 154.82 35.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.363 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 35.0 m -155.07 123.67 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.23 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 2.6 pt-20 -170.88 -178.68 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 111.111 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.428 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 4.8 p -127.91 -170.37 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.018 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.7 t -85.35 174.52 9.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.755 0.312 . . . . 0.0 110.288 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -34.36 -85.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.05 -171.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.499 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 162' ' ' GLN . 4.3 p 64.72 -67.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.836 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER 54.53 94.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 110.783 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -105.18 -67.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.1 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.96 77.84 0.38 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.793 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.537 HD23 HN21 ' A' ' 185' ' ' GNP . 0.5 OUTLIER -93.7 -29.05 15.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -54.62 -60.25 3.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -43.31 -37.06 2.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 156' ' ' GLU . 23.9 t -59.37 -62.28 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.755 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 66.2 m-85 -52.08 -28.94 19.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 1.9 m-20 -63.07 -41.8 99.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -45.55 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 110.908 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.7 70.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 50.0 mm -86.35 -52.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.4 tm? -55.05 -39.65 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.64 -47.4 70.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.87 35.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.7 tp -50.85 -44.83 59.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.037 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 58.88 61.44 4.76 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.18 154.54 72.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.21 152.34 61.62 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.656 2.237 . . . . 0.0 112.349 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.84 159.96 58.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.25 138.77 37.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.633 2.222 . . . . 0.0 112.306 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -56.05 160.67 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -44.38 96.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 7.2 tt -143.98 151.94 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.7 154.72 51.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.025 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.492 ' CD2' ' CE1' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -89.09 137.45 29.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.438 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 50.7 Cg_exo -55.25 -63.6 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.45 2.1 . . . . 0.0 111.793 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.88 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.164 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.79 88.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -118.79 -173.12 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.02 128.97 10.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.6 85.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.433 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -53.87 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.73 154.18 24.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 96.75 4.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 86.0 t -80.18 121.65 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.439 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -125.87 177.27 17.16 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.127 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.3 138.52 39.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 111.004 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -139.0 112.94 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.16 60.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.646 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 12.7 p -41.22 -33.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.606 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.8 t -140.09 -37.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.445 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.96 20.96 1.59 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.71 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.34 -158.63 0.9 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.6 0.238 . . . . 0.0 110.394 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.402 ' HB3' HG11 ' B' ' 87' ' ' VAL . 1.0 OUTLIER -103.41 164.53 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.803 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 11.5 p -95.73 162.53 13.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.1 46.18 33.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.568 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.432 ' HB2' ' CB ' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -61.53 124.36 80.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.561 0.219 . . . . 0.0 110.862 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.507 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 63.7 Cg_exo -50.62 159.66 2.1 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.366 2.044 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.01 -57.26 3.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.276 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -72.51 -56.09 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.508 ' CG ' ' CD2' ' A' ' 67' ' ' LEU . 8.6 m0 -46.24 -55.34 7.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' B' ' 99' ' ' MET . . . -54.76 -45.94 74.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.109 0.481 . . . . 0.0 110.447 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 55.0 mtp85 -58.52 -41.41 85.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.88 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -50.3 -55.88 13.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.253 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.32 -69.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' B' ' 109' ' ' THR . 8.8 tp60 -79.14 -100.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.2 p -168.17 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 120.872 0.367 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.403 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.4 OUTLIER -150.95 174.25 13.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.217 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.58 72.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -57.63 88.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.621 0.725 . . . . 0.0 111.608 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 169.19 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -110.33 -32.41 6.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -94.82 45.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -155.91 27.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 133.82 44.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.537 HN21 HD23 ' A' ' 165' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.824 0.345 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.1 124.08 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.21 141.03 28.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.402 ' CG2' ' OD2' ' A' ' 76' ' ' ASP . 3.9 mt -146.7 129.34 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -131.65 95.35 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.568 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 t -77.35 100.44 5.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 94.0 t -84.4 113.25 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.656 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 16' ' ' LYS . 27.4 m -85.04 140.0 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.549 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 104' ' ' HIS . 11.8 p -126.49 154.88 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.679 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . 147.6 -169.19 28.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.666 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.94 29.6 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -125.12 -41.57 0.36 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 85.64 -23.68 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 81' ' ' CYS . 28.7 m -48.7 -23.83 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . -120.56 -33.78 0.99 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.603 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 44.3 mtmt -63.82 -76.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 111.406 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 17.4 p -98.24 -43.9 6.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.253 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' SG ' ' PB ' ' A' ' 185' ' ' GNP . 58.2 m -52.61 -23.82 7.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.757 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' A' ' 23' ' ' TYR . 18.8 tp -61.8 -71.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' A' ' 40' ' ' TYR . 14.2 mt -44.12 -29.13 0.57 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 6.8 mm -65.79 -45.12 92.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.369 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.535 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 78.5 p -94.93 -13.15 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.81 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 165' ' ' LEU . 2.9 m-30 -95.93 -67.45 0.85 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.437 ' CG2' ' HB2' ' B' ' 81' ' ' PHE . 58.6 m -82.74 -81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.647 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.504 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -47.23 -40.44 16.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.274 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t30 64.79 41.38 5.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.1 OUTLIER -126.84 -159.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.38 155.66 76.21 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 65.1 Cg_exo -36.79 132.47 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.017 2.478 . . . . 0.0 113.118 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m -97.91 -82.83 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.556 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.78 108.77 20.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' O3G' ' A' ' 185' ' ' GNP . 1.4 t80 -66.45 109.29 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.294 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.4 p -160.63 133.23 4.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.383 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 36' ' ' VAL . 90.5 Cg_exo -41.26 93.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.353 2.035 . . . . 0.0 111.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 17' ' ' THR . 23.8 m -53.07 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.328 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.48 HG13 ' CD2' ' B' ' 96' ' ' PHE . 2.2 t -77.48 -24.6 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -150.56 -75.49 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.699 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 5.7 m-20 60.27 117.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.778 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 16.0 t-20 -107.13 156.66 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.557 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CD1' HD11 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.06 168.97 22.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.258 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.31 138.76 53.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' B' ' 78' ' ' PRO . 11.0 m -147.04 131.45 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.2 m -116.66 103.12 10.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' B' ' 75' ' ' ILE . 40.6 t -98.91 121.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.041 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.3 mtm -87.05 100.09 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.528 ' CD1' ' CZ ' ' A' ' 51' ' ' TYR . 14.1 mt -98.3 93.82 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 17.34 79.93 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.364 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 35.52 5.43 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -141.19 128.33 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.483 0.182 . . . . 0.0 110.928 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 168.7 3.24 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.05 . . . . 0.0 112.232 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 46' ' ' ILE . 2.4 m-85 -147.96 156.08 42.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 p -130.52 99.93 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 10.4 tt -133.53 160.56 37.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -153.4 149.27 20.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 20' ' ' LEU . 16.3 mt -99.14 104.11 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 111.214 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 5.5 m-85 -83.39 112.66 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 7.2 t70 -66.93 134.09 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 111.237 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.471 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -145.12 155.33 43.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.765 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.46 -176.37 4.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.212 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -110.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tp 50.29 -161.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.366 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -132.52 40.0 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -131.69 21.04 4.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 58' ' ' THR . 2.7 m-85 -111.34 -27.99 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.74 -41.28 22.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -69.06 -36.7 77.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.404 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.9 OUTLIER -98.0 29.05 3.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.576 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 2.6 tpt180 -88.73 -66.12 0.16 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 87.5 Cg_exo -37.27 -31.28 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.844 2.363 . . . . 0.0 112.827 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -51.99 -31.53 29.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.483 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -91.8 -25.47 19.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.9 OUTLIER 50.47 170.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.748 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.2 Cg_exo -68.67 -20.78 40.04 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.075 2.517 . . . . 0.0 112.666 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.52 -10.95 39.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.512 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.42 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.5 t -48.71 -23.82 1.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 111.639 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 75' ' ' THR . 4.2 m-20 77.25 -152.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.67 148.85 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 7' ' ' VAL . 4.6 m-85 -100.39 131.92 46.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD2' HG13 ' A' ' 8' ' ' VAL . 48.9 tp -103.74 115.97 31.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.137 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.38 150.76 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 111.799 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' SG ' ' CZ3' ' A' ' 97' ' ' TRP . 31.4 p -92.75 170.73 9.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -161.86 101.34 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.385 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.464 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 41.9 t -68.33 129.92 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 115' ' ' THR . 27.4 m -121.51 49.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -115.68 -69.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -100.2 103.44 23.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.733 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.411 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 80.2 Cg_exo -44.8 -27.61 2.5 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.584 2.189 . . . . 0.0 112.504 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -64.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 4.8 m -58.33 -34.95 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -45.61 -41.35 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.263 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.77 -61.26 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.735 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.4 m-20 -59.63 -38.68 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' ' CE3' ' A' ' 97' ' ' TRP . 92.5 t -47.5 -52.75 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 11.2 tttm -65.16 -47.83 75.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.479 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -82.36 8.17 12.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.36 -37.41 2.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.67 0.271 . . . . 0.0 111.558 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.49 ' CE3' ' CG1' ' A' ' 93' ' ' VAL . 22.6 m0 -92.28 -28.93 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.67 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.496 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 33.1 t -74.47 -44.09 5.62 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 27.0 Cg_exo -62.34 -23.11 74.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.321 2.014 . . . . 0.0 112.345 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.9 -14.9 27.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.618 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -46.62 -33.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.388 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 p -81.06 -34.19 32.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -61.9 -27.29 68.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.406 ' CD2' HG22 ' A' ' 9' ' ' VAL . 98.1 m-70 -113.44 -24.58 9.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.44 ' SG ' ' CG ' ' A' ' 78' ' ' PHE . 2.1 m -120.62 92.02 47.5 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 55.9 Cg_endo -70.18 99.33 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.634 2.223 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 44.29 41.55 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.4 m -117.64 142.2 30.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.28 133.86 30.58 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.433 ' CB ' HD13 ' A' ' 101' ' ' ILE . 6.8 p90 -115.45 149.54 37.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.996 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 148.03 46.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 tp -116.03 142.26 47.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.628 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 79' ' ' LEU . 1.4 m -153.54 176.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.32 138.13 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.4 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.439 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -158.35 153.13 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 28.5 mm-40 -151.84 98.42 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.652 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.418 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 mt -90.44 -46.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -25.81 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.439 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -77.22 -43.09 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 117' ' ' ILE . 0.6 OUTLIER -52.2 -29.03 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.17 47.01 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.982 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 140.93 29.1 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.793 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.75 -36.56 33.38 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -82.63 -30.43 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.1 m -56.03 -63.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -50.53 -39.16 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.1 -55.87 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.711 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.76 45.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.57 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.33 -26.28 4.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 110.368 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.69 -24.13 63.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.802 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -84.15 -22.76 30.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 9.1 m-80 -93.92 30.05 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt 70.58 28.21 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -160.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.44 82.57 0.17 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 54.1 Cg_exo -52.46 166.69 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.435 HG22 ' CG2' ' A' ' 141' ' ' THR . 4.8 mt -101.59 122.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.433 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.1 p -112.98 176.51 1.46 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.433 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.6 Cg_exo -54.56 -20.37 20.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.607 2.205 . . . . 0.0 112.371 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.72 -47.94 15.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.435 ' CG2' HG22 ' A' ' 137' ' ' ILE . 96.9 m -51.18 -49.83 60.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.01 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.33 -35.63 77.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.809 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -59.09 4.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.8 tp -61.82 -27.29 68.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -73.2 -31.89 64.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.47 -45.51 65.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -23.07 25.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.049 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.472 ' CD1' ' CB ' ' A' ' 151' ' ' ALA . 4.5 pp -108.48 -16.55 14.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt 75.12 -69.73 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 -172.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.432 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 62.1 t -68.29 -8.95 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.748 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.49 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.977 0.417 . . . . 0.0 111.003 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 112' ' ' LEU . 2.8 p90 -153.47 154.54 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 2.6 m -158.2 124.47 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.769 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -171.18 166.65 7.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.412 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.44 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 16.7 p -123.48 -173.63 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.22 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 116' ' ' GLN . 3.6 p -88.2 162.86 16.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB3' HO2' ' A' ' 185' ' ' GNP . . . -52.91 -173.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.443 HD23 ' CB ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER 52.14 30.14 7.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.02 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 -68.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.82 105.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -102.3 -64.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.13 88.82 0.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.604 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 23' ' ' TYR . 2.4 mt -93.95 -10.86 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.553 0.216 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -41.13 81.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -57.8 -50.97 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 55.6 t -52.33 -66.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.179 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -40.73 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -50.14 -55.49 14.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -48.81 66.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.83 -28.97 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.096 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.453 ' CG2' ' CD1' ' A' ' 46' ' ' ILE . 26.0 mm -93.57 -27.67 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -26.4 62.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.12 5.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.29 52.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -48.97 -26.32 2.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.86 143.01 23.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.94 158.04 3.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.562 2.175 . . . . 0.0 112.404 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.73 176.57 4.98 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.178 . . . . 0.0 112.223 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 182' ' ' PRO . 3.9 mt-10 -72.0 -62.82 1.45 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 181' ' ' GLU . 59.4 Cg_endo -72.19 61.9 3.33 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.571 2.18 . . . . 0.0 112.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 146.37 21.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.4 tptp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.918 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.68 -85.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.428 ' CD1' HG13 ' A' ' 44' ' ' VAL . 8.3 tt -135.12 151.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.088 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 40.1 t -134.78 148.72 50.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.17 88.44 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.635 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.431 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . 9.4 Cg_endo -52.42 -172.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.61 2.207 . . . . 0.0 112.004 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.406 ' O ' ' N ' ' B' ' 81' ' ' PHE . 34.4 p -165.93 -40.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.204 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 71.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.504 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.2 t80 -93.35 139.58 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -153.37 129.26 10.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 78.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 110.372 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -52.69 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.542 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -131.16 101.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.561 0.219 . . . . 0.0 111.395 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . 0.456 ' O ' ' CD2' ' B' ' 86' ' ' HIS . 13.5 p-80 -85.4 96.78 9.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 88.0 t -78.43 158.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.243 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.43 ' N ' HG13 ' B' ' 87' ' ' VAL . . . -143.18 171.18 25.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.099 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.37 116.04 28.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.903 0.383 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.438 ' CB ' HG21 ' B' ' 97' ' ' THR . 49.9 t0 -136.51 124.06 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.23 0.72 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.976 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.404 ' CG1' HG21 ' B' ' 93' ' ' THR . 7.2 p -43.66 -29.09 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.861 0.362 . . . . 0.0 111.368 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.404 HG21 ' CG1' ' B' ' 92' ' ' VAL . 1.4 p -155.4 25.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.803 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.38 20.68 65.73 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.29 -163.25 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.48 ' CD2' HG13 ' A' ' 36' ' ' VAL . 1.1 m-85 -105.04 164.57 11.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.438 HG21 ' CB ' ' B' ' 90' ' ' ASP . 1.3 p -98.72 144.11 28.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.428 ' CA ' ' HB ' ' B' ' 113' ' ' THR . . . 74.51 45.18 24.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.471 ' CG ' ' CB ' ' B' ' 104' ' ' ALA . 2.4 tpt -49.95 105.67 0.54 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.619 0.247 . . . . 0.0 110.998 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' B' ' 104' ' ' ALA . 74.2 Cg_exo -48.88 144.32 15.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.481 2.12 . . . . 0.0 112.22 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -46.87 -47.29 21.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.176 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.53 -65.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.509 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 4.0 m0 -49.51 -53.51 22.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.599 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.471 ' CB ' ' CG ' ' B' ' 99' ' ' MET . . . -52.62 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.166 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 2.8 mtt-85 -51.24 -32.79 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.812 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -49.79 -57.64 6.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -72.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.952 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' B' ' 109' ' ' THR . 2.8 pt20 -81.98 -113.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.229 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 0.5 OUTLIER 158.75 65.78 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.499 0.32 . . . . 0.0 111.071 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER 170.07 125.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 111.345 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.4 OUTLIER -84.98 75.34 10.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.332 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.445 HD11 ' N ' ' B' ' 112' ' ' ILE . 0.4 OUTLIER -57.96 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.604 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 1.2 m 158.76 -46.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.819 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -98.05 -27.74 14.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.5 t -50.2 160.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.6 -170.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -74.58 152.1 39.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.899 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.535 ' N3 ' ' CB ' ' A' ' 22' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.25 121.31 15.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.26 151.83 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -144.55 120.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 143.18 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.1 m -136.04 155.3 50.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.795 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.462 ' CG1' ' CG2' ' A' ' 58' ' ' THR . 41.9 t -138.19 158.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 58' ' ' THR . 7.7 p -110.95 160.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.175 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' N ' HG23 ' A' ' 8' ' ' VAL . 7.4 p -151.53 133.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.57 177.25 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -76.98 117.82 18.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.56 178.69 16.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.342 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' CB ' ' CB ' ' A' ' 18' ' ' CYS . . . -131.57 0.41 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG13 ' CG2' ' A' ' 113' ' ' VAL . 3.8 t -54.81 -20.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -56.9 -109.3 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.452 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 3.9 mptp? -98.86 -53.88 3.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HB ' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -43.85 -77.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.487 ' CB ' ' CB ' ' A' ' 13' ' ' ALA . 40.0 t -66.19 -24.72 66.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.953 0.406 . . . . 0.0 111.351 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD12 ' CD2' ' A' ' 23' ' ' TYR . 15.4 tp -63.08 -72.78 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.357 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 1.3 mm? -41.59 -38.26 1.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -49.37 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.64 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -93.76 -50.21 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 112.001 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.496 ' CD2' HD12 ' A' ' 19' ' ' LEU . 2.6 t80 -53.75 -31.66 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 94.5 m -108.91 -87.7 0.5 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.551 -0.459 . . . . 0.0 112.119 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.488 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.8 t -55.09 -24.75 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.558 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' SER . 17.6 t-20 72.21 51.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.806 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD3' ' CE1' ' B' ' 81' ' ' PHE . 8.6 pttt -135.15 -167.48 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.512 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.482 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -124.72 154.33 70.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.794 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 88.0 Cg_exo -41.5 146.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.848 2.365 . . . . 0.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -103.01 -81.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.779 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.67 114.94 26.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.746 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.2 t80 -67.88 107.81 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 ' CG1' ' HD2' ' A' ' 34' ' ' PRO . 97.2 t -158.7 140.12 9.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.281 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' CG1' ' A' ' 33' ' ' VAL . 80.1 Cg_exo -43.51 91.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.381 2.054 . . . . 0.0 111.898 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.3 m -52.5 89.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.271 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' B' ' 87' ' ' VAL . 25.2 t -95.6 22.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.416 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 2.2 t80 168.04 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.178 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.54 109.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.728 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.4 t30 -107.42 168.38 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD2' ' CE2' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -153.12 168.91 24.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.423 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.64 124.09 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.725 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.15 138.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.387 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.0 m -136.92 108.21 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 m -98.05 116.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 100.36 13.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.767 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.9 mm -72.81 90.7 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.6 77.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 35.34 4.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.33 93.28 36.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.12 121.15 6.41 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -117.34 162.62 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 t -112.88 97.24 6.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.572 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.72 160.1 15.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.12 100.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.442 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 1.4 mm? -78.17 126.98 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 3.4 m-85 -108.7 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.607 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -74.27 -163.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.933 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.462 ' CG2' ' CG1' ' A' ' 7' ' ' VAL . 69.4 p -159.48 169.02 24.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.98 65.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 27.02 22.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -137.59 23.53 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 0.0 111.026 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 48.56 27.85 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.04 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -98.76 26.74 5.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD1' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -88.76 -22.26 23.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -43.94 -28.88 0.5 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -49.55 -60.48 2.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.848 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.493 HD23 ' CE3' ' B' ' 103' ' ' TRP . 1.9 mp -65.84 -176.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.383 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -100.85 -63.67 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 59.3 Cg_endo -95.42 -59.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.338 2.025 . . . . 0.0 113.001 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.498 HD21 ' CH2' ' B' ' 103' ' ' TRP . 23.3 mt 62.52 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 120.838 0.351 . . . . 0.0 110.761 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 25.6 p -90.98 -14.38 31.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.037 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 49.34 173.31 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.56 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.3 Cg_exo -68.0 -23.3 40.64 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.839 2.359 . . . . 0.0 112.282 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -11.95 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.1 t -47.49 -25.7 1.16 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.613 0.244 . . . . 0.0 111.506 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 47.33 -91.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.035 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' THR . 44.9 t -95.37 161.23 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.553 0.216 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 9.4 m-85 -122.77 147.07 46.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' CD1' ' CG1' ' A' ' 113' ' ' VAL . 1.9 mm? -103.91 147.15 27.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.065 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.32 97.18 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.09 100.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' C ' ' A' ' 113' ' ' VAL . 38.6 p90 -116.84 144.02 45.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.14 164.4 24.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 115' ' ' THR . 32.2 m -131.63 42.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.993 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.45 72.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.417 ' CB ' HD13 ' A' ' 129' ' ' LEU . 1.0 OUTLIER 74.99 153.65 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.045 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HA ' ' CB ' ' A' ' 90' ' ' PHE . 27.5 Cg_exo -61.51 -13.72 31.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.681 2.254 . . . . 0.0 112.58 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.6 t -43.41 -71.79 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 45.9 m -80.77 -26.91 36.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.546 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.409 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 1.7 t80 -47.67 -61.4 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.049 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -50.23 -54.44 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -54.26 -45.67 72.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 89' ' ' SER . 98.4 t -47.59 -50.04 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.414 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 1.3 mtmt -78.26 -44.42 25.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.422 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -77.84 5.32 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.48 -36.97 2.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.613 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -95.31 -41.96 8.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.517 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 46.1 t -49.87 -44.49 78.41 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.359 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_exo -55.05 -31.08 73.26 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.284 1.989 . . . . 0.0 111.957 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.7 -17.33 26.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -45.33 -31.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.861 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.433 ' N ' HG21 ' A' ' 101' ' ' ILE . 68.2 p -71.13 -42.91 68.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.444 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -52.21 -36.15 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.329 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.472 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m80 -89.95 -36.68 14.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 17.3 t -98.02 115.61 65.74 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.36 -63.78 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.428 2.086 . . . . 0.0 112.475 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.7 34.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.421 HG21 ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -109.4 160.17 28.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' CD ' HG21 ' A' ' 108' ' ' THR . 50.0 Cg_exo -53.46 169.55 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.539 2.16 . . . . 0.0 112.392 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -127.39 143.28 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 124.29 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.32 162.56 14.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.712 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG2' HG13 ' A' ' 14' ' ' VAL . 15.1 m -155.6 121.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.196 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.54 168.43 13.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.346 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.481 ' CG2' ' N7 ' ' A' ' 185' ' ' GNP . 12.8 t -172.51 -165.4 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.46 ' OE1' H5'2 ' A' ' 185' ' ' GNP . 0.0 OUTLIER 66.73 94.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 50.8 mt -98.61 -40.26 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.059 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.85 -27.84 66.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.433 ' CD1' ' HG2' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -62.22 -58.62 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' NH1' HG23 ' A' ' 138' ' ' THR . 1.7 ptm180 -53.55 161.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.4 27.0 5.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.86 160.02 59.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.22 -38.37 61.17 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.535 2.157 . . . . 0.0 112.328 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -87.75 -29.76 20.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.0 m -53.17 -61.19 2.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.71 -37.66 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -58.42 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -33.87 62.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.562 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.48 -26.21 4.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.39 -24.01 66.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.798 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -94.1 -17.97 22.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -92.56 22.29 4.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.744 0.307 . . . . 0.0 111.093 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 10.7 mmmm 69.29 39.54 1.65 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.852 0.358 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 12.7 pt20 47.38 -163.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.088 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 64.65 84.56 0.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.426 ' CB ' HD23 ' A' ' 129' ' ' LEU . 52.5 Cg_endo -69.52 -177.62 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.637 2.225 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 3.9 mm -94.81 105.3 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.423 HG23 ' NH1' ' A' ' 120' ' ' ARG . 1.6 p -99.04 167.89 10.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.77 -27.6 27.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.739 2.292 . . . . 0.0 112.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -91.15 -28.68 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.2 m -49.15 -48.63 44.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.14 -59.82 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.47 -36.05 31.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -51.04 67.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.522 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.5 tp -58.08 -34.22 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.491 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.487 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -58.06 -58.0 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -51.79 -41.23 61.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -51.26 -29.88 15.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.1 pp -126.69 21.92 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.75 -86.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 57.36 -178.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 38.9 t -70.37 -7.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 77.03 151.02 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.853 0.358 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' HB1' ' A' ' 146' ' ' ALA . 8.2 p90 -152.63 148.49 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -158.08 124.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.289 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.31 172.3 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.4 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 2.3 m -131.57 -173.54 3.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -87.76 158.75 18.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 111.038 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.462 ' CB ' " H1'" ' A' ' 185' ' ' GNP . . . -53.57 -172.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 67.14 -66.76 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.744 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 159' ' ' ALA . 10.0 p -76.13 -79.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.842 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 68.28 116.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -99.07 -67.96 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.71 96.04 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.455 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.494 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -92.83 -10.77 35.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -54.88 -40.9 70.22 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.423 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 42.5 m-80 -55.51 -65.95 0.5 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 169' ' ' PHE . 7.4 p -51.41 -39.24 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CD2' ' HG ' ' B' ' 77' ' ' LEU . 0.1 OUTLIER -54.22 -43.27 70.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.492 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 22.9 t0 -62.56 -45.98 90.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -59.03 -26.07 64.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.33 -61.28 2.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 173' ' ' ILE . 1.3 mp -67.65 -56.92 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.533 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 4.6 tp -50.92 -25.83 5.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.01 -60.91 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.92 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.9 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 57.01 88.71 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.15 152.53 72.48 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.526 2.15 . . . . 0.0 112.321 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.96 129.11 17.83 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.612 2.208 . . . . 0.0 112.36 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 181' ' ' GLU . 4.0 pt-20 -108.91 98.32 29.16 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.47 119.76 6.7 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.491 2.127 . . . . 0.0 112.245 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -62.44 167.31 4.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.92 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.4 m 63.73 -75.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' B' ' 73' ' ' GLY . 6.2 tt -142.8 151.55 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 7.3 t -125.61 140.08 53.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.486 ' HG ' ' CD2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -72.63 134.56 81.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -50.56 148.01 16.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.393 2.062 . . . . 0.0 112.169 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 4.3 t -112.29 -34.73 5.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -77.21 164.66 25.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.503 ' CE2' ' CD2' ' A' ' 40' ' ' TYR . 8.0 t80 175.69 118.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.475 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -149.32 133.69 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.055 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.422 ' NE2' ' HB3' ' B' ' 86' ' ' HIS . 1.4 t-160 -68.98 86.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' B' ' 85' ' ' ILE . 38.9 p -69.39 -74.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.409 ' N ' ' OG1' ' B' ' 84' ' ' THR . 0.9 OUTLIER -115.97 111.51 35.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . 0.422 ' HB3' ' NE2' ' B' ' 83' ' ' HIS . 5.2 p80 -98.92 96.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.865 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 22.1 t -83.39 132.5 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -132.69 177.91 18.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.487 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -76.82 115.89 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.411 ' OD1' ' CG2' ' B' ' 92' ' ' VAL . 24.5 t0 -107.41 117.64 34.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -10.37 59.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.411 ' CG2' ' OD1' ' B' ' 90' ' ' ASP . 58.5 t -45.73 -50.02 3.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.598 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 14.2 t -154.06 56.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.11 27.31 5.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -118.75 -177.66 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.419 ' HB3' HG11 ' B' ' 87' ' ' VAL . 6.2 m-85 -97.24 164.79 12.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.21 156.8 16.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.754 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' B' ' 113' ' ' THR . . . 49.94 52.32 26.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.503 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.411 ' SD ' ' CD1' ' B' ' 107' ' ' LEU . 0.0 OUTLIER -63.52 121.37 69.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' B' ' 103' ' ' TRP . 79.4 Cg_exo -46.07 162.34 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.175 1.917 . . . . 0.0 111.794 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -42.7 -64.2 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -45.77 64.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.498 ' CH2' HD21 ' A' ' 70' ' ' LEU . 11.6 m0 -52.86 -46.49 67.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.35 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.444 ' HB1' ' CA ' ' B' ' 110' ' ' SER . . . -61.48 -63.18 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.952 0.406 . . . . 0.0 110.666 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.6 mtp180 -51.24 -34.51 32.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.472 ' CD2' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -50.05 -58.12 6.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.873 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.28 -69.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.429 ' OE1' ' CG1' ' B' ' 112' ' ' ILE . 5.1 tt0 -79.03 -98.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 23.5 p -160.53 -35.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.444 ' CA ' ' HB1' ' B' ' 104' ' ' ALA . 0.5 OUTLIER -166.33 169.04 14.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 111.703 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.43 ' ND2' ' OG ' ' B' ' 115' ' ' SER . 8.0 p30 -68.2 67.89 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.646 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.488 HD11 ' N ' ' B' ' 112' ' ' ILE . 0.3 OUTLIER -56.71 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.869 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.456 ' CG2' ' HA3' ' B' ' 98' ' ' GLY . 1.8 t 160.78 42.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.94 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.43 ' OG ' ' ND2' ' B' ' 111' ' ' ASN . 1.0 OUTLIER 47.75 38.67 8.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 111.07 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 71.83 152.67 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -59.05 148.94 29.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.982 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 tttt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.878 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.481 ' N7 ' ' CG2' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.4 ' H1 ' ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.71 158.26 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.792 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 m -136.3 118.15 15.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CG2' ' HB2' ' A' ' 76' ' ' ASP . 1.3 mp -126.41 149.39 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 75' ' ' THR . 12.1 mmtp -135.81 95.42 3.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.568 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.0 m -77.45 154.57 32.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.429 ' CA ' ' HE3' ' A' ' 16' ' ' LYS . 53.0 t -136.43 159.22 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.048 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 57' ' ' ASP . 12.5 p -100.86 159.12 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -150.53 129.04 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.035 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.74 139.86 4.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.448 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.4 m-20 -69.98 71.72 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 81' ' ' CYS . . . -156.73 -148.24 5.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.774 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.562 ' CB ' ' H1 ' ' A' ' 187' ' ' HOH . . . -148.91 -35.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 HG11 ' N7 ' ' A' ' 185' ' ' GNP . 20.3 t -47.7 -23.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -52.08 -105.22 0.01 OUTLIER Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.586 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' HE3' ' CA ' ' A' ' 7' ' ' VAL . 41.5 mttm -95.61 -56.05 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.459 HG22 ' H2 ' ' A' ' 187' ' ' HOH . 0.0 OUTLIER -44.26 -75.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.972 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 35.4 t -55.74 -39.68 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' ' CG ' ' A' ' 23' ' ' TYR . 5.1 tp -54.16 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.15 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD11 ' CD1' ' A' ' 40' ' ' TYR . 74.9 mt -39.89 -38.16 0.65 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.431 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -54.05 -69.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.149 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.418 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -91.31 -34.05 15.08 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CG ' ' CD1' ' A' ' 19' ' ' LEU . 4.2 t80 -72.6 -45.75 57.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.435 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 97.5 m -89.81 -85.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' B' ' 81' ' ' PHE . 3.3 t -54.56 -28.35 45.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.832 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 77.75 52.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 9.3 pttt -137.71 -166.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.537 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -127.72 170.54 10.06 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.577 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 81.9 Cg_exo -40.33 140.59 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.801 2.334 . . . . 0.0 112.706 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.61 -84.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE1' ' CG ' ' B' ' 86' ' ' HIS . 13.2 pt-20 -96.31 119.43 34.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.19 109.26 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.167 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -159.84 139.0 8.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 36' ' ' VAL . 95.4 Cg_exo -41.73 96.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.43 2.087 . . . . 0.0 111.904 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.431 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 3.1 m -47.1 89.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.273 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG12 ' CG ' ' B' ' 96' ' ' PHE . 58.2 t -95.18 -47.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.487 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 49.2 t80 -162.5 82.19 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.232 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 19.8 m-20 -83.01 124.91 30.86 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' CB ' HD11 ' B' ' 85' ' ' ILE . 44.7 t30 -107.89 154.28 21.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.845 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.38 168.91 23.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.225 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.21 115.28 29.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.51 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.441 ' HB ' ' CG ' ' B' ' 78' ' ' PRO . 1.4 m -139.8 130.04 30.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.303 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.5 m -125.79 112.4 15.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.078 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.66 116.94 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.07 0.462 . . . . 0.0 110.333 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.8 mtm -89.48 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.275 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.03 133.39 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.23 63.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.388 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 -24.35 26.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.648 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.6 151.9 59.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.56 169.71 18.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.651 2.234 . . . . 0.0 112.297 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.06 168.47 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.9 97.12 4.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tt -134.06 158.7 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.62 136.44 5.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.594 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 mp -93.42 103.02 15.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.83 0.348 . . . . 0.0 110.814 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 2.6 m-85 -84.62 128.34 34.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' HA ' ' CG1' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -91.22 174.43 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 111.222 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -162.39 146.45 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -27.62 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.64 -22.49 33.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.4 174.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -103.51 25.39 9.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.79 22.41 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 -4.95 59.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.345 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.11 -30.41 0.75 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -42.25 42.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.381 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -93.53 21.79 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.799 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -83.73 -45.65 0.79 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.298 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 78.4 Cg_exo -46.91 -25.98 4.38 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.372 2.048 . . . . 0.0 112.115 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.521 ' CD1' ' CD1' ' B' ' 103' ' ' TRP . 2.6 mt -75.03 -28.43 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 3.6 p -86.77 -29.83 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.764 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CG ' ' O ' ' A' ' 71' ' ' SER . 2.4 p90 51.3 161.55 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.946 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.39 -22.53 29.08 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.125 . . . . 0.0 112.158 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -10.65 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.454 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' LYS . 12.1 t -44.68 -26.74 0.41 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.78 0.324 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 75.43 -154.08 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.593 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.64 156.71 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 1.1 p90 -129.39 161.57 30.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.42 ' CD1' HG12 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -103.97 160.4 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.329 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' LEU . 3.7 t -128.55 150.7 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.453 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 1.8 m -111.77 142.96 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.383 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 82' ' ' PHE . 51.1 p90 178.12 112.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.849 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.7 p -57.23 165.77 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.83 29.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.316 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 96.4 t -89.49 -78.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.05 117.83 67.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.429 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 52.3 Cg_exo -54.35 -21.93 25.04 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.449 2.099 . . . . 0.0 112.475 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.16 -35.19 16.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 11.7 t -80.26 -35.68 35.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.164 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -45.89 -43.7 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.86 -61.43 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.4 m-80 -63.86 -42.06 97.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.483 HG12 ' CZ3' ' A' ' 97' ' ' TRP . 97.9 t -41.38 -48.2 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.903 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 1.2 tppt? -83.59 -52.33 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 8.02 5.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.9 tttp -128.26 -39.39 1.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.483 ' CZ3' HG12 ' A' ' 93' ' ' VAL . 52.2 m0 -94.92 -28.61 15.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.7 t -65.47 -44.44 66.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.728 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.4 Cg_exo -49.82 -35.11 38.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.153 1.902 . . . . 0.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -11.9 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 16.7 tt -45.74 -31.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.746 0.307 . . . . 0.0 111.548 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 p -81.77 -27.44 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -64.41 -37.72 88.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.26 -51.09 9.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 15.9 p -82.93 141.6 43.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.16 -45.83 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.629 2.219 . . . . 0.0 112.214 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 172.61 56.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.09 163.78 47.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 52.1 Cg_exo -52.33 164.22 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.609 2.206 . . . . 0.0 112.326 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 14.1 p90 -132.37 137.23 47.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 80' ' ' VAL . 4.9 mt -110.23 121.39 45.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -106.41 128.93 54.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.3 m -128.05 147.71 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.116 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . -167.21 122.58 1.06 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.275 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.429 ' HB ' ' CA ' ' A' ' 158' ' ' SER . 78.1 p -157.66 153.53 26.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 111.439 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.754 ' OE1' H5'1 ' A' ' 185' ' ' GNP . 0.0 OUTLIER 178.16 99.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.67 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.424 ' CG1' ' OG ' ' A' ' 158' ' ' SER . 33.1 mt -99.99 -29.79 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.13 -30.28 34.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.441 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -92.16 -46.04 7.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 111.562 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 34.4 ptt180 -45.65 -34.0 3.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 111.164 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.75 55.98 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.87 156.16 38.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.07 -56.25 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 m -64.03 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 94.8 m -49.15 -62.25 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.043 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -50.4 -41.25 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.37 -62.59 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -34.52 76.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 136' ' ' PRO . 0.5 OUTLIER -50.82 -26.0 5.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.358 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.6 59.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.867 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -78.76 -23.19 45.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 4.5 m120 -94.08 30.08 1.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 70.53 19.41 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.242 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.87 112.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 83.6 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.408 ' N ' HD22 ' A' ' 129' ' ' LEU . 28.4 Cg_endo -62.71 96.26 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.592 2.195 . . . . 0.0 112.12 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 5.6 mt -47.74 122.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.404 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -104.21 171.02 5.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.07 -22.45 39.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.725 2.283 . . . . 0.0 112.514 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -91.0 -28.65 17.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 137' ' ' ILE . 25.3 m -49.49 -59.39 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.054 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.18 -46.9 46.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.14 79.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -54.4 -46.71 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.29 -49.24 78.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . . . -64.86 -29.58 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -73.58 -40.54 63.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.94 -37.69 86.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 4.5 pp -82.12 -21.16 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 68.6 126.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.728 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 179.59 -159.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.138 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 12.1 p -44.36 -45.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 111.443 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.42 142.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.673 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 40.3 p90 -153.07 160.74 42.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.372 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -158.01 123.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.686 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.68 153.01 3.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.413 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 10.2 p -101.86 -173.83 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.968 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 1.6 p -88.44 174.4 8.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.543 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -47.94 178.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.907 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.416 ' CD2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 mm? 59.01 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.967 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 159' ' ' ALA . 6.7 p -56.03 176.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -163.22 103.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.036 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 157' ' ' CYS . 1.8 mtpp -95.35 -24.69 16.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.49 79.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.532 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 12.9 mt -71.06 -41.68 70.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.432 ' NZ ' ' HA ' ' B' ' 76' ' ' SER . 0.1 OUTLIER -45.43 -27.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.543 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -60.64 -72.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.474 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 23' ' ' TYR . 13.2 p -47.49 -35.13 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.734 0.302 . . . . 0.0 111.087 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -73.23 -38.93 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -54.01 -42.05 68.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.208 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -80.46 -34.49 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.463 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.85 82.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.798 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.12 -27.24 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.914 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.65 -49.03 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.578 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.16 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.8 -21.92 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.1 41.67 1.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -135.62 68.66 66.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.72 151.61 5.07 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.489 2.126 . . . . 0.0 112.294 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.18 147.65 88.37 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.579 2.186 . . . . 0.0 112.224 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.09 137.57 84.67 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.14 -177.16 3.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.53 2.154 . . . . 0.0 112.341 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -54.03 129.03 32.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -51.43 -36.26 43.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.963 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 23.1 mm -144.1 142.59 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 166' ' ' LYS . 0.5 OUTLIER -138.45 134.52 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 133.67 76.25 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.618 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.441 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 49.3 Cg_exo -55.46 -53.06 6.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.447 2.098 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 45.3 m 59.71 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.026 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -56.13 108.67 0.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.689 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -141.84 -175.84 4.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.346 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -153.28 138.25 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.64 99.28 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.344 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -69.73 -77.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.485 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.436 ' CG2' ' HD3' ' B' ' 100' ' ' PRO . 1.2 mp -122.25 128.58 75.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . 0.446 ' CG ' ' OE1' ' A' ' 31' ' ' GLU . 3.0 p-80 -105.26 96.14 6.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' B' ' 99' ' ' MET . 24.6 t -84.59 149.45 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.674 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.07 24.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.165 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -108.7 129.14 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 41.6 t0 -140.29 130.84 25.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.85 20.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.015 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -45.87 -27.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.352 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -152.11 -39.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.41 7.64 2.15 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.291 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.58 -170.99 2.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.013 0.406 . . . . 0.0 110.688 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 2.9 m-85 -86.8 162.4 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 3.1 p -109.93 153.99 23.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.68 27.59 13.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.375 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.461 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.0 OUTLIER -77.15 141.36 66.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.295 . . . . 0.0 111.452 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.436 ' HD3' ' CG2' ' B' ' 85' ' ' ILE . 81.5 Cg_exo -39.56 138.46 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.848 2.365 . . . . 0.0 112.693 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.22 -60.38 2.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.161 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.93 -50.29 27.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.521 ' CD1' ' CD1' ' A' ' 70' ' ' LEU . 1.7 m0 -55.22 -55.21 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.223 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -55.7 -55.01 37.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.321 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 7.9 mtt-85 -49.61 -45.0 47.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.043 0.449 . . . . 0.0 110.649 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -54.99 16.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.97 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.433 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.62 -69.26 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.347 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' B' ' 110' ' ' SER . 0.0 OUTLIER -78.61 -94.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.383 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.435 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 17.6 p -160.78 -45.84 0.04 OUTLIER 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER -159.27 166.92 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.94 0.4 . . . . 0.0 111.876 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' B' ' 99' ' ' MET . 27.4 t-20 -63.79 75.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' B' ' 113' ' ' THR . 0.0 OUTLIER -57.52 89.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.55 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 61.0 m 123.18 51.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.688 1.195 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.428 ' CB ' ' OD1' ' B' ' 111' ' ' ASN . 5.3 tttp 179.73 -63.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.646 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -65.64 138.85 58.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.64 115.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 158.52 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.754 H5'1 ' OE1' ' A' ' 116' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.562 ' H1 ' ' CB ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -89.12 140.63 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -107.14 128.81 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mm -120.14 118.0 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' O ' ' CG2' ' A' ' 75' ' ' THR . 8.2 mmtt -116.67 96.03 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.518 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.45 108.45 10.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 71' ' ' SER . 3.3 t -84.44 158.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.663 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.443 HG13 ' CB ' ' A' ' 16' ' ' LYS . 29.7 t -136.51 141.58 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.979 0.418 . . . . 0.0 111.828 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' N ' HG11 ' A' ' 8' ' ' VAL . 22.0 t -144.69 121.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.76 42.41 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.866 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -89.14 -48.36 7.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -160.23 1.71 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.176 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . . . -136.57 4.63 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 ' N ' ' HB3' ' A' ' 81' ' ' CYS . 61.9 t -47.76 -23.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -115.55 -61.59 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.753 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' CB ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -51.25 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' O2B' ' A' ' 185' ' ' GNP . 85.3 m -96.56 -68.98 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.469 ' SG ' ' PA ' ' A' ' 185' ' ' GNP . 8.2 m -48.02 -21.0 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 tm? -56.88 -74.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.651 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 19' ' ' LEU . 27.7 mt -63.49 -26.6 68.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.618 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -66.28 -44.34 91.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.865 179.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.486 ' CB ' ' C2 ' ' A' ' 185' ' ' GNP . 1.1 m -94.81 -11.82 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.862 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 19' ' ' LEU . 3.9 m-30 -95.54 -67.67 0.84 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 112.112 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' B' ' 79' ' ' SER . 46.5 m -83.85 -81.22 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.22 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.524 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -48.84 -35.63 15.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.184 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 10.0 t-20 51.31 65.21 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.254 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' CE ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -147.95 -175.35 4.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.464 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -102.78 157.98 32.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.644 0.259 . . . . 0.0 110.609 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 79.2 Cg_exo -39.55 145.82 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.732 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -99.57 -82.27 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' ' CE1' ' B' ' 86' ' ' HIS . 8.0 pt-20 -102.06 118.29 36.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.4 t80 -70.05 110.49 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 92.0 t -158.96 138.34 8.35 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 36' ' ' VAL . 85.1 Cg_exo -44.85 91.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.307 2.005 . . . . 0.0 111.684 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' VAL . 88.2 m -51.92 87.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.505 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' B' ' 96' ' ' PHE . 45.8 t -82.32 -28.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 1.8 t80 -141.87 -64.37 0.43 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 37' ' ' PHE . 11.3 t0 52.75 104.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.17 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 25.0 t30 -107.21 156.59 18.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.452 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 0.1 OUTLIER -151.04 169.01 22.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.746 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.03 141.96 46.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -160.82 126.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -109.44 110.95 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 169' ' ' PHE . 24.5 t -98.6 119.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 39.6 mtm -84.96 99.79 11.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 51' ' ' TYR . 4.8 mt -103.17 89.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.703 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.74 17.01 55.62 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.212 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.94 35.07 8.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -136.22 137.84 25.69 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.81 157.7 60.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.545 2.163 . . . . 0.0 112.336 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -147.05 167.1 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.176 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -129.2 97.24 4.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.375 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 28.6 tp -112.87 155.98 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.333 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -158.34 121.65 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.312 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD11 ' CG2' ' A' ' 8' ' ' VAL . 3.7 mm? -75.94 105.63 7.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.881 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 7.4 m-85 -84.11 103.23 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -72.35 120.9 18.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.702 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 HG21 ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -136.66 170.39 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.414 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -124.1 -40.51 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.73 47.94 88.47 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.501 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -40.13 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 165.78 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.546 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' O ' ' CG ' ' A' ' 66' ' ' ARG . 52.6 p30 -86.99 -22.59 25.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CD1' HG21 ' A' ' 58' ' ' THR . 28.3 m-85 -67.02 -21.37 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.168 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -48.02 -26.05 1.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.244 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 3.6 ptp180 -93.98 -27.87 16.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -103.21 18.1 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -93.05 -30.21 0.3 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -55.62 -20.81 28.82 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.53 1.487 . . . . 0.0 111.899 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' B' ' 103' ' ' TRP . 0.8 OUTLIER -72.81 -25.98 61.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 18.8 m -101.58 -21.46 14.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 55.31 104.87 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.51 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 34.1 Cg_endo -64.69 -23.66 63.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -88.0 -9.92 51.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.345 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -37.53 -53.69 1.17 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -169.92 -88.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 111' ' ' LEU . 9.9 p -128.21 163.72 31.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.683 0.278 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 5.6 m-85 -111.85 138.52 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.03 143.17 33.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.522 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 111' ' ' LEU . 2.9 t -132.3 153.05 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.797 0.332 . . . . 0.0 111.268 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.464 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -144.4 132.57 21.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.427 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.28 164.89 36.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.806 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -62.83 180.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 ' CA ' HG23 ' A' ' 137' ' ' ILE . 4.9 m -156.35 43.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.288 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 ' CG1' ' CB ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -154.13 -86.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -52.64 110.13 1.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.57 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.49 -15.95 44.5 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.024 . . . . 0.0 112.476 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.7 p -64.8 -23.65 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 p -95.95 -42.94 8.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -39.69 21.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 1.1 mm-40 -58.63 -55.56 33.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.8 m-20 -64.9 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 63.4 t -48.3 -67.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.69 -37.43 76.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.419 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 91' ' ' GLU . 28.7 mm-40 -74.05 -2.53 24.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -127.98 -35.02 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.412 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 60.4 m95 -88.7 -36.73 16.02 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 58.6 t -57.8 -46.3 99.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 85.9 Cg_endo -79.49 -21.5 8.73 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.558 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.58 -36.57 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.407 HD12 ' CG ' ' A' ' 110' ' ' PHE . 15.7 tt -50.62 -28.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.813 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -73.61 -38.46 65.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.573 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -56.63 -44.04 80.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 68' ' ' ARG . 1.7 t60 -88.87 -32.32 17.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.447 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 3.3 m -111.7 87.94 8.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.604 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 -78.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.46 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -126.78 48.1 2.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.85 139.51 35.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.748 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.61 165.26 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CE1' HD12 ' A' ' 149' ' ' LEU . 6.7 p90 -148.29 151.23 35.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.061 0.458 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD2' ' CD1' ' A' ' 154' ' ' TYR . 1.1 mp -125.6 119.73 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' CB ' ' HB ' ' A' ' 80' ' ' VAL . 1.4 pt? -135.14 119.58 17.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.645 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' CE2' ' A' ' 154' ' ' TYR . 10.1 p -156.57 111.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.885 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.47 169.12 40.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.668 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.9 t -174.82 137.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.863 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.432 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -166.72 84.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.741 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mt -77.39 -32.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -87.0 -23.68 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -95.86 -0.79 50.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.682 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' CB ' ' CG1' ' A' ' 85' ' ' VAL . 1.3 ptt85 -94.56 26.02 3.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.919 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.6 41.19 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.981 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.54 127.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.07 -44.18 49.37 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -57.45 -27.91 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -57.86 -68.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -49.42 -37.43 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.69 -66.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -34.16 72.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.876 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mt -50.15 -26.17 4.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.449 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.03 61.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.921 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -18.65 36.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.214 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.83 30.1 1.91 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.179 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt 73.77 29.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 58.93 -161.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.48 90.14 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.32 118.57 5.76 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.587 2.191 . . . . 0.0 112.312 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.434 HG23 ' CA ' ' A' ' 84' ' ' VAL . 7.2 mt -49.85 123.78 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.423 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -118.91 176.44 1.7 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.0 Cg_exo -54.17 -22.01 24.24 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.201 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -84.42 -36.27 22.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.7 m -51.51 -61.81 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -48.63 -45.72 38.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' HG3' ' CG1' ' A' ' 155' ' ' VAL . 2.4 tm-20 -57.39 -40.48 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.562 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -58.9 -34.34 71.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.536 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.84 -32.23 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.738 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.65 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -83.96 -35.22 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.414 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 43.0 m-20 -54.5 -61.51 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.479 HD12 ' CE1' ' A' ' 110' ' ' PHE . 3.4 pp -58.89 -18.1 30.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.304 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.91 80.84 0.07 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.939 0.4 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 149' ' ' LEU . . . -134.39 -173.72 3.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 153' ' ' LYS . 88.9 t -47.54 -29.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 58.33 124.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.243 0.544 . . . . 0.0 111.686 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.536 ' CE2' ' CG1' ' A' ' 113' ' ' VAL . 0.2 OUTLIER -153.79 126.09 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 19.8 m -97.23 131.88 43.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.766 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.477 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 2.5 pm0 -162.73 138.68 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.794 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.423 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 6.7 m -102.3 -174.59 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 p -88.47 165.29 15.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.012 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -59.53 -159.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.57 25.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -173.28 -72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.493 ' NE2' ' N2 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER 69.63 115.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.771 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -103.49 -68.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.09 96.08 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.512 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -93.61 -10.65 33.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.527 0.203 . . . . 0.0 111.371 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -34.29 54.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 110.065 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -66.44 -33.09 74.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 66.7 t -64.81 -63.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CZ ' ' CG ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -51.35 -32.29 25.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.9 -52.39 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.12 -28.31 4.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 169' ' ' PHE . 16.4 mm -94.78 -38.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.757 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.6 tt -54.96 -34.24 63.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.59 -25.43 59.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.065 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mp -94.5 46.51 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.47 ' CB ' ' CD ' ' A' ' 179' ' ' PRO . 1.8 mm-40 -60.35 -63.42 4.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 178' ' ' GLU . 55.6 Cg_endo -70.21 170.49 17.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.325 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.61 147.58 51.67 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.536 2.157 . . . . 0.0 112.201 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.36 151.24 77.5 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.55 90.81 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.594 2.196 . . . . 0.0 112.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -110.95 122.72 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.6 m -64.44 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.329 . . . . 0.0 110.802 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 tt -104.01 148.83 8.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -138.2 138.72 38.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 126.81 84.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.622 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.527 ' CG ' ' CZ ' ' A' ' 169' ' ' PHE . 9.0 Cg_endo -51.9 171.26 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 24' ' ' THR . 41.9 t -136.65 -67.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -51.49 95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.524 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.4 t80 -114.3 141.22 47.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.43 131.86 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 91.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.192 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.65 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.02 120.17 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . 0.443 ' CE1' ' O ' ' A' ' 31' ' ' GLU . 3.5 t-160 -103.98 96.56 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 44.6 t -79.86 155.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.04 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.437 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -146.48 178.26 24.27 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.236 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -85.97 112.76 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -103.76 98.24 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -0.08 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.029 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.47 -47.89 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.99 -21.81 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.433 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.25 12.73 6.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.554 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.83 -175.94 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.8 0.333 . . . . 0.0 110.815 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.53 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 4.1 m-85 -82.05 164.6 21.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.14 150.87 19.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.441 ' CA ' ' OG1' ' B' ' 113' ' ' THR . . . 48.54 48.66 28.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.457 ' HE3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -57.77 125.6 73.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.549 0.214 . . . . 0.0 110.974 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' B' ' 103' ' ' TRP . 69.6 Cg_exo -49.85 152.95 6.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.04 1.826 . . . . 0.0 111.595 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 8.4 pt-20 -43.32 -48.46 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 111.517 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -78.95 -52.95 7.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.548 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 4.9 m0 -50.12 -51.06 46.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.419 0.628 . . . . 0.0 110.052 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -61.93 -55.57 28.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.78 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 76.0 mtt180 -53.76 -44.44 70.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.428 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -48.85 -57.5 6.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -95.23 -68.86 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.295 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.457 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.9 tp60 -77.71 -101.6 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.353 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 4.1 p -168.16 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.684 0.278 . . . . 0.0 111.447 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.51 174.2 11.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.129 0.49 . . . . 0.0 111.836 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -68.56 84.98 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' B' ' 113' ' ' THR . 3.6 tp -57.57 88.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 157.88 -25.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.488 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' B' ' 113' ' ' THR . 0.2 OUTLIER 82.81 47.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.589 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.1 m -53.01 -31.86 43.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -178.19 135.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -110.56 165.02 12.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 tttt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.002 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.526 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.24 126.8 54.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.752 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -94.1 150.9 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.967 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 pt -155.87 147.07 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.048 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.83 115.38 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.09 154.36 31.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -145.31 144.95 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.421 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 57' ' ' ASP . 7.2 p -118.78 136.02 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -127.08 122.88 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.95 168.81 12.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.86 129.89 55.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' CA ' ' HB2' ' A' ' 81' ' ' CYS . . . 163.89 -27.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . 84.76 -41.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 16.0 t -48.42 -23.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.67 0.271 . . . . 0.0 111.667 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 113' ' ' VAL . . . -56.71 -114.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.11 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -96.15 -65.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -34.2 -73.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -52.67 -36.56 57.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.39 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' HG ' ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -49.7 -70.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 40' ' ' TYR . 1.3 mm? -40.61 -37.21 0.69 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' HG21 ' A' ' 25' ' ' THR . 6.6 mm -52.37 -69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.509 ' CB ' ' C8 ' ' A' ' 185' ' ' GNP . 5.7 t -88.33 -50.71 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.471 0.653 . . . . 0.0 110.448 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CD2' ' CD1' ' A' ' 165' ' ' LEU . 21.9 t80 -46.13 -49.86 16.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.548 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.436 ' CG2' ' CG1' ' A' ' 42' ' ' VAL . 52.3 m -96.71 -89.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.6 OUTLIER -55.28 -26.16 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.2 t-20 70.59 58.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 10.1 pttt -134.84 -161.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' " O3'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -132.57 148.83 71.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.286 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 75.4 Cg_exo -39.34 133.72 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.758 2.306 . . . . 0.0 112.72 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -84.88 0.51 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.64 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.316 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' O3G' ' A' ' 185' ' ' GNP . 1.2 t80 -66.49 97.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.158 0.504 . . . . 0.0 111.041 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.5 p -154.33 137.34 10.22 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.815 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 36' ' ' VAL . 62.6 Cg_exo -36.55 89.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.876 2.384 . . . . 0.0 112.645 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 33' ' ' VAL . 58.4 m -53.54 89.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.013 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG13 ' CG ' ' B' ' 96' ' ' PHE . 3.3 t -79.14 -25.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 5.1 t80 -149.14 -70.85 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.7 m-20 63.28 130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.47 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 6.6 t-20 -108.01 157.77 17.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.104 0.478 . . . . 0.0 111.359 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 m-85 -152.78 160.31 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.078 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.22 126.67 50.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.49 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' CG1' ' CB ' ' B' ' 78' ' ' PRO . 1.5 m -148.94 140.05 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.101 0.477 . . . . 0.0 111.895 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.2 m -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.894 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.21 123.13 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.212 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.418 ' HE1' ' CB ' ' B' ' 76' ' ' SER . 12.6 mtm -90.7 100.08 12.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.17 105.27 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.93 15.11 76.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 38.41 4.82 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.775 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -141.69 124.2 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.496 0.189 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.96 161.54 15.44 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.624 2.216 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.23 165.15 30.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.6 112.56 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.423 ' CD2' ' HG ' ' A' ' 55' ' ' LEU . 4.6 tt -119.86 138.46 53.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -126.33 102.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.214 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -83.98 149.69 26.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.411 . . . . 0.0 111.4 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.527 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 15.3 m-85 -138.93 116.79 11.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.679 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 4.2 t70 -69.91 152.75 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.474 HG23 ' CE1' ' A' ' 104' ' ' HIS . 1.6 m -157.54 128.85 6.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.33 33.84 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.409 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' HA3' ' CD2' ' A' ' 104' ' ' HIS . . . 48.18 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.27 -169.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.894 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.88 -25.77 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.15 -23.4 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 68' ' ' ARG . 4.3 m-85 -64.47 -12.6 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -40.3 -44.97 2.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.788 0.328 . . . . 0.0 111.586 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' B' ' 107' ' ' LEU . 0.0 OUTLIER -73.41 -35.56 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.498 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD2' ' CZ3' ' B' ' 103' ' ' TRP . 11.1 tp -90.38 10.53 24.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.117 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 1.6 tmt_? -82.93 -63.82 0.26 Allowed Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 68' ' ' ARG . 4.2 Cg_endo -46.59 -26.73 4.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.412 2.075 . . . . 0.0 111.756 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.511 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 8.5 mp -54.28 -39.51 66.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.581 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.466 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 88.3 p -92.49 -15.28 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 61.26 139.93 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.696 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.66 -45.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -10.27 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.549 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 76' ' ' ASP . 10.3 t -40.4 -48.45 2.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER 171.51 -167.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.784 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 111' ' ' LEU . 11.9 p -58.26 162.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.517 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CD1' ' SG ' ' A' ' 105' ' ' CYS . 16.4 m-85 -112.01 143.2 43.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -103.5 145.88 29.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.101 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 113' ' ' VAL . 3.9 t -131.65 151.35 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.944 0.402 . . . . 0.0 111.482 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.474 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -121.28 103.55 9.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.697 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 112' ' ' LEU . 25.0 p90 -128.87 123.01 31.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.443 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.462 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -130.73 -74.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.268 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' CG1' ' CG2' ' A' ' 125' ' ' THR . 22.6 t -50.5 -70.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.02 100.86 0.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.954 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.6 -21.74 65.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.642 2.228 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -48.15 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 p -77.84 -37.45 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 84' ' ' VAL . 2.3 t80 -50.97 -66.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -41.52 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -60.99 -65.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.442 ' CG1' ' CB ' ' A' ' 82' ' ' PHE . 93.0 t -40.68 -41.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.906 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -60.78 -69.69 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.48 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -80.9 8.34 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.59 -43.03 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -95.41 -37.1 11.09 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.2 t -50.02 -58.3 9.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 21.1 Cg_endo -60.67 -22.04 71.49 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.171 1.914 . . . . 0.0 112.031 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -32.05 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.454 HG23 ' CG ' ' A' ' 110' ' ' PHE . 22.1 mt -49.84 -26.51 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 p -74.55 -36.87 63.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -63.74 -38.42 91.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.776 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.474 ' CE1' HG23 ' A' ' 58' ' ' THR . 6.5 m-70 -95.76 -24.38 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.439 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 2.9 m -121.53 97.77 46.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.749 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.49 -61.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.585 2.19 . . . . 0.0 112.414 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.24 32.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 161.31 26.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.87 129.35 24.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.53 2.153 . . . . 0.0 112.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CG ' HG23 ' A' ' 101' ' ' ILE . 12.8 p90 -118.1 124.74 48.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.431 ' CD1' ' HB ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -96.85 119.5 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.447 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.495 ' HG ' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp -97.94 102.05 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' HA3' ' A' ' 15' ' ' GLY . 26.8 m -106.77 139.1 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 111.271 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.484 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -165.31 144.08 8.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.533 ' CG2' HN21 ' A' ' 185' ' ' GNP . 0.0 OUTLIER 173.17 151.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -167.76 94.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.81 -27.4 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.724 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' CB ' HD11 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -96.36 -48.07 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 111.45 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.28 -59.33 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.084 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.439 ' HB3' ' CG2' ' A' ' 85' ' ' VAL . 33.5 mmt180 -66.97 -174.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 5.7 m-20 81.9 39.49 0.05 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -96.58 169.68 8.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.716 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.71 -19.41 24.25 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.5 t -84.38 -46.69 11.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.444 ' CG2' ' CG1' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -48.83 -60.84 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.031 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -50.83 -40.62 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.15 -46.03 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -83.76 -35.98 23.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.95 -26.51 4.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.51 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.52 65.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -78.41 -47.39 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.52 -26.33 68.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.99 52.37 9.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 1.4 tt0 -128.55 -86.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 134' ' ' GLN . 2.5 mtmt 166.72 161.34 0.11 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.686 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.33 100.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.468 2.112 . . . . 0.0 112.159 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 5.8 mt -48.67 119.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -111.08 177.08 1.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -55.13 -20.52 24.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.434 2.089 . . . . 0.0 112.219 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -80.06 -45.4 18.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.424 ' CG2' HG22 ' A' ' 137' ' ' ILE . 97.8 m -53.38 -45.54 69.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.93 -42.68 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.61 -37.22 86.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.724 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -53.98 47.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.96 -42.38 84.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.43 -41.96 66.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.092 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -45.43 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.99 -42.48 99.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.3 pp -80.09 -26.48 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 0.8 OUTLIER 67.04 118.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.984 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -160.03 -161.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 15.7 t -70.62 -7.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.19 140.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 110.791 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 146' ' ' ALA . 3.0 p90 -152.71 148.29 27.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 111.454 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -158.47 124.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.832 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.87 149.62 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.539 ' O ' ' N2 ' ' A' ' 185' ' ' GNP . 2.6 p -108.27 -174.58 2.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.8 OUTLIER -86.16 159.6 19.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.469 ' CB ' " H1'" ' A' ' 185' ' ' GNP . . . -55.21 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.474 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 68.78 -62.67 0.38 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.126 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.47 -68.83 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.277 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.87 118.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.711 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -105.53 -68.27 0.88 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.075 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.08 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -86.44 -10.19 54.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.643 0.259 . . . . 0.0 111.196 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.87 -45.63 30.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.735 0.302 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -58.8 -62.88 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 165' ' ' LEU . 7.4 p -47.75 -26.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.19 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -50.43 13.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.372 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -49.96 -29.28 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.15 -39.76 22.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.048 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.72 -22.31 43.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.96 -30.17 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.175 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 tt -80.74 -26.09 37.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.69 65.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.89 -27.2 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.63 -30.66 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.84 150.71 37.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.07 146.52 17.17 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.57 2.18 . . . . 0.0 112.383 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 161.45 45.92 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.571 2.181 . . . . 0.0 112.314 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.442 ' N ' ' HD2' ' A' ' 182' ' ' PRO . 1.3 tm-20 -49.71 -60.39 5.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.061 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 181' ' ' GLU . 39.4 Cg_endo -67.14 162.82 36.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.582 2.188 . . . . 0.0 112.335 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -115.71 116.39 27.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -50.73 63.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.96 151.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.418 ' CB ' ' HE1' ' A' ' 45' ' ' MET . 16.1 t -135.09 137.62 43.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.414 ' CD2' ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -67.48 141.5 95.59 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.806 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.472 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 Cg_exo -51.64 166.41 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.177 . . . . 0.0 112.28 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 81' ' ' PHE . 0.4 OUTLIER -139.56 -66.57 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.68 86.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.523 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 9.1 t80 -108.61 134.26 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.66 111.98 3.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.486 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 83' ' ' HIS . 27.2 p-80 -68.37 109.4 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.059 0.457 . . . . 0.0 109.943 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 1.5 p -77.17 -62.57 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.786 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -121.9 143.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.764 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.65 96.57 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 25.1 t -78.21 149.08 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 87' ' ' VAL . . . -146.24 177.63 24.47 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.352 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.22 129.62 47.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.439 ' CB ' HG22 ' B' ' 97' ' ' THR . 68.3 t0 -137.89 132.19 32.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 1.37 19.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.142 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -45.44 -27.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 120.912 0.387 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 13.2 t -153.41 -42.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.58 34.26 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.418 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.28 175.44 10.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 110.46 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.474 ' CG ' HG13 ' A' ' 36' ' ' VAL . 2.2 m-85 -71.98 160.48 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.561 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.439 HG22 ' CB ' ' B' ' 90' ' ' ASP . 16.9 p -104.76 156.27 18.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.166 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.53 39.57 74.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.14 123.34 19.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.537 0.208 . . . . 0.0 110.675 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.438 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 84.7 Cg_exo -46.75 154.54 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.275 1.983 . . . . 0.0 112.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -45.57 -48.27 14.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.282 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.39 -55.7 5.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.535 ' CZ3' ' CD2' ' A' ' 67' ' ' LEU . 2.2 m0 -48.54 -53.36 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -57.68 -61.93 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.239 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 43.4 mtt85 -48.04 -45.23 31.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HG ' ' HG ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -48.33 -57.88 5.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -94.81 -67.73 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.107 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.436 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.9 tp60 -77.39 -99.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 2.9 p -166.58 -40.22 0.02 OUTLIER 'General case' 0 C--N 1.338 0.084 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.66 176.51 11.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.993 0.425 . . . . 0.0 111.473 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.73 72.73 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.81 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -57.72 87.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 111.178 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' B' ' 112' ' ' ILE . 1.9 m 178.27 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.665 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -130.1 -41.35 1.28 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 70.83 38.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.13 115.54 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -100.3 145.44 28.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.539 ' N2 ' ' O ' ' A' ' 157' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 68.68 129.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.09 149.63 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 76' ' ' ASP . 21.5 mt -140.48 153.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -129.56 96.22 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 37.4 t -81.36 107.96 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 58' ' ' THR . 58.2 t -84.27 154.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 16' ' ' LYS . 2.4 t -140.5 139.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 104' ' ' HIS . 3.0 m -133.02 156.12 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.068 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . 147.63 178.54 22.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.647 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -25.46 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.71 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.01 -24.13 49.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.355 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' C ' ' HB2' ' A' ' 18' ' ' CYS . . . 70.02 7.58 6.29 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' N ' ' HB3' ' A' ' 81' ' ' CYS . 16.1 t -49.04 -24.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 111.251 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -107.77 -43.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.541 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -67.35 -74.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.776 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' H2 ' ' A' ' 188' ' ' HOH . 0.0 OUTLIER -97.68 -52.94 3.58 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.424 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -55.29 -25.59 35.09 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 1.6 tm? -56.47 -73.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.423 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 HD13 ' CD2' ' A' ' 40' ' ' TYR . 18.7 mt -63.24 -25.36 68.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 110.553 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 1.1 mp -62.9 -47.29 93.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.858 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.535 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 82.8 p -94.13 -17.32 22.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.558 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 3.7 m-30 -88.22 -66.8 0.88 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.002 0.429 . . . . 0.0 112.047 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -89.04 -83.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.182 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.512 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -42.77 -44.32 4.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.448 ' N ' HG21 ' A' ' 25' ' ' THR . 16.6 t-20 64.42 41.65 5.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HD2' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -131.99 141.42 49.27 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.475 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -63.63 164.33 16.47 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 70.9 Cg_exo -38.21 150.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.952 2.434 . . . . 0.0 113.078 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 t -108.96 -83.1 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.24 114.59 26.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.637 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.33 107.88 5.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 6.5 p -160.63 139.44 7.65 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.29 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' VAL . 80.8 Cg_exo -39.45 93.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.568 2.179 . . . . 0.0 111.874 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 m -48.09 87.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.781 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.475 HG12 ' CG ' ' B' ' 96' ' ' PHE . 92.2 t -89.77 -35.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 60.8 t80 -170.86 119.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.777 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 3.2 m-20 -119.44 138.27 53.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.425 ' C ' ' CG ' ' A' ' 40' ' ' TYR . 8.7 t-20 -106.65 157.6 17.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.173 0.511 . . . . 0.0 111.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.472 ' CD2' HD13 ' A' ' 20' ' ' LEU . 1.2 m-85 -152.89 161.9 41.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.64 117.75 30.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.48 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HB ' ' CG ' ' B' ' 78' ' ' PRO . 23.8 m -136.6 167.75 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.393 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.8 m -156.39 85.98 1.0 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.874 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.1 m -98.6 176.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -140.46 157.34 45.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.183 0.516 . . . . 0.0 111.565 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -129.82 88.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.139 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.4 74.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.483 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.93 -34.37 3.29 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.025 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.88 133.28 76.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.662 0.231 . . . . 0.0 111.202 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 174.57 4.87 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.594 2.196 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.469 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -153.5 155.06 35.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.6 97.06 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.4 pp -134.17 161.03 36.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -140.66 138.06 8.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.307 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 19' ' ' LEU . 3.8 mp -75.7 107.18 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.09 102.99 12.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -73.4 144.11 46.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.302 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.482 HG23 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.51 179.42 9.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -138.32 163.36 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 43.7 1.62 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.72 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.622 0.249 . . . . 0.0 110.843 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 174.48 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.791 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.66 42.82 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' CD2' HG23 ' A' ' 58' ' ' THR . 4.4 m-85 -106.42 -24.62 12.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.673 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -45.76 -34.39 3.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.048 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -51.94 -36.05 47.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.988 0.423 . . . . 0.0 110.483 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.536 ' CD1' ' CE3' ' B' ' 103' ' ' TRP . 2.5 mt -96.01 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.386 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.3 mtt180 -56.76 -71.15 0.28 Allowed Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.563 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 33.9 Cg_endo -64.18 -29.42 64.74 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.059 1.839 . . . . 0.0 110.649 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 9.8 mp -52.43 -24.79 8.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -155.72 33.18 0.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.455 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -35.23 151.03 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.985 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 2.8 Cg_exo -75.67 -32.01 4.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.895 2.397 . . . . 0.0 112.606 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -57.6 -17.84 16.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.701 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -46.74 -52.89 12.95 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.592 0.234 . . . . 0.0 111.396 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 1.0 OUTLIER 176.99 -159.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.062 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.98 163.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.619 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 6.0 m-85 -115.62 132.69 56.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 0.0 110.863 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 13.3 tp -103.66 143.54 32.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.115 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 113' ' ' VAL . 2.6 t -133.75 150.66 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.438 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -125.06 153.38 42.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -162.24 158.72 24.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.93 164.26 25.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG11 ' CG2' ' A' ' 137' ' ' ILE . 60.6 t -147.08 55.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 120' ' ' ARG . 68.9 t -151.9 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.426 ' N ' HG11 ' A' ' 85' ' ' VAL . 5.8 m -66.77 150.16 97.83 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 0.0 110.73 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' CG ' ' HG2' ' A' ' 128' ' ' LYS . 72.1 Cg_endo -77.39 -36.63 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.588 2.192 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 p -53.13 -38.9 63.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 -24.92 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CD1' HD11 ' A' ' 137' ' ' ILE . 2.2 t80 -69.91 -61.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -26.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.2 m-20 -75.58 -60.96 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.501 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 12.7 m -47.55 -27.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.669 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 23.3 tttt -78.47 -61.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.44 8.37 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.995 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 6.7 ttpt -114.37 -37.82 4.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.635 0.255 . . . . 0.0 111.34 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 19.0 m95 -95.3 -42.12 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.604 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.5 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.2 t -53.57 -43.63 96.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.8 Cg_exo -73.88 -31.4 8.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 112.499 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.11 -33.07 24.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 12.9 tt -48.61 -29.31 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.43 ' N ' HG21 ' A' ' 101' ' ' ILE . 7.7 p -66.62 -42.69 86.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.652 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -63.18 -33.0 74.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.472 ' CD2' HG12 ' A' ' 9' ' ' VAL . 12.4 m80 -79.76 -31.33 40.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 108' ' ' THR . 18.6 p -130.68 122.39 19.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 48.0 Cg_exo -55.63 -64.92 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.489 2.126 . . . . 0.0 112.351 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -156.7 31.46 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 105' ' ' CYS . 1.8 t -97.25 150.03 36.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.05 144.65 27.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.802 2.335 . . . . 0.0 112.14 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -121.92 157.33 31.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' VAL . 8.1 mt -127.66 145.25 50.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.474 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 5.7 mt -120.34 159.4 25.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.512 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 80' ' ' VAL . 10.8 m -156.11 106.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.909 0.385 . . . . 0.0 111.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.5 128.15 6.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.39 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.421 ' HB ' ' N ' ' A' ' 158' ' ' SER . 48.3 p -153.79 142.91 21.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 111.192 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.412 ' HG2' ' CD1' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -178.84 36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.868 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.441 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 5.4 pt -56.24 -21.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.266 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' CB ' HD11 ' A' ' 160' ' ' LEU . 9.9 t0 -96.09 -26.04 15.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' CD1' ' HG2' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -65.72 -56.53 11.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' CB ' HG12 ' A' ' 85' ' ' VAL . 7.0 tmm_? -46.68 100.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.84 -44.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.86 132.12 66.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.07 -36.57 96.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.422 2.082 . . . . 0.0 112.231 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.9 m -49.24 -45.04 44.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.987 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -53.77 -59.86 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.4 mp -60.16 -40.61 84.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.958 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.58 -61.67 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 2.0 ttpp -73.05 -36.01 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 136' ' ' PRO . 10.5 mt -50.29 -25.92 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.88 -20.75 57.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -91.22 -37.08 13.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.0 -27.66 66.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -78.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 179.14 -46.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 150.15 65.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 50.7 Cg_exo -53.58 174.38 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.615 2.21 . . . . 0.0 112.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.453 HD11 ' CD1' ' A' ' 90' ' ' PHE . 5.9 mt -92.5 122.62 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.2 p -110.81 167.71 8.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 81.9 Cg_exo -47.84 -25.44 6.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -46.72 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.2 m -52.16 -51.35 58.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.02 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.022 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.7 -35.29 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.73 94.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.12 -45.52 84.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -25.59 66.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.37 -64.04 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD13 ' N ' ' A' ' 150' ' ' LYS . 3.9 pp -51.32 -25.19 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.411 ' N ' HD13 ' A' ' 149' ' ' LEU . 11.0 mttp 65.59 108.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 149' ' ' LEU . . . -145.64 -161.01 1.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 92.8 t -60.93 -20.11 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.316 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 78.25 137.99 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.166 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 50.0 p90 -153.2 166.27 33.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.25 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 154' ' ' TYR . 28.2 m -158.36 124.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.818 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.77 152.52 3.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.433 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 13.8 p -111.18 -173.64 2.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.441 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 11.1 t -87.79 156.49 19.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.554 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -56.73 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.207 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.41 HD11 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 53.36 25.09 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.95 -65.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.469 ' NE2' ' CD1' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 64.74 122.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.35 -67.96 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 100.17 0.16 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.396 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.469 ' CD1' ' NE2' ' A' ' 162' ' ' GLN . 4.8 mt -93.68 -10.68 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.542 0.211 . . . . 0.0 111.539 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.44 -28.05 1.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.383 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -78.4 -60.9 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.045 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 169' ' ' PHE . 7.7 p -50.01 -41.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -69.49 -40.84 76.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -50.27 -53.03 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.07 -51.54 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.05 -30.69 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.237 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.48 HD13 ' CD1' ' A' ' 169' ' ' PHE . 5.9 mt -91.76 -24.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.9 tp -80.33 -52.58 7.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -31.29 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.306 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.26 66.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.271 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.414 ' CD1' HG13 ' A' ' 46' ' ' ILE . 2.2 mp -90.34 48.28 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CB ' ' CD ' ' A' ' 179' ' ' PRO . 6.5 mt-10 -56.56 -62.17 5.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 178' ' ' GLU . 36.3 Cg_endo -65.41 110.73 1.65 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.678 2.252 . . . . 0.0 112.466 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -51.76 178.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.521 2.147 . . . . 0.0 112.189 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.93 156.6 47.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.57 95.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.631 2.22 . . . . 0.0 112.401 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.12 175.87 6.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.999 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -117.6 -53.91 2.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mm -104.02 144.23 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.69 153.08 48.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.202 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.91 135.79 28.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.639 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.434 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 52.5 Cg_exo -54.21 -172.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.562 2.174 . . . . 0.0 112.205 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 60.4 p -162.56 -53.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.548 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.5 62.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.403 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.512 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.0 t80 -81.32 131.02 35.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -153.59 120.06 5.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.18 102.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.425 ' OG1' ' CD1' ' B' ' 85' ' ' ILE . 0.6 OUTLIER -77.53 -60.77 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.592 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.425 ' CD1' ' OG1' ' B' ' 84' ' ' THR . 1.0 OUTLIER -120.69 134.61 63.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.934 0.397 . . . . 0.0 111.971 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -120.88 96.5 5.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.623 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 47.1 t -79.95 148.05 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.752 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.412 ' N ' HG11 ' B' ' 87' ' ' VAL . . . -144.77 177.76 23.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -95.94 131.93 41.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.41 120.18 13.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.32 -0.66 26.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.72 -26.51 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.282 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.9 t -149.05 -41.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.082 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.97 25.98 0.87 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.672 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.76 -162.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.74 0.305 . . . . 0.0 110.546 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.475 ' CG ' HG12 ' A' ' 36' ' ' VAL . 1.2 m-85 -100.25 164.2 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.22 167.12 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.11 33.61 22.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.441 ' CB ' ' HB3' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -47.21 109.04 0.98 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.501 0.191 . . . . 0.0 110.709 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 97.0 Cg_exo -40.19 153.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.7 2.266 . . . . 0.0 112.811 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -45.34 -57.9 3.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.194 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.49 -54.19 36.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.536 ' CE3' ' CD1' ' A' ' 67' ' ' LEU . 4.7 m0 -49.21 -63.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 0.0 110.788 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' B' ' 110' ' ' SER . . . -47.49 -70.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.765 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 3.9 mtp180 -44.62 -37.07 3.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.436 ' CD1' HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -50.37 -56.18 12.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.134 179.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.464 ' CD1' ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.42 -70.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.43 ' O ' ' CG2' ' B' ' 109' ' ' THR . 4.8 tt0 -79.98 -99.06 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 29.9 p -160.35 -35.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.442 ' N ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -161.66 -173.42 3.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.018 0.437 . . . . 0.0 111.951 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' B' ' 100' ' ' PRO . 0.3 OUTLIER -84.79 81.86 8.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.83 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -56.59 88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.614 0.721 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 170.29 -57.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.703 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -113.07 -27.46 8.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.832 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -62.92 -74.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 60.24 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -66.86 151.27 47.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.995 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.9 mttm . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.82 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.554 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.553 ' H2 ' HG23 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.824 0.345 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 63.31 117.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.42 169.34 8.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.405 ' CG2' ' OD2' ' A' ' 76' ' ' ASP . 2.5 pt -160.23 134.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mptt -125.53 147.79 49.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -133.48 134.48 43.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -115.21 151.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 58' ' ' THR . 9.2 p -93.24 160.87 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 104' ' ' HIS . 7.3 p -152.61 129.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 174.21 17.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.78 84.66 2.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 81' ' ' CYS . . . -171.9 -147.21 5.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 18' ' ' CYS . . . -178.95 32.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.492 ' CG1' ' HB2' ' A' ' 81' ' ' CYS . 3.3 p -81.32 4.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -84.04 -103.89 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.286 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HE2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 ttpm? -97.38 -13.2 21.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.32 -74.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -74.16 -34.88 63.98 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.089 -0.382 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.551 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.11 -74.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.584 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.471 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 18.2 mt -47.93 -42.27 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.876 0.37 . . . . 0.0 111.067 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.479 HD12 ' CE2' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -49.13 -68.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.42 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -93.18 -56.99 2.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.551 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 4.1 t80 -50.12 -26.8 4.85 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 84.9 m -113.82 -91.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.925 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 4.1 t -51.87 -24.22 5.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.964 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.94 52.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -132.5 -166.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.647 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -130.78 147.08 64.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.04 151.97 5.31 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.752 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 t -105.81 -80.54 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.7 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.51 105.95 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.4 p -160.55 138.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 36' ' ' VAL . 72.3 Cg_exo -39.21 92.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.689 2.26 . . . . 0.0 112.272 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' VAL . 1.4 m -50.25 91.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.197 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' B' ' 87' ' ' VAL . 1.9 t -81.86 -26.35 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CD2' ' CG ' ' B' ' 100' ' ' PRO . 9.3 t80 -148.63 -77.01 0.16 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.804 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 40' ' ' TYR . 59.0 t0 58.27 112.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 16.4 t-20 -106.33 159.62 15.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.005 0.431 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.487 ' CD1' ' HE2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -152.12 168.85 23.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.063 -178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.97 133.14 50.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' B' ' 78' ' ' PRO . 1.2 m -162.51 133.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.479 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.0 m -131.34 116.27 17.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' TYR . 4.0 m -98.08 117.19 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.052 0.453 . . . . 0.0 110.581 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -91.31 102.0 14.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' B' ' 74' ' ' SER . 9.7 mm -82.34 121.22 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.186 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.79 25.38 61.34 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.62 19.62 67.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.62 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -115.82 151.31 46.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.662 0.268 . . . . 0.0 110.795 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.56 139.55 64.64 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.584 2.189 . . . . 0.0 112.357 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.424 ' CB ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -151.58 174.52 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.657 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.78 111.32 9.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.235 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.31 129.7 38.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.39 103.41 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.005 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' CD1' HD22 ' A' ' 20' ' ' LEU . 23.6 mt -125.83 154.46 42.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -144.56 125.94 14.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 15.0 t0 -67.66 161.83 24.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -168.73 157.73 8.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.79 -175.26 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.09 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.46 -145.72 4.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 mt 51.77 -162.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.91 52.4 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.18 28.25 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.34 -19.33 17.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -44.05 -29.21 0.57 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.789 0.328 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -56.72 -46.64 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.584 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' CD1' ' CZ3' ' B' ' 103' ' ' TRP . 40.5 mt -94.25 23.31 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 tmt_? -57.02 -57.86 21.75 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.99 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.8 Cg_endo -47.95 -22.3 3.32 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.641 2.227 . . . . 0.0 113.053 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.483 HD11 ' CE2' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -88.68 -15.02 35.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 17.3 m -108.04 -31.37 7.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 47.76 94.35 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 73.7 Cg_exo -49.51 -36.8 40.81 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.668 2.245 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.36 59.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.592 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 76' ' ' ASP . 14.7 t -41.32 -50.65 3.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.7 0.286 . . . . 0.0 111.629 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 75' ' ' THR . 0.6 OUTLIER 171.72 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.685 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.0 154.84 2.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 105' ' ' CYS . 0.7 OUTLIER -104.26 163.69 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.156 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -114.48 139.01 49.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 4.1 t -131.09 134.44 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.492 ' HB2' ' CG1' ' A' ' 14' ' ' VAL . 42.3 t -134.49 154.63 51.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 112.05 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 2.8 p90 -124.03 108.33 12.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.589 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.2 p -37.39 102.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.177 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.6 t 56.86 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.386 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -162.04 -81.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.562 0.22 . . . . 0.0 111.511 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m 54.27 102.25 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.516 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.18 -30.25 64.79 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.393 2.062 . . . . 0.0 112.322 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 p -71.72 -23.6 61.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.11 -22.6 19.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.154 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.448 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -48.92 -69.81 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.353 . . . . 0.0 111.032 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -51.74 -36.84 48.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 51.0 m-20 -64.04 -63.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.1 t -43.06 -32.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.717 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.43 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.0 -69.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.847 0.356 . . . . 0.0 111.417 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -80.25 8.04 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 15.3 tttt -115.09 -45.3 2.96 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -95.42 -38.46 10.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.2 t -51.64 -44.51 90.24 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.631 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.6 Cg_exo -55.92 -21.6 34.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 112.256 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.92 -31.18 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.125 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 98' ' ' VAL . 56.0 mt -48.14 -31.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.3 p -64.05 -34.84 78.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.633 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -72.78 -33.18 66.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.468 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 1.3 m-70 -79.17 -43.87 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 17.8 p -103.64 134.01 19.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_endo -83.86 72.91 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.386 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.0 26.38 15.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -107.85 142.15 24.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -51.46 172.23 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 6.7 p90 -148.57 138.7 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -95.26 119.51 33.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -97.9 121.84 40.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.436 HG21 ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.4 137.36 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.405 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.513 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -174.67 156.45 22.94 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.759 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 116' ' ' GLN . 1.4 t 173.45 177.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.113 0.482 . . . . 0.0 111.297 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.452 ' HG3' " C5'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -174.59 52.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.292 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 mt -37.11 -31.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.966 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -58.49 -64.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.614 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.409 ' N ' HD21 ' A' ' 119' ' ' LEU . 3.7 mm? -95.97 -23.97 16.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.688 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 7.3 tmm_? -41.9 -30.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.447 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 61.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.04 157.6 36.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.979 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.5 -34.79 34.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.679 2.253 . . . . 0.0 112.272 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.7 m -69.79 -45.82 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -57.05 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -61.19 -32.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -69.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 mt -50.34 -25.98 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.92 57.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.226 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 4.5 mmtp -87.1 -28.4 22.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.883 0.373 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.4 -18.2 57.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.236 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER 63.15 26.73 15.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.79 122.45 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -50.25 153.07 2.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.66 136.75 27.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.448 HG12 ' CZ ' ' A' ' 90' ' ' PHE . 5.2 mp -72.42 99.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.031 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.464 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -90.27 179.79 1.41 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.711 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 51.7 Cg_exo -53.11 -21.6 16.97 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.487 2.125 . . . . 0.0 112.326 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -38.09 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 19.3 m -52.35 -48.81 65.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.98 -60.07 3.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -52.53 -27.4 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.29 13.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.731 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 tp -54.77 -36.89 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.49 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -64.68 -39.74 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -58.74 -42.8 89.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -23.98 66.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.794 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' ALA . 3.7 pp -119.08 19.18 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.74 -85.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 59.79 179.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 43.0 t -67.83 -14.87 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.17 141.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.719 0.295 . . . . 0.0 110.492 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 146' ' ' ALA . 7.9 p90 -152.8 157.42 40.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 168' ' ' VAL . 1.2 m -158.1 122.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.476 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -172.42 150.65 2.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 72.1 m -102.15 -173.46 2.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.864 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.406 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 16.1 t -87.85 174.14 8.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 111.35 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -61.64 -175.87 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 65.03 -71.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' ALA . 35.8 p -69.11 -83.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 69.77 113.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.489 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.4 ' CD ' ' SG ' ' A' ' 157' ' ' CYS . 5.7 mttp -101.4 -67.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 111.222 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.77 88.18 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.527 ' CB ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -93.84 -15.24 25.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.546 0.212 . . . . 0.0 111.288 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -42.78 73.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.867 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -52.77 -64.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.9 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 155' ' ' VAL . 7.6 p -49.32 -29.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 173' ' ' ILE . 0.1 OUTLIER -59.01 -44.86 91.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.801 179.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 36.3 t0 -61.18 -37.5 83.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.019 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 0.2 OUTLIER -71.15 -22.27 62.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.576 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.44 -54.05 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.064 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 10.4 mt -63.46 -39.12 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 13.1 tp -76.5 -36.08 58.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.05 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -53.61 -46.46 70.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.24 57.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.069 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -53.97 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.022 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.25 68.11 3.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.799 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.63 108.32 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.322 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.67 101.34 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.461 2.107 . . . . 0.0 112.223 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.426 ' CB ' ' CD ' ' A' ' 182' ' ' PRO . 4.2 mm-40 -67.76 -61.62 4.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 181' ' ' GLU . 36.3 Cg_endo -65.25 119.51 6.55 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.585 2.19 . . . . 0.0 112.366 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.67 175.47 10.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.895 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.431 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 2.8 m -50.53 -44.72 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 170' ' ' ASP . 0.7 OUTLIER -144.16 133.64 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.03 142.79 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -70.53 136.77 85.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 51.0 Cg_exo -54.43 154.4 19.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.516 2.144 . . . . 0.0 112.019 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.7 m -116.88 -83.29 0.64 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.394 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.79 99.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.49 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 13.8 t80 -123.19 129.46 51.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.23 142.31 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.0 102.51 1.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.613 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -86.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.438 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.432 HD11 ' CB ' ' A' ' 39' ' ' ASN . 1.1 mp -104.35 127.47 58.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 111.191 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -105.79 99.18 8.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 74.1 t -85.56 151.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.403 ' CA ' HG23 ' A' ' 33' ' ' VAL . . . -146.33 165.58 28.23 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.054 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.63 106.75 18.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.412 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 16.0 t0 -124.08 118.24 26.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.71 21.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.34 -27.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-O 121.027 0.441 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' B' ' 95' ' ' GLU . 0.1 OUTLIER -152.11 20.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.981 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.92 68.45 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.038 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 10.2 pt-20 -132.41 164.89 25.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.079 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' A' ' 67' ' ' LEU . 7.4 m-85 -79.11 154.65 29.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.811 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 19.1 p -93.5 169.47 10.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.21 23.54 8.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.418 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.437 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -49.82 106.16 0.6 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.492 0.186 . . . . 0.0 110.959 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 67.2 Cg_exo -36.0 152.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 112.906 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -66.69 0.28 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.716 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.28 -52.0 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.075 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.515 ' CZ3' ' CD1' ' A' ' 67' ' ' LEU . 3.5 m0 -48.27 -62.5 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.127 0.489 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' B' ' 99' ' ' MET . . . -47.57 -69.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.546 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 0.6 OUTLIER -46.64 -38.5 9.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.421 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.424 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -49.48 -57.11 7.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.37 . . . . 0.0 110.568 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.3 -69.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.452 ' O ' ' CG2' ' B' ' 109' ' ' THR . 8.3 tp60 -79.18 -100.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.785 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.3 p -168.62 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.034 0.445 . . . . 0.0 110.736 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' B' ' 114' ' ' LYS . 0.3 OUTLIER -134.23 170.58 15.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.212 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' B' ' 99' ' ' MET . 10.9 m120 -54.31 -63.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -121.32 87.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.557 0.694 . . . . 0.0 109.37 178.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 7.5 m 69.66 -63.33 0.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' B' ' 110' ' ' SER . 1.8 mtpt -147.23 40.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.16 -67.88 0.2 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -86.45 145.74 26.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -92.13 143.83 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.938 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.472 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.8 91.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -89.86 159.51 16.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.25 136.96 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.262 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 4.4 mptt -118.91 96.41 5.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.22 97.36 4.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 12.7 t -84.45 111.26 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.77 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 10.7 m -105.43 129.57 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.39 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.49 138.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.98 120.52 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.649 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.86 -31.23 70.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.029 0.442 . . . . 0.0 110.488 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.12 83.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' CG2' ' A' ' 17' ' ' THR . . . 54.01 23.49 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.889 0.376 . . . . 0.0 111.032 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' CG1' ' N7 ' ' A' ' 185' ' ' GNP . 45.3 t -91.19 -17.89 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.488 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . -130.2 -8.82 3.18 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.263 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' CG ' ' N ' ' A' ' 17' ' ' THR . 1.8 pttt -94.9 -57.59 2.4 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 5.2 t -96.59 -41.8 8.36 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.013 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' C8 ' ' A' ' 185' ' ' GNP . 2.8 m -64.28 -25.93 68.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.523 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -42.75 -72.74 0.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.585 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 40' ' ' TYR . 16.4 mt -63.45 -33.81 76.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.152 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 25' ' ' THR . 0.8 OUTLIER -55.29 -43.72 72.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.146 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 15.0 m -95.96 -26.68 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.523 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 3.7 m-30 -80.73 -67.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' B' ' 81' ' ' PHE . 55.0 m -79.65 -83.03 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.487 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.525 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -50.53 -24.86 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.187 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.28 38.71 2.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.7 OUTLIER -114.24 -165.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.981 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -122.37 141.84 35.68 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.953 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 51.7 Cg_exo -34.86 136.44 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.209 2.606 . . . . 0.0 113.267 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -105.78 -84.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.442 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.73 95.34 5.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.203 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' CD1' ' O1G' ' A' ' 185' ' ' GNP . 1.3 t80 -66.48 105.91 1.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.229 0.537 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.6 p -160.63 134.06 4.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.541 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.22 89.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.435 2.09 . . . . 0.0 112.221 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -72.98 86.65 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.113 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.485 ' CG2' ' CG1' ' B' ' 87' ' ' VAL . 22.9 m -68.09 -22.54 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.244 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 2.9 t80 -129.21 -76.2 0.55 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.569 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' OD1' ' CE1' ' A' ' 40' ' ' TYR . 32.8 t0 61.39 118.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.599 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 12.0 t-20 -107.49 148.98 28.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.576 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.471 ' CE1' ' OD1' ' A' ' 38' ' ' ASP . 1.2 m-85 -141.49 143.1 33.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.213 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.99 131.54 40.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.592 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' CG1' ' CB ' ' B' ' 78' ' ' PRO . 3.2 m -150.53 163.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.122 0.487 . . . . 0.0 111.618 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.3 m -155.73 101.41 2.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.001 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' B' ' 76' ' ' SER . 11.9 t -98.41 130.96 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.211 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 19.5 mtm -91.06 99.92 12.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.912 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -101.48 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.67 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.01 12.94 72.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.355 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.21 34.22 6.85 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.706 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -141.78 134.81 14.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.582 0.23 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.35 167.96 10.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.113 . . . . 0.0 112.287 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -153.81 168.49 26.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.8 p -135.24 97.4 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.505 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 9.8 tt -115.82 160.92 19.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -161.11 120.81 0.97 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 19' ' ' LEU . 10.0 mp -77.04 102.82 6.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.918 0.39 . . . . 0.0 110.927 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 9.8 m-85 -84.1 104.95 14.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' CG2' ' A' ' 58' ' ' THR . 40.0 m-20 -66.84 175.85 2.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.716 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.422 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 23.1 p -161.43 128.95 4.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.49 170.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.51 66.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.35 150.45 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.314 . . . . 0.0 110.918 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 34.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -116.7 20.54 13.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -78.38 -10.48 59.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.382 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -42.54 -30.64 0.37 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -79.55 -45.56 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.548 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 1.4 mp -95.18 25.27 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.448 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -98.02 -49.61 0.22 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.675 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 60.1 Cg_exo -51.41 -43.1 51.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 121.965 1.776 . . . . 0.0 111.838 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' B' ' 103' ' ' TRP . 1.0 OUTLIER -49.08 -24.57 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.246 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.482 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 1.3 p -104.52 -20.65 13.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.336 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 60.38 139.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.895 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -47.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.584 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -69.23 -10.69 58.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.537 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.437 HG23 ' CG2' ' A' ' 7' ' ' VAL . 6.2 t -40.89 -52.21 3.09 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.17 -167.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.4 162.41 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 105' ' ' CYS . 15.0 m-85 -110.48 134.61 52.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER -104.31 120.33 40.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.16 153.76 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.488 ' HB2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -144.64 175.89 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 111.672 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -167.21 -176.05 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.703 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 115' ' ' THR . 24.9 t -135.07 44.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG12 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 177.38 -70.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.3 m -44.48 100.6 0.23 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.194 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.91 -36.4 83.53 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.667 2.245 . . . . 0.0 112.296 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 t -49.95 -32.37 14.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -96.0 -33.08 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CE1' HG12 ' A' ' 137' ' ' ILE . 1.4 t80 -55.76 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -48.86 -26.13 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' CA ' ' HG3' ' A' ' 96' ' ' LYS . 17.9 m-20 -73.2 -65.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.083 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.1 t -41.71 -33.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.829 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 9.2 ttpt -79.09 -62.38 1.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.17 7.79 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG3' ' CA ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -117.8 -41.57 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.821 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -95.23 -39.58 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.507 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 98.1 t -47.57 -43.31 49.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.632 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.8 Cg_exo -67.76 -31.85 31.25 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.525 2.15 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -93.13 -22.76 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.437 HD12 ' CG ' ' A' ' 110' ' ' PHE . 10.2 tt -47.05 -27.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 p -74.94 -40.14 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.25 -39.12 81.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 110.407 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 7.2 m-70 -93.73 -26.18 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -123.86 66.54 39.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.44 111.56 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.66 2.24 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.96 48.7 22.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.014 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 69.9 m -140.89 140.59 21.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.833 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.419 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 19.5 Cg_endo -58.4 169.98 2.7 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 0.0 111.914 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.437 ' CG ' HD12 ' A' ' 101' ' ' ILE . 3.1 p90 -159.84 137.72 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.411 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 mp -100.96 124.29 46.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.154 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.484 ' HG ' ' CZ ' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -134.71 102.12 5.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 154' ' ' TYR . 4.0 p -145.3 108.0 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 155.47 42.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.437 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 1.2 p -148.16 115.76 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -169.97 72.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 157' ' ' CYS . 24.9 mt -64.87 -62.52 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -50.93 -60.0 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.64 -48.37 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.439 ' CG ' HG12 ' A' ' 85' ' ' VAL . 22.0 ttp85 -50.34 -28.23 7.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.61 -15.46 61.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.485 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.84 143.83 38.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.757 0.313 . . . . 0.0 110.967 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.74 -45.02 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.0 m -49.25 -40.2 33.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -53.6 -63.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -50.97 -39.51 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.92 -63.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.09 -34.6 66.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 136' ' ' PRO . 1.2 mt -50.15 -26.28 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.959 0.409 . . . . 0.0 110.459 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.42 61.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.908 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.54 -16.66 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -93.63 29.59 1.98 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.16 33.64 2.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 50.04 -163.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.28 75.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 57.2 Cg_endo -70.69 169.14 20.83 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.697 2.265 . . . . 0.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 90' ' ' PHE . 4.0 mp -97.95 131.9 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.117 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.478 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -129.57 -179.24 0.96 Allowed Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.266 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 61.2 Cg_exo -52.14 -21.26 12.41 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.442 2.095 . . . . 0.0 112.496 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.0 -40.79 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.437 ' CG2' HG22 ' A' ' 137' ' ' ILE . 96.8 m -48.37 -47.24 37.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.184 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.89 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -32.0 73.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.414 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -55.43 -49.61 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.481 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.12 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.501 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.533 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -68.53 -49.07 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -63.46 -35.14 79.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -31.01 71.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.735 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.66 -20.12 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 146' ' ' ALA . 5.4 mmtm 63.13 93.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.55 -173.43 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 9.2 p -41.72 -45.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.606 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 112.81 139.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.589 1.18 . . . . 0.0 109.959 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -153.65 140.57 19.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.687 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 154' ' ' TYR . 34.7 m -158.47 125.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.666 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.429 ' CG ' HG12 ' A' ' 113' ' ' VAL . 3.4 pt-20 -161.02 174.15 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.652 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.443 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 16.9 p -135.23 -170.73 2.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.995 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 164.44 17.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.815 0.34 . . . . 0.0 110.506 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -40.72 -90.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.067 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.07 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.699 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 170.04 -66.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.647 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.527 ' NE2' ' N2 ' ' A' ' 185' ' ' GNP . 4.0 mm-40 43.73 96.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.604 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.84 -49.47 3.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.74 68.52 0.35 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.973 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.52 ' CD2' ' CD1' ' A' ' 23' ' ' TYR . 2.6 tp -93.02 -22.27 19.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 111.408 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -41.93 75.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.01 -65.21 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.67 -49.1 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.466 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 39.8 t80 -55.09 -43.79 74.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.639 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -53.09 -43.16 66.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.42 -44.82 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.818 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.83 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.925 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.458 HG13 ' CE2' ' A' ' 169' ' ' PHE . 19.6 mm -94.95 -30.2 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.36 -46.18 80.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.87 -26.24 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.216 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.56 63.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.69 65.96 6.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.421 ' CB ' ' CD ' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -71.96 -61.01 2.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 178' ' ' GLU . 54.6 Cg_endo -69.79 158.64 56.24 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.611 2.207 . . . . 0.0 112.403 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.36 175.92 9.36 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 108.39 1.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.44 151.83 9.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.449 2.099 . . . . 0.0 112.275 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 -178.82 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 60.23 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' B' ' 73' ' ' GLY . 8.5 tt -127.13 145.87 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.423 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.39 132.19 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 145.32 83.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.491 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 73.9 Cg_exo -50.49 -175.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.733 2.288 . . . . 0.0 112.545 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 73.4 m -153.72 -63.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.525 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.2 t80 -98.44 139.71 33.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.81 124.76 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.783 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.453 ' CD2' ' OD1' ' A' ' 38' ' ' ASP . 2.9 t-160 -68.21 78.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -50.51 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.98 -179.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -119.33 110.34 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -91.22 96.54 10.62 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.485 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 60.3 t -78.1 137.27 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.562 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.61 177.74 17.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.191 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -78.11 123.86 27.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 111.034 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -114.95 97.87 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.08 -18.68 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.585 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 p -45.37 -46.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 111.493 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -121.94 -10.74 8.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.687 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.58 18.92 21.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.309 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -124.47 -160.73 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.648 0.261 . . . . 0.0 110.708 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -98.34 164.32 12.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.46 167.94 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 47.84 33.83 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.373 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.447 ' HE3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.99 117.86 5.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.46 0.171 . . . . 0.0 111.179 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.438 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 92.4 Cg_exo -42.88 155.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.054 . . . . 0.0 112.294 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -47.77 -54.05 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -55.85 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.548 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 6.0 m0 -47.83 -57.54 5.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.73 -65.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.346 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' B' ' 109' ' ' THR . 3.7 mtt-85 -49.11 -44.52 42.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.43 -61.24 1.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -94.75 -68.79 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.273 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' B' ' 109' ' ' THR . 0.1 OUTLIER -78.45 -97.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.89 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 22.5 p -160.48 -55.06 0.05 Allowed 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -151.63 172.44 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 112.121 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' B' ' 113' ' ' THR . 7.2 p30 -64.37 75.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.537 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -56.55 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.483 0.658 . . . . 0.0 111.004 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 1.2 m 160.27 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.63 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 23.0 tttp 78.98 43.63 0.07 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.34 -64.0 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.812 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 74.28 118.47 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -126.02 134.89 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.529 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.421 ' O ' ' CG2' ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.819 0.342 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.9 -171.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 135.63 36.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.982 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 pt -149.63 111.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -134.26 99.73 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.404 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 6.0 m -77.27 152.4 34.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.418 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 17.4 t -136.9 143.9 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.285 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 9' ' ' VAL . 6.5 p -85.01 160.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' N ' HG23 ' A' ' 8' ' ' VAL . 3.9 m -138.09 121.18 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.22 173.9 31.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.22 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -89.54 110.42 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.0 110.769 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -161.15 -39.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 83.45 -47.99 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 81' ' ' CYS . 18.5 m -47.07 -25.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 8' ' ' VAL . . . -56.33 -94.44 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.477 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' HE2' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -96.83 -71.57 0.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 18' ' ' CYS . 1.1 t -36.0 -58.42 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' N ' ' CG2' ' A' ' 17' ' ' THR . 10.9 m -68.94 -26.86 65.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.964 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 23' ' ' TYR . 3.0 tp -58.38 -76.85 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.819 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD13 ' CD1' ' A' ' 40' ' ' TYR . 12.9 mt -48.91 -33.35 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.856 -0.528 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD11 ' N ' ' A' ' 21' ' ' ILE . 1.2 mp -51.16 -68.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.495 ' HB3' ' N2 ' ' A' ' 185' ' ' GNP . 3.6 t -93.33 -57.19 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.571 ' CE1' ' CD1' ' A' ' 169' ' ' PHE . 10.4 t80 -39.28 -39.89 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 62.7 m -104.72 -75.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 0.6 OUTLIER -71.22 -15.33 62.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 9.5 t-20 65.59 36.92 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 111.165 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 tttp 176.6 164.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -134.22 60.97 47.64 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.69 0.281 . . . . 0.0 111.748 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 80.9 Cg_endo -91.63 126.56 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.064 2.51 . . . . 0.0 112.516 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.7 p 171.82 -88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.991 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.96 153.04 13.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.0 t80 -91.02 111.92 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 110.835 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.0 t -158.67 140.38 9.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.0 Cg_exo -46.61 91.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.262 1.975 . . . . 0.0 111.446 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.453 ' HB ' ' H2 ' ' A' ' 188' ' ' HOH . 54.5 m -52.9 87.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.544 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' PRO . 37.2 t -75.4 -25.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 109.898 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -148.29 -68.82 0.23 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.247 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 3.0 m-20 57.97 111.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.331 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 11.2 t-20 -107.96 148.82 29.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.08 142.15 25.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.599 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.22 152.17 25.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 24' ' ' THR . 1.2 m -162.43 148.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -132.09 104.81 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.31 117.23 41.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.5 . . . . 0.0 110.58 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.422 ' HE1' ' CB ' ' B' ' 76' ' ' SER . 3.8 mtm -100.23 100.01 10.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.947 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.3 tt -109.85 109.54 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.982 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.25 15.81 61.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.545 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.68 -43.01 1.94 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.616 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.61 142.91 66.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.293 . . . . 0.0 111.057 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.81 173.98 11.85 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.322 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -153.28 146.46 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -99.72 97.42 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' A' ' 173' ' ' ILE . 7.9 tt -112.33 156.5 22.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.994 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -151.99 112.33 0.53 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.354 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.407 ' CD1' HD22 ' A' ' 53' ' ' LEU . 3.6 mp -85.5 103.34 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 6.4 m-85 -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.35 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.17 166.36 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.7 m -169.32 128.59 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.544 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 64' ' ' TYR . . . -77.94 -73.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.69 -137.67 6.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 mt 71.73 -174.23 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -96.08 -16.89 21.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.393 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -76.34 -19.27 58.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.4 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.461 ' CE1' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -70.33 -16.79 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.542 0.21 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -48.04 -25.73 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -91.99 -40.95 10.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' CD2' ' CZ3' ' B' ' 103' ' ' TRP . 27.3 tp -86.78 1.13 53.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.51 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.01 -47.28 0.39 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.838 -0.164 . . . . 0.0 111.282 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 76.3 Cg_exo -49.08 -25.21 8.78 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.19 1.927 . . . . 0.0 111.411 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.502 ' HB2' ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -65.02 -28.15 69.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.497 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 22.5 m -100.15 -14.89 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.262 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 54.58 141.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 123.252 0.621 . . . . 0.0 112.03 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.99 -34.51 2.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -10.71 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.322 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 9.0 t -40.6 -47.88 2.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.572 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 1.3 m-20 169.06 -168.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 111' ' ' LEU . 12.2 p -58.29 141.97 14.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.448 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 105' ' ' CYS . 10.3 m-85 -92.9 143.7 26.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -103.68 115.94 31.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.219 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 110' ' ' PHE . 2.7 t -89.26 93.69 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.962 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.439 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 28.1 p -67.62 110.38 3.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.744 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.491 ' CD2' HG13 ' A' ' 93' ' ' VAL . 2.6 t80 -131.92 105.8 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.42 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -50.66 156.83 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 ' CG1' ' CG2' ' A' ' 137' ' ' ILE . 63.0 t -83.49 -75.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 ' CG1' ' HD3' ' A' ' 87' ' ' PRO . 97.9 t -69.26 -101.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.7 m 33.72 57.59 1.76 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD3' ' CG1' ' A' ' 85' ' ' VAL . 2.7 Cg_endo -46.06 -25.65 3.04 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.9 2.4 . . . . 0.0 112.362 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.39 -26.04 26.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 16.1 m -96.28 -38.78 9.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.254 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -45.17 -66.99 0.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.238 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 -55.55 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -54.17 -64.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.914 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' A' ' 82' ' ' PHE . 48.0 t -41.37 -36.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.813 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 25.1 tptp -63.2 -69.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.78 8.62 11.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tptp -117.43 -44.93 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -95.12 -28.19 15.2 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 24.5 t -70.03 -44.56 21.5 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.704 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.5 Cg_exo -51.06 -29.31 27.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.23 1.953 . . . . 0.0 112.57 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -93.11 -17.51 23.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.666 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 9.6 tt -47.5 -35.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.805 0.336 . . . . 0.0 111.29 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 p -65.62 -38.33 89.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -61.67 -29.46 70.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.179 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -87.06 -48.96 7.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 28.9 p -104.04 96.55 9.66 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 111.005 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.56 100.45 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.573 2.182 . . . . 0.0 112.334 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.82 5.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 m -117.32 131.17 24.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.55 175.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.483 2.122 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CE1' ' CD1' ' A' ' 149' ' ' LEU . 3.9 p90 -163.15 159.42 22.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 77' ' ' VAL . 8.7 mp -111.96 120.08 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.847 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 1.3 tm? -95.19 102.49 14.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.69 160.39 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.373 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.45 137.3 6.51 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.364 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.478 ' CG2' ' C6 ' ' A' ' 185' ' ' GNP . 6.5 p -130.26 -155.62 0.71 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.1 tp60 82.4 77.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.4 HG13 ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -100.12 -34.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -78.04 -51.72 9.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.268 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -40.37 59.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CB ' HG22 ' A' ' 85' ' ' VAL . 7.6 ptt85 -72.44 61.93 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -137.72 46.7 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.022 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.32 145.89 34.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.62 -45.21 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.317 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -49.96 -45.93 51.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.79 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -29.62 20.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.8 mm -66.09 -57.35 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.054 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -48.43 -38.19 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.056 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -39.09 17.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.976 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 mt -51.18 -25.54 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.409 . . . . 0.0 110.436 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.82 -19.18 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -31.9 33.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -67.62 -19.46 65.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.13 46.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.49 133.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.5 168.18 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.54 129.22 32.73 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.468 ' CG2' ' CG1' ' A' ' 84' ' ' VAL . 8.5 mt -60.41 129.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.471 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -128.09 179.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.948 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 73.0 Cg_exo -51.75 -21.67 11.9 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.674 2.25 . . . . 0.0 112.508 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.58 -53.37 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.4 m -46.21 -47.52 17.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.133 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.34 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -33.79 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.577 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -58.51 -56.62 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 17.9 tp -59.09 -52.94 63.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -57.91 -41.01 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.408 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.402 ' HA ' ' OH ' ' A' ' 154' ' ' TYR . 48.4 ttt-85 -50.16 -41.56 49.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.44 -21.74 64.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' CD1' ' CE1' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -74.84 -28.47 60.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 tttt 66.83 58.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.648 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -107.28 -177.97 3.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.412 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 66.3 t -48.86 -64.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 178.97 160.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.756 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -154.34 111.23 3.35 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 23.6 m -158.27 120.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.859 0.362 . . . . 0.0 110.412 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -173.18 -178.63 1.79 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.61 -173.42 4.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.89 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.4 ' OG ' HG13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -87.2 155.94 19.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.267 0.556 . . . . 0.0 111.301 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.531 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -57.18 -158.85 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER 47.86 26.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.802 179.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.512 ' NE2' ' N2 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER 73.62 121.46 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -105.42 -68.28 0.87 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.178 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.86 85.19 0.11 Allowed Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.549 ' CB ' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -94.05 -10.11 34.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.728 0.299 . . . . 0.0 111.669 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -43.74 -29.44 0.52 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.925 0.393 . . . . 0.0 111.135 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 155' ' ' VAL . 16.1 m-20 -64.37 -47.4 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.557 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 86.1 t -54.45 -47.62 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.571 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -69.97 -38.76 76.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.746 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.37 -42.34 66.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.269 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.43 ' CB ' ' HG2' ' A' ' 153' ' ' LYS . 1.6 tp10 -90.03 -41.53 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.72 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -60.48 -35.73 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 29.6 mm -86.11 -44.65 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.37 -41.13 85.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -52.3 -40.03 61.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.56 -23.83 29.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 tp -48.91 -64.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.06 80.7 5.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.37 104.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.59 137.94 58.22 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.593 2.195 . . . . 0.0 112.236 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 6.0 mm-40 -86.24 -47.48 0.55 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 79.3 Cg_exo -48.15 121.79 6.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.471 2.114 . . . . 0.0 112.402 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 107.63 15.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.4 mttp . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.966 -179.925 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.22 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.35 142.61 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.058 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.422 ' CB ' ' HE1' ' A' ' 45' ' ' MET . 0.7 OUTLIER -129.48 144.89 51.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -72.53 129.29 87.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.72 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.459 ' CD ' ' CE2' ' A' ' 169' ' ' PHE . 9.2 Cg_endo -51.91 149.64 19.88 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.4 ' O ' ' N ' ' B' ' 81' ' ' PHE . 75.4 m -120.37 -64.07 1.29 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -47.53 93.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.548 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.3 t80 -119.75 135.87 54.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.89 131.24 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.487 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.22 88.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.474 . . . . 0.0 110.397 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -76.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.661 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.431 HD11 ' CB ' ' A' ' 39' ' ' ASN . 1.1 mp -121.4 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.931 0.396 . . . . 0.0 111.788 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -105.31 97.48 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.907 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 41.5 t -77.62 145.38 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.707 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.415 ' CA ' HG13 ' A' ' 33' ' ' VAL . . . -146.31 167.49 27.94 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.227 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -92.19 126.82 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 37.1 t0 -135.82 135.14 39.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.758 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.42 1.72 18.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.009 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 11.5 m -45.5 -27.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -153.41 -44.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.837 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.57 35.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.367 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -144.66 -160.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.752 0.311 . . . . 0.0 110.598 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.56 147.3 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.437 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -90.71 178.49 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.74 32.28 32.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.473 ' CG ' ' CB ' ' B' ' 104' ' ' ALA . 1.8 tpt -44.1 101.92 0.27 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 0.0 111.423 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.431 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 82.7 Cg_exo -45.51 151.95 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.114 1.876 . . . . 0.0 112.077 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -43.97 -63.84 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.929 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -64.7 -61.29 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.747 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.543 ' CZ3' ' CD2' ' A' ' 67' ' ' LEU . 3.1 m0 -46.39 -50.62 16.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.473 ' CB ' ' CG ' ' B' ' 99' ' ' MET . . . -61.14 -66.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.0 ptm180 -47.35 -27.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.915 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' CD1' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -63.05 -62.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.331 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -59.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.679 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' B' ' 109' ' ' THR . 6.8 tp60 -77.82 -99.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.2 p -166.74 -52.17 0.03 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.891 0.377 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.1 -176.5 5.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.434 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' B' ' 99' ' ' MET . 26.7 t-20 -82.41 80.48 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.845 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.492 ' N ' ' CD1' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -57.14 88.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.701 0.762 . . . . 0.0 111.402 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' B' ' 112' ' ' ILE . 0.2 OUTLIER 164.63 -30.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.344 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.61 -66.48 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.671 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.4 t 45.06 95.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 174.32 145.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -109.37 146.26 34.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 tptt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.844 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.531 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.453 ' H2 ' ' HB ' ' A' ' 35' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.41 141.59 43.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 t -119.98 111.8 18.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -115.88 151.98 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.33 96.26 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.78 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.7 104.8 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.418 ' CG2' ' OG1' ' A' ' 75' ' ' THR . 25.7 t -84.71 158.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 34.4 m -140.76 150.71 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.405 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' CA ' HG22 ' A' ' 14' ' ' VAL . 2.8 m -145.12 135.2 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.335 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.72 146.08 4.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.69 152.58 39.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.58 0.228 . . . . 0.0 110.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.76 96.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.976 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' N ' ' H2 ' ' A' ' 187' ' ' HOH . . . 67.61 64.13 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.141 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 HG22 ' CA ' ' A' ' 9' ' ' VAL . 7.6 p -48.56 -24.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.2 -32.84 2.6 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HD2' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.14 -73.45 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.637 0.256 . . . . 0.0 111.56 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.0 p -39.52 -61.31 0.82 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.775 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . 6.1 p -46.43 -37.3 7.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 23' ' ' TYR . 5.9 tp -67.94 -71.46 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 mm? -38.18 -41.37 0.59 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.753 0.311 . . . . 0.0 111.604 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 4.4 mm -61.04 -45.05 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.445 ' OG ' ' C4 ' ' A' ' 185' ' ' GNP . 90.8 p -94.2 -64.02 1.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' B' ' 77' ' ' LEU . 27.1 t80 -49.38 -47.88 47.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.197 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.435 ' HA ' ' CD2' ' B' ' 77' ' ' LEU . 94.5 m -97.45 -95.76 0.21 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.501 ' HB ' ' CE2' ' B' ' 81' ' ' PHE . 5.0 t -41.23 -29.38 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 t30 68.13 24.25 7.74 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' CE ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -112.41 -160.02 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.196 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.01 156.61 74.01 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 63.2 Cg_exo -36.68 142.33 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.071 2.514 . . . . 0.0 113.133 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.95 -83.32 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.537 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.94 97.31 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.377 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.38 106.45 1.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.098 0.475 . . . . 0.0 110.97 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.424 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 4.4 p -160.6 139.64 7.79 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.179 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 36' ' ' VAL . 62.4 Cg_exo -37.66 100.2 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.764 2.31 . . . . 0.0 112.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 m -47.0 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.257 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG12 ' CG ' ' B' ' 96' ' ' PHE . 91.2 t -91.21 -43.67 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 84.0 t80 -172.57 106.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.746 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 30.0 m-20 -107.52 127.36 53.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 31.4 t-20 -107.48 147.01 31.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.113 0.482 . . . . 0.0 111.309 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.27 161.11 43.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.187 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.82 116.75 29.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.182 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 55' ' ' LEU . 1.3 m -124.92 124.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 0.0 111.76 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -122.27 95.94 4.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.459 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 76' ' ' SER . 10.7 p -97.34 116.78 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.8 mtm -89.04 114.99 26.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.047 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' B' ' 74' ' ' SER . 9.0 mt -115.8 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 73' ' ' GLY . . . 85.79 18.73 59.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.21 33.45 44.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.544 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -139.15 147.33 52.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.66 162.9 35.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.491 2.127 . . . . 0.0 112.207 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.34 167.53 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.37 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.5 m -131.87 97.04 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.214 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.75 158.94 16.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.29 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.92 103.72 0.26 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.054 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -78.39 103.32 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -83.71 102.95 12.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.172 179.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -71.38 -178.07 2.0 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.985 0.421 . . . . 0.0 111.111 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 ' CG2' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -170.53 172.81 5.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.701 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.39 -61.45 1.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.253 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.51 18.46 9.04 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 mt -94.33 -173.83 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.801 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.67 39.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -135.64 12.33 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.346 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.522 ' CE2' ' CG2' ' A' ' 58' ' ' THR . 1.3 m-85 -86.69 2.68 47.73 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.525 0.202 . . . . 0.0 111.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -49.43 -25.63 2.7 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -39.07 12.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.84 26.32 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.538 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.568 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.49 -26.57 0.3 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 72.5 Cg_endo -76.72 -22.91 11.51 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.455 1.437 . . . . 0.0 111.667 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 7.4 mt -60.19 -18.27 47.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -94.38 -27.24 16.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.04 168.47 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.976 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 72' ' ' TYR . 14.1 Cg_endo -57.4 -17.62 27.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.422 2.081 . . . . 0.0 112.198 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -10.76 38.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.2 t -38.3 -30.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.03 -154.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 78' ' ' PHE . 41.4 t -57.84 161.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -111.94 122.08 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.945 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.434 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 1.9 tp -103.83 121.51 43.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.291 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.484 HG13 ' CZ3' ' A' ' 97' ' ' TRP . 2.3 t -131.06 138.12 54.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.95 152.99 48.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 26.9 p90 -138.65 176.13 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HA ' ' NE2' ' A' ' 116' ' ' GLN . 91.5 p -89.69 120.03 30.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 116' ' ' GLN . 32.3 m -93.06 40.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 120' ' ' ARG . 19.4 m -95.46 -45.77 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 2.0 p -139.46 139.35 22.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.74 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' HG2' ' CB ' ' A' ' 132' ' ' ASN . 42.6 Cg_endo -68.53 -17.81 43.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.579 2.186 . . . . 0.0 112.469 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -51.68 -23.73 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -93.32 -29.91 15.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.169 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 2.7 m-85 -46.44 -44.93 17.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.193 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.65 -58.26 8.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -63.17 -36.71 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG11 ' CE3' ' A' ' 97' ' ' TRP . 72.7 t -48.63 -65.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.435 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 13.0 mtmm -73.33 -37.25 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.71 -12.39 61.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.9 tttm -119.03 -25.88 6.11 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ3' HG13 ' A' ' 80' ' ' VAL . 31.2 m0 -93.29 -49.03 6.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.625 0.25 . . . . 0.0 111.313 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.507 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.8 t -47.6 -43.93 52.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.1 Cg_exo -67.38 -26.53 41.09 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.53 2.154 . . . . 0.0 112.589 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.05 -35.21 15.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.439 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -47.67 -27.58 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.367 . . . . 0.0 111.294 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.419 ' N ' HG21 ' A' ' 101' ' ' ILE . 38.3 p -89.13 -33.23 17.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -51.92 -44.68 63.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 -46.59 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -97.34 104.23 19.12 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.746 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -41.65 -51.12 4.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.554 2.17 . . . . 0.0 112.565 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -173.79 48.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 56.6 m -103.97 142.79 25.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 78.7 Cg_exo -39.79 129.08 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.547 2.165 . . . . 0.0 112.086 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.473 ' CE1' ' HB1' ' A' ' 151' ' ' ALA . 8.6 p90 -102.53 173.75 6.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.164 0.507 . . . . 0.0 111.48 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.52 ' CD2' ' CE2' ' A' ' 154' ' ' TYR . 3.0 mt -151.74 126.25 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.876 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 tt -143.63 125.64 15.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.675 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.525 ' CG1' ' CD2' ' A' ' 154' ' ' TYR . 7.1 p -157.05 134.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.326 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.471 ' HA2' ' CE1' ' A' ' 82' ' ' PHE . . . -105.94 158.62 15.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.555 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.492 ' CG2' ' C8 ' ' A' ' 185' ' ' GNP . 13.0 t -168.87 144.36 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.733 0.302 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HG3' " C4'" ' A' ' 185' ' ' GNP . 2.3 mt-30 172.06 55.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.45 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 158' ' ' SER . 38.3 mt -52.88 -24.46 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 28.0 t70 -82.26 -55.22 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.231 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -63.29 -40.76 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' CB ' ' HA ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -66.25 71.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -174.97 53.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.45 161.24 25.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.12 -26.17 15.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.832 2.355 . . . . 0.0 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -28.71 16.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.98 -68.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.088 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -45.36 -39.69 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.445 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -61.29 2.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.14 -35.38 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -49.7 -27.74 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 110.686 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.95 -20.36 62.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.404 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -89.92 -21.56 22.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.19 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 1.3 t-20 -88.21 -26.67 22.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.172 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 166.78 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 87.18 -175.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 1.4 tmmt? 63.22 129.03 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.5 140.18 62.0 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.429 2.086 . . . . 0.0 112.458 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.9 mt -70.2 118.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.969 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.81 156.9 34.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.334 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.07 -29.46 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.293 2.662 . . . . 0.0 112.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.31 -43.74 73.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.412 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.58 -66.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.32 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 114' ' ' GLY . . . -47.41 -47.69 26.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.246 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.435 ' CG ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -56.39 -44.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -39.97 75.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.0 -52.34 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.599 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.45 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -81.37 -35.52 30.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.9 -52.13 8.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.254 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -94.34 30.82 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.242 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.03 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 110' ' ' PHE . . . 51.65 -176.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.156 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 42.5 t -71.46 -8.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.81 152.1 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.52 0.328 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.525 ' CD2' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -153.16 151.8 30.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.088 0.471 . . . . 0.0 111.884 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.435 ' HA ' ' CG ' ' A' ' 143' ' ' GLU . 33.2 m -158.75 124.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.447 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.89 -178.46 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.349 0.595 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.7 p -141.77 -168.21 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.431 ' HB2' ' HB ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -82.92 161.22 21.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 109.976 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.497 ' HA ' HN22 ' A' ' 185' ' ' GNP . . . -45.54 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.959 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.436 ' CD2' ' HB2' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -37.04 -42.72 0.43 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.057 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.6 p -86.77 171.71 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.154 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.522 ' NE2' HN21 ' A' ' 185' ' ' GNP . 0.6 OUTLIER -163.39 89.01 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.166 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 -68.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.951 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.37 77.02 0.39 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.507 HD22 HN21 ' A' ' 185' ' ' GNP . 0.2 OUTLIER -94.02 -32.81 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.138 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -65.66 -43.67 88.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.401 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 47.0 m-20 -51.72 -66.02 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 154' ' ' TYR . 2.1 p -42.92 -56.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.562 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CD2' HG13 ' A' ' 173' ' ' ILE . 1.0 OUTLIER -52.12 -33.2 38.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 5.0 t0 -70.0 -31.14 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -88.99 -26.24 21.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.16 -24.53 21.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.988 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.494 HG13 ' CD2' ' A' ' 169' ' ' PHE . 15.8 mm -94.98 -57.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.1 tp -53.53 -24.67 14.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.77 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.62 -23.66 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.73 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.02 142.44 0.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.3 154.19 61.38 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.609 2.206 . . . . 0.0 112.243 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 171.42 16.31 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.23 151.52 81.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.22 124.42 12.9 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.197 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.23 87.21 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.932 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -60.85 -68.81 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 tt -144.03 151.43 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 10.8 t -136.03 130.12 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.516 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -47.17 139.47 7.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 67.6 Cg_exo -50.68 142.47 31.79 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.345 2.03 . . . . 0.0 112.189 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 166.78 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.724 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.51 110.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 20' ' ' LEU . 4.5 p90 -81.08 172.73 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.305 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -130.04 135.98 48.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.9 95.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.181 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -72.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 0.9 OUTLIER -125.24 138.88 52.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.024 0.44 . . . . 0.0 111.936 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.16 98.03 5.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.715 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 61.2 t -77.65 152.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.881 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.39 177.88 24.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.152 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -77.16 124.59 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 110.788 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' B' ' 97' ' ' THR . 11.0 t0 -114.86 108.33 16.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.132 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.1 -19.35 62.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.2 -57.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.016 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -146.05 53.04 1.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.06 30.08 7.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -118.21 -176.75 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 0.3 OUTLIER -99.27 164.15 12.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.644 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.433 HG22 ' CB ' ' B' ' 90' ' ' ASP . 10.3 p -104.29 166.8 10.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 46.73 26.87 2.9 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.433 ' O ' ' CB ' ' B' ' 111' ' ' ASN . 1.2 mtp -48.5 137.55 12.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.598 0.237 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.475 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 52.7 Cg_exo -53.8 151.39 26.15 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.238 1.959 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 2.7 mt-10 -44.63 -55.46 5.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.599 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 1.4 tm0? -70.84 -46.56 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.535 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m0 -51.1 -57.91 7.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' B' ' 110' ' ' SER . . . -53.1 -67.37 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.098 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' B' ' 102' ' ' GLN . 10.8 ptt85 -44.66 -40.98 6.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.397 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.97 -55.08 19.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.83 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.46 -69.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.191 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' B' ' 110' ' ' SER . 7.3 tt0 -79.47 -96.3 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 16.8 p -164.07 -56.62 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.539 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -125.85 173.46 9.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.608 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' B' ' 99' ' ' MET . 0.8 OUTLIER -59.58 -55.76 30.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.2 86.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.752 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 71.65 -62.37 0.46 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.563 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.54 38.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.408 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.2 OUTLIER 58.44 163.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.93 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.32 144.69 40.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.26 163.91 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 89.4 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.89 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.816 " H3'" ' O2A' ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.471 ' H2 ' ' N ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.787 0.327 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.43 122.18 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.65 147.23 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.741 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.443 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 10.5 mt -131.46 104.18 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.274 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.415 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -102.72 96.48 6.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.744 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -80.81 122.07 26.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.477 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 71.8 t -97.69 154.05 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 2.5 t -120.17 166.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.389 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG21 ' CE1' ' A' ' 104' ' ' HIS . 7.4 p -157.51 121.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.45 169.28 27.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.289 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 4.0 m-20 -87.3 134.11 33.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.7 -45.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . 77.31 -66.13 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 82' ' ' PHE . 23.4 m -48.07 -24.67 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.747 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.478 ' CA ' ' HA ' ' A' ' 81' ' ' CYS . . . -55.25 -91.09 0.01 OUTLIER Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.162 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 57' ' ' ASP . 2.1 ttpm? -96.07 -72.84 0.62 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -40.51 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' O ' " H2'" ' A' ' 185' ' ' GNP . 69.6 m -49.52 -29.82 7.4 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.22 0.533 . . . . 0.0 110.833 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.0 -73.99 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.03 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 1.5 mt -48.46 -29.45 4.1 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 25' ' ' THR . 6.4 mm -53.69 -65.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.245 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -95.71 -17.96 20.85 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -179.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CE1' ' CZ ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -97.24 -40.92 8.53 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.501 ' CB ' ' HA ' ' A' ' 20' ' ' LEU . 41.2 m -94.56 20.95 7.8 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.083 -0.386 . . . . 0.0 111.668 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.48 HG22 ' CD1' ' B' ' 81' ' ' PHE . 3.3 t -177.13 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.211 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 25' ' ' THR . 9.8 m-80 81.2 51.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -133.93 -178.78 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.177 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -123.56 146.55 50.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.0 Cg_exo -35.62 146.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.661 2.908 . . . . 0.0 112.975 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -76.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.828 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.77 114.29 25.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.661 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 1.7 t80 -66.84 111.28 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.072 0.463 . . . . 0.0 111.121 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 87.8 t -159.51 131.3 4.1 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.2 Cg_exo -44.79 92.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.183 1.922 . . . . 0.0 111.451 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' VAL . 97.8 m -50.72 88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.684 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' PRO . 2.4 t -79.79 -42.84 22.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.504 ' CD2' ' HG3' ' B' ' 100' ' ' PRO . 2.8 t80 -124.76 -68.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.084 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 2.1 m-20 54.62 111.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.811 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.4 t-20 -106.99 160.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.038 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.524 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -148.29 162.36 39.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -178.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.09 148.06 30.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG2' ' HG ' ' A' ' 53' ' ' LEU . 19.9 m -151.61 158.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.259 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -154.93 87.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 51' ' ' TYR . 33.2 m -99.49 168.22 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.416 ' CE ' ' CB ' ' B' ' 76' ' ' SER . 19.1 mtm -121.44 101.53 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 51' ' ' TYR . 6.8 mm -93.32 90.1 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.41 20.35 60.49 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.38 34.43 8.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.558 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -138.62 138.65 22.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.65 165.37 2.51 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.53 2.153 . . . . 0.0 112.297 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.476 ' CD2' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -152.91 136.93 16.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.6 m -135.4 97.82 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HG ' ' CG2' ' A' ' 42' ' ' VAL . 1.5 pp -133.67 160.53 37.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -140.76 123.94 2.47 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 20' ' ' LEU . 33.8 mt -75.73 117.49 17.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 3.6 m-85 -95.16 116.96 29.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 5.2 t70 -75.96 162.21 28.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.521 ' CG2' ' CD2' ' A' ' 64' ' ' TYR . 21.9 m -168.08 147.79 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.434 ' N ' HG21 ' A' ' 58' ' ' THR . . . -179.76 -83.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.079 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.51 19.3 26.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.449 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 63.73 51.93 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 63.47 28.43 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.17 22.38 7.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CD2' ' CG2' ' A' ' 58' ' ' THR . 0.2 OUTLIER -86.68 -2.55 58.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.525 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.59 -28.92 0.65 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 110.639 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -73.97 -45.36 50.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.489 HD12 ' CE2' ' B' ' 96' ' ' PHE . 52.4 mt -89.92 16.5 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -69.36 -59.36 5.03 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.473 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 10.5 Cg_endo -53.84 -19.64 15.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.466 2.11 . . . . 0.0 112.424 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -79.66 -27.44 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.455 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -103.83 -9.65 18.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.511 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 41.77 91.95 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.296 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 47.9 Cg_exo -55.85 -42.21 69.42 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -69.05 -10.91 59.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.59 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 72' ' ' TYR . 12.2 t -45.02 -48.47 11.59 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.666 0.27 . . . . 0.0 111.565 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' N ' ' CG2' ' A' ' 75' ' ' THR . 0.6 OUTLIER -170.74 -159.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.431 ' CG2' HD13 ' A' ' 111' ' ' LEU . 10.1 p -58.25 162.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 104' ' ' HIS . 0.4 OUTLIER -111.2 133.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.301 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' CD1' ' OH ' ' A' ' 154' ' ' TYR . 1.3 tp -104.21 116.07 31.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 58.9 t -103.34 154.59 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.416 . . . . 0.0 111.79 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 15' ' ' GLY . 23.8 p -115.2 117.69 31.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.811 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CB ' ' O ' ' A' ' 113' ' ' VAL . 9.9 t80 -99.12 165.71 11.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.608 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -83.26 136.85 34.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.473 0.654 . . . . 0.0 111.489 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 116' ' ' GLN . 98.8 t -51.68 -81.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.272 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -121.54 -96.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.734 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 7.1 t 39.91 93.29 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HG3' ' CD1' ' A' ' 129' ' ' LEU . 84.4 Cg_exo -45.47 -26.78 2.94 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.553 2.168 . . . . 0.0 112.462 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -57.79 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.424 ' CB ' ' HB3' ' A' ' 86' ' ' SER . 0.3 OUTLIER -47.49 -43.05 24.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.459 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 1.5 t80 -48.13 -67.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.94 -42.43 65.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.112 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -61.39 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 97' ' ' TRP . 28.4 m -47.47 -26.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.666 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.95 -59.7 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.357 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 7.88 8.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -113.36 -41.01 3.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.629 0.252 . . . . 0.0 111.525 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.475 ' CZ2' ' HB2' ' A' ' 11' ' ' ASP . 4.4 m95 -95.54 -43.34 8.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 91.1 t -45.14 -58.23 6.01 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 13.9 Cg_endo -57.16 -17.93 27.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.437 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 -28.07 16.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.483 HD13 ' CD2' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -49.66 -35.6 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.3 -31.56 67.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.56 -43.3 93.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.64 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 78' ' ' PHE . 12.1 m80 -76.25 -64.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.207 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 24.4 p -68.32 112.73 11.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.701 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 34.0 Cg_exo -61.07 -66.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.584 2.189 . . . . 0.0 112.341 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -145.93 23.78 1.36 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.8 146.15 33.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.57 173.47 6.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.475 2.117 . . . . 0.0 111.894 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 4.8 p90 -150.28 -179.04 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.507 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . 2.2 mp -137.16 142.99 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.217 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.429 ' O ' ' CB ' ' A' ' 154' ' ' TYR . 1.3 tp -112.86 125.98 54.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 111.473 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.543 ' CG2' ' CE2' ' A' ' 154' ' ' TYR . 3.5 t -106.31 135.71 43.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.413 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.04 143.55 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 5.2 t -161.05 -169.79 2.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.677 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.453 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 172.49 72.57 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.773 0.32 . . . . 0.0 111.368 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 157' ' ' CYS . 14.8 mt -98.75 -67.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.941 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -42.18 18.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -44.94 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -19.94 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.37 -28.09 0.8 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.309 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.21 116.2 10.0 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.59 -56.17 3.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.512 2.141 . . . . 0.0 112.639 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -43.82 -39.17 3.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -57.98 -64.01 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.27 -40.54 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -48.92 -38.55 23.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -89.94 -37.37 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.274 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.419 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 8.6 tp -48.95 -30.69 6.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.302 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.34 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.635 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -82.39 -25.77 33.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.53 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 7.3 m120 -85.1 -25.22 27.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.976 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 161.41 -23.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.567 0.542 . . . . 0.0 111.304 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 89.67 -43.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.978 0.511 . . . . 0.0 110.553 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.67 50.02 4.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.353 179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 73.2 Cg_endo -76.68 -47.37 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.622 2.214 . . . . 0.0 112.769 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.484 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 2.2 mm -106.82 136.67 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 111.211 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 17.2 p -159.74 155.37 22.51 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -47.47 -25.29 4.97 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.708 2.272 . . . . 0.0 112.197 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 -35.36 14.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.27 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.3 m -58.97 -50.21 74.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.007 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.58 11.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.43 ' HG3' ' CG1' ' A' ' 155' ' ' VAL . 1.4 tt0 -62.76 -39.04 92.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -58.93 -49.16 78.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.662 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.44 -36.1 70.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.622 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.43 -23.98 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.73 -41.57 37.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -51.34 -47.3 62.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.69 -9.85 58.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.384 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.91 116.55 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.64 -176.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' A' ' 111' ' ' LEU . 63.3 t -64.25 -14.51 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.571 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 78.78 160.1 0.19 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 111.076 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.543 ' CE2' ' CG2' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -152.57 110.88 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.003 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.43 ' CG1' ' HG3' ' A' ' 143' ' ' GLU . 2.2 m -118.07 123.5 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' OE2' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -172.05 -178.33 2.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 0.9 OUTLIER -130.5 166.97 19.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.251 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 115' ' ' THR . 0.1 OUTLIER -88.6 99.94 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.517 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' CB ' HD23 ' A' ' 160' ' ' LEU . . . 46.22 -175.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.538 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 41.24 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.119 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 75.5 p 40.47 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.984 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 76.45 79.99 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.821 0.343 . . . . 0.0 110.991 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.67 -68.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.34 57.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.73 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HG ' ' CD2' ' A' ' 23' ' ' TYR . 1.6 tp -93.74 -29.0 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -72.44 -57.4 4.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.417 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 72.4 m-80 -44.09 -56.71 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 111.12 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 155' ' ' VAL . 2.4 p -55.07 -39.9 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.41 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.26 -25.62 59.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.739 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 4.4 t70 -85.14 -28.61 25.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -75.38 -39.58 58.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.89 -44.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.437 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 169' ' ' PHE . 28.7 mm -70.68 -62.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.362 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -54.67 -21.55 11.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.263 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.52 92.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 111.265 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -75.34 -24.02 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.324 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.43 -29.08 5.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.966 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.66 142.87 46.25 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.22 148.84 69.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.568 2.179 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.7 143.59 68.95 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.554 2.169 . . . . 0.0 112.27 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 41.43 59.65 8.8 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.683 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.37 122.68 8.0 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.179 . . . . 0.0 112.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.93 119.27 32.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.5 -63.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tt -138.62 151.21 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.416 ' CB ' ' CE ' ' A' ' 45' ' ' MET . 1.1 t -130.52 167.55 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.769 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -103.7 136.97 19.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.83 178.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.434 2.089 . . . . 0.0 112.1 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -150.75 -48.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.271 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -49.26 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.48 ' CD1' HG22 ' A' ' 25' ' ' THR . 21.6 t80 59.5 119.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 111.04 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -153.23 127.52 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 92.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.282 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 70.1 p -77.22 -85.75 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 0.9 OUTLIER -92.94 109.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.745 -179.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -98.11 96.86 8.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.924 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 59.3 t -83.18 143.23 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.652 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.437 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -146.57 177.82 24.65 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.069 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -99.2 125.31 44.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.441 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 38.3 t0 -137.55 131.58 31.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.809 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 2.28 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.043 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.89 -28.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 120.892 0.377 . . . . 0.0 111.404 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -150.27 -44.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.851 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.36 34.44 0.28 Allowed Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.448 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.22 -166.6 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.285 . . . . 0.0 110.473 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.489 ' CE2' HD12 ' A' ' 67' ' ' LEU . 9.0 m-85 -87.63 162.24 17.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 7.7 p -103.33 163.98 11.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 49.43 27.16 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.171 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.4 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -47.65 134.16 10.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.886 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.504 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 59.1 Cg_exo -53.32 142.64 56.62 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.367 2.045 . . . . 0.0 112.205 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.14 -47.89 12.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.919 0.39 . . . . 0.0 110.807 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -54.39 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.51 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.498 ' CD1' ' HB3' ' A' ' 70' ' ' LEU . 18.7 m0 -53.15 -61.47 2.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' B' ' 110' ' ' SER . . . -43.13 -67.69 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.594 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 17.4 mtt85 -48.1 -41.76 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.034 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.71 -56.68 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.422 ' CD1' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.78 -70.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.252 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.45 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.2 tt0 -79.05 -96.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.684 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 9.3 p -165.68 -55.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.44 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 15.8 m -126.02 -179.32 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' B' ' 116' ' ' GLU . 0.7 OUTLIER -66.77 -59.66 3.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' B' ' 113' ' ' THR . 0.5 OUTLIER -138.74 86.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.554 177.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' B' ' 112' ' ' ILE . 7.3 t 49.69 33.16 5.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.296 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 113' ' ' THR . 1.9 tttp 85.42 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.646 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.428 ' CB ' HG21 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -165.56 117.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.006 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.424 ' HG3' ' ND2' ' B' ' 111' ' ' ASN . 3.4 tt0 -118.15 54.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.05 152.95 32.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.9 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.533 " H2'" ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.805 0.336 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -124.81 125.55 44.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 111.68 23.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -129.22 132.23 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.265 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -113.57 157.46 22.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.397 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -128.74 112.97 14.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 73' ' ' PRO . 10.7 t -87.04 98.67 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 16' ' ' LYS . 22.5 m -114.4 145.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.597 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 104' ' ' HIS . 32.8 m -137.94 121.34 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.54 167.41 38.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.852 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.09 -62.48 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.057 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.69 -137.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.597 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.601 ' CB ' ' H1 ' ' A' ' 187' ' ' HOH . . . -173.27 30.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 2.8 t -65.14 -12.52 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . -120.25 -24.84 2.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.644 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.21 -74.36 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.423 0.612 . . . . 0.0 112.159 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.436 HG22 ' H2 ' ' A' ' 188' ' ' HOH . 25.8 m -77.92 -63.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.706 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB3' ' C8 ' ' A' ' 185' ' ' GNP . 13.0 m -49.09 -45.5 43.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.079 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm? -39.73 -72.65 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.213 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 40' ' ' TYR . 16.8 mt -61.99 -19.27 62.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.602 0.239 . . . . 0.0 111.205 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.452 ' HA ' HG21 ' A' ' 25' ' ' THR . 1.0 OUTLIER -67.97 -48.22 75.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.357 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.463 ' OG ' ' C8 ' ' A' ' 185' ' ' GNP . 39.0 m -93.28 -20.54 20.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.662 0.268 . . . . 0.0 111.239 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 4.4 m-30 -84.0 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.83 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -87.75 -83.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.238 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.518 ' HB ' ' CD1' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -49.12 -26.98 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.257 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 p-10 47.19 41.97 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 110.821 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -132.51 134.89 45.56 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -59.49 154.36 44.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 57.9 Cg_exo -34.9 145.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.18 2.587 . . . . 0.0 113.221 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.02 -83.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -100.93 115.67 30.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.92 103.5 4.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 35' ' ' THR . 66.1 t -152.98 139.43 12.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 33' ' ' VAL . 98.6 Cg_exo -42.02 92.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.5 2.133 . . . . 0.0 111.737 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' VAL . 72.7 m -52.97 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.552 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' B' ' 96' ' ' PHE . 23.8 t -74.99 -32.74 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 3.2 t80 -144.96 -66.28 0.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.729 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 37' ' ' PHE . 4.4 m-20 55.18 108.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.391 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 46.9 t-20 -107.63 157.21 18.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.008 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.479 ' HB3' ' CE1' ' B' ' 81' ' ' PHE . 0.1 OUTLIER -150.93 167.71 26.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.952 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -123.12 156.98 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 15.6 m -160.71 147.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.087 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.3 m -124.08 101.41 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.543 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 173' ' ' ILE . 15.8 m -98.61 141.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 21.5 mtm -105.18 100.19 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.482 HD11 ' CD1' ' A' ' 51' ' ' TYR . 5.1 mp -104.77 92.78 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.73 16.69 61.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.395 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.98 38.8 6.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.603 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -141.64 139.17 18.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.656 0.265 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.1 168.07 14.79 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.642 2.228 . . . . 0.0 112.387 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CD1' HD11 ' A' ' 46' ' ' ILE . 4.9 m-85 -152.08 160.75 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.289 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -136.06 97.4 3.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.233 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 7.7 tt -132.59 160.55 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.207 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.42 139.88 6.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.34 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 79' ' ' LEU . 1.1 mt -79.33 104.13 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.057 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 5' ' ' LYS . 4.2 m-85 -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 4.8 t0 -71.38 -169.46 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.746 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.484 HG21 ' CG ' ' A' ' 64' ' ' TYR . 4.0 m -166.99 163.57 15.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' CB ' HD23 ' A' ' 61' ' ' LEU . . . -92.79 -74.69 0.51 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.74 61.57 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.851 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -132.31 -168.57 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.98 86.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 3.4 t0 76.03 43.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.041 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.485 ' O ' ' CG ' ' A' ' 64' ' ' TYR . 5.0 t80 50.63 35.72 12.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.1 -152.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 18.8 mmt180 -87.52 -1.39 57.91 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.132 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.541 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 4.1 mp -81.97 58.28 3.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -63.59 -70.06 0.51 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.7 Cg_endo -68.23 -22.5 40.27 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.026 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.508 ' HB3' ' CD1' ' B' ' 103' ' ' TRP . 3.9 mt -57.48 -20.65 32.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.022 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.415 ' OG ' ' CE2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -112.08 -34.12 6.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.095 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.513 ' CG ' ' HB ' ' A' ' 75' ' ' THR . 1.0 OUTLIER 66.04 76.33 0.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.673 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 77.8 Cg_exo -50.58 -55.18 4.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.854 2.369 . . . . 0.0 112.974 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -67.46 -8.04 30.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.513 ' HB ' ' CG ' ' A' ' 72' ' ' TYR . 8.8 t -33.05 -53.94 0.37 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.47 -161.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.802 0.335 . . . . 0.0 111.024 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' A' ' 109' ' ' PRO . 66.2 t -58.98 150.28 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 39.1 p90 -139.93 128.74 23.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.901 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 55' ' ' LEU . 1.8 pt? -103.77 116.23 31.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 111' ' ' LEU . 10.1 t -94.24 154.53 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.482 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.423 ' N ' HG11 ' A' ' 80' ' ' VAL . 7.7 p -67.08 171.84 5.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -163.78 105.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.81 0.338 . . . . 0.0 111.335 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -58.63 111.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG1' HG23 ' A' ' 137' ' ' ILE . 90.8 t -103.02 87.21 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 111.164 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 86' ' ' SER . 0.5 OUTLIER 169.12 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.481 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.476 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 68.2 m -46.99 103.59 0.37 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 111.025 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.62 -40.12 80.46 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.48 2.12 . . . . 0.0 112.363 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.8 t -53.6 -25.33 17.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.029 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 -36.7 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.025 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -60.13 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.86 -31.9 73.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.6 m-20 -69.29 -61.9 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.476 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 29.9 m -48.73 -36.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.313 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.438 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -61.31 -63.07 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -82.68 8.01 13.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.895 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.9 tttt -117.23 -36.53 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.674 0.274 . . . . 0.0 111.338 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.476 ' CZ2' ' CG1' ' A' ' 93' ' ' VAL . 28.5 m0 -93.38 -41.55 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.261 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.4 t -48.91 -57.96 9.86 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.3 Cg_endo -59.11 -18.04 41.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 112.305 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -84.76 -51.24 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.851 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 7.6 pt -51.29 -24.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.1 p -74.78 -28.99 60.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.362 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -70.87 -35.14 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.529 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 9' ' ' VAL . 8.4 m-70 -107.71 -2.43 20.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.739 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 3.5 m -149.62 58.03 3.09 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.63 55.9 5.07 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.747 2.298 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt 176.9 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.364 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 t -73.17 146.07 86.6 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 20.0 Cg_endo -60.29 178.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.644 2.229 . . . . 0.0 111.961 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 33.6 p90 -137.31 158.79 43.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -135.14 127.53 30.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.475 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -104.31 101.38 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.064 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -107.43 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . -168.74 159.13 32.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.805 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.493 ' HB ' HN21 ' A' ' 185' ' ' GNP . 0.2 OUTLIER -167.89 -64.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 0.0 110.756 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.414 ' NE2' HD11 ' A' ' 119' ' ' LEU . 0.8 OUTLIER 48.86 60.43 3.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.007 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.1 mt -65.71 -31.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.428 ' CB ' HD22 ' A' ' 160' ' ' LEU . 11.9 p-10 -81.75 -49.15 10.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.414 HD11 ' NE2' ' A' ' 116' ' ' GLN . 9.3 tt -49.65 -49.19 48.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -57.74 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.789 179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.0 t0 75.96 31.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -93.73 157.32 38.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.35 -39.75 5.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -25.75 59.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.9 m -56.21 -68.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -46.81 -40.86 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.415 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -62.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.12 -34.83 68.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -50.3 -25.86 4.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.418 . . . . 0.0 110.706 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.76 46.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.39 26.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.082 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -93.02 -30.0 15.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 169.02 146.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 129' ' ' LEU . 5.8 mmmt 60.61 145.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 140.97 70.57 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 141' ' ' THR . 4.3 mt -50.71 126.3 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -98.75 167.3 11.61 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.338 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.39 -22.98 22.57 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.827 2.351 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.22 -35.67 14.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.488 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 22.9 m -46.45 -42.5 15.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.057 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -51.29 56.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -54.57 -38.79 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -52.12 -55.87 18.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.287 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.33 -32.67 57.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -63.51 -49.75 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.664 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.606 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -25.43 58.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 151' ' ' ALA . 3.0 pp -122.65 19.89 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.21 -83.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 58.78 176.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 78.7 t -76.02 -7.35 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.78 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 82.85 141.35 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.694 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.488 ' CE2' ' HB3' ' A' ' 146' ' ' ALA . 5.8 p90 -153.21 153.4 32.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.799 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 2.0 m -158.56 123.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.413 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.75 157.97 14.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.993 0.425 . . . . 0.0 111.482 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.448 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 1.8 m -119.01 -173.51 2.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.172 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.449 ' HA ' ' N2 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -86.29 152.68 22.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.507 -179.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' CB ' HO2' ' A' ' 185' ' ' GNP . . . -40.48 -76.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.567 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -36.05 -33.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.652 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -82.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.476 ' NE2' ' CD2' ' A' ' 165' ' ' LEU . 0.9 OUTLIER 63.41 97.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -65.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.06 75.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.685 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 4.5 pp -93.13 -10.15 36.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.771 0.32 . . . . 0.0 111.377 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 -26.33 3.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.851 0.358 . . . . 0.0 110.179 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.99 -51.28 68.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 98.6 t -53.7 -49.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.31 -33.36 73.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.314 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -68.85 -36.94 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.76 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -44.83 27.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.59 62.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.462 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 16.7 mt -82.62 -43.76 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.2 -52.78 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.46 -33.14 29.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.019 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.83 -26.96 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -49.94 -51.25 42.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 60.68 87.44 0.13 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.68 143.14 23.08 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.532 2.155 . . . . 0.0 112.218 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.14 132.51 43.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 112.268 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.442 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 3.4 mt-10 -71.13 -51.37 10.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 69.5 Cg_exo -50.99 -175.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.61 2.206 . . . . 0.0 112.244 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 164.06 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.0 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.849 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 62.9 m -50.29 -80.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 tt -119.6 151.95 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.194 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -134.14 165.64 24.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -87.87 137.93 31.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.434 ' HD3' ' CG1' ' A' ' 44' ' ' VAL . 38.4 Cg_endo -66.68 -167.46 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.613 2.209 . . . . 0.0 112.131 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.421 ' O ' ' N ' ' B' ' 81' ' ' PHE . 81.1 p -168.34 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.43 78.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.518 ' CD1' ' HB ' ' A' ' 25' ' ' THR . 86.2 t80 -74.66 152.01 39.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -153.62 96.3 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.606 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -68.96 69.75 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.161 0.505 . . . . 0.0 109.662 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -43.79 -85.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.59 130.79 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -111.63 97.15 6.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.387 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 16.6 t -77.84 157.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 112.047 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.27 177.89 24.32 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -112.16 123.01 49.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.482 ' CB ' ' CG2' ' B' ' 97' ' ' THR . 14.8 t0 -140.26 127.84 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.733 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.59 -5.8 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.793 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.59 -29.09 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-O 120.802 0.334 . . . . 0.0 111.656 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 3.5 p -153.89 24.3 0.5 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.069 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.55 37.22 74.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.83 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.82 179.8 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.722 0.296 . . . . 0.0 110.878 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.473 ' CD2' HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -74.76 164.13 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.482 ' CG2' ' CB ' ' B' ' 90' ' ' ASP . 27.1 p -126.6 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.163 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.72 29.67 26.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.58 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.415 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -74.4 164.77 58.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.081 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.78 142.23 63.11 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.707 2.272 . . . . 0.0 112.343 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -45.71 -60.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -50.34 72.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.61 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.541 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 6.2 m0 -46.8 -63.38 1.04 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 110.411 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -51.01 -60.06 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 31.2 mtt-85 -48.77 -41.04 31.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.136 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.02 -56.73 8.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.47 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.462 ' CD1' ' HG ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -95.06 -68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.062 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' B' ' 109' ' ' THR . 7.0 tp60 -77.87 -101.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.338 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 3.0 p -167.08 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.337 0.061 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' B' ' 104' ' ' ALA . 5.0 m -140.42 172.77 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.7 OUTLIER -56.96 -67.21 0.34 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.471 ' CG2' ' CB ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -138.85 85.95 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 177.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' B' ' 114' ' ' LYS . 1.3 m 57.76 33.38 23.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.506 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' B' ' 113' ' ' THR . 15.1 ttmt 82.34 67.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.471 ' CB ' ' CG2' ' B' ' 112' ' ' ILE . 0.1 OUTLIER -141.12 124.69 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.32 -51.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -124.63 127.22 47.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.964 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.493 ' C8 ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.601 ' H1 ' ' CB ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.436 ' H2 ' HG22 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -71.2 132.65 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 m -94.24 112.81 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.92 133.09 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 104.34 7.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.3 m -77.33 99.06 5.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.665 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' CG1' ' CE1' ' A' ' 104' ' ' HIS . 10.8 t -84.61 159.45 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.465 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 58.4 t -130.47 148.73 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 80' ' ' VAL . 12.6 p -138.41 132.64 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.92 146.11 17.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.631 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.505 ' CB ' ' CZ2' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -72.05 126.22 29.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.89 -42.16 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.603 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' HB3' ' PB ' ' A' ' 185' ' ' GNP . . . 47.8 38.9 9.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.443 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 1.9 t -109.27 -14.01 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.77 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -135.67 -55.3 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -43.11 -66.26 0.39 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.171 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.417 ' HB ' ' O2B' ' A' ' 185' ' ' GNP . 88.7 m -95.15 -50.53 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -50.5 -44.39 56.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.326 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 18.1 tp -50.09 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.003 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.476 HD13 ' CD1' ' A' ' 40' ' ' TYR . 3.9 mt -51.14 -29.95 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 120.653 0.263 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -55.71 -69.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.353 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB3' HN22 ' A' ' 185' ' ' GNP . 0.3 OUTLIER -90.79 -10.49 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 19' ' ' LEU . 7.7 t80 -95.37 -59.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.48 ' CG2' ' CG1' ' A' ' 42' ' ' VAL . 63.5 m -73.67 -45.61 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.333 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.488 ' HB ' ' CD1' ' B' ' 81' ' ' PHE . 0.6 OUTLIER -113.97 3.83 15.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 p30 43.38 58.06 3.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 111.741 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 10.8 pttt -134.0 -164.74 1.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.511 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -134.21 166.45 29.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 46.5 Cg_exo -36.02 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.147 2.565 . . . . 0.0 113.47 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.64 -85.22 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.368 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.709 0.29 . . . . 0.0 110.286 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.1 t80 -80.91 106.39 12.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 111.623 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' THR . 12.7 m -158.99 145.3 12.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.093 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 36' ' ' VAL . 81.2 Cg_exo -44.73 88.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' VAL . 66.0 m -55.19 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.386 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' B' ' 96' ' ' PHE . 3.6 t -84.34 -21.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.651 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.578 ' CE1' ' CE2' ' A' ' 56' ' ' PHE . 2.2 t80 -147.96 -65.36 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.627 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 37' ' ' PHE . 7.4 m-20 54.33 109.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.271 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 28.0 t-20 -106.88 147.99 29.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.12 0.486 . . . . 0.0 110.968 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.476 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -139.07 169.2 18.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.785 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.81 141.55 45.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.306 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' CG1' ' CG2' ' A' ' 24' ' ' THR . 2.4 m -162.83 159.57 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.35 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.8 m -145.37 104.41 3.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.175 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.438 ' CG1' HD12 ' A' ' 173' ' ' ILE . 42.2 t -98.27 117.51 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 21.6 mtm -76.68 99.96 5.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.011 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 51' ' ' TYR . 66.0 mt -92.96 89.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.0 70.12 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.572 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.53 -17.82 30.51 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.859 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.29 138.85 25.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.66 0.267 . . . . 0.0 111.112 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -68.73 166.49 25.95 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.625 2.217 . . . . 0.0 112.341 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 46' ' ' ILE . 23.1 m-85 -153.94 173.73 15.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 97.26 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 9.6 tt -101.68 161.31 13.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.82 118.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.425 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 20' ' ' LEU . 5.5 mp -75.88 105.62 7.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.362 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -83.23 103.46 12.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.036 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -75.67 172.68 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 HG21 ' CE1' ' A' ' 64' ' ' TYR . 2.2 m -167.05 171.37 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.48 -161.07 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 61' ' ' LEU . . . -60.18 -16.08 39.98 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.75 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 1.5 tp 80.17 132.58 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 0.0 111.228 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 169.86 -34.91 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.593 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -116.21 -12.41 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.712 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -48.83 -33.96 11.54 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -47.49 -28.07 2.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.053 0.454 . . . . 0.0 110.424 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -82.04 -46.77 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.234 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' B' ' 103' ' ' TRP . 1.4 mp -92.49 49.56 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -99.65 -31.17 0.23 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 28.0 Cg_exo -37.14 -49.8 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.486 2.124 . . . . 0.0 114.025 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.545 ' CD2' ' CD1' ' B' ' 103' ' ' TRP . 0.1 OUTLIER -94.8 32.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 72' ' ' TYR . 4.4 p -134.04 -52.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.6 OUTLIER 41.56 98.89 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.805 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -45.62 -34.63 11.62 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.523 2.149 . . . . 0.0 112.579 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.93 -10.37 52.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.591 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.486 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 13.7 t -37.66 -49.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 75' ' ' THR . 0.2 OUTLIER 165.79 -165.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.678 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 10.9 p -64.84 125.69 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.766 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CD1' ' CB ' ' A' ' 105' ' ' CYS . 42.4 p90 -96.54 133.81 40.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.587 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 2.2 pp -103.59 116.05 31.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' LEU . 5.1 t -94.99 154.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.423 ' HB3' ' N ' ' A' ' 15' ' ' GLY . 5.8 p -111.5 160.0 17.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 111.385 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 40.7 p90 -152.66 103.9 2.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 14' ' ' VAL . 22.8 t -54.5 118.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.001 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -88.74 81.86 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.223 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' CG1' HD23 ' A' ' 119' ' ' LEU . 1.6 m -131.68 79.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.5 m 71.23 151.08 0.14 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.793 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.15 -22.03 14.18 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.541 2.161 . . . . 0.0 112.419 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -52.49 -32.43 40.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -91.09 -30.83 16.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.016 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.454 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -47.55 -65.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.17 -28.43 67.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 23.2 m-20 -69.84 -84.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.476 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 2.3 m -43.75 -29.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.693 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 12.6 tttt -70.57 -69.39 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -81.44 7.63 11.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.064 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.1 -42.59 3.92 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.413 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.505 ' CZ2' ' CB ' ' A' ' 11' ' ' ASP . 12.7 m95 -95.27 -43.36 8.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 68.7 t -48.41 -44.36 64.23 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.57 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 48.0 Cg_exo -55.68 -23.43 40.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.017 1.811 . . . . 0.0 112.166 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -93.53 -30.01 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.854 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -49.43 -26.41 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.138 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' N ' HG13 ' A' ' 101' ' ' ILE . 19.6 p -77.4 -32.13 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -64.54 -49.6 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.526 ' CE1' ' CG1' ' A' ' 7' ' ' VAL . 55.4 t-80 -65.54 -66.94 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.53 ' CB ' ' CD1' ' A' ' 78' ' ' PHE . 1.2 m -104.5 90.83 3.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.92 118.04 5.33 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.675 2.25 . . . . 0.0 112.572 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.3 51.99 15.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.235 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.87 144.09 51.41 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 99.2 Cg_exo -42.0 147.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.512 2.141 . . . . 0.0 112.102 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.7 p90 -139.41 139.38 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -126.93 119.81 27.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.42 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 1.8 mt -90.34 102.12 14.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.72 96.75 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . -117.61 -119.42 2.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 157' ' ' CYS . 20.2 m 69.11 167.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 111.438 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 176.43 112.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.484 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 159' ' ' ALA . 54.4 mt -91.82 -22.61 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.411 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.83 -44.23 7.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.469 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.433 HD23 ' CG1' ' A' ' 85' ' ' VAL . 1.9 tt -74.7 -47.87 29.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -48.99 -29.39 4.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.107 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.96 51.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -114.23 142.06 27.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.39 -21.64 18.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.552 2.168 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -43.17 57.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 p -56.36 -62.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -48.54 -46.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.41 -58.78 3.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.24 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -36.12 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.906 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -26.43 3.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.39 64.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -85.32 -41.5 15.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -61.39 -23.37 65.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.99 64.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.19 -171.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 167.6 9.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.15 120.93 6.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.538 2.158 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.61 121.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.235 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -117.96 164.8 18.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.833 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HG3' ' CG2' ' A' ' 115' ' ' THR . 75.3 Cg_exo -49.16 -26.21 10.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.568 2.179 . . . . 0.0 112.311 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.78 -51.05 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.6 m -54.87 -55.79 26.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 82' ' ' PHE . . . -50.11 -49.18 52.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -54.61 -42.09 70.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -46.85 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.689 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -55.98 -48.72 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.867 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.81 68.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -70.36 -43.59 69.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.769 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -59.44 -26.25 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.6 pp -103.15 -23.26 13.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.999 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 26.4 tptt 60.25 116.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -162.08 -161.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.299 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.451 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 9.2 p -44.93 -43.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.494 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 89.95 145.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.452 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 112' ' ' LEU . 48.8 p90 -153.05 150.97 29.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.885 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 m -158.36 122.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.434 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.464 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -172.04 124.74 0.53 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.553 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 115' ' ' THR . 0.6 OUTLIER -128.51 119.52 25.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -156.99 175.19 14.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.386 0.612 . . . . 0.0 112.497 -177.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 158' ' ' SER . . . 136.15 88.93 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.899 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 58.73 26.01 14.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 p -147.85 -72.08 0.21 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.466 ' NE2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 75.51 114.12 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.248 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 3.4 tttt -105.9 -45.12 4.45 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.11 71.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.621 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.563 ' CD1' HN21 ' A' ' 185' ' ' GNP . 0.1 OUTLIER -95.05 -16.91 22.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.973 0.416 . . . . 0.0 111.25 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -24.92 2.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 18.4 m-80 -71.79 -61.38 1.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.478 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 169' ' ' PHE . 11.4 p -45.52 -32.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CD2' HD13 ' A' ' 173' ' ' ILE . 1.1 t80 -77.04 -35.28 56.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 167' ' ' ASN . 3.8 t70 -58.25 -35.52 71.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.357 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.14 -44.5 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.777 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.98 64.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.989 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.489 HD13 ' CD2' ' A' ' 169' ' ' PHE . 5.1 mt -93.63 -54.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -59.8 -29.73 68.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.72 62.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.95 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -80.23 -23.51 40.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.68 42.04 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.9 110.73 2.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.21 157.01 56.17 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.96 171.21 11.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.76 112.57 5.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.32 114.11 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.44 2.093 . . . . 0.0 112.143 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.56 101.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.1 tttp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.965 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 75' ' ' ILE . 5.2 p 69.7 -62.19 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.429 HG21 ' N ' ' B' ' 76' ' ' SER . 8.6 mt -144.1 137.21 23.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.429 ' N ' HG21 ' B' ' 75' ' ' ILE . 1.4 m -131.59 152.48 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.99 145.92 99.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.745 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.41 ' HB2' HG22 ' A' ' 24' ' ' THR . 61.0 Cg_exo -52.65 -167.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.552 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 84.3 p -149.67 -79.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.85 119.7 12.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.488 ' CD1' ' HB ' ' A' ' 25' ' ' THR . 12.8 t80 -132.78 130.23 39.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.658 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.33 136.45 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 90.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -57.41 -81.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.59 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 mp -115.59 110.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.78 0.324 . . . . 0.0 111.717 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . 0.405 ' O ' ' ND1' ' B' ' 86' ' ' HIS . 8.7 p80 -85.4 96.84 9.69 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 41.0 t -87.83 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.225 0.536 . . . . 0.0 112.304 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 96' ' ' PHE . . . -142.61 177.8 21.49 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.362 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -101.05 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.3 0.55 . . . . 0.0 111.141 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 9.0 t0 -140.47 114.48 9.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.622 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.73 -5.17 31.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.973 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 p -45.74 -28.24 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.859 0.362 . . . . 0.0 111.176 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' B' ' 95' ' ' GLU . 0.0 OUTLIER -149.25 18.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.08 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.59 17.44 64.61 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.901 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 18.6 pt-20 -128.62 -163.28 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.719 0.295 . . . . 0.0 110.708 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 67' ' ' LEU . 6.6 m-30 -96.04 164.62 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -95.69 136.39 36.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' B' ' 111' ' ' ASN . . . 49.12 36.91 22.46 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.995 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.514 ' CE ' ' HB3' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -77.56 165.63 49.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.243 0.544 . . . . 0.0 112.31 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 51.5 Cg_exo -54.69 141.6 75.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.116 2.544 . . . . 0.0 112.26 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -56.02 -22.25 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 110.399 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.42 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.77 -64.73 0.81 Allowed 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.545 ' CD1' ' CD2' ' A' ' 70' ' ' LEU . 4.7 m0 -51.44 -60.09 3.52 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.437 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -40.51 -65.25 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 21.7 mtp85 -62.68 -35.48 79.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.768 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' B' ' 102' ' ' GLN . 0.9 OUTLIER -49.64 -55.49 13.5 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -72.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.138 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' B' ' 109' ' ' THR . 9.0 tp60 -82.67 -105.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.565 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 1.4 t 156.03 58.77 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.194 0.598 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' B' ' 115' ' ' SER . 0.6 OUTLIER 172.02 126.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.972 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.41 ' HB3' ' HA3' ' B' ' 98' ' ' GLY . 15.0 m120 -50.49 -70.49 0.08 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' B' ' 113' ' ' THR . 0.6 OUTLIER -121.25 85.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' B' ' 114' ' ' LYS . 9.4 t 45.18 25.35 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.268 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' B' ' 113' ' ' THR . 2.4 mttp 157.36 74.23 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.635 0.374 . . . . 0.0 110.703 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' B' ' 110' ' ' SER . 3.9 p -37.64 135.15 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.804 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -165.64 69.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.32 138.88 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.563 HN21 ' CD1' ' A' ' 165' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.15 121.35 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.81 120.47 40.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.61 130.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.42 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -135.83 96.61 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.965 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.417 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 8.2 m -80.35 147.01 31.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 4.4 t -122.16 159.88 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.431 . . . . 0.0 111.669 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' CG1' ' HA2' ' A' ' 15' ' ' GLY . 6.5 m -123.0 169.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.795 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -157.51 120.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.014 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.484 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 145.17 -161.78 28.15 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.702 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -118.25 169.26 9.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.733 0.301 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 90.54 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.223 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 81' ' ' CYS . . . 53.47 71.7 0.48 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.742 0.306 . . . . 0.0 110.244 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 8' ' ' VAL . 1.6 m -47.07 -25.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' HA2' ' CG1' ' A' ' 8' ' ' VAL . . . 140.85 -40.45 1.36 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.577 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -97.46 -74.23 0.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.1 t -35.37 -51.81 0.61 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.687 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' PA ' ' A' ' 185' ' ' GNP . 0.9 OUTLIER -66.26 -45.99 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.726 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -59.36 -68.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.48 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.515 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 17.7 mt -40.71 -45.38 2.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.159 0.504 . . . . 0.0 111.148 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -46.26 -70.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.547 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 14.5 t -95.2 -60.76 1.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.243 0.544 . . . . 0.0 111.564 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CE1' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -44.43 -26.63 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.929 -178.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 99.1 m -109.16 -89.92 0.47 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.195 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.498 ' HB ' ' CG ' ' B' ' 81' ' ' PHE . 1.4 t -64.14 -19.91 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.697 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.7 t30 70.41 32.75 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.355 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HB3' ' CG2' ' A' ' 25' ' ' THR . 4.9 ttpt -127.9 138.04 52.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' CZ ' " O3'" ' A' ' 185' ' ' GNP . 1.6 m-85 -81.67 149.29 63.88 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.736 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.11 153.89 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.788 2.326 . . . . 0.0 112.723 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -108.06 -71.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.67 109.76 17.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.608 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.83 92.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 73.3 t -138.1 131.29 16.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.426 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 36' ' ' VAL . 97.9 Cg_exo -42.26 93.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 111.837 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.477 ' HB ' ' H1 ' ' A' ' 188' ' ' HOH . 81.5 m -51.48 87.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.38 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 34' ' ' PRO . 93.8 t -77.05 -37.43 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 2.7 t80 -136.38 -63.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.745 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 35' ' ' THR . 11.5 t0 56.25 114.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.5 t-20 -108.11 153.09 23.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.379 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -144.33 169.25 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 0.0 111.343 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.07 138.08 46.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 24' ' ' THR . 2.3 m -162.37 139.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.302 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 51' ' ' TYR . 51.6 m -132.71 110.85 10.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.188 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.07 117.07 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mtm -94.42 100.28 12.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.129 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.6 mt -93.13 114.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 17.94 78.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.02 29.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.524 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.09 130.41 63.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.504 0.192 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.11 160.38 42.78 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.595 2.197 . . . . 0.0 112.405 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' THR . 36.2 m-85 -146.74 165.19 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.157 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -121.11 97.67 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.497 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 7.2 tt -113.79 157.23 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -151.9 113.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 2.3 mt -90.32 117.19 28.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.389 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -89.27 144.53 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.063 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -104.44 -163.69 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.904 0.383 . . . . 0.0 111.536 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.49 HG21 ' CD1' ' A' ' 64' ' ' TYR . 89.2 m -153.53 161.04 42.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.93 74.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.45 -22.85 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.366 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.55 176.37 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.784 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -81.94 67.75 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.08 19.4 4.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.367 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.49 ' CD1' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -89.61 -10.37 46.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.253 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.15 -31.02 0.86 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.834 0.35 . . . . 0.0 111.022 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -71.9 -39.76 69.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.476 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 103' ' ' TRP . 23.5 mt -90.09 6.54 42.01 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.299 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -47.74 -43.02 49.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_exo -60.5 -19.0 57.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.209 1.939 . . . . 0.0 112.021 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD12 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -106.5 -48.22 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.817 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 33.75 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -41.04 153.73 0.23 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.463 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.74 -25.27 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.743 2.295 . . . . 0.0 112.774 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -65.51 -11.19 41.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.739 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 2.5 t -42.99 -54.18 4.39 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.45 -152.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.774 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.42 158.22 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.681 0.277 . . . . 0.0 110.676 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 7' ' ' VAL . 1.4 m-85 -115.47 145.79 42.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' CB ' ' CG1' ' A' ' 8' ' ' VAL . 2.2 mm? -104.05 135.7 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.846 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 112' ' ' LEU . 3.0 t -115.56 153.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.981 0.419 . . . . 0.0 111.729 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 23.0 p -110.05 155.28 22.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 30.9 p90 -178.9 109.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -54.28 -170.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.563 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.06 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.429 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -47.18 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.474 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.6 m -68.43 110.72 6.27 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.498 0.19 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.79 -21.87 50.45 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.527 2.152 . . . . 0.0 112.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -30.62 46.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.162 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 m -92.98 -26.99 17.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.441 ' CZ ' HD12 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -48.73 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.197 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.62 -43.64 36.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -54.87 -69.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.429 HG13 ' CB ' ' A' ' 82' ' ' PHE . 93.2 t -39.66 -44.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.933 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -58.74 -69.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.673 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.74 8.23 8.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -116.76 -43.72 2.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.715 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 13.8 m95 -95.64 -39.09 10.08 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.5 t -51.63 -45.47 91.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.489 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.3 Cg_exo -46.45 -38.44 21.04 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.359 2.039 . . . . 0.0 112.359 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.977 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.6 mm -49.28 -26.66 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 p -90.34 -22.4 21.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -69.14 -37.31 78.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.673 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -103.71 -70.6 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.662 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.78 108.73 1.51 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.43 -65.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.25 28.42 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.842 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.61 148.16 34.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.448 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . 53.1 Cg_exo -53.71 161.61 4.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.523 2.148 . . . . 0.0 112.157 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.0 126.14 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 111.073 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.08 120.57 41.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.8 mt -90.68 149.31 22.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 ' CG2' ' HA3' ' A' ' 15' ' ' GLY . 29.2 m -156.82 173.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.951 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 115' ' ' THR . . . 138.36 -125.94 3.33 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.634 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 114' ' ' GLY . 0.6 OUTLIER 77.59 148.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.308 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HB3' ' CB ' ' A' ' 119' ' ' LEU . 16.7 mp0 -137.38 128.49 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.0 mt -98.65 -38.38 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.13 -23.46 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.444 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 1.3 tt -73.02 -15.31 61.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.474 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -69.3 -163.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.727 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 22.95 13.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.127 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.84 141.89 33.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.799 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.71 -46.97 29.79 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -69.06 -33.34 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.6 m -52.59 -66.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -57.97 -38.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.014 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.73 -61.52 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -35.77 77.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.675 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.2 -26.21 4.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.488 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.02 -23.08 63.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -85.15 -24.6 27.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -95.1 29.27 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.6 34.8 2.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 52.33 -162.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt 65.88 89.23 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.35 143.63 75.68 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.576 2.184 . . . . 0.0 112.319 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.441 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 6.0 mt -56.49 121.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -106.07 172.39 3.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.62 -19.95 25.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.696 2.264 . . . . 0.0 112.318 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -85.53 -31.62 22.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.435 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.6 m -59.93 -48.49 81.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.946 0.403 . . . . 0.0 110.676 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.6 -47.97 58.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.42 -41.73 73.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.304 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -47.22 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.56 -35.83 75.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.441 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.523 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -65.18 -30.63 71.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.083 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -75.1 -51.25 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -52.42 -48.01 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.86 -26.88 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 65.19 122.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.975 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -165.03 -160.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 17.3 t -61.37 -16.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.546 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.31 144.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.567 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CE2' ' CB ' ' A' ' 146' ' ' ALA . 37.5 p90 -152.15 144.09 23.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 124.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' CB ' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -171.03 -178.69 2.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 14.6 p -133.09 -173.18 3.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.36 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 t -87.48 159.66 18.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.787 0.327 . . . . 0.0 110.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 22' ' ' SER . . . -56.32 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 159' ' ' ALA . 0.6 OUTLIER 51.6 33.89 11.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.253 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 160' ' ' LEU . 1.4 p -167.82 -84.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.197 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.431 ' NE2' HD23 ' A' ' 165' ' ' LEU . 0.8 OUTLIER 73.43 104.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.019 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 -68.53 0.86 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.963 0.411 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.53 77.5 0.39 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.928 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' A' ' 23' ' ' TYR . 1.7 tp -92.19 -36.94 12.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.0 111.569 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -26.31 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.332 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -66.33 -73.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.0 p -44.59 -37.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.5 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.3 -44.2 97.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 0.0 110.653 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -59.28 -40.0 84.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.436 ' HG2' ' CE ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -77.82 -47.38 19.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.24 66.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.3 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.7 mm -82.21 -57.0 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.04 -29.02 11.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.089 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.63 63.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.02 -14.53 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.495 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 tp -91.88 21.23 5.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.258 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.433 ' CB ' ' HD3' ' A' ' 179' ' ' PRO . 1.4 mm-40 -92.39 -52.66 0.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 178' ' ' GLU . 38.3 Cg_exo -56.96 154.77 31.08 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.609 2.206 . . . . 0.0 112.338 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.9 131.95 22.11 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 144.79 96.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.07 -167.78 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.613 2.208 . . . . 0.0 112.359 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -66.43 91.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.953 179.91 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.18 -64.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.8 tt -140.75 151.88 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 2.2 m -130.77 133.35 45.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.19 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.49 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -62.1 136.99 95.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 169' ' ' PHE . 77.3 Cg_exo -48.68 144.05 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.401 2.067 . . . . 0.0 112.372 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -104.39 -54.71 2.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -67.56 162.43 23.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.498 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 6.1 t80 174.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.52 139.71 18.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.27 70.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.28 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.696 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.428 HG22 ' N ' ' B' ' 100' ' ' PRO . 1.3 mp -109.65 108.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 111.654 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -87.79 96.87 10.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.052 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 17.2 t -81.13 145.26 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.553 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -145.08 174.7 25.03 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.232 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -108.98 117.64 34.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.411 ' CB ' HG22 ' B' ' 97' ' ' THR . 42.2 t0 -123.89 136.18 54.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.972 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.41 0.77 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.894 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.421 HG11 ' CG2' ' B' ' 93' ' ' THR . 7.7 p -48.22 -25.96 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.885 0.374 . . . . 0.0 111.304 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.421 ' CG2' HG11 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -155.79 -39.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.325 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.84 11.91 2.53 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.406 ' CG ' HG22 ' B' ' 93' ' ' THR . 0.7 OUTLIER -122.85 172.11 8.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.889 0.344 . . . . 0.0 110.553 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.44 ' CG ' HG13 ' A' ' 36' ' ' VAL . 1.8 m-85 -67.73 158.06 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.365 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.411 HG22 ' CB ' ' B' ' 90' ' ' ASP . 29.2 p -119.71 165.88 13.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.91 27.62 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.909 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.411 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -77.33 163.1 66.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.933 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.428 ' N ' HG22 ' B' ' 85' ' ' ILE . 72.1 Cg_exo -48.52 136.21 26.46 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.246 . . . . 0.0 112.409 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.18 -39.75 14.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.028 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -47.62 34.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 67' ' ' LEU . 4.8 m0 -49.3 -59.97 3.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.546 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' B' ' 110' ' ' SER . . . -52.49 -59.57 4.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.033 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.7 mtt180 -48.46 -42.18 31.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.871 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.439 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.14 -54.63 19.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.63 -69.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' B' ' 110' ' ' SER . 6.2 tt0 -79.53 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.586 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 4.7 p -166.03 -46.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.444 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.2 OUTLIER -131.59 167.21 19.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.965 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -56.28 -54.85 40.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -134.87 86.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.879 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m 74.68 -60.38 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.817 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' B' ' 110' ' ' SER . 0.6 OUTLIER -152.98 42.52 0.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.188 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.3 OUTLIER 48.63 81.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.831 0.348 . . . . 0.0 111.029 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -109.38 117.19 33.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -119.96 89.35 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 pttt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.9 179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.472 ' PA ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.477 ' H1 ' ' HB ' ' A' ' 35' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.88 171.42 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.62 139.19 54.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp -125.72 139.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.21 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -114.98 138.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.675 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.53 110.76 22.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 16.4 t -87.59 145.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.649 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 19.6 m -137.79 167.07 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.665 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' CG1' HG23 ' A' ' 101' ' ' ILE . 9.1 p -163.76 136.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 97' ' ' TRP . . . 139.44 148.93 5.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.821 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 160.68 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.638 0.256 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.84 86.28 0.01 OUTLIER Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.991 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' CB ' ' O1A' ' A' ' 185' ' ' GNP . . . 72.8 67.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.178 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 8' ' ' VAL . 3.7 p -48.7 -24.99 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . 125.18 -27.9 5.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.393 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -96.91 -73.46 0.6 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 111.443 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 3.3 p -45.82 -66.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.711 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' SG ' ' CB ' ' A' ' 13' ' ' ALA . 11.7 p -41.49 -48.12 3.83 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.792 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.9 -69.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.705 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.528 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 83.6 mt -40.53 -59.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' N ' HD11 ' A' ' 21' ' ' ILE . 1.1 mp -36.33 -55.65 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 1.2 t -93.72 -67.1 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.381 0.61 . . . . 0.0 110.672 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 165' ' ' LEU . 24.5 t80 -40.13 -66.68 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.835 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.3 m -85.95 -80.23 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 111.648 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -36.04 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.296 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.41 55.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.468 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HE3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -173.93 -174.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -101.13 166.46 12.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 80.0 Cg_exo -44.45 146.67 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.505 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.4 m -102.51 -82.25 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.709 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.54 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.519 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.38 92.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' CG1' ' HA2' ' B' ' 88' ' ' GLY . 92.7 t -136.31 138.74 27.84 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 36' ' ' VAL . 86.4 Cg_exo -42.93 106.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.352 2.035 . . . . 0.0 111.504 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 39.7 m -47.07 88.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 34' ' ' PRO . 89.7 t -98.03 -51.64 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.504 ' HB2' ' CZ3' ' B' ' 103' ' ' TRP . 60.0 t80 -163.35 95.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.751 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 25.9 m-20 -96.99 123.02 40.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.1 t-20 -108.07 150.25 27.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.832 0.349 . . . . 0.0 110.636 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.36 169.18 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.201 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.1 140.57 39.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.643 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 ' CB ' ' HB3' ' B' ' 78' ' ' PRO . 3.6 m -159.14 157.57 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.032 0.444 . . . . 0.0 111.908 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 51' ' ' TYR . 53.8 m -155.95 108.33 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 m -98.35 119.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.415 ' HE1' ' CB ' ' B' ' 76' ' ' SER . 30.3 mtm -74.95 104.91 5.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.884 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mm -94.78 111.44 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 20.67 71.35 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.561 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 41.57 8.18 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -140.59 147.82 50.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.792 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.9 153.09 77.77 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.565 2.177 . . . . 0.0 112.274 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.416 ' O ' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -147.98 162.04 40.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -135.31 97.39 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.573 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 54' ' ' GLY . 7.4 tt -124.69 159.6 30.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.411 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -154.7 123.56 1.39 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 6.2 mp -75.87 119.65 20.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 6.9 m-85 -108.18 120.52 42.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' N ' ' HE3' ' A' ' 16' ' ' LYS . 1.4 t70 -67.77 174.74 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.338 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 64' ' ' TYR . 15.4 m -169.97 166.13 9.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.422 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 104' ' ' HIS . . . -136.28 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.472 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 104' ' ' HIS . . . -78.32 -128.95 0.51 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.708 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.416 ' CD2' ' OD2' ' A' ' 65' ' ' ASP . 3.4 mm? 62.33 152.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.494 ' HA ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 mp0 -45.97 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.319 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 7.0 m-20 -90.69 57.04 3.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 1.5 t80 47.12 43.61 14.48 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' OD2' ' CD2' ' A' ' 61' ' ' LEU . 1.0 OUTLIER 71.22 -140.65 0.05 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -95.32 -1.93 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.192 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.527 ' CD1' ' CZ3' ' B' ' 103' ' ' TRP . 68.1 mt -88.0 51.73 2.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.369 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -94.06 -43.48 0.3 Allowed Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 13.1 Cg_exo -69.8 -42.74 3.1 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.19 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -86.51 11.91 11.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.631 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' ' CZ2' ' B' ' 103' ' ' TRP . 3.3 t -166.21 32.04 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.57 0.224 . . . . 0.0 111.043 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.484 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 7.6 p90 -33.34 122.36 0.45 Allowed Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.068 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 104' ' ' HIS . 26.7 Cg_exo -62.48 -27.3 76.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.536 2.157 . . . . 0.0 112.587 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.98 -10.03 45.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.86 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 72' ' ' TYR . 3.5 t -36.01 -55.01 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.41 -158.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.497 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.93 163.24 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.298 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 9.0 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.426 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.437 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.3 tp -130.16 123.82 31.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.21 147.14 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.056 0.455 . . . . 0.0 111.943 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.409 ' HB2' ' HA3' ' A' ' 15' ' ' GLY . 17.8 m -139.63 155.27 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.408 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' HG13 ' A' ' 93' ' ' VAL . 6.7 p90 -162.21 164.17 27.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.78 157.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 116' ' ' GLN . 59.0 t -111.76 -75.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.09 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -47.14 -81.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.42 105.13 0.47 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.871 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 -17.04 48.69 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.47 2.113 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t -48.91 -27.3 3.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.411 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 23.2 t -96.12 -37.59 10.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.456 ' CD2' HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -49.78 -62.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -50.23 -57.34 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.032 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 5.6 m-20 -51.34 -59.64 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.48 HG13 ' CD2' ' A' ' 82' ' ' PHE . 61.3 t -44.33 -38.95 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.671 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.9 -62.28 1.48 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.02 7.99 5.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -121.3 -43.89 2.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.492 ' CE2' ' HA3' ' A' ' 10' ' ' GLY . 20.0 m95 -95.59 -34.12 12.13 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 94.7 t -49.58 -47.28 78.66 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.2 Cg_endo -74.94 -11.56 21.59 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.051 1.834 . . . . 0.0 112.459 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.61 -43.48 9.61 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.09 0.472 . . . . 0.0 110.68 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HG23 ' CG1' ' A' ' 9' ' ' VAL . 11.7 pt -51.11 -34.97 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.484 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.6 p -52.87 -47.6 67.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.326 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.494 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 15.6 t60 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.183 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 66.5 m-70 -79.96 -31.47 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 28.1 p -111.88 94.52 24.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.953 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -51.73 -55.19 4.18 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.568 2.179 . . . . 0.0 112.412 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 31.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 139.94 24.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 152' ' ' VAL . 75.7 Cg_exo -51.27 -172.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.629 2.219 . . . . 0.0 112.259 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 15.3 p90 -161.3 129.65 4.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.29 129.94 44.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.474 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 1.2 pt? -131.8 133.38 44.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.561 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 154' ' ' TYR . 2.7 m -141.16 176.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.375 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.8 142.92 14.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.143 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' C5 ' ' A' ' 185' ' ' GNP . 38.0 p -128.91 108.71 10.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 1.2 mt-30 170.7 66.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.426 HG12 ' CB ' ' A' ' 158' ' ' SER . 4.9 pt -98.64 -23.41 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.64 -36.99 11.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.73 -18.74 34.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.302 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -51.23 -23.79 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 111.15 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -44.73 -28.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' O ' ' CG2' ' A' ' 125' ' ' THR . 28.2 p-10 -66.53 116.72 37.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.23 -22.58 41.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.42 2.08 . . . . 0.0 112.275 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -56.07 -43.93 78.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 122' ' ' ASP . 10.1 t -50.95 -33.02 22.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.0 mp -81.23 -42.76 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -49.48 -48.68 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -36.94 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.983 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.89 -26.63 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.18 63.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -94.22 -37.5 11.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -56.14 -24.42 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.17 53.33 0.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.13 170.36 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.425 ' HD3' ' CD ' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -76.91 154.99 83.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.425 ' CD ' ' HD3' ' A' ' 135' ' ' LYS . 76.6 Cg_exo -49.98 122.1 8.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.231 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' A' ' 90' ' ' PHE . 6.4 mt -50.98 125.19 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -130.89 -179.8 1.14 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.551 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 76.9 Cg_exo -51.14 -22.69 11.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.438 2.092 . . . . 0.0 112.221 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.33 -42.5 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.428 ' CG2' HG22 ' A' ' 137' ' ' ILE . 57.2 m -49.92 -56.35 10.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.41 -38.09 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.85 -48.43 81.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.08 62.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -38.05 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.243 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.05 -45.27 83.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.768 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -58.1 -45.71 86.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -56.89 13.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.808 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.474 ' CD1' ' CB ' ' A' ' 151' ' ' ALA . 3.5 pp -62.17 -27.29 68.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 72.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.094 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 149' ' ' LEU . . . -109.07 -179.6 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 68.9 t -46.74 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 159.14 136.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.43 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 146' ' ' ALA . 11.1 p90 -153.15 141.84 20.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 111.544 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.06 124.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.854 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.65 -178.81 2.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.733 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.19 -173.32 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.64 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.426 ' CB ' HG12 ' A' ' 117' ' ' ILE . 5.0 p -87.2 156.0 19.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.349 . . . . 0.0 110.527 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.535 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -51.78 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.294 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.403 ' O ' ' CG2' ' A' ' 161' ' ' THR . 0.2 OUTLIER 55.0 24.03 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.422 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 169.9 128.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -126.31 121.73 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -101.2 -43.63 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.85 85.67 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 7.0 mt -85.3 -37.25 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -52.99 -24.84 10.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -63.45 -69.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.123 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 169' ' ' PHE . 7.6 p -47.27 -41.98 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.479 ' CD1' ' OH ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -67.59 -49.08 64.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -47.14 -45.37 22.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.428 ' HG3' ' CG ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -84.29 -47.68 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -53.95 -33.21 56.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 23.3 mm -87.84 -33.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.17 -56.75 13.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.72 -32.49 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.03 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.0 tp -54.3 -25.41 23.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 68.41 96.4 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.27 169.58 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.625 2.216 . . . . 0.0 112.384 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.89 146.79 60.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.586 2.19 . . . . 0.0 112.264 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 2.0 mm-40 -54.71 -51.98 74.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 80.0 Cg_exo -47.44 124.63 9.62 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.572 2.181 . . . . 0.0 112.326 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.76 159.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -51.33 -76.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.96 0.41 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 tt -115.69 151.74 17.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.415 ' CB ' ' HE1' ' A' ' 45' ' ' MET . 0.5 OUTLIER -135.93 135.15 39.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.379 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.47 136.33 70.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.527 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.47 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 71.7 Cg_exo -50.7 143.69 28.34 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.479 2.12 . . . . 0.0 112.411 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.1 -70.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -58.08 88.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.509 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 9.5 t80 -113.25 136.28 52.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.34 130.0 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.386 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 96.95 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.926 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 1.1 mp -101.53 139.72 22.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.994 0.426 . . . . 0.0 111.979 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' B' ' 86' ' ' HIS . 52.1 p-80 -120.38 96.55 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.335 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 46.9 t -83.47 152.54 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.86 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.455 ' HA2' ' CG1' ' A' ' 33' ' ' VAL . . . -146.42 177.85 24.49 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.503 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.53 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 1.2 m-20 -132.68 134.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 1.11 20.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.909 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.412 HG11 ' N ' ' B' ' 93' ' ' THR . 7.3 p -46.08 -27.84 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.412 ' N ' HG11 ' B' ' 92' ' ' VAL . 6.2 t -148.58 -42.02 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.044 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.79 29.67 0.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.467 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -138.18 -159.47 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.704 0.288 . . . . 0.0 110.457 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 67' ' ' LEU . 3.5 m-85 -98.99 164.24 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.758 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -109.41 171.76 7.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 44.26 28.12 1.32 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.773 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.83 129.46 21.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.562 0.22 . . . . 0.0 110.883 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.423 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 50.3 Cg_exo -53.92 140.4 68.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.375 2.05 . . . . 0.0 111.884 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -42.67 -45.88 4.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.252 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -56.78 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.797 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.527 ' CZ3' ' CD1' ' A' ' 67' ' ' LEU . 3.6 m0 -52.36 -58.74 5.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.143 0.496 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' B' ' 108' ' ' GLN . . . -45.58 -70.32 0.11 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.136 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -47.32 -38.56 13.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.041 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -43.82 -64.88 0.58 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.859 0.361 . . . . 0.0 110.12 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.432 HD12 ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.09 -70.25 0.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' B' ' 110' ' ' SER . 0.6 OUTLIER -80.71 -160.39 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -154.23 57.43 0.71 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.26 -0.275 . . . . 0.0 111.042 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.435 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.4 OUTLIER 167.74 124.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.157 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -48.1 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' B' ' 115' ' ' SER . 0.7 OUTLIER -127.18 86.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.874 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.17 88.05 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.398 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' B' ' 116' ' ' GLU . 0.2 OUTLIER 58.0 37.25 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.974 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.413 ' O ' ' CG2' ' B' ' 112' ' ' ILE . 0.2 OUTLIER 65.65 -71.59 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 114' ' ' LYS . 0.5 OUTLIER 68.05 -81.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -75.9 118.83 19.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 19.7 mttp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.945 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.535 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.54 136.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -102.31 142.25 33.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.23 138.76 52.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.216 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.52 96.33 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.566 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.48 107.93 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 3.0 t -84.58 150.48 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 7.5 p -135.34 146.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -133.75 121.03 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.955 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' CD2' ' A' ' 97' ' ' TRP . . . 147.97 -174.32 27.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.68 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.68 155.4 49.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.367 . . . . 0.0 111.178 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 88.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.94 53.78 12.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' CG1' ' HD3' ' A' ' 16' ' ' LYS . 10.0 p -80.54 2.68 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.345 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 109.87 -29.62 9.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.663 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 57' ' ' ASP . 9.5 pttt -51.42 -67.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.773 -0.251 . . . . 0.0 111.635 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.548 ' CG2' ' H1 ' ' A' ' 188' ' ' HOH . 0.2 OUTLIER -96.81 -26.37 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' O ' ' N7 ' ' A' ' 185' ' ' GNP . 35.2 t -61.24 -58.42 8.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.424 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' TYR . 14.5 mt -50.99 -73.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.393 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' CD1' ' CG ' ' A' ' 40' ' ' TYR . 15.1 mt -39.35 -40.34 0.78 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -51.96 -67.35 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.456 ' CB ' ' C8 ' ' A' ' 185' ' ' GNP . 1.8 t -93.27 -53.36 4.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.24 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 169' ' ' PHE . 13.9 t80 -44.51 -30.03 0.81 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.061 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 93.7 m -125.33 -101.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.492 HG22 ' CZ ' ' B' ' 81' ' ' PHE . 4.7 t -40.37 -34.8 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 75.65 47.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -151.4 136.91 17.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' " O2'" ' A' ' 185' ' ' GNP . 1.0 OUTLIER -58.42 166.7 2.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 28' ' ' PHE . 11.8 Cg_endo -55.69 171.81 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.945 2.43 . . . . 0.0 112.858 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 t -116.24 -75.38 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.099 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 129.06 39.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -90.66 104.32 16.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.198 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.444 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 5.2 p -160.78 140.51 8.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.915 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 55.7 Cg_exo -35.38 91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.933 2.422 . . . . 0.0 112.291 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' VAL . 98.8 m -51.32 87.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.15 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' B' ' 87' ' ' VAL . 88.6 t -84.9 -33.74 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 16.9 t80 -173.61 128.81 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.877 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 m-20 -127.86 148.98 50.49 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.778 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.435 ' CB ' ' OG1' ' B' ' 84' ' ' THR . 2.8 t-20 -107.07 157.27 17.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 0.0 110.69 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' CD1' ' A' ' 20' ' ' LEU . 4.2 m-85 -152.82 169.29 23.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.237 0.542 . . . . 0.0 112.006 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.6 115.56 18.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.642 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -141.13 155.53 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.438 . . . . 0.0 111.557 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.2 m -156.33 95.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.099 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' CG1' ' HD3' ' B' ' 78' ' ' PRO . 27.4 m -98.42 178.35 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.427 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 2.7 mtt -115.07 157.26 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 51' ' ' TYR . 18.0 mt -158.24 89.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.585 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.17 3.02 79.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.77 26.91 5.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -141.63 138.82 17.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.638 0.256 . . . . 0.0 111.127 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.44 174.38 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.578 2.185 . . . . 0.0 112.198 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.87 171.2 17.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.002 0.43 . . . . 0.0 111.155 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -136.3 97.02 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.337 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 11.3 tp -98.22 157.71 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.954 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -163.22 103.01 0.21 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.426 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 20' ' ' LEU . 3.4 mm? -75.78 105.05 6.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.763 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.26 107.48 15.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.178 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -67.84 130.4 42.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.323 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 HG23 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.45 163.74 32.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . . . -103.34 -53.62 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.411 . . . . 0.0 111.004 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.23 -45.64 1.1 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.268 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -151.76 17.91 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 13.2 mt-10 -103.43 83.59 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.139 0.495 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 78.28 -3.49 2.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.604 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 24.2 m-85 -85.26 -13.7 48.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.747 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -39.49 -47.13 1.81 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.013 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -54.06 37.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 2.3 mp -78.59 82.24 4.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.19 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 24.1 ptt180 -88.2 -35.02 0.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 2.5 Cg_endo -82.68 7.95 4.86 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.081 . . . . 0.0 112.73 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.527 HD21 ' CE2' ' B' ' 103' ' ' TRP . 39.0 mt -51.54 111.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.485 0.659 . . . . 0.0 111.471 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 70.18 4.78 5.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.433 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 59.97 154.7 0.1 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.466 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.93 -52.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.947 2.432 . . . . 0.0 112.932 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -69.86 -8.2 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.986 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.444 ' CG2' HG22 ' A' ' 7' ' ' VAL . 1.1 t -32.79 -73.52 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.56 -155.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 p -66.86 162.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -98.5 127.34 44.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 13.5 tp -103.69 115.47 30.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.274 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' CG2' ' A' ' 14' ' ' VAL . 2.5 t -131.9 153.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.446 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 14' ' ' VAL . 62.6 m -142.65 172.02 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.511 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 50.8 p90 -164.41 151.72 11.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.105 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.47 136.8 42.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 ' CG1' ' HA2' ' A' ' 114' ' ' GLY . 5.3 m -107.15 68.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.12 -85.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.13 163.8 55.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.803 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 132' ' ' ASN . 51.7 Cg_endo -69.17 -22.53 34.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.58 2.187 . . . . 0.0 112.287 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 p -70.18 -33.83 72.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.2 p -51.89 -46.25 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -51.92 -69.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.067 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.93 -29.22 55.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.002 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.5 m-20 -62.47 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.446 HG12 ' CG ' ' A' ' 82' ' ' PHE . 7.2 p -41.38 -31.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.14 -70.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.842 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.57 8.11 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 27.3 tttm -113.68 -40.62 3.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CD2' ' HA3' ' A' ' 10' ' ' GLY . 11.0 m95 -95.96 -13.58 23.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 2.5 m -53.02 -32.57 10.37 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.5 Cg_exo -68.78 -41.87 5.26 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.782 1.654 . . . . 0.0 112.217 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' CG ' HD11 ' A' ' 61' ' ' LEU . 19.0 mp0 -58.56 -43.67 89.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.481 ' CG2' ' CD2' ' A' ' 110' ' ' PHE . 71.3 mt -48.58 -26.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -84.67 -37.16 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.58 -34.56 51.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -102.94 -61.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 8.4 m -109.29 85.61 3.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.2 -11.66 29.1 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.632 2.221 . . . . 0.0 112.794 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -152.78 40.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 111.419 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 139.88 36.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.853 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.18 143.96 17.82 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.542 2.161 . . . . 0.0 112.113 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.6 p90 -131.39 130.52 42.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' CD1' ' HB ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -101.28 136.09 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.394 179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 154' ' ' TYR . 2.2 pp -146.78 114.19 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 154' ' ' TYR . 10.0 p -129.1 152.3 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.382 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -73.16 -176.92 32.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.305 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.505 ' HA ' ' N2 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -174.14 172.36 3.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 111.426 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HG2' " C4'" ' A' ' 185' ' ' GNP . 14.1 mt-30 72.53 108.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.455 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 41.7 mt -98.48 -59.83 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 119' ' ' LEU . 24.9 p30 -55.02 -22.51 15.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.42 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 7.3 tp -61.93 -48.11 81.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 1.6 ptt180 -58.91 -22.89 60.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.72 -23.8 7.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -54.22 135.6 59.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.58 -42.55 64.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.522 2.148 . . . . 0.0 112.397 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -38.69 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 126' ' ' ILE . 19.7 p -59.05 -64.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.412 ' N ' ' OG1' ' A' ' 125' ' ' THR . 4.6 mp -48.65 -43.68 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.069 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.59 -32.93 68.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mt -50.81 -26.23 5.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.928 0.394 . . . . 0.0 110.295 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.35 -22.44 60.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.928 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.48 -22.51 37.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 87' ' ' PRO . 25.6 t30 -94.04 30.59 1.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.957 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 34.69 0.37 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.788 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.71 -160.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.45 95.65 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.773 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.56 141.8 56.69 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.608 2.205 . . . . 0.0 112.363 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.1 mt -67.47 125.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.442 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -124.43 177.73 1.68 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 51.1 Cg_exo -54.23 -24.7 35.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.691 2.26 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -86.36 -39.02 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.027 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.8 m -49.97 -48.29 52.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -49.91 61.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.04 -47.93 68.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.52 -40.62 59.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.593 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.477 HD11 ' CE2' ' A' ' 90' ' ' PHE . 8.5 tt -61.38 -41.69 97.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.524 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -53.33 -54.93 29.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -55.05 -38.83 68.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -51.49 -32.67 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.6 pp -125.39 21.86 7.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.142 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 58.1 -84.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.993 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 58.07 175.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 6.1 t -61.52 -15.99 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.484 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.45 140.84 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 110.466 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CE1' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -153.39 151.57 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 168' ' ' VAL . 14.9 m -157.93 123.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.579 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.36 152.21 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.152 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.54 ' O ' ' N2 ' ' A' ' 185' ' ' GNP . 83.3 m -101.82 -177.53 3.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.493 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 30.8 t -86.77 156.6 19.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.049 0.452 . . . . 0.0 111.594 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.468 ' HB2' " C1'" ' A' ' 185' ' ' GNP . . . -55.04 -169.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.029 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 50.87 24.89 1.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.549 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -174.17 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 57.66 115.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.338 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -64.07 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.28 92.98 0.11 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.419 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -93.79 -10.37 34.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.477 0.18 . . . . 0.0 111.455 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.16 -43.32 3.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.336 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.94 -67.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.732 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 155' ' ' VAL . 7.3 p -50.27 -28.78 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.78 -51.26 70.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.146 179.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 2.5 p30 -63.13 -32.24 73.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.4 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 175' ' ' ALA . 24.6 tp10 -70.14 -30.68 67.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.98 -29.36 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 44.5 mm -94.95 -66.36 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -49.94 -45.76 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.979 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -55.34 -25.56 35.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.33 -29.23 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.057 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -92.7 44.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -146.97 83.43 7.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.54 162.03 38.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.612 2.208 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 156.64 55.35 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.582 2.188 . . . . 0.0 112.324 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -50.69 106.14 0.61 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.98 91.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.48 2.12 . . . . 0.0 112.273 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.51 95.67 6.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 28.5 m -55.34 -42.56 74.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.6 149.19 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.22 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 176.1 8.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -94.88 140.37 22.49 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' CG1' ' A' ' 44' ' ' VAL . 52.9 Cg_exo -54.61 -164.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.437 2.091 . . . . 0.0 112.103 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -167.79 -65.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.59 95.59 2.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.985 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.492 ' CZ ' HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -129.02 148.93 51.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.141 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -153.22 140.45 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.93 0.395 . . . . 0.0 111.758 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -75.48 95.34 3.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.051 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -77.02 -42.49 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' B' ' 98' ' ' GLY . 2.0 mt -129.07 147.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 111.558 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -141.12 97.16 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 63.3 t -78.25 125.07 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 111.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 172.92 15.91 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.869 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -98.62 111.23 23.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.29 128.78 43.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.36 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.15 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.918 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . 0.413 HG11 ' N ' ' B' ' 93' ' ' THR . 7.5 p -41.5 -30.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 111.591 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.47 ' CG2' ' CG ' ' B' ' 95' ' ' GLU . 1.1 t -151.61 21.1 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.151 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.96 25.27 67.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.47 ' CG ' ' CG2' ' B' ' 93' ' ' THR . 8.3 pt-20 -145.71 171.84 14.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -70.54 164.75 24.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.421 . . . . 0.0 110.745 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -110.45 176.68 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 43.05 28.54 0.76 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.87 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.447 ' HE2' ' CD2' ' A' ' 67' ' ' LEU . 3.0 mtp -57.74 124.63 69.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.252 . . . . 0.0 110.956 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.491 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 49.2 Cg_exo -38.86 152.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.792 2.328 . . . . 0.0 112.692 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' B' ' 105' ' ' ARG . 2.8 mt-10 -47.58 -43.24 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.065 0.459 . . . . 0.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -72.56 -57.67 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.246 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.527 ' CE2' HD21 ' A' ' 70' ' ' LEU . 13.1 m0 -48.31 -60.26 2.8 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.601 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' B' ' 99' ' ' MET . . . -47.47 -67.99 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 10.2 mtp85 -52.23 -34.4 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.032 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -45.75 -65.64 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.434 HD13 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -63.22 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.56 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' B' ' 110' ' ' SER . 0.4 OUTLIER -78.8 -100.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.677 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' B' ' 108' ' ' GLN . 11.7 p -164.94 -57.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.226 0 CA-C-O 120.788 0.327 . . . . 0.0 111.851 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.456 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -127.7 158.89 36.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.382 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.6 OUTLIER -45.15 -57.44 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.055 0.455 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.88 86.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m 73.19 -61.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.684 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -147.76 48.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.7 OUTLIER 70.46 162.21 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.782 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.43 -27.5 11.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.24 135.88 57.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.54 ' N2 ' ' O ' ' A' ' 157' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.548 ' H1 ' ' CG2' ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.85 0.357 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -94.6 120.93 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.8 t -99.73 147.15 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.415 ' CD1' ' OH ' ' A' ' 51' ' ' TYR . 65.8 mt -135.66 103.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.426 ' O ' ' CG2' ' A' ' 75' ' ' THR . 5.6 mmtp -95.67 98.31 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -77.77 112.35 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.113 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 59.6 t -91.09 150.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 16' ' ' LYS . 7.3 p -139.51 147.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.063 0.458 . . . . 0.0 111.529 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 60' ' ' GLY . 7.1 p -138.27 120.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.534 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.62 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.769 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -20.87 15.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.782 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.431 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . -78.37 -45.17 10.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.69 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 18' ' ' CYS . . . 73.47 3.0 4.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' CG1' ' HA3' ' A' ' 114' ' ' GLY . 5.4 t -57.78 -17.93 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.242 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -81.25 -124.32 0.65 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.422 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -34.06 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -50.91 -71.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 51.7 t -48.03 -46.45 33.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.126 0.489 . . . . 0.0 110.985 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 69.4 tp -46.14 -59.78 2.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.537 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 40' ' ' TYR . 21.8 mt -44.69 -49.15 10.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.708 0.29 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 27' ' ' LYS . 3.4 mm -42.58 -49.19 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.491 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.464 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -93.68 -61.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.453 0.644 . . . . 0.0 110.256 178.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 165' ' ' LEU . 1.2 t80 -39.8 -66.85 0.26 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.249 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' B' ' 78' ' ' PRO . 50.6 m -96.57 -77.54 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.366 0.603 . . . . 0.0 111.151 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.537 ' CG2' ' CZ ' ' B' ' 81' ' ' PHE . 0.2 OUTLIER -36.29 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.225 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t30 47.72 65.08 1.37 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 110.616 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.16 -169.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.316 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.485 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -111.91 157.89 38.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -51.2 143.05 34.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.669 2.246 . . . . 0.0 112.438 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 p -95.12 -80.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.22 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.89 109.33 21.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.02 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.11 107.73 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.103 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG13 ' CA ' ' B' ' 88' ' ' GLY . 59.2 t -157.89 131.89 5.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' VAL . 94.7 Cg_exo -41.86 92.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.379 2.053 . . . . 0.0 111.969 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.423 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 40.4 m -53.11 87.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.268 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' PRO . 12.2 t -73.41 -27.04 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 110.058 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 39' ' ' ASN . 15.8 t80 -146.85 -79.78 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.312 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER 60.69 118.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.119 -179.089 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 t-20 -107.7 156.86 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -152.49 144.89 24.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.005 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.11 140.2 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.139 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 ' CG1' HG22 ' A' ' 24' ' ' THR . 25.6 m -154.81 132.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.4 m -125.39 95.31 4.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.13 123.75 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -72.8 100.18 2.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG2' HD23 ' A' ' 177' ' ' LEU . 24.7 mm -90.48 89.37 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.44 12.74 55.62 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 4.7 58.96 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.125 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.13 150.61 43.23 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.03 0.415 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.29 162.44 7.74 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.679 2.252 . . . . 0.0 112.126 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' OH ' ' CD1' ' A' ' 4' ' ' ILE . 7.0 t80 -154.11 153.28 31.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.952 0.406 . . . . 0.0 111.459 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 p -136.31 97.43 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.223 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 tt -112.51 144.89 41.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -127.5 112.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.183 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 5.6 mp -77.96 102.93 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.308 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 1.3 m-85 -88.86 103.01 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.01 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -73.57 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.94 0.4 . . . . 0.0 111.246 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.05 -171.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -156.69 149.27 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 9' ' ' VAL . . . -109.01 99.49 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.36 -65.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 170.02 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.736 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -111.14 27.29 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -91.42 -23.05 20.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -27.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' O ' ' CD2' ' B' ' 107' ' ' LEU . 22.1 mtt180 -48.67 -40.27 27.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.877 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -92.12 40.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.638 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tpt180 -81.59 -66.46 0.23 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.499 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 19.3 Cg_endo -58.91 -15.16 25.73 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.56 2.173 . . . . 0.0 112.626 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.41 -13.0 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.108 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 1.3 t -111.6 -19.49 12.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.319 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 39.01 95.86 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.801 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 37.9 Cg_endo -66.2 -45.58 5.42 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.609 2.206 . . . . 0.0 112.183 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -12.08 47.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 6.6 t -40.56 -46.8 2.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.414 ' OD2' ' CG2' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -172.64 -160.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.749 0.309 . . . . 0.0 111.058 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -58.17 154.18 2.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.731 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -106.76 138.79 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.27 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -104.11 122.61 45.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.093 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.9 153.77 8.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.065 0.46 . . . . 0.0 111.919 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.27 155.66 18.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CZ ' HG22 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -166.07 121.66 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.968 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.88 164.4 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 115' ' ' THR . 34.5 t -147.67 66.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.318 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 120' ' ' ARG . 70.8 t -151.27 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.76 137.71 43.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HG3' ' CB ' ' A' ' 132' ' ' ASN . 57.9 Cg_endo -72.06 -19.47 26.42 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.556 2.171 . . . . 0.0 112.325 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.8 p -56.91 -52.23 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.81 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -29.82 63.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -45.86 54.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -47.54 85.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -61.1 -66.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 82' ' ' PHE . 28.7 m -43.53 -40.84 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.664 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 19.2 tttm -57.44 -68.03 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.53 8.4 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.138 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.02 -38.69 3.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.404 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CE3' ' HB ' ' A' ' 93' ' ' VAL . 49.9 m0 -95.23 -40.89 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.511 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.51 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 60.7 t -55.85 -44.09 99.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 39.5 Cg_exo -60.22 -19.65 58.31 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.33 2.02 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.71 -30.8 56.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 8.4 tp -49.16 -31.4 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.198 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -77.71 -44.04 29.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -51.86 -37.76 53.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 5.3 m-70 -97.2 -61.72 1.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 4.7 t -74.42 108.89 5.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.501 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.49 -60.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.392 2.062 . . . . 0.0 112.419 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -154.68 36.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.29 153.98 40.83 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.89 145.68 97.67 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.606 2.204 . . . . 0.0 111.97 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 20.1 p90 -123.1 127.48 48.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.314 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' CD1' HG13 ' A' ' 152' ' ' VAL . 6.8 tt -109.14 119.29 39.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.045 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 mp -90.99 155.14 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.229 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG1' HD11 ' A' ' 19' ' ' LEU . 3.0 t -148.78 165.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' HA3' ' CG1' ' A' ' 14' ' ' VAL . . . 143.41 154.63 6.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.433 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -176.78 164.48 2.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.408 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -172.25 93.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.815 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -25.72 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.855 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -95.26 -30.91 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.795 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -78.41 -44.72 24.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.449 ' HA ' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -53.14 -23.49 8.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 55.89 2.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.3 m-20 -111.11 150.04 41.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 -57.95 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.716 2.277 . . . . 0.0 112.374 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -34.57 75.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 54.2 m -55.49 -72.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.818 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 122' ' ' ASP . 3.7 mp -52.03 -39.1 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -32.08 30.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.048 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.67 -39.34 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.524 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 17.6 mt -49.9 -26.14 3.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.457 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.43 67.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -25.35 22.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.427 ' CB ' ' HG3' ' A' ' 87' ' ' PRO . 9.6 m120 -115.95 30.23 7.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 103.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.973 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -42.69 150.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 10.1 mttt 47.94 48.43 5.88 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 73.8 Cg_endo -75.88 -46.15 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.561 2.174 . . . . 0.0 112.562 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.427 HG23 ' CG1' ' A' ' 84' ' ' VAL . 5.7 mm -99.85 129.94 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -148.86 164.5 21.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.76 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.78 -23.31 8.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.546 2.164 . . . . 0.0 112.315 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -90.64 -41.23 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.1 m -49.02 -57.69 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.89 -49.56 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.65 -38.11 80.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -50.36 73.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.1 tp -57.25 -37.93 73.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . . . -71.57 -26.53 62.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ttt-85 -73.43 -40.7 64.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.21 -44.7 94.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 4.4 pp -71.77 -26.39 62.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.412 ' N ' HD13 ' A' ' 149' ' ' LEU . 9.0 tptt 69.05 109.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 149' ' ' LEU . . . -150.62 -161.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 91.2 t -56.82 -20.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.305 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 75.07 139.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.197 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 112' ' ' LEU . 39.6 p90 -152.8 162.09 41.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.7 m -158.13 124.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.695 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.62 167.55 7.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.422 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 17.4 p -118.9 -173.24 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -87.68 165.04 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.973 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' CB ' HD23 ' A' ' 160' ' ' LEU . . . -51.43 -175.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.435 HD23 ' CB ' ' A' ' 159' ' ' ALA . 1.7 mm? 66.23 -69.29 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.276 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.93 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.409 ' NE2' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 68.61 108.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.667 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -68.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.35 96.57 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 23' ' ' TYR . 19.2 mt -93.24 -17.62 23.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.68 0.276 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -62.92 -49.96 72.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.455 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 166' ' ' LYS . 23.1 m-80 -48.8 -71.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.42 ' CG1' ' OH ' ' A' ' 23' ' ' TYR . 3.5 p -47.62 -30.06 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -64.42 -38.21 90.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.779 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.442 ' CB ' HG13 ' B' ' 75' ' ' ILE . 17.4 t0 -63.63 -35.54 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.127 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -81.79 -24.63 35.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.851 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.73 41.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 21.2 mt -88.71 -48.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.204 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.46 -27.77 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.82 -37.14 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.52 -20.58 19.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.432 HD23 ' CG2' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -82.99 -24.58 32.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.017 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.431 ' CB ' ' HD3' ' A' ' 179' ' ' PRO . 3.8 mm-40 -51.31 -54.41 38.81 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 178' ' ' GLU . 57.3 Cg_exo -51.74 110.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.53 2.153 . . . . 0.0 112.225 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.47 137.38 11.33 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.459 2.106 . . . . 0.0 112.38 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.02 63.75 19.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.63 102.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.599 2.199 . . . . 0.0 112.371 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -56.32 130.46 44.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.98 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.3 p -99.36 -39.55 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.442 HG13 ' CB ' ' A' ' 170' ' ' ASP . 6.7 mm -140.33 139.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 3.5 p -138.69 141.85 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.24 131.67 88.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.439 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 53.1 Cg_exo -54.63 154.29 20.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.399 2.066 . . . . 0.0 112.273 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.86 -43.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.87 61.63 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.976 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 23.7 t80 -74.39 149.8 40.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.65 101.72 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -72.34 69.31 0.81 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' B' ' 85' ' ' ILE . 44.8 p -52.43 -85.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.245 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.435 ' N ' ' OG1' ' B' ' 84' ' ' THR . 0.5 OUTLIER -96.95 145.32 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.096 0.474 . . . . 0.0 112.092 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.95 96.89 4.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.519 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 29.7 t -78.03 157.29 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.969 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.433 ' CA ' HG13 ' A' ' 33' ' ' VAL . . . -146.43 177.92 24.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -84.52 119.08 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.425 ' CB ' HG22 ' B' ' 97' ' ' THR . 13.8 t0 -111.01 98.32 7.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.23 61.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 p -46.92 -33.47 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.308 . . . . 0.0 111.436 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' B' ' 95' ' ' GLU . 7.8 t -148.16 23.72 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.17 25.39 72.25 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.622 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 17.4 pt-20 -119.84 -166.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.732 0.301 . . . . 0.0 110.791 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 m-85 -103.9 163.74 12.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.425 HG22 ' CB ' ' B' ' 90' ' ' ASP . 1.6 p -104.64 150.05 25.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.576 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.415 ' HA3' ' ND2' ' B' ' 111' ' ' ASN . . . 69.5 43.93 66.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.473 ' CG ' ' CB ' ' B' ' 104' ' ' ALA . 2.7 tpt -47.28 103.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.551 0.215 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.493 ' HG2' ' CD2' ' A' ' 37' ' ' PHE . 77.5 Cg_exo -50.3 147.44 16.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.487 2.125 . . . . 0.0 111.915 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -66.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -65.7 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.417 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.522 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -46.71 -56.85 5.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.201 0.524 . . . . 0.0 110.552 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.473 ' CB ' ' CG ' ' B' ' 99' ' ' MET . . . -55.26 -60.91 2.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.653 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 6.1 mtt-85 -42.42 -36.23 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.368 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -60.81 -60.72 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.32 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.18 -64.36 1.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.481 ' O ' ' CG2' ' B' ' 109' ' ' THR . 5.5 tp60 -76.93 -79.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.236 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 6.0 p 96.78 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.366 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 171.26 93.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.958 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.438 ' CB ' ' HB2' ' B' ' 115' ' ' SER . 1.7 t30 -49.78 92.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.611 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' B' ' 113' ' ' THR . 0.4 OUTLIER -58.64 86.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.187 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' B' ' 112' ' ' ILE . 0.7 OUTLIER 153.45 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.444 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 41.35 63.49 1.23 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.562 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' B' ' 111' ' ' ASN . 0.5 OUTLIER -41.34 138.56 1.21 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 111.314 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.7 -58.35 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.84 96.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 32.9 tttt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.977 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.488 " H3'" ' PA ' ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.769 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.58 167.57 11.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -91.83 132.63 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.25 133.41 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -123.27 149.44 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.722 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.97 96.05 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 78' ' ' PHE . 56.4 t -100.79 128.01 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' CG2' ' HG2' ' A' ' 16' ' ' LYS . 18.5 m -106.73 169.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.28 121.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.98 -140.58 5.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HB2' ' CE2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -126.5 -78.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' VAL . . . -60.36 -147.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' CB ' ' SG ' ' A' ' 18' ' ' CYS . . . -60.81 78.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 110.78 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.487 ' HA ' ' N ' ' A' ' 81' ' ' CYS . 2.5 t -73.81 -1.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.142 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . 95.62 -24.74 28.08 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HG2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.32 -64.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -96.09 -34.35 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB2' ' C8 ' ' A' ' 185' ' ' GNP . 3.3 p -66.39 -45.19 80.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HG ' ' CD1' ' A' ' 23' ' ' TYR . 8.1 tp -61.29 -73.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.959 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -43.86 -48.45 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.397 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -47.74 -69.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.01 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 2.1 t -93.2 -60.89 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.462 . . . . 0.0 111.971 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.543 ' CE2' ' CB ' ' A' ' 165' ' ' LEU . 8.2 t80 -47.6 -24.96 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.6 m -111.36 -96.25 0.42 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.562 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.508 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.6 t -60.07 -21.76 61.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 27.9 t-20 72.1 30.38 2.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.9 OUTLIER -125.78 134.75 51.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -69.21 160.12 80.17 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.042 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.2 Cg_endo -50.64 169.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.965 2.444 . . . . 0.0 112.409 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -74.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 134.11 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.21 110.06 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.424 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -154.78 138.85 11.27 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.497 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 36' ' ' VAL . 93.8 Cg_exo -41.18 109.07 0.1 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.46 2.107 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 HG23 ' CE ' ' A' ' 16' ' ' LYS . 18.1 m -47.16 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.297 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' CG ' ' B' ' 96' ' ' PHE . 61.3 t -103.78 -53.77 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.886 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.493 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 45.8 t80 -159.0 78.46 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 12.2 m-20 -80.59 121.52 25.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 26.6 t-20 -107.07 151.2 25.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.037 0.446 . . . . 0.0 111.272 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.2 160.03 43.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.216 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.25 116.97 29.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.906 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.452 ' CG1' ' CB ' ' B' ' 78' ' ' PRO . 1.4 m -146.08 132.07 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.059 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.0 m -127.49 112.19 14.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.838 0.352 . . . . 0.0 110.215 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.485 HG23 ' CD2' ' A' ' 169' ' ' PHE . 92.6 t -97.73 117.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.215 0.531 . . . . 0.0 110.143 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -93.42 106.09 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.294 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.418 HG21 ' CD1' ' B' ' 75' ' ' ILE . 7.2 mt -85.82 100.97 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.845 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.25 19.86 56.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.361 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.33 -46.31 1.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.595 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.72 139.69 97.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.663 0.268 . . . . 0.0 111.031 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.0 158.71 49.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.13 150.03 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.4 p -86.63 97.8 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.718 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.429 ' HG ' ' CD1' ' A' ' 173' ' ' ILE . 1.0 OUTLIER -133.76 137.31 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.409 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -162.25 145.4 10.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.551 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 3.1 mm? -75.88 114.34 14.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.636 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.2 103.72 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.062 0.458 . . . . 0.0 109.843 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 1.5 m-20 -67.51 137.12 55.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.424 ' CG2' ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -176.07 135.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.806 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -76.52 -61.97 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.221 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.99 89.56 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -118.63 -38.5 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 166.81 -30.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.22 -24.21 27.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 59' ' ' ALA . 18.7 m-85 -56.6 -20.19 19.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -41.77 -30.26 0.23 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.768 0.318 . . . . 0.0 111.446 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -70.01 -48.66 57.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD2' ' CE3' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -88.56 49.55 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.552 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -99.45 -43.39 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.0 Cg_exo -58.12 -14.63 19.93 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.63 2.22 . . . . 0.0 112.979 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -104.07 -15.6 15.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.103 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -132.9 22.07 4.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.494 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 15.1 p90 -46.61 114.33 2.67 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.106 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 37.8 Cg_endo -65.72 -21.42 58.61 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.562 2.175 . . . . 0.0 112.32 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -65.92 -11.79 49.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.231 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.494 ' HB ' ' CD1' ' A' ' 72' ' ' TYR . 8.9 t -41.47 -48.55 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 111.47 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 2.6 m-20 -164.54 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 24.9 t -132.14 156.7 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 110' ' ' PHE . 36.2 p90 -144.57 140.96 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 111.462 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.429 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.65 150.0 24.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 111' ' ' LEU . 2.5 t -131.34 154.62 40.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.186 0.517 . . . . 0.0 111.913 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.487 ' N ' ' HA ' ' A' ' 14' ' ' VAL . 10.1 p -68.15 172.93 5.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.815 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CZ ' ' CD2' ' A' ' 145' ' ' LEU . 0.9 OUTLIER 179.44 100.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.62 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 m -58.57 91.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 ' CA ' HG22 ' A' ' 137' ' ' ILE . 10.4 m -83.52 54.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' CG2' ' N ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -150.6 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.531 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.481 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 4.2 t -57.5 135.76 82.04 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.618 0.247 . . . . 0.0 110.64 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.25 -39.42 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.548 2.165 . . . . 0.0 112.478 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.24 -24.02 6.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.18 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 70.5 m -88.68 -40.34 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -42.32 -53.04 4.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.686 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -48.34 -55.41 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.364 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.0 m-20 -70.78 -37.89 73.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.189 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.478 HG11 ' CE3' ' A' ' 97' ' ' TRP . 98.6 t -44.09 -45.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.639 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -85.69 -47.79 9.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.38 7.67 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -128.56 -38.09 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.478 ' CE3' HG11 ' A' ' 93' ' ' VAL . 46.1 m0 -95.13 -26.54 15.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.516 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 59.7 t -67.35 -44.1 45.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.563 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 41.6 Cg_exo -56.87 -34.98 98.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.324 2.016 . . . . 0.0 112.308 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.16 -33.29 74.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.6 mt -49.17 -40.25 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.5 p -77.3 -21.44 53.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.328 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.45 -37.2 77.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.86 0.362 . . . . 0.0 110.678 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 73' ' ' PRO . 22.1 m-70 -106.51 -39.75 5.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.813 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 3.9 m -99.25 102.74 16.9 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -42.99 -62.29 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.479 2.119 . . . . 0.0 112.403 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -171.67 40.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 155.76 41.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.646 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.91 118.21 2.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.457 2.104 . . . . 0.0 112.179 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.2 p90 -104.89 141.99 35.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.431 ' CD1' ' HB ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.319 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 3.5 mt -129.49 158.11 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.989 0.423 . . . . 0.0 111.244 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.56 155.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.44 39.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.415 ' HB ' ' CB ' ' A' ' 158' ' ' SER . 73.0 p -146.29 160.04 42.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.699 0.285 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.42 35.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.406 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 20.0 mt -97.04 -61.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.987 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.66 -35.88 11.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.79 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -70.52 -32.21 69.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' CG ' HG22 ' A' ' 85' ' ' VAL . 7.0 ttm180 -76.63 59.38 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -129.21 37.29 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.87 141.64 22.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.44 -49.57 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.556 2.171 . . . . 0.0 112.265 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m -57.77 -22.98 49.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -48.83 -66.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -57.69 -45.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.154 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -50.19 52.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.37 -35.09 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.91 -25.56 4.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.495 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.26 -21.41 56.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.081 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -83.38 -20.05 34.93 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.98 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.89 30.55 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 77.79 32.95 0.38 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.39 -161.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.14 93.25 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.2 124.85 13.12 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.548 2.165 . . . . 0.0 112.064 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.469 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 3.7 mt -50.55 120.29 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -118.12 158.41 46.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 3.7 Cg_exo -40.3 -29.42 0.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.071 2.514 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -36.75 21.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' THR . 93.5 m -48.05 -47.61 33.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.31 -46.58 46.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -42.95 84.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.42 -53.47 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 14.8 tp -57.26 -31.95 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.467 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -66.66 -31.59 72.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -70.34 -47.64 60.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -23.14 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.4 pp -106.3 -24.26 12.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.073 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 1.2 tttt 62.16 120.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.845 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -159.7 -161.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 5.1 t -67.37 -15.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.574 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.32 146.02 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 112' ' ' LEU . 24.3 p90 -152.79 126.25 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.186 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 3.1 t -138.12 123.39 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -170.73 -179.63 2.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.402 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 17.6 p -130.62 -173.22 3.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.415 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 8.7 t -87.15 163.2 17.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.702 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.525 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -52.25 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.058 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 69.73 -63.25 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.64 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.2 p -89.51 -169.62 2.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -172.56 109.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -100.39 -38.75 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.44 88.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.304 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.543 ' CB ' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -91.98 -11.54 35.8 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -34.22 37.36 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -57.09 -45.43 83.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.283 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 31.1 t -54.76 -52.96 37.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.472 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 44' ' ' VAL . 1.4 m-30 -70.15 -28.25 65.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -53.93 -52.12 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.775 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.9 -33.9 16.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -66.14 -38.38 88.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.429 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 42.3 mm -86.66 -44.17 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.4 tm? -64.43 -31.94 73.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.75 -29.29 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.98 66.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.18 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.71 38.3 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 12.1 tp10 -78.27 -46.65 2.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.286 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 90.3 Cg_endo -81.3 145.99 15.39 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.401 2.068 . . . . 0.0 112.324 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.72 156.71 56.86 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.536 2.157 . . . . 0.0 112.273 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.48 ' CB ' ' CD ' ' A' ' 182' ' ' PRO . 1.4 mt-10 -160.12 -66.46 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 181' ' ' GLU . 33.7 Cg_endo -63.95 82.99 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.486 2.124 . . . . 0.0 112.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.14 168.8 16.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -27.49 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.339 . . . . 0.0 110.898 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.418 ' CD1' HG21 ' A' ' 46' ' ' ILE . 19.9 mm -144.03 137.41 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.65 133.54 32.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.2 143.23 69.28 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.59 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.452 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 51.3 Cg_exo -54.12 152.36 24.84 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.352 2.035 . . . . 0.0 112.062 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -117.19 -37.07 3.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.89 163.05 27.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.508 ' CD2' ' HB ' ' A' ' 25' ' ' THR . 27.6 t80 -167.46 130.35 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.624 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -153.42 116.67 4.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 69.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.414 ' N ' ' O ' ' B' ' 82' ' ' GLU . 8.2 p -57.9 -77.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.247 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.434 ' CG2' ' HG3' ' B' ' 100' ' ' PRO . 1.1 mp -103.76 139.44 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.499 . . . . 0.0 112.279 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -123.11 96.21 4.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.101 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.491 ' CG1' ' CG1' ' A' ' 36' ' ' VAL . 57.7 t -88.08 144.51 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.891 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.36 176.85 20.05 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.989 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -77.35 113.42 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.99 108.05 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.66 -17.2 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.307 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 10.2 p -43.01 -35.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.643 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 18.2 p -157.79 45.33 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.54 27.39 5.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.62 -168.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.719 0.295 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.531 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -106.0 164.49 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.829 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 1.9 p -99.45 165.31 11.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.419 ' CA ' ' OG1' ' B' ' 113' ' ' THR . . . 49.09 51.73 24.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.762 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.423 ' HE3' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -60.48 119.33 42.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.441 ' HG2' ' CD2' ' A' ' 37' ' ' PHE . 58.4 Cg_exo -49.56 156.46 2.9 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.291 1.994 . . . . 0.0 112.146 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.67 -57.1 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.455 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -69.94 -52.52 23.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.225 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.539 ' CE3' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -50.1 -57.77 6.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.725 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -48.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.204 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 77.5 mtt180 -54.76 -34.29 62.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.242 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.432 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.05 -61.04 2.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.925 0.393 . . . . 0.0 109.978 179.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.41 -70.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.15 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' B' ' 109' ' ' THR . 4.0 pt20 -80.74 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.203 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 0.5 OUTLIER 159.05 62.58 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.459 0.304 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 168.41 108.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.384 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' B' ' 111' ' ' ASN . 0.8 OUTLIER -65.39 74.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . 0.441 HD11 ' N ' ' B' ' 112' ' ' ILE . 0.5 OUTLIER -57.48 87.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.196 0.522 . . . . 0.0 111.311 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.419 ' OG1' ' CA ' ' B' ' 98' ' ' GLY . 4.2 m 179.92 -50.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.173 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -36.69 2.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.757 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.77 108.18 13.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.51 -83.56 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -73.59 109.9 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.525 ' N3 ' ' N ' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 69.44 140.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.27 144.68 46.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 53' ' ' LEU . 9.1 pt -119.87 114.57 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 0.8 OUTLIER -135.11 100.05 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -77.93 130.21 36.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.803 HG13 HG21 ' A' ' 75' ' ' THR . 2.1 m -96.67 150.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 16' ' ' LYS . 17.9 t -125.63 154.29 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.362 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 59' ' ' ALA . 7.2 p -149.64 121.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.738 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . 130.6 -179.52 16.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.93 -179.53 5.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.48 77.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.379 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 81' ' ' CYS . . . 53.41 84.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.738 HG11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -109.23 4.26 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.286 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.865 ' CA ' HD12 ' A' ' 19' ' ' LEU . . . 97.09 -18.19 57.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.281 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.818 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -62.92 -74.19 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.773 0.321 . . . . 0.0 111.515 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.796 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -96.62 -25.88 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 19' ' ' LEU . 2.1 p -65.61 -48.11 73.38 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.705 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD12 ' CA ' ' A' ' 15' ' ' GLY . 4.3 mt -61.26 -73.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.349 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 40' ' ' TYR . 11.2 mt -40.8 -43.42 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.981 0.419 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.773 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -48.71 -69.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.806 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 1.8 t -93.79 -55.39 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CZ ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -51.96 -19.25 1.7 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.498 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.452 ' CB ' ' HA ' ' A' ' 20' ' ' LEU . 43.2 m -123.94 -86.23 0.64 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.232 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.453 ' CG2' ' HD3' ' A' ' 27' ' ' LYS . 4.7 t -65.83 -14.21 60.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' ILE . 36.0 t30 79.03 -56.28 0.44 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.908 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -47.74 145.74 2.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.996 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.773 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -88.48 167.01 20.32 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.7 Cg_endo -45.82 165.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.993 2.462 . . . . 0.0 112.688 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.8 t -119.56 -76.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.98 113.94 25.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.643 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.28 109.3 4.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 111.056 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' HD2' ' A' ' 34' ' ' PRO . 67.2 t -157.52 138.03 9.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.478 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 84.3 Cg_exo -43.81 92.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.314 2.009 . . . . 0.0 111.617 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.813 HG23 ' CG ' ' A' ' 38' ' ' ASP . 56.8 m -51.98 87.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 34' ' ' PRO . 20.9 t -79.54 -28.23 12.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 109.762 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' B' ' 85' ' ' ILE . 3.7 t80 -146.62 -68.76 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.813 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.2 m-20 60.47 131.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.389 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' HB2' HD12 ' B' ' 85' ' ' ILE . 5.6 t-20 -108.0 159.81 16.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.796 ' OH ' HG23 ' A' ' 17' ' ' THR . 3.7 m-85 -152.18 157.44 41.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -115.29 137.94 51.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.176 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 41' ' ' ALA . 3.2 m -162.2 164.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 51' ' ' TYR . 84.8 m -155.94 99.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.483 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 76' ' ' SER . 3.1 m -98.54 117.15 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.5 mtm -91.37 102.12 14.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.21 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 177' ' ' LEU . 1.7 mp -87.3 107.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 20.84 77.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.39 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -141.67 100.47 6.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.949 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.38 155.95 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.501 2.134 . . . . 0.0 112.196 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.67 ' H ' HG23 ' A' ' 43' ' ' THR . 2.3 m-85 -154.16 169.63 23.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 111.327 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 97.22 4.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.321 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -105.04 161.26 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 111.375 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.833 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -160.27 127.3 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.057 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.043 HD11 HD23 ' A' ' 79' ' ' LEU . 1.8 mm? -75.93 103.23 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.9 103.0 12.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.022 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 58' ' ' THR . 1.5 m-20 -78.19 142.57 37.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 57' ' ' ASP . 2.2 p -167.72 178.68 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . . . -127.17 -66.71 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . 104.06 54.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.757 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER 170.48 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.324 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' A' ' 61' ' ' LEU . 22.7 mt-10 -85.79 89.96 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.186 0.517 . . . . 0.0 111.886 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 61.71 13.66 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.02 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.838 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 93.7 m-85 -102.62 -29.07 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -49.21 -27.37 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -93.49 -31.54 14.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.699 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -94.02 24.16 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -85.31 -46.31 0.63 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.205 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.7 Cg_exo -50.16 -23.15 9.14 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.834 HD22 ' CG ' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -76.24 -26.05 55.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.339 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.447 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 2.3 m -92.62 -23.42 19.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 2.0 p90 46.29 102.7 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.501 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.81 -34.28 8.29 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.657 2.238 . . . . 0.0 112.663 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.83 -10.66 50.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.563 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 HG13 ' A' ' 7' ' ' VAL . 8.3 t -38.42 -51.66 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.2 OUTLIER 167.97 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.9 p -58.44 162.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.5 135.46 40.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.043 HD23 HD11 ' A' ' 55' ' ' LEU . 12.6 tp -109.95 115.78 30.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.059 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.482 ' HB ' HD23 ' A' ' 112' ' ' LEU . 2.1 t -131.23 145.86 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.434 ' HB3' ' CA ' ' A' ' 14' ' ' VAL . 11.4 t -139.17 158.66 43.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.913 ' HB3' HG11 ' A' ' 93' ' ' VAL . 7.6 p90 -152.37 149.52 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -51.36 160.77 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.802 HG13 HG22 ' A' ' 137' ' ' ILE . 73.0 t -109.09 -69.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 125' ' ' THR . 67.0 t -52.03 -73.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.88 106.16 0.61 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD3' HG23 ' A' ' 125' ' ' THR . 68.8 Cg_endo -74.3 -25.76 13.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.528 2.152 . . . . 0.0 112.551 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.69 -24.16 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.8 m -96.15 -30.69 13.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.158 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.95 -69.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.125 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -50.47 -48.29 56.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' CA ' ' HG3' ' A' ' 96' ' ' LYS . 1.5 m-80 -53.2 -69.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 82' ' ' PHE . 61.5 t -40.45 -30.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.925 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.61 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.38 8.42 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.953 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG3' ' CA ' ' A' ' 92' ' ' ASN . 21.8 mmtm -113.3 -44.79 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.611 ' HD1' HG13 ' A' ' 93' ' ' VAL . 10.4 m95 -95.55 -36.79 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 94.1 t -52.5 -44.74 95.2 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.511 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 52.9 Cg_exo -52.51 -28.47 36.35 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.288 1.992 . . . . 0.0 112.288 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -77.94 -22.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 80' ' ' VAL . 21.6 mm -49.17 -31.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -85.01 -24.87 28.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 60' ' ' GLY . 9.9 t60 -65.78 -37.22 85.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -103.71 -19.66 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.256 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 12.2 m -152.88 74.49 7.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.761 0.315 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -12.57 33.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.617 2.211 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.57 21.16 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.255 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 135.67 25.04 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.85 159.63 4.87 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.498 2.132 . . . . 0.0 112.148 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 16.5 p90 -135.76 134.93 39.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 154' ' ' TYR . 4.6 mt -111.85 122.03 46.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' CE2' ' A' ' 82' ' ' PHE . 12.4 mt -91.15 162.94 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' PHE . 49.0 t -152.79 141.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.1 104.45 0.35 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.392 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 157' ' ' CYS . 71.1 p -137.84 137.56 38.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER 177.32 71.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 pt -98.69 -22.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.7 -24.41 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 116' ' ' GLN . 5.9 tt -75.15 -27.91 59.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.62 ' CB ' HG21 ' A' ' 85' ' ' VAL . 1.1 ptp180 -50.22 139.66 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.65 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.023 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -54.16 120.94 27.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.2 -41.42 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t -49.53 -31.67 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 129' ' ' LEU . 85.7 m -56.83 -58.98 5.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -51.38 -45.34 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -42.53 61.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -37.27 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 125' ' ' THR . 4.4 mt -50.71 -25.51 4.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.496 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.62 -20.46 53.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.21 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -81.3 -27.03 35.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.8 -8.36 57.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.454 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 62.89 26.45 15.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -100.84 -26.33 13.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.77 168.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.27 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.802 HG22 HG13 ' A' ' 84' ' ' VAL . 5.6 mt -51.52 135.37 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.224 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -132.31 177.75 2.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -53.35 -21.15 16.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.64 -42.34 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.499 ' HB ' HG23 ' A' ' 137' ' ' ILE . 22.7 m -50.88 -46.75 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.27 -40.43 58.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -43.87 97.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -51.55 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.799 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.78 -44.42 77.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -60.47 -31.38 70.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.86 -44.11 86.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.53 -50.64 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -68.14 -27.32 66.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.5 OUTLIER 70.59 108.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.82 -162.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 152' ' ' VAL . 57.3 t -67.34 -11.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.678 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 73.87 139.77 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.703 0.287 . . . . 0.0 110.86 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 24.6 p90 -153.11 162.64 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 155' ' ' VAL . 26.9 m -158.32 124.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.624 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -171.06 166.37 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.574 ' O ' HG21 ' A' ' 115' ' ' THR . 18.2 p -113.82 -173.13 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.413 ' CA ' ' HB ' ' A' ' 115' ' ' THR . 8.4 t -87.61 166.81 14.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.898 0.38 . . . . 0.0 111.029 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.664 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.16 -174.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.412 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.664 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.4 mm? 67.72 -64.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 166.14 11.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.72 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -142.01 122.94 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -105.07 -37.33 6.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 165.44 79.87 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.72 HD11 ' OE1' ' A' ' 162' ' ' GLN . 4.0 mt -83.89 -25.14 30.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 111.029 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -52.78 -31.46 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 166' ' ' LYS . 12.1 m-80 -65.28 -65.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.74 -27.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -74.3 -35.13 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.272 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.444 ' CB ' HG13 ' B' ' 75' ' ' ILE . 5.1 t70 -63.26 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.516 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 -25.6 25.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.769 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.99 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.054 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 46' ' ' ILE . 31.6 mm -94.8 -23.71 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.8 tt -72.5 -45.96 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.87 71.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.553 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -90.63 -19.67 23.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -47.47 -41.54 20.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.151 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.06 -83.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 46' ' ' ILE . 8.4 mm -91.67 140.03 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.481 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.9 m -128.38 139.58 52.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -75.88 138.73 69.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.551 ' CB ' HG12 ' A' ' 42' ' ' VAL . 65.6 Cg_exo -51.3 146.85 22.98 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.461 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 30.8 t -108.41 -51.3 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 1.5 t0 -77.49 167.88 20.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 6.5 t80 171.41 124.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -153.19 132.38 12.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 111.382 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -68.91 95.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.472 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -74.51 -62.86 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.576 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.513 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -116.87 113.94 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.888 0.375 . . . . 0.0 111.499 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.08 96.91 7.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.198 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.463 HG22 ' HD3' ' B' ' 100' ' ' PRO . 39.4 t -79.31 137.77 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.445 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -133.14 177.56 18.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -77.26 136.48 38.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' B' ' 97' ' ' THR . 10.0 t0 -124.21 110.1 14.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.11 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.752 HG12 HG23 ' B' ' 93' ' ' THR . 48.9 t -40.98 -48.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.848 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.752 HG23 HG12 ' B' ' 92' ' ' VAL . 3.4 p -155.48 50.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 47.73 33.42 9.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.421 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' B' ' 90' ' ' ASP . 11.8 pt-20 -118.31 -178.01 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.325 . . . . 0.0 110.79 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.802 ' HE2' HD13 ' A' ' 67' ' ' LEU . 2.3 m-85 -101.95 164.23 11.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.503 HG22 HD13 ' B' ' 112' ' ' ILE . 19.4 p -109.78 168.86 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 48.71 27.58 6.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.568 ' CE ' HD21 ' A' ' 67' ' ' LEU . 2.7 mtp -52.64 131.11 46.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.593 0.235 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.483 ' CA ' HG21 ' B' ' 85' ' ' ILE . 81.3 Cg_exo -49.5 145.74 15.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.554 2.17 . . . . 0.0 112.19 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -45.59 -39.93 8.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -78.57 -51.12 10.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.525 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.555 ' HA ' HD13 ' A' ' 70' ' ' LEU . 2.6 m0 -53.76 -55.43 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 109.622 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -51.64 -62.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.841 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 15.9 ptt85 -55.95 -36.31 67.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.301 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.834 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -46.83 -63.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -96.2 -69.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.193 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.563 ' C ' HG22 ' B' ' 109' ' ' THR . 0.6 OUTLIER -80.4 -105.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.071 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.563 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.34 -24.14 0.0 OUTLIER 'General case' 0 C--N 1.351 0.653 0 C-N-CA 122.43 0.292 . . . . 0.0 111.361 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.5 107.9 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.332 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -43.43 -50.81 6.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 110.847 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.542 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -103.15 132.43 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -103.49 153.22 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.002 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 3' ' ' THR . 5.4 pt -158.04 121.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.981 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 112.88 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -91.86 128.73 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.817 HG21 ' CB ' ' A' ' 71' ' ' SER . 59.1 t -107.24 159.06 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.994 0.426 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 79' ' ' LEU . 4.9 m -126.79 163.24 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 80' ' ' VAL . 3.5 t -153.68 123.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.212 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 14' ' ' VAL . . . 147.7 168.97 14.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.735 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -60.0 -152.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -40.73 141.48 0.92 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 55.89 62.48 2.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.182 0.515 . . . . 0.0 109.701 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.741 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.9 t -54.68 -19.62 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 132.6 -36.04 2.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.795 ' N ' HG11 ' A' ' 8' ' ' VAL . 7.5 mmtt -95.91 -73.71 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.237 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.619 HG22 ' OD2' ' A' ' 57' ' ' ASP . 4.7 t -36.09 -53.06 0.79 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 5.4 p -63.8 -48.6 76.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.785 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 15' ' ' GLY . 12.5 mt -55.71 -72.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 55' ' ' LEU . 8.6 mt -38.09 -43.05 0.71 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.588 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -49.4 -69.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -93.47 -54.16 3.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.157 0.503 . . . . 0.0 111.452 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.818 ' HA ' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -51.31 -21.82 2.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.411 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 77.2 m -120.63 -88.07 0.63 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.832 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.76 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 5.0 t -54.89 -30.46 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.219 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.6 OUTLIER 76.64 51.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -158.83 116.28 2.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.768 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -45.85 168.39 0.11 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.884 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 61.7 Cg_exo -53.05 158.32 6.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.743 2.295 . . . . 0.0 112.981 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.1 t -107.44 -76.25 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.779 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.45 108.04 19.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.377 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.8 100.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.45 . . . . 0.0 111.161 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 ' HD2' ' A' ' 34' ' ' PRO . 96.5 t -151.51 139.51 12.85 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.207 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 36' ' ' VAL . 98.1 Cg_exo -41.58 91.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.385 2.056 . . . . 0.0 112.04 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 38' ' ' ASP . 93.0 m -54.25 87.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 34' ' ' PRO . 59.5 t -85.99 -24.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.398 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.6 t80 -142.39 -66.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.907 ' CG ' HG23 ' A' ' 35' ' ' THR . 6.1 m-20 53.71 107.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 41.7 t30 -107.6 153.08 23.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.794 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CE1' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.47 168.82 22.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.71 115.62 28.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.712 HG22 HD11 ' A' ' 55' ' ' LEU . 12.3 m -134.38 137.68 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.658 HG23 ' H ' ' A' ' 51' ' ' TYR . 55.1 m -136.7 108.59 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG12 ' O ' ' B' ' 76' ' ' SER . 4.8 m -98.24 117.29 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.052 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 27.2 mtm -79.4 100.98 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 173' ' ' ILE . 5.6 mm -87.95 91.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.43 16.04 74.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.709 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.09 25.8 10.9 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.736 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.0 mt-10 -124.65 131.26 24.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.554 0.216 . . . . 0.0 110.793 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 159.07 28.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.466 2.111 . . . . 0.0 112.271 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.658 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -154.04 161.51 41.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -136.44 97.42 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.531 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 53' ' ' LEU . 9.0 tt -107.34 131.76 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.266 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -97.17 134.24 11.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.252 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.932 HD22 ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -113.19 103.1 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.945 0.402 . . . . 0.0 110.905 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 4.1 m-85 -102.11 111.28 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.619 ' OD2' HG22 ' A' ' 17' ' ' THR . 4.5 t70 -88.01 171.4 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.426 ' O ' HG21 ' A' ' 14' ' ' VAL . 8.4 p -139.56 -175.7 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.715 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -101.02 -23.44 14.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.071 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . . . 74.71 51.78 7.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.359 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.0 174.89 11.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.88 30.77 2.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.1 28.81 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.877 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.8 m-85 -101.14 -11.74 19.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -43.06 -28.51 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.675 0.274 . . . . 0.0 111.592 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 3.5 mtt85 -45.02 -62.82 1.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.763 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.3 mp -72.33 173.5 8.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 5.2 tpp180 -101.0 -72.66 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.5 Cg_endo -71.4 -58.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.036 1.824 . . . . 0.0 113.06 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 64' ' ' TYR . 63.4 mt 50.1 25.65 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.817 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER 164.17 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.02 175.25 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 111.072 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 34.3 Cg_exo -61.9 -24.41 77.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.645 2.23 . . . . 0.0 112.17 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -68.06 -10.12 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.608 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -36.94 -32.15 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t0 51.62 -151.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.537 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 175' ' ' ALA . 40.6 t -57.56 156.2 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.692 0.282 . . . . 0.0 110.478 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -113.34 134.51 54.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.808 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.93 122.22 44.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.08 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 t -130.35 101.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.0 t -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.669 ' CB ' HG11 ' A' ' 93' ' ' VAL . 38.2 p90 -137.34 124.68 21.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.008 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 p -52.96 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.2 86.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.666 HG12 ' OE1' ' A' ' 116' ' ' GLN . 30.3 m -122.92 75.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.79 148.48 0.12 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 51.9 Cg_exo -54.6 -19.34 17.88 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.749 2.299 . . . . 0.0 112.591 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 t -46.59 -73.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.39 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.3 m -61.28 -24.57 66.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -51.32 -58.96 4.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.035 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -49.65 -60.72 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -53.32 -63.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' SER . 72.9 t -41.14 -29.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.959 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.9 tttt -74.84 -69.51 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.664 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.73 7.98 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.39 -43.34 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.648 0.261 . . . . 0.0 111.553 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.663 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.1 m95 -95.3 -40.12 9.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.5 t -52.65 -44.2 94.64 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.512 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.4 Cg_exo -59.79 -28.82 88.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.278 1.985 . . . . 0.0 112.235 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -24.29 60.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.7 mt -49.48 -27.81 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -76.87 -28.15 55.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -70.81 -44.8 65.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CE1' ' CD2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -89.02 -33.72 17.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 2.7 m -107.6 129.63 23.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.654 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.61 -83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.444 2.096 . . . . 0.0 112.64 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -153.52 83.68 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.854 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -151.59 163.92 22.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.854 ' HD2' HG22 ' A' ' 108' ' ' THR . 59.4 Cg_exo -52.09 130.24 34.27 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.451 2.101 . . . . 0.0 112.037 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -102.6 125.77 49.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -106.69 121.4 44.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.687 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -114.1 162.59 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.087 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 114' ' ' GLY . 3.1 t -146.84 166.3 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -161.12 101.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.529 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' GLY . 41.2 p -158.48 142.23 15.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.431 . . . . 0.0 111.238 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.666 ' OE1' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -174.79 40.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.453 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 158' ' ' SER . 10.1 mt -37.83 -37.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.838 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.59 -43.82 96.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.741 HD23 ' OD2' ' A' ' 122' ' ' ASP . 2.0 mt -86.99 -45.55 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 5.1 tmm_? -48.93 -26.24 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.9 46.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' A' ' 119' ' ' LEU . 2.3 m-20 -107.23 156.09 38.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.05 -49.89 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.17 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -50.05 -47.71 53.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -51.99 -31.76 30.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.218 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 24.0 mm -63.56 -54.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.66 -40.91 13.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -84.86 -37.84 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -49.58 -32.73 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.337 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.01 65.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.103 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -24.02 19.67 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.314 . . . . 0.0 110.867 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 18.7 m120 -95.98 30.19 2.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 26.65 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 49.19 -166.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.58 86.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.876 ' HA ' HD21 ' A' ' 129' ' ' LEU . 74.0 Cg_exo -48.38 169.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.575 2.184 . . . . 0.0 112.317 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.1 mt -94.13 130.27 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -110.75 168.42 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.962 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 48.8 Cg_exo -56.58 -17.74 23.37 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.714 2.276 . . . . 0.0 112.562 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -82.55 -32.93 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.194 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.3 m -56.69 -62.78 1.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.971 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.95 -50.58 26.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 tt0 -55.38 -39.86 70.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -53.66 -54.73 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.645 HD13 ' CE1' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -54.57 -37.15 65.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.692 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.796 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.23 -46.78 82.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -57.76 -44.68 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.626 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -22.29 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.037 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.563 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 2.9 pp -121.38 21.27 11.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 43.9 tttm 56.16 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.07 174.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.044 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 60.9 t -59.49 -17.76 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.46 135.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.647 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.796 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 13.6 p90 -152.9 154.82 35.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.363 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 168' ' ' VAL . 35.0 m -155.07 123.67 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.23 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.6 pt-20 -170.88 -178.68 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 111.111 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.8 p -127.91 -170.37 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.018 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.544 ' HB3' HD12 ' A' ' 117' ' ' ILE . 1.7 t -85.35 174.52 9.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.755 0.312 . . . . 0.0 110.288 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.509 ' HB1' ' OG ' ' A' ' 22' ' ' SER . . . -34.36 -85.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.05 -171.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.499 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 162' ' ' GLN . 4.3 p 64.72 -67.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.836 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 54.53 94.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 110.783 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -105.18 -67.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.1 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.96 77.84 0.38 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.793 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.818 HD21 ' HA ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -93.7 -29.05 15.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' B' ' 77' ' ' LEU . 4.6 mmtp -54.62 -60.25 3.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.294 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -43.31 -37.06 2.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 156' ' ' GLU . 23.9 t -59.37 -62.28 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.755 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.75 ' CE1' HD21 ' B' ' 77' ' ' LEU . 66.2 m-85 -52.08 -28.94 19.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.474 ' OD1' HG21 ' B' ' 75' ' ' ILE . 1.9 m-20 -63.07 -41.8 99.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -88.62 -45.55 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 110.908 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.7 70.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.682 HG21 HD11 ' A' ' 46' ' ' ILE . 50.0 mm -86.35 -52.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 174' ' ' LEU . 3.4 tm? -55.05 -39.65 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.477 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -53.64 -47.4 70.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.87 35.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.7 tp -50.85 -44.83 59.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.037 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -44.38 96.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.474 HG21 ' OD1' ' A' ' 170' ' ' ASP . 7.2 tt -143.98 151.94 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -134.7 154.72 51.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.025 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -89.09 137.45 29.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.446 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 50.7 Cg_exo -55.25 -63.6 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.45 2.1 . . . . 0.0 111.793 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.88 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.164 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.79 88.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.76 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -118.79 -173.12 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.02 128.97 10.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.6 85.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.433 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.493 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -53.87 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -120.73 154.18 24.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 96.75 4.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.531 HG12 ' HB ' ' A' ' 36' ' ' VAL . 86.0 t -80.18 121.65 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.462 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -125.87 177.27 17.16 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.127 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.3 138.52 39.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 111.004 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.856 ' HB2' HG23 ' B' ' 97' ' ' THR . 4.4 t0 -139.0 112.94 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.16 60.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.646 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.596 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -41.22 -33.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.606 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.596 HG22 HG13 ' B' ' 92' ' ' VAL . 3.8 t -140.09 -37.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.96 20.96 1.59 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.71 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.34 -158.63 0.9 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.6 0.238 . . . . 0.0 110.394 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.42 ' CD1' HG11 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -103.41 164.53 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.803 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.856 HG23 ' HB2' ' B' ' 90' ' ' ASP . 11.5 p -95.73 162.53 13.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.1 46.18 33.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.568 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -61.53 124.36 80.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.561 0.219 . . . . 0.0 110.862 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.54 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 63.7 Cg_exo -50.62 159.66 2.1 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.366 2.044 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.01 -57.26 3.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.276 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -72.51 -56.09 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.613 ' CE2' HD23 ' A' ' 70' ' ' LEU . 8.6 m0 -46.24 -55.34 7.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -54.76 -45.94 74.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.109 0.481 . . . . 0.0 110.447 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 55.0 mtp85 -58.52 -41.41 85.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.88 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -50.3 -55.88 13.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.253 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.32 -69.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.758 ' O ' HG23 ' B' ' 109' ' ' THR . 5.2 tp-100 -79.14 -100.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -168.17 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 120.872 0.367 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.409 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -150.95 174.25 13.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.217 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.58 72.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.621 0.725 . . . . 0.0 111.608 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.824 0.345 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.1 124.08 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.21 141.03 28.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.467 HG23 ' OD2' ' A' ' 76' ' ' ASP . 3.9 mt -146.7 129.34 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -131.65 95.35 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.568 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.9 t -77.35 100.44 5.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.722 HG23 ' OG1' ' A' ' 75' ' ' THR . 94.0 t -84.4 113.25 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.656 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.965 HG12 ' HB3' ' A' ' 79' ' ' LEU . 27.4 m -85.04 140.0 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.549 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 80' ' ' VAL . 11.8 p -126.49 154.88 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.679 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . 147.6 -169.19 28.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.666 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.94 29.6 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -125.12 -41.57 0.36 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 85.64 -23.68 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 81' ' ' CYS . 28.7 m -48.7 -23.83 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.833 ' HA3' HG23 ' A' ' 113' ' ' VAL . . . -120.56 -33.78 0.99 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.603 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 10' ' ' GLY . 44.3 mtmt -63.82 -76.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 111.406 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.021 HG21 ' CG2' ' A' ' 35' ' ' THR . 17.4 p -98.24 -43.9 6.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.253 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 58.2 m -52.61 -23.82 7.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.757 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 23' ' ' TYR . 18.8 tp -61.8 -71.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 55' ' ' LEU . 14.2 mt -44.12 -29.13 0.57 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.8 mm -65.79 -45.12 92.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.369 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' LEU . 78.5 p -94.93 -13.15 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.81 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.003 ' CD1' HD13 ' A' ' 165' ' ' LEU . 2.9 m-30 -95.93 -67.45 0.85 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.612 HG22 ' HB2' ' B' ' 81' ' ' PHE . 58.6 m -82.74 -81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.647 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.702 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -47.23 -40.44 16.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.274 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.481 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 2.4 t30 64.79 41.38 5.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.702 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -126.84 -159.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.38 155.66 76.21 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 65.1 Cg_exo -36.79 132.47 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.017 2.478 . . . . 0.0 113.118 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m -97.91 -82.83 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.556 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.78 108.77 20.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.45 109.29 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.294 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.4 p -160.63 133.23 4.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.383 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 36' ' ' VAL . 90.5 Cg_exo -41.26 93.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.353 2.035 . . . . 0.0 111.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 1.021 ' CG2' HG21 ' A' ' 17' ' ' THR . 23.8 m -53.07 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.328 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' B' ' 96' ' ' PHE . 2.2 t -77.48 -24.6 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -150.56 -75.49 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.699 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.748 ' CG ' HG23 ' A' ' 35' ' ' THR . 5.7 m-20 60.27 117.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.778 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.579 ' CB ' HD12 ' B' ' 85' ' ' ILE . 16.0 t-20 -107.13 156.66 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.557 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.06 168.97 22.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.258 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.31 138.76 53.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.0 m -147.04 131.45 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.2 m -116.66 103.12 10.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.883 HG22 ' HD3' ' B' ' 78' ' ' PRO . 40.6 t -98.91 121.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.041 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.3 mtm -87.05 100.09 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.011 HD12 ' CZ ' ' A' ' 51' ' ' TYR . 14.1 mt -98.3 93.82 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 17.34 79.93 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.364 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 35.52 5.43 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -141.19 128.33 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.483 0.182 . . . . 0.0 110.928 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 168.7 3.24 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.05 . . . . 0.0 112.232 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.011 ' CZ ' HD12 ' A' ' 46' ' ' ILE . 2.4 m-85 -147.96 156.08 42.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 p -130.52 99.93 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 54' ' ' GLY . 10.4 tt -133.53 160.56 37.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.783 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -153.4 149.27 20.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 20' ' ' LEU . 16.3 mt -99.14 104.11 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 111.214 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' A' ' 7' ' ' VAL . 5.5 m-85 -83.39 112.66 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 7.2 t70 -66.93 134.09 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 111.237 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -145.12 155.33 43.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.765 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.46 -176.37 4.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.212 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -110.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tp 50.29 -161.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.366 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -132.52 40.0 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -131.69 21.04 4.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 58' ' ' THR . 2.7 m-85 -111.34 -27.99 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.74 -41.28 22.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.825 ' HG3' HD12 ' A' ' 67' ' ' LEU . 4.1 ptp85 -69.06 -36.7 77.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.404 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -98.0 29.05 3.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.576 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 2.6 tpt180 -88.73 -66.12 0.16 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 87.5 Cg_exo -37.27 -31.28 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.844 2.363 . . . . 0.0 112.827 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -51.99 -31.53 29.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.722 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -91.8 -25.47 19.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.9 OUTLIER 50.47 170.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.748 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.2 Cg_exo -68.67 -20.78 40.04 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.075 2.517 . . . . 0.0 112.666 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.52 -10.95 39.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.512 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.5 t -48.71 -23.82 1.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 111.639 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 4' ' ' ILE . 4.2 m-20 77.25 -152.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.67 148.85 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 7' ' ' VAL . 4.6 m-85 -100.39 131.92 46.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.965 ' HB3' HG12 ' A' ' 8' ' ' VAL . 48.9 tp -103.74 115.97 31.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.137 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' VAL . 4.6 t -110.38 150.76 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 111.799 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 31.4 p -92.75 170.73 9.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -161.86 101.34 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.385 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.464 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 41.9 t -68.33 129.92 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 142' ' ' ALA . 27.4 m -121.51 49.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -115.68 -69.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -100.2 103.44 23.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.733 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 80.2 Cg_exo -44.8 -27.61 2.5 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.584 2.189 . . . . 0.0 112.504 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -64.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.8 m -58.33 -34.95 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -45.61 -41.35 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.263 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.77 -61.26 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.735 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.4 m-20 -59.63 -38.68 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 89' ' ' SER . 92.5 t -47.5 -52.75 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.2 tttm -65.16 -47.83 75.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.479 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -82.36 8.17 12.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.36 -37.41 2.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.67 0.271 . . . . 0.0 111.558 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.801 ' CE3' HG13 ' A' ' 93' ' ' VAL . 22.6 m0 -92.28 -28.93 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.67 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.804 ' O ' HG22 ' A' ' 101' ' ' ILE . 33.1 t -74.47 -44.09 5.62 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 27.0 Cg_exo -62.34 -23.11 74.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.321 2.014 . . . . 0.0 112.345 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.9 -14.9 27.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.618 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -46.62 -33.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.388 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 p -81.06 -34.19 32.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -61.9 -27.29 68.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.44 -24.58 9.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 101' ' ' ILE . 2.1 m -120.62 92.02 47.5 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 55.9 Cg_endo -70.18 99.33 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.634 2.223 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 44.29 41.55 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 109' ' ' PRO . 53.4 m -117.64 142.2 30.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 108' ' ' THR . 6.9 Cg_endo -49.28 133.86 30.58 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.852 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.8 p90 -115.45 149.54 37.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.996 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 148.03 46.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 tp -116.03 142.26 47.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.628 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.879 HG12 ' OE1' ' A' ' 156' ' ' GLU . 1.4 m -153.54 176.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.32 138.13 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.4 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.702 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -158.35 153.13 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.601 ' CB ' HG13 ' A' ' 85' ' ' VAL . 28.5 mm-40 -151.84 98.42 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.652 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.854 HD11 ' HB2' ' A' ' 157' ' ' CYS . 2.8 mt -90.44 -46.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -25.81 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.535 HD12 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -77.22 -43.09 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -52.2 -29.03 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.17 47.01 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.982 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -89.05 140.93 29.1 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.793 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.75 -36.56 33.38 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -82.63 -30.43 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.771 HG22 ' CD1' ' A' ' 129' ' ' LEU . 61.1 m -56.03 -63.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.7 mp -50.53 -39.16 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.1 -55.87 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.711 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.76 45.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.57 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.33 -26.28 4.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 110.368 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.69 -24.13 63.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.802 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -84.15 -22.76 30.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 9.1 m-80 -93.92 30.05 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt 70.58 28.21 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -160.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.44 82.57 0.17 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.809 ' HA ' HD21 ' A' ' 129' ' ' LEU . 54.1 Cg_exo -52.46 166.69 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 84' ' ' VAL . 4.8 mt -101.59 122.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.457 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.1 p -112.98 176.51 1.46 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.6 Cg_exo -54.56 -20.37 20.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.607 2.205 . . . . 0.0 112.371 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.72 -47.94 15.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.473 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.9 m -51.18 -49.83 60.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -53.2 -50.01 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.33 -35.63 77.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.809 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -59.09 4.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.8 tp -61.82 -27.29 68.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 154' ' ' TYR . . . -73.2 -31.89 64.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.47 -45.51 65.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -23.07 25.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.049 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.806 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.5 pp -108.48 -16.55 14.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt 75.12 -69.73 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 -172.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 152' ' ' VAL . 62.1 t -68.29 -8.95 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.748 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.49 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.977 0.417 . . . . 0.0 111.003 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CZ ' ' HB1' ' A' ' 146' ' ' ALA . 2.8 p90 -153.47 154.54 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.653 ' H ' HG22 ' A' ' 168' ' ' VAL . 2.6 m -158.2 124.47 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.769 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.879 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -171.18 166.65 7.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.412 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.7 p -123.48 -173.63 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.22 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 116' ' ' GLN . 3.6 p -88.2 162.86 16.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.91 -173.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER 52.14 30.14 7.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.02 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 -68.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.481 ' NE2' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 60.82 105.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -102.3 -64.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.13 88.82 0.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.604 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.003 HD13 ' CD1' ' A' ' 23' ' ' TYR . 2.4 mt -93.95 -10.86 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.553 0.216 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -57.7 -41.13 81.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 110.332 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.402 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 4.0 m-80 -57.8 -50.97 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 155' ' ' VAL . 55.6 t -52.33 -66.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.179 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.402 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -49.15 -40.73 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.559 ' HA ' HD13 ' B' ' 75' ' ' ILE . 48.4 t0 -50.14 -55.49 14.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -48.81 66.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.83 -28.97 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.096 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 46' ' ' ILE . 26.0 mm -93.57 -27.67 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -26.4 62.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.12 5.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.29 52.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 177' ' ' LEU . 5.9 tt -48.97 -26.32 2.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.864 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.68 -85.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 44' ' ' VAL . 8.3 tt -135.12 151.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.088 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.611 ' O ' HG13 ' A' ' 44' ' ' VAL . 40.1 t -134.78 148.72 50.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.17 88.44 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.635 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.883 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.4 Cg_endo -52.42 -172.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.61 2.207 . . . . 0.0 112.004 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.406 ' O ' ' N ' ' B' ' 81' ' ' PHE . 34.4 p -165.93 -40.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.204 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 71.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.612 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.2 t80 -93.35 139.58 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -153.37 129.26 10.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 78.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 110.372 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.542 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.642 HG21 ' HA ' ' B' ' 100' ' ' PRO . 0.5 OUTLIER -131.16 101.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.561 0.219 . . . . 0.0 111.395 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -85.4 96.78 9.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.374 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.51 HG12 ' N ' ' B' ' 88' ' ' GLY . 88.0 t -78.43 158.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.243 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.51 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -143.18 171.18 25.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.099 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.37 116.04 28.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.903 0.383 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.697 ' CB ' HG23 ' B' ' 97' ' ' THR . 49.9 t0 -136.51 124.06 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.23 0.72 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.976 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.848 HG13 HG23 ' B' ' 93' ' ' THR . 7.2 p -43.66 -29.09 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.861 0.362 . . . . 0.0 111.368 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.848 HG23 HG13 ' B' ' 92' ' ' VAL . 1.4 p -155.4 25.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.803 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.38 20.68 65.73 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.426 ' CD ' ' HG1' ' B' ' 93' ' ' THR . 17.5 pt-20 -125.29 -163.25 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.779 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -105.04 164.57 11.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.697 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.3 p -98.72 144.11 28.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.51 45.18 24.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.313 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.603 ' HE1' HD21 ' A' ' 67' ' ' LEU . 2.4 tpt -49.95 105.67 0.54 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.619 0.247 . . . . 0.0 110.998 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.642 ' HA ' HG21 ' B' ' 85' ' ' ILE . 74.2 Cg_exo -48.88 144.32 15.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.481 2.12 . . . . 0.0 112.22 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -46.87 -47.29 21.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.176 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.53 -65.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.812 ' CE3' HD23 ' A' ' 67' ' ' LEU . 4.0 m0 -49.51 -53.51 22.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.599 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.566 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -52.62 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.166 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 2.8 mtt-85 -51.24 -32.79 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.812 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.79 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -49.79 -57.64 6.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.685 HD21 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.54 -72.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.952 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.565 ' C ' HG22 ' B' ' 109' ' ' THR . 2.8 pt20 -81.98 -113.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.229 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.565 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 158.75 65.78 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.499 0.32 . . . . 0.0 111.071 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER 170.07 125.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 111.345 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.4 OUTLIER -84.98 75.34 10.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.332 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.25 121.31 15.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.26 151.83 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -144.55 120.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 143.18 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.1 m -136.04 155.3 50.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.795 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 71' ' ' SER . 41.9 t -138.19 158.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.633 HG13 ' OG1' ' A' ' 58' ' ' THR . 7.7 p -110.95 160.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.175 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.533 ' N ' HG22 ' A' ' 8' ' ' VAL . 7.4 p -151.53 133.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.57 177.25 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -76.98 117.82 18.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.56 178.69 16.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.342 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 18' ' ' CYS . . . -131.57 0.41 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 113' ' ' VAL . 3.8 t -54.81 -20.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.475 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.9 -109.3 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.452 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE2' HD23 ' A' ' 79' ' ' LEU . 3.9 mptp? -98.86 -53.88 3.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.577 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -43.85 -77.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.559 ' H ' HG23 ' A' ' 17' ' ' THR . 40.0 t -66.19 -24.72 66.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.953 0.406 . . . . 0.0 111.351 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 23' ' ' TYR . 15.4 tp -63.08 -72.78 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.357 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.995 HD11 HD23 ' A' ' 55' ' ' LEU . 1.3 mm? -41.59 -38.26 1.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.646 ' O ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -49.37 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.64 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -93.76 -50.21 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 112.001 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' A' ' 19' ' ' LEU . 2.6 t80 -53.75 -31.66 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 94.5 m -108.91 -87.7 0.5 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.551 -0.459 . . . . 0.0 112.119 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 21' ' ' ILE . 1.8 t -55.09 -24.75 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.558 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' SER . 17.6 t-20 72.21 51.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.806 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 21' ' ' ILE . 8.6 pttt -135.15 -167.48 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.512 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -124.72 154.33 70.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.794 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 88.0 Cg_exo -41.5 146.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.848 2.365 . . . . 0.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -103.01 -81.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.779 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.67 114.94 26.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.746 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.2 t80 -67.88 107.81 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 ' HD2' ' A' ' 34' ' ' PRO . 97.2 t -158.7 140.12 9.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.281 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.1 Cg_exo -43.51 91.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.381 2.054 . . . . 0.0 111.898 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.577 HG21 ' HB ' ' A' ' 17' ' ' THR . 23.3 m -52.5 89.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.271 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' PRO . 25.2 t -95.6 22.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.416 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.2 t80 168.04 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.178 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER 54.54 109.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.728 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.4 t30 -107.42 168.38 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD2' ' CE2' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -153.12 168.91 24.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.423 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.64 124.09 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.725 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 53' ' ' LEU . 27.4 m -150.15 138.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 51' ' ' TYR . 32.0 m -136.92 108.21 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.062 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 76' ' ' SER . 2.6 m -98.05 116.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 100.36 13.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.767 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 46' ' ' ILE . 2.9 mm -72.81 90.7 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.6 77.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 35.34 4.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.33 93.28 36.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.12 121.15 6.41 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.728 ' O ' HG23 ' A' ' 43' ' ' THR . 1.4 m-30 -117.34 162.62 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 52' ' ' THR . 2.7 t -112.88 97.24 6.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.572 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 54' ' ' GLY . 1.2 tt -107.72 160.1 15.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -155.12 100.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.365 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HD11 ' A' ' 20' ' ' LEU . 1.4 mm? -78.17 126.98 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 3.4 m-85 -108.7 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.607 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -74.27 -163.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.933 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.633 ' OG1' HG13 ' A' ' 8' ' ' VAL . 69.4 p -159.48 169.02 24.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . -73.45 -37.98 65.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 27.02 22.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -137.59 23.53 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 0.0 111.026 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 48.56 27.85 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.04 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.892 ' HB2' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -98.76 26.74 5.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.917 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -88.76 -22.26 23.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -43.94 -28.88 0.5 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -49.55 -60.48 2.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.848 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.9 mp -65.84 -176.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.383 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.55 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -100.85 -63.67 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 59.3 Cg_endo -95.42 -59.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.338 2.025 . . . . 0.0 113.001 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.917 HD13 ' CD2' ' A' ' 64' ' ' TYR . 23.3 mt 62.52 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 120.838 0.351 . . . . 0.0 110.761 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.861 ' CB ' HG21 ' A' ' 7' ' ' VAL . 25.6 p -90.98 -14.38 31.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.037 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 49.34 173.31 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.56 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.3 Cg_exo -68.0 -23.3 40.64 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.839 2.359 . . . . 0.0 112.282 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -11.95 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.1 t -47.49 -25.7 1.16 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.613 0.244 . . . . 0.0 111.506 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 47.33 -91.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.035 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 78' ' ' PHE . 44.9 t -95.37 161.23 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.553 0.216 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG12 ' A' ' 77' ' ' VAL . 9.4 m-85 -122.77 147.07 46.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 113' ' ' VAL . 1.9 mm? -103.91 147.15 27.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.065 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.32 97.18 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.09 100.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' A' ' 93' ' ' VAL . 38.6 p90 -116.84 144.02 45.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.14 164.4 24.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 115' ' ' THR . 32.2 m -131.63 42.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.993 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.45 72.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.99 153.65 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.045 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 90' ' ' PHE . 27.5 Cg_exo -61.51 -13.72 31.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.681 2.254 . . . . 0.0 112.58 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.6 t -43.41 -71.79 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.9 m -80.77 -26.91 36.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.546 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 1.7 t80 -47.67 -61.4 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.049 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -50.23 -54.44 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -54.26 -45.67 72.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 89' ' ' SER . 98.4 t -47.59 -50.04 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.414 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.3 mtmt -78.26 -44.42 25.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.422 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -77.84 5.32 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.48 -36.97 2.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.613 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -95.31 -41.96 8.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 94' ' ' LYS . 46.1 t -49.87 -44.49 78.41 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.359 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_exo -55.05 -31.08 73.26 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.284 1.989 . . . . 0.0 111.957 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.7 -17.33 26.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -45.33 -31.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.861 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.2 p -71.13 -42.91 68.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.444 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -52.21 -36.15 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.329 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.472 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m80 -89.95 -36.68 14.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 17.3 t -98.02 115.61 65.74 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.36 -63.78 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.428 2.086 . . . . 0.0 112.475 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.7 34.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.87 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -109.4 160.17 28.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.87 ' HD2' HG22 ' A' ' 108' ' ' THR . 50.0 Cg_exo -53.46 169.55 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.539 2.16 . . . . 0.0 112.392 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -127.39 143.28 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 124.29 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.949 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.32 162.56 14.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.712 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 79' ' ' LEU . 15.1 m -155.6 121.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.196 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.54 168.43 13.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.346 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.529 ' O ' HG21 ' A' ' 84' ' ' VAL . 12.8 t -172.51 -165.4 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.904 ' HG2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 66.73 94.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 157' ' ' CYS . 50.8 mt -98.61 -40.26 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.059 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.85 -27.84 66.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.904 HD12 ' HG2' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -62.22 -58.62 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.55 161.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.4 27.0 5.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -83.86 160.02 59.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.22 -38.37 61.17 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.535 2.157 . . . . 0.0 112.328 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -87.75 -29.76 20.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.0 m -53.17 -61.19 2.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -57.71 -37.66 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -58.42 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -33.87 62.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.562 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.703 HD21 ' N ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.48 -26.21 4.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.39 -24.01 66.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.798 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -94.1 -17.97 22.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -92.56 22.29 4.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.744 0.307 . . . . 0.0 111.093 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 10.7 mmmm 69.29 39.54 1.65 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.852 0.358 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 12.7 pt20 47.38 -163.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.088 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 64.65 84.56 0.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.703 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.5 Cg_endo -69.52 -177.62 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.637 2.225 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 3.9 mm -94.81 105.3 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.6 p -99.04 167.89 10.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 64.7 Cg_exo -51.77 -27.6 27.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.739 2.292 . . . . 0.0 112.179 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -91.15 -28.68 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.2 m -49.15 -48.63 44.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.14 -59.82 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -50.47 -36.05 31.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -51.04 67.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.522 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.529 HD21 ' HE2' ' A' ' 94' ' ' LYS . 16.5 tp -58.08 -34.22 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.491 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.881 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -58.06 -58.0 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -51.79 -41.23 61.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -51.26 -29.88 15.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.1 pp -126.69 21.92 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.75 -86.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 57.36 -178.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 152' ' ' VAL . 38.9 t -70.37 -7.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 77.03 151.02 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.853 0.358 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.949 ' OH ' HD12 ' A' ' 112' ' ' LEU . 8.2 p90 -152.63 148.49 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.08 124.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.289 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.31 172.3 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.747 ' HB3' HD11 ' A' ' 117' ' ' ILE . 2.3 m -131.57 -173.54 3.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -87.76 158.75 18.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 111.038 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.63 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -53.57 -172.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.5 mm? 67.14 -66.76 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.744 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 159' ' ' ALA . 10.0 p -76.13 -79.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.842 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.753 HE21 HD11 ' A' ' 165' ' ' LEU . 1.2 tt0 68.28 116.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -99.07 -67.96 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.71 96.04 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.455 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.753 HD11 HE21 ' A' ' 162' ' ' GLN . 0.2 OUTLIER -92.83 -10.77 35.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -54.88 -40.9 70.22 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.445 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 42.5 m-80 -55.51 -65.95 0.5 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 155' ' ' VAL . 7.4 p -51.41 -39.24 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CD2' ' HG ' ' B' ' 77' ' ' LEU . 0.1 OUTLIER -54.22 -43.27 70.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.492 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' HD13 ' B' ' 75' ' ' ILE . 22.9 t0 -62.56 -45.98 90.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 14.8 mm-40 -59.03 -26.07 64.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.33 -61.28 2.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.3 mp -67.65 -56.92 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.533 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 4.6 tp -50.92 -25.83 5.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.75 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -60.01 -60.91 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.92 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.9 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.4 m 63.73 -75.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 170' ' ' ASP . 6.2 tt -142.8 151.55 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 t -125.61 140.08 53.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -72.63 134.56 81.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.425 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 64.5 Cg_exo -50.56 148.01 16.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.393 2.062 . . . . 0.0 112.169 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 4.3 t -112.29 -34.73 5.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -77.21 164.66 25.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.503 ' CE2' ' CD2' ' A' ' 40' ' ' TYR . 8.0 t80 175.69 118.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.475 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -149.32 133.69 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.055 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' B' ' 86' ' ' HIS . 1.4 t-160 -68.98 86.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.643 ' OG1' HD12 ' B' ' 85' ' ' ILE . 38.9 p -69.39 -74.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.731 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -115.97 111.51 35.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 86' ' ' HIS . . . . . 0.438 ' HB3' ' NE2' ' B' ' 83' ' ' HIS . 5.2 p80 -98.92 96.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.865 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 22.1 t -83.39 132.5 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -132.69 177.91 18.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.487 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -76.82 115.89 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.886 ' OD1' HG23 ' B' ' 92' ' ' VAL . 24.5 t0 -107.41 117.64 34.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -10.37 59.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.886 HG23 ' OD1' ' B' ' 90' ' ' ASP . 58.5 t -45.73 -50.02 3.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.598 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 93' ' ' THR . 14.2 t -154.06 56.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.11 27.31 5.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.405 ' CD ' HG22 ' B' ' 93' ' ' THR . 20.9 pt-20 -118.75 -177.66 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.445 ' HB3' HG12 ' B' ' 87' ' ' VAL . 6.2 m-85 -97.24 164.79 12.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.545 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.0 OUTLIER -95.21 156.8 16.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.754 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.94 52.32 26.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.503 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.636 ' HE1' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -63.52 121.37 69.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 103' ' ' TRP . 79.4 Cg_exo -46.07 162.34 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.175 1.917 . . . . 0.0 111.794 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -42.7 -64.2 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -45.77 64.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.572 ' HB3' HD21 ' A' ' 67' ' ' LEU . 11.6 m0 -52.86 -46.49 67.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.35 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -61.48 -63.18 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.952 0.406 . . . . 0.0 110.666 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.6 mtp180 -51.24 -34.51 32.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.541 HD21 ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -50.05 -58.12 6.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.873 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.616 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.28 -69.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.56 ' O ' HG23 ' B' ' 109' ' ' THR . 5.1 tt0 -79.03 -98.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 108' ' ' GLN . 23.5 p -160.53 -35.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.415 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.5 OUTLIER -166.33 169.04 14.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 111.703 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' B' ' 99' ' ' MET . 0.5 OUTLIER -68.2 67.89 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.646 178.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.528 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.869 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.507 ' OE1' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -78.71 158.26 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.792 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 m -136.3 118.15 15.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.507 HD11 ' OE1' ' A' ' 2' ' ' GLN . 1.3 mp -126.41 149.39 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 12.1 mmtp -135.81 95.42 3.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.568 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.0 m -77.45 154.57 32.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 56' ' ' PHE . 53.0 t -136.43 159.22 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.048 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 57' ' ' ASP . 12.5 p -100.86 159.12 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 8' ' ' VAL . 13.0 p -150.53 129.04 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.74 139.86 4.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.448 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.4 m-20 -69.98 71.72 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -156.73 -148.24 5.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.774 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . -148.91 -35.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.949 HG11 ' HA2' ' A' ' 114' ' ' GLY . 20.3 t -47.7 -23.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 113' ' ' VAL . . . -52.08 -105.22 0.01 OUTLIER Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.586 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.839 ' HG2' HD23 ' A' ' 55' ' ' LEU . 41.5 mttm -95.61 -56.05 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -44.26 -75.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.972 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.748 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 35.4 t -55.74 -39.68 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.538 HD11 ' CG ' ' A' ' 23' ' ' TYR . 5.1 tp -54.16 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.15 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.023 HD21 HD22 ' A' ' 55' ' ' LEU . 74.9 mt -39.89 -38.16 0.65 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -54.05 -69.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.149 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.495 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -91.31 -34.05 15.08 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.538 ' CG ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -72.6 -45.75 57.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.557 ' OG1' HD23 ' A' ' 20' ' ' LEU . 97.5 m -89.81 -85.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 3.3 t -54.56 -28.35 45.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.832 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 77.75 52.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 9.3 pttt -137.71 -166.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.537 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -127.72 170.54 10.06 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.577 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 81.9 Cg_exo -40.33 140.59 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.801 2.334 . . . . 0.0 112.706 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.61 -84.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE1' ' CG ' ' B' ' 86' ' ' HIS . 13.2 pt-20 -96.31 119.43 34.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.19 109.26 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.167 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -159.84 139.0 8.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 36' ' ' VAL . 95.4 Cg_exo -41.73 96.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.43 2.087 . . . . 0.0 111.904 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 17' ' ' THR . 3.1 m -47.1 89.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.273 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 34' ' ' PRO . 58.2 t -95.18 -47.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' B' ' 87' ' ' VAL . 49.2 t80 -162.5 82.19 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.232 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 19.8 m-20 -83.01 124.91 30.86 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' B' ' 85' ' ' ILE . 44.7 t30 -107.89 154.28 21.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.845 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.38 168.91 23.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.225 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.21 115.28 29.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.51 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.4 m -139.8 130.04 30.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.303 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 51' ' ' TYR . 93.5 m -125.79 112.4 15.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.078 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 173' ' ' ILE . 2.6 m -97.66 116.94 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.07 0.462 . . . . 0.0 110.333 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.8 mtm -89.48 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.275 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG23 ' O ' ' B' ' 74' ' ' SER . 1.8 mp -87.03 133.39 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.23 63.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.388 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 -24.35 26.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.648 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.6 151.9 59.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.56 169.71 18.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.651 2.234 . . . . 0.0 112.297 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER -154.06 168.47 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.9 97.12 4.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.5 tt -134.06 158.7 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.661 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -152.62 136.44 5.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.594 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.023 HD22 HD21 ' A' ' 20' ' ' LEU . 8.6 mp -93.42 103.02 15.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.83 0.348 . . . . 0.0 110.814 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.657 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 m-85 -84.62 128.34 34.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.718 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -91.22 174.43 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 111.222 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.655 HG21 ' CE1' ' A' ' 104' ' ' HIS . 3.6 m -162.39 146.45 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -27.62 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.64 -22.49 33.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.4 174.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -103.51 25.39 9.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.79 22.41 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -87.2 -4.95 59.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.345 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.11 -30.41 0.75 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' C ' HD21 ' B' ' 107' ' ' LEU . 1.0 OUTLIER -76.72 -42.25 42.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.381 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.5 OUTLIER -93.53 21.79 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.799 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -83.73 -45.65 0.79 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.298 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 78.4 Cg_exo -46.91 -25.98 4.38 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.372 2.048 . . . . 0.0 112.115 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.966 HD13 ' CD1' ' B' ' 103' ' ' TRP . 2.6 mt -75.03 -28.43 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 3.6 p -86.77 -29.83 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.764 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CG ' ' O ' ' A' ' 71' ' ' SER . 2.4 p90 51.3 161.55 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.946 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 55.7 Cg_endo -70.39 -22.53 29.08 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.125 . . . . 0.0 112.158 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -10.65 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.454 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.653 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.1 t -44.68 -26.74 0.41 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.78 0.324 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 75.43 -154.08 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.593 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.8 p -57.64 156.71 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 1.1 p90 -129.39 161.57 30.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.8 HD22 ' HB2' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -103.97 160.4 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.329 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.667 HG21 HD23 ' A' ' 112' ' ' LEU . 3.7 t -128.55 150.7 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 1.8 m -111.77 142.96 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.383 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB2' HG11 ' A' ' 93' ' ' VAL . 51.1 p90 178.12 112.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.849 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.7 p -57.23 165.77 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 115' ' ' THR . 27.8 m -132.83 29.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.316 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.942 HG13 ' HA ' ' A' ' 120' ' ' ARG . 96.4 t -89.49 -78.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.05 117.83 67.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 52.3 Cg_exo -54.35 -21.93 25.04 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.449 2.099 . . . . 0.0 112.475 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.16 -35.19 16.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.958 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.7 t -80.26 -35.68 35.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.164 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -45.89 -43.7 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.86 -61.43 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.4 m-80 -63.86 -42.06 97.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 89' ' ' SER . 97.9 t -41.38 -48.2 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.903 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 tppt? -83.59 -52.33 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 8.02 5.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.9 tttp -128.26 -39.39 1.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.592 ' CE3' HG13 ' A' ' 93' ' ' VAL . 52.2 m0 -94.92 -28.61 15.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.7 t -65.47 -44.44 66.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.728 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.4 Cg_exo -49.82 -35.11 38.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.153 1.902 . . . . 0.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -11.9 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 98' ' ' VAL . 16.7 tt -45.74 -31.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.746 0.307 . . . . 0.0 111.548 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 p -81.77 -27.44 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -64.41 -37.72 88.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.655 ' CE1' HG21 ' A' ' 58' ' ' THR . 1.5 t60 -80.26 -51.09 9.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 15.9 p -82.93 141.6 43.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.16 -45.83 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.629 2.219 . . . . 0.0 112.214 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 172.61 56.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -136.09 163.78 47.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.469 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 52.1 Cg_exo -52.33 164.22 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.609 2.206 . . . . 0.0 112.326 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 14.1 p90 -132.37 137.23 47.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.8 ' HB2' HD22 ' A' ' 79' ' ' LEU . 4.9 mt -110.23 121.39 45.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -106.41 128.93 54.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.515 HG12 ' OE1' ' A' ' 156' ' ' GLU . 16.3 m -128.05 147.71 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.116 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.949 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -167.21 122.58 1.06 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.275 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 84' ' ' VAL . 78.1 p -157.66 153.53 26.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 111.439 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER 178.16 99.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.67 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.424 ' CG1' ' OG ' ' A' ' 158' ' ' SER . 33.1 mt -99.99 -29.79 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.13 -30.28 34.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -92.16 -46.04 7.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 111.562 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.942 ' HA ' HG13 ' A' ' 85' ' ' VAL . 34.4 ptt180 -45.65 -34.0 3.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 111.164 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.75 55.98 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.704 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -107.87 156.16 38.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.07 -56.25 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 m -64.03 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 129' ' ' LEU . 94.8 m -49.15 -62.25 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.043 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.4 -41.25 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.37 -62.59 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -34.52 76.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.5 OUTLIER -50.82 -26.0 5.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.358 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.6 59.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.867 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -78.76 -23.19 45.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 4.5 m120 -94.08 30.08 1.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 70.53 19.41 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.242 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.87 112.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 83.6 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 129' ' ' LEU . 28.4 Cg_endo -62.71 96.26 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.592 2.195 . . . . 0.0 112.12 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 5.6 mt -47.74 122.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.404 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -104.21 171.02 5.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 51.2 Cg_exo -56.07 -22.45 39.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.725 2.283 . . . . 0.0 112.514 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -91.0 -28.65 17.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.462 ' CG2' HG23 ' A' ' 137' ' ' ILE . 25.3 m -49.49 -59.39 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.054 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.18 -46.9 46.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.14 79.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -54.4 -46.71 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' CD2' HD23 ' A' ' 149' ' ' LEU . 3.0 tt -59.29 -49.24 78.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 149' ' ' LEU . . . -64.86 -29.58 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -73.58 -40.54 63.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.94 -37.69 86.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 146' ' ' ALA . 4.5 pp -82.12 -21.16 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.5 tttt 68.6 126.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 179.59 -159.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.138 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 153' ' ' LYS . 12.1 p -44.36 -45.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 111.443 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.42 142.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.673 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 168' ' ' VAL . 40.3 p90 -153.07 160.74 42.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.372 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 167' ' ' ASN . 2.8 m -158.01 123.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -170.68 153.01 3.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.424 ' CB ' ' HD2' ' A' ' 163' ' ' LYS . 10.2 p -101.86 -173.83 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.968 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 1.6 p -88.44 174.4 8.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -47.94 178.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.907 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 160' ' ' LEU . 3.6 mm? 59.01 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.967 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 159' ' ' ALA . 6.7 p -56.03 176.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.444 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -163.22 103.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.036 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HD2' ' CB ' ' A' ' 157' ' ' CYS . 1.8 mtpp -95.35 -24.69 16.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.49 79.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.532 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 12.9 mt -71.06 -41.68 70.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' B' ' 76' ' ' SER . 0.1 OUTLIER -45.43 -27.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.543 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 155' ' ' VAL . 5.5 m120 -60.64 -72.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.474 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.641 HG21 ' OE1' ' A' ' 156' ' ' GLU . 13.2 p -47.49 -35.13 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.734 0.302 . . . . 0.0 111.087 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.68 ' O ' HD12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -73.23 -38.93 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -54.01 -42.05 68.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.208 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -80.46 -34.49 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.463 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.85 82.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.798 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.4 mt -90.12 -27.24 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.914 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.65 -49.03 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.578 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.16 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.8 -21.92 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -92.1 41.67 1.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.3 p -51.43 -36.26 43.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 23.1 mm -144.1 142.59 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -138.45 134.52 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -74.74 133.67 76.25 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.618 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.794 ' HB2' HG12 ' A' ' 42' ' ' VAL . 49.3 Cg_exo -55.46 -53.06 6.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.447 2.098 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 45.3 m 59.71 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.026 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -56.13 108.67 0.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.689 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.693 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -141.84 -175.84 4.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.346 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -153.28 138.25 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.64 99.28 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.344 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.534 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -69.73 -77.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.485 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.624 HG21 ' CD ' ' B' ' 100' ' ' PRO . 1.2 mp -122.25 128.58 75.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' HIS . . . . . 0.446 ' CG ' ' OE1' ' A' ' 31' ' ' GLU . 3.0 p-80 -105.26 96.14 6.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.945 HG22 ' HA ' ' B' ' 99' ' ' MET . 24.6 t -84.59 149.45 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.674 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.05 178.07 24.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -108.7 129.14 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 41.6 t0 -140.29 130.84 25.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.85 20.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.015 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.939 HG13 HG22 ' B' ' 93' ' ' THR . 13.7 p -45.87 -27.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.352 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.939 HG22 HG13 ' B' ' 92' ' ' VAL . 1.2 t -152.11 -39.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.41 7.64 2.15 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.291 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.466 ' HG3' ' NE2' ' B' ' 108' ' ' GLN . 4.6 pt-20 -118.58 -170.99 2.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.013 0.406 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.9 m-85 -86.8 162.4 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 3.1 p -109.93 153.99 23.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.68 27.59 13.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.375 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.945 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -77.15 141.36 66.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.295 . . . . 0.0 111.452 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.624 ' CD ' HG21 ' B' ' 85' ' ' ILE . 81.5 Cg_exo -39.56 138.46 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.848 2.365 . . . . 0.0 112.693 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.22 -60.38 2.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.161 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.93 -50.29 27.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.966 ' CD1' HD13 ' A' ' 70' ' ' LEU . 1.7 m0 -55.22 -55.21 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.223 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -55.7 -55.01 37.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.321 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 7.9 mtt-85 -49.61 -45.0 47.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.043 0.449 . . . . 0.0 110.649 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.59 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.92 -54.99 16.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.97 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.62 -69.26 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.347 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.6 ' O ' HG23 ' B' ' 109' ' ' THR . 0.2 OUTLIER -78.61 -94.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.383 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.6 HG23 ' O ' ' B' ' 108' ' ' GLN . 17.6 p -160.78 -45.84 0.04 OUTLIER 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER -159.27 166.92 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.94 0.4 . . . . 0.0 111.876 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' B' ' 99' ' ' MET . 27.4 t-20 -63.79 75.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -89.12 140.63 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -107.14 128.81 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.869 HG23 ' OD2' ' A' ' 76' ' ' ASP . 5.3 mm -120.14 118.0 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.663 ' O ' HG21 ' A' ' 75' ' ' THR . 8.2 mmtt -116.67 96.03 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.518 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.45 108.45 10.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 71' ' ' SER . 3.3 t -84.44 158.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.663 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.878 HG11 ' N ' ' A' ' 16' ' ' LYS . 29.7 t -136.51 141.58 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.979 0.418 . . . . 0.0 111.828 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 80' ' ' VAL . 22.0 t -144.69 121.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.76 42.41 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.866 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -89.14 -48.36 7.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -160.23 1.71 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.176 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 18' ' ' CYS . . . -136.57 4.63 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' N ' ' HB3' ' A' ' 81' ' ' CYS . 61.9 t -47.76 -23.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.706 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . -115.55 -61.59 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.753 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.878 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -51.25 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 85.3 m -96.56 -68.98 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.705 ' H ' ' HB1' ' A' ' 13' ' ' ALA . 8.2 m -48.02 -21.0 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 23' ' ' TYR . 3.3 tm? -56.88 -74.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.651 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 HG11 ' A' ' 42' ' ' VAL . 27.7 mt -63.49 -26.6 68.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.618 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.69 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -66.28 -44.34 91.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.865 179.026 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 m -94.81 -11.82 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.862 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.04 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.9 m-30 -95.54 -67.67 0.84 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 112.112 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' HA ' ' B' ' 79' ' ' SER . 46.5 m -83.85 -81.22 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.22 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.793 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -48.84 -35.63 15.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.184 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 55.1 t30 51.31 65.21 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.254 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -147.95 -175.35 4.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.464 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -102.78 157.98 32.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.644 0.259 . . . . 0.0 110.609 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 79.2 Cg_exo -39.55 145.82 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.732 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -99.57 -82.27 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HG3' ' ND1' ' B' ' 86' ' ' HIS . 8.0 pt-20 -102.06 118.29 36.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.4 t80 -70.05 110.49 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.0 t -158.96 138.34 8.35 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 85.1 Cg_exo -44.85 91.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.307 2.005 . . . . 0.0 111.684 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.926 HG23 ' HB2' ' A' ' 38' ' ' ASP . 88.2 m -51.92 87.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.505 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' B' ' 96' ' ' PHE . 45.8 t -82.32 -28.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 1.8 t80 -141.87 -64.37 0.43 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.926 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.3 t0 52.75 104.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.17 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 25.0 t30 -107.21 156.59 18.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -151.04 169.01 22.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.746 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -114.03 141.96 46.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -160.82 126.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.5 m -109.44 110.95 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.787 HG22 ' HD3' ' B' ' 78' ' ' PRO . 24.5 t -98.6 119.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 39.6 mtm -84.96 99.79 11.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 51' ' ' TYR . 4.8 mt -103.17 89.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.703 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.74 17.01 55.62 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.212 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.94 35.07 8.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.9 mm-40 -136.22 137.84 25.69 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.81 157.7 60.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.545 2.163 . . . . 0.0 112.336 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.757 ' H ' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -147.05 167.1 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.176 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 52' ' ' THR . 4.9 t -129.2 97.24 4.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.375 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.603 ' HB3' HG23 ' A' ' 42' ' ' VAL . 28.6 tp -112.87 155.98 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.333 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -158.34 121.65 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.312 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' HG ' ' A' ' 20' ' ' LEU . 3.7 mm? -75.94 105.63 7.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.881 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 7.4 m-85 -84.11 103.23 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -72.35 120.9 18.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.702 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.416 ' HB ' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -136.66 170.39 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . . . -124.1 -40.51 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.73 47.94 88.47 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.501 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -40.13 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 165.78 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.546 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 64' ' ' TYR . 52.6 p30 -86.99 -22.59 25.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.771 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 28.3 m-85 -67.02 -21.37 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.168 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.6 m-20 -48.02 -26.05 1.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.244 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 3.6 ptp180 -93.98 -27.87 16.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.034 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -103.21 18.1 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -93.05 -30.21 0.3 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -55.62 -20.81 28.82 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.53 1.487 . . . . 0.0 111.899 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.8 OUTLIER -72.81 -25.98 61.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 18.8 m -101.58 -21.46 14.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.665 ' O ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER 55.31 104.87 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.51 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 34.1 Cg_endo -64.69 -23.66 63.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -88.0 -9.92 51.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.345 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 72' ' ' TYR . 7.7 t -37.53 -53.69 1.17 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.869 ' OD2' HG23 ' A' ' 4' ' ' ILE . 3.3 m-20 -169.92 -88.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.735 HG21 ' CD1' ' A' ' 111' ' ' LEU . 9.9 p -128.21 163.72 31.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.683 0.278 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 77' ' ' VAL . 5.6 m-85 -111.85 138.52 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.823 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.03 143.17 33.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.522 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.9 t -132.3 153.05 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.797 0.332 . . . . 0.0 111.268 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -144.4 132.57 21.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.427 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.468 ' CB ' HG11 ' A' ' 93' ' ' VAL . 33.3 p90 -152.28 164.89 36.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.6 t -62.83 180.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.805 HG21 ' HA ' ' A' ' 115' ' ' THR . 4.9 m -156.35 43.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.288 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CB ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -154.13 -86.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.448 ' H ' HG23 ' A' ' 85' ' ' VAL . 1.5 m -52.64 110.13 1.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 22.4 Cg_endo -61.49 -15.95 44.5 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.024 . . . . 0.0 112.476 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.7 p -64.8 -23.65 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.5 p -95.95 -42.94 8.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -39.69 21.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 1.1 mm-40 -58.63 -55.56 33.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.8 m-20 -64.9 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 89' ' ' SER . 63.4 t -48.3 -67.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.719 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.69 -37.43 76.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.419 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 91' ' ' GLU . 28.7 mm-40 -74.05 -2.53 24.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -127.98 -35.02 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 60.4 m95 -88.7 -36.73 16.02 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 101' ' ' ILE . 58.6 t -57.8 -46.3 99.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 85.9 Cg_endo -79.49 -21.5 8.73 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.558 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.58 -36.57 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.7 tt -50.62 -28.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.813 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -73.61 -38.46 65.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.573 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -56.63 -44.04 80.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.87 -32.32 17.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.429 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 3.3 m -111.7 87.94 8.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.604 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 -78.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.46 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -126.78 48.1 2.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -126.85 139.51 35.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.748 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.7 Cg_exo -49.61 165.26 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.7 p90 -148.29 151.23 35.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.061 0.458 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.051 HD23 ' CD1' ' A' ' 154' ' ' TYR . 1.1 mp -125.6 119.73 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 149' ' ' LEU . 1.4 pt? -135.14 119.58 17.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.645 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.873 HG12 ' CZ ' ' A' ' 154' ' ' TYR . 10.1 p -156.57 111.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.885 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.68 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -86.47 169.12 40.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.668 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.805 ' HA ' HG21 ' A' ' 84' ' ' VAL . 13.9 t -174.82 137.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.863 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.45 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -166.72 84.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.741 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 157' ' ' CYS . 4.3 mt -77.39 -32.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -87.0 -23.68 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.45 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -95.86 -0.79 50.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.682 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.708 ' CB ' HG11 ' A' ' 85' ' ' VAL . 1.3 ptt85 -94.56 26.02 3.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.919 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.6 41.19 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.981 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.54 127.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.07 -44.18 49.37 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -57.45 -27.91 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 129' ' ' LEU . 2.4 m -57.86 -68.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.52 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -49.42 -37.43 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.69 -66.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -70.42 -34.16 72.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.876 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 125' ' ' THR . 3.4 mt -50.15 -26.17 4.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.03 61.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.921 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -18.65 36.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.214 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -93.83 30.1 1.91 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.179 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt 73.77 29.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 58.93 -161.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.48 90.14 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.32 118.57 5.76 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.587 2.191 . . . . 0.0 112.312 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.478 HG23 ' CG2' ' A' ' 141' ' ' THR . 7.2 mt -49.85 123.78 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -118.91 176.44 1.7 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.0 Cg_exo -54.17 -22.01 24.24 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.201 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -84.42 -36.27 22.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.478 ' CG2' HG23 ' A' ' 137' ' ' ILE . 19.7 m -51.51 -61.81 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.68 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -48.63 -45.72 38.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 155' ' ' VAL . 2.4 tm-20 -57.39 -40.48 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.562 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -58.9 -34.34 71.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.536 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.647 HD11 ' HD2' ' A' ' 94' ' ' LYS . 1.2 tt -71.84 -32.23 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.738 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.65 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -83.96 -35.22 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 43.0 m-20 -54.5 -61.51 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 112' ' ' LEU . 3.4 pp -58.89 -18.1 30.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.304 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.91 80.84 0.07 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.939 0.4 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -134.39 -173.72 3.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 88.9 t -47.54 -29.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 58.33 124.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.243 0.544 . . . . 0.0 111.686 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 1.051 ' CD1' HD23 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -153.79 126.09 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 143' ' ' GLU . 19.8 m -97.23 131.88 43.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.766 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.743 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.5 pm0 -162.73 138.68 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.794 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.641 ' HB3' HD11 ' A' ' 117' ' ' ILE . 6.7 m -102.3 -174.59 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 p -88.47 165.29 15.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.012 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -59.53 -159.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER 49.57 25.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -173.28 -72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.568 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.4 OUTLIER 69.63 115.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.771 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -103.49 -68.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.09 96.08 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.04 HD13 ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -93.61 -10.65 33.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.527 0.203 . . . . 0.0 111.371 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -34.29 54.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 110.065 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -66.44 -33.09 74.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 156' ' ' GLU . 66.7 t -64.81 -63.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CZ ' ' CG ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -51.35 -32.29 25.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.524 ' HA ' HD13 ' B' ' 75' ' ' ILE . 61.9 t0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.9 -52.39 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.12 -28.31 4.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.586 HD11 HD22 ' A' ' 53' ' ' LEU . 16.4 mm -94.78 -38.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.757 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 174' ' ' LEU . 3.6 tt -54.96 -34.24 63.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -74.59 -25.43 59.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mp -94.5 46.51 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.887 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.6 m -64.44 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.329 . . . . 0.0 110.802 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 170' ' ' ASP . 5.9 tt -104.01 148.83 8.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -138.2 138.72 38.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.56 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -60.18 126.81 84.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.622 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.787 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.0 Cg_endo -51.9 171.26 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.9 t -136.65 -67.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -51.49 95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.473 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.4 t80 -114.3 141.22 47.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.43 131.86 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 91.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.192 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.499 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -62.3 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.65 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.56 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -127.02 120.17 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 86' ' ' HIS . . . . . 0.453 ' ND1' ' HG3' ' A' ' 31' ' ' GLU . 3.5 t-160 -103.98 96.56 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.484 HG22 ' HD3' ' B' ' 100' ' ' PRO . 44.6 t -79.86 155.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.04 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.46 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.48 178.26 24.27 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.236 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -85.97 112.76 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.667 ' CB ' HG23 ' B' ' 97' ' ' THR . 10.8 t0 -103.76 98.24 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -0.08 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.029 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.772 HG13 HG22 ' B' ' 93' ' ' THR . 12.3 p -57.47 -47.89 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.772 HG22 HG13 ' B' ' 92' ' ' VAL . 0.8 OUTLIER -120.99 -21.81 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.433 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.25 12.73 6.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.554 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.546 ' HG2' HG23 ' B' ' 93' ' ' THR . 16.7 pt-20 -121.83 -175.94 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.8 0.333 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 1.034 ' CE2' HD13 ' A' ' 67' ' ' LEU . 4.1 m-85 -82.05 164.6 21.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.667 HG23 ' CB ' ' B' ' 90' ' ' ASP . 0.3 OUTLIER -95.14 150.87 19.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.66 28.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.705 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -57.77 125.6 73.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.549 0.214 . . . . 0.0 110.974 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.484 ' HD3' HG22 ' B' ' 87' ' ' VAL . 69.6 Cg_exo -49.85 152.95 6.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.04 1.826 . . . . 0.0 111.595 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 8.4 pt-20 -43.32 -48.46 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 111.517 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -78.95 -52.95 7.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.866 ' CG ' HD13 ' A' ' 70' ' ' LEU . 4.9 m0 -50.12 -51.06 46.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.419 0.628 . . . . 0.0 110.052 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.705 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.93 -55.57 28.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.78 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 76.0 mtt180 -53.76 -44.44 70.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -48.85 -57.5 6.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -95.23 -68.86 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.295 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.75 ' O ' HG23 ' B' ' 109' ' ' THR . 5.0 tp-100 -77.71 -101.6 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.353 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.75 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.1 p -168.16 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.684 0.278 . . . . 0.0 111.447 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.51 174.2 11.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.129 0.49 . . . . 0.0 111.836 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.403 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 1.0 OUTLIER -68.56 84.98 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 112' ' ' ILE . 3.6 tp . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.096 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.24 126.8 54.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.752 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 m -94.1 150.9 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.967 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 3' ' ' THR . 3.0 pt -155.87 147.07 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.83 115.38 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' HB3' HD23 ' A' ' 55' ' ' LEU . 54.0 t -78.09 154.36 31.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 56' ' ' PHE . 6.6 t -145.31 144.95 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.421 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 57' ' ' ASP . 7.2 p -118.78 136.02 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 9' ' ' VAL . 13.5 p -127.08 122.88 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.95 168.81 12.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.86 129.89 55.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.89 -27.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . 84.76 -41.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.702 HG11 ' HA2' ' A' ' 114' ' ' GLY . 16.0 t -48.42 -23.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.67 0.271 . . . . 0.0 111.667 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -56.71 -114.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.11 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.61 ' CG ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -96.15 -65.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -34.2 -73.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.788 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -52.67 -36.56 57.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.39 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -49.7 -70.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.549 HD13 ' OG1' ' A' ' 24' ' ' THR . 1.3 mm? -40.61 -37.21 0.69 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 25' ' ' THR . 6.6 mm -52.37 -69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.533 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 5.7 t -88.33 -50.71 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.471 0.653 . . . . 0.0 110.448 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CD2' ' CD1' ' A' ' 165' ' ' LEU . 21.9 t80 -46.13 -49.86 16.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.548 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 42' ' ' VAL . 52.3 m -96.71 -89.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.871 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -55.28 -26.16 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.2 t-20 70.59 58.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.871 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.1 pttt -134.84 -161.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.44 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -132.57 148.83 71.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.286 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 75.4 Cg_exo -39.34 133.72 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.758 2.306 . . . . 0.0 112.72 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -84.88 0.51 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.64 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.316 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.49 97.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.158 0.504 . . . . 0.0 111.041 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.5 p -154.33 137.34 10.22 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.815 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.6 Cg_exo -36.55 89.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.876 2.384 . . . . 0.0 112.645 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.863 HG23 ' CG ' ' A' ' 38' ' ' ASP . 58.4 m -53.54 89.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.013 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.818 HG11 ' CG ' ' B' ' 96' ' ' PHE . 3.3 t -79.14 -25.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 5.1 t80 -149.14 -70.85 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.863 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.7 m-20 63.28 130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.47 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 6.6 t-20 -108.01 157.77 17.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.104 0.478 . . . . 0.0 111.359 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 m-85 -152.78 160.31 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.078 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' B' ' 81' ' ' PHE . . . -121.22 126.67 50.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.49 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.725 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.5 m -148.94 140.05 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.101 0.477 . . . . 0.0 111.895 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.2 m -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.894 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.862 HG13 ' O ' ' B' ' 76' ' ' SER . 40.4 t -98.21 123.13 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.212 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtm -90.7 100.08 12.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.17 105.27 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.93 15.11 76.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 38.41 4.82 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.775 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.3 mm-40 -141.69 124.2 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.496 0.189 . . . . 0.0 110.817 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.96 161.54 15.44 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.624 2.216 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.617 ' H ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -146.23 165.15 30.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.6 112.56 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 54' ' ' GLY . 4.6 tt -119.86 138.46 53.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -126.33 102.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.214 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -83.98 149.69 26.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.411 . . . . 0.0 111.4 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.3 m-85 -138.93 116.79 11.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.679 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.577 ' HA ' HG12 ' A' ' 8' ' ' VAL . 4.2 t70 -69.91 152.75 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 64' ' ' TYR . 1.6 m -157.54 128.85 6.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.33 33.84 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.409 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 48.18 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.27 -169.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.894 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.88 -25.77 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.15 -23.4 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.755 ' CE2' HD23 ' A' ' 67' ' ' LEU . 4.3 m-85 -64.47 -12.6 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -40.3 -44.97 2.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.788 0.328 . . . . 0.0 111.586 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HG3' HD22 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -73.41 -35.56 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.498 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.085 HD21 ' CZ3' ' B' ' 103' ' ' TRP . 11.1 tp -90.38 10.53 24.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.117 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 1.6 tmt_? -82.93 -63.82 0.26 Allowed Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 68' ' ' ARG . 4.2 Cg_endo -46.59 -26.73 4.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.412 2.075 . . . . 0.0 111.756 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.908 HD22 HD12 ' A' ' 67' ' ' LEU . 8.5 mp -54.28 -39.51 66.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.581 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.491 ' HB2' HG21 ' A' ' 7' ' ' VAL . 88.3 p -92.49 -15.28 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 61.26 139.93 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.696 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 97.0 Cg_endo -80.66 -45.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -10.27 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.549 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 76' ' ' ASP . 10.3 t -40.4 -48.45 2.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 171.51 -167.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.784 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.9 p -58.26 162.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.517 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' N ' HG22 ' A' ' 77' ' ' VAL . 16.4 m-85 -112.01 143.2 43.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -103.5 145.88 29.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.101 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 112' ' ' LEU . 3.9 t -131.65 151.35 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.944 0.402 . . . . 0.0 111.482 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -121.28 103.55 9.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.697 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.972 ' CB ' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -128.87 123.01 31.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.443 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.885 ' O ' HD12 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -130.73 -74.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.268 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.53 HG12 ' CG2' ' A' ' 125' ' ' THR . 22.6 t -50.5 -70.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.02 100.86 0.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.954 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.6 -21.74 65.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.642 2.228 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -48.15 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 p -77.84 -37.45 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 84' ' ' VAL . 2.3 t80 -50.97 -66.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -41.52 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -60.99 -65.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 82' ' ' PHE . 93.0 t -40.68 -41.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.906 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -60.78 -69.69 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.48 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -80.9 8.34 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.59 -43.03 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.604 ' HD1' HG13 ' A' ' 93' ' ' VAL . 17.5 m95 -95.41 -37.1 11.09 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.2 t -50.02 -58.3 9.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 21.1 Cg_endo -60.67 -22.04 71.49 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.171 1.914 . . . . 0.0 112.031 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -32.05 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG21 ' CG ' ' A' ' 110' ' ' PHE . 22.1 mt -49.84 -26.51 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 p -74.55 -36.87 63.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -63.74 -38.42 91.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.776 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 6.5 m-70 -95.76 -24.38 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 2.9 m -121.53 97.77 46.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.749 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 87.4 Cg_exo -46.49 -61.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.585 2.19 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.24 32.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 161.31 26.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.87 129.35 24.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.53 2.153 . . . . 0.0 112.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' HG21 ' A' ' 101' ' ' ILE . 12.8 p90 -118.1 124.74 48.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.609 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -96.85 119.5 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.447 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.603 HD12 ' HB ' ' A' ' 80' ' ' VAL . 38.6 tp -97.94 102.05 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 15' ' ' GLY . 26.8 m -106.77 139.1 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 111.271 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.702 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -165.31 144.08 8.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.837 HG21 ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER 173.17 151.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.58 ' H ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -167.76 94.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.81 -27.4 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.724 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.774 ' CB ' HD13 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -96.36 -48.07 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 111.45 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.63 HD13 ' C ' ' A' ' 119' ' ' LEU . 2.4 tm? -66.28 -59.33 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.084 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' N ' HD13 ' A' ' 119' ' ' LEU . 33.5 mmt180 -66.97 -174.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 5.7 m-20 81.9 39.49 0.05 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.706 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -96.58 169.68 8.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.716 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.71 -19.41 24.25 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.5 t -84.38 -46.69 11.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.53 ' CG2' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -48.83 -60.84 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.031 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.83 -40.62 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.15 -46.03 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -83.76 -35.98 23.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 135' ' ' LYS . 1.6 tp -49.95 -26.51 4.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.51 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.52 65.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -78.41 -47.39 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.52 -26.33 68.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.99 52.37 9.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 1.4 tt0 -128.55 -86.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.75 ' C ' HD21 ' A' ' 129' ' ' LEU . 2.5 mtmt 166.72 161.34 0.11 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.686 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.687 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 Cg_exo -52.33 100.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.468 2.112 . . . . 0.0 112.159 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 84' ' ' VAL . 5.8 mt -48.67 119.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.458 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -111.08 177.08 1.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -55.13 -20.52 24.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.434 2.089 . . . . 0.0 112.219 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -80.06 -45.4 18.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.462 ' HB ' HG23 ' A' ' 137' ' ' ILE . 97.8 m -53.38 -45.54 69.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.93 -42.68 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.61 -37.22 86.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.724 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -53.98 47.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.96 -42.38 84.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.814 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.43 -41.96 66.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.092 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -45.43 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.99 -42.48 99.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -80.09 -26.48 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.718 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.8 OUTLIER 67.04 118.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.984 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.03 -161.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 152' ' ' VAL . 15.7 t -70.62 -7.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.19 140.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 110.791 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.814 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 p90 -152.71 148.29 27.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 111.454 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 154' ' ' TYR . 2.8 m -158.47 124.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.832 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.837 ' O ' HG21 ' A' ' 115' ' ' THR . 2.0 pt-20 -171.87 149.62 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 2.6 p -108.27 -174.58 2.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -86.16 159.6 19.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.21 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.474 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 68.78 -62.67 0.38 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.126 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -85.47 -68.83 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.277 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.87 118.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.711 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -105.53 -68.27 0.88 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.075 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.08 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.661 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -86.44 -10.19 54.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.643 0.259 . . . . 0.0 111.196 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.822 ' HD3' HD12 ' B' ' 77' ' ' LEU . 0.1 OUTLIER -47.87 -45.63 30.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.735 0.302 . . . . 0.0 111.162 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -58.8 -62.88 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.4 p -47.75 -26.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.19 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.552 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -76.61 -50.43 13.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.372 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 174' ' ' LEU . 5.3 t0 -49.96 -29.28 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.15 -39.76 22.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.048 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.72 -22.31 43.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 38.5 mm -91.96 -30.17 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.175 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 170' ' ' ASP . 1.7 tt -80.74 -26.09 37.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.69 65.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.413 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -87.89 -27.2 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.63 -30.66 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -50.73 63.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 44' ' ' VAL . 7.3 tt -143.96 151.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.862 ' O ' HG13 ' A' ' 44' ' ' VAL . 16.1 t -135.09 137.62 43.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.822 HD12 ' HD3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -67.48 141.5 95.59 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.806 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.761 ' HD2' HD23 ' B' ' 77' ' ' LEU . 53.7 Cg_exo -51.64 166.41 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.177 . . . . 0.0 112.28 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 81' ' ' PHE . 0.4 OUTLIER -139.56 -66.57 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.68 86.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 9.1 t80 -108.61 134.26 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.66 111.98 3.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.486 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 83' ' ' HIS . 27.2 p-80 -68.37 109.4 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.059 0.457 . . . . 0.0 109.943 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.563 ' OG1' HD12 ' B' ' 85' ' ' ILE . 1.5 p -77.17 -62.57 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.786 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.563 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.7 OUTLIER -121.9 143.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.764 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.65 96.57 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.464 HG13 ' O ' ' B' ' 97' ' ' THR . 25.1 t -78.21 149.08 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.24 177.63 24.47 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.352 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.22 129.62 47.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.408 ' CB ' HG23 ' B' ' 97' ' ' THR . 68.3 t0 -137.89 132.19 32.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 1.37 19.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.142 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -45.44 -27.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 120.912 0.387 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.422 HG23 ' N ' ' B' ' 94' ' ' GLY . 13.2 t -153.41 -42.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' GLY . . . . . 0.422 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.58 34.26 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.418 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.424 ' OE2' HD11 ' B' ' 112' ' ' ILE . 0.2 OUTLIER -147.28 175.44 10.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.935 ' CE2' HD22 ' A' ' 67' ' ' LEU . 2.2 m-85 -71.98 160.48 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.561 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.464 ' O ' HG13 ' B' ' 87' ' ' VAL . 16.9 p -104.76 156.27 18.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.166 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.53 39.57 74.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.704 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -51.14 123.34 19.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.537 0.208 . . . . 0.0 110.675 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.472 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 84.7 Cg_exo -46.75 154.54 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.275 1.983 . . . . 0.0 112.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -45.57 -48.27 14.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.282 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.39 -55.7 5.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 1.085 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.2 m0 -48.54 -53.36 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.704 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -57.68 -61.93 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.239 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 43.4 mtt85 -48.04 -45.23 31.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -48.33 -57.88 5.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.687 HD12 ' O ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -94.81 -67.73 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.107 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.725 ' O ' HG23 ' B' ' 109' ' ' THR . 5.0 tp-100 -77.39 -99.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.725 HG23 ' O ' ' B' ' 108' ' ' GLN . 2.9 p -166.58 -40.22 0.02 OUTLIER 'General case' 0 C--N 1.338 0.084 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.66 176.51 11.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.993 0.425 . . . . 0.0 111.473 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.73 72.73 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.81 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 111.178 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 68.68 129.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.09 149.63 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.419 HD13 ' HB1' ' A' ' 176' ' ' ALA . 21.5 mt -140.48 153.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -129.56 96.22 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 37.4 t -81.36 107.96 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 8' ' ' VAL . 58.2 t -84.27 154.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 15' ' ' GLY . 2.4 t -140.5 139.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 104' ' ' HIS . 3.0 m -133.02 156.12 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.068 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . 147.63 178.54 22.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.647 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -25.46 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.71 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -84.01 -24.13 49.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.355 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 70.02 7.58 6.29 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.673 ' HB ' HG23 ' A' ' 113' ' ' VAL . 16.1 t -49.04 -24.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 111.251 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.869 ' C ' HG11 ' A' ' 8' ' ' VAL . . . -107.77 -43.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.541 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.652 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -67.35 -74.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.776 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.533 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -97.68 -52.94 3.58 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -55.29 -25.59 35.09 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.6 tm? -56.47 -73.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.423 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.732 ' HG ' HD22 ' A' ' 55' ' ' LEU . 18.7 mt -63.24 -25.36 68.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 110.553 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 27' ' ' LYS . 1.1 mp -62.9 -47.29 93.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.858 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 82.8 p -94.13 -17.32 22.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.558 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.7 m-30 -88.22 -66.8 0.88 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.002 0.429 . . . . 0.0 112.047 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -89.04 -83.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.182 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -42.77 -44.32 4.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.433 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 16.6 t-20 64.42 41.65 5.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -131.99 141.42 49.27 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.475 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -63.63 164.33 16.47 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 70.9 Cg_exo -38.21 150.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.952 2.434 . . . . 0.0 113.078 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 t -108.96 -83.1 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.24 114.59 26.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.637 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.33 107.88 5.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 34' ' ' PRO . 6.5 p -160.63 139.44 7.65 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.29 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 Cg_exo -39.45 93.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.568 2.179 . . . . 0.0 111.874 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 m -48.09 87.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.781 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 34' ' ' PRO . 92.2 t -89.77 -35.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 60.8 t80 -170.86 119.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.777 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 3.2 m-20 -119.44 138.27 53.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' HD12 ' B' ' 85' ' ' ILE . 8.7 t-20 -106.65 157.6 17.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.173 0.511 . . . . 0.0 111.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CG ' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -152.89 161.9 41.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 80' ' ' ASP . . . -117.64 117.75 30.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.48 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' CB ' ' B' ' 78' ' ' PRO . 23.8 m -136.6 167.75 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.393 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 41.8 m -156.39 85.98 1.0 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.874 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.578 HG21 HG12 ' A' ' 173' ' ' ILE . 28.1 m -98.6 176.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.435 ' C ' HD13 ' A' ' 46' ' ' ILE . 5.7 mtm -140.46 157.34 45.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.183 0.516 . . . . 0.0 111.565 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.947 HD11 ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -129.82 88.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.139 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.4 74.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.483 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.93 -34.37 3.29 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.025 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.88 133.28 76.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.662 0.231 . . . . 0.0 111.202 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 174.57 4.87 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.594 2.196 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.947 ' CD1' HD11 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -153.5 155.06 35.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.6 97.06 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 53' ' ' LEU . 2.4 pp -134.17 161.03 36.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.66 138.06 8.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.732 HD22 ' HG ' ' A' ' 20' ' ' LEU . 3.8 mp -75.7 107.18 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.09 102.99 12.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -73.4 144.11 46.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.302 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.805 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.51 179.42 9.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.596 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -138.32 163.36 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 43.7 1.62 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? -70.72 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.622 0.249 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 174.48 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.791 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.66 42.82 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.805 ' CE2' HG22 ' A' ' 58' ' ' THR . 4.4 m-85 -106.42 -24.62 12.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.673 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -45.76 -34.39 3.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.048 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.491 ' O ' HD21 ' B' ' 107' ' ' LEU . 4.3 mtt85 -51.94 -36.05 47.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.988 0.423 . . . . 0.0 110.483 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 70' ' ' LEU . 2.5 mt -96.01 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.386 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.3 mtt180 -56.76 -71.15 0.28 Allowed Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.563 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 33.9 Cg_endo -64.18 -29.42 64.74 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.059 1.839 . . . . 0.0 110.649 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 67' ' ' LEU . 9.8 mp -52.43 -24.79 8.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -155.72 33.18 0.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.455 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -35.23 151.03 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.985 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 2.8 Cg_exo -75.67 -32.01 4.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.895 2.397 . . . . 0.0 112.606 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -57.6 -17.84 16.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.701 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 76' ' ' ASP . 6.3 t -46.74 -52.89 12.95 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.592 0.234 . . . . 0.0 111.396 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 75' ' ' THR . 1.0 OUTLIER 176.99 -159.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.062 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.3 p -57.98 163.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 6.0 m-85 -115.62 132.69 56.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 0.0 110.863 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.3 tp -103.66 143.54 32.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.115 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.823 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.6 t -133.75 150.66 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -125.06 153.38 42.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.529 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 p90 -162.24 158.72 24.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.93 164.26 25.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 137' ' ' ILE . 60.6 t -147.08 55.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 120' ' ' ARG . 68.9 t -151.9 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 125' ' ' THR . 5.8 m -66.77 150.16 97.83 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 0.0 110.73 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 72.1 Cg_endo -77.39 -36.63 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.588 2.192 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 p -53.13 -38.9 63.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 -24.92 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.576 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.2 t80 -69.91 -61.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -26.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.2 m-20 -75.58 -60.96 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 90' ' ' PHE . 12.7 m -47.55 -27.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.669 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HE3' HD11 ' A' ' 145' ' ' LEU . 23.3 tttt -78.47 -61.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -82.44 8.37 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.995 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 6.7 ttpt -114.37 -37.82 4.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.635 0.255 . . . . 0.0 111.34 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.537 ' HE1' HG12 ' A' ' 93' ' ' VAL . 19.0 m95 -95.3 -42.12 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.604 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.887 ' O ' HG22 ' A' ' 101' ' ' ILE . 63.2 t -53.57 -43.63 96.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.8 Cg_exo -73.88 -31.4 8.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 112.499 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.11 -33.07 24.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 98' ' ' VAL . 12.9 tt -48.61 -29.31 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -66.62 -42.69 86.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.652 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -63.18 -33.0 74.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.413 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 12.4 m80 -79.76 -31.33 40.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.449 ' HB2' ' CG2' ' A' ' 108' ' ' THR . 18.6 p -130.68 122.39 19.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 48.0 Cg_exo -55.63 -64.92 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.489 2.126 . . . . 0.0 112.351 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -156.7 31.46 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 105' ' ' CYS . 1.8 t -97.25 150.03 36.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.05 144.65 27.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.802 2.335 . . . . 0.0 112.14 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 101' ' ' ILE . 4.5 p90 -121.92 157.33 31.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.1 mt -127.66 145.25 50.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.55 HD23 ' HB ' ' A' ' 80' ' ' VAL . 5.7 mt -120.34 159.4 25.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.512 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.8 m -156.11 106.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.909 0.385 . . . . 0.0 111.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.673 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -123.5 128.15 6.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.39 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 158' ' ' SER . 48.3 p -153.79 142.91 21.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 111.192 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.745 ' HG2' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -178.84 36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.868 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.464 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 5.4 pt -56.24 -21.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.266 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.735 ' CB ' HD13 ' A' ' 160' ' ' LEU . 9.9 t0 -96.09 -26.04 15.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.745 HD13 ' HG2' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -65.72 -56.53 11.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.597 ' HB2' HG22 ' A' ' 85' ' ' VAL . 7.0 tmm_? -46.68 100.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.84 -44.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -54.86 132.12 66.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 47.5 Cg_exo -56.07 -36.57 96.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.422 2.082 . . . . 0.0 112.231 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.9 m -49.24 -45.04 44.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.987 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.841 HG22 ' OG ' ' A' ' 86' ' ' SER . 68.3 p -53.77 -59.86 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 3.4 mp -60.16 -40.61 84.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.58 -61.67 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 2.0 ttpp -73.05 -36.01 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 136' ' ' PRO . 10.5 mt -50.29 -25.92 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.88 -20.75 57.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -91.22 -37.08 13.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.0 -27.66 66.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -78.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 179.14 -46.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 150.15 65.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.636 ' HA ' HD13 ' A' ' 129' ' ' LEU . 50.7 Cg_exo -53.58 174.38 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.615 2.21 . . . . 0.0 112.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.746 HG22 HG13 ' A' ' 84' ' ' VAL . 5.9 mt -92.5 122.62 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.2 p -110.81 167.71 8.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 81.9 Cg_exo -47.84 -25.44 6.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -46.72 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.511 ' HB ' HG23 ' A' ' 137' ' ' ILE . 7.2 m -52.16 -51.35 58.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -49.89 -41.02 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.022 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.7 -35.29 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.73 94.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.615 HD11 ' HE3' ' A' ' 94' ' ' LYS . 12.8 tp -65.12 -45.52 84.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -25.59 66.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.37 -64.04 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 150' ' ' LYS . 3.9 pp -51.32 -25.19 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.778 ' N ' HD12 ' A' ' 149' ' ' LEU . 11.0 mttp 65.59 108.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -145.64 -161.01 1.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 92.8 t -60.93 -20.11 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.316 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 78.25 137.99 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.166 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 50.0 p90 -153.2 166.27 33.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.25 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 155' ' ' VAL . 28.2 m -158.36 124.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.818 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.77 152.52 3.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.8 p -111.18 -173.64 2.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.464 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 11.1 t -87.79 156.49 19.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.524 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -56.73 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.207 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 53.36 25.09 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.95 -65.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 1.016 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.3 OUTLIER 64.74 122.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.35 -67.96 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 100.17 0.16 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.396 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.016 HD11 ' NE2' ' A' ' 162' ' ' GLN . 4.8 mt -93.68 -10.68 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.542 0.211 . . . . 0.0 111.539 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.44 -28.05 1.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.383 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -78.4 -60.9 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.045 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.7 p -50.01 -41.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.463 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -69.49 -40.84 76.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -50.27 -53.03 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.07 -51.54 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.05 -30.69 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.237 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.578 HG12 HG21 ' A' ' 44' ' ' VAL . 5.9 mt -91.76 -24.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.9 tp -80.33 -52.58 7.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -31.29 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.306 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -66.54 -23.26 66.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.271 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 46' ' ' ILE . 2.2 mp -90.34 48.28 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -117.6 -53.91 2.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' MET . 18.8 mm -104.02 144.23 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.69 153.08 48.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.202 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -90.91 135.79 28.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.639 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' B' ' 77' ' ' LEU . 52.5 Cg_exo -54.21 -172.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.562 2.174 . . . . 0.0 112.205 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 60.4 p -162.56 -53.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.548 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ASP . . . . . 0.667 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.2 m-20 -67.5 62.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.403 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.0 t80 -81.32 131.02 35.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -153.59 120.06 5.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.18 102.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.507 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.6 OUTLIER -77.53 -60.77 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.592 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.507 HD12 ' OG1' ' B' ' 84' ' ' THR . 1.0 OUTLIER -120.69 134.61 63.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.934 0.397 . . . . 0.0 111.971 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -120.88 96.5 5.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.623 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.547 HG22 ' HD3' ' B' ' 100' ' ' PRO . 47.1 t -79.95 148.05 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.752 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.77 177.76 23.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.288 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -95.94 131.93 41.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.718 ' CG ' HG23 ' B' ' 97' ' ' THR . 3.1 p-10 -140.41 120.18 13.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.32 -0.66 26.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.613 HG13 HG22 ' B' ' 93' ' ' THR . 13.9 p -47.72 -26.51 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.282 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.613 HG22 HG13 ' B' ' 92' ' ' VAL . 3.9 t -149.05 -41.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.082 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.97 25.98 0.87 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.672 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.76 -162.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.74 0.305 . . . . 0.0 110.546 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.2 m-85 -100.25 164.2 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.718 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -100.22 167.12 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.11 33.61 22.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.432 ' O ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -47.21 109.04 0.98 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.501 0.191 . . . . 0.0 110.709 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.547 ' HD3' HG22 ' B' ' 87' ' ' VAL . 97.0 Cg_exo -40.19 153.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.7 2.266 . . . . 0.0 112.811 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -45.34 -57.9 3.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.194 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.49 -54.19 36.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.536 ' CE3' ' CD1' ' A' ' 67' ' ' LEU . 4.7 m0 -49.21 -63.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 0.0 110.788 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.49 -70.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.765 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 3.9 mtp180 -44.62 -37.07 3.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -50.37 -56.18 12.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.134 179.347 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.917 HD11 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.42 -70.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.539 ' O ' HG23 ' B' ' 109' ' ' THR . 4.8 tt0 -79.98 -99.06 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 108' ' ' GLN . 29.9 p -160.35 -35.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.565 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -161.66 -173.42 3.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.018 0.437 . . . . 0.0 111.951 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' B' ' 100' ' ' PRO . 0.3 OUTLIER -84.79 81.86 8.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.83 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 121.614 0.721 . . . . 0.0 111.349 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.824 0.345 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 63.31 117.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.42 169.34 8.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 176' ' ' ALA . 2.5 pt -160.23 134.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' ASP . 2.7 mptt -125.53 147.79 49.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLY . 20.7 m -133.48 134.48 43.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.841 HG12 ' HG1' ' A' ' 58' ' ' THR . 3.0 t -115.21 151.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 9' ' ' VAL . 9.2 p -93.24 160.87 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' N ' HG22 ' A' ' 8' ' ' VAL . 7.3 p -152.61 129.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 174.21 17.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.78 84.66 2.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 81' ' ' CYS . . . -171.9 -147.21 5.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 17' ' ' THR . . . -178.95 32.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.954 HG13 HD12 ' A' ' 79' ' ' LEU . 3.3 p -81.32 4.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -84.04 -103.89 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.286 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HE2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 ttpm? -97.38 -13.2 21.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.775 HG23 ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.32 -74.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -74.16 -34.88 63.98 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.089 -0.382 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.731 HD23 ' CG2' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.11 -74.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.584 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD21 HD12 ' A' ' 55' ' ' LEU . 18.2 mt -47.93 -42.27 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.876 0.37 . . . . 0.0 111.067 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -49.13 -68.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.517 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -93.18 -56.99 2.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.646 ' CD1' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -50.12 -26.8 4.85 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 84.9 m -113.82 -91.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.925 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 21' ' ' ILE . 4.1 t -51.87 -24.22 5.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.964 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.8 t-20 65.94 52.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' CE1' ' B' ' 81' ' ' PHE . 0.0 OUTLIER -132.5 -166.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.647 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -130.78 147.08 64.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.04 151.97 5.31 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.752 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 t -105.81 -80.54 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -75.7 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.51 105.95 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 3.4 p -160.55 138.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 33' ' ' VAL . 72.3 Cg_exo -39.21 92.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.689 2.26 . . . . 0.0 112.272 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.548 HG22 ' OD2' ' A' ' 57' ' ' ASP . 1.4 m -50.25 91.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.197 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' HG11 ' B' ' 87' ' ' VAL . 1.9 t -81.86 -26.35 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HE2' HD13 ' B' ' 85' ' ' ILE . 9.3 t80 -148.63 -77.01 0.16 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.804 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 40' ' ' TYR . 59.0 t0 58.27 112.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 16.4 t-20 -106.33 159.62 15.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.005 0.431 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -152.12 168.85 23.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.063 -178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.653 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -104.97 133.14 50.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.704 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.2 m -162.51 133.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.479 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 51' ' ' TYR . 88.0 m -131.34 116.27 17.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.13 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 78' ' ' PRO . 4.0 m -98.08 117.19 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.052 0.453 . . . . 0.0 110.581 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -91.31 102.0 14.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 173' ' ' ILE . 9.7 mm -82.34 121.22 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.186 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.79 25.38 61.34 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.62 19.62 67.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.62 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -115.82 151.31 46.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.662 0.268 . . . . 0.0 110.795 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.56 139.55 64.64 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.584 2.189 . . . . 0.0 112.357 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.519 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -151.58 174.52 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.657 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.78 111.32 9.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.235 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 55' ' ' LEU . 4.9 tt -73.31 129.7 38.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -112.39 103.41 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.005 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 53' ' ' LEU . 23.6 mt -125.83 154.46 42.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -144.56 125.94 14.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD2' HG22 ' A' ' 35' ' ' THR . 15.0 t0 -67.66 161.83 24.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.841 ' HG1' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -168.73 157.73 8.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 64' ' ' TYR . . . -119.79 -175.26 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.46 -145.72 4.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 mt 51.77 -162.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.91 52.4 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.18 28.25 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.553 ' HE1' ' HB3' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -99.34 -19.33 17.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -44.05 -29.21 0.57 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.789 0.328 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -56.72 -46.64 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.584 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.954 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 40.5 mt -94.25 23.31 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 tmt_? -57.02 -57.86 21.75 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.99 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.8 Cg_endo -47.95 -22.3 3.32 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.641 2.227 . . . . 0.0 113.053 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HB3' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -88.68 -15.02 35.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 7' ' ' VAL . 17.3 m -108.04 -31.37 7.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 47.76 94.35 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 73.7 Cg_exo -49.51 -36.8 40.81 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.668 2.245 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.36 59.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.592 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 76' ' ' ASP . 14.7 t -41.32 -50.65 3.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.7 0.286 . . . . 0.0 111.629 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.81 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.6 OUTLIER 171.72 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.685 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' PHE . 9.9 p -58.0 154.84 2.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 105' ' ' CYS . 0.7 OUTLIER -104.26 163.69 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.156 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HG13 ' A' ' 14' ' ' VAL . 1.2 mm? -114.48 139.01 49.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 110' ' ' PHE . 4.1 t -131.09 134.44 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.556 ' HB2' HG12 ' A' ' 14' ' ' VAL . 42.3 t -134.49 154.63 51.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 112.05 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 2.8 p90 -124.03 108.33 12.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.589 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.2 p -37.39 102.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.177 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.043 HG12 HG22 ' A' ' 85' ' ' VAL . 98.6 t 56.86 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.386 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.043 HG22 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.04 -81.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.562 0.22 . . . . 0.0 111.511 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.505 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 m 54.27 102.25 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.18 -30.25 64.79 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.393 2.062 . . . . 0.0 112.322 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 p -71.72 -23.6 61.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -93.11 -22.6 19.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.154 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -48.92 -69.81 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.353 . . . . 0.0 111.032 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -51.74 -36.84 48.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 51.0 m-20 -64.04 -63.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 89' ' ' SER . 61.1 t -43.06 -32.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.0 -69.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.847 0.356 . . . . 0.0 111.417 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -80.25 8.04 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 15.3 tttt -115.09 -45.3 2.96 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.651 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.7 m95 -95.42 -38.46 10.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.2 t -51.64 -44.51 90.24 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.631 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.6 Cg_exo -55.92 -21.6 34.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 112.256 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.92 -31.18 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.125 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.519 HG23 HG11 ' A' ' 9' ' ' VAL . 56.0 mt -48.14 -31.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.3 p -64.05 -34.84 78.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.633 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -72.78 -33.18 66.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.468 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -79.17 -43.87 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.831 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 17.8 p -103.64 134.01 19.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_endo -83.86 72.91 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.386 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.0 26.38 15.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 1.6 m -107.85 142.15 24.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 63.0 Cg_exo -51.46 172.23 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 80' ' ' VAL . 6.7 p90 -148.57 138.7 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -95.26 119.51 33.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.7 HD12 ' HE2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -97.9 121.84 40.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.933 HG23 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.4 137.36 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.405 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.513 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -174.67 156.45 22.94 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.759 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 1.4 t 173.45 177.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.113 0.482 . . . . 0.0 111.297 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.705 HE22 HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -174.59 52.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.292 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 158' ' ' SER . 28.9 mt -37.11 -31.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -58.49 -64.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.614 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.705 HD23 HE22 ' A' ' 116' ' ' GLN . 3.7 mm? -95.97 -23.97 16.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.688 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.808 ' HG2' HG21 ' A' ' 85' ' ' VAL . 7.3 tmm_? -41.9 -30.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.447 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 61.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -109.04 157.6 36.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.979 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.5 -34.79 34.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.679 2.253 . . . . 0.0 112.272 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.7 m -69.79 -45.82 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.654 HG21 ' O ' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -55.13 -57.05 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 122' ' ' ASP . 5.1 mp -61.19 -32.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -69.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -50.34 -25.98 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.92 57.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.226 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 4.5 mmtp -87.1 -28.4 22.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.883 0.373 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -18.2 57.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.236 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER 63.15 26.73 15.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.79 122.45 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -50.25 153.07 2.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.66 136.75 27.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 141' ' ' THR . 5.2 mp -72.42 99.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.031 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -90.27 179.79 1.41 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.711 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 51.7 Cg_exo -53.11 -21.6 16.97 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.487 2.125 . . . . 0.0 112.326 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -38.09 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.621 ' HB ' HG23 ' A' ' 137' ' ' ILE . 19.3 m -52.35 -48.81 65.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.98 -60.07 3.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -52.53 -27.4 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.29 13.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.731 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 tp -54.77 -36.89 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.952 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -64.68 -39.74 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -58.74 -42.8 89.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -23.98 66.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.794 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.684 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.7 pp -119.08 19.18 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.74 -85.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.684 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.79 179.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 43.0 t -67.83 -14.87 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.443 ' CG ' ' HG2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 80.17 141.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.719 0.295 . . . . 0.0 110.492 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.952 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 7.9 p90 -152.8 157.42 40.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.1 122.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.476 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.546 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.9 pt-20 -172.42 150.65 2.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.4 ' SG ' ' CD ' ' A' ' 163' ' ' LYS . 72.1 m -102.15 -173.46 2.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.864 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.483 ' HB3' HD12 ' A' ' 117' ' ' ILE . 16.1 t -87.85 174.14 8.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 111.35 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.543 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -61.64 -175.87 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 65.03 -71.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.022 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' ALA . 35.8 p -69.11 -83.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.673 ' CG ' HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER 69.77 113.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.489 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.4 ' CD ' ' SG ' ' A' ' 157' ' ' CYS . 5.7 mttp -101.4 -67.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 111.222 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.77 88.18 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -93.84 -15.24 25.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.546 0.212 . . . . 0.0 111.288 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -42.78 73.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.867 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -52.77 -64.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.9 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -49.32 -29.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.74 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -59.01 -44.86 91.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.801 179.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.933 ' HA ' HD13 ' B' ' 75' ' ' ILE . 36.3 t0 -61.18 -37.5 83.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.019 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.2 OUTLIER -71.15 -22.27 62.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.576 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.44 -54.05 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.064 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 46' ' ' ILE . 10.4 mt -63.46 -39.12 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 177' ' ' LEU . 13.1 tp -76.5 -36.08 58.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.05 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -53.61 -46.46 70.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.81 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -75.91 -28.24 57.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.069 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -53.97 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.022 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.799 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.8 m -50.53 -44.72 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 170' ' ' ASP . 0.7 OUTLIER -144.16 133.64 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.03 142.79 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -70.53 136.77 85.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.704 ' HB2' HG12 ' A' ' 42' ' ' VAL . 51.0 Cg_exo -54.43 154.4 19.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.516 2.144 . . . . 0.0 112.019 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.7 m -116.88 -83.29 0.64 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.394 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.79 99.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 13.8 t80 -123.19 129.46 51.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.23 142.31 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.0 102.51 1.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.613 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -86.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.438 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.609 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -104.35 127.47 58.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 111.191 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -105.79 99.18 8.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 36' ' ' VAL . 74.1 t -85.56 151.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.33 165.58 28.23 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.054 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.63 106.75 18.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.601 ' HB2' HG23 ' B' ' 97' ' ' THR . 16.0 t0 -124.08 118.24 26.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.71 21.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 1.063 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -47.34 -27.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-O 121.027 0.441 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' THR . . . . . 1.063 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -152.11 20.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.981 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.92 68.45 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.038 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.908 ' HG2' HG23 ' B' ' 93' ' ' THR . 10.2 pt-20 -132.41 164.89 25.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.079 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.609 ' HD2' ' HE1' ' B' ' 99' ' ' MET . 7.4 m-85 -79.11 154.65 29.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.811 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.601 HG23 ' HB2' ' B' ' 90' ' ' ASP . 19.1 p -93.5 169.47 10.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.21 23.54 8.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.418 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.609 ' HE1' ' HD2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -49.82 106.16 0.6 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.492 0.186 . . . . 0.0 110.959 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 67.2 Cg_exo -36.0 152.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 112.906 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -66.69 0.28 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.716 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.28 -52.0 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.075 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.954 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.5 m0 -48.27 -62.5 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.127 0.489 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.57 -69.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.546 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 0.6 OUTLIER -46.64 -38.5 9.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.421 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -49.48 -57.11 7.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.37 . . . . 0.0 110.568 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.77 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.3 -69.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.751 ' O ' HG23 ' B' ' 109' ' ' THR . 5.2 tp-100 -79.18 -100.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.785 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.751 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.3 p -168.62 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.034 0.445 . . . . 0.0 110.736 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.519 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -134.23 170.58 15.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.212 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 99' ' ' MET . 10.4 m-80 -54.31 -63.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.722 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.557 0.694 . . . . 0.0 109.37 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.8 91.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -89.86 159.51 16.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.25 136.96 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.262 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 4.4 mptt -118.91 96.41 5.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.22 97.36 4.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 75' ' ' THR . 12.7 t -84.45 111.26 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.77 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 55' ' ' LEU . 10.7 m -105.43 129.57 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.39 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.784 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.1 p -126.49 138.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.078 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.98 120.52 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.649 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.86 -31.23 70.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.029 0.442 . . . . 0.0 110.488 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.12 83.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.96 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 54.01 23.49 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.889 0.376 . . . . 0.0 111.032 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CG1' ' OG1' ' A' ' 115' ' ' THR . 45.3 t -91.19 -17.89 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . -130.2 -8.82 3.18 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.263 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.623 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.8 pttt -94.9 -57.59 2.4 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.96 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 5.2 t -96.59 -41.8 8.36 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.013 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 2.8 m -64.28 -25.93 68.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -42.75 -72.74 0.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.585 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' HB2' ' A' ' 40' ' ' TYR . 16.4 mt -63.45 -33.81 76.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.152 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -55.29 -43.72 72.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.146 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 -26.68 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.806 ' HB3' HD21 ' B' ' 77' ' ' LEU . 3.7 m-30 -80.73 -67.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 81' ' ' PHE . 55.0 m -79.65 -83.03 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.487 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.53 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -50.53 -24.86 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.187 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 p30 44.28 38.71 2.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -114.24 -165.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.981 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -122.37 141.84 35.68 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.953 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 51.7 Cg_exo -34.86 136.44 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.209 2.606 . . . . 0.0 113.267 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -105.78 -84.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.442 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 95.34 5.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.203 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.48 105.91 1.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.229 0.537 . . . . 0.0 111.378 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.6 p -160.63 134.06 4.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.541 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.22 89.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.435 2.09 . . . . 0.0 112.221 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.474 HG21 ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -72.98 86.65 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.113 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.792 HG21 ' CD2' ' B' ' 96' ' ' PHE . 22.9 m -68.09 -22.54 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.244 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 2.9 t80 -129.21 -76.2 0.55 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.569 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' HG21 ' A' ' 35' ' ' THR . 32.8 t0 61.39 118.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.599 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' CB ' HD12 ' B' ' 85' ' ' ILE . 12.0 t-20 -107.49 148.98 28.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.576 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.567 ' HB2' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -141.49 143.1 33.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.213 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.99 131.54 40.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.592 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.2 m -150.53 163.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.122 0.487 . . . . 0.0 111.618 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 51' ' ' TYR . 93.3 m -155.73 101.41 2.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.001 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.945 HG13 ' O ' ' B' ' 76' ' ' SER . 11.9 t -98.41 130.96 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.211 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.5 mtm -91.06 99.92 12.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 177' ' ' LEU . 19.8 mt -101.48 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.67 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.01 12.94 72.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.355 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.21 34.22 6.85 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.706 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 45' ' ' MET . 24.4 mt-10 -141.78 134.81 14.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.582 0.23 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.35 167.96 10.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.113 . . . . 0.0 112.287 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' H ' HG23 ' A' ' 43' ' ' THR . 2.9 m-85 -153.81 168.49 26.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.288 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.8 p -135.24 97.4 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.505 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.8 tt -115.82 160.92 19.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.812 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -161.11 120.81 0.97 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 16' ' ' LYS . 10.0 mp -77.04 102.82 6.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.918 0.39 . . . . 0.0 110.927 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 9.8 m-85 -84.1 104.95 14.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 58' ' ' THR . 40.0 m-20 -66.84 175.85 2.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.716 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 57' ' ' ASP . 23.1 p -161.43 128.95 4.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -58.49 170.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.51 66.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.538 HD22 ' H ' ' A' ' 61' ' ' LEU . 2.6 mm? -63.35 150.45 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.314 . . . . 0.0 110.918 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 34.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -116.7 20.54 13.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -78.38 -10.48 59.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.382 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -42.54 -30.64 0.37 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -79.55 -45.56 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 70' ' ' LEU . 1.4 mp -95.18 25.27 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -98.02 -49.61 0.22 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.675 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 60.1 Cg_exo -51.41 -43.1 51.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 121.965 1.776 . . . . 0.0 111.838 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.846 HD22 ' CG ' ' B' ' 103' ' ' TRP . 1.0 OUTLIER -49.08 -24.57 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.246 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.812 ' N ' HD12 ' A' ' 70' ' ' LEU . 1.3 p -104.52 -20.65 13.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.336 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.572 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 60.38 139.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.895 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . 96.9 Cg_endo -82.7 -47.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.584 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -69.23 -10.69 58.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.537 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 HG23 ' A' ' 7' ' ' VAL . 6.2 t -40.89 -52.21 3.09 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -173.17 -167.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.036 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.1 p -65.4 162.41 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 77' ' ' VAL . 15.0 m-85 -110.48 134.61 52.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.503 ' CB ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -104.31 120.33 40.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.5 t -131.16 153.76 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.5 ' HB2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -144.64 175.89 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 111.672 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG11 ' A' ' 93' ' ' VAL . 11.0 p90 -167.21 -176.05 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.703 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.9 t -135.07 44.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.38 -70.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 59.3 m -44.48 100.6 0.23 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.194 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.91 -36.4 83.53 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.667 2.245 . . . . 0.0 112.296 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 t -49.95 -32.37 14.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 t -96.0 -33.08 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 1.4 t80 -55.76 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -48.86 -26.13 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 17.9 m-20 -73.2 -65.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.083 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.648 HG13 ' HD1' ' A' ' 97' ' ' TRP . 61.1 t -41.71 -33.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.829 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HD3' HD11 ' A' ' 145' ' ' LEU . 9.2 ttpt -79.09 -62.38 1.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.17 7.79 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -117.8 -41.57 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.821 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.648 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.2 m95 -95.23 -39.58 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 98.1 t -47.57 -43.31 49.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.632 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.8 Cg_exo -67.76 -31.85 31.25 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.525 2.15 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -93.13 -22.76 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 10.2 tt -47.05 -27.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 p -74.94 -40.14 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.25 -39.12 81.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 110.407 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 7.2 m-70 -93.73 -26.18 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -123.86 66.54 39.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 73' ' ' PRO . 36.3 Cg_endo -65.44 111.56 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.66 2.24 . . . . 0.0 112.472 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.96 48.7 22.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.014 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 109' ' ' PRO . 69.9 m -140.89 140.59 21.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.833 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 108' ' ' THR . 19.5 Cg_endo -58.4 169.98 2.7 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 0.0 111.914 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' CB ' HD11 ' A' ' 101' ' ' ILE . 3.1 p90 -159.84 137.72 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.411 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 mp -100.96 124.29 46.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.154 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CZ ' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -134.71 102.12 5.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.626 HG23 ' CB ' ' A' ' 142' ' ' ALA . 4.0 p -145.3 108.0 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 155.47 42.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 156' ' ' GLU . 1.2 p -148.16 115.76 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -169.97 72.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 157' ' ' CYS . 24.9 mt -64.87 -62.52 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -50.93 -60.0 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -48.64 -48.37 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.592 ' HG3' HG11 ' A' ' 85' ' ' VAL . 22.0 ttp85 -50.34 -28.23 7.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.61 -15.46 61.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.485 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.54 ' O ' HD12 ' A' ' 126' ' ' ILE . 4.3 m-20 -53.84 143.83 38.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.757 0.313 . . . . 0.0 110.967 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.74 -45.02 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.0 m -49.25 -40.2 33.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -53.6 -63.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.8 mp -50.97 -39.51 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.92 -63.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.09 -34.6 66.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 136' ' ' PRO . 1.2 mt -50.15 -26.28 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.959 0.409 . . . . 0.0 110.459 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.42 61.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.908 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.54 -16.66 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -93.63 29.59 1.98 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.16 33.64 2.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 50.04 -163.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.28 75.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.629 ' HB3' HD13 ' A' ' 129' ' ' LEU . 57.2 Cg_endo -70.69 169.14 20.83 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.697 2.265 . . . . 0.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.643 HG23 ' CG2' ' A' ' 141' ' ' THR . 4.0 mp -97.95 131.9 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.117 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.478 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -129.57 -179.24 0.96 Allowed Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.266 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 61.2 Cg_exo -52.14 -21.26 12.41 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.442 2.095 . . . . 0.0 112.496 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.0 -40.79 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.643 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.8 m -48.37 -47.24 37.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.184 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.626 ' CB ' HG23 ' A' ' 113' ' ' VAL . . . -49.2 -50.89 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.835 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -32.0 73.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.414 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -55.43 -49.61 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.481 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 149' ' ' LEU . 6.5 tt -66.12 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.501 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -68.53 -49.07 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -63.46 -35.14 79.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -31.01 71.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.735 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 145' ' ' LEU . 4.1 pp -98.66 -20.12 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.664 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mmtm 63.13 93.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.556 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -136.55 -173.43 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 153' ' ' LYS . 9.2 p -41.72 -45.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.606 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 112.81 139.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.589 1.18 . . . . 0.0 109.959 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.879 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -153.65 140.57 19.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.687 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 155' ' ' VAL . 34.7 m -158.47 125.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.666 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.4 pt-20 -161.02 174.15 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.652 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.944 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.9 p -135.23 -170.73 2.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.995 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 164.44 17.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.815 0.34 . . . . 0.0 110.506 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -40.72 -90.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.067 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.07 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.699 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 170.04 -66.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.647 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 43.73 96.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.604 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.84 -49.47 3.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.74 68.52 0.35 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.973 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.694 HD21 ' CD1' ' A' ' 23' ' ' TYR . 2.6 tp -93.02 -22.27 19.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 111.408 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -41.93 75.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.01 -65.21 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 169' ' ' PHE . 7.5 p -46.67 -49.1 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.466 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 39.8 t80 -55.09 -43.79 74.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.639 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' B' ' 75' ' ' ILE . 45.5 m-20 -53.09 -43.16 66.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.42 -44.82 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.83 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.925 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 169' ' ' PHE . 19.6 mm -94.95 -30.2 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.36 -46.18 80.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.87 -26.24 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.216 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -65.93 -50.56 63.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' HD13 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -90.69 65.96 6.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.944 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 60.23 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 170' ' ' ASP . 8.5 tt -127.13 145.87 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.945 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.39 132.19 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.74 145.32 83.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' B' ' 77' ' ' LEU . 73.9 Cg_exo -50.49 -175.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.733 2.288 . . . . 0.0 112.545 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 73.4 m -153.72 -63.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.504 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 2.2 t80 -98.44 139.71 33.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.81 124.76 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.783 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.453 ' CD2' ' OD1' ' A' ' 38' ' ' ASP . 2.9 t-160 -68.21 78.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.98 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.572 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -119.33 110.34 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -91.22 96.54 10.62 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 36' ' ' VAL . 60.3 t -78.1 137.27 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.562 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.61 177.74 17.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.191 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -78.11 123.86 27.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 111.034 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.566 ' CG ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -114.95 97.87 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.08 -18.68 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.585 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.536 HG13 ' N ' ' B' ' 93' ' ' THR . 13.3 p -45.37 -46.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 111.493 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.536 ' N ' HG13 ' B' ' 92' ' ' VAL . 6.6 t -121.94 -10.74 8.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.687 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.58 18.92 21.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.309 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.406 ' CD ' HG21 ' B' ' 93' ' ' THR . 14.1 pt-20 -124.47 -160.73 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.648 0.261 . . . . 0.0 110.708 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.792 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -98.34 164.32 12.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.566 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -101.46 167.94 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 47.84 33.83 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.373 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.595 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.99 117.86 5.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.46 0.171 . . . . 0.0 111.179 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.458 ' HD3' HG22 ' B' ' 87' ' ' VAL . 92.4 Cg_exo -42.88 155.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.054 . . . . 0.0 112.294 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -47.77 -54.05 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -69.19 -55.85 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.846 ' CG ' HD22 ' A' ' 70' ' ' LEU . 6.0 m0 -47.83 -57.54 5.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -49.73 -65.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.346 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' B' ' 109' ' ' THR . 3.7 mtt-85 -49.11 -44.52 42.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.43 -61.24 1.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.3 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.656 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -94.75 -68.79 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.273 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.561 ' O ' HG23 ' B' ' 109' ' ' THR . 0.1 OUTLIER -78.45 -97.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.89 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.561 HG23 ' O ' ' B' ' 108' ' ' GLN . 22.5 p -160.48 -55.06 0.05 Allowed 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -151.63 172.44 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 112.121 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' B' ' 111' ' ' ASN . 1.0 OUTLIER -64.37 75.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.537 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.483 0.658 . . . . 0.0 111.004 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.819 0.342 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.9 -171.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 135.63 36.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.982 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.675 HG22 ' HB1' ' A' ' 176' ' ' ALA . 4.8 pt -149.63 111.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -134.26 99.73 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.432 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 6.0 m -77.27 152.4 34.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 56' ' ' PHE . 17.4 t -136.9 143.9 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.285 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 9' ' ' VAL . 6.5 p -85.01 160.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' HG22 ' A' ' 8' ' ' VAL . 3.9 m -138.09 121.18 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.22 173.9 31.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.22 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.409 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.3 m-20 -89.54 110.42 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.0 110.769 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -161.15 -39.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.786 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 83.45 -47.99 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.482 ' O ' HD13 ' A' ' 19' ' ' LEU . 18.5 m -47.07 -25.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.33 -94.44 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.477 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HZ1' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.83 -71.57 0.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.923 ' O ' HD13 ' A' ' 21' ' ' ILE . 1.1 t -36.0 -58.42 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.786 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 10.9 m -68.94 -26.86 65.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.964 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 15' ' ' GLY . 3.0 tp -58.38 -76.85 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.819 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 42' ' ' VAL . 12.9 mt -48.91 -33.35 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.856 -0.528 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 17' ' ' THR . 1.2 mp -51.16 -68.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 t -93.33 -57.19 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.593 ' O ' HD21 ' B' ' 77' ' ' LEU . 10.4 t80 -39.28 -39.89 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.661 HG21 HG12 ' A' ' 42' ' ' VAL . 62.7 m -104.72 -75.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -71.22 -15.33 62.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 52.6 t30 65.59 36.92 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 111.165 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 1.5 tttp 176.6 164.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -134.22 60.97 47.64 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.69 0.281 . . . . 0.0 111.748 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 80.9 Cg_endo -91.63 126.56 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.064 2.51 . . . . 0.0 112.516 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.7 p 171.82 -88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.991 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.96 153.04 13.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.0 t80 -91.02 111.92 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 110.835 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 34' ' ' PRO . 95.0 t -158.67 140.38 9.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' A' ' 33' ' ' VAL . 82.0 Cg_exo -46.61 91.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.262 1.975 . . . . 0.0 111.446 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.809 HG23 ' CG ' ' A' ' 38' ' ' ASP . 54.5 m -52.9 87.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.544 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.504 HG11 ' CG ' ' B' ' 96' ' ' PHE . 37.2 t -75.4 -25.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 109.898 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.557 ' HE2' HD13 ' B' ' 85' ' ' ILE . 4.2 t80 -148.29 -68.82 0.23 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.247 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.809 ' CG ' HG23 ' A' ' 35' ' ' THR . 3.0 m-20 57.97 111.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.331 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.587 ' HB3' HD12 ' B' ' 85' ' ' ILE . 11.2 t-20 -107.96 148.82 29.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.08 142.15 25.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.599 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -83.22 152.17 25.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 24' ' ' THR . 1.2 m -162.43 148.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -132.09 104.81 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 173' ' ' ILE . 4.0 t -97.31 117.23 41.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.5 . . . . 0.0 110.58 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.8 mtm -100.23 100.01 10.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.947 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 46' ' ' ILE . 12.3 tt -109.85 109.54 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.25 15.81 61.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.545 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.68 -43.01 1.94 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.616 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.61 142.91 66.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.293 . . . . 0.0 111.057 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.81 173.98 11.85 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.322 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -153.28 146.46 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -99.72 97.42 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.033 HD21 HD12 ' A' ' 55' ' ' LEU . 7.9 tt -112.33 156.5 22.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.994 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.99 112.33 0.53 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.033 HD12 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -85.5 103.34 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.927 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.4 m-85 -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.35 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 14.2 t70 -72.17 166.36 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 64' ' ' TYR . 43.7 m -169.32 128.59 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.544 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -77.94 -73.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.69 -137.67 6.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 mt 71.73 -174.23 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -96.08 -16.89 21.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.393 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 71.5 m-20 -76.34 -19.27 58.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.4 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -70.33 -16.79 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.542 0.21 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -48.04 -25.73 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 5.7 ptp180 -91.99 -40.95 10.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.052 HD22 ' CE2' ' B' ' 96' ' ' PHE . 27.3 tp -86.78 1.13 53.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.51 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.01 -47.28 0.39 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.838 -0.164 . . . . 0.0 111.282 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 76.3 Cg_exo -49.08 -25.21 8.78 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.19 1.927 . . . . 0.0 111.411 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.77 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -65.02 -28.15 69.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.497 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 22.5 m -100.15 -14.89 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.262 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 54.58 141.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 123.252 0.621 . . . . 0.0 112.03 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.99 -34.51 2.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -10.71 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.322 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.495 HG21 HG23 ' A' ' 7' ' ' VAL . 9.0 t -40.6 -47.88 2.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.572 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 4' ' ' ILE . 1.3 m-20 169.06 -168.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 111' ' ' LEU . 12.2 p -58.29 141.97 14.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.448 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 105' ' ' CYS . 10.3 m-85 -92.9 143.7 26.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.627 HD23 ' HZ1' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.68 115.94 31.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.219 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 101' ' ' ILE . 2.7 t -89.26 93.69 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.962 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.455 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 28.1 p -67.62 110.38 3.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.744 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 93' ' ' VAL . 2.6 t80 -131.92 105.8 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.42 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -50.66 156.83 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.914 HG13 HG22 ' A' ' 137' ' ' ILE . 63.0 t -83.49 -75.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 120' ' ' ARG . 97.9 t -69.26 -101.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.522 ' N ' HG12 ' A' ' 85' ' ' VAL . 17.7 m 33.72 57.59 1.76 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.605 ' HD3' HG12 ' A' ' 85' ' ' VAL . 2.7 Cg_endo -46.06 -25.65 3.04 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.9 2.4 . . . . 0.0 112.362 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.39 -26.04 26.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.1 m -96.28 -38.78 9.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.254 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -45.17 -66.99 0.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.238 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 -55.55 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -54.17 -64.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.914 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 89' ' ' SER . 48.0 t -41.37 -36.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.813 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HD3' HD21 ' A' ' 145' ' ' LEU . 25.1 tptp -63.2 -69.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 2.4 mp0 -82.78 8.62 11.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tptp -117.43 -44.93 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' HD1' HG13 ' A' ' 93' ' ' VAL . 14.4 m95 -95.12 -28.19 15.2 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.825 ' O ' HG22 ' A' ' 101' ' ' ILE . 24.5 t -70.03 -44.56 21.5 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.704 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.5 Cg_exo -51.06 -29.31 27.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.23 1.953 . . . . 0.0 112.57 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -93.11 -17.51 23.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.666 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.894 HD11 HG22 ' A' ' 80' ' ' VAL . 9.6 tt -47.5 -35.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.805 0.336 . . . . 0.0 111.29 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 p -65.62 -38.33 89.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -61.67 -29.46 70.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.179 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -87.06 -48.96 7.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 28.9 p -104.04 96.55 9.66 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 111.005 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.56 100.45 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.573 2.182 . . . . 0.0 112.334 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.82 5.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 m -117.32 131.17 24.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.55 175.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.483 2.122 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 149' ' ' LEU . 3.9 p90 -163.15 159.42 22.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.7 mp -111.96 120.08 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.847 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.513 HD13 ' C ' ' A' ' 112' ' ' LEU . 1.3 tm? -95.19 102.49 14.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.69 160.39 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.373 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -147.45 137.3 6.51 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.364 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.5 p -130.26 -155.62 0.71 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.1 tp60 82.4 77.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.415 HG13 ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -100.12 -34.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -78.04 -51.72 9.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.268 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -51.54 -40.37 59.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.873 ' HB2' HG21 ' A' ' 85' ' ' VAL . 7.6 ptt85 -72.44 61.93 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -137.72 46.7 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.022 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.32 145.89 34.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.62 -45.21 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.317 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -49.96 -45.93 51.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.79 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -29.62 20.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.8 mm -66.09 -57.35 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.054 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -48.43 -38.19 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.056 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -39.09 17.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.976 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.482 HD13 ' HG3' ' A' ' 136' ' ' PRO . 6.2 mt -51.18 -25.54 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.409 . . . . 0.0 110.436 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.82 -19.18 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -31.9 33.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -67.62 -19.46 65.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.13 46.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.49 133.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.5 168.18 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.54 129.22 32.73 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.914 HG22 HG13 ' A' ' 84' ' ' VAL . 8.5 mt -60.41 129.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.471 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -128.09 179.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.948 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 73.0 Cg_exo -51.75 -21.67 11.9 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.674 2.25 . . . . 0.0 112.508 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.58 -53.37 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.547 ' CG2' HG23 ' A' ' 137' ' ' ILE . 54.4 m -46.21 -47.52 17.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.34 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -33.79 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.577 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -58.51 -56.62 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.506 HD21 ' HD3' ' A' ' 94' ' ' LYS . 17.9 tp -59.09 -52.94 63.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.434 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.642 ' CA ' HD23 ' A' ' 149' ' ' LEU . . . -57.91 -41.01 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.408 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.401 ' HA ' ' OH ' ' A' ' 154' ' ' TYR . 48.4 ttt-85 -50.16 -41.56 49.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.44 -21.74 64.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.935 HD13 ' CE1' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -74.84 -28.47 60.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 tttt 66.83 58.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.648 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -107.28 -177.97 3.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.412 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 66.3 t -48.86 -64.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 178.97 160.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.756 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.802 ' HE2' ' HB3' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -154.34 111.23 3.35 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 168' ' ' VAL . 23.6 m -158.27 120.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.859 0.362 . . . . 0.0 110.412 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -173.18 -178.63 1.79 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.61 -173.42 4.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.89 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.415 ' OG ' HG13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -87.2 155.94 19.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.267 0.556 . . . . 0.0 111.301 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 22' ' ' SER . . . -57.18 -158.85 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER 47.86 26.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.802 179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.559 HE22 ' C ' ' A' ' 22' ' ' SER . 2.7 mm-40 73.62 121.46 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -105.42 -68.28 0.87 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.178 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.428 ' C ' HD23 ' A' ' 165' ' ' LEU . . . -162.86 85.19 0.11 Allowed Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.375 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -94.05 -10.11 34.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.728 0.299 . . . . 0.0 111.669 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -43.74 -29.44 0.52 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.925 0.393 . . . . 0.0 111.135 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 155' ' ' VAL . 16.1 m-20 -64.37 -47.4 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.557 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 155' ' ' VAL . 86.1 t -54.45 -47.62 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.571 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -69.97 -38.76 76.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.746 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.37 -42.34 66.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.269 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.436 ' CB ' ' HG2' ' A' ' 153' ' ' LYS . 1.6 tp10 -90.03 -41.53 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.72 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -60.48 -35.73 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 44' ' ' VAL . 29.6 mm -86.11 -44.65 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.37 -41.13 85.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -52.3 -40.03 61.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.675 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -84.56 -23.83 29.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 46' ' ' ILE . 4.0 tp -48.91 -64.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.22 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -96.35 142.61 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.058 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.48 144.89 51.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -72.53 129.29 87.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.72 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.579 ' HB2' HG12 ' A' ' 42' ' ' VAL . 9.2 Cg_endo -51.91 149.64 19.88 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.4 ' O ' ' N ' ' B' ' 81' ' ' PHE . 75.4 m -120.37 -64.07 1.29 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -47.53 93.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 2.3 t80 -119.75 135.87 54.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.89 131.24 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.487 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.22 88.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.474 . . . . 0.0 110.397 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.572 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -56.11 -76.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.661 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -121.4 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.931 0.396 . . . . 0.0 111.788 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -105.31 97.48 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.907 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.5 t -77.62 145.38 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.707 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -146.31 167.49 27.94 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.227 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -92.19 126.82 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' B' ' 92' ' ' VAL . 37.1 t0 -135.82 135.14 39.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.758 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.42 1.72 18.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.009 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.619 HG13 ' OD1' ' B' ' 90' ' ' ASP . 11.5 m -45.5 -27.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.441 HG23 ' N ' ' B' ' 94' ' ' GLY . 12.8 t -153.41 -44.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.837 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' GLY . . . . . 0.441 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.57 35.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.367 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -144.66 -160.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.752 0.311 . . . . 0.0 110.598 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 1.052 ' CE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.56 147.3 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.437 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -90.71 178.49 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.525 ' HA2' ' ND2' ' B' ' 111' ' ' ASN . . . 51.74 32.28 32.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.334 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.633 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 1.8 tpt -44.1 101.92 0.27 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 0.0 111.423 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.454 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 82.7 Cg_exo -45.51 151.95 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.114 1.876 . . . . 0.0 112.077 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -43.97 -63.84 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.929 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -64.7 -61.29 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.747 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 67' ' ' LEU . 3.1 m0 -46.39 -50.62 16.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.633 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.14 -66.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.0 ptm180 -47.35 -27.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.915 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.648 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -63.05 -62.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.331 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -94.89 -59.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.679 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 109' ' ' THR . 4.7 tp-100 -77.82 -99.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.72 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -166.74 -52.17 0.03 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.891 0.377 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 99' ' ' MET . 0.3 OUTLIER -154.1 -176.5 5.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.434 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.525 ' ND2' ' HA2' ' B' ' 98' ' ' GLY . 0.2 OUTLIER -82.41 80.48 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.845 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.701 0.762 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.41 141.59 43.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 t -119.98 111.8 18.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -115.88 151.98 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -128.33 96.26 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.7 104.8 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 8' ' ' VAL . 25.7 t -84.71 158.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.72 HG23 ' CG2' ' A' ' 14' ' ' VAL . 34.4 m -140.76 150.71 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.405 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.8 m -145.12 135.2 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.335 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.72 146.08 4.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.69 152.58 39.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.58 0.228 . . . . 0.0 110.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 49.76 96.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.976 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 67.61 64.13 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.141 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 8' ' ' VAL . 7.6 p -48.56 -24.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.2 -32.84 2.6 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.919 ' HE3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.14 -73.45 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.637 0.256 . . . . 0.0 111.56 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.831 HG23 ' OD1' ' A' ' 57' ' ' ASP . 18.0 p -39.52 -61.31 0.82 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.775 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 6.1 p -46.43 -37.3 7.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 79' ' ' LEU . 5.9 tp -67.94 -71.46 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD12 ' CD2' ' B' ' 81' ' ' PHE . 1.7 mm? -38.18 -41.37 0.59 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.753 0.311 . . . . 0.0 111.604 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.719 HG21 ' HD3' ' A' ' 29' ' ' PRO . 4.4 mm -61.04 -45.05 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' LEU . 90.8 p -94.2 -64.02 1.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.74 ' CD1' HD12 ' A' ' 165' ' ' LEU . 27.1 t80 -49.38 -47.88 47.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.197 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' HD2' ' B' ' 81' ' ' PHE . 94.5 m -97.45 -95.76 0.21 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.93 HG21 ' CE ' ' A' ' 27' ' ' LYS . 5.0 t -41.23 -29.38 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 t30 68.13 24.25 7.74 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.93 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -112.41 -160.02 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.196 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.01 156.61 74.01 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.719 ' HD3' HG21 ' A' ' 21' ' ' ILE . 63.2 Cg_exo -36.68 142.33 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.071 2.514 . . . . 0.0 113.133 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.95 -83.32 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.537 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.94 97.31 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.377 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.38 106.45 1.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.098 0.475 . . . . 0.0 110.97 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 ' HD2' ' A' ' 34' ' ' PRO . 4.4 p -160.6 139.64 7.79 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.179 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.4 Cg_exo -37.66 100.2 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.764 2.31 . . . . 0.0 112.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.554 HG23 HG21 ' A' ' 17' ' ' THR . 4.9 m -47.0 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.257 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 34' ' ' PRO . 91.2 t -91.21 -43.67 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' B' ' 87' ' ' VAL . 84.0 t80 -172.57 106.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.746 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB2' HG22 ' A' ' 17' ' ' THR . 30.0 m-20 -107.52 127.36 53.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.65 ' HB3' HD12 ' B' ' 85' ' ' ILE . 31.4 t-20 -107.48 147.01 31.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.113 0.482 . . . . 0.0 111.309 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.695 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.27 161.11 43.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.187 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.82 116.75 29.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.182 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 55' ' ' LEU . 1.3 m -124.92 124.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 0.0 111.76 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -122.27 95.94 4.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.459 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.88 HG23 ' O ' ' B' ' 76' ' ' SER . 10.7 p -97.34 116.78 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.8 mtm -89.04 114.99 26.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.047 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.691 HG23 ' O ' ' B' ' 74' ' ' SER . 9.0 mt -115.8 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 73' ' ' GLY . . . 85.79 18.73 59.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.21 33.45 44.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.544 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -139.15 147.33 52.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.66 162.9 35.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.491 2.127 . . . . 0.0 112.207 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -154.34 167.53 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.5 m -131.87 97.04 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.214 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.75 158.94 16.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.29 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.92 103.72 0.26 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.054 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.39 103.32 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -83.71 102.95 12.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.172 179.423 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.831 ' OD1' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -71.38 -178.07 2.0 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.985 0.421 . . . . 0.0 111.111 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -170.53 172.81 5.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.701 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -87.39 -61.45 1.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.253 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.51 18.46 9.04 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 mt -94.33 -173.83 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.801 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.67 39.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -135.64 12.33 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.346 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.697 ' CE2' HG22 ' A' ' 58' ' ' THR . 1.3 m-85 -86.69 2.68 47.73 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.525 0.202 . . . . 0.0 111.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.3 p-10 -49.43 -25.63 2.7 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -39.07 12.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.94 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -96.84 26.32 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.538 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.568 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.49 -26.57 0.3 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 72.5 Cg_endo -76.72 -22.91 11.51 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.455 1.437 . . . . 0.0 111.667 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' B' ' 103' ' ' TRP . 7.4 mt -60.19 -18.27 47.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -94.38 -27.24 16.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.04 168.47 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.976 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 72' ' ' TYR . 14.1 Cg_endo -57.4 -17.62 27.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.422 2.081 . . . . 0.0 112.198 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -10.76 38.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.2 t -38.3 -30.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.03 -154.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 41.4 t -57.84 161.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -111.94 122.08 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.945 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.919 HD23 ' HE3' ' A' ' 16' ' ' LYS . 1.9 tp -103.83 121.51 43.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.291 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.734 ' N ' HD12 ' A' ' 79' ' ' LEU . 2.3 t -131.06 138.12 54.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.95 152.99 48.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HE1' HG12 ' A' ' 84' ' ' VAL . 26.9 p90 -138.65 176.13 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' A' ' 116' ' ' GLN . 91.5 p -89.69 120.03 30.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.537 HG12 ' HE1' ' A' ' 82' ' ' PHE . 32.3 m -93.06 40.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.786 HG12 ' N ' ' A' ' 120' ' ' ARG . 19.4 m -95.46 -45.77 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 85' ' ' VAL . 2.0 p -139.46 139.35 22.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.74 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 132' ' ' ASN . 42.6 Cg_endo -68.53 -17.81 43.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.579 2.186 . . . . 0.0 112.469 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -51.68 -23.73 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -93.32 -29.91 15.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.169 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 2.7 m-85 -46.44 -44.93 17.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.193 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.65 -58.26 8.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -63.17 -36.71 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 89' ' ' SER . 72.7 t -48.63 -65.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.435 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HD3' HD11 ' A' ' 145' ' ' LEU . 13.0 mtmm -73.33 -37.25 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.71 -12.39 61.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.9 tttm -119.03 -25.88 6.11 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.638 ' CZ3' HG13 ' A' ' 93' ' ' VAL . 31.2 m0 -93.29 -49.03 6.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.625 0.25 . . . . 0.0 111.313 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.8 t -47.6 -43.93 52.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.1 Cg_exo -67.38 -26.53 41.09 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.53 2.154 . . . . 0.0 112.589 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.05 -35.21 15.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.439 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -47.67 -27.58 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.367 . . . . 0.0 111.294 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -89.13 -33.23 17.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -51.92 -44.68 63.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.408 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -84.32 -46.59 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -97.34 104.23 19.12 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.746 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 95.9 Cg_exo -41.65 -51.12 4.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.554 2.17 . . . . 0.0 112.565 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -173.79 48.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.621 HG23 ' HD2' ' A' ' 109' ' ' PRO . 56.6 m -103.97 142.79 25.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.621 ' HD2' HG23 ' A' ' 108' ' ' THR . 78.7 Cg_exo -39.79 129.08 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.547 2.165 . . . . 0.0 112.086 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.6 p90 -102.53 173.75 6.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.164 0.507 . . . . 0.0 111.48 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.985 HD22 ' CE2' ' A' ' 154' ' ' TYR . 3.0 mt -151.74 126.25 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.876 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 4.1 tt -143.63 125.64 15.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.675 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 154' ' ' TYR . 7.1 p -157.05 134.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.326 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.629 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -105.94 158.62 15.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.555 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.0 t -168.87 144.36 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.733 0.302 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 2.3 mt-30 172.06 55.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.45 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 158' ' ' SER . 38.3 mt -52.88 -24.46 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.442 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 28.0 t70 -82.26 -55.22 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.231 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.47 ' C ' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -63.29 -40.76 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.786 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -66.25 71.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -174.97 53.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -98.45 161.24 25.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.99 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.12 -26.17 15.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.832 2.355 . . . . 0.0 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -28.71 16.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.98 -68.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.088 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.2 mp -45.36 -39.69 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.445 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -61.29 2.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.14 -35.38 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -49.7 -27.74 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 110.686 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.95 -20.36 62.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.404 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -89.92 -21.56 22.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.19 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.465 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 1.3 t-20 -88.21 -26.67 22.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.172 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 166.78 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 87.18 -175.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 1.4 tmmt? 63.22 129.03 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.5 140.18 62.0 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.429 2.086 . . . . 0.0 112.458 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG23 ' CB ' ' A' ' 141' ' ' THR . 5.9 mt -70.2 118.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.969 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.81 156.9 34.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.334 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.07 -29.46 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.293 2.662 . . . . 0.0 112.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.31 -43.74 73.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.412 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.412 ' CB ' HG23 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -46.58 -66.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.32 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.629 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -47.41 -47.69 26.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.246 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -56.39 -44.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -39.97 75.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.68 HD11 ' HD3' ' A' ' 94' ' ' LYS . 1.8 tm? -57.0 -52.34 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.599 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 112' ' ' LEU . . . -60.57 -26.45 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -81.37 -35.52 30.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.9 -52.13 8.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.254 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -94.34 30.82 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.242 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.03 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 149' ' ' LEU . . . 51.65 -176.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.156 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 152' ' ' VAL . 42.5 t -71.46 -8.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.81 152.1 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.52 0.328 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.985 ' CE2' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -153.16 151.8 30.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.088 0.471 . . . . 0.0 111.884 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.2 m -158.75 124.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.447 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.89 -178.46 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.349 0.595 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.7 p -141.77 -168.21 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -82.92 161.22 21.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 109.976 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -45.54 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.959 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -37.04 -42.72 0.43 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.057 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.6 p -86.77 171.71 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.154 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.39 89.01 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 -68.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.951 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.37 77.02 0.39 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.74 HD12 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -94.02 -32.81 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.138 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -65.66 -43.67 88.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 47.0 m-20 -51.72 -66.02 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 154' ' ' TYR . 2.1 p -42.92 -56.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.562 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 1.0 OUTLIER -52.12 -33.2 38.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 5.0 t0 -70.0 -31.14 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -88.99 -26.24 21.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.16 -24.53 21.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.988 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.643 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 15.8 mm -94.98 -57.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.1 tp -53.53 -24.67 14.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.77 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.62 -23.66 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.437 HD11 HD13 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -49.73 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -60.85 -68.81 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 tt -144.03 151.43 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.8 t -136.03 130.12 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.68 HD11 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -47.17 139.47 7.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 67.6 Cg_exo -50.68 142.47 31.79 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.345 2.03 . . . . 0.0 112.189 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 166.78 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.724 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.51 110.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.762 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.5 p90 -81.08 172.73 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.305 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -130.04 135.98 48.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.9 95.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.181 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -72.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -125.24 138.88 52.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.024 0.44 . . . . 0.0 111.936 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.16 98.03 5.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.715 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 37' ' ' PHE . 61.2 t -77.65 152.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.881 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.415 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.39 177.88 24.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.152 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -77.16 124.59 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 110.788 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.595 ' CB ' HG23 ' B' ' 97' ' ' THR . 11.0 t0 -114.86 108.33 16.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.132 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.1 -19.35 62.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.2 -57.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.016 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 93' ' ' THR . 14.6 t -146.05 53.04 1.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.06 30.08 7.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' B' ' 93' ' ' THR . 17.1 pt-20 -118.21 -176.75 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.94 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -99.27 164.15 12.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.644 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.595 HG23 ' CB ' ' B' ' 90' ' ' ASP . 10.3 p -104.29 166.8 10.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 46.73 26.87 2.9 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.642 ' HE1' HD21 ' A' ' 67' ' ' LEU . 1.2 mtp -48.5 137.55 12.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.598 0.237 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.51 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 52.7 Cg_exo -53.8 151.39 26.15 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.238 1.959 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -44.63 -55.46 5.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.599 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.906 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.4 tm0? -70.84 -46.56 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.711 ' CG ' HD13 ' A' ' 70' ' ' LEU . 3.6 m0 -51.1 -57.91 7.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -53.1 -67.37 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.098 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.8 ptt85 -44.66 -40.98 6.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.397 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.906 HD23 ' OE1' ' B' ' 102' ' ' GLN . 0.1 OUTLIER -50.97 -55.08 19.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.83 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.64 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -94.46 -69.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.646 ' O ' HG23 ' B' ' 109' ' ' THR . 35.0 tt0 -79.47 -96.3 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.646 HG23 ' O ' ' B' ' 108' ' ' GLN . 16.8 p -164.07 -56.62 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.539 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.697 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -125.85 173.46 9.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.608 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' B' ' 99' ' ' MET . 0.8 OUTLIER -59.58 -55.76 30.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.563 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.752 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.787 0.327 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.43 122.18 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.65 147.23 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.741 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.764 HD13 ' HB3' ' A' ' 176' ' ' ALA . 10.5 mt -131.46 104.18 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.274 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -102.72 96.48 6.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.744 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -80.81 122.07 26.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 71.8 t -97.69 154.05 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.5 t -120.17 166.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.389 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.759 HG11 ' HA ' ' A' ' 101' ' ' ILE . 7.4 p -157.51 121.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.45 169.28 27.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.289 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.473 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 4.0 m-20 -87.3 134.11 33.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -171.7 -45.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.95 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 77.31 -66.13 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 82' ' ' PHE . 23.4 m -48.07 -24.67 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.747 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -55.25 -91.09 0.01 OUTLIER Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.162 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 2.1 ttpm? -96.07 -72.84 0.62 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -40.51 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.95 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 69.6 m -49.52 -29.82 7.4 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.22 0.533 . . . . 0.0 110.833 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -53.0 -73.99 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.03 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.5 mt -48.46 -29.45 4.1 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.4 mm -53.69 -65.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.245 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -95.71 -17.96 20.85 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -179.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.608 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -97.24 -40.92 8.53 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.847 ' OG1' HD23 ' A' ' 20' ' ' LEU . 41.2 m -94.56 20.95 7.8 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.083 -0.386 . . . . 0.0 111.668 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.601 HG21 ' CD1' ' B' ' 81' ' ' PHE . 3.3 t -177.13 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.211 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 6.1 m120 81.2 51.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.903 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -133.93 -178.78 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.177 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -123.56 146.55 50.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.89 ' HD3' HG21 ' A' ' 21' ' ' ILE . 3.0 Cg_exo -35.62 146.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.661 2.908 . . . . 0.0 112.975 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -76.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.828 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.77 114.29 25.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.661 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.7 t80 -66.84 111.28 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.072 0.463 . . . . 0.0 111.121 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 87.8 t -159.51 131.3 4.1 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.2 Cg_exo -44.79 92.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.183 1.922 . . . . 0.0 111.451 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.871 HG23 ' CG ' ' A' ' 38' ' ' ASP . 97.8 m -50.72 88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.684 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.976 HG12 ' OH ' ' A' ' 64' ' ' TYR . 2.4 t -79.79 -42.84 22.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.8 t80 -124.76 -68.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.084 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.871 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.1 m-20 54.62 111.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.811 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.4 t-20 -106.99 160.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.038 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -148.29 162.36 39.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -178.667 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.09 148.06 30.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.9 m -151.61 158.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.259 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -154.93 87.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.2 m -99.49 168.22 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.418 ' HE2' ' CB ' ' B' ' 76' ' ' SER . 19.1 mtm -121.44 101.53 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' A' ' 51' ' ' TYR . 6.8 mm -93.32 90.1 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.41 20.35 60.49 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.38 34.43 8.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.558 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 21.5 mt-10 -138.62 138.65 22.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 52.8 Cg_exo -54.65 165.37 2.51 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.53 2.153 . . . . 0.0 112.297 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -152.91 136.93 16.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.6 m -135.4 97.82 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.5 pp -133.67 160.53 37.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.76 123.94 2.47 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.882 ' HB2' HD11 ' A' ' 20' ' ' LEU . 33.8 mt -75.73 117.49 17.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 3.6 m-85 -95.16 116.96 29.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 5.2 t70 -75.96 162.21 28.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.049 HG23 ' CD2' ' A' ' 64' ' ' TYR . 21.9 m -168.08 147.79 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.76 -83.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.079 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.631 ' C ' HD22 ' A' ' 61' ' ' LEU . . . 56.51 19.3 26.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.449 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 60' ' ' GLY . 1.4 mm? 63.73 51.93 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 63.47 28.43 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -125.17 22.38 7.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.049 ' CD2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -86.68 -2.55 58.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.525 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.59 -28.92 0.65 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 110.639 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -73.97 -45.36 50.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.892 HD23 HD21 ' B' ' 107' ' ' LEU . 52.4 mt -89.92 16.5 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -69.36 -59.36 5.03 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.473 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 10.5 Cg_endo -53.84 -19.64 15.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.466 2.11 . . . . 0.0 112.424 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -79.66 -27.44 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.455 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -103.83 -9.65 18.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.511 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 41.77 91.95 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.296 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.442 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 47.9 Cg_exo -55.85 -42.21 69.42 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -69.05 -10.91 59.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.59 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' TYR . 12.2 t -45.02 -48.47 11.59 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.666 0.27 . . . . 0.0 111.565 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -170.74 -159.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' LEU . 10.1 p -58.25 162.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.508 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -111.2 133.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.301 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' OH ' ' A' ' 154' ' ' TYR . 1.3 tp -104.21 116.07 31.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 58.9 t -103.34 154.59 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.416 . . . . 0.0 111.79 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 15' ' ' GLY . 23.8 p -115.2 117.69 31.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.811 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.936 ' CD1' HD21 ' A' ' 112' ' ' LEU . 9.9 t80 -99.12 165.71 11.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.608 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.588 ' HB3' HG21 ' A' ' 93' ' ' VAL . 1.5 t -83.26 136.85 34.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.473 0.654 . . . . 0.0 111.489 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 119' ' ' LEU . 98.8 t -51.68 -81.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.272 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -121.54 -96.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.734 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.732 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.1 t 39.91 93.29 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.532 ' HG3' HD12 ' A' ' 129' ' ' LEU . 84.4 Cg_exo -45.47 -26.78 2.94 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.553 2.168 . . . . 0.0 112.462 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -57.79 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.606 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -47.49 -43.05 24.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.459 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.722 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 t80 -48.13 -67.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.94 -42.43 65.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.112 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -61.39 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 90' ' ' PHE . 28.4 m -47.47 -26.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.666 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.95 -59.7 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.357 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 7.88 8.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -113.36 -41.01 3.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.629 0.252 . . . . 0.0 111.525 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.569 ' HE1' HG12 ' A' ' 93' ' ' VAL . 4.4 m95 -95.54 -43.34 8.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 101' ' ' ILE . 91.1 t -45.14 -58.23 6.01 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 13.9 Cg_endo -57.16 -17.93 27.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.437 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 -28.07 16.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -49.66 -35.6 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.3 -31.56 67.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.56 -43.3 93.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.64 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CE1' HG23 ' A' ' 9' ' ' VAL . 12.1 m80 -76.25 -64.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.207 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 24.4 p -68.32 112.73 11.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.701 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 34.0 Cg_exo -61.07 -66.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.584 2.189 . . . . 0.0 112.341 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -145.93 23.78 1.36 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.8 146.15 33.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.57 173.47 6.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.475 2.117 . . . . 0.0 111.894 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 4.8 p90 -150.28 -179.04 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 77' ' ' VAL . 2.2 mp -137.16 142.99 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.217 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD21 ' CD1' ' A' ' 82' ' ' PHE . 1.3 tp -112.86 125.98 54.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 111.473 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.841 HG13 ' OE2' ' A' ' 156' ' ' GLU . 3.5 t -106.31 135.71 43.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.413 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.04 143.55 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 84' ' ' VAL . 5.2 t -161.05 -169.79 2.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.677 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 172.49 72.57 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.773 0.32 . . . . 0.0 111.368 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 157' ' ' CYS . 14.8 mt -98.75 -67.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.941 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -42.18 18.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -53.56 -44.94 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.664 ' HD3' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -68.34 -19.94 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.37 -28.09 0.8 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.309 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.55 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -54.21 116.2 10.0 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.59 -56.17 3.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.512 2.141 . . . . 0.0 112.639 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -43.82 -39.17 3.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -57.98 -64.01 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.664 HD11 ' HD3' ' A' ' 120' ' ' ARG . 4.6 mp -57.27 -40.54 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -48.92 -38.55 23.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -89.94 -37.37 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.274 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.532 HD12 ' HG3' ' A' ' 87' ' ' PRO . 8.6 tp -48.95 -30.69 6.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.302 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.34 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.635 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -82.39 -25.77 33.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.53 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 7.3 m120 -85.1 -25.22 27.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.976 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 161.41 -23.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.567 0.542 . . . . 0.0 111.304 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 89.67 -43.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.978 0.511 . . . . 0.0 110.553 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.67 50.02 4.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.353 179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.496 ' HG2' HD11 ' A' ' 129' ' ' LEU . 73.2 Cg_endo -76.68 -47.37 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.622 2.214 . . . . 0.0 112.769 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.627 HD12 ' CD1' ' A' ' 90' ' ' PHE . 2.2 mm -106.82 136.67 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 111.211 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -159.74 155.37 22.51 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 5.2 Cg_endo -47.47 -25.29 4.97 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.708 2.272 . . . . 0.0 112.197 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 -35.36 14.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.27 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 136' ' ' PRO . 9.3 m -58.97 -50.21 74.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.007 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.58 11.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.699 ' HG3' HG13 ' A' ' 155' ' ' VAL . 1.4 tt0 -62.76 -39.04 92.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -58.93 -49.16 78.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.662 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 94' ' ' LYS . 5.1 tt -57.44 -36.1 70.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.622 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 112' ' ' LEU . . . -73.43 -23.98 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.73 -41.57 37.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -51.34 -47.3 62.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 149' ' ' LEU . 4.4 pp -70.69 -9.85 58.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.91 116.55 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.64 -176.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 111' ' ' LEU . 63.3 t -64.25 -14.51 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.571 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.638 ' O ' HD23 ' A' ' 111' ' ' LEU . 1.3 pttt 78.78 160.1 0.19 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 111.076 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.779 ' OH ' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -152.57 110.88 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.003 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.699 HG13 ' HG3' ' A' ' 143' ' ' GLU . 2.2 m -118.07 123.5 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.841 ' OE2' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -172.05 -178.33 2.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.532 ' HB2' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -130.5 166.97 19.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.251 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' HG21 ' A' ' 115' ' ' THR . 0.1 OUTLIER -88.6 99.94 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.517 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.697 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 46.22 -175.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.538 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 41.24 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.119 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 75.5 p 40.47 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.984 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.959 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 76.45 79.99 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.821 0.343 . . . . 0.0 110.991 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.67 -68.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.34 57.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.73 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.959 HD22 ' HG3' ' A' ' 162' ' ' GLN . 1.6 tp -93.74 -29.0 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -72.44 -57.4 4.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.434 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 72.4 m-80 -44.09 -56.71 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 111.12 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.42 HG13 ' HE2' ' A' ' 23' ' ' TYR . 2.4 p -55.07 -39.9 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.41 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.26 -25.62 59.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.739 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 4.4 t70 -85.14 -28.61 25.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.722 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 48.2 mm-40 -75.38 -39.58 58.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.89 -44.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.437 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 46' ' ' ILE . 28.7 mm -70.68 -62.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.362 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -54.67 -21.55 11.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.263 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -62.31 -45.52 92.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 111.265 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -75.34 -24.02 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.324 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.43 -29.08 5.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.966 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.5 -63.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tt -138.62 151.21 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' MET . 1.1 t -130.52 167.55 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.769 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -103.7 136.97 19.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.742 ' HG2' HG23 ' A' ' 24' ' ' THR . 51.0 Cg_exo -52.83 178.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.434 2.089 . . . . 0.0 112.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -150.75 -48.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.271 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -49.26 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 25' ' ' THR . 21.6 t80 59.5 119.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 111.04 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -153.23 127.52 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 92.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.282 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.473 ' OG1' HD12 ' B' ' 85' ' ' ILE . 70.1 p -77.22 -85.75 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.662 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -92.94 109.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.745 -179.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -98.11 96.86 8.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.924 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 59.3 t -83.18 143.23 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.652 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.57 177.82 24.65 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.069 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -99.2 125.31 44.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.467 ' CB ' HG23 ' B' ' 97' ' ' THR . 38.3 t0 -137.55 131.58 31.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.809 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 2.28 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.043 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.89 -28.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 120.892 0.377 . . . . 0.0 111.404 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.467 HG21 ' OE2' ' B' ' 95' ' ' GLU . 13.6 t -150.27 -44.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.851 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' GLY . . . . . 0.436 ' N ' HG23 ' B' ' 93' ' ' THR . . . 134.36 34.44 0.28 Allowed Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.448 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' B' ' 93' ' ' THR . 12.0 pt-20 -147.22 -166.6 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.285 . . . . 0.0 110.473 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 67' ' ' LEU . 9.0 m-85 -87.63 162.24 17.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.467 HG23 ' CB ' ' B' ' 90' ' ' ASP . 7.7 p -103.33 163.98 11.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 49.43 27.16 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.171 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -47.65 134.16 10.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.886 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.541 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 59.1 Cg_exo -53.32 142.64 56.62 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.367 2.045 . . . . 0.0 112.205 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' B' ' 102' ' ' GLN . 12.7 pt-20 -45.14 -47.89 12.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.919 0.39 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -69.54 -54.39 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.51 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 70' ' ' LEU . 18.7 m0 -53.15 -61.47 2.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -43.13 -67.69 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.594 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 17.4 mtt85 -48.1 -41.76 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.034 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.71 -56.68 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.78 -70.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.252 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.705 ' O ' HG23 ' B' ' 109' ' ' THR . 7.2 tt0 -79.05 -96.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.684 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.705 HG23 ' O ' ' B' ' 108' ' ' GLN . 9.3 p -165.68 -55.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.758 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 15.8 m -126.02 -179.32 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' B' ' 99' ' ' MET . 0.7 OUTLIER -66.77 -59.66 3.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.698 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.554 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.805 0.336 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -124.81 125.55 44.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 111.68 23.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' HB1' ' A' ' 176' ' ' ALA . 2.1 mt -129.22 132.23 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.265 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -113.57 157.46 22.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.397 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -128.74 112.97 14.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 73' ' ' PRO . 10.7 t -87.04 98.67 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 16' ' ' LYS . 22.5 m -114.4 145.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.597 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 58' ' ' THR . 32.8 m -137.94 121.34 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.54 167.41 38.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.852 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.09 -62.48 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.057 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.69 -137.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.597 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . . . -173.27 30.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.838 HG11 ' HA2' ' A' ' 114' ' ' GLY . 2.8 t -65.14 -12.52 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . -120.25 -24.84 2.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.644 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.643 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.21 -74.36 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.423 0.612 . . . . 0.0 112.159 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.465 ' O ' HD13 ' A' ' 21' ' ' ILE . 25.8 m -77.92 -63.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.706 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 13.0 m -49.09 -45.5 43.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.079 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.685 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.4 tm? -39.73 -72.65 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.213 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 19' ' ' LEU . 16.8 mt -61.99 -19.27 62.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.602 0.239 . . . . 0.0 111.205 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 25' ' ' THR . 1.0 OUTLIER -67.97 -48.22 75.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.357 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 m -93.28 -20.54 20.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.662 0.268 . . . . 0.0 111.239 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.736 ' CE1' HD22 ' A' ' 165' ' ' LEU . 4.4 m-30 -84.0 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.83 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 42' ' ' VAL . 85.0 m -87.75 -83.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.238 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -49.12 -26.98 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.257 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 p-10 47.19 41.97 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 110.821 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -132.51 134.89 45.56 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -59.49 154.36 44.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.498 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 57.9 Cg_exo -34.9 145.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.18 2.587 . . . . 0.0 113.221 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.02 -83.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -100.93 115.67 30.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.92 103.5 4.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HD2' ' A' ' 34' ' ' PRO . 66.1 t -152.98 139.43 12.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD2' HG13 ' A' ' 33' ' ' VAL . 98.6 Cg_exo -42.02 92.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.5 2.133 . . . . 0.0 111.737 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.712 HG23 ' CG ' ' A' ' 38' ' ' ASP . 72.7 m -52.97 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.552 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.838 HG11 ' CD2' ' B' ' 96' ' ' PHE . 23.8 t -74.99 -32.74 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' HG21 ' B' ' 87' ' ' VAL . 3.2 t80 -144.96 -66.28 0.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.729 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.712 ' CG ' HG23 ' A' ' 35' ' ' THR . 4.4 m-20 55.18 108.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.391 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.513 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 46.9 t-20 -107.63 157.21 18.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.008 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.93 167.71 26.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.952 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 82' ' ' GLU . . . -123.12 156.98 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 53' ' ' LEU . 15.6 m -160.71 147.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.087 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.3 m -124.08 101.41 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.543 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 173' ' ' ILE . 15.8 m -98.61 141.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.5 mtm -105.18 100.19 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.738 HD13 ' CE1' ' A' ' 51' ' ' TYR . 5.1 mp -104.77 92.78 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.73 16.69 61.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.395 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.98 38.8 6.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.603 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 20.1 mt-10 -141.64 139.17 18.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.656 0.265 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.1 168.07 14.79 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.642 2.228 . . . . 0.0 112.387 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.738 ' CE1' HD13 ' A' ' 46' ' ' ILE . 4.9 m-85 -152.08 160.75 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.289 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -136.06 97.4 3.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.233 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 42' ' ' VAL . 7.7 tt -132.59 160.55 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.207 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.7 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -156.42 139.88 6.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 79' ' ' LEU . 1.1 mt -79.33 104.13 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.057 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' ' HD2' ' A' ' 5' ' ' LYS . 4.2 m-85 -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' OD2' HG21 ' A' ' 35' ' ' THR . 4.8 t0 -71.38 -169.46 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.746 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 9' ' ' VAL . 4.0 m -166.99 163.57 15.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . . . -92.79 -74.69 0.51 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.936 ' O ' HD13 ' A' ' 61' ' ' LEU . . . 131.74 61.57 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.851 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -132.31 -168.57 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.98 86.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 3.4 t0 76.03 43.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.041 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 5.0 t80 50.63 35.72 12.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.1 -152.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 18.8 mmt180 -87.52 -1.39 57.91 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.132 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.821 ' CG ' HD12 ' A' ' 70' ' ' LEU . 4.1 mp -81.97 58.28 3.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -63.59 -70.06 0.51 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.7 Cg_endo -68.23 -22.5 40.27 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.026 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.821 HD12 ' CG ' ' A' ' 67' ' ' LEU . 3.9 mt -57.48 -20.65 32.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.022 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.08 -34.12 6.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.541 ' CG ' ' HB ' ' A' ' 75' ' ' THR . 1.0 OUTLIER 66.04 76.33 0.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.673 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.926 ' HA ' HG21 ' A' ' 7' ' ' VAL . 77.8 Cg_exo -50.58 -55.18 4.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.854 2.369 . . . . 0.0 112.974 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -67.46 -8.04 30.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.774 HG22 HG23 ' A' ' 7' ' ' VAL . 8.8 t -33.05 -53.94 0.37 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER 170.47 -161.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.802 0.335 . . . . 0.0 111.024 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.92 HG22 ' HG2' ' A' ' 109' ' ' PRO . 66.2 t -58.98 150.28 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 39.1 p90 -139.93 128.74 23.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.901 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 55' ' ' LEU . 1.8 pt? -103.77 116.23 31.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 9' ' ' VAL . 10.1 t -94.24 154.53 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.482 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.7 p -67.08 171.84 5.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.355 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 t80 -163.78 105.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.81 0.338 . . . . 0.0 111.335 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -58.63 111.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.759 HG13 HG21 ' A' ' 137' ' ' ILE . 90.8 t -103.02 87.21 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 111.164 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.781 HG11 HD22 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 169.12 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.481 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.719 ' N ' HG22 ' A' ' 85' ' ' VAL . 68.2 m -46.99 103.59 0.37 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 111.025 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.62 -40.12 80.46 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.48 2.12 . . . . 0.0 112.363 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.8 t -53.6 -25.33 17.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.029 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 -36.7 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.025 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -49.35 -60.13 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.86 -31.9 73.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.6 m-20 -69.29 -61.9 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.744 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 29.9 m -48.73 -36.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.313 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -61.31 -63.07 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -82.68 8.01 13.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.895 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.9 tttt -117.23 -36.53 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.674 0.274 . . . . 0.0 111.338 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.744 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 28.5 m0 -93.38 -41.55 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.261 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.4 t -48.91 -57.96 9.86 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.3 Cg_endo -59.11 -18.04 41.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 112.305 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -84.76 -51.24 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.851 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 7.6 pt -51.29 -24.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.1 p -74.78 -28.99 60.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.362 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -70.87 -35.14 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.529 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.537 ' ND1' HG11 ' A' ' 9' ' ' VAL . 5.8 m80 -107.71 -2.43 20.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.739 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 3.5 m -149.62 58.03 3.09 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.63 55.9 5.07 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.747 2.298 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt 176.9 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.364 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 t -73.17 146.07 86.6 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.92 ' HG2' HG22 ' A' ' 77' ' ' VAL . 20.0 Cg_endo -60.29 178.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.644 2.229 . . . . 0.0 111.961 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 33.6 p90 -137.31 158.79 43.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD21 ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -135.14 127.53 30.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.475 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -104.31 101.38 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.064 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG12 ' OE1' ' A' ' 156' ' ' GLU . 3.5 m -107.43 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.838 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -168.74 159.13 32.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.805 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.873 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -167.89 -64.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 0.0 110.756 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 119' ' ' LEU . 0.2 OUTLIER 48.86 60.43 3.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.007 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 157' ' ' CYS . 9.1 mt -65.71 -31.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.821 ' HB3' HD23 ' A' ' 160' ' ' LEU . 11.9 p-10 -81.75 -49.15 10.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 85' ' ' VAL . 9.3 tt -49.65 -49.19 48.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.789 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.0 t0 75.96 31.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.668 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -93.73 157.32 38.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.35 -39.75 5.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -25.75 59.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.9 m -56.21 -68.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -46.81 -40.86 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.415 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -62.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.12 -34.83 68.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -50.3 -25.86 4.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.418 . . . . 0.0 110.706 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.76 46.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.39 26.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.082 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.411 ' HB3' ' HD3' ' A' ' 133' ' ' LYS . 11.4 m120 -93.02 -30.0 15.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -175.01 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 169.02 146.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 129' ' ' LEU . 5.8 mmmt 60.61 145.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 140.97 70.57 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 84' ' ' VAL . 4.3 mt -50.71 126.3 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -98.75 167.3 11.61 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.338 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' HG23 ' A' ' 115' ' ' THR . 52.1 Cg_exo -53.39 -22.98 22.57 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.827 2.351 . . . . 0.0 112.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.22 -35.67 14.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.488 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.479 ' CG2' HG23 ' A' ' 137' ' ' ILE . 22.9 m -46.45 -42.5 15.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.057 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -51.29 56.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 6.1 tm-20 -54.57 -38.79 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -52.12 -55.87 18.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.287 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 145' ' ' LEU . 3.9 tt -54.33 -32.67 57.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.069 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.929 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.51 -49.75 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.664 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.606 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -25.43 58.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.0 pp -122.65 19.89 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.21 -83.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 176.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 152' ' ' VAL . 78.7 t -76.02 -7.35 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.78 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.457 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER 82.85 141.35 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.694 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.929 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 5.8 p90 -153.21 153.4 32.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.799 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.0 m -158.56 123.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.413 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.429 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -165.75 157.97 14.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.993 0.425 . . . . 0.0 111.482 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.873 ' HA ' HG21 ' A' ' 115' ' ' THR . 1.8 m -119.01 -173.51 2.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.172 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.29 152.68 22.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.507 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -40.48 -76.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.567 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -36.05 -33.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.652 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -82.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 63.41 97.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -65.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.06 75.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.685 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.736 HD22 ' CE1' ' A' ' 23' ' ' TYR . 4.5 pp -93.13 -10.15 36.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.771 0.32 . . . . 0.0 111.377 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -49.77 -26.33 3.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.851 0.358 . . . . 0.0 110.179 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.99 -51.28 68.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 155' ' ' VAL . 98.6 t -53.7 -49.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.31 -33.36 73.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.314 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.504 ' CG ' HG21 ' B' ' 75' ' ' ILE . 63.6 t0 -68.85 -36.94 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.76 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -44.83 27.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.59 62.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 44' ' ' VAL . 16.7 mt -82.62 -43.76 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.2 -52.78 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -51.46 -33.14 29.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -90.83 -26.96 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -49.94 -51.25 42.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 62.9 m -50.29 -80.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.625 HD11 ' CD1' ' A' ' 173' ' ' ILE . 5.9 tt -119.6 151.95 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.194 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -134.14 165.64 24.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -87.87 137.93 31.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 44' ' ' VAL . 38.4 Cg_endo -66.68 -167.46 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.613 2.209 . . . . 0.0 112.131 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.421 ' O ' ' N ' ' B' ' 81' ' ' PHE . 81.1 p -168.34 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.43 78.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 86.2 t80 -74.66 152.01 39.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.62 96.3 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.606 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -68.96 69.75 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.161 0.505 . . . . 0.0 109.662 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.554 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -43.79 -85.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.794 HG21 ' N ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -112.59 130.79 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -111.63 97.15 6.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.387 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 37' ' ' PHE . 16.6 t -77.84 157.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 112.047 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.27 177.89 24.32 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -112.16 123.01 49.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.526 ' CB ' HG21 ' B' ' 97' ' ' THR . 14.8 t0 -140.26 127.84 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.733 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.59 -5.8 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.793 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.803 HG13 HG23 ' B' ' 93' ' ' THR . 7.6 p -43.59 -29.09 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-O 120.802 0.334 . . . . 0.0 111.656 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.803 HG23 HG13 ' B' ' 92' ' ' VAL . 3.5 p -153.89 24.3 0.5 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.55 37.22 74.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.83 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.82 179.8 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.722 0.296 . . . . 0.0 110.878 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.838 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -74.76 164.13 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.526 HG21 ' CB ' ' B' ' 90' ' ' ASP . 27.1 p -126.6 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.163 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' B' ' 111' ' ' ASN . . . 51.72 29.67 26.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.58 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.73 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -74.4 164.77 58.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.081 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.794 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.0 Cg_exo -53.78 142.23 63.11 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.707 2.272 . . . . 0.0 112.343 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -45.71 -60.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -50.34 72.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.61 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.787 ' CE3' HD23 ' A' ' 67' ' ' LEU . 6.2 m0 -46.8 -63.38 1.04 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 110.411 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -51.01 -60.06 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 31.2 mtt-85 -48.77 -41.04 31.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.136 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.691 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.02 -56.73 8.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.47 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -95.06 -68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.062 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.742 ' O ' HG23 ' B' ' 109' ' ' THR . 4.8 tp-100 -77.87 -101.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.338 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.742 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.0 p -167.08 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.337 0.061 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.679 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 5.0 m -140.42 172.77 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.7 OUTLIER -56.96 -67.21 0.34 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -71.2 132.65 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 m -94.24 112.81 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' HB1' ' A' ' 176' ' ' ALA . 2.9 mt -114.92 133.09 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 104.34 7.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' HB3' HD23 ' A' ' 79' ' ' LEU . 14.3 m -77.33 99.06 5.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.665 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.73 HG11 ' CE1' ' A' ' 104' ' ' HIS . 10.8 t -84.61 159.45 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 79' ' ' LEU . 58.4 t -130.47 148.73 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 101' ' ' ILE . 12.6 p -138.41 132.64 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.92 146.11 17.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.631 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -72.05 126.22 29.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.89 -42.16 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.603 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' CYS . . . 47.8 38.9 9.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 83' ' ' SER . 1.9 t -109.27 -14.01 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.77 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -135.67 -55.3 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -43.11 -66.26 0.39 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.171 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.736 ' O ' HD13 ' A' ' 21' ' ' ILE . 88.7 m -95.15 -50.53 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -50.5 -44.39 56.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.326 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 55' ' ' LEU . 18.1 tp -50.09 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.003 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.083 HD21 HD13 ' A' ' 55' ' ' LEU . 3.9 mt -51.14 -29.95 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 120.653 0.263 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -55.71 -69.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.353 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.519 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -90.79 -10.49 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.757 ' CD2' HD12 ' A' ' 165' ' ' LEU . 7.7 t80 -95.37 -59.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.677 HG21 ' CG1' ' A' ' 42' ' ' VAL . 63.5 m -73.67 -45.61 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.333 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -113.97 3.83 15.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.5 p30 43.38 58.06 3.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 111.741 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.8 pttt -134.0 -164.74 1.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.511 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.528 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -134.21 166.45 29.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 46.5 Cg_exo -36.02 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.147 2.565 . . . . 0.0 113.47 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.64 -85.22 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.368 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.709 0.29 . . . . 0.0 110.286 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.1 t80 -80.91 106.39 12.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 111.623 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' THR . 12.7 m -158.99 145.3 12.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.093 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 36' ' ' VAL . 81.2 Cg_exo -44.73 88.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.825 HG23 ' CG ' ' A' ' 38' ' ' ASP . 66.0 m -55.19 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.386 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG11 ' CZ ' ' B' ' 96' ' ' PHE . 3.6 t -84.34 -21.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.651 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.2 t80 -147.96 -65.36 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.627 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.825 ' CG ' HG23 ' A' ' 35' ' ' THR . 7.4 m-20 54.33 109.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.271 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB3' HD12 ' B' ' 85' ' ' ILE . 28.0 t-20 -106.88 147.99 29.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.12 0.486 . . . . 0.0 110.968 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.629 ' CG ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -139.07 169.2 18.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.785 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -111.81 141.55 45.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.306 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.677 ' CG1' HG21 ' A' ' 24' ' ' THR . 2.4 m -162.83 159.57 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.35 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 51' ' ' TYR . 54.8 m -145.37 104.41 3.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.175 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.075 HG11 HD13 ' A' ' 173' ' ' ILE . 42.2 t -98.27 117.51 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.6 mtm -76.68 99.96 5.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.683 HD11 ' CG2' ' A' ' 173' ' ' ILE . 66.0 mt -92.96 89.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.0 70.12 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.572 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.53 -17.82 30.51 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.859 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -91.29 138.85 25.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.66 0.267 . . . . 0.0 111.112 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -68.73 166.49 25.95 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.625 2.217 . . . . 0.0 112.341 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 43' ' ' THR . 23.1 m-85 -153.94 173.73 15.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 97.26 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -101.68 161.31 13.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -159.82 118.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.425 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.083 HD13 HD21 ' A' ' 20' ' ' LEU . 5.5 mp -75.88 105.62 7.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.362 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -83.23 103.46 12.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.036 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.8 OUTLIER -75.67 172.68 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.739 HG23 ' CE1' ' A' ' 64' ' ' TYR . 2.2 m -167.05 171.37 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . . . -102.48 -161.07 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 61' ' ' LEU . . . -60.18 -16.08 39.98 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.75 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD13 HG23 ' A' ' 9' ' ' VAL . 1.5 tp 80.17 132.58 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 0.0 111.228 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 35.9 tt0 169.86 -34.91 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.593 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -116.21 -12.41 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.712 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.739 ' CE1' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -48.83 -33.96 11.54 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -47.49 -28.07 2.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.053 0.454 . . . . 0.0 110.424 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -82.04 -46.77 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.234 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.023 HD22 ' CE2' ' B' ' 96' ' ' PHE . 1.4 mp -92.49 49.56 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -99.65 -31.17 0.23 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 28.0 Cg_exo -37.14 -49.8 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.486 2.124 . . . . 0.0 114.025 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' B' ' 103' ' ' TRP . 0.1 OUTLIER -94.8 32.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 72' ' ' TYR . 4.4 p -134.04 -52.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.6 OUTLIER 41.56 98.89 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.805 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 105' ' ' CYS . 82.3 Cg_exo -45.62 -34.63 11.62 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.523 2.149 . . . . 0.0 112.579 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.93 -10.37 52.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.591 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 13.7 t -37.66 -49.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 165.79 -165.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.678 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 109' ' ' PRO . 10.9 p -64.84 125.69 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.766 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CD1' ' CB ' ' A' ' 105' ' ' CYS . 42.4 p90 -96.54 133.81 40.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.587 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 8' ' ' VAL . 2.2 pp -103.59 116.05 31.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.1 t -94.99 154.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 15' ' ' GLY . 5.8 p -111.5 160.0 17.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 111.385 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 82' ' ' PHE . 40.7 p90 -152.66 103.9 2.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 14' ' ' VAL . 22.8 t -54.5 118.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.001 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -88.74 81.86 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.223 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' HD22 ' A' ' 119' ' ' LEU . 1.6 m -131.68 79.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.456 ' C ' HD11 ' A' ' 137' ' ' ILE . 5.5 m 71.23 151.08 0.14 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' N ' HD11 ' A' ' 137' ' ' ILE . 55.1 Cg_exo -52.15 -22.03 14.18 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.541 2.161 . . . . 0.0 112.419 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -52.49 -32.43 40.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -91.09 -30.83 16.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.016 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -47.55 -65.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.17 -28.43 67.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 23.2 m-20 -69.84 -84.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 89' ' ' SER . 2.3 m -43.75 -29.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.693 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 12.6 tttt -70.57 -69.39 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -81.44 7.63 11.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.064 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.1 -42.59 3.92 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.413 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.743 ' CD1' HG12 ' A' ' 93' ' ' VAL . 12.7 m95 -95.27 -43.36 8.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 68.7 t -48.41 -44.36 64.23 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.57 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 48.0 Cg_exo -55.68 -23.43 40.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.017 1.811 . . . . 0.0 112.166 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -93.53 -30.01 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.854 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.882 ' HA ' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -49.43 -26.41 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.138 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.418 ' N ' HG13 ' A' ' 101' ' ' ILE . 19.6 p -77.4 -32.13 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -64.54 -49.6 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.73 ' CE1' HG11 ' A' ' 7' ' ' VAL . 55.4 t-80 -65.54 -66.94 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.53 ' CB ' ' CD1' ' A' ' 78' ' ' PHE . 1.2 m -104.5 90.83 3.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 42.9 Cg_endo -67.92 118.04 5.33 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.675 2.25 . . . . 0.0 112.572 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.3 51.99 15.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.235 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.709 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.3 OUTLIER -132.87 144.09 51.41 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.709 ' HD2' HG22 ' A' ' 108' ' ' THR . 99.2 Cg_exo -42.0 147.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.512 2.141 . . . . 0.0 112.102 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.7 p90 -139.41 139.38 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -126.93 119.81 27.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.42 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 1.8 mt -90.34 102.12 14.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.72 96.75 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 14' ' ' VAL . . . -117.61 -119.42 2.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.798 HG21 ' HA ' ' A' ' 157' ' ' CYS . 20.2 m 69.11 167.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 111.438 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.492 ' OE1' HD13 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 176.43 112.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.484 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 157' ' ' CYS . 54.4 mt -91.82 -22.61 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.411 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.83 -44.23 7.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.469 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.533 HD22 ' CG1' ' A' ' 85' ' ' VAL . 1.9 tt -74.7 -47.87 29.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -48.99 -29.39 4.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.107 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.96 51.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 126' ' ' ILE . 11.3 m-20 -114.23 142.06 27.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.39 -21.64 18.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.552 2.168 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -43.17 57.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 p -56.36 -62.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -48.54 -46.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.41 -58.78 3.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.24 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -36.12 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.906 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -26.43 3.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.39 64.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -85.32 -41.5 15.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -61.39 -23.37 65.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.99 64.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.19 -171.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 167.6 9.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.15 120.93 6.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.538 2.158 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 87' ' ' PRO . 7.8 mt -56.61 121.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.235 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -117.96 164.8 18.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.833 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 115' ' ' THR . 75.3 Cg_exo -49.16 -26.21 10.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.568 2.179 . . . . 0.0 112.311 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.78 -51.05 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.6 m -54.87 -55.79 26.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.11 -49.18 52.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' CD ' HG12 ' A' ' 155' ' ' VAL . 7.9 mt-10 -54.61 -42.09 70.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -46.85 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.689 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.832 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -55.98 -48.72 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.867 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.81 68.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -70.36 -43.59 69.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.769 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -59.44 -26.25 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.6 pp -103.15 -23.26 13.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.999 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 149' ' ' LEU . 26.4 tptt 60.25 116.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -162.08 -161.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.299 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 111' ' ' LEU . 9.2 p -44.93 -43.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.494 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 89.95 145.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.452 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.495 ' O ' HG13 ' A' ' 155' ' ' VAL . 48.8 p90 -153.05 150.97 29.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.885 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.604 HG12 ' CD ' ' A' ' 143' ' ' GLU . 8.4 m -158.36 122.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.434 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.671 ' CG ' HG11 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -172.04 124.74 0.53 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.553 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.798 ' HA ' HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -128.51 119.52 25.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.71 ' OG ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -156.99 175.19 14.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.386 0.612 . . . . 0.0 112.497 -177.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.823 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 136.15 88.93 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.899 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.823 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 58.73 26.01 14.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 p -147.85 -72.08 0.21 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.815 ' OE1' HD11 ' A' ' 165' ' ' LEU . 3.2 mt-30 75.51 114.12 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.248 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 3.4 tttt -105.9 -45.12 4.45 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.11 71.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.621 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.815 HD11 ' OE1' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -95.05 -16.91 22.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.973 0.416 . . . . 0.0 111.25 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.414 ' HA ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.32 -24.92 2.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 13.7 m120 -71.79 -61.38 1.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.478 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 156' ' ' GLU . 11.4 p -45.52 -32.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.781 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.1 t80 -77.04 -35.28 56.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.853 ' CG ' HD12 ' B' ' 75' ' ' ILE . 3.8 t70 -58.25 -35.52 71.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.357 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 6.7 mm-40 -76.14 -44.5 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.777 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.98 64.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.989 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 1.075 HD13 HG11 ' A' ' 44' ' ' VAL . 5.1 mt -93.63 -54.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -59.8 -29.73 68.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -54.87 -33.72 62.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.95 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 4' ' ' ILE . . . -80.23 -23.51 40.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.68 42.04 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 75' ' ' ILE . 5.2 p 69.7 -62.19 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 170' ' ' ASP . 8.6 mt -144.1 137.21 23.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.55 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.4 m -131.59 152.48 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.99 145.92 99.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.745 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.471 ' HB2' HG23 ' A' ' 24' ' ' THR . 61.0 Cg_exo -52.65 -167.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.552 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 84.3 p -149.67 -79.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.85 119.7 12.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.62 ' HB2' HG22 ' A' ' 24' ' ' THR . 12.8 t80 -132.78 130.23 39.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.658 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.33 136.45 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 90.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -81.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.59 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.654 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.1 mp -115.59 110.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.78 0.324 . . . . 0.0 111.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 86' ' ' HIS . 8.7 p80 -85.4 96.84 9.69 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.0 t -87.83 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.225 0.536 . . . . 0.0 112.304 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' B' ' 96' ' ' PHE . . . -142.61 177.8 21.49 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.362 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 2.6 t80 -101.05 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.3 0.55 . . . . 0.0 111.141 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.855 ' HB2' HG23 ' B' ' 97' ' ' THR . 9.0 t0 -140.47 114.48 9.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.622 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.73 -5.17 31.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.973 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 1.076 HG13 HG22 ' B' ' 93' ' ' THR . 14.7 p -45.74 -28.24 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.859 0.362 . . . . 0.0 111.176 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' THR . . . . . 1.076 HG22 HG13 ' B' ' 92' ' ' VAL . 0.0 OUTLIER -149.25 18.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.08 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.59 17.44 64.61 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.901 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.887 ' HG2' HG23 ' B' ' 93' ' ' THR . 18.6 pt-20 -128.62 -163.28 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.719 0.295 . . . . 0.0 110.708 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 1.023 ' CE2' HD22 ' A' ' 67' ' ' LEU . 6.6 m-30 -96.04 164.62 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.855 HG23 ' HB2' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -95.69 136.39 36.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.437 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 49.12 36.91 22.46 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.995 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -77.56 165.63 49.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.243 0.544 . . . . 0.0 112.31 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.654 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.5 Cg_exo -54.69 141.6 75.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.116 2.544 . . . . 0.0 112.26 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -56.02 -22.25 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 110.399 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.786 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.77 -64.73 0.81 Allowed 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.995 ' CG ' HD11 ' A' ' 70' ' ' LEU . 4.7 m0 -51.44 -60.09 3.52 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.437 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.834 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -40.51 -65.25 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 21.7 mtp85 -62.68 -35.48 79.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.768 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.593 HD23 ' O ' ' B' ' 102' ' ' GLN . 0.9 OUTLIER -49.64 -55.49 13.5 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -96.43 -72.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.138 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.47 ' C ' HG22 ' B' ' 109' ' ' THR . 5.4 tp-100 -82.67 -105.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.565 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 1.4 t 156.03 58.77 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.194 0.598 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.834 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER 172.02 126.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.972 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 66.9 m-20 -50.49 -70.49 0.08 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.611 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.15 121.35 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.81 120.47 40.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.61 130.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' O ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -135.83 96.61 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.965 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 77' ' ' VAL . 8.2 m -80.35 147.01 31.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 8' ' ' VAL . 4.4 t -122.16 159.88 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.431 . . . . 0.0 111.669 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.749 HG11 ' HA3' ' A' ' 15' ' ' GLY . 6.5 m -123.0 169.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.795 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 58' ' ' THR . 11.1 m -157.51 120.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.014 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 145.17 -161.78 28.15 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.702 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -118.25 169.26 9.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.733 0.301 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 90.54 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.223 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.588 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . 53.47 71.7 0.48 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.742 0.306 . . . . 0.0 110.244 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.674 HG23 HG21 ' A' ' 8' ' ' VAL . 1.6 m -47.07 -25.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.749 ' HA3' HG11 ' A' ' 8' ' ' VAL . . . 140.85 -40.45 1.36 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.577 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -97.46 -74.23 0.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.919 ' O ' HD13 ' A' ' 21' ' ' ILE . 5.1 t -35.37 -51.81 0.61 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.687 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.26 -45.99 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.726 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.766 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -59.36 -68.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.48 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 55' ' ' LEU . 17.7 mt -40.71 -45.38 2.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.159 0.504 . . . . 0.0 111.148 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -46.26 -70.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.547 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.63 ' N ' HG22 ' A' ' 21' ' ' ILE . 14.5 t -95.2 -60.76 1.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.243 0.544 . . . . 0.0 111.564 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.766 ' CD1' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -44.43 -26.63 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.929 -178.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.612 HG21 HG11 ' A' ' 42' ' ' VAL . 99.1 m -109.16 -89.92 0.47 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.195 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 27' ' ' LYS . 1.4 t -64.14 -19.91 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.697 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.7 t30 70.41 32.75 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.355 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' A' ' 25' ' ' THR . 4.9 ttpt -127.9 138.04 52.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HA ' HG23 ' A' ' 21' ' ' ILE . 1.6 m-85 -81.67 149.29 63.88 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.736 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.11 153.89 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.788 2.326 . . . . 0.0 112.723 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -108.06 -71.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.67 109.76 17.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.608 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.83 92.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 73.3 t -138.1 131.29 16.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.426 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 97.9 Cg_exo -42.26 93.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 111.837 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.932 HG23 ' HB2' ' A' ' 38' ' ' ASP . 81.5 m -51.48 87.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.38 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 96' ' ' PHE . 93.8 t -77.05 -37.43 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.755 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.7 t80 -136.38 -63.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.745 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.932 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.5 t0 56.25 114.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.596 ' HB3' HD12 ' B' ' 85' ' ' ILE . 10.5 t-20 -108.11 153.09 23.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.379 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.616 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -144.33 169.25 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 0.0 111.343 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.66 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -110.07 138.08 46.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 41' ' ' ALA . 2.3 m -162.37 139.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.302 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 51' ' ' TYR . 51.6 m -132.71 110.85 10.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.188 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 HD11 ' B' ' 75' ' ' ILE . 60.6 t -98.07 117.07 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mtm -94.42 100.28 12.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.129 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.77 HD11 ' CG2' ' A' ' 173' ' ' ILE . 8.6 mt -93.13 114.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 17.94 78.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.02 29.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.524 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.09 130.41 63.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.504 0.192 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.11 160.38 42.78 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.595 2.197 . . . . 0.0 112.405 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.927 ' O ' HG23 ' A' ' 43' ' ' THR . 36.2 m-85 -146.74 165.19 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.157 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -121.11 97.67 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.497 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.892 HD21 ' CD2' ' A' ' 55' ' ' LEU . 7.2 tt -113.79 157.23 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.732 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.9 113.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 20' ' ' LEU . 2.3 mt -90.32 117.19 28.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.389 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -89.27 144.53 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.063 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD2' HG21 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -104.44 -163.69 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.904 0.383 . . . . 0.0 111.536 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.56 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.2 m -153.53 161.04 42.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 58' ' ' THR . . . -61.45 -49.93 74.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.45 -22.85 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.366 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.672 HD13 ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -115.55 176.37 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.784 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 100' ' ' GLU . 1.8 mp0 -81.94 67.75 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.672 ' OD1' HD13 ' A' ' 61' ' ' LEU . 6.0 m-20 -132.08 19.4 4.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CD1' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -89.61 -10.37 46.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.253 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.15 -31.02 0.86 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.834 0.35 . . . . 0.0 111.022 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -71.9 -39.76 69.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.476 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.056 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 23.5 mt -90.09 6.54 42.01 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.299 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -47.74 -43.02 49.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_exo -60.5 -19.0 57.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.209 1.939 . . . . 0.0 112.021 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.938 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -106.5 -48.22 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.817 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 33.75 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -41.04 153.73 0.23 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.463 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' HIS . 97.7 Cg_endo -84.74 -25.27 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.743 2.295 . . . . 0.0 112.774 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -65.51 -11.19 41.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.739 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 5' ' ' LYS . 2.5 t -42.99 -54.18 4.39 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER 178.45 -152.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.774 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -57.42 158.22 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.681 0.277 . . . . 0.0 110.676 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 77' ' ' VAL . 1.4 m-85 -115.47 145.79 42.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.69 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 mm? -104.05 135.7 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.846 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 101' ' ' ILE . 3.0 t -115.56 153.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.981 0.419 . . . . 0.0 111.729 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 23.0 p -110.05 155.28 22.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.845 ' HA ' HG11 ' A' ' 93' ' ' VAL . 30.9 p90 -178.9 109.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -54.28 -170.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.563 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 85' ' ' VAL . 26.9 m -152.06 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.429 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -47.18 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.474 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.468 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.6 m -68.43 110.72 6.27 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.498 0.19 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.534 ' CG ' HD22 ' A' ' 129' ' ' LEU . 34.2 Cg_exo -57.79 -21.87 50.45 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.527 2.152 . . . . 0.0 112.389 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -30.62 46.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.162 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 m -92.98 -26.99 17.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -48.73 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.197 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.62 -43.64 36.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -54.87 -69.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 82' ' ' PHE . 93.2 t -39.66 -44.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.933 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.74 -69.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.673 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.74 8.23 8.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -116.76 -43.72 2.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.715 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.609 ' HD1' HG13 ' A' ' 93' ' ' VAL . 13.8 m95 -95.64 -39.09 10.08 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.5 t -51.63 -45.47 91.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.489 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.3 Cg_exo -46.45 -38.44 21.04 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.359 2.039 . . . . 0.0 112.359 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.977 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 80' ' ' VAL . 19.6 mm -49.28 -26.66 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 p -90.34 -22.4 21.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -69.14 -37.31 78.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.673 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 73' ' ' PRO . 32.7 m-70 -103.71 -70.6 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.662 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.78 108.73 1.51 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.43 -65.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.25 28.42 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.842 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -95.61 148.16 34.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . 53.1 Cg_exo -53.71 161.61 4.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.523 2.148 . . . . 0.0 112.157 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -128.0 126.14 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 111.073 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.603 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -105.08 120.57 41.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.496 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.864 HD12 ' OH ' ' A' ' 154' ' ' TYR . 2.8 mt -90.68 149.31 22.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.638 HG21 HD13 ' A' ' 19' ' ' LEU . 29.2 m -156.82 173.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.951 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.751 ' O ' HG22 ' A' ' 115' ' ' THR . . . 138.36 -125.94 3.33 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.634 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 114' ' ' GLY . 0.6 OUTLIER 77.59 148.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.308 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 119' ' ' LEU . 16.7 mp0 -137.38 128.49 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 157' ' ' CYS . 62.0 mt -98.65 -38.38 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.13 -23.46 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.444 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 85' ' ' VAL . 1.3 tt -73.02 -15.31 61.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.474 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -69.3 -163.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.727 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 22.95 13.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.127 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.556 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.2 m-20 -86.84 141.89 33.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.799 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.71 -46.97 29.79 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -69.06 -33.34 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.6 m -52.59 -66.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.97 -38.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.014 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.73 -61.52 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -35.77 77.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.675 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.534 HD22 ' CG ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -50.2 -26.21 4.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.488 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.02 -23.08 63.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -85.15 -24.6 27.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -95.1 29.27 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.6 34.8 2.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 52.33 -162.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt 65.88 89.23 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.4 ' HA ' HD11 ' A' ' 129' ' ' LEU . 50.1 Cg_exo -55.35 143.63 75.68 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.576 2.184 . . . . 0.0 112.319 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.543 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.0 mt -56.49 121.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.7 p -106.07 172.39 3.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 52.3 Cg_exo -55.62 -19.95 25.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.696 2.264 . . . . 0.0 112.318 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -85.53 -31.62 22.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 137' ' ' ILE . 85.6 m -59.93 -48.49 81.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.946 0.403 . . . . 0.0 110.676 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.566 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -50.6 -47.97 58.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.688 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.42 -41.73 73.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.304 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -47.22 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD21 ' HE2' ' A' ' 94' ' ' LYS . 6.6 tp -59.56 -35.83 75.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -65.18 -30.63 71.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.083 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -75.1 -51.25 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -52.42 -48.01 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.86 -26.88 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 65.19 122.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.975 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -165.03 -160.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.591 ' HB ' HD12 ' A' ' 111' ' ' LEU . 17.3 t -61.37 -16.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.546 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.31 144.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.567 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.891 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 37.5 p90 -152.15 144.09 23.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 124.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.03 -178.69 2.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HA ' HG21 ' A' ' 115' ' ' THR . 14.6 p -133.09 -173.18 3.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.36 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 t -87.48 159.66 18.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.787 0.327 . . . . 0.0 110.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.619 ' CB ' HD22 ' A' ' 160' ' ' LEU . . . -56.32 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 161' ' ' THR . 0.6 OUTLIER 51.6 33.89 11.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.253 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 160' ' ' LEU . 1.4 p -167.82 -84.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.197 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.55 ' OE1' HD22 ' A' ' 165' ' ' LEU . 2.2 mt-30 73.43 104.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.019 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 -68.53 0.86 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.963 0.411 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.53 77.5 0.39 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.928 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 23' ' ' TYR . 1.7 tp -92.19 -36.94 12.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.0 111.569 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -26.31 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.332 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -66.33 -73.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.0 p -44.59 -37.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.5 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.3 -44.2 97.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 0.0 110.653 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.412 ' HA ' HD13 ' B' ' 75' ' ' ILE . 1.4 t0 -59.28 -40.0 84.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HG2' ' CE ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -77.82 -47.38 19.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.24 66.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.3 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.804 HG13 HD11 ' B' ' 75' ' ' ILE . 34.7 mm -82.21 -57.0 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.04 -29.02 11.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.089 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.63 63.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.02 -14.53 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.495 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 tp -91.88 21.23 5.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.258 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.882 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.18 -64.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.804 HD11 HG13 ' A' ' 173' ' ' ILE . 5.8 tt -140.75 151.88 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 2.2 m -130.77 133.35 45.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.19 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -62.1 136.99 95.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.517 ' CB ' HG12 ' A' ' 42' ' ' VAL . 77.3 Cg_exo -48.68 144.05 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.401 2.067 . . . . 0.0 112.372 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -104.39 -54.71 2.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 33.2 m-20 -67.56 162.43 23.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.498 ' CE1' HG21 ' A' ' 25' ' ' THR . 6.1 t80 174.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 84' ' ' THR . 10.6 pt-20 -153.52 139.71 18.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.27 70.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLU . 0.0 OUTLIER -42.28 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.696 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.879 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.3 mp -109.65 108.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 111.654 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -87.79 96.87 10.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.052 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.755 HG21 ' HB3' ' A' ' 37' ' ' PHE . 17.2 t -81.13 145.26 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.553 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -145.08 174.7 25.03 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.232 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -108.98 117.64 34.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.52 ' HB2' HG21 ' B' ' 97' ' ' THR . 42.2 t0 -123.89 136.18 54.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.972 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.41 0.77 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.894 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 1.058 HG13 HG22 ' B' ' 93' ' ' THR . 7.7 p -48.22 -25.96 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.885 0.374 . . . . 0.0 111.304 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' THR . . . . . 1.058 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -155.79 -39.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.325 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.84 11.91 2.53 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' B' ' 93' ' ' THR . 0.7 OUTLIER -122.85 172.11 8.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.889 0.344 . . . . 0.0 110.553 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 67' ' ' LEU . 1.8 m-85 -67.73 158.06 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.365 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.63 HG22 HD13 ' B' ' 112' ' ' ILE . 29.2 p -119.71 165.88 13.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.539 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 48.91 27.62 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.909 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.661 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.1 OUTLIER -77.33 163.1 66.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.933 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.879 ' N ' HG21 ' B' ' 85' ' ' ILE . 72.1 Cg_exo -48.52 136.21 26.46 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.246 . . . . 0.0 112.409 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.18 -39.75 14.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.028 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -47.62 34.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 1.056 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 4.8 m0 -49.3 -59.97 3.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.546 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -52.49 -59.57 4.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.033 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.7 mtt180 -48.46 -42.18 31.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.871 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.14 -54.63 19.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.702 HD11 HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -94.63 -69.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.727 ' O ' HG23 ' B' ' 109' ' ' THR . 36.8 tt0 -79.53 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.586 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.727 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.7 p -166.03 -46.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.677 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.2 OUTLIER -131.59 167.21 19.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.965 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -56.28 -54.85 40.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.63 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.879 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.88 171.42 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.62 139.19 54.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.673 HG21 ' HB1' ' A' ' 176' ' ' ALA . 1.1 mp -125.72 139.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.21 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -114.98 138.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.675 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.53 110.76 22.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' PRO . 16.4 t -87.59 145.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.649 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' A' ' 14' ' ' VAL . 19.6 m -137.79 167.07 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.665 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.894 HG21 ' CE1' ' A' ' 104' ' ' HIS . 9.1 p -163.76 136.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 139.44 148.93 5.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.821 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 160.68 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.638 0.256 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 46.84 86.28 0.01 OUTLIER Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.991 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 72.8 67.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.178 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.7 p -48.7 -24.99 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.18 -27.9 5.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.393 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -96.91 -73.46 0.6 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 111.443 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.825 HG23 ' OD2' ' A' ' 57' ' ' ASP . 3.3 p -45.82 -66.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.711 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 11.7 p -41.49 -48.12 3.83 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.792 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.9 -69.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.705 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.656 HD13 ' HZ ' ' B' ' 81' ' ' PHE . 83.6 mt -40.53 -59.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 17' ' ' THR . 1.1 mp -36.33 -55.65 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 t -93.72 -67.1 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.381 0.61 . . . . 0.0 110.672 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.786 ' CD2' HD13 ' A' ' 165' ' ' LEU . 24.5 t80 -40.13 -66.68 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.835 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.3 m -85.95 -80.23 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 111.648 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.726 HG21 ' HE3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -36.04 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.296 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.41 55.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.468 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HE3' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -173.93 -174.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -101.13 166.46 12.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 80.0 Cg_exo -44.45 146.67 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.505 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.4 m -102.51 -82.25 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.709 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.54 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.519 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.38 92.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.7 t -136.31 138.74 27.84 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.768 ' O ' HG23 ' A' ' 36' ' ' VAL . 86.4 Cg_exo -42.93 106.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.352 2.035 . . . . 0.0 111.504 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 39.7 m -47.07 88.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 34' ' ' PRO . 89.7 t -98.03 -51.64 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' B' ' 87' ' ' VAL . 60.0 t80 -163.35 95.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.751 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 25.9 m-20 -96.99 123.02 40.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.556 ' HB3' HD12 ' B' ' 85' ' ' ILE . 9.1 t-20 -108.07 150.25 27.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.832 0.349 . . . . 0.0 110.636 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.36 169.18 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.201 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -107.1 140.57 39.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.643 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.6 m -159.14 157.57 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.032 0.444 . . . . 0.0 111.908 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 51' ' ' TYR . 53.8 m -155.95 108.33 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 76' ' ' SER . 3.4 m -98.35 119.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.3 mtm -74.95 104.91 5.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.884 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mm -94.78 111.44 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 20.67 71.35 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.561 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 41.57 8.18 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -140.59 147.82 50.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.792 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.9 153.09 77.77 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.565 2.177 . . . . 0.0 112.274 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -147.98 162.04 40.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -135.31 97.39 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.573 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 54' ' ' GLY . 7.4 tt -124.69 159.6 30.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -154.7 123.56 1.39 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 20' ' ' LEU . 6.2 mp -75.87 119.65 20.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 6.9 m-85 -108.18 120.52 42.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.4 t70 -67.77 174.74 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.338 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.63 ' OG1' HG13 ' A' ' 7' ' ' VAL . 15.4 m -169.97 166.13 9.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.422 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 58' ' ' THR . . . -136.28 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.472 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.452 ' HA2' ' CE1' ' A' ' 104' ' ' HIS . . . -78.32 -128.95 0.51 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.708 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? 62.33 152.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 mp0 -45.97 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.319 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 7.0 m-20 -90.69 57.04 3.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 1.5 t80 47.12 43.61 14.48 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' OD2' ' CD2' ' A' ' 61' ' ' LEU . 1.0 OUTLIER 71.22 -140.65 0.05 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -95.32 -1.93 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.192 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.035 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 68.1 mt -88.0 51.73 2.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.369 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -94.06 -43.48 0.3 Allowed Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 13.1 Cg_exo -69.8 -42.74 3.1 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.19 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -86.51 11.91 11.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.631 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.488 ' HB2' ' CZ2' ' B' ' 103' ' ' TRP . 3.3 t -166.21 32.04 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.57 0.224 . . . . 0.0 111.043 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.512 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 7.6 p90 -33.34 122.36 0.45 Allowed Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.068 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.78 ' HA ' HG21 ' A' ' 7' ' ' VAL . 26.7 Cg_exo -62.48 -27.3 76.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.536 2.157 . . . . 0.0 112.587 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.98 -10.03 45.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.86 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.626 ' CG2' HG23 ' A' ' 7' ' ' VAL . 3.5 t -36.01 -55.01 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.458 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER -172.41 -158.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.497 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.7 p -57.93 163.24 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG22 ' A' ' 77' ' ' VAL . 9.0 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.426 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 8' ' ' VAL . 10.3 tp -130.16 123.82 31.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.1 t -131.21 147.14 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.056 0.455 . . . . 0.0 111.943 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.499 ' SG ' HG23 ' A' ' 113' ' ' VAL . 17.8 m -139.63 155.27 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.408 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CD2' HG11 ' A' ' 93' ' ' VAL . 6.7 p90 -162.21 164.17 27.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.78 157.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.474 HG13 HG22 ' A' ' 137' ' ' ILE . 59.0 t -111.76 -75.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.09 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -47.14 -81.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -49.42 105.13 0.47 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.871 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 43.1 Cg_endo -67.48 -17.04 48.69 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.47 2.113 . . . . 0.0 112.473 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t -48.91 -27.3 3.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.2 t -96.12 -37.59 10.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -49.78 -62.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -50.23 -57.34 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.032 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 5.6 m-20 -51.34 -59.64 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 89' ' ' SER . 61.3 t -44.33 -38.95 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.671 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.9 -62.28 1.48 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.02 7.99 5.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -121.3 -43.89 2.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.652 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.0 m95 -95.59 -34.12 12.13 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 94' ' ' LYS . 94.7 t -49.58 -47.28 78.66 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.2 Cg_endo -74.94 -11.56 21.59 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.051 1.834 . . . . 0.0 112.459 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.61 -43.48 9.61 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.09 0.472 . . . . 0.0 110.68 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 9' ' ' VAL . 11.7 pt -51.11 -34.97 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.484 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 81.6 p -52.87 -47.6 67.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.513 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 15.6 t60 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.183 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.894 ' CE1' HG21 ' A' ' 9' ' ' VAL . 29.3 m80 -79.96 -31.47 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 28.1 p -111.88 94.52 24.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.953 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -51.73 -55.19 4.18 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.568 2.179 . . . . 0.0 112.412 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 31.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -114.89 139.94 24.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.947 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 152' ' ' VAL . 75.7 Cg_exo -51.27 -172.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.629 2.219 . . . . 0.0 112.259 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 15.3 p90 -161.3 129.65 4.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.563 ' CD1' HG21 ' A' ' 77' ' ' VAL . 7.5 mp -97.29 129.94 44.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 149' ' ' LEU . 1.2 pt? -131.8 133.38 44.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.561 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 154' ' ' TYR . 2.7 m -141.16 176.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.375 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 84' ' ' VAL . . . -131.8 142.92 14.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.143 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.0 p -128.91 108.71 10.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 111.238 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.638 ' HB3' HG22 ' A' ' 85' ' ' VAL . 1.2 mt-30 170.7 66.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 157' ' ' CYS . 4.9 pt -98.64 -23.41 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.64 -36.99 11.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.73 -18.74 34.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.302 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.8 ' HA ' HG11 ' A' ' 85' ' ' VAL . 10.6 ptm180 -51.23 -23.79 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -44.73 -28.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.96 ' O ' HG22 ' A' ' 125' ' ' THR . 28.2 p-10 -66.53 116.72 37.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 126' ' ' ILE . 45.9 Cg_exo -56.23 -22.58 41.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.42 2.08 . . . . 0.0 112.275 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -56.07 -43.93 78.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 122' ' ' ASP . 10.1 t -50.95 -33.02 22.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.0 mp -81.23 -42.76 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -49.48 -48.68 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -78.88 -36.94 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.983 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 125' ' ' THR . 0.7 OUTLIER -49.89 -26.63 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 110.5 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.18 63.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -94.22 -37.5 11.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -56.14 -24.42 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.17 53.33 0.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.13 170.36 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.433 ' HD3' ' HD2' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -76.91 154.99 83.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 138' ' ' THR . 76.6 Cg_exo -49.98 122.1 8.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.231 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.4 mt -50.98 125.19 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -130.89 -179.8 1.14 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.551 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 76.9 Cg_exo -51.14 -22.69 11.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.438 2.092 . . . . 0.0 112.221 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.33 -42.5 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.53 ' CG2' HG23 ' A' ' 137' ' ' ILE . 57.2 m -49.92 -56.35 10.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.41 -38.09 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.9 tt0 -59.85 -48.43 81.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.08 62.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -56.69 -38.05 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.243 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.015 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.05 -45.27 83.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.768 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -58.1 -45.71 86.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -56.89 13.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.808 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.682 ' CD2' HD11 ' A' ' 112' ' ' LEU . 3.5 pp -62.17 -27.29 68.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 72.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.094 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -109.07 -179.6 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 109' ' ' PRO . 68.9 t -46.74 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 159.14 136.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.43 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 1.015 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 11.1 p90 -153.15 141.84 20.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 111.544 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -158.06 124.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.854 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.65 -178.81 2.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.733 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.47 ' HB2' HD13 ' A' ' 117' ' ' ILE . 28.3 p -136.19 -173.32 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.446 ' CB ' HG12 ' A' ' 117' ' ' ILE . 5.0 p -87.2 156.0 19.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.349 . . . . 0.0 110.527 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.478 ' C ' HD12 ' A' ' 160' ' ' LEU . . . -51.78 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.294 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 161' ' ' THR . 0.2 OUTLIER 55.0 24.03 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.422 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 169.9 128.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.442 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -126.31 121.73 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -101.2 -43.63 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.85 85.67 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 23' ' ' TYR . 7.0 mt -85.3 -37.25 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -52.99 -24.84 10.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 155' ' ' VAL . 49.5 m-20 -63.45 -69.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.123 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.27 -41.98 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -67.59 -49.08 64.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.606 ' HA ' HG21 ' B' ' 75' ' ' ILE . 56.3 t0 -47.14 -45.37 22.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -84.29 -47.68 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -53.95 -33.21 56.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.557 HG13 HD11 ' B' ' 75' ' ' ILE . 23.3 mm -87.84 -33.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.2 tp -53.17 -56.75 13.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.72 -32.49 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -77.03 -28.03 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.598 HD12 ' OH ' ' A' ' 51' ' ' TYR . 39.0 tp -54.3 -25.41 23.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -51.33 -76.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.96 0.41 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 170' ' ' ASP . 5.1 tt -115.69 151.74 17.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -135.93 135.15 39.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.379 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.693 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -55.47 136.33 70.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.527 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.693 ' HD2' HD23 ' B' ' 77' ' ' LEU . 71.7 Cg_exo -50.7 143.69 28.34 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.479 2.12 . . . . 0.0 112.411 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.1 -70.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -58.08 88.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.656 ' HZ ' HD13 ' A' ' 20' ' ' LEU . 9.5 t80 -113.25 136.28 52.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.34 130.0 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.386 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 96.95 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.926 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -101.53 139.72 22.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.994 0.426 . . . . 0.0 111.979 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' B' ' 86' ' ' HIS . 52.1 p-80 -120.38 96.55 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.335 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 37' ' ' PHE . 46.9 t -83.47 152.54 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.86 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.42 177.85 24.49 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.503 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.53 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.635 ' OD2' HG21 ' B' ' 97' ' ' THR . 1.2 m-20 -132.68 134.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 1.11 20.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.909 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.526 HG13 HG22 ' B' ' 93' ' ' THR . 7.3 p -46.08 -27.84 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.526 HG22 HG13 ' B' ' 92' ' ' VAL . 6.2 t -148.58 -42.02 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.044 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.79 29.67 0.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.467 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -138.18 -159.47 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.704 0.288 . . . . 0.0 110.457 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' CG1' ' B' ' 87' ' ' VAL . 3.5 m-85 -98.99 164.24 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.758 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.635 HG21 ' OD2' ' B' ' 90' ' ' ASP . 34.3 p -109.41 171.76 7.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 44.26 28.12 1.32 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.773 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' B' ' 108' ' ' GLN . 0.9 OUTLIER -49.83 129.46 21.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.562 0.22 . . . . 0.0 110.883 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 50.3 Cg_exo -53.92 140.4 68.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.375 2.05 . . . . 0.0 111.884 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -42.67 -45.88 4.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.252 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -56.78 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.797 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 1.035 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.6 m0 -52.36 -58.74 5.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.143 0.496 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' B' ' 108' ' ' GLN . . . -45.58 -70.32 0.11 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.136 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -47.32 -38.56 13.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.041 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.82 -64.88 0.58 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.859 0.361 . . . . 0.0 110.12 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -70.25 0.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' B' ' 99' ' ' MET . 0.7 OUTLIER -80.71 -160.39 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -154.23 57.43 0.71 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.26 -0.275 . . . . 0.0 111.042 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.74 124.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.157 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 4.4 m120 -48.1 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.603 HD13 HG22 ' B' ' 97' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.874 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.54 136.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -102.31 142.25 33.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.23 138.76 52.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.216 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.52 96.33 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.566 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.48 107.93 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' CG2' HG21 ' A' ' 75' ' ' THR . 3.0 t -84.58 150.48 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LYS . 7.5 p -135.34 146.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 78' ' ' PHE . 5.5 m -133.75 121.03 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' A' ' 97' ' ' TRP . . . 147.97 -174.32 27.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.68 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.68 155.4 49.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.367 . . . . 0.0 111.178 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 88.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . 49.94 53.78 12.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.668 HG13 HG21 ' A' ' 8' ' ' VAL . 10.0 p -80.54 2.68 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.345 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 109.87 -29.62 9.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.663 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.815 ' HB3' HG11 ' A' ' 8' ' ' VAL . 9.5 pttt -51.42 -67.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.773 -0.251 . . . . 0.0 111.635 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.735 ' O ' HD13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.81 -26.37 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 21' ' ' ILE . 35.2 t -61.24 -58.42 8.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.424 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.998 HD12 HD21 ' A' ' 79' ' ' LEU . 14.5 mt -50.99 -73.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.393 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 55' ' ' LEU . 15.1 mt -39.35 -40.34 0.78 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -51.96 -67.35 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 1.8 t -93.27 -53.36 4.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.24 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.893 ' O ' HD21 ' B' ' 77' ' ' LEU . 13.9 t80 -44.51 -30.03 0.81 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.061 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 25' ' ' THR . 93.7 m -125.33 -101.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.608 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 4.7 t -40.37 -34.8 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' ILE . 3.5 t-20 75.65 47.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -151.4 136.91 17.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -58.42 166.7 2.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 28' ' ' PHE . 11.8 Cg_endo -55.69 171.81 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.945 2.43 . . . . 0.0 112.858 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 t -116.24 -75.38 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.099 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 129.06 39.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -90.66 104.32 16.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.198 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.592 HG23 ' HD2' ' A' ' 34' ' ' PRO . 5.2 p -160.78 140.51 8.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.915 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD2' HG23 ' A' ' 33' ' ' VAL . 55.7 Cg_exo -35.38 91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.933 2.422 . . . . 0.0 112.291 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 57' ' ' ASP . 98.8 m -51.32 87.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.15 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' B' ' 96' ' ' PHE . 88.6 t -84.9 -33.74 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.521 ' CE1' ' HG3' ' B' ' 100' ' ' PRO . 16.9 t80 -173.61 128.81 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.877 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 m-20 -127.86 148.98 50.49 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.778 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HB2' HD12 ' B' ' 85' ' ' ILE . 2.8 t-20 -107.07 157.27 17.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 0.0 110.69 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.568 ' OH ' HG23 ' A' ' 17' ' ' THR . 4.2 m-85 -152.82 169.29 23.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.237 0.542 . . . . 0.0 112.006 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' B' ' 81' ' ' PHE . . . -127.6 115.56 18.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG12 ' CB ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -141.13 155.53 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.438 . . . . 0.0 111.557 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.2 m -156.33 95.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.099 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.666 HG21 HG21 ' A' ' 173' ' ' ILE . 27.4 m -98.42 178.35 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.427 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 2.7 mtt -115.07 157.26 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.766 HD12 ' CE1' ' A' ' 51' ' ' TYR . 18.0 mt -158.24 89.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.585 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.17 3.02 79.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.77 26.91 5.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.0 pt-20 -141.63 138.82 17.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.638 0.256 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 43.4 Cg_exo -56.44 174.38 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.578 2.185 . . . . 0.0 112.198 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.766 ' CE1' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.87 171.2 17.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.002 0.43 . . . . 0.0 111.155 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -136.3 97.02 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.337 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 11.3 tp -98.22 157.71 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.954 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -163.22 103.01 0.21 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.426 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.03 HD11 HD23 ' A' ' 79' ' ' LEU . 3.4 mm? -75.78 105.05 6.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.763 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.7 m-85 -83.26 107.48 15.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.178 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -67.84 130.4 42.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.323 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.839 HG22 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.45 163.74 32.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -103.34 -53.62 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.411 . . . . 0.0 111.004 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.23 -45.64 1.1 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.268 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -151.76 17.91 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 13.2 mt-10 -103.43 83.59 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.139 0.495 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 78.28 -3.49 2.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.604 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.839 ' CD2' HG22 ' A' ' 58' ' ' THR . 24.2 m-85 -85.26 -13.7 48.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.747 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -39.49 -47.13 1.81 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.013 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -54.06 37.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.758 ' CB ' HD11 ' A' ' 70' ' ' LEU . 2.3 mp -78.59 82.24 4.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.19 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 24.1 ptt180 -88.2 -35.02 0.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 2.5 Cg_endo -82.68 7.95 4.86 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.081 . . . . 0.0 112.73 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.955 HD22 ' CE2' ' B' ' 103' ' ' TRP . 39.0 mt -51.54 111.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.485 0.659 . . . . 0.0 111.471 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.636 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 70.18 4.78 5.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.433 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 59.97 154.7 0.1 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.466 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.93 -52.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.947 2.432 . . . . 0.0 112.932 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -8.2 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.986 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 76' ' ' ASP . 1.1 t -32.79 -73.52 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.729 ' H ' HG23 ' A' ' 75' ' ' THR . 3.7 m-20 -161.56 -155.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 78' ' ' PHE . 14.1 p -66.86 162.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -98.5 127.34 44.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.03 HD23 HD11 ' A' ' 55' ' ' LEU . 13.5 tp -103.69 115.47 30.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.274 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.515 HG13 ' CG2' ' A' ' 14' ' ' VAL . 2.5 t -131.9 153.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.446 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 14' ' ' VAL . 62.6 m -142.65 172.02 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.511 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.738 ' HB3' HG21 ' A' ' 93' ' ' VAL . 50.8 p90 -164.41 151.72 11.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.105 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.47 136.8 42.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 115' ' ' THR . 5.3 m -107.15 68.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.12 -85.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.13 163.8 55.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.803 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.432 ' CB ' ' HB2' ' A' ' 132' ' ' ASN . 51.7 Cg_endo -69.17 -22.53 34.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.58 2.187 . . . . 0.0 112.287 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 p -70.18 -33.83 72.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.2 p -51.89 -46.25 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -51.92 -69.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.067 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.93 -29.22 55.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.002 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.5 m-20 -62.47 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 82' ' ' PHE . 7.2 p -41.38 -31.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.14 -70.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.842 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.57 8.11 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 27.3 tttm -113.68 -40.62 3.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.676 ' HD1' HG23 ' A' ' 93' ' ' VAL . 11.0 m95 -95.96 -13.58 23.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 94' ' ' LYS . 2.5 m -53.02 -32.57 10.37 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.5 Cg_exo -68.78 -41.87 5.26 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.782 1.654 . . . . 0.0 112.217 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' CG ' HD12 ' A' ' 61' ' ' LEU . 19.0 mp0 -58.56 -43.67 89.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.841 HG21 ' CD2' ' A' ' 110' ' ' PHE . 71.3 mt -48.58 -26.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -84.67 -37.16 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.58 -34.56 51.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -102.94 -61.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 8.4 m -109.29 85.61 3.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.2 -11.66 29.1 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.632 2.221 . . . . 0.0 112.794 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -152.78 40.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 111.419 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.4 139.88 36.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.853 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.1 Cg_exo -49.18 143.96 17.82 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.542 2.161 . . . . 0.0 112.113 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.841 ' CD2' HG21 ' A' ' 101' ' ' ILE . 1.6 p90 -131.39 130.52 42.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.28 136.09 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.394 179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.2 pp -146.78 114.19 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.672 HG11 ' CD ' ' A' ' 156' ' ' GLU . 10.0 p -129.1 152.3 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.382 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.484 ' HA3' HG13 ' A' ' 84' ' ' VAL . . . -73.16 -176.92 32.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.305 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.858 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -174.14 172.36 3.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 111.426 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.906 ' OE1' HD22 ' A' ' 119' ' ' LEU . 14.1 mt-30 72.53 108.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' A' ' 139' ' ' PRO . 41.7 mt -98.48 -59.83 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 119' ' ' LEU . 24.9 p30 -55.02 -22.51 15.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.906 HD22 ' OE1' ' A' ' 116' ' ' GLN . 7.3 tp -61.93 -48.11 81.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.956 ' HA ' HG12 ' A' ' 85' ' ' VAL . 1.6 ptt180 -58.91 -22.89 60.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.72 -23.8 7.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 29.6 m-20 -54.22 135.6 59.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 43.3 Cg_exo -56.58 -42.55 64.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.522 2.148 . . . . 0.0 112.397 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -38.69 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 120' ' ' ARG . 19.7 p -59.05 -64.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.6 mp -48.65 -43.68 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.069 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD2' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.59 -32.93 68.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -50.81 -26.23 5.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.928 0.394 . . . . 0.0 110.295 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.35 -22.44 60.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.928 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.48 -22.51 37.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 87' ' ' PRO . 25.6 t30 -94.04 30.59 1.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.957 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 34.69 0.37 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.788 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.71 -160.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.45 95.65 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.773 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.416 ' HA ' HD22 ' A' ' 129' ' ' LEU . 42.0 Cg_endo -67.56 141.8 56.69 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.608 2.205 . . . . 0.0 112.363 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 90' ' ' PHE . 4.1 mt -67.47 125.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -124.43 177.73 1.68 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' A' ' 117' ' ' ILE . 51.1 Cg_exo -54.23 -24.7 35.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.691 2.26 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -86.36 -39.02 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.027 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.8 m -49.97 -48.29 52.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -49.91 61.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.04 -47.93 68.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.52 -40.62 59.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.593 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 145' ' ' LEU . 8.5 tt -61.38 -41.69 97.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.967 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -53.33 -54.93 29.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -55.05 -38.83 68.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -51.49 -32.67 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 151' ' ' ALA . 1.6 pp -125.39 21.86 7.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.142 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 58.1 -84.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.993 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 149' ' ' LEU . . . 58.07 175.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 6.1 t -61.52 -15.99 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.484 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.45 140.84 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 110.466 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.967 ' CE1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -153.39 151.57 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 155' ' ' VAL . 14.9 m -157.93 123.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.579 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.672 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.7 pt-20 -172.36 152.21 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.152 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 83.3 m -101.82 -177.53 3.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.485 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 30.8 t -86.77 156.6 19.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.049 0.452 . . . . 0.0 111.594 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.906 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.04 -169.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.029 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 50.87 24.89 1.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.549 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -174.17 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 57.66 115.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.338 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -64.07 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.28 92.98 0.11 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.419 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -93.79 -10.37 34.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.477 0.18 . . . . 0.0 111.455 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.16 -43.32 3.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.336 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.94 -67.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.732 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.685 HG13 ' OH ' ' A' ' 23' ' ' TYR . 7.3 p -50.27 -28.78 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.78 -51.26 70.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.146 179.427 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 2.5 p30 -63.13 -32.24 73.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.4 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 24.6 tp10 -70.14 -30.68 67.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.98 -29.36 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.717 HG22 HD11 ' A' ' 46' ' ' ILE . 44.5 mm -94.95 -66.36 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -49.94 -45.76 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.979 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -55.34 -25.56 35.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -61.33 -29.23 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.057 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -92.7 44.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 28.5 m -55.34 -42.56 74.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.6 149.19 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.22 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 176.1 8.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.893 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -94.88 140.37 22.49 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.655 ' CB ' HG12 ' A' ' 42' ' ' VAL . 52.9 Cg_exo -54.61 -164.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.437 2.091 . . . . 0.0 112.103 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -167.79 -65.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.59 95.59 2.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.985 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -129.02 148.93 51.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.141 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -153.22 140.45 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.93 0.395 . . . . 0.0 111.758 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -75.48 95.34 3.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.051 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -77.02 -42.49 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 39' ' ' ASN . 2.0 mt -129.07 147.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 111.558 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -141.12 97.16 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.484 ' CG2' ' HD3' ' B' ' 100' ' ' PRO . 63.3 t -78.25 125.07 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 111.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 172.92 15.91 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.869 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -98.62 111.23 23.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.444 ' CG ' HG21 ' B' ' 97' ' ' THR . 1.1 m-20 -129.29 128.78 43.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.36 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.15 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.918 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.938 HG13 HG22 ' B' ' 93' ' ' THR . 7.5 p -41.5 -30.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 111.591 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.938 HG22 HG13 ' B' ' 92' ' ' VAL . 1.1 t -151.61 21.1 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.151 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.96 25.27 67.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.852 ' CG ' HG23 ' B' ' 93' ' ' THR . 8.3 pt-20 -145.71 171.84 14.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -70.54 164.75 24.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.421 . . . . 0.0 110.745 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.444 HG21 ' CG ' ' B' ' 90' ' ' ASP . 66.1 p -110.45 176.68 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 43.05 28.54 0.76 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.87 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.712 ' CE ' HD21 ' A' ' 67' ' ' LEU . 3.0 mtp -57.74 124.63 69.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.252 . . . . 0.0 110.956 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.521 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 49.2 Cg_exo -38.86 152.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.792 2.328 . . . . 0.0 112.692 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' B' ' 105' ' ' ARG . 2.8 mt-10 -47.58 -43.24 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.065 0.459 . . . . 0.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.488 ' HG2' HD23 ' B' ' 106' ' ' LEU . 0.0 OUTLIER -72.56 -57.67 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.246 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.955 ' CE2' HD22 ' A' ' 70' ' ' LEU . 13.1 m0 -48.31 -60.26 2.8 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.601 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' C ' ' B' ' 110' ' ' SER . . . -47.47 -67.99 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.2 mtp85 -52.23 -34.4 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.032 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -45.75 -65.64 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.696 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -63.22 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.56 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.69 ' O ' HG23 ' B' ' 109' ' ' THR . 0.4 OUTLIER -78.8 -100.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.677 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.69 HG23 ' O ' ' B' ' 108' ' ' GLN . 11.7 p -164.94 -57.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.226 0 CA-C-O 120.788 0.327 . . . . 0.0 111.851 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.572 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -127.7 158.89 36.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.382 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 99' ' ' MET . 0.6 OUTLIER -45.15 -57.44 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.055 0.455 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.602 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.85 0.357 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -94.6 120.93 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.8 t -99.73 147.15 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.866 HG23 ' OD2' ' A' ' 76' ' ' ASP . 65.8 mt -135.66 103.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB2' HG21 ' A' ' 75' ' ' THR . 5.6 mmtp -95.67 98.31 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -77.77 112.35 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.113 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 59.6 t -91.09 150.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 79' ' ' LEU . 7.3 p -139.51 147.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.063 0.458 . . . . 0.0 111.529 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 60' ' ' GLY . 7.1 p -138.27 120.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.534 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.62 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.769 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -20.87 15.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.782 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -78.37 -45.17 10.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.69 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 73.47 3.0 4.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' HA2' ' A' ' 114' ' ' GLY . 5.4 t -57.78 -17.93 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.242 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -81.25 -124.32 0.65 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.422 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -34.06 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.604 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -50.91 -71.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' THR . 51.7 t -48.03 -46.45 33.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.126 0.489 . . . . 0.0 110.985 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.883 HD13 HG11 ' A' ' 113' ' ' VAL . 69.4 tp -46.14 -59.78 2.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.537 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 55' ' ' LEU . 21.8 mt -44.69 -49.15 10.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.708 0.29 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 27' ' ' LYS . 3.4 mm -42.58 -49.19 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.491 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.68 -61.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.453 0.644 . . . . 0.0 110.256 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.941 ' OH ' HG13 ' A' ' 168' ' ' VAL . 1.2 t80 -39.8 -66.85 0.26 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.249 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.839 HG23 ' HB2' ' B' ' 78' ' ' PRO . 50.6 m -96.57 -77.54 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.366 0.603 . . . . 0.0 111.151 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.775 HG23 ' CE2' ' B' ' 81' ' ' PHE . 0.2 OUTLIER -36.29 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.225 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t30 47.72 65.08 1.37 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 110.616 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.16 -169.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.316 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -111.91 157.89 38.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -51.2 143.05 34.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.669 2.246 . . . . 0.0 112.438 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 p -95.12 -80.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.22 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.89 109.33 21.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.02 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.6 t80 -66.11 107.73 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.103 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA2' ' B' ' 88' ' ' GLY . 59.2 t -157.89 131.89 5.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' VAL . 94.7 Cg_exo -41.86 92.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.379 2.053 . . . . 0.0 111.969 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 38' ' ' ASP . 40.4 m -53.11 87.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.268 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.808 HG13 ' OH ' ' A' ' 64' ' ' TYR . 12.2 t -73.41 -27.04 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 110.058 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.715 ' HE2' HD13 ' B' ' 85' ' ' ILE . 15.8 t80 -146.85 -79.78 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.312 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.831 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.0 OUTLIER 60.69 118.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.119 -179.089 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 t-20 -107.7 156.86 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -152.49 144.89 24.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.005 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.11 140.2 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.139 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 24' ' ' THR . 25.6 m -154.81 132.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 51' ' ' TYR . 61.4 m -125.39 95.31 4.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 ' O ' ' B' ' 76' ' ' SER . 2.9 m -98.13 123.75 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.403 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -72.8 100.18 2.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.923 HD11 HG21 ' A' ' 173' ' ' ILE . 24.7 mm -90.48 89.37 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.44 12.74 55.62 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 4.7 58.96 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.125 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.13 150.61 43.23 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.03 0.415 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.29 162.44 7.74 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.679 2.252 . . . . 0.0 112.126 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.628 ' H ' HG23 ' A' ' 43' ' ' THR . 7.0 t80 -154.11 153.28 31.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.952 0.406 . . . . 0.0 111.459 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 p -136.31 97.43 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.223 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 54' ' ' GLY . 5.8 tt -112.51 144.89 41.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.762 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -127.5 112.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.183 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 16' ' ' LYS . 5.6 mp -77.96 102.93 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.308 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 1.3 m-85 -88.86 103.01 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.01 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.667 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -73.57 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.94 0.4 . . . . 0.0 111.246 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.05 -171.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.965 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . . . -156.69 149.27 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' VAL . . . -109.01 99.49 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.36 -65.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 170.02 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.736 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -111.14 27.29 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.965 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -91.42 -23.05 20.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -27.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.603 ' O ' HD23 ' B' ' 107' ' ' LEU . 22.1 mtt180 -48.67 -40.27 27.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.877 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD22 ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -92.12 40.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.638 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tpt180 -81.59 -66.46 0.23 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.499 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 19.3 Cg_endo -58.91 -15.16 25.73 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.56 2.173 . . . . 0.0 112.626 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.762 HD12 ' CG ' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.41 -13.0 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.108 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 1.3 t -111.6 -19.49 12.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.319 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 39.01 95.86 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.801 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 37.9 Cg_endo -66.2 -45.58 5.42 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.609 2.206 . . . . 0.0 112.183 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -12.08 47.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 5' ' ' LYS . 6.6 t -40.56 -46.8 2.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -172.64 -160.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.749 0.309 . . . . 0.0 111.058 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -58.17 154.18 2.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.731 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -106.76 138.79 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.27 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -104.11 122.61 45.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.093 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 101' ' ' ILE . 4.0 t -106.9 153.77 8.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.065 0.46 . . . . 0.0 111.919 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.27 155.66 18.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CZ ' HG23 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -166.07 121.66 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.968 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.88 164.4 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.651 ' HA ' HG21 ' A' ' 137' ' ' ILE . 34.5 t -147.67 66.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.318 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 120' ' ' ARG . 70.8 t -151.27 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -82.76 137.71 43.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 57.9 Cg_endo -72.06 -19.47 26.42 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.556 2.171 . . . . 0.0 112.325 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.8 p -56.91 -52.23 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.81 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -29.82 63.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -50.3 -45.86 54.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -47.54 85.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -61.1 -66.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 28.7 m -43.53 -40.84 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.664 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.2 tttm -57.44 -68.03 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 5.1 mt-10 -82.53 8.4 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.138 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.02 -38.69 3.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.404 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.584 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 49.9 m0 -95.23 -40.89 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.511 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 101' ' ' ILE . 60.7 t -55.85 -44.09 99.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 39.5 Cg_exo -60.22 -19.65 58.31 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.33 2.02 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.71 -30.8 56.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.885 HG22 ' O ' ' A' ' 98' ' ' VAL . 8.4 tp -49.16 -31.4 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.198 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -77.71 -44.04 29.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -51.86 -37.76 53.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 5.3 m-70 -97.2 -61.72 1.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 4.7 t -74.42 108.89 5.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.501 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.49 -60.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.392 2.062 . . . . 0.0 112.419 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -154.68 36.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.727 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -107.29 153.98 40.83 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD2' HG22 ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.89 145.68 97.67 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.606 2.204 . . . . 0.0 111.97 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 20.1 p90 -123.1 127.48 48.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.314 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.649 HD12 ' CG1' ' A' ' 152' ' ' VAL . 6.8 tt -109.14 119.29 39.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.045 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 mp -90.99 155.14 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.229 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 19' ' ' LEU . 3.0 t -148.78 165.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.705 ' HA2' HG12 ' A' ' 14' ' ' VAL . . . 143.41 154.63 6.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.799 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -176.78 164.48 2.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.421 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -172.25 93.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.815 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -25.72 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.855 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -95.26 -30.91 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.795 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.421 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -78.41 -44.72 24.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HA ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -53.14 -23.49 8.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 55.89 2.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.9 ' O ' HD12 ' A' ' 126' ' ' ILE . 1.3 m-20 -111.11 150.04 41.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 -57.95 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.716 2.277 . . . . 0.0 112.374 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -34.57 75.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 120' ' ' ARG . 54.2 m -55.49 -72.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.818 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 122' ' ' ASP . 3.7 mp -52.03 -39.1 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -32.08 30.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.048 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.67 -39.34 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.524 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 136' ' ' PRO . 17.6 mt -49.9 -26.14 3.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.457 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.43 67.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -25.35 22.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.454 ' CB ' ' HG3' ' A' ' 87' ' ' PRO . 9.6 m120 -115.95 30.23 7.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 103.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.973 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 6.3 pt20 -42.69 150.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 10.1 mttt 47.94 48.43 5.88 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.842 ' HD2' HD13 ' A' ' 129' ' ' LEU . 73.8 Cg_endo -75.88 -46.15 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.561 2.174 . . . . 0.0 112.562 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 84' ' ' VAL . 5.7 mm -99.85 129.94 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -148.86 164.5 21.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 75.6 Cg_exo -49.78 -23.31 8.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.546 2.164 . . . . 0.0 112.315 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -90.64 -41.23 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.1 m -49.02 -57.69 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.89 -49.56 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.65 -38.11 80.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -50.36 73.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.1 tp -57.25 -37.93 73.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -71.57 -26.53 62.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ttt-85 -73.43 -40.7 64.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.21 -44.7 94.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.4 pp -71.77 -26.39 62.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.694 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.0 tptt 69.05 109.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.62 -161.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.649 ' CG1' HD12 ' A' ' 111' ' ' LEU . 91.2 t -56.82 -20.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.305 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 75.07 139.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.197 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 39.6 p90 -152.8 162.09 41.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.7 m -158.13 124.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.695 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.571 ' CD ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -170.62 167.55 7.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.104 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.799 ' HA ' HG21 ' A' ' 115' ' ' THR . 17.4 p -118.9 -173.24 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -87.68 165.04 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.973 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.575 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -51.43 -175.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 66.23 -69.29 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.276 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.93 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.732 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.91 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 68.61 108.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.667 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -68.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.35 96.57 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.91 HD11 ' NE2' ' A' ' 162' ' ' GLN . 19.2 mt -93.24 -17.62 23.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.68 0.276 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -62.92 -49.96 72.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.455 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 166' ' ' LYS . 7.2 m120 -48.8 -71.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.941 HG13 ' OH ' ' A' ' 23' ' ' TYR . 3.5 p -47.62 -30.06 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -64.42 -38.21 90.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.779 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.448 ' CB ' HG13 ' B' ' 75' ' ' ILE . 17.4 t0 -63.63 -35.54 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.127 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 3.1 mm-40 -81.79 -24.63 35.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.73 41.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 46' ' ' ILE . 21.2 mt -88.71 -48.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.46 -27.77 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -50.82 -37.14 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.74 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -94.52 -20.58 19.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.318 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -82.99 -24.58 32.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.017 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.876 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.3 p -99.36 -39.55 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.448 HG13 ' CB ' ' A' ' 170' ' ' ASP . 6.7 mm -140.33 139.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.897 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 p -138.69 141.85 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.013 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -70.24 131.67 88.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.839 ' HB2' HG23 ' A' ' 24' ' ' THR . 53.1 Cg_exo -54.63 154.29 20.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.399 2.066 . . . . 0.0 112.273 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.86 -43.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.87 61.63 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.976 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.775 ' CE2' HG23 ' A' ' 25' ' ' THR . 23.7 t80 -74.39 149.8 40.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.65 101.72 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -72.34 69.31 0.81 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.803 ' OG1' HD12 ' B' ' 85' ' ' ILE . 44.8 p -52.43 -85.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.245 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.803 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.5 OUTLIER -96.95 145.32 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.096 0.474 . . . . 0.0 112.092 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.95 96.89 4.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.519 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.602 HG22 ' HD3' ' B' ' 100' ' ' PRO . 29.7 t -78.03 157.29 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.969 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.589 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.43 177.92 24.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -84.52 119.08 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.615 ' CB ' HG23 ' B' ' 97' ' ' THR . 13.8 t0 -111.01 98.32 7.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.23 61.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.562 HG13 HG22 ' B' ' 93' ' ' THR . 13.4 p -46.92 -33.47 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.308 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.562 HG22 HG13 ' B' ' 92' ' ' VAL . 7.8 t -148.16 23.72 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.17 25.39 72.25 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.622 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.412 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 17.4 pt-20 -119.84 -166.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.732 0.301 . . . . 0.0 110.791 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 1.02 ' CE2' HD11 ' A' ' 67' ' ' LEU . 2.2 m-85 -103.9 163.74 12.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.615 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.6 p -104.64 150.05 25.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.576 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' ND2' ' B' ' 111' ' ' ASN . . . 69.5 43.93 66.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' B' ' 104' ' ' ALA . 2.7 tpt -47.28 103.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.551 0.215 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.602 ' HD3' HG22 ' B' ' 87' ' ' VAL . 77.5 Cg_exo -50.3 147.44 16.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.487 2.125 . . . . 0.0 111.915 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -66.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -65.7 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.417 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 1.04 ' CE3' HD22 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -46.71 -56.85 5.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.201 0.524 . . . . 0.0 110.552 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.611 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -55.26 -60.91 2.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.653 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.784 ' O ' HG22 ' B' ' 109' ' ' THR . 6.1 mtt-85 -42.42 -36.23 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.368 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.759 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -60.81 -60.72 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.32 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.18 -64.36 1.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.703 ' O ' HG23 ' B' ' 109' ' ' THR . 3.6 tp-100 -76.93 -79.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.236 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.784 HG22 ' O ' ' B' ' 105' ' ' ARG . 6.0 p 96.78 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.366 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 171.26 93.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.958 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.425 ' ND2' ' HA2' ' B' ' 98' ' ' GLY . 1.7 t30 -49.78 92.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.611 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.187 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.769 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.58 167.57 11.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -91.83 132.63 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.647 HD13 ' CB ' ' A' ' 176' ' ' ALA . 25.1 mt -116.25 133.41 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.3 OUTLIER -123.27 149.44 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.722 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.97 96.05 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.82 HG21 ' O ' ' A' ' 71' ' ' SER . 56.4 t -100.79 128.01 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.867 ' HB ' HG12 ' A' ' 14' ' ' VAL . 18.5 m -106.73 169.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.2 p -158.28 121.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.98 -140.58 5.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB2' ' CE2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -126.5 -78.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -60.36 -147.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.912 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -60.81 78.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 110.78 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.5 t -73.81 -1.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.142 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . 95.62 -24.74 28.08 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -60.32 -64.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.852 HG23 ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -96.09 -34.35 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.912 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 3.3 p -66.39 -45.19 80.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 79' ' ' LEU . 8.1 tp -61.29 -73.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.959 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -43.86 -48.45 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.397 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -47.74 -69.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.01 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.1 t -93.2 -60.89 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.462 . . . . 0.0 111.971 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.56 ' CD2' HD11 ' A' ' 19' ' ' LEU . 8.2 t80 -47.6 -24.96 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.702 HG21 HG11 ' A' ' 42' ' ' VAL . 79.6 m -111.36 -96.25 0.42 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.562 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.463 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.6 t -60.07 -21.76 61.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 27.9 t-20 72.1 30.38 2.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.9 OUTLIER -125.78 134.75 51.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -69.21 160.12 80.17 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.042 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.2 Cg_endo -50.64 169.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.965 2.444 . . . . 0.0 112.409 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -74.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 134.11 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.21 110.06 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -154.78 138.85 11.27 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.497 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 36' ' ' VAL . 93.8 Cg_exo -41.18 109.07 0.1 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.46 2.107 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 16' ' ' LYS . 18.1 m -47.16 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.297 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 34' ' ' PRO . 61.3 t -103.78 -53.77 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.886 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' B' ' 85' ' ' ILE . 45.8 t80 -159.0 78.46 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 12.2 m-20 -80.59 121.52 25.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.656 ' HB3' HD12 ' B' ' 85' ' ' ILE . 26.6 t-20 -107.07 151.2 25.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.037 0.446 . . . . 0.0 111.272 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.2 160.03 43.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.216 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.25 116.97 29.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.906 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 24' ' ' THR . 1.4 m -146.08 132.07 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.059 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 51' ' ' TYR . 21.0 m -127.49 112.19 14.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.838 0.352 . . . . 0.0 110.215 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 76' ' ' SER . 92.6 t -97.73 117.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.215 0.531 . . . . 0.0 110.143 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.4 mtm -93.42 106.09 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.294 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.68 HG23 HD13 ' B' ' 75' ' ' ILE . 7.2 mt -85.82 100.97 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.845 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 74' ' ' SER . . . 86.25 19.86 56.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.361 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.33 -46.31 1.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.595 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.4 pt-20 -65.72 139.69 97.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.663 0.268 . . . . 0.0 111.031 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.0 158.71 49.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -154.13 150.03 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.4 p -86.63 97.8 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.718 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -133.76 137.31 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.865 ' N ' HD22 ' A' ' 53' ' ' LEU . . . -162.25 145.4 10.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.551 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 79' ' ' LEU . 3.1 mm? -75.88 114.34 14.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.636 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.646 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -83.2 103.72 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.062 0.458 . . . . 0.0 109.843 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.852 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 m-20 -67.51 137.12 55.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.685 HG21 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -176.07 135.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.806 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -76.52 -61.97 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.221 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.99 89.56 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -118.63 -38.5 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 166.81 -30.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.22 -24.21 27.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 18.7 m-85 -56.6 -20.19 19.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -41.77 -30.26 0.23 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.768 0.318 . . . . 0.0 111.446 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -70.01 -48.66 57.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.081 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -88.56 49.55 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.552 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -99.45 -43.39 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.0 Cg_exo -58.12 -14.63 19.93 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.63 2.22 . . . . 0.0 112.979 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.713 HD22 ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -104.07 -15.6 15.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.103 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.82 ' O ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -132.9 22.07 4.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 15.1 p90 -46.61 114.33 2.67 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.106 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HG2' ' HA ' ' A' ' 105' ' ' CYS . 37.8 Cg_endo -65.72 -21.42 58.61 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.562 2.175 . . . . 0.0 112.32 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -65.92 -11.79 49.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.231 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' ' 72' ' ' TYR . 8.9 t -41.47 -48.55 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 111.47 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 75' ' ' THR . 2.6 m-20 -164.54 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.608 HG21 ' CB ' ' A' ' 175' ' ' ALA . 24.9 t -132.14 156.7 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE2' HG23 ' A' ' 101' ' ' ILE . 36.2 p90 -144.57 140.96 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 111.462 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.65 150.0 24.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.5 t -131.34 154.62 40.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.186 0.517 . . . . 0.0 111.913 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.503 ' N ' ' HA ' ' A' ' 14' ' ' VAL . 10.1 p -68.15 172.93 5.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.815 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CZ ' ' CD2' ' A' ' 145' ' ' LEU . 0.9 OUTLIER 179.44 100.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.62 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 m -58.57 91.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.882 HG11 ' HB2' ' A' ' 142' ' ' ALA . 10.4 m -83.52 54.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.721 HG22 ' N ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -150.6 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.531 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.721 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.2 t -57.5 135.76 82.04 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.618 0.247 . . . . 0.0 110.64 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 98.4 Cg_endo -78.25 -39.42 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.548 2.165 . . . . 0.0 112.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.24 -24.02 6.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.18 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 93' ' ' VAL . 70.5 m -88.68 -40.34 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CZ ' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -42.32 -53.04 4.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.686 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -48.34 -55.41 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.364 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.0 m-20 -70.78 -37.89 73.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.189 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.944 HG23 ' O ' ' A' ' 89' ' ' SER . 98.6 t -44.09 -45.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.639 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -85.69 -47.79 9.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.38 7.67 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -128.56 -38.09 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.908 ' CE3' HG13 ' A' ' 93' ' ' VAL . 46.1 m0 -95.13 -26.54 15.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.61 HG23 ' HA ' ' A' ' 94' ' ' LYS . 59.7 t -67.35 -44.1 45.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.563 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 41.6 Cg_exo -56.87 -34.98 98.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.324 2.016 . . . . 0.0 112.308 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.16 -33.29 74.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.536 HG23 ' CE2' ' A' ' 78' ' ' PHE . 47.6 mt -49.17 -40.25 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.5 p -77.3 -21.44 53.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.328 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.45 -37.2 77.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.86 0.362 . . . . 0.0 110.678 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 73' ' ' PRO . 22.1 m-70 -106.51 -39.75 5.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.813 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 3.9 m -99.25 102.74 16.9 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 87.6 Cg_exo -42.99 -62.29 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.479 2.119 . . . . 0.0 112.403 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -171.67 40.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 155.76 41.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.646 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.91 118.21 2.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.457 2.104 . . . . 0.0 112.179 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.2 p90 -104.89 141.99 35.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.319 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 111' ' ' LEU . 3.5 mt -129.49 158.11 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.989 0.423 . . . . 0.0 111.244 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.8 m -156.56 155.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.44 39.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 158' ' ' SER . 73.0 p -146.29 160.04 42.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.699 0.285 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.42 35.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 157' ' ' CYS . 20.0 mt -97.04 -61.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.987 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.66 -35.88 11.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.79 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 119' ' ' LEU . 6.0 tt -70.52 -32.21 69.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HG3' HG23 ' A' ' 85' ' ' VAL . 7.0 ttm180 -76.63 59.38 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -129.21 37.29 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.87 141.64 22.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.44 -49.57 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.556 2.171 . . . . 0.0 112.265 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m -57.77 -22.98 49.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.547 HG22 HD12 ' A' ' 129' ' ' LEU . 5.2 m -48.83 -66.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.69 -45.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -50.19 52.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -81.37 -35.09 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 125' ' ' THR . 2.8 mt -50.91 -25.56 4.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.495 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.26 -21.41 56.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.081 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -83.38 -20.05 34.93 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.98 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.89 30.55 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 77.79 32.95 0.38 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.39 -161.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.14 93.25 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 37.5 Cg_endo -66.2 124.85 13.12 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.548 2.165 . . . . 0.0 112.064 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.508 HG21 ' CA ' ' A' ' 84' ' ' VAL . 3.7 mt -50.55 120.29 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -118.12 158.41 46.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 3.7 Cg_exo -40.3 -29.42 0.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.071 2.514 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -36.75 21.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' THR . 93.5 m -48.05 -47.61 33.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.882 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -49.31 -46.58 46.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -57.66 -42.95 84.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.42 -53.47 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 14.8 tp -57.26 -31.95 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.467 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.875 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -66.66 -31.59 72.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -70.34 -47.64 60.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -23.14 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 pp -106.3 -24.26 12.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.073 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 1.2 tttt 62.16 120.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.845 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.7 -161.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 5.1 t -67.37 -15.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.574 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.32 146.02 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.875 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 24.3 p90 -152.79 126.25 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.186 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.1 t -138.12 123.39 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -170.73 -179.63 2.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.469 ' HB2' HD11 ' A' ' 117' ' ' ILE . 17.6 p -130.62 -173.22 3.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 115' ' ' THR . 8.7 t -87.15 163.2 17.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.702 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.75 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.25 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.058 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.75 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 69.73 -63.25 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.64 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.2 p -89.51 -169.62 2.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.484 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -172.56 109.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -100.39 -38.75 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.44 88.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.304 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.67 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -91.98 -11.54 35.8 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -34.22 37.36 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -57.09 -45.43 83.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.283 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' VAL . 31.1 t -54.76 -52.96 37.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.472 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' CB ' ' HH ' ' A' ' 23' ' ' TYR . 1.4 m-30 -70.15 -28.25 65.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -53.93 -52.12 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.775 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 1.5 tp10 -89.9 -33.9 16.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -66.14 -38.38 88.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.858 HD12 ' HG ' ' A' ' 53' ' ' LEU . 42.3 mm -86.66 -44.17 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.4 tm? -64.43 -31.94 73.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 77' ' ' VAL . . . -51.75 -29.29 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.647 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -63.64 -20.98 66.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.18 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.71 38.3 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.286 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -50.45 -27.49 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.339 . . . . 0.0 110.898 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -144.03 137.41 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.867 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -138.65 133.54 32.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.604 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -77.2 143.23 69.28 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.59 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 42' ' ' VAL . 51.3 Cg_exo -54.12 152.36 24.84 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.352 2.035 . . . . 0.0 112.062 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -117.19 -37.07 3.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.89 163.05 27.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 27.6 t80 -167.46 130.35 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.624 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -153.42 116.67 4.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 69.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.427 ' N ' ' O ' ' B' ' 82' ' ' GLU . 8.2 p -57.9 -77.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.247 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.783 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -103.76 139.44 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.499 . . . . 0.0 112.279 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -123.11 96.21 4.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.101 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' A' ' 36' ' ' VAL . 57.7 t -88.08 144.51 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.891 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.36 176.85 20.05 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.989 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -77.35 113.42 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.568 ' CB ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -107.99 108.05 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.66 -17.2 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.307 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' VAL . . . . . 0.529 HG12 ' CG ' ' B' ' 90' ' ' ASP . 10.2 p -43.01 -35.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.509 HG23 HG22 ' B' ' 92' ' ' VAL . 18.2 p -157.79 45.33 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.05 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.54 27.39 5.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.62 -168.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.719 0.295 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 1.081 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -106.0 164.49 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.829 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.568 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.9 p -99.45 165.31 11.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.964 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.09 51.73 24.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.762 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -60.48 119.33 42.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.665 ' HG3' HG21 ' B' ' 85' ' ' ILE . 58.4 Cg_exo -49.56 156.46 2.9 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.291 1.994 . . . . 0.0 112.146 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.67 -57.1 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.455 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.422 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.1 tm0? -69.94 -52.52 23.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.225 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -50.1 -57.77 6.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.725 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.616 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -48.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.204 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 77.5 mtt180 -54.76 -34.29 62.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.242 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.659 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.05 -61.04 2.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.925 0.393 . . . . 0.0 109.978 179.404 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.681 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -70.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.15 178.324 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 108' ' ' GLN . . . . . 0.556 ' C ' HG22 ' B' ' 109' ' ' THR . 4.0 pt20 -80.74 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.203 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.556 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.05 62.58 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.459 0.304 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 110' ' ' SER . . . . . 0.616 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.1 OUTLIER 168.41 108.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.384 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.8 OUTLIER -65.39 74.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 121.196 0.522 . . . . 0.0 111.311 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 69.44 140.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.27 144.68 46.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 53' ' ' LEU . 9.1 pt -119.87 114.57 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 0.8 OUTLIER -135.11 100.05 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -77.93 130.21 36.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.803 HG13 HG21 ' A' ' 75' ' ' THR . 2.1 m -96.67 150.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 16' ' ' LYS . 17.9 t -125.63 154.29 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.362 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 59' ' ' ALA . 7.2 p -149.64 121.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.738 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . 130.6 -179.52 16.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.93 -179.53 5.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.48 77.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.379 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB2' " C5'" ' A' ' 185' ' ' GNP . . . 53.41 84.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.738 HG11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -109.23 4.26 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.286 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.865 ' CA ' HD12 ' A' ' 19' ' ' LEU . . . 97.09 -18.19 57.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.281 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.818 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -62.92 -74.19 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.773 0.321 . . . . 0.0 111.515 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.796 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -96.62 -25.88 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' SG ' ' C8 ' ' A' ' 185' ' ' GNP . 2.1 p -65.61 -48.11 73.38 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.705 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD12 ' CA ' ' A' ' 15' ' ' GLY . 4.3 mt -61.26 -73.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.349 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 40' ' ' TYR . 11.2 mt -40.8 -43.42 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.981 0.419 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.773 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -48.71 -69.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.806 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 1.8 t -93.79 -55.39 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CZ ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -51.96 -19.25 1.7 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.498 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.452 ' CB ' ' HA ' ' A' ' 20' ' ' LEU . 43.2 m -123.94 -86.23 0.64 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.232 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.453 ' CG2' ' HD3' ' A' ' 27' ' ' LYS . 4.7 t -65.83 -14.21 60.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' ILE . 36.0 t30 79.03 -56.28 0.44 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.908 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -47.74 145.74 2.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.996 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.773 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -88.48 167.01 20.32 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.7 Cg_endo -45.82 165.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.993 2.462 . . . . 0.0 112.688 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.8 t -119.56 -76.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.98 113.94 25.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.643 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.28 109.3 4.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 111.056 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' HD2' ' A' ' 34' ' ' PRO . 67.2 t -157.52 138.03 9.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.478 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 84.3 Cg_exo -43.81 92.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.314 2.009 . . . . 0.0 111.617 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.813 HG23 ' CG ' ' A' ' 38' ' ' ASP . 56.8 m -51.98 87.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 34' ' ' PRO . 20.9 t -79.54 -28.23 12.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 109.762 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' B' ' 85' ' ' ILE . 3.7 t80 -146.62 -68.76 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.813 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.2 m-20 60.47 131.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.389 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' HB2' HD12 ' B' ' 85' ' ' ILE . 5.6 t-20 -108.0 159.81 16.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.796 ' OH ' HG23 ' A' ' 17' ' ' THR . 3.7 m-85 -152.18 157.44 41.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -115.29 137.94 51.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.176 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 41' ' ' ALA . 3.2 m -162.2 164.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 51' ' ' TYR . 84.8 m -155.94 99.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.483 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 76' ' ' SER . 3.1 m -98.54 117.15 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.5 mtm -91.37 102.12 14.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.21 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 177' ' ' LEU . 1.7 mp -87.3 107.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 20.84 77.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.39 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -141.67 100.47 6.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.949 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.38 155.95 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.501 2.134 . . . . 0.0 112.196 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.67 ' H ' HG23 ' A' ' 43' ' ' THR . 2.3 m-85 -154.16 169.63 23.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 111.327 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 97.22 4.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.321 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -105.04 161.26 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 111.375 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.833 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -160.27 127.3 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.057 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.043 HD11 HD23 ' A' ' 79' ' ' LEU . 1.8 mm? -75.93 103.23 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.9 103.0 12.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.022 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 58' ' ' THR . 1.5 m-20 -78.19 142.57 37.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 57' ' ' ASP . 2.2 p -167.72 178.68 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . . . -127.17 -66.71 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . 104.06 54.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.757 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER 170.48 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.324 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' A' ' 61' ' ' LEU . 22.7 mt-10 -85.79 89.96 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.186 0.517 . . . . 0.0 111.886 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 61.71 13.66 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.02 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.838 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 93.7 m-85 -102.62 -29.07 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -49.21 -27.37 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -93.49 -31.54 14.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.699 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -94.02 24.16 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -85.31 -46.31 0.63 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.205 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.7 Cg_exo -50.16 -23.15 9.14 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.834 HD22 ' CG ' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -76.24 -26.05 55.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.339 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.447 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 2.3 m -92.62 -23.42 19.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 2.0 p90 46.29 102.7 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.501 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.81 -34.28 8.29 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.657 2.238 . . . . 0.0 112.663 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.83 -10.66 50.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.563 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 HG13 ' A' ' 7' ' ' VAL . 8.3 t -38.42 -51.66 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.2 OUTLIER 167.97 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.9 p -58.44 162.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.5 135.46 40.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.043 HD23 HD11 ' A' ' 55' ' ' LEU . 12.6 tp -109.95 115.78 30.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.059 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 ' HB ' HD23 ' A' ' 112' ' ' LEU . 2.1 t -131.23 145.86 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.434 ' HB3' ' CA ' ' A' ' 14' ' ' VAL . 11.4 t -139.17 158.66 43.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.913 ' HB3' HG11 ' A' ' 93' ' ' VAL . 7.6 p90 -152.37 149.52 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -51.36 160.77 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.802 HG13 HG22 ' A' ' 137' ' ' ILE . 73.0 t -109.09 -69.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 125' ' ' THR . 67.0 t -52.03 -73.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.88 106.16 0.61 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD3' HG23 ' A' ' 125' ' ' THR . 68.8 Cg_endo -74.3 -25.76 13.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.528 2.152 . . . . 0.0 112.551 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.69 -24.16 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.8 m -96.15 -30.69 13.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.158 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.95 -69.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.125 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -50.47 -48.29 56.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' CA ' ' HG3' ' A' ' 96' ' ' LYS . 1.5 m-80 -53.2 -69.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 82' ' ' PHE . 61.5 t -40.45 -30.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.925 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.61 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.38 8.42 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.953 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG3' ' CA ' ' A' ' 92' ' ' ASN . 21.8 mmtm -113.3 -44.79 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.611 ' HD1' HG13 ' A' ' 93' ' ' VAL . 10.4 m95 -95.55 -36.79 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 94.1 t -52.5 -44.74 95.2 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.511 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 52.9 Cg_exo -52.51 -28.47 36.35 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.288 1.992 . . . . 0.0 112.288 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -77.94 -22.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 80' ' ' VAL . 21.6 mm -49.17 -31.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -85.01 -24.87 28.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 60' ' ' GLY . 9.9 t60 -65.78 -37.22 85.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -103.71 -19.66 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.256 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 12.2 m -152.88 74.49 7.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.761 0.315 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -12.57 33.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.617 2.211 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.57 21.16 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.255 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 135.67 25.04 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.85 159.63 4.87 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.498 2.132 . . . . 0.0 112.148 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 16.5 p90 -135.76 134.93 39.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 154' ' ' TYR . 4.6 mt -111.85 122.03 46.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' CE2' ' A' ' 82' ' ' PHE . 12.4 mt -91.15 162.94 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' PHE . 49.0 t -152.79 141.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.1 104.45 0.35 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.392 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 157' ' ' CYS . 71.1 p -137.84 137.56 38.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER 177.32 71.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 pt -98.69 -22.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.7 -24.41 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 116' ' ' GLN . 5.9 tt -75.15 -27.91 59.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.62 ' CB ' HG21 ' A' ' 85' ' ' VAL . 1.1 ptp180 -50.22 139.66 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.65 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.023 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -54.16 120.94 27.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.2 -41.42 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t -49.53 -31.67 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 129' ' ' LEU . 85.7 m -56.83 -58.98 5.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -51.38 -45.34 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -42.53 61.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -37.27 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 125' ' ' THR . 4.4 mt -50.71 -25.51 4.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.496 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.62 -20.46 53.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.21 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -81.3 -27.03 35.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.8 -8.36 57.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.454 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 62.89 26.45 15.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -100.84 -26.33 13.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.77 168.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.27 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.802 HG22 HG13 ' A' ' 84' ' ' VAL . 5.6 mt -51.52 135.37 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.224 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -132.31 177.75 2.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -53.35 -21.15 16.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.64 -42.34 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.499 ' HB ' HG23 ' A' ' 137' ' ' ILE . 22.7 m -50.88 -46.75 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.27 -40.43 58.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -43.87 97.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -51.55 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.799 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.78 -44.42 77.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -60.47 -31.38 70.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.86 -44.11 86.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.53 -50.64 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -68.14 -27.32 66.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.5 OUTLIER 70.59 108.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.82 -162.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 152' ' ' VAL . 57.3 t -67.34 -11.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.678 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 73.87 139.77 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.703 0.287 . . . . 0.0 110.86 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 24.6 p90 -153.11 162.64 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 155' ' ' VAL . 26.9 m -158.32 124.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.624 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -171.06 166.37 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.574 ' O ' HG21 ' A' ' 115' ' ' THR . 18.2 p -113.82 -173.13 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.413 ' CA ' ' HB ' ' A' ' 115' ' ' THR . 8.4 t -87.61 166.81 14.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.898 0.38 . . . . 0.0 111.029 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.664 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.16 -174.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.412 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.664 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.4 mm? 67.72 -64.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 166.14 11.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.72 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -142.01 122.94 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -105.07 -37.33 6.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 165.44 79.87 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.72 HD11 ' OE1' ' A' ' 162' ' ' GLN . 4.0 mt -83.89 -25.14 30.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 111.029 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -52.78 -31.46 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 166' ' ' LYS . 12.1 m-80 -65.28 -65.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.74 -27.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -74.3 -35.13 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.272 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.444 ' CB ' HG13 ' B' ' 75' ' ' ILE . 5.1 t70 -63.26 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.516 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 -25.6 25.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.769 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.99 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.054 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 46' ' ' ILE . 31.6 mm -94.8 -23.71 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.8 tt -72.5 -45.96 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.87 71.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.553 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -90.63 -19.67 23.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -47.47 -41.54 20.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.151 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 50.51 81.83 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.84 102.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.73 135.75 71.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.588 2.192 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.08 145.86 31.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 74.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.557 2.171 . . . . 0.0 112.257 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.26 129.53 54.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.881 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.06 -83.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 46' ' ' ILE . 8.4 mm -91.67 140.03 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.481 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.9 m -128.38 139.58 52.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -75.88 138.73 69.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.551 ' CB ' HG12 ' A' ' 42' ' ' VAL . 65.6 Cg_exo -51.3 146.85 22.98 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.461 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 30.8 t -108.41 -51.3 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 1.5 t0 -77.49 167.88 20.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 6.5 t80 171.41 124.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -153.19 132.38 12.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 111.382 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -68.91 95.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.472 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -74.51 -62.86 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.576 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.513 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -116.87 113.94 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.888 0.375 . . . . 0.0 111.499 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.08 96.91 7.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.198 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.463 HG22 ' HD3' ' B' ' 100' ' ' PRO . 39.4 t -79.31 137.77 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.445 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -133.14 177.56 18.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -77.26 136.48 38.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' B' ' 97' ' ' THR . 10.0 t0 -124.21 110.1 14.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.11 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.752 HG12 HG23 ' B' ' 93' ' ' THR . 48.9 t -40.98 -48.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.848 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.752 HG23 HG12 ' B' ' 92' ' ' VAL . 3.4 p -155.48 50.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 47.73 33.42 9.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.421 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' B' ' 90' ' ' ASP . 11.8 pt-20 -118.31 -178.01 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.325 . . . . 0.0 110.79 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.802 ' HE2' HD13 ' A' ' 67' ' ' LEU . 2.3 m-85 -101.95 164.23 11.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.503 HG22 HD13 ' B' ' 112' ' ' ILE . 19.4 p -109.78 168.86 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 48.71 27.58 6.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.568 ' CE ' HD21 ' A' ' 67' ' ' LEU . 2.7 mtp -52.64 131.11 46.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.593 0.235 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.483 ' CA ' HG21 ' B' ' 85' ' ' ILE . 81.3 Cg_exo -49.5 145.74 15.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.554 2.17 . . . . 0.0 112.19 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -45.59 -39.93 8.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -78.57 -51.12 10.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.525 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.555 ' HA ' HD13 ' A' ' 70' ' ' LEU . 2.6 m0 -53.76 -55.43 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 109.622 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -51.64 -62.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.841 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 15.9 ptt85 -55.95 -36.31 67.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.301 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.834 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -46.83 -63.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -96.2 -69.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.193 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.563 ' C ' HG22 ' B' ' 109' ' ' THR . 0.6 OUTLIER -80.4 -105.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.071 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.563 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.34 -24.14 0.0 OUTLIER 'General case' 0 C--N 1.351 0.653 0 C-N-CA 122.43 0.292 . . . . 0.0 111.361 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.5 107.9 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.332 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -43.43 -50.81 6.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 110.847 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.542 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.7 OUTLIER -130.4 87.09 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 7.0 m 68.99 -63.52 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.064 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' B' ' 116' ' ' GLU . 9.4 mtpt -132.05 39.67 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.985 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m 60.8 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 114' ' ' LYS . 0.6 OUTLIER -177.89 153.98 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -93.34 97.93 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.876 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.534 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.713 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -103.15 132.43 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -103.49 153.22 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.002 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 3' ' ' THR . 5.4 pt -158.04 121.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.981 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 112.88 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -91.86 128.73 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.817 HG21 ' CB ' ' A' ' 71' ' ' SER . 59.1 t -107.24 159.06 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.994 0.426 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 79' ' ' LEU . 4.9 m -126.79 163.24 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 80' ' ' VAL . 3.5 t -153.68 123.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.212 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 14' ' ' VAL . . . 147.7 168.97 14.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.735 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -60.0 -152.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -40.73 141.48 0.92 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 55.89 62.48 2.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.182 0.515 . . . . 0.0 109.701 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.741 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.9 t -54.68 -19.62 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 132.6 -36.04 2.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.795 ' N ' HG11 ' A' ' 8' ' ' VAL . 7.5 mmtt -95.91 -73.71 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.237 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 188' ' ' HOH . 4.7 t -36.09 -53.06 0.79 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 5.4 p -63.8 -48.6 76.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.785 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 15' ' ' GLY . 12.5 mt -55.71 -72.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 55' ' ' LEU . 8.6 mt -38.09 -43.05 0.71 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.588 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -49.4 -69.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -93.47 -54.16 3.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.157 0.503 . . . . 0.0 111.452 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.818 ' HA ' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -51.31 -21.82 2.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.411 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 77.2 m -120.63 -88.07 0.63 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.832 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.76 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 5.0 t -54.89 -30.46 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.219 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.6 OUTLIER 76.64 51.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -158.83 116.28 2.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.768 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -45.85 168.39 0.11 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.884 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 61.7 Cg_exo -53.05 158.32 6.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.743 2.295 . . . . 0.0 112.981 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.1 t -107.44 -76.25 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.779 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.45 108.04 19.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.377 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.8 100.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.45 . . . . 0.0 111.161 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 ' HD2' ' A' ' 34' ' ' PRO . 96.5 t -151.51 139.51 12.85 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.207 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 36' ' ' VAL . 98.1 Cg_exo -41.58 91.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.385 2.056 . . . . 0.0 112.04 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 38' ' ' ASP . 93.0 m -54.25 87.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 34' ' ' PRO . 59.5 t -85.99 -24.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.398 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.6 t80 -142.39 -66.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.907 ' CG ' HG23 ' A' ' 35' ' ' THR . 6.1 m-20 53.71 107.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 41.7 t30 -107.6 153.08 23.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.794 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CE1' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.47 168.82 22.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.71 115.62 28.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.712 HG22 HD11 ' A' ' 55' ' ' LEU . 12.3 m -134.38 137.68 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.658 HG23 ' H ' ' A' ' 51' ' ' TYR . 55.1 m -136.7 108.59 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG12 ' O ' ' B' ' 76' ' ' SER . 4.8 m -98.24 117.29 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.052 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 27.2 mtm -79.4 100.98 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 173' ' ' ILE . 5.6 mm -87.95 91.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.43 16.04 74.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.709 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.09 25.8 10.9 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.736 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.0 mt-10 -124.65 131.26 24.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.554 0.216 . . . . 0.0 110.793 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 159.07 28.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.466 2.111 . . . . 0.0 112.271 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.658 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -154.04 161.51 41.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -136.44 97.42 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.531 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 53' ' ' LEU . 9.0 tt -107.34 131.76 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.266 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -97.17 134.24 11.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.252 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.932 HD22 ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -113.19 103.1 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.945 0.402 . . . . 0.0 110.905 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 4.1 m-85 -102.11 111.28 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.619 ' OD2' HG22 ' A' ' 17' ' ' THR . 4.5 t70 -88.01 171.4 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.426 ' O ' HG21 ' A' ' 14' ' ' VAL . 8.4 p -139.56 -175.7 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.715 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -101.02 -23.44 14.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.071 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . . . 74.71 51.78 7.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.359 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.0 174.89 11.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.88 30.77 2.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.1 28.81 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.877 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.8 m-85 -101.14 -11.74 19.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -43.06 -28.51 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.675 0.274 . . . . 0.0 111.592 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 3.5 mtt85 -45.02 -62.82 1.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.763 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.3 mp -72.33 173.5 8.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 5.2 tpp180 -101.0 -72.66 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.5 Cg_endo -71.4 -58.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.036 1.824 . . . . 0.0 113.06 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 64' ' ' TYR . 63.4 mt 50.1 25.65 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.817 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER 164.17 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.02 175.25 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 111.072 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 34.3 Cg_exo -61.9 -24.41 77.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.645 2.23 . . . . 0.0 112.17 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -68.06 -10.12 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.608 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -36.94 -32.15 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t0 51.62 -151.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.537 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 175' ' ' ALA . 40.6 t -57.56 156.2 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.692 0.282 . . . . 0.0 110.478 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -113.34 134.51 54.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.808 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.93 122.22 44.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.08 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 t -130.35 101.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.0 t -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.669 ' CB ' HG11 ' A' ' 93' ' ' VAL . 38.2 p90 -137.34 124.68 21.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.008 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 p -52.96 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.2 86.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.666 HG12 ' OE1' ' A' ' 116' ' ' GLN . 30.3 m -122.92 75.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.79 148.48 0.12 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 51.9 Cg_exo -54.6 -19.34 17.88 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.749 2.299 . . . . 0.0 112.591 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 t -46.59 -73.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.39 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.3 m -61.28 -24.57 66.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -51.32 -58.96 4.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.035 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -49.65 -60.72 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -53.32 -63.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' SER . 72.9 t -41.14 -29.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.959 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.9 tttt -74.84 -69.51 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.664 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.73 7.98 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.39 -43.34 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.648 0.261 . . . . 0.0 111.553 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.663 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.1 m95 -95.3 -40.12 9.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.5 t -52.65 -44.2 94.64 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.512 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.4 Cg_exo -59.79 -28.82 88.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.278 1.985 . . . . 0.0 112.235 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -24.29 60.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.7 mt -49.48 -27.81 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -76.87 -28.15 55.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -70.81 -44.8 65.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CE1' ' CD2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -89.02 -33.72 17.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 2.7 m -107.6 129.63 23.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.654 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.61 -83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.444 2.096 . . . . 0.0 112.64 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -153.52 83.68 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.854 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -151.59 163.92 22.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.854 ' HD2' HG22 ' A' ' 108' ' ' THR . 59.4 Cg_exo -52.09 130.24 34.27 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.451 2.101 . . . . 0.0 112.037 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -102.6 125.77 49.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -106.69 121.4 44.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.687 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -114.1 162.59 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.087 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 114' ' ' GLY . 3.1 t -146.84 166.3 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -161.12 101.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.529 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' GLY . 41.2 p -158.48 142.23 15.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.431 . . . . 0.0 111.238 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.666 ' OE1' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -174.79 40.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.453 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 158' ' ' SER . 10.1 mt -37.83 -37.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.838 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.59 -43.82 96.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.741 HD23 ' OD2' ' A' ' 122' ' ' ASP . 2.0 mt -86.99 -45.55 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 5.1 tmm_? -48.93 -26.24 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.9 46.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' A' ' 119' ' ' LEU . 2.3 m-20 -107.23 156.09 38.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.05 -49.89 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.17 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -50.05 -47.71 53.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -51.99 -31.76 30.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.218 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 24.0 mm -63.56 -54.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.66 -40.91 13.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -84.86 -37.84 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -49.58 -32.73 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.337 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.01 65.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.103 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -24.02 19.67 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.314 . . . . 0.0 110.867 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 18.7 m120 -95.98 30.19 2.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 26.65 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 49.19 -166.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.58 86.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.876 ' HA ' HD21 ' A' ' 129' ' ' LEU . 74.0 Cg_exo -48.38 169.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.575 2.184 . . . . 0.0 112.317 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.1 mt -94.13 130.27 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -110.75 168.42 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.962 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 48.8 Cg_exo -56.58 -17.74 23.37 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.714 2.276 . . . . 0.0 112.562 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -82.55 -32.93 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.194 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.3 m -56.69 -62.78 1.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.971 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.95 -50.58 26.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 tt0 -55.38 -39.86 70.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -53.66 -54.73 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.645 HD13 ' CE1' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -54.57 -37.15 65.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.692 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.796 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.23 -46.78 82.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -57.76 -44.68 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.626 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -22.29 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.037 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.563 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 2.9 pp -121.38 21.27 11.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 43.9 tttm 56.16 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.07 174.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.044 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 60.9 t -59.49 -17.76 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.46 135.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.647 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.796 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 13.6 p90 -152.9 154.82 35.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.363 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 168' ' ' VAL . 35.0 m -155.07 123.67 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.23 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.6 pt-20 -170.88 -178.68 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 111.111 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.428 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 4.8 p -127.91 -170.37 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.018 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.544 ' HB3' HD12 ' A' ' 117' ' ' ILE . 1.7 t -85.35 174.52 9.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.755 0.312 . . . . 0.0 110.288 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.531 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -34.36 -85.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.05 -171.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.499 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 162' ' ' GLN . 4.3 p 64.72 -67.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.836 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 54.53 94.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 110.783 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -105.18 -67.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.1 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.96 77.84 0.38 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.793 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.818 HD21 ' HA ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -93.7 -29.05 15.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' B' ' 77' ' ' LEU . 4.6 mmtp -54.62 -60.25 3.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.294 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -43.31 -37.06 2.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 156' ' ' GLU . 23.9 t -59.37 -62.28 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.755 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.75 ' CE1' HD21 ' B' ' 77' ' ' LEU . 66.2 m-85 -52.08 -28.94 19.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' OD1' HG21 ' B' ' 75' ' ' ILE . 1.9 m-20 -63.07 -41.8 99.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -88.62 -45.55 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 110.908 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.7 70.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.682 HG21 HD11 ' A' ' 46' ' ' ILE . 50.0 mm -86.35 -52.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 174' ' ' LEU . 3.4 tm? -55.05 -39.65 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.477 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -53.64 -47.4 70.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.87 35.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.7 tp -50.85 -44.83 59.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.037 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 58.88 61.44 4.76 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.554 ' HG3' HD21 ' A' ' 174' ' ' LEU . 44.0 Cg_endo -68.18 154.54 72.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.21 152.34 61.62 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.656 2.237 . . . . 0.0 112.349 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.84 159.96 58.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.25 138.77 37.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.633 2.222 . . . . 0.0 112.306 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -56.05 160.67 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -44.38 96.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.474 HG21 ' OD1' ' A' ' 170' ' ' ASP . 7.2 tt -143.98 151.94 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -134.7 154.72 51.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.025 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -89.09 137.45 29.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.446 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 50.7 Cg_exo -55.25 -63.6 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.45 2.1 . . . . 0.0 111.793 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.88 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.164 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.79 88.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.76 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -118.79 -173.12 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.02 128.97 10.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.6 85.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.433 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.493 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -53.87 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -120.73 154.18 24.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 96.75 4.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.531 HG12 ' HB ' ' A' ' 36' ' ' VAL . 86.0 t -80.18 121.65 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.462 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -125.87 177.27 17.16 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.127 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.3 138.52 39.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 111.004 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.856 ' HB2' HG23 ' B' ' 97' ' ' THR . 4.4 t0 -139.0 112.94 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.16 60.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.646 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.596 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -41.22 -33.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.606 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.596 HG22 HG13 ' B' ' 92' ' ' VAL . 3.8 t -140.09 -37.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.96 20.96 1.59 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.71 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.34 -158.63 0.9 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.6 0.238 . . . . 0.0 110.394 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.42 ' CD1' HG11 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -103.41 164.53 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.803 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.856 HG23 ' HB2' ' B' ' 90' ' ' ASP . 11.5 p -95.73 162.53 13.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.1 46.18 33.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.568 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -61.53 124.36 80.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.561 0.219 . . . . 0.0 110.862 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.54 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 63.7 Cg_exo -50.62 159.66 2.1 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.366 2.044 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.01 -57.26 3.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.276 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -72.51 -56.09 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.613 ' CE2' HD23 ' A' ' 70' ' ' LEU . 8.6 m0 -46.24 -55.34 7.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -54.76 -45.94 74.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.109 0.481 . . . . 0.0 110.447 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 55.0 mtp85 -58.52 -41.41 85.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.88 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -50.3 -55.88 13.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.253 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.32 -69.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.758 ' O ' HG23 ' B' ' 109' ' ' THR . 5.2 tp-100 -79.14 -100.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -168.17 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 120.872 0.367 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.409 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -150.95 174.25 13.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.217 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.58 72.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.691 ' O ' HG23 ' B' ' 113' ' ' THR . 0.0 OUTLIER -57.63 88.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.621 0.725 . . . . 0.0 111.608 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.691 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 169.19 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -110.33 -32.41 6.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -94.82 45.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -155.91 27.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 133.82 44.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.531 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.722 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.824 0.345 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.1 124.08 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.21 141.03 28.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.467 HG23 ' OD2' ' A' ' 76' ' ' ASP . 3.9 mt -146.7 129.34 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -131.65 95.35 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.568 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.9 t -77.35 100.44 5.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.722 HG23 ' OG1' ' A' ' 75' ' ' THR . 94.0 t -84.4 113.25 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.656 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.965 HG12 ' HB3' ' A' ' 79' ' ' LEU . 27.4 m -85.04 140.0 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.549 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 80' ' ' VAL . 11.8 p -126.49 154.88 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.679 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . 147.6 -169.19 28.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.666 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.94 29.6 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -125.12 -41.57 0.36 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 85.64 -23.68 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 81' ' ' CYS . 28.7 m -48.7 -23.83 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.833 ' HA3' HG23 ' A' ' 113' ' ' VAL . . . -120.56 -33.78 0.99 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.603 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 10' ' ' GLY . 44.3 mtmt -63.82 -76.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 111.406 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.021 HG21 ' CG2' ' A' ' 35' ' ' THR . 17.4 p -98.24 -43.9 6.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.253 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' SG ' ' PB ' ' A' ' 185' ' ' GNP . 58.2 m -52.61 -23.82 7.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.757 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 23' ' ' TYR . 18.8 tp -61.8 -71.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 55' ' ' LEU . 14.2 mt -44.12 -29.13 0.57 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.8 mm -65.79 -45.12 92.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.369 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.535 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 78.5 p -94.93 -13.15 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.81 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.003 ' CD1' HD13 ' A' ' 165' ' ' LEU . 2.9 m-30 -95.93 -67.45 0.85 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.612 HG22 ' HB2' ' B' ' 81' ' ' PHE . 58.6 m -82.74 -81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.647 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.702 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -47.23 -40.44 16.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.274 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.481 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 2.4 t30 64.79 41.38 5.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.702 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -126.84 -159.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.38 155.66 76.21 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 65.1 Cg_exo -36.79 132.47 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.017 2.478 . . . . 0.0 113.118 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m -97.91 -82.83 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.556 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.78 108.77 20.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HA ' ' O3G' ' A' ' 185' ' ' GNP . 1.4 t80 -66.45 109.29 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.294 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.4 p -160.63 133.23 4.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.383 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 36' ' ' VAL . 90.5 Cg_exo -41.26 93.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.353 2.035 . . . . 0.0 111.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 1.021 ' CG2' HG21 ' A' ' 17' ' ' THR . 23.8 m -53.07 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.328 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' B' ' 96' ' ' PHE . 2.2 t -77.48 -24.6 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -150.56 -75.49 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.699 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.748 ' CG ' HG23 ' A' ' 35' ' ' THR . 5.7 m-20 60.27 117.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.778 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.579 ' CB ' HD12 ' B' ' 85' ' ' ILE . 16.0 t-20 -107.13 156.66 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.557 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.06 168.97 22.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.258 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.31 138.76 53.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.0 m -147.04 131.45 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.2 m -116.66 103.12 10.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.883 HG22 ' HD3' ' B' ' 78' ' ' PRO . 40.6 t -98.91 121.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.041 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.3 mtm -87.05 100.09 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.011 HD12 ' CZ ' ' A' ' 51' ' ' TYR . 14.1 mt -98.3 93.82 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 17.34 79.93 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.364 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 35.52 5.43 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -141.19 128.33 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.483 0.182 . . . . 0.0 110.928 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 168.7 3.24 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.05 . . . . 0.0 112.232 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.011 ' CZ ' HD12 ' A' ' 46' ' ' ILE . 2.4 m-85 -147.96 156.08 42.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 p -130.52 99.93 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 54' ' ' GLY . 10.4 tt -133.53 160.56 37.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.783 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -153.4 149.27 20.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 20' ' ' LEU . 16.3 mt -99.14 104.11 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 111.214 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' A' ' 7' ' ' VAL . 5.5 m-85 -83.39 112.66 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 7.2 t70 -66.93 134.09 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 111.237 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -145.12 155.33 43.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.765 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.46 -176.37 4.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.212 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -110.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tp 50.29 -161.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.366 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -132.52 40.0 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -131.69 21.04 4.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 58' ' ' THR . 2.7 m-85 -111.34 -27.99 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.74 -41.28 22.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.825 ' HG3' HD12 ' A' ' 67' ' ' LEU . 4.1 ptp85 -69.06 -36.7 77.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.404 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -98.0 29.05 3.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.576 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 2.6 tpt180 -88.73 -66.12 0.16 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 87.5 Cg_exo -37.27 -31.28 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.844 2.363 . . . . 0.0 112.827 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -51.99 -31.53 29.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.722 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -91.8 -25.47 19.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.9 OUTLIER 50.47 170.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.748 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.2 Cg_exo -68.67 -20.78 40.04 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.075 2.517 . . . . 0.0 112.666 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.52 -10.95 39.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.512 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.5 t -48.71 -23.82 1.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 111.639 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 4' ' ' ILE . 4.2 m-20 77.25 -152.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.67 148.85 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 7' ' ' VAL . 4.6 m-85 -100.39 131.92 46.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.965 ' HB3' HG12 ' A' ' 8' ' ' VAL . 48.9 tp -103.74 115.97 31.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.137 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' VAL . 4.6 t -110.38 150.76 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 111.799 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 31.4 p -92.75 170.73 9.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -161.86 101.34 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.385 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.464 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 41.9 t -68.33 129.92 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 142' ' ' ALA . 27.4 m -121.51 49.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -115.68 -69.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -100.2 103.44 23.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.733 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 80.2 Cg_exo -44.8 -27.61 2.5 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.584 2.189 . . . . 0.0 112.504 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -64.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.8 m -58.33 -34.95 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -45.61 -41.35 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.263 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.77 -61.26 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.735 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.4 m-20 -59.63 -38.68 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 89' ' ' SER . 92.5 t -47.5 -52.75 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.2 tttm -65.16 -47.83 75.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.479 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -82.36 8.17 12.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.36 -37.41 2.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.67 0.271 . . . . 0.0 111.558 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.801 ' CE3' HG13 ' A' ' 93' ' ' VAL . 22.6 m0 -92.28 -28.93 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.67 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.804 ' O ' HG22 ' A' ' 101' ' ' ILE . 33.1 t -74.47 -44.09 5.62 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 27.0 Cg_exo -62.34 -23.11 74.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.321 2.014 . . . . 0.0 112.345 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.9 -14.9 27.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.618 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -46.62 -33.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.388 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 p -81.06 -34.19 32.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -61.9 -27.29 68.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.44 -24.58 9.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 101' ' ' ILE . 2.1 m -120.62 92.02 47.5 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 55.9 Cg_endo -70.18 99.33 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.634 2.223 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 44.29 41.55 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 109' ' ' PRO . 53.4 m -117.64 142.2 30.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 108' ' ' THR . 6.9 Cg_endo -49.28 133.86 30.58 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.852 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.8 p90 -115.45 149.54 37.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.996 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 148.03 46.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 tp -116.03 142.26 47.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.628 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.879 HG12 ' OE1' ' A' ' 156' ' ' GLU . 1.4 m -153.54 176.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.32 138.13 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.4 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.702 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -158.35 153.13 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.601 ' CB ' HG13 ' A' ' 85' ' ' VAL . 28.5 mm-40 -151.84 98.42 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.652 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.854 HD11 ' HB2' ' A' ' 157' ' ' CYS . 2.8 mt -90.44 -46.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -25.81 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.535 HD12 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -77.22 -43.09 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -52.2 -29.03 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.17 47.01 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.982 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -89.05 140.93 29.1 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.793 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.75 -36.56 33.38 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -82.63 -30.43 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.771 HG22 ' CD1' ' A' ' 129' ' ' LEU . 61.1 m -56.03 -63.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.7 mp -50.53 -39.16 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.1 -55.87 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.711 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.76 45.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.57 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.33 -26.28 4.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 110.368 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.69 -24.13 63.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.802 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -84.15 -22.76 30.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 9.1 m-80 -93.92 30.05 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt 70.58 28.21 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -160.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.44 82.57 0.17 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.809 ' HA ' HD21 ' A' ' 129' ' ' LEU . 54.1 Cg_exo -52.46 166.69 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 84' ' ' VAL . 4.8 mt -101.59 122.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.457 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.1 p -112.98 176.51 1.46 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.6 Cg_exo -54.56 -20.37 20.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.607 2.205 . . . . 0.0 112.371 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.72 -47.94 15.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.473 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.9 m -51.18 -49.83 60.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -53.2 -50.01 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.33 -35.63 77.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.809 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -59.09 4.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.8 tp -61.82 -27.29 68.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 154' ' ' TYR . . . -73.2 -31.89 64.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.47 -45.51 65.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -23.07 25.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.049 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.806 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.5 pp -108.48 -16.55 14.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt 75.12 -69.73 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 -172.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 152' ' ' VAL . 62.1 t -68.29 -8.95 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.748 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.49 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.977 0.417 . . . . 0.0 111.003 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CZ ' ' HB1' ' A' ' 146' ' ' ALA . 2.8 p90 -153.47 154.54 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.653 ' H ' HG22 ' A' ' 168' ' ' VAL . 2.6 m -158.2 124.47 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.769 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.879 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -171.18 166.65 7.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.412 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.7 p -123.48 -173.63 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.22 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 116' ' ' GLN . 3.6 p -88.2 162.86 16.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.91 -173.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER 52.14 30.14 7.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.02 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 -68.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.481 ' NE2' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 60.82 105.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -102.3 -64.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.13 88.82 0.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.604 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.003 HD13 ' CD1' ' A' ' 23' ' ' TYR . 2.4 mt -93.95 -10.86 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.553 0.216 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -57.7 -41.13 81.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 110.332 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.402 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 4.0 m-80 -57.8 -50.97 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 155' ' ' VAL . 55.6 t -52.33 -66.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.179 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.402 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -49.15 -40.73 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.559 ' HA ' HD13 ' B' ' 75' ' ' ILE . 48.4 t0 -50.14 -55.49 14.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -48.81 66.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.83 -28.97 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.096 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 46' ' ' ILE . 26.0 mm -93.57 -27.67 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -26.4 62.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.12 5.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.29 52.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 177' ' ' LEU . 5.9 tt -48.97 -26.32 2.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.86 143.01 23.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.94 158.04 3.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.562 2.175 . . . . 0.0 112.404 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.73 176.57 4.98 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.178 . . . . 0.0 112.223 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 182' ' ' PRO . 3.9 mt-10 -72.0 -62.82 1.45 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 181' ' ' GLU . 59.4 Cg_endo -72.19 61.9 3.33 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.571 2.18 . . . . 0.0 112.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 146.37 21.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.4 tptp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.918 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.68 -85.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 44' ' ' VAL . 8.3 tt -135.12 151.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.088 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.611 ' O ' HG13 ' A' ' 44' ' ' VAL . 40.1 t -134.78 148.72 50.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.17 88.44 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.635 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.883 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.4 Cg_endo -52.42 -172.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.61 2.207 . . . . 0.0 112.004 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.406 ' O ' ' N ' ' B' ' 81' ' ' PHE . 34.4 p -165.93 -40.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.204 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 71.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.612 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.2 t80 -93.35 139.58 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -153.37 129.26 10.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 78.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 110.372 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.542 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.642 HG21 ' HA ' ' B' ' 100' ' ' PRO . 0.5 OUTLIER -131.16 101.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.561 0.219 . . . . 0.0 111.395 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -85.4 96.78 9.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.374 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.51 HG12 ' N ' ' B' ' 88' ' ' GLY . 88.0 t -78.43 158.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.243 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.51 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -143.18 171.18 25.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.099 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.37 116.04 28.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.903 0.383 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.697 ' CB ' HG23 ' B' ' 97' ' ' THR . 49.9 t0 -136.51 124.06 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.23 0.72 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.976 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.848 HG13 HG23 ' B' ' 93' ' ' THR . 7.2 p -43.66 -29.09 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.861 0.362 . . . . 0.0 111.368 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.848 HG23 HG13 ' B' ' 92' ' ' VAL . 1.4 p -155.4 25.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.803 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.38 20.68 65.73 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.426 ' CD ' ' HG1' ' B' ' 93' ' ' THR . 17.5 pt-20 -125.29 -163.25 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.779 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -105.04 164.57 11.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.697 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.3 p -98.72 144.11 28.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' HB ' ' B' ' 113' ' ' THR . . . 74.51 45.18 24.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.603 ' HE1' HD21 ' A' ' 67' ' ' LEU . 2.4 tpt -49.95 105.67 0.54 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.619 0.247 . . . . 0.0 110.998 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.642 ' HA ' HG21 ' B' ' 85' ' ' ILE . 74.2 Cg_exo -48.88 144.32 15.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.481 2.12 . . . . 0.0 112.22 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -46.87 -47.29 21.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.176 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.53 -65.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.812 ' CE3' HD23 ' A' ' 67' ' ' LEU . 4.0 m0 -49.51 -53.51 22.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.599 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.566 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -52.62 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.166 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 2.8 mtt-85 -51.24 -32.79 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.812 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.79 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -49.79 -57.64 6.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.685 HD21 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.54 -72.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.952 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.565 ' C ' HG22 ' B' ' 109' ' ' THR . 2.8 pt20 -81.98 -113.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.229 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.565 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 158.75 65.78 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.499 0.32 . . . . 0.0 111.071 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER 170.07 125.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 111.345 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.4 OUTLIER -84.98 75.34 10.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.332 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -57.96 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.604 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 1.2 m 158.76 -46.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.819 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -98.05 -27.74 14.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.5 t -50.2 160.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.6 -170.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -74.58 152.1 39.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.899 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.555 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.25 121.31 15.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.26 151.83 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -144.55 120.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 143.18 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.1 m -136.04 155.3 50.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.795 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 71' ' ' SER . 41.9 t -138.19 158.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.633 HG13 ' OG1' ' A' ' 58' ' ' THR . 7.7 p -110.95 160.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.175 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' N ' HG22 ' A' ' 8' ' ' VAL . 7.4 p -151.53 133.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.57 177.25 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -76.98 117.82 18.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.56 178.69 16.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.342 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 18' ' ' CYS . . . -131.57 0.41 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 113' ' ' VAL . 3.8 t -54.81 -20.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.475 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.9 -109.3 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.452 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE2' HD23 ' A' ' 79' ' ' LEU . 3.9 mptp? -98.86 -53.88 3.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.577 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -43.85 -77.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.559 ' H ' HG23 ' A' ' 17' ' ' THR . 40.0 t -66.19 -24.72 66.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.953 0.406 . . . . 0.0 111.351 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 23' ' ' TYR . 15.4 tp -63.08 -72.78 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.357 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.995 HD11 HD23 ' A' ' 55' ' ' LEU . 1.3 mm? -41.59 -38.26 1.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.646 ' O ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -49.37 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.64 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -93.76 -50.21 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 112.001 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' A' ' 19' ' ' LEU . 2.6 t80 -53.75 -31.66 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 94.5 m -108.91 -87.7 0.5 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.551 -0.459 . . . . 0.0 112.119 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 21' ' ' ILE . 1.8 t -55.09 -24.75 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.558 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' SER . 17.6 t-20 72.21 51.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.806 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 21' ' ' ILE . 8.6 pttt -135.15 -167.48 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.512 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -124.72 154.33 70.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.794 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 88.0 Cg_exo -41.5 146.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.848 2.365 . . . . 0.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -103.01 -81.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.779 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.67 114.94 26.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.746 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.2 t80 -67.88 107.81 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 ' HD2' ' A' ' 34' ' ' PRO . 97.2 t -158.7 140.12 9.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.281 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.1 Cg_exo -43.51 91.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.381 2.054 . . . . 0.0 111.898 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.577 HG21 ' HB ' ' A' ' 17' ' ' THR . 23.3 m -52.5 89.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.271 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' PRO . 25.2 t -95.6 22.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.416 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.2 t80 168.04 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.178 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER 54.54 109.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.728 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.4 t30 -107.42 168.38 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD2' ' CE2' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -153.12 168.91 24.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.423 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.64 124.09 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.725 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 53' ' ' LEU . 27.4 m -150.15 138.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 51' ' ' TYR . 32.0 m -136.92 108.21 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.062 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 76' ' ' SER . 2.6 m -98.05 116.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 100.36 13.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.767 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 46' ' ' ILE . 2.9 mm -72.81 90.7 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.6 77.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 35.34 4.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.33 93.28 36.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.12 121.15 6.41 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.728 ' O ' HG23 ' A' ' 43' ' ' THR . 1.4 m-30 -117.34 162.62 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 52' ' ' THR . 2.7 t -112.88 97.24 6.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.572 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 54' ' ' GLY . 1.2 tt -107.72 160.1 15.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -155.12 100.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.365 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HD11 ' A' ' 20' ' ' LEU . 1.4 mm? -78.17 126.98 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 3.4 m-85 -108.7 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.607 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -74.27 -163.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.933 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.633 ' OG1' HG13 ' A' ' 8' ' ' VAL . 69.4 p -159.48 169.02 24.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . -73.45 -37.98 65.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 27.02 22.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -137.59 23.53 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 0.0 111.026 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 48.56 27.85 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.04 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.892 ' HB2' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -98.76 26.74 5.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.917 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -88.76 -22.26 23.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -43.94 -28.88 0.5 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -49.55 -60.48 2.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.848 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.9 mp -65.84 -176.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.383 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.55 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -100.85 -63.67 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 59.3 Cg_endo -95.42 -59.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.338 2.025 . . . . 0.0 113.001 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.917 HD13 ' CD2' ' A' ' 64' ' ' TYR . 23.3 mt 62.52 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 120.838 0.351 . . . . 0.0 110.761 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.861 ' CB ' HG21 ' A' ' 7' ' ' VAL . 25.6 p -90.98 -14.38 31.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.037 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 49.34 173.31 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.56 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.3 Cg_exo -68.0 -23.3 40.64 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.839 2.359 . . . . 0.0 112.282 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -11.95 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.1 t -47.49 -25.7 1.16 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.613 0.244 . . . . 0.0 111.506 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 47.33 -91.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.035 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 78' ' ' PHE . 44.9 t -95.37 161.23 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.553 0.216 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG12 ' A' ' 77' ' ' VAL . 9.4 m-85 -122.77 147.07 46.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 113' ' ' VAL . 1.9 mm? -103.91 147.15 27.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.065 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.32 97.18 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.09 100.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' A' ' 93' ' ' VAL . 38.6 p90 -116.84 144.02 45.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.14 164.4 24.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 115' ' ' THR . 32.2 m -131.63 42.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.993 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.45 72.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.99 153.65 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.045 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 90' ' ' PHE . 27.5 Cg_exo -61.51 -13.72 31.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.681 2.254 . . . . 0.0 112.58 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.6 t -43.41 -71.79 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.9 m -80.77 -26.91 36.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.546 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 1.7 t80 -47.67 -61.4 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.049 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -50.23 -54.44 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -54.26 -45.67 72.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 89' ' ' SER . 98.4 t -47.59 -50.04 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.414 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.3 mtmt -78.26 -44.42 25.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.422 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -77.84 5.32 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.48 -36.97 2.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.613 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -95.31 -41.96 8.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 94' ' ' LYS . 46.1 t -49.87 -44.49 78.41 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.359 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_exo -55.05 -31.08 73.26 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.284 1.989 . . . . 0.0 111.957 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.7 -17.33 26.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -45.33 -31.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.861 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.2 p -71.13 -42.91 68.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.444 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -52.21 -36.15 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.329 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.472 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m80 -89.95 -36.68 14.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 17.3 t -98.02 115.61 65.74 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.36 -63.78 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.428 2.086 . . . . 0.0 112.475 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.7 34.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.87 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -109.4 160.17 28.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.87 ' HD2' HG22 ' A' ' 108' ' ' THR . 50.0 Cg_exo -53.46 169.55 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.539 2.16 . . . . 0.0 112.392 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -127.39 143.28 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 124.29 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.949 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.32 162.56 14.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.712 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 79' ' ' LEU . 15.1 m -155.6 121.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.196 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.54 168.43 13.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.346 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.922 HG21 ' N7 ' ' A' ' 185' ' ' GNP . 12.8 t -172.51 -165.4 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.904 ' HG2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 66.73 94.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 157' ' ' CYS . 50.8 mt -98.61 -40.26 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.059 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.85 -27.84 66.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.904 HD12 ' HG2' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -62.22 -58.62 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.55 161.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.4 27.0 5.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -83.86 160.02 59.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.22 -38.37 61.17 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.535 2.157 . . . . 0.0 112.328 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -87.75 -29.76 20.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.0 m -53.17 -61.19 2.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -57.71 -37.66 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -58.42 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -33.87 62.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.562 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.703 HD21 ' N ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.48 -26.21 4.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.39 -24.01 66.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.798 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -94.1 -17.97 22.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -92.56 22.29 4.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.744 0.307 . . . . 0.0 111.093 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 10.7 mmmm 69.29 39.54 1.65 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.852 0.358 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 12.7 pt20 47.38 -163.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.088 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 64.65 84.56 0.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.703 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.5 Cg_endo -69.52 -177.62 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.637 2.225 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 3.9 mm -94.81 105.3 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.6 p -99.04 167.89 10.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 64.7 Cg_exo -51.77 -27.6 27.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.739 2.292 . . . . 0.0 112.179 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -91.15 -28.68 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.2 m -49.15 -48.63 44.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.14 -59.82 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -50.47 -36.05 31.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -51.04 67.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.522 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.529 HD21 ' HE2' ' A' ' 94' ' ' LYS . 16.5 tp -58.08 -34.22 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.491 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.881 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -58.06 -58.0 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -51.79 -41.23 61.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -51.26 -29.88 15.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.1 pp -126.69 21.92 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.75 -86.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 57.36 -178.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 152' ' ' VAL . 38.9 t -70.37 -7.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 77.03 151.02 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.853 0.358 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.949 ' OH ' HD12 ' A' ' 112' ' ' LEU . 8.2 p90 -152.63 148.49 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.08 124.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.289 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.31 172.3 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.747 ' HB3' HD11 ' A' ' 117' ' ' ILE . 2.3 m -131.57 -173.54 3.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -87.76 158.75 18.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 111.038 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.63 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -53.57 -172.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.5 mm? 67.14 -66.76 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.744 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 159' ' ' ALA . 10.0 p -76.13 -79.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.842 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.516 ' OE1' HD11 ' A' ' 165' ' ' LEU . 1.8 tt0 68.28 116.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -99.07 -67.96 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.71 96.04 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.455 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.516 HD11 ' OE1' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -92.83 -10.77 35.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -54.88 -40.9 70.22 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.445 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 42.5 m-80 -55.51 -65.95 0.5 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 155' ' ' VAL . 7.4 p -51.41 -39.24 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CD2' ' HG ' ' B' ' 77' ' ' LEU . 0.1 OUTLIER -54.22 -43.27 70.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.492 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' HD13 ' B' ' 75' ' ' ILE . 22.9 t0 -62.56 -45.98 90.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 14.8 mm-40 -59.03 -26.07 64.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.33 -61.28 2.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.3 mp -67.65 -56.92 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.533 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 4.6 tp -50.92 -25.83 5.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.75 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -60.01 -60.91 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.92 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.9 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 57.01 88.71 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.15 152.53 72.48 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.526 2.15 . . . . 0.0 112.321 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.96 129.11 17.83 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.612 2.208 . . . . 0.0 112.36 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 4.0 pt-20 -108.91 98.32 29.16 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.47 119.76 6.7 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.491 2.127 . . . . 0.0 112.245 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -62.44 167.31 4.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.92 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.4 m 63.73 -75.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 170' ' ' ASP . 6.2 tt -142.8 151.55 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 t -125.61 140.08 53.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -72.63 134.56 81.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.425 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 64.5 Cg_exo -50.56 148.01 16.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.393 2.062 . . . . 0.0 112.169 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 4.3 t -112.29 -34.73 5.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -77.21 164.66 25.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.503 ' CE2' ' CD2' ' A' ' 40' ' ' TYR . 8.0 t80 175.69 118.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.475 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -149.32 133.69 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.055 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' B' ' 86' ' ' HIS . 1.4 t-160 -68.98 86.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.643 ' OG1' HD12 ' B' ' 85' ' ' ILE . 38.9 p -69.39 -74.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.757 HG23 ' OE2' ' B' ' 116' ' ' GLU . 0.9 OUTLIER -115.97 111.51 35.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 86' ' ' HIS . . . . . 0.438 ' HB3' ' NE2' ' B' ' 83' ' ' HIS . 5.2 p80 -98.92 96.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.865 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 22.1 t -83.39 132.5 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -132.69 177.91 18.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.487 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -76.82 115.89 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.886 ' OD1' HG23 ' B' ' 92' ' ' VAL . 24.5 t0 -107.41 117.64 34.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -10.37 59.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.886 HG23 ' OD1' ' B' ' 90' ' ' ASP . 58.5 t -45.73 -50.02 3.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.598 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 93' ' ' THR . 14.2 t -154.06 56.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.11 27.31 5.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.405 ' CD ' HG22 ' B' ' 93' ' ' THR . 20.9 pt-20 -118.75 -177.66 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.445 ' HB3' HG12 ' B' ' 87' ' ' VAL . 6.2 m-85 -97.24 164.79 12.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.545 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.0 OUTLIER -95.21 156.8 16.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.754 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.476 ' HA2' ' CG2' ' B' ' 113' ' ' THR . . . 49.94 52.32 26.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.503 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.636 ' HE1' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -63.52 121.37 69.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 103' ' ' TRP . 79.4 Cg_exo -46.07 162.34 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.175 1.917 . . . . 0.0 111.794 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -42.7 -64.2 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -45.77 64.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.572 ' HB3' HD21 ' A' ' 67' ' ' LEU . 11.6 m0 -52.86 -46.49 67.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.35 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -61.48 -63.18 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.952 0.406 . . . . 0.0 110.666 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.6 mtp180 -51.24 -34.51 32.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.541 HD21 ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -50.05 -58.12 6.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.873 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.616 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.28 -69.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.56 ' O ' HG23 ' B' ' 109' ' ' THR . 5.1 tt0 -79.03 -98.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 108' ' ' GLN . 23.5 p -160.53 -35.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.415 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.5 OUTLIER -166.33 169.04 14.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 111.703 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' B' ' 115' ' ' SER . 0.5 OUTLIER -68.2 67.89 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.646 178.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.528 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.3 OUTLIER -56.71 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.869 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.476 ' CG2' ' HA2' ' B' ' 98' ' ' GLY . 1.8 t 160.78 42.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.94 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.519 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 1.0 OUTLIER 47.75 38.67 8.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 111.07 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.757 ' OE2' HG23 ' B' ' 85' ' ' ILE . 2.7 mp0 71.83 152.67 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -59.05 148.94 29.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.982 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 tttt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.878 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.922 ' N7 ' HG21 ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' OE1' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -78.71 158.26 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.792 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 m -136.3 118.15 15.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.507 HD11 ' OE1' ' A' ' 2' ' ' GLN . 1.3 mp -126.41 149.39 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 12.1 mmtp -135.81 95.42 3.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.568 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.0 m -77.45 154.57 32.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 56' ' ' PHE . 53.0 t -136.43 159.22 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.048 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 57' ' ' ASP . 12.5 p -100.86 159.12 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 8' ' ' VAL . 13.0 p -150.53 129.04 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.74 139.86 4.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.448 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.4 m-20 -69.98 71.72 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -156.73 -148.24 5.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.774 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . -148.91 -35.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.949 HG11 ' HA2' ' A' ' 114' ' ' GLY . 20.3 t -47.7 -23.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 113' ' ' VAL . . . -52.08 -105.22 0.01 OUTLIER Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.586 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.839 ' HG2' HD23 ' A' ' 55' ' ' LEU . 41.5 mttm -95.61 -56.05 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -44.26 -75.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.972 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.748 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 35.4 t -55.74 -39.68 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.538 HD11 ' CG ' ' A' ' 23' ' ' TYR . 5.1 tp -54.16 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.15 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.023 HD21 HD22 ' A' ' 55' ' ' LEU . 74.9 mt -39.89 -38.16 0.65 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -54.05 -69.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.149 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.495 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -91.31 -34.05 15.08 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.538 ' CG ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -72.6 -45.75 57.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.557 ' OG1' HD23 ' A' ' 20' ' ' LEU . 97.5 m -89.81 -85.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 3.3 t -54.56 -28.35 45.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.832 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 77.75 52.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 9.3 pttt -137.71 -166.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.537 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -127.72 170.54 10.06 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.577 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 81.9 Cg_exo -40.33 140.59 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.801 2.334 . . . . 0.0 112.706 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.61 -84.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE1' ' CG ' ' B' ' 86' ' ' HIS . 13.2 pt-20 -96.31 119.43 34.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.19 109.26 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.167 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -159.84 139.0 8.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 36' ' ' VAL . 95.4 Cg_exo -41.73 96.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.43 2.087 . . . . 0.0 111.904 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 17' ' ' THR . 3.1 m -47.1 89.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.273 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 34' ' ' PRO . 58.2 t -95.18 -47.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' B' ' 87' ' ' VAL . 49.2 t80 -162.5 82.19 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.232 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 19.8 m-20 -83.01 124.91 30.86 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' B' ' 85' ' ' ILE . 44.7 t30 -107.89 154.28 21.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.845 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.38 168.91 23.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.225 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.21 115.28 29.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.51 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.4 m -139.8 130.04 30.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.303 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 51' ' ' TYR . 93.5 m -125.79 112.4 15.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.078 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 173' ' ' ILE . 2.6 m -97.66 116.94 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.07 0.462 . . . . 0.0 110.333 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.8 mtm -89.48 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.275 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG23 ' O ' ' B' ' 74' ' ' SER . 1.8 mp -87.03 133.39 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.23 63.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.388 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 -24.35 26.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.648 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.6 151.9 59.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.56 169.71 18.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.651 2.234 . . . . 0.0 112.297 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER -154.06 168.47 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.9 97.12 4.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.5 tt -134.06 158.7 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.661 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -152.62 136.44 5.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.594 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.023 HD22 HD21 ' A' ' 20' ' ' LEU . 8.6 mp -93.42 103.02 15.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.83 0.348 . . . . 0.0 110.814 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.657 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 m-85 -84.62 128.34 34.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.718 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -91.22 174.43 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 111.222 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.655 HG21 ' CE1' ' A' ' 104' ' ' HIS . 3.6 m -162.39 146.45 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -27.62 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.64 -22.49 33.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.4 174.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -103.51 25.39 9.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.79 22.41 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -87.2 -4.95 59.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.345 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.11 -30.41 0.75 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' C ' HD21 ' B' ' 107' ' ' LEU . 1.0 OUTLIER -76.72 -42.25 42.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.381 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.5 OUTLIER -93.53 21.79 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.799 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -83.73 -45.65 0.79 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.298 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 78.4 Cg_exo -46.91 -25.98 4.38 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.372 2.048 . . . . 0.0 112.115 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.966 HD13 ' CD1' ' B' ' 103' ' ' TRP . 2.6 mt -75.03 -28.43 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 3.6 p -86.77 -29.83 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.764 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CG ' ' O ' ' A' ' 71' ' ' SER . 2.4 p90 51.3 161.55 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.946 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 55.7 Cg_endo -70.39 -22.53 29.08 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.125 . . . . 0.0 112.158 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -10.65 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.454 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.653 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.1 t -44.68 -26.74 0.41 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.78 0.324 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 75.43 -154.08 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.593 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.8 p -57.64 156.71 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 1.1 p90 -129.39 161.57 30.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.8 HD22 ' HB2' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -103.97 160.4 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.329 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.667 HG21 HD23 ' A' ' 112' ' ' LEU . 3.7 t -128.55 150.7 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 1.8 m -111.77 142.96 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.383 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB2' HG11 ' A' ' 93' ' ' VAL . 51.1 p90 178.12 112.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.849 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.7 p -57.23 165.77 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 115' ' ' THR . 27.8 m -132.83 29.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.316 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.942 HG13 ' HA ' ' A' ' 120' ' ' ARG . 96.4 t -89.49 -78.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.05 117.83 67.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 52.3 Cg_exo -54.35 -21.93 25.04 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.449 2.099 . . . . 0.0 112.475 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.16 -35.19 16.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.958 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.7 t -80.26 -35.68 35.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.164 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -45.89 -43.7 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.86 -61.43 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.4 m-80 -63.86 -42.06 97.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 89' ' ' SER . 97.9 t -41.38 -48.2 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.903 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 tppt? -83.59 -52.33 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 8.02 5.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.9 tttp -128.26 -39.39 1.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.592 ' CE3' HG13 ' A' ' 93' ' ' VAL . 52.2 m0 -94.92 -28.61 15.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.7 t -65.47 -44.44 66.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.728 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.4 Cg_exo -49.82 -35.11 38.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.153 1.902 . . . . 0.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -11.9 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 98' ' ' VAL . 16.7 tt -45.74 -31.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.746 0.307 . . . . 0.0 111.548 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 p -81.77 -27.44 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -64.41 -37.72 88.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.655 ' CE1' HG21 ' A' ' 58' ' ' THR . 1.5 t60 -80.26 -51.09 9.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 15.9 p -82.93 141.6 43.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.16 -45.83 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.629 2.219 . . . . 0.0 112.214 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 172.61 56.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -136.09 163.78 47.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 52.1 Cg_exo -52.33 164.22 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.609 2.206 . . . . 0.0 112.326 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 14.1 p90 -132.37 137.23 47.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.8 ' HB2' HD22 ' A' ' 79' ' ' LEU . 4.9 mt -110.23 121.39 45.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -106.41 128.93 54.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.515 HG12 ' OE1' ' A' ' 156' ' ' GLU . 16.3 m -128.05 147.71 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.116 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.949 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -167.21 122.58 1.06 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.275 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 84' ' ' VAL . 78.1 p -157.66 153.53 26.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 111.439 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.753 ' OE1' H5'1 ' A' ' 185' ' ' GNP . 0.0 OUTLIER 178.16 99.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.67 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.424 ' CG1' ' OG ' ' A' ' 158' ' ' SER . 33.1 mt -99.99 -29.79 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.13 -30.28 34.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -92.16 -46.04 7.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 111.562 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.942 ' HA ' HG13 ' A' ' 85' ' ' VAL . 34.4 ptt180 -45.65 -34.0 3.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 111.164 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.75 55.98 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.704 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -107.87 156.16 38.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.07 -56.25 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 m -64.03 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 129' ' ' LEU . 94.8 m -49.15 -62.25 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.043 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.4 -41.25 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.37 -62.59 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -34.52 76.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.5 OUTLIER -50.82 -26.0 5.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.358 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.6 59.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.867 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -78.76 -23.19 45.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 4.5 m120 -94.08 30.08 1.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 70.53 19.41 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.242 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.87 112.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 83.6 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 129' ' ' LEU . 28.4 Cg_endo -62.71 96.26 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.592 2.195 . . . . 0.0 112.12 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 5.6 mt -47.74 122.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.404 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -104.21 171.02 5.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 51.2 Cg_exo -56.07 -22.45 39.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.725 2.283 . . . . 0.0 112.514 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -91.0 -28.65 17.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.462 ' CG2' HG23 ' A' ' 137' ' ' ILE . 25.3 m -49.49 -59.39 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.054 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.18 -46.9 46.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.14 79.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -54.4 -46.71 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' CD2' HD23 ' A' ' 149' ' ' LEU . 3.0 tt -59.29 -49.24 78.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 149' ' ' LEU . . . -64.86 -29.58 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -73.58 -40.54 63.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.94 -37.69 86.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 146' ' ' ALA . 4.5 pp -82.12 -21.16 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.5 tttt 68.6 126.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 179.59 -159.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.138 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 153' ' ' LYS . 12.1 p -44.36 -45.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 111.443 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.42 142.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.673 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 168' ' ' VAL . 40.3 p90 -153.07 160.74 42.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.372 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 167' ' ' ASN . 2.8 m -158.01 123.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -170.68 153.01 3.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' CB ' ' HD2' ' A' ' 163' ' ' LYS . 10.2 p -101.86 -173.83 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.968 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 1.6 p -88.44 174.4 8.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.874 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -47.94 178.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.907 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 160' ' ' LEU . 3.6 mm? 59.01 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.967 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 159' ' ' ALA . 6.7 p -56.03 176.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.444 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -163.22 103.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.036 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HD2' ' CB ' ' A' ' 157' ' ' CYS . 1.8 mtpp -95.35 -24.69 16.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.49 79.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.532 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 12.9 mt -71.06 -41.68 70.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' B' ' 76' ' ' SER . 0.1 OUTLIER -45.43 -27.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.543 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 155' ' ' VAL . 5.5 m120 -60.64 -72.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.474 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.641 HG21 ' OE1' ' A' ' 156' ' ' GLU . 13.2 p -47.49 -35.13 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.734 0.302 . . . . 0.0 111.087 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.68 ' O ' HD12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -73.23 -38.93 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -54.01 -42.05 68.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.208 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -80.46 -34.49 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.463 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.85 82.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.798 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.4 mt -90.12 -27.24 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.914 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.65 -49.03 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.578 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.16 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.8 -21.92 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -92.1 41.67 1.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -135.62 68.66 66.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.72 151.61 5.07 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.489 2.126 . . . . 0.0 112.294 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.18 147.65 88.37 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.579 2.186 . . . . 0.0 112.224 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.09 137.57 84.67 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.14 -177.16 3.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.53 2.154 . . . . 0.0 112.341 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -54.03 129.03 32.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.3 p -51.43 -36.26 43.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 23.1 mm -144.1 142.59 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -138.45 134.52 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -74.74 133.67 76.25 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.618 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.794 ' HB2' HG12 ' A' ' 42' ' ' VAL . 49.3 Cg_exo -55.46 -53.06 6.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.447 2.098 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 45.3 m 59.71 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.026 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -56.13 108.67 0.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.689 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.693 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -141.84 -175.84 4.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.346 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -153.28 138.25 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.64 99.28 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.344 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.534 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -69.73 -77.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.485 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.624 HG21 ' CD ' ' B' ' 100' ' ' PRO . 1.2 mp -122.25 128.58 75.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' HIS . . . . . 0.446 ' CG ' ' OE1' ' A' ' 31' ' ' GLU . 3.0 p-80 -105.26 96.14 6.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.945 HG22 ' HA ' ' B' ' 99' ' ' MET . 24.6 t -84.59 149.45 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.674 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.05 178.07 24.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -108.7 129.14 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 41.6 t0 -140.29 130.84 25.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.85 20.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.015 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.939 HG13 HG22 ' B' ' 93' ' ' THR . 13.7 p -45.87 -27.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.352 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.939 HG22 HG13 ' B' ' 92' ' ' VAL . 1.2 t -152.11 -39.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.41 7.64 2.15 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.291 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.466 ' HG3' ' NE2' ' B' ' 108' ' ' GLN . 4.6 pt-20 -118.58 -170.99 2.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.013 0.406 . . . . 0.0 110.688 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.9 m-85 -86.8 162.4 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 3.1 p -109.93 153.99 23.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.68 27.59 13.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.375 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.945 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -77.15 141.36 66.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.295 . . . . 0.0 111.452 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.624 ' CD ' HG21 ' B' ' 85' ' ' ILE . 81.5 Cg_exo -39.56 138.46 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.848 2.365 . . . . 0.0 112.693 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.22 -60.38 2.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.161 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.93 -50.29 27.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.966 ' CD1' HD13 ' A' ' 70' ' ' LEU . 1.7 m0 -55.22 -55.21 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.223 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -55.7 -55.01 37.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.321 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 7.9 mtt-85 -49.61 -45.0 47.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.043 0.449 . . . . 0.0 110.649 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.59 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.92 -54.99 16.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.97 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.62 -69.26 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.347 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.6 ' O ' HG23 ' B' ' 109' ' ' THR . 0.2 OUTLIER -78.61 -94.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.383 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.6 HG23 ' O ' ' B' ' 108' ' ' GLN . 17.6 p -160.78 -45.84 0.04 OUTLIER 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER -159.27 166.92 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.94 0.4 . . . . 0.0 111.876 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' B' ' 99' ' ' MET . 27.4 t-20 -63.79 75.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' B' ' 113' ' ' THR . 0.0 OUTLIER -57.52 89.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.674 HG22 ' O ' ' B' ' 113' ' ' THR . 61.0 m 123.18 51.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.688 1.195 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.428 ' CB ' ' OD1' ' B' ' 111' ' ' ASN . 5.3 tttp 179.73 -63.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.646 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -65.64 138.85 58.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.64 115.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 158.52 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.874 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.494 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -89.12 140.63 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -107.14 128.81 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.869 HG23 ' OD2' ' A' ' 76' ' ' ASP . 5.3 mm -120.14 118.0 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.663 ' O ' HG21 ' A' ' 75' ' ' THR . 8.2 mmtt -116.67 96.03 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.518 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.45 108.45 10.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 71' ' ' SER . 3.3 t -84.44 158.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.663 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.878 HG11 ' N ' ' A' ' 16' ' ' LYS . 29.7 t -136.51 141.58 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.979 0.418 . . . . 0.0 111.828 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 80' ' ' VAL . 22.0 t -144.69 121.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.76 42.41 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.866 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -89.14 -48.36 7.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -160.23 1.71 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.176 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 18' ' ' CYS . . . -136.57 4.63 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.894 HG13 ' O6 ' ' A' ' 185' ' ' GNP . 61.9 t -47.76 -23.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.706 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . -115.55 -61.59 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.753 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.878 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -51.25 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 187' ' ' HOH . 85.3 m -96.56 -68.98 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.705 ' H ' ' HB1' ' A' ' 13' ' ' ALA . 8.2 m -48.02 -21.0 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 23' ' ' TYR . 3.3 tm? -56.88 -74.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.651 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 HG11 ' A' ' 42' ' ' VAL . 27.7 mt -63.49 -26.6 68.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.618 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.69 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -66.28 -44.34 91.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.865 179.026 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.486 ' CB ' ' C2 ' ' A' ' 185' ' ' GNP . 1.1 m -94.81 -11.82 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.862 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.04 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.9 m-30 -95.54 -67.67 0.84 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 112.112 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' HA ' ' B' ' 79' ' ' SER . 46.5 m -83.85 -81.22 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.22 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.793 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -48.84 -35.63 15.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.184 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 55.1 t30 51.31 65.21 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.254 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -147.95 -175.35 4.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.464 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -102.78 157.98 32.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.644 0.259 . . . . 0.0 110.609 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 79.2 Cg_exo -39.55 145.82 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.732 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -99.57 -82.27 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HG3' ' ND1' ' B' ' 86' ' ' HIS . 8.0 pt-20 -102.06 118.29 36.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.4 t80 -70.05 110.49 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.0 t -158.96 138.34 8.35 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 85.1 Cg_exo -44.85 91.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.307 2.005 . . . . 0.0 111.684 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.926 HG23 ' HB2' ' A' ' 38' ' ' ASP . 88.2 m -51.92 87.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.505 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' B' ' 96' ' ' PHE . 45.8 t -82.32 -28.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 1.8 t80 -141.87 -64.37 0.43 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.926 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.3 t0 52.75 104.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.17 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 25.0 t30 -107.21 156.59 18.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -151.04 169.01 22.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.746 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -114.03 141.96 46.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -160.82 126.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.5 m -109.44 110.95 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.787 HG22 ' HD3' ' B' ' 78' ' ' PRO . 24.5 t -98.6 119.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 39.6 mtm -84.96 99.79 11.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 51' ' ' TYR . 4.8 mt -103.17 89.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.703 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.74 17.01 55.62 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.212 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.94 35.07 8.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.9 mm-40 -136.22 137.84 25.69 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.81 157.7 60.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.545 2.163 . . . . 0.0 112.336 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.757 ' H ' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -147.05 167.1 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.176 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 52' ' ' THR . 4.9 t -129.2 97.24 4.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.375 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.603 ' HB3' HG23 ' A' ' 42' ' ' VAL . 28.6 tp -112.87 155.98 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.333 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -158.34 121.65 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.312 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' HG ' ' A' ' 20' ' ' LEU . 3.7 mm? -75.94 105.63 7.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.881 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 7.4 m-85 -84.11 103.23 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -72.35 120.9 18.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.702 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.416 ' HB ' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -136.66 170.39 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . . . -124.1 -40.51 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.73 47.94 88.47 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.501 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -40.13 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 165.78 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.546 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 64' ' ' TYR . 52.6 p30 -86.99 -22.59 25.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.771 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 28.3 m-85 -67.02 -21.37 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.168 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.6 m-20 -48.02 -26.05 1.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.244 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 3.6 ptp180 -93.98 -27.87 16.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.034 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -103.21 18.1 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -93.05 -30.21 0.3 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -55.62 -20.81 28.82 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.53 1.487 . . . . 0.0 111.899 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.8 OUTLIER -72.81 -25.98 61.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 18.8 m -101.58 -21.46 14.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.665 ' O ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER 55.31 104.87 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.51 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 34.1 Cg_endo -64.69 -23.66 63.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -88.0 -9.92 51.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.345 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 72' ' ' TYR . 7.7 t -37.53 -53.69 1.17 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.869 ' OD2' HG23 ' A' ' 4' ' ' ILE . 3.3 m-20 -169.92 -88.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.735 HG21 ' CD1' ' A' ' 111' ' ' LEU . 9.9 p -128.21 163.72 31.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.683 0.278 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 77' ' ' VAL . 5.6 m-85 -111.85 138.52 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.823 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.03 143.17 33.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.522 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.9 t -132.3 153.05 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.797 0.332 . . . . 0.0 111.268 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -144.4 132.57 21.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.427 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.468 ' CB ' HG11 ' A' ' 93' ' ' VAL . 33.3 p90 -152.28 164.89 36.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.6 t -62.83 180.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.805 HG21 ' HA ' ' A' ' 115' ' ' THR . 4.9 m -156.35 43.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.288 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CB ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -154.13 -86.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.448 ' H ' HG23 ' A' ' 85' ' ' VAL . 1.5 m -52.64 110.13 1.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 22.4 Cg_endo -61.49 -15.95 44.5 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.024 . . . . 0.0 112.476 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.7 p -64.8 -23.65 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.5 p -95.95 -42.94 8.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -39.69 21.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 1.1 mm-40 -58.63 -55.56 33.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.8 m-20 -64.9 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 89' ' ' SER . 63.4 t -48.3 -67.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.719 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.69 -37.43 76.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.419 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 91' ' ' GLU . 28.7 mm-40 -74.05 -2.53 24.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -127.98 -35.02 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 60.4 m95 -88.7 -36.73 16.02 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 101' ' ' ILE . 58.6 t -57.8 -46.3 99.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 85.9 Cg_endo -79.49 -21.5 8.73 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.558 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.58 -36.57 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.7 tt -50.62 -28.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.813 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -73.61 -38.46 65.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.573 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -56.63 -44.04 80.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.87 -32.32 17.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.429 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 3.3 m -111.7 87.94 8.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.604 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 -78.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.46 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -126.78 48.1 2.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -126.85 139.51 35.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.748 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.7 Cg_exo -49.61 165.26 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.7 p90 -148.29 151.23 35.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.061 0.458 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.051 HD23 ' CD1' ' A' ' 154' ' ' TYR . 1.1 mp -125.6 119.73 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 149' ' ' LEU . 1.4 pt? -135.14 119.58 17.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.645 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.873 HG12 ' CZ ' ' A' ' 154' ' ' TYR . 10.1 p -156.57 111.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.885 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.68 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -86.47 169.12 40.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.668 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.805 ' HA ' HG21 ' A' ' 84' ' ' VAL . 13.9 t -174.82 137.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.863 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.45 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -166.72 84.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.741 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 157' ' ' CYS . 4.3 mt -77.39 -32.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -87.0 -23.68 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.45 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -95.86 -0.79 50.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.682 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.708 ' CB ' HG11 ' A' ' 85' ' ' VAL . 1.3 ptt85 -94.56 26.02 3.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.919 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.6 41.19 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.981 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.54 127.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.07 -44.18 49.37 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -57.45 -27.91 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 129' ' ' LEU . 2.4 m -57.86 -68.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.52 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -49.42 -37.43 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.69 -66.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -70.42 -34.16 72.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.876 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 125' ' ' THR . 3.4 mt -50.15 -26.17 4.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.03 61.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.921 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -18.65 36.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.214 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -93.83 30.1 1.91 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.179 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt 73.77 29.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 58.93 -161.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.48 90.14 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.32 118.57 5.76 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.587 2.191 . . . . 0.0 112.312 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.478 HG23 ' CG2' ' A' ' 141' ' ' THR . 7.2 mt -49.85 123.78 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -118.91 176.44 1.7 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.0 Cg_exo -54.17 -22.01 24.24 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.201 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -84.42 -36.27 22.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.478 ' CG2' HG23 ' A' ' 137' ' ' ILE . 19.7 m -51.51 -61.81 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.68 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -48.63 -45.72 38.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 155' ' ' VAL . 2.4 tm-20 -57.39 -40.48 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.562 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -58.9 -34.34 71.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.536 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.647 HD11 ' HD2' ' A' ' 94' ' ' LYS . 1.2 tt -71.84 -32.23 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.738 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.65 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -83.96 -35.22 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 43.0 m-20 -54.5 -61.51 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 112' ' ' LEU . 3.4 pp -58.89 -18.1 30.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.304 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.91 80.84 0.07 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.939 0.4 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -134.39 -173.72 3.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 88.9 t -47.54 -29.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 58.33 124.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.243 0.544 . . . . 0.0 111.686 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 1.051 ' CD1' HD23 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -153.79 126.09 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 143' ' ' GLU . 19.8 m -97.23 131.88 43.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.766 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.743 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.5 pm0 -162.73 138.68 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.794 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.641 ' HB3' HD11 ' A' ' 117' ' ' ILE . 6.7 m -102.3 -174.59 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 p -88.47 165.29 15.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.012 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -59.53 -159.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER 49.57 25.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -173.28 -72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.568 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.4 OUTLIER 69.63 115.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.771 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -103.49 -68.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.09 96.08 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.04 HD13 ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -93.61 -10.65 33.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.527 0.203 . . . . 0.0 111.371 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -34.29 54.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 110.065 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -66.44 -33.09 74.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 156' ' ' GLU . 66.7 t -64.81 -63.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CZ ' ' CG ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -51.35 -32.29 25.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' HA ' HD13 ' B' ' 75' ' ' ILE . 61.9 t0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.9 -52.39 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.12 -28.31 4.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.586 HD11 HD22 ' A' ' 53' ' ' LEU . 16.4 mm -94.78 -38.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.757 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 174' ' ' LEU . 3.6 tt -54.96 -34.24 63.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -74.59 -25.43 59.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mp -94.5 46.51 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.47 ' CB ' ' CD ' ' A' ' 179' ' ' PRO . 1.8 mm-40 -60.35 -63.42 4.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 178' ' ' GLU . 55.6 Cg_endo -70.21 170.49 17.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.325 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.61 147.58 51.67 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.536 2.157 . . . . 0.0 112.201 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.36 151.24 77.5 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.55 90.81 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.594 2.196 . . . . 0.0 112.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -110.95 122.72 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.6 m -64.44 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.329 . . . . 0.0 110.802 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 170' ' ' ASP . 5.9 tt -104.01 148.83 8.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -138.2 138.72 38.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.56 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -60.18 126.81 84.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.622 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.787 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.0 Cg_endo -51.9 171.26 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.9 t -136.65 -67.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -51.49 95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.473 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.4 t80 -114.3 141.22 47.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.43 131.86 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 91.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.192 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.499 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -62.3 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.65 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.56 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -127.02 120.17 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 86' ' ' HIS . . . . . 0.453 ' ND1' ' HG3' ' A' ' 31' ' ' GLU . 3.5 t-160 -103.98 96.56 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.484 HG22 ' HD3' ' B' ' 100' ' ' PRO . 44.6 t -79.86 155.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.04 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.46 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.48 178.26 24.27 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.236 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -85.97 112.76 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.667 ' CB ' HG23 ' B' ' 97' ' ' THR . 10.8 t0 -103.76 98.24 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -0.08 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.029 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.772 HG13 HG22 ' B' ' 93' ' ' THR . 12.3 p -57.47 -47.89 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.772 HG22 HG13 ' B' ' 92' ' ' VAL . 0.8 OUTLIER -120.99 -21.81 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.433 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.25 12.73 6.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.554 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.546 ' HG2' HG23 ' B' ' 93' ' ' THR . 16.7 pt-20 -121.83 -175.94 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.8 0.333 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 1.034 ' CE2' HD13 ' A' ' 67' ' ' LEU . 4.1 m-85 -82.05 164.6 21.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.667 HG23 ' CB ' ' B' ' 90' ' ' ASP . 0.3 OUTLIER -95.14 150.87 19.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.441 ' CA ' ' OG1' ' B' ' 113' ' ' THR . . . 48.54 48.66 28.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.705 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -57.77 125.6 73.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.549 0.214 . . . . 0.0 110.974 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.484 ' HD3' HG22 ' B' ' 87' ' ' VAL . 69.6 Cg_exo -49.85 152.95 6.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.04 1.826 . . . . 0.0 111.595 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 8.4 pt-20 -43.32 -48.46 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 111.517 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -78.95 -52.95 7.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.866 ' CG ' HD13 ' A' ' 70' ' ' LEU . 4.9 m0 -50.12 -51.06 46.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.419 0.628 . . . . 0.0 110.052 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.705 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.93 -55.57 28.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.78 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 76.0 mtt180 -53.76 -44.44 70.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -48.85 -57.5 6.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -95.23 -68.86 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.295 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.75 ' O ' HG23 ' B' ' 109' ' ' THR . 5.0 tp-100 -77.71 -101.6 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.353 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.75 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.1 p -168.16 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.684 0.278 . . . . 0.0 111.447 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.51 174.2 11.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.129 0.49 . . . . 0.0 111.836 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' B' ' 99' ' ' MET . 3.8 p30 -68.56 84.98 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.696 ' O ' HG23 ' B' ' 113' ' ' THR . 3.6 tp -57.57 88.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.696 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 157.88 -25.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.488 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' B' ' 113' ' ' THR . 0.2 OUTLIER 82.81 47.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.589 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.1 m -53.01 -31.86 43.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -178.19 135.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -110.56 165.02 12.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 tttt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.002 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.894 ' O6 ' HG13 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.525 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.24 126.8 54.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.752 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 m -94.1 150.9 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.967 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 3' ' ' THR . 3.0 pt -155.87 147.07 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.83 115.38 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' HB3' HD23 ' A' ' 55' ' ' LEU . 54.0 t -78.09 154.36 31.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 56' ' ' PHE . 6.6 t -145.31 144.95 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.421 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 57' ' ' ASP . 7.2 p -118.78 136.02 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 9' ' ' VAL . 13.5 p -127.08 122.88 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.95 168.81 12.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.86 129.89 55.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.89 -27.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . 84.76 -41.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG11 ' HA2' ' A' ' 114' ' ' GLY . 16.0 t -48.42 -23.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.67 0.271 . . . . 0.0 111.667 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -56.71 -114.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.11 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.61 ' CG ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -96.15 -65.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -34.2 -73.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.788 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -52.67 -36.56 57.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.39 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -49.7 -70.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.549 HD13 ' OG1' ' A' ' 24' ' ' THR . 1.3 mm? -40.61 -37.21 0.69 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 25' ' ' THR . 6.6 mm -52.37 -69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.533 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 5.7 t -88.33 -50.71 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.471 0.653 . . . . 0.0 110.448 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CD2' ' CD1' ' A' ' 165' ' ' LEU . 21.9 t80 -46.13 -49.86 16.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.548 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 42' ' ' VAL . 52.3 m -96.71 -89.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.871 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -55.28 -26.16 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.2 t-20 70.59 58.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.871 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.1 pttt -134.84 -161.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' " O3'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -132.57 148.83 71.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.286 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 75.4 Cg_exo -39.34 133.72 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.758 2.306 . . . . 0.0 112.72 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -84.88 0.51 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.64 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.316 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' O3G' ' A' ' 185' ' ' GNP . 1.2 t80 -66.49 97.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.158 0.504 . . . . 0.0 111.041 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.5 p -154.33 137.34 10.22 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.815 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.6 Cg_exo -36.55 89.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.876 2.384 . . . . 0.0 112.645 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.863 HG23 ' CG ' ' A' ' 38' ' ' ASP . 58.4 m -53.54 89.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.013 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.818 HG11 ' CG ' ' B' ' 96' ' ' PHE . 3.3 t -79.14 -25.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 5.1 t80 -149.14 -70.85 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.863 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.7 m-20 63.28 130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.47 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 6.6 t-20 -108.01 157.77 17.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.104 0.478 . . . . 0.0 111.359 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 m-85 -152.78 160.31 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.078 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' B' ' 81' ' ' PHE . . . -121.22 126.67 50.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.49 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.725 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.5 m -148.94 140.05 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.101 0.477 . . . . 0.0 111.895 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.2 m -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.894 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.862 HG13 ' O ' ' B' ' 76' ' ' SER . 40.4 t -98.21 123.13 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.212 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtm -90.7 100.08 12.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.17 105.27 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.93 15.11 76.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 38.41 4.82 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.775 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.3 mm-40 -141.69 124.2 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.496 0.189 . . . . 0.0 110.817 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.96 161.54 15.44 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.624 2.216 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.617 ' H ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -146.23 165.15 30.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.6 112.56 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 54' ' ' GLY . 4.6 tt -119.86 138.46 53.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -126.33 102.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.214 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -83.98 149.69 26.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.411 . . . . 0.0 111.4 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.3 m-85 -138.93 116.79 11.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.679 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.577 ' HA ' HG12 ' A' ' 8' ' ' VAL . 4.2 t70 -69.91 152.75 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 64' ' ' TYR . 1.6 m -157.54 128.85 6.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.33 33.84 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.409 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 48.18 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.27 -169.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.894 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.88 -25.77 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.15 -23.4 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.755 ' CE2' HD23 ' A' ' 67' ' ' LEU . 4.3 m-85 -64.47 -12.6 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -40.3 -44.97 2.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.788 0.328 . . . . 0.0 111.586 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HG3' HD22 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -73.41 -35.56 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.498 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.085 HD21 ' CZ3' ' B' ' 103' ' ' TRP . 11.1 tp -90.38 10.53 24.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.117 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 1.6 tmt_? -82.93 -63.82 0.26 Allowed Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 68' ' ' ARG . 4.2 Cg_endo -46.59 -26.73 4.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.412 2.075 . . . . 0.0 111.756 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.908 HD22 HD12 ' A' ' 67' ' ' LEU . 8.5 mp -54.28 -39.51 66.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.581 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.491 ' HB2' HG21 ' A' ' 7' ' ' VAL . 88.3 p -92.49 -15.28 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 61.26 139.93 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.696 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 97.0 Cg_endo -80.66 -45.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -10.27 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.549 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 76' ' ' ASP . 10.3 t -40.4 -48.45 2.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 171.51 -167.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.784 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.9 p -58.26 162.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.517 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' N ' HG22 ' A' ' 77' ' ' VAL . 16.4 m-85 -112.01 143.2 43.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -103.5 145.88 29.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.101 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 112' ' ' LEU . 3.9 t -131.65 151.35 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.944 0.402 . . . . 0.0 111.482 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -121.28 103.55 9.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.697 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.972 ' CB ' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -128.87 123.01 31.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.443 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.885 ' O ' HD12 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -130.73 -74.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.268 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.53 HG12 ' CG2' ' A' ' 125' ' ' THR . 22.6 t -50.5 -70.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.02 100.86 0.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.954 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.6 -21.74 65.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.642 2.228 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -48.15 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 p -77.84 -37.45 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 84' ' ' VAL . 2.3 t80 -50.97 -66.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -41.52 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -60.99 -65.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 82' ' ' PHE . 93.0 t -40.68 -41.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.906 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -60.78 -69.69 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.48 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -80.9 8.34 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.59 -43.03 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.604 ' HD1' HG13 ' A' ' 93' ' ' VAL . 17.5 m95 -95.41 -37.1 11.09 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.2 t -50.02 -58.3 9.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 21.1 Cg_endo -60.67 -22.04 71.49 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.171 1.914 . . . . 0.0 112.031 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -32.05 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG21 ' CG ' ' A' ' 110' ' ' PHE . 22.1 mt -49.84 -26.51 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 p -74.55 -36.87 63.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -63.74 -38.42 91.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.776 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 6.5 m-70 -95.76 -24.38 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 2.9 m -121.53 97.77 46.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.749 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 87.4 Cg_exo -46.49 -61.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.585 2.19 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.24 32.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 161.31 26.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.87 129.35 24.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.53 2.153 . . . . 0.0 112.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' HG21 ' A' ' 101' ' ' ILE . 12.8 p90 -118.1 124.74 48.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -96.85 119.5 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.447 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.603 HD12 ' HB ' ' A' ' 80' ' ' VAL . 38.6 tp -97.94 102.05 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 15' ' ' GLY . 26.8 m -106.77 139.1 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 111.271 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.702 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -165.31 144.08 8.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.837 HG21 ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER 173.17 151.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.58 ' H ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -167.76 94.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.81 -27.4 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.724 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.774 ' CB ' HD13 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -96.36 -48.07 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 111.45 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.63 HD13 ' C ' ' A' ' 119' ' ' LEU . 2.4 tm? -66.28 -59.33 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.084 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' N ' HD13 ' A' ' 119' ' ' LEU . 33.5 mmt180 -66.97 -174.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 5.7 m-20 81.9 39.49 0.05 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -96.58 169.68 8.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.716 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.71 -19.41 24.25 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.5 t -84.38 -46.69 11.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.53 ' CG2' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -48.83 -60.84 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.031 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.83 -40.62 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.15 -46.03 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -83.76 -35.98 23.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 135' ' ' LYS . 1.6 tp -49.95 -26.51 4.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.51 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.52 65.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -78.41 -47.39 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.52 -26.33 68.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.99 52.37 9.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 1.4 tt0 -128.55 -86.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.75 ' C ' HD21 ' A' ' 129' ' ' LEU . 2.5 mtmt 166.72 161.34 0.11 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.686 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.687 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 Cg_exo -52.33 100.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.468 2.112 . . . . 0.0 112.159 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 84' ' ' VAL . 5.8 mt -48.67 119.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.458 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -111.08 177.08 1.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -55.13 -20.52 24.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.434 2.089 . . . . 0.0 112.219 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -80.06 -45.4 18.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.462 ' HB ' HG23 ' A' ' 137' ' ' ILE . 97.8 m -53.38 -45.54 69.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.93 -42.68 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.61 -37.22 86.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.724 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -53.98 47.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.96 -42.38 84.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.814 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.43 -41.96 66.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.092 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -45.43 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.99 -42.48 99.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -80.09 -26.48 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.718 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.8 OUTLIER 67.04 118.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.984 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.03 -161.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 152' ' ' VAL . 15.7 t -70.62 -7.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.19 140.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 110.791 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.814 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 p90 -152.71 148.29 27.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 111.454 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 154' ' ' TYR . 2.8 m -158.47 124.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.832 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.837 ' O ' HG21 ' A' ' 115' ' ' THR . 2.0 pt-20 -171.87 149.62 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.539 ' O ' ' N2 ' ' A' ' 185' ' ' GNP . 2.6 p -108.27 -174.58 2.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.495 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.8 OUTLIER -86.16 159.6 19.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.21 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.474 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 68.78 -62.67 0.38 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.126 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -85.47 -68.83 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.277 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.87 118.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.711 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -105.53 -68.27 0.88 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.075 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.08 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.661 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -86.44 -10.19 54.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.643 0.259 . . . . 0.0 111.196 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.822 ' HD3' HD12 ' B' ' 77' ' ' LEU . 0.1 OUTLIER -47.87 -45.63 30.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.735 0.302 . . . . 0.0 111.162 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -58.8 -62.88 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.4 p -47.75 -26.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.19 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.552 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -76.61 -50.43 13.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.372 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 174' ' ' LEU . 5.3 t0 -49.96 -29.28 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.15 -39.76 22.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.048 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.72 -22.31 43.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 38.5 mm -91.96 -30.17 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.175 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 170' ' ' ASP . 1.7 tt -80.74 -26.09 37.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.69 65.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.413 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -87.89 -27.2 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.63 -30.66 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.84 150.71 37.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.07 146.52 17.17 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.57 2.18 . . . . 0.0 112.383 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 161.45 45.92 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.571 2.181 . . . . 0.0 112.314 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.455 ' N ' ' HD2' ' A' ' 182' ' ' PRO . 1.3 tm-20 -49.71 -60.39 5.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.061 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 181' ' ' GLU . 39.4 Cg_endo -67.14 162.82 36.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.582 2.188 . . . . 0.0 112.335 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -115.71 116.39 27.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -50.73 63.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 44' ' ' VAL . 7.3 tt -143.96 151.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.862 ' O ' HG13 ' A' ' 44' ' ' VAL . 16.1 t -135.09 137.62 43.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.822 HD12 ' HD3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -67.48 141.5 95.59 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.806 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.761 ' HD2' HD23 ' B' ' 77' ' ' LEU . 53.7 Cg_exo -51.64 166.41 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.177 . . . . 0.0 112.28 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 81' ' ' PHE . 0.4 OUTLIER -139.56 -66.57 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.68 86.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 9.1 t80 -108.61 134.26 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.66 111.98 3.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.486 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 83' ' ' HIS . 27.2 p-80 -68.37 109.4 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.059 0.457 . . . . 0.0 109.943 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.563 ' OG1' HD12 ' B' ' 85' ' ' ILE . 1.5 p -77.17 -62.57 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.786 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.563 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.7 OUTLIER -121.9 143.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.764 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.65 96.57 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.464 HG13 ' O ' ' B' ' 97' ' ' THR . 25.1 t -78.21 149.08 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.24 177.63 24.47 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.352 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.22 129.62 47.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.408 ' CB ' HG23 ' B' ' 97' ' ' THR . 68.3 t0 -137.89 132.19 32.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 1.37 19.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.142 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -45.44 -27.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 120.912 0.387 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.422 HG23 ' N ' ' B' ' 94' ' ' GLY . 13.2 t -153.41 -42.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' GLY . . . . . 0.422 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.58 34.26 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.418 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.424 ' OE2' HD11 ' B' ' 112' ' ' ILE . 0.2 OUTLIER -147.28 175.44 10.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.935 ' CE2' HD22 ' A' ' 67' ' ' LEU . 2.2 m-85 -71.98 160.48 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.561 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.464 ' O ' HG13 ' B' ' 87' ' ' VAL . 16.9 p -104.76 156.27 18.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.166 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.53 39.57 74.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.704 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -51.14 123.34 19.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.537 0.208 . . . . 0.0 110.675 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.472 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 84.7 Cg_exo -46.75 154.54 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.275 1.983 . . . . 0.0 112.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -45.57 -48.27 14.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.282 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.39 -55.7 5.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 1.085 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.2 m0 -48.54 -53.36 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.704 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -57.68 -61.93 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.239 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 43.4 mtt85 -48.04 -45.23 31.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -48.33 -57.88 5.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.687 HD12 ' O ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -94.81 -67.73 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.107 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.725 ' O ' HG23 ' B' ' 109' ' ' THR . 5.0 tp-100 -77.39 -99.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.725 HG23 ' O ' ' B' ' 108' ' ' GLN . 2.9 p -166.58 -40.22 0.02 OUTLIER 'General case' 0 C--N 1.338 0.084 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.66 176.51 11.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.993 0.425 . . . . 0.0 111.473 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.73 72.73 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.81 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -57.72 87.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 111.178 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m 178.27 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.665 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -130.1 -41.35 1.28 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 70.83 38.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.13 115.54 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -100.3 145.44 28.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.735 ' N2 ' HG23 ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 68.68 129.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.09 149.63 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.419 HD13 ' HB1' ' A' ' 176' ' ' ALA . 21.5 mt -140.48 153.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -129.56 96.22 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 37.4 t -81.36 107.96 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 8' ' ' VAL . 58.2 t -84.27 154.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 15' ' ' GLY . 2.4 t -140.5 139.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 104' ' ' HIS . 3.0 m -133.02 156.12 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.068 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . 147.63 178.54 22.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.647 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -25.46 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.71 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -84.01 -24.13 49.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.355 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 187' ' ' HOH . . . 70.02 7.58 6.29 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.747 HG13 ' N7 ' ' A' ' 185' ' ' GNP . 16.1 t -49.04 -24.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 111.251 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.869 ' C ' HG11 ' A' ' 8' ' ' VAL . . . -107.77 -43.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.541 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.652 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -67.35 -74.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.776 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.533 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -97.68 -52.94 3.58 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -55.29 -25.59 35.09 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.6 tm? -56.47 -73.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.423 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.732 ' HG ' HD22 ' A' ' 55' ' ' LEU . 18.7 mt -63.24 -25.36 68.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 110.553 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 27' ' ' LYS . 1.1 mp -62.9 -47.29 93.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.858 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.535 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 82.8 p -94.13 -17.32 22.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.558 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.7 m-30 -88.22 -66.8 0.88 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.002 0.429 . . . . 0.0 112.047 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -89.04 -83.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.182 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -42.77 -44.32 4.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 16.6 t-20 64.42 41.65 5.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -131.99 141.42 49.27 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.475 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -63.63 164.33 16.47 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 70.9 Cg_exo -38.21 150.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.952 2.434 . . . . 0.0 113.078 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 t -108.96 -83.1 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.24 114.59 26.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.637 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.33 107.88 5.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 34' ' ' PRO . 6.5 p -160.63 139.44 7.65 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.29 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 Cg_exo -39.45 93.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.568 2.179 . . . . 0.0 111.874 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 m -48.09 87.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.781 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 34' ' ' PRO . 92.2 t -89.77 -35.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 60.8 t80 -170.86 119.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.777 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 3.2 m-20 -119.44 138.27 53.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' HD12 ' B' ' 85' ' ' ILE . 8.7 t-20 -106.65 157.6 17.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.173 0.511 . . . . 0.0 111.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CG ' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -152.89 161.9 41.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 80' ' ' ASP . . . -117.64 117.75 30.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.48 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' CB ' ' B' ' 78' ' ' PRO . 23.8 m -136.6 167.75 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.393 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 41.8 m -156.39 85.98 1.0 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.874 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.578 HG21 HG12 ' A' ' 173' ' ' ILE . 28.1 m -98.6 176.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.435 ' C ' HD13 ' A' ' 46' ' ' ILE . 5.7 mtm -140.46 157.34 45.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.183 0.516 . . . . 0.0 111.565 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.947 HD11 ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -129.82 88.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.139 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.4 74.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.483 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.93 -34.37 3.29 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.025 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.88 133.28 76.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.662 0.231 . . . . 0.0 111.202 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 174.57 4.87 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.594 2.196 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.947 ' CD1' HD11 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -153.5 155.06 35.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.6 97.06 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 53' ' ' LEU . 2.4 pp -134.17 161.03 36.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.66 138.06 8.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.732 HD22 ' HG ' ' A' ' 20' ' ' LEU . 3.8 mp -75.7 107.18 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.09 102.99 12.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -73.4 144.11 46.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.302 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.805 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.51 179.42 9.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.596 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -138.32 163.36 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 43.7 1.62 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? -70.72 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.622 0.249 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 174.48 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.791 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.66 42.82 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.805 ' CE2' HG22 ' A' ' 58' ' ' THR . 4.4 m-85 -106.42 -24.62 12.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.673 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -45.76 -34.39 3.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.048 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.491 ' O ' HD21 ' B' ' 107' ' ' LEU . 4.3 mtt85 -51.94 -36.05 47.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.988 0.423 . . . . 0.0 110.483 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 70' ' ' LEU . 2.5 mt -96.01 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.386 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.3 mtt180 -56.76 -71.15 0.28 Allowed Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.563 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 33.9 Cg_endo -64.18 -29.42 64.74 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.059 1.839 . . . . 0.0 110.649 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 67' ' ' LEU . 9.8 mp -52.43 -24.79 8.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -155.72 33.18 0.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.455 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -35.23 151.03 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.985 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 2.8 Cg_exo -75.67 -32.01 4.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.895 2.397 . . . . 0.0 112.606 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -57.6 -17.84 16.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.701 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 76' ' ' ASP . 6.3 t -46.74 -52.89 12.95 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.592 0.234 . . . . 0.0 111.396 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 75' ' ' THR . 1.0 OUTLIER 176.99 -159.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.062 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.3 p -57.98 163.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 6.0 m-85 -115.62 132.69 56.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 0.0 110.863 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.3 tp -103.66 143.54 32.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.115 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.823 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.6 t -133.75 150.66 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -125.06 153.38 42.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.529 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 p90 -162.24 158.72 24.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.93 164.26 25.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 137' ' ' ILE . 60.6 t -147.08 55.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 120' ' ' ARG . 68.9 t -151.9 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 125' ' ' THR . 5.8 m -66.77 150.16 97.83 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 0.0 110.73 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 72.1 Cg_endo -77.39 -36.63 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.588 2.192 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 p -53.13 -38.9 63.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 -24.92 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.576 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.2 t80 -69.91 -61.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -26.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.2 m-20 -75.58 -60.96 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 90' ' ' PHE . 12.7 m -47.55 -27.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.669 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HE3' HD11 ' A' ' 145' ' ' LEU . 23.3 tttt -78.47 -61.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -82.44 8.37 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.995 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 6.7 ttpt -114.37 -37.82 4.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.635 0.255 . . . . 0.0 111.34 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.537 ' HE1' HG12 ' A' ' 93' ' ' VAL . 19.0 m95 -95.3 -42.12 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.604 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.887 ' O ' HG22 ' A' ' 101' ' ' ILE . 63.2 t -53.57 -43.63 96.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.8 Cg_exo -73.88 -31.4 8.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 112.499 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.11 -33.07 24.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 98' ' ' VAL . 12.9 tt -48.61 -29.31 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -66.62 -42.69 86.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.652 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -63.18 -33.0 74.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.413 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 12.4 m80 -79.76 -31.33 40.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.449 ' HB2' ' CG2' ' A' ' 108' ' ' THR . 18.6 p -130.68 122.39 19.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 48.0 Cg_exo -55.63 -64.92 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.489 2.126 . . . . 0.0 112.351 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -156.7 31.46 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 105' ' ' CYS . 1.8 t -97.25 150.03 36.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.05 144.65 27.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.802 2.335 . . . . 0.0 112.14 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 101' ' ' ILE . 4.5 p90 -121.92 157.33 31.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.1 mt -127.66 145.25 50.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.55 HD23 ' HB ' ' A' ' 80' ' ' VAL . 5.7 mt -120.34 159.4 25.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.512 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.8 m -156.11 106.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.909 0.385 . . . . 0.0 111.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.673 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -123.5 128.15 6.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.39 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 158' ' ' SER . 48.3 p -153.79 142.91 21.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 111.192 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.745 ' HG2' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -178.84 36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.868 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.464 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 5.4 pt -56.24 -21.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.266 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.735 ' CB ' HD13 ' A' ' 160' ' ' LEU . 9.9 t0 -96.09 -26.04 15.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.745 HD13 ' HG2' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -65.72 -56.53 11.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.597 ' HB2' HG22 ' A' ' 85' ' ' VAL . 7.0 tmm_? -46.68 100.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.84 -44.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -54.86 132.12 66.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 47.5 Cg_exo -56.07 -36.57 96.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.422 2.082 . . . . 0.0 112.231 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.9 m -49.24 -45.04 44.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.987 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.841 HG22 ' OG ' ' A' ' 86' ' ' SER . 68.3 p -53.77 -59.86 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 3.4 mp -60.16 -40.61 84.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.58 -61.67 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 2.0 ttpp -73.05 -36.01 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 136' ' ' PRO . 10.5 mt -50.29 -25.92 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.88 -20.75 57.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -91.22 -37.08 13.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.0 -27.66 66.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -78.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 179.14 -46.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 150.15 65.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.636 ' HA ' HD13 ' A' ' 129' ' ' LEU . 50.7 Cg_exo -53.58 174.38 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.615 2.21 . . . . 0.0 112.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.746 HG22 HG13 ' A' ' 84' ' ' VAL . 5.9 mt -92.5 122.62 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.2 p -110.81 167.71 8.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 81.9 Cg_exo -47.84 -25.44 6.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -46.72 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.511 ' HB ' HG23 ' A' ' 137' ' ' ILE . 7.2 m -52.16 -51.35 58.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -49.89 -41.02 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.022 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.7 -35.29 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.73 94.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.615 HD11 ' HE3' ' A' ' 94' ' ' LYS . 12.8 tp -65.12 -45.52 84.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -25.59 66.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.37 -64.04 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 150' ' ' LYS . 3.9 pp -51.32 -25.19 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.778 ' N ' HD12 ' A' ' 149' ' ' LEU . 11.0 mttp 65.59 108.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -145.64 -161.01 1.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 92.8 t -60.93 -20.11 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.316 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 78.25 137.99 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.166 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 50.0 p90 -153.2 166.27 33.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.25 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 155' ' ' VAL . 28.2 m -158.36 124.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.818 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.77 152.52 3.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.433 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 13.8 p -111.18 -173.64 2.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.464 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 11.1 t -87.79 156.49 19.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.554 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -56.73 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.207 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 53.36 25.09 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.95 -65.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.866 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 64.74 122.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.35 -67.96 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 100.17 0.16 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.396 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.866 HD11 ' OE1' ' A' ' 162' ' ' GLN . 4.8 mt -93.68 -10.68 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.542 0.211 . . . . 0.0 111.539 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.44 -28.05 1.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.383 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -78.4 -60.9 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.045 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.7 p -50.01 -41.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.463 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -69.49 -40.84 76.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -50.27 -53.03 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.07 -51.54 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.05 -30.69 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.237 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.578 HG12 HG21 ' A' ' 44' ' ' VAL . 5.9 mt -91.76 -24.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.9 tp -80.33 -52.58 7.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -31.29 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.306 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -66.54 -23.26 66.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.271 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 46' ' ' ILE . 2.2 mp -90.34 48.28 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB2' ' CD ' ' A' ' 179' ' ' PRO . 6.5 mt-10 -56.56 -62.17 5.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.451 ' CD ' ' HB2' ' A' ' 178' ' ' GLU . 36.3 Cg_endo -65.41 110.73 1.65 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.678 2.252 . . . . 0.0 112.466 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -51.76 178.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.521 2.147 . . . . 0.0 112.189 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.93 156.6 47.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.57 95.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.631 2.22 . . . . 0.0 112.401 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.12 175.87 6.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.999 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -117.6 -53.91 2.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' MET . 18.8 mm -104.02 144.23 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.69 153.08 48.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.202 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -90.91 135.79 28.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.639 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' B' ' 77' ' ' LEU . 52.5 Cg_exo -54.21 -172.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.562 2.174 . . . . 0.0 112.205 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 60.4 p -162.56 -53.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.548 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ASP . . . . . 0.667 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.2 m-20 -67.5 62.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.403 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.0 t80 -81.32 131.02 35.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -153.59 120.06 5.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.18 102.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.507 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.6 OUTLIER -77.53 -60.77 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.592 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.507 HD12 ' OG1' ' B' ' 84' ' ' THR . 1.0 OUTLIER -120.69 134.61 63.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.934 0.397 . . . . 0.0 111.971 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -120.88 96.5 5.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.623 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.547 HG22 ' HD3' ' B' ' 100' ' ' PRO . 47.1 t -79.95 148.05 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.752 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.77 177.76 23.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.288 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -95.94 131.93 41.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.718 ' CG ' HG23 ' B' ' 97' ' ' THR . 3.1 p-10 -140.41 120.18 13.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.32 -0.66 26.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.613 HG13 HG22 ' B' ' 93' ' ' THR . 13.9 p -47.72 -26.51 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.282 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.613 HG22 HG13 ' B' ' 92' ' ' VAL . 3.9 t -149.05 -41.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.082 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.97 25.98 0.87 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.672 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.76 -162.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.74 0.305 . . . . 0.0 110.546 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.2 m-85 -100.25 164.2 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.718 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -100.22 167.12 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.11 33.61 22.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.432 ' O ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -47.21 109.04 0.98 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.501 0.191 . . . . 0.0 110.709 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.547 ' HD3' HG22 ' B' ' 87' ' ' VAL . 97.0 Cg_exo -40.19 153.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.7 2.266 . . . . 0.0 112.811 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -45.34 -57.9 3.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.194 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.49 -54.19 36.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.536 ' CE3' ' CD1' ' A' ' 67' ' ' LEU . 4.7 m0 -49.21 -63.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 0.0 110.788 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.49 -70.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.765 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 3.9 mtp180 -44.62 -37.07 3.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -50.37 -56.18 12.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.134 179.347 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.917 HD11 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.42 -70.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.539 ' O ' HG23 ' B' ' 109' ' ' THR . 4.8 tt0 -79.98 -99.06 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 108' ' ' GLN . 29.9 p -160.35 -35.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.565 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -161.66 -173.42 3.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.018 0.437 . . . . 0.0 111.951 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' B' ' 100' ' ' PRO . 0.3 OUTLIER -84.79 81.86 8.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.83 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.693 ' O ' HG23 ' B' ' 113' ' ' THR . 0.0 OUTLIER -56.59 88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.614 0.721 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.693 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 170.29 -57.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.703 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -113.07 -27.46 8.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.832 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' B' ' 111' ' ' ASN . 2.4 m -62.92 -74.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 60.24 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -66.86 151.27 47.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.995 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.9 mttm . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.82 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.747 ' N7 ' HG13 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.868 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.824 0.345 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 63.31 117.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.42 169.34 8.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 176' ' ' ALA . 2.5 pt -160.23 134.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' ASP . 2.7 mptt -125.53 147.79 49.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLY . 20.7 m -133.48 134.48 43.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.841 HG12 ' HG1' ' A' ' 58' ' ' THR . 3.0 t -115.21 151.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 9' ' ' VAL . 9.2 p -93.24 160.87 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' N ' HG22 ' A' ' 8' ' ' VAL . 7.3 p -152.61 129.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 174.21 17.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.78 84.66 2.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 81' ' ' CYS . . . -171.9 -147.21 5.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 17' ' ' THR . . . -178.95 32.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.954 HG13 HD12 ' A' ' 79' ' ' LEU . 3.3 p -81.32 4.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -84.04 -103.89 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.286 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HE2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 ttpm? -97.38 -13.2 21.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.775 HG23 ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.32 -74.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -74.16 -34.88 63.98 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.089 -0.382 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.731 HD23 ' CG2' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.11 -74.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.584 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD21 HD12 ' A' ' 55' ' ' LEU . 18.2 mt -47.93 -42.27 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.876 0.37 . . . . 0.0 111.067 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -49.13 -68.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.517 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -93.18 -56.99 2.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.646 ' CD1' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -50.12 -26.8 4.85 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 84.9 m -113.82 -91.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.925 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 21' ' ' ILE . 4.1 t -51.87 -24.22 5.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.964 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.8 t-20 65.94 52.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' CE1' ' B' ' 81' ' ' PHE . 0.0 OUTLIER -132.5 -166.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.647 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -130.78 147.08 64.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.04 151.97 5.31 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.752 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 t -105.81 -80.54 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -75.7 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.51 105.95 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 3.4 p -160.55 138.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 33' ' ' VAL . 72.3 Cg_exo -39.21 92.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.689 2.26 . . . . 0.0 112.272 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.548 HG22 ' OD2' ' A' ' 57' ' ' ASP . 1.4 m -50.25 91.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.197 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' HG11 ' B' ' 87' ' ' VAL . 1.9 t -81.86 -26.35 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HE2' HD13 ' B' ' 85' ' ' ILE . 9.3 t80 -148.63 -77.01 0.16 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.804 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 40' ' ' TYR . 59.0 t0 58.27 112.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 16.4 t-20 -106.33 159.62 15.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.005 0.431 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -152.12 168.85 23.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.063 -178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.653 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -104.97 133.14 50.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.704 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.2 m -162.51 133.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.479 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 51' ' ' TYR . 88.0 m -131.34 116.27 17.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.13 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 78' ' ' PRO . 4.0 m -98.08 117.19 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.052 0.453 . . . . 0.0 110.581 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -91.31 102.0 14.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 173' ' ' ILE . 9.7 mm -82.34 121.22 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.186 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.79 25.38 61.34 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.62 19.62 67.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.62 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -115.82 151.31 46.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.662 0.268 . . . . 0.0 110.795 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.56 139.55 64.64 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.584 2.189 . . . . 0.0 112.357 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.519 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -151.58 174.52 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.657 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.78 111.32 9.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.235 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 55' ' ' LEU . 4.9 tt -73.31 129.7 38.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -112.39 103.41 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.005 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 53' ' ' LEU . 23.6 mt -125.83 154.46 42.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -144.56 125.94 14.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD2' HG22 ' A' ' 35' ' ' THR . 15.0 t0 -67.66 161.83 24.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.841 ' HG1' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -168.73 157.73 8.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 64' ' ' TYR . . . -119.79 -175.26 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.46 -145.72 4.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 mt 51.77 -162.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.91 52.4 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.18 28.25 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.553 ' HE1' ' HB3' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -99.34 -19.33 17.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -44.05 -29.21 0.57 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.789 0.328 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -56.72 -46.64 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.584 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.954 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 40.5 mt -94.25 23.31 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 tmt_? -57.02 -57.86 21.75 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.99 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.8 Cg_endo -47.95 -22.3 3.32 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.641 2.227 . . . . 0.0 113.053 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HB3' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -88.68 -15.02 35.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 7' ' ' VAL . 17.3 m -108.04 -31.37 7.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 47.76 94.35 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 73.7 Cg_exo -49.51 -36.8 40.81 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.668 2.245 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.36 59.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.592 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 76' ' ' ASP . 14.7 t -41.32 -50.65 3.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.7 0.286 . . . . 0.0 111.629 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.81 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.6 OUTLIER 171.72 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.685 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' PHE . 9.9 p -58.0 154.84 2.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 105' ' ' CYS . 0.7 OUTLIER -104.26 163.69 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.156 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HG13 ' A' ' 14' ' ' VAL . 1.2 mm? -114.48 139.01 49.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 110' ' ' PHE . 4.1 t -131.09 134.44 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.556 ' HB2' HG12 ' A' ' 14' ' ' VAL . 42.3 t -134.49 154.63 51.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 112.05 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 2.8 p90 -124.03 108.33 12.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.589 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.2 p -37.39 102.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.177 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.043 HG12 HG22 ' A' ' 85' ' ' VAL . 98.6 t 56.86 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.386 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.043 HG22 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.04 -81.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.562 0.22 . . . . 0.0 111.511 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.505 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 m 54.27 102.25 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.18 -30.25 64.79 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.393 2.062 . . . . 0.0 112.322 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 p -71.72 -23.6 61.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -93.11 -22.6 19.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.154 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -48.92 -69.81 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.353 . . . . 0.0 111.032 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -51.74 -36.84 48.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 51.0 m-20 -64.04 -63.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 89' ' ' SER . 61.1 t -43.06 -32.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.0 -69.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.847 0.356 . . . . 0.0 111.417 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -80.25 8.04 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 15.3 tttt -115.09 -45.3 2.96 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.651 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.7 m95 -95.42 -38.46 10.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.2 t -51.64 -44.51 90.24 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.631 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.6 Cg_exo -55.92 -21.6 34.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 112.256 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.92 -31.18 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.125 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.519 HG23 HG11 ' A' ' 9' ' ' VAL . 56.0 mt -48.14 -31.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.3 p -64.05 -34.84 78.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.633 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -72.78 -33.18 66.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.468 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -79.17 -43.87 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.831 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 17.8 p -103.64 134.01 19.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_endo -83.86 72.91 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.386 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.0 26.38 15.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 1.6 m -107.85 142.15 24.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 63.0 Cg_exo -51.46 172.23 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 80' ' ' VAL . 6.7 p90 -148.57 138.7 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -95.26 119.51 33.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.7 HD12 ' HE2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -97.9 121.84 40.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.933 HG23 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.4 137.36 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.405 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.513 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -174.67 156.45 22.94 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.759 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 1.4 t 173.45 177.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.113 0.482 . . . . 0.0 111.297 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.705 HE22 HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -174.59 52.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.292 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 158' ' ' SER . 28.9 mt -37.11 -31.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -58.49 -64.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.614 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.705 HD23 HE22 ' A' ' 116' ' ' GLN . 3.7 mm? -95.97 -23.97 16.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.688 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.808 ' HG2' HG21 ' A' ' 85' ' ' VAL . 7.3 tmm_? -41.9 -30.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.447 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 61.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -109.04 157.6 36.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.979 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.5 -34.79 34.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.679 2.253 . . . . 0.0 112.272 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.7 m -69.79 -45.82 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.654 HG21 ' O ' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -55.13 -57.05 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 122' ' ' ASP . 5.1 mp -61.19 -32.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -69.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -50.34 -25.98 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.92 57.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.226 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 4.5 mmtp -87.1 -28.4 22.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.883 0.373 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.4 -18.2 57.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.236 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER 63.15 26.73 15.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.79 122.45 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -50.25 153.07 2.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.66 136.75 27.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 141' ' ' THR . 5.2 mp -72.42 99.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.031 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -90.27 179.79 1.41 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.711 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 51.7 Cg_exo -53.11 -21.6 16.97 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.487 2.125 . . . . 0.0 112.326 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -38.09 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.621 ' HB ' HG23 ' A' ' 137' ' ' ILE . 19.3 m -52.35 -48.81 65.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.98 -60.07 3.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -52.53 -27.4 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.29 13.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.731 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 tp -54.77 -36.89 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.952 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -64.68 -39.74 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -58.74 -42.8 89.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -23.98 66.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.794 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.684 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.7 pp -119.08 19.18 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.74 -85.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.684 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.79 179.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 43.0 t -67.83 -14.87 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.443 ' CG ' ' HG2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 80.17 141.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.719 0.295 . . . . 0.0 110.492 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.952 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 7.9 p90 -152.8 157.42 40.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.1 122.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.476 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.546 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.9 pt-20 -172.42 150.65 2.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 72.1 m -102.15 -173.46 2.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.864 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.483 ' HB3' HD12 ' A' ' 117' ' ' ILE . 16.1 t -87.85 174.14 8.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 111.35 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.634 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -61.64 -175.87 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 65.03 -71.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.022 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' ALA . 35.8 p -69.11 -83.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.673 ' CG ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 69.77 113.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.489 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.4 ' CD ' ' SG ' ' A' ' 157' ' ' CYS . 5.7 mttp -101.4 -67.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 111.222 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.77 88.18 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -93.84 -15.24 25.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.546 0.212 . . . . 0.0 111.288 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -42.78 73.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.867 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -52.77 -64.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.9 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -49.32 -29.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.74 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -59.01 -44.86 91.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.801 179.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.933 ' HA ' HD13 ' B' ' 75' ' ' ILE . 36.3 t0 -61.18 -37.5 83.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.019 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.2 OUTLIER -71.15 -22.27 62.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.576 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.44 -54.05 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.064 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 46' ' ' ILE . 10.4 mt -63.46 -39.12 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 177' ' ' LEU . 13.1 tp -76.5 -36.08 58.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.05 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -53.61 -46.46 70.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.81 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -75.91 -28.24 57.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.069 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -53.97 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.022 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.25 68.11 3.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.799 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 38.4 Cg_endo -66.63 108.32 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.322 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 38.2 Cg_endo -66.67 101.34 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.461 2.107 . . . . 0.0 112.223 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.432 ' N ' ' HD2' ' A' ' 182' ' ' PRO . 4.2 mm-40 -67.76 -61.62 4.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 181' ' ' GLU . 36.3 Cg_endo -65.25 119.51 6.55 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.585 2.19 . . . . 0.0 112.366 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.67 175.47 10.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.895 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.8 m -50.53 -44.72 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 170' ' ' ASP . 0.7 OUTLIER -144.16 133.64 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.03 142.79 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -70.53 136.77 85.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.704 ' HB2' HG12 ' A' ' 42' ' ' VAL . 51.0 Cg_exo -54.43 154.4 19.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.516 2.144 . . . . 0.0 112.019 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.7 m -116.88 -83.29 0.64 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.394 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.79 99.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 13.8 t80 -123.19 129.46 51.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.23 142.31 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.0 102.51 1.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.613 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -86.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.438 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.609 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -104.35 127.47 58.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 111.191 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -105.79 99.18 8.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 36' ' ' VAL . 74.1 t -85.56 151.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.33 165.58 28.23 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.054 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.63 106.75 18.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.601 ' HB2' HG23 ' B' ' 97' ' ' THR . 16.0 t0 -124.08 118.24 26.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.71 21.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 1.063 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -47.34 -27.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-O 121.027 0.441 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' THR . . . . . 1.063 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -152.11 20.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.981 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.92 68.45 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.038 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.908 ' HG2' HG23 ' B' ' 93' ' ' THR . 10.2 pt-20 -132.41 164.89 25.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.079 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.609 ' HD2' ' HE1' ' B' ' 99' ' ' MET . 7.4 m-85 -79.11 154.65 29.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.811 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.601 HG23 ' HB2' ' B' ' 90' ' ' ASP . 19.1 p -93.5 169.47 10.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.21 23.54 8.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.418 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.609 ' HE1' ' HD2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -49.82 106.16 0.6 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.492 0.186 . . . . 0.0 110.959 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 67.2 Cg_exo -36.0 152.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 112.906 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -66.69 0.28 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.716 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.28 -52.0 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.075 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.954 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.5 m0 -48.27 -62.5 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.127 0.489 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.57 -69.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.546 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 0.6 OUTLIER -46.64 -38.5 9.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.421 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -49.48 -57.11 7.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.37 . . . . 0.0 110.568 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.77 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.3 -69.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.751 ' O ' HG23 ' B' ' 109' ' ' THR . 5.2 tp-100 -79.18 -100.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.785 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.751 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.3 p -168.62 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.034 0.445 . . . . 0.0 110.736 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.519 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -134.23 170.58 15.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.212 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 99' ' ' MET . 10.4 m-80 -54.31 -63.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.722 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.0 OUTLIER -121.32 87.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.557 0.694 . . . . 0.0 109.37 178.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.445 ' OG1' HD13 ' B' ' 112' ' ' ILE . 7.5 m 69.66 -63.33 0.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' B' ' 110' ' ' SER . 1.8 mtpt -147.23 40.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.16 -67.88 0.2 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -86.45 145.74 26.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -92.13 143.83 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.938 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.634 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.8 91.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -89.86 159.51 16.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.25 136.96 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.262 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 4.4 mptt -118.91 96.41 5.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.22 97.36 4.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 75' ' ' THR . 12.7 t -84.45 111.26 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.77 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 55' ' ' LEU . 10.7 m -105.43 129.57 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.39 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.784 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.1 p -126.49 138.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.078 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.98 120.52 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.649 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.86 -31.23 70.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.029 0.442 . . . . 0.0 110.488 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.12 83.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.96 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 54.01 23.49 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.889 0.376 . . . . 0.0 111.032 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG13 ' N7 ' ' A' ' 185' ' ' GNP . 45.3 t -91.19 -17.89 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . -130.2 -8.82 3.18 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.263 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.623 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.8 pttt -94.9 -57.59 2.4 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.96 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 5.2 t -96.59 -41.8 8.36 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.013 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' C8 ' ' A' ' 185' ' ' GNP . 2.8 m -64.28 -25.93 68.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -42.75 -72.74 0.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.585 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' HB2' ' A' ' 40' ' ' TYR . 16.4 mt -63.45 -33.81 76.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.152 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -55.29 -43.72 72.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.146 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.521 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 15.0 m -95.96 -26.68 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.806 ' HB3' HD21 ' B' ' 77' ' ' LEU . 3.7 m-30 -80.73 -67.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 81' ' ' PHE . 55.0 m -79.65 -83.03 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.487 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.53 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -50.53 -24.86 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.187 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 p30 44.28 38.71 2.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -114.24 -165.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.981 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -122.37 141.84 35.68 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.953 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 51.7 Cg_exo -34.86 136.44 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.209 2.606 . . . . 0.0 113.267 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -105.78 -84.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.442 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 95.34 5.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.203 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' CD1' ' O1G' ' A' ' 185' ' ' GNP . 1.3 t80 -66.48 105.91 1.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.229 0.537 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.6 p -160.63 134.06 4.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.541 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.22 89.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.435 2.09 . . . . 0.0 112.221 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.474 HG21 ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -72.98 86.65 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.113 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.792 HG21 ' CD2' ' B' ' 96' ' ' PHE . 22.9 m -68.09 -22.54 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.244 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 2.9 t80 -129.21 -76.2 0.55 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.569 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' HG21 ' A' ' 35' ' ' THR . 32.8 t0 61.39 118.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.599 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' CB ' HD12 ' B' ' 85' ' ' ILE . 12.0 t-20 -107.49 148.98 28.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.576 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.567 ' HB2' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -141.49 143.1 33.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.213 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.99 131.54 40.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.592 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.2 m -150.53 163.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.122 0.487 . . . . 0.0 111.618 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 51' ' ' TYR . 93.3 m -155.73 101.41 2.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.001 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.945 HG13 ' O ' ' B' ' 76' ' ' SER . 11.9 t -98.41 130.96 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.211 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.5 mtm -91.06 99.92 12.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 177' ' ' LEU . 19.8 mt -101.48 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.67 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.01 12.94 72.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.355 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.21 34.22 6.85 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.706 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 45' ' ' MET . 24.4 mt-10 -141.78 134.81 14.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.582 0.23 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.35 167.96 10.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.113 . . . . 0.0 112.287 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' H ' HG23 ' A' ' 43' ' ' THR . 2.9 m-85 -153.81 168.49 26.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.288 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.8 p -135.24 97.4 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.505 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.8 tt -115.82 160.92 19.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.812 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -161.11 120.81 0.97 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 16' ' ' LYS . 10.0 mp -77.04 102.82 6.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.918 0.39 . . . . 0.0 110.927 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 9.8 m-85 -84.1 104.95 14.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 58' ' ' THR . 40.0 m-20 -66.84 175.85 2.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.716 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 57' ' ' ASP . 23.1 p -161.43 128.95 4.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -58.49 170.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.51 66.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.538 HD22 ' H ' ' A' ' 61' ' ' LEU . 2.6 mm? -63.35 150.45 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.314 . . . . 0.0 110.918 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 34.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -116.7 20.54 13.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -78.38 -10.48 59.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.382 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -42.54 -30.64 0.37 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -79.55 -45.56 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 70' ' ' LEU . 1.4 mp -95.18 25.27 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -98.02 -49.61 0.22 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.675 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 60.1 Cg_exo -51.41 -43.1 51.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 121.965 1.776 . . . . 0.0 111.838 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.846 HD22 ' CG ' ' B' ' 103' ' ' TRP . 1.0 OUTLIER -49.08 -24.57 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.246 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.812 ' N ' HD12 ' A' ' 70' ' ' LEU . 1.3 p -104.52 -20.65 13.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.336 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.572 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 60.38 139.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.895 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . 96.9 Cg_endo -82.7 -47.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.584 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -69.23 -10.69 58.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.537 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 HG23 ' A' ' 7' ' ' VAL . 6.2 t -40.89 -52.21 3.09 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -173.17 -167.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.036 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.1 p -65.4 162.41 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 77' ' ' VAL . 15.0 m-85 -110.48 134.61 52.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 ' CB ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -104.31 120.33 40.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.5 t -131.16 153.76 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.5 ' HB2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -144.64 175.89 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 111.672 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG11 ' A' ' 93' ' ' VAL . 11.0 p90 -167.21 -176.05 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.703 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.9 t -135.07 44.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.38 -70.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 59.3 m -44.48 100.6 0.23 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.194 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.91 -36.4 83.53 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.667 2.245 . . . . 0.0 112.296 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 t -49.95 -32.37 14.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 t -96.0 -33.08 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 1.4 t80 -55.76 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -48.86 -26.13 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 17.9 m-20 -73.2 -65.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.083 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.648 HG13 ' HD1' ' A' ' 97' ' ' TRP . 61.1 t -41.71 -33.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.829 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HD3' HD11 ' A' ' 145' ' ' LEU . 9.2 ttpt -79.09 -62.38 1.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.17 7.79 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -117.8 -41.57 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.821 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.648 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.2 m95 -95.23 -39.58 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 98.1 t -47.57 -43.31 49.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.632 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.8 Cg_exo -67.76 -31.85 31.25 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.525 2.15 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -93.13 -22.76 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 10.2 tt -47.05 -27.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 p -74.94 -40.14 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.25 -39.12 81.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 110.407 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 7.2 m-70 -93.73 -26.18 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -123.86 66.54 39.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 73' ' ' PRO . 36.3 Cg_endo -65.44 111.56 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.66 2.24 . . . . 0.0 112.472 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.96 48.7 22.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.014 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 109' ' ' PRO . 69.9 m -140.89 140.59 21.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.833 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 108' ' ' THR . 19.5 Cg_endo -58.4 169.98 2.7 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 0.0 111.914 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' CB ' HD11 ' A' ' 101' ' ' ILE . 3.1 p90 -159.84 137.72 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.411 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 mp -100.96 124.29 46.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.154 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CZ ' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -134.71 102.12 5.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.626 HG23 ' CB ' ' A' ' 142' ' ' ALA . 4.0 p -145.3 108.0 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 155.47 42.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 156' ' ' GLU . 1.2 p -148.16 115.76 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -169.97 72.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 157' ' ' CYS . 24.9 mt -64.87 -62.52 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -50.93 -60.0 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -48.64 -48.37 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.592 ' HG3' HG11 ' A' ' 85' ' ' VAL . 22.0 ttp85 -50.34 -28.23 7.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.61 -15.46 61.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.485 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.54 ' O ' HD12 ' A' ' 126' ' ' ILE . 4.3 m-20 -53.84 143.83 38.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.757 0.313 . . . . 0.0 110.967 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.74 -45.02 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.0 m -49.25 -40.2 33.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -53.6 -63.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.8 mp -50.97 -39.51 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.92 -63.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.09 -34.6 66.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 136' ' ' PRO . 1.2 mt -50.15 -26.28 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.959 0.409 . . . . 0.0 110.459 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.42 61.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.908 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.54 -16.66 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -93.63 29.59 1.98 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.16 33.64 2.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 50.04 -163.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.28 75.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.629 ' HB3' HD13 ' A' ' 129' ' ' LEU . 57.2 Cg_endo -70.69 169.14 20.83 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.697 2.265 . . . . 0.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.643 HG23 ' CG2' ' A' ' 141' ' ' THR . 4.0 mp -97.95 131.9 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.117 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.478 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -129.57 -179.24 0.96 Allowed Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.266 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 61.2 Cg_exo -52.14 -21.26 12.41 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.442 2.095 . . . . 0.0 112.496 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.0 -40.79 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.643 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.8 m -48.37 -47.24 37.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.184 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.626 ' CB ' HG23 ' A' ' 113' ' ' VAL . . . -49.2 -50.89 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.835 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -32.0 73.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.414 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -55.43 -49.61 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.481 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 149' ' ' LEU . 6.5 tt -66.12 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.501 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -68.53 -49.07 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -63.46 -35.14 79.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -31.01 71.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.735 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 145' ' ' LEU . 4.1 pp -98.66 -20.12 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.664 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mmtm 63.13 93.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.556 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -136.55 -173.43 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 153' ' ' LYS . 9.2 p -41.72 -45.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.606 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 112.81 139.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.589 1.18 . . . . 0.0 109.959 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.879 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -153.65 140.57 19.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.687 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 155' ' ' VAL . 34.7 m -158.47 125.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.666 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.4 pt-20 -161.02 174.15 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.652 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.944 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.9 p -135.23 -170.73 2.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.995 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 164.44 17.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.815 0.34 . . . . 0.0 110.506 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -40.72 -90.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.067 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.07 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.699 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 170.04 -66.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.647 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 43.73 96.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.604 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.84 -49.47 3.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.74 68.52 0.35 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.973 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.694 HD21 ' CD1' ' A' ' 23' ' ' TYR . 2.6 tp -93.02 -22.27 19.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 111.408 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -41.93 75.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.01 -65.21 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 169' ' ' PHE . 7.5 p -46.67 -49.1 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.466 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 39.8 t80 -55.09 -43.79 74.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.639 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' B' ' 75' ' ' ILE . 45.5 m-20 -53.09 -43.16 66.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.42 -44.82 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.83 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.925 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 169' ' ' PHE . 19.6 mm -94.95 -30.2 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.36 -46.18 80.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.87 -26.24 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.216 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -65.93 -50.56 63.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' HD13 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -90.69 65.96 6.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.944 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -71.96 -61.01 2.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 178' ' ' GLU . 54.6 Cg_endo -69.79 158.64 56.24 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.611 2.207 . . . . 0.0 112.403 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.36 175.92 9.36 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 108.39 1.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.44 151.83 9.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.449 2.099 . . . . 0.0 112.275 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 -178.82 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 60.23 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 170' ' ' ASP . 8.5 tt -127.13 145.87 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.945 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.39 132.19 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.74 145.32 83.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' B' ' 77' ' ' LEU . 73.9 Cg_exo -50.49 -175.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.733 2.288 . . . . 0.0 112.545 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 73.4 m -153.72 -63.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.504 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 2.2 t80 -98.44 139.71 33.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.81 124.76 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.783 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.453 ' CD2' ' OD1' ' A' ' 38' ' ' ASP . 2.9 t-160 -68.21 78.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.98 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.572 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -119.33 110.34 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -91.22 96.54 10.62 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 36' ' ' VAL . 60.3 t -78.1 137.27 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.562 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.61 177.74 17.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.191 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -78.11 123.86 27.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 111.034 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.566 ' CG ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -114.95 97.87 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.08 -18.68 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.585 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.536 HG13 ' N ' ' B' ' 93' ' ' THR . 13.3 p -45.37 -46.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 111.493 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.536 ' N ' HG13 ' B' ' 92' ' ' VAL . 6.6 t -121.94 -10.74 8.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.687 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.58 18.92 21.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.309 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.406 ' CD ' HG21 ' B' ' 93' ' ' THR . 14.1 pt-20 -124.47 -160.73 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.648 0.261 . . . . 0.0 110.708 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.792 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -98.34 164.32 12.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.566 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -101.46 167.94 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 47.84 33.83 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.373 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.595 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.99 117.86 5.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.46 0.171 . . . . 0.0 111.179 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.458 ' HD3' HG22 ' B' ' 87' ' ' VAL . 92.4 Cg_exo -42.88 155.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.054 . . . . 0.0 112.294 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -47.77 -54.05 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -69.19 -55.85 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.846 ' CG ' HD22 ' A' ' 70' ' ' LEU . 6.0 m0 -47.83 -57.54 5.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -49.73 -65.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.346 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' B' ' 109' ' ' THR . 3.7 mtt-85 -49.11 -44.52 42.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.43 -61.24 1.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.3 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.656 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -94.75 -68.79 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.273 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.561 ' O ' HG23 ' B' ' 109' ' ' THR . 0.1 OUTLIER -78.45 -97.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.89 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.561 HG23 ' O ' ' B' ' 108' ' ' GLN . 22.5 p -160.48 -55.06 0.05 Allowed 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -151.63 172.44 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 112.121 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' B' ' 99' ' ' MET . 7.2 p30 -64.37 75.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.537 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -56.55 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.483 0.658 . . . . 0.0 111.004 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 1.2 m 160.27 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.63 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 116' ' ' GLU . 23.0 tttp 78.98 43.63 0.07 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.34 -64.0 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.812 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 114' ' ' LYS . 2.9 tt0 74.28 118.47 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -126.02 134.89 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.565 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.88 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.819 0.342 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.9 -171.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 135.63 36.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.982 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.675 HG22 ' HB1' ' A' ' 176' ' ' ALA . 4.8 pt -149.63 111.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -134.26 99.73 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.432 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 6.0 m -77.27 152.4 34.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 56' ' ' PHE . 17.4 t -136.9 143.9 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.285 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 9' ' ' VAL . 6.5 p -85.01 160.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' HG22 ' A' ' 8' ' ' VAL . 3.9 m -138.09 121.18 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.22 173.9 31.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.22 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.409 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.3 m-20 -89.54 110.42 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.0 110.769 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -161.15 -39.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.786 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 83.45 -47.99 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG12 ' N7 ' ' A' ' 185' ' ' GNP . 18.5 m -47.07 -25.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.33 -94.44 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.477 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HZ1' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.83 -71.57 0.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.923 ' O ' HD13 ' A' ' 21' ' ' ILE . 1.1 t -36.0 -58.42 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.786 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 10.9 m -68.94 -26.86 65.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.964 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 15' ' ' GLY . 3.0 tp -58.38 -76.85 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.819 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 42' ' ' VAL . 12.9 mt -48.91 -33.35 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.856 -0.528 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 17' ' ' THR . 1.2 mp -51.16 -68.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 t -93.33 -57.19 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.593 ' O ' HD21 ' B' ' 77' ' ' LEU . 10.4 t80 -39.28 -39.89 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.661 HG21 HG12 ' A' ' 42' ' ' VAL . 62.7 m -104.72 -75.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -71.22 -15.33 62.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 52.6 t30 65.59 36.92 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 111.165 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 1.5 tttp 176.6 164.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -134.22 60.97 47.64 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.69 0.281 . . . . 0.0 111.748 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 80.9 Cg_endo -91.63 126.56 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.064 2.51 . . . . 0.0 112.516 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.7 p 171.82 -88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.991 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.96 153.04 13.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.0 t80 -91.02 111.92 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 110.835 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 34' ' ' PRO . 95.0 t -158.67 140.38 9.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' A' ' 33' ' ' VAL . 82.0 Cg_exo -46.61 91.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.262 1.975 . . . . 0.0 111.446 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.809 HG23 ' CG ' ' A' ' 38' ' ' ASP . 54.5 m -52.9 87.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.544 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.504 HG11 ' CG ' ' B' ' 96' ' ' PHE . 37.2 t -75.4 -25.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 109.898 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.557 ' HE2' HD13 ' B' ' 85' ' ' ILE . 4.2 t80 -148.29 -68.82 0.23 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.247 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.809 ' CG ' HG23 ' A' ' 35' ' ' THR . 3.0 m-20 57.97 111.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.331 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.587 ' HB3' HD12 ' B' ' 85' ' ' ILE . 11.2 t-20 -107.96 148.82 29.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.08 142.15 25.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.599 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -83.22 152.17 25.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 24' ' ' THR . 1.2 m -162.43 148.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -132.09 104.81 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 173' ' ' ILE . 4.0 t -97.31 117.23 41.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.5 . . . . 0.0 110.58 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.8 mtm -100.23 100.01 10.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.947 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 46' ' ' ILE . 12.3 tt -109.85 109.54 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.25 15.81 61.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.545 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.68 -43.01 1.94 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.616 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.61 142.91 66.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.293 . . . . 0.0 111.057 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.81 173.98 11.85 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.322 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -153.28 146.46 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -99.72 97.42 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.033 HD21 HD12 ' A' ' 55' ' ' LEU . 7.9 tt -112.33 156.5 22.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.994 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.99 112.33 0.53 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.033 HD12 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -85.5 103.34 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.927 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.4 m-85 -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.35 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 14.2 t70 -72.17 166.36 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 64' ' ' TYR . 43.7 m -169.32 128.59 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.544 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -77.94 -73.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.69 -137.67 6.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 mt 71.73 -174.23 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -96.08 -16.89 21.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.393 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 71.5 m-20 -76.34 -19.27 58.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.4 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -70.33 -16.79 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.542 0.21 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -48.04 -25.73 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 5.7 ptp180 -91.99 -40.95 10.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.052 HD22 ' CE2' ' B' ' 96' ' ' PHE . 27.3 tp -86.78 1.13 53.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.51 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.01 -47.28 0.39 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.838 -0.164 . . . . 0.0 111.282 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 76.3 Cg_exo -49.08 -25.21 8.78 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.19 1.927 . . . . 0.0 111.411 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.77 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -65.02 -28.15 69.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.497 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 22.5 m -100.15 -14.89 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.262 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 54.58 141.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 123.252 0.621 . . . . 0.0 112.03 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.99 -34.51 2.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -10.71 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.322 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.495 HG21 HG23 ' A' ' 7' ' ' VAL . 9.0 t -40.6 -47.88 2.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.572 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 4' ' ' ILE . 1.3 m-20 169.06 -168.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 111' ' ' LEU . 12.2 p -58.29 141.97 14.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.448 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 105' ' ' CYS . 10.3 m-85 -92.9 143.7 26.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.627 HD23 ' HZ1' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.68 115.94 31.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.219 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 101' ' ' ILE . 2.7 t -89.26 93.69 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.962 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.455 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 28.1 p -67.62 110.38 3.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.744 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 93' ' ' VAL . 2.6 t80 -131.92 105.8 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.42 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -50.66 156.83 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.914 HG13 HG22 ' A' ' 137' ' ' ILE . 63.0 t -83.49 -75.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 120' ' ' ARG . 97.9 t -69.26 -101.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.522 ' N ' HG12 ' A' ' 85' ' ' VAL . 17.7 m 33.72 57.59 1.76 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.605 ' HD3' HG12 ' A' ' 85' ' ' VAL . 2.7 Cg_endo -46.06 -25.65 3.04 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.9 2.4 . . . . 0.0 112.362 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.39 -26.04 26.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.1 m -96.28 -38.78 9.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.254 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -45.17 -66.99 0.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.238 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 -55.55 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -54.17 -64.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.914 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 89' ' ' SER . 48.0 t -41.37 -36.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.813 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HD3' HD21 ' A' ' 145' ' ' LEU . 25.1 tptp -63.2 -69.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 2.4 mp0 -82.78 8.62 11.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tptp -117.43 -44.93 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' HD1' HG13 ' A' ' 93' ' ' VAL . 14.4 m95 -95.12 -28.19 15.2 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.825 ' O ' HG22 ' A' ' 101' ' ' ILE . 24.5 t -70.03 -44.56 21.5 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.704 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.5 Cg_exo -51.06 -29.31 27.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.23 1.953 . . . . 0.0 112.57 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -93.11 -17.51 23.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.666 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.894 HD11 HG22 ' A' ' 80' ' ' VAL . 9.6 tt -47.5 -35.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.805 0.336 . . . . 0.0 111.29 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 p -65.62 -38.33 89.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -61.67 -29.46 70.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.179 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -87.06 -48.96 7.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 28.9 p -104.04 96.55 9.66 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 111.005 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.56 100.45 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.573 2.182 . . . . 0.0 112.334 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.82 5.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 m -117.32 131.17 24.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.55 175.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.483 2.122 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 149' ' ' LEU . 3.9 p90 -163.15 159.42 22.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.7 mp -111.96 120.08 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.847 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.513 HD13 ' C ' ' A' ' 112' ' ' LEU . 1.3 tm? -95.19 102.49 14.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.69 160.39 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.373 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -147.45 137.3 6.51 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.364 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.97 HG21 ' C6 ' ' A' ' 185' ' ' GNP . 6.5 p -130.26 -155.62 0.71 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.1 tp60 82.4 77.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.415 HG13 ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -100.12 -34.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -78.04 -51.72 9.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.268 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -51.54 -40.37 59.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.873 ' HB2' HG21 ' A' ' 85' ' ' VAL . 7.6 ptt85 -72.44 61.93 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -137.72 46.7 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.022 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.32 145.89 34.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.62 -45.21 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.317 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -49.96 -45.93 51.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.79 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -29.62 20.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.8 mm -66.09 -57.35 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.054 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -48.43 -38.19 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.056 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -39.09 17.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.976 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.482 HD13 ' HG3' ' A' ' 136' ' ' PRO . 6.2 mt -51.18 -25.54 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.409 . . . . 0.0 110.436 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.82 -19.18 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -31.9 33.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -67.62 -19.46 65.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.13 46.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.49 133.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.5 168.18 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.54 129.22 32.73 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.914 HG22 HG13 ' A' ' 84' ' ' VAL . 8.5 mt -60.41 129.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.471 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -128.09 179.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.948 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 73.0 Cg_exo -51.75 -21.67 11.9 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.674 2.25 . . . . 0.0 112.508 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.58 -53.37 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.547 ' CG2' HG23 ' A' ' 137' ' ' ILE . 54.4 m -46.21 -47.52 17.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.34 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -33.79 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.577 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -58.51 -56.62 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.506 HD21 ' HD3' ' A' ' 94' ' ' LYS . 17.9 tp -59.09 -52.94 63.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.434 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.642 ' CA ' HD23 ' A' ' 149' ' ' LEU . . . -57.91 -41.01 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.408 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.401 ' HA ' ' OH ' ' A' ' 154' ' ' TYR . 48.4 ttt-85 -50.16 -41.56 49.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.44 -21.74 64.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.935 HD13 ' CE1' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -74.84 -28.47 60.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 tttt 66.83 58.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.648 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -107.28 -177.97 3.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.412 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 66.3 t -48.86 -64.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 178.97 160.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.756 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.802 ' HE2' ' HB3' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -154.34 111.23 3.35 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 168' ' ' VAL . 23.6 m -158.27 120.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.859 0.362 . . . . 0.0 110.412 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -173.18 -178.63 1.79 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.61 -173.42 4.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.89 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.415 ' OG ' HG13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -87.2 155.94 19.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.267 0.556 . . . . 0.0 111.301 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 22' ' ' SER . . . -57.18 -158.85 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER 47.86 26.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.802 179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.559 HE22 ' C ' ' A' ' 22' ' ' SER . 2.7 mm-40 73.62 121.46 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -105.42 -68.28 0.87 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.178 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.428 ' C ' HD23 ' A' ' 165' ' ' LEU . . . -162.86 85.19 0.11 Allowed Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.375 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -94.05 -10.11 34.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.728 0.299 . . . . 0.0 111.669 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -43.74 -29.44 0.52 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.925 0.393 . . . . 0.0 111.135 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 155' ' ' VAL . 16.1 m-20 -64.37 -47.4 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.557 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 155' ' ' VAL . 86.1 t -54.45 -47.62 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.571 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -69.97 -38.76 76.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.746 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.37 -42.34 66.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.269 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.436 ' CB ' ' HG2' ' A' ' 153' ' ' LYS . 1.6 tp10 -90.03 -41.53 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.72 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -60.48 -35.73 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 44' ' ' VAL . 29.6 mm -86.11 -44.65 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.37 -41.13 85.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -52.3 -40.03 61.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.675 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -84.56 -23.83 29.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 46' ' ' ILE . 4.0 tp -48.91 -64.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.06 80.7 5.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.37 104.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.59 137.94 58.22 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.593 2.195 . . . . 0.0 112.236 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 6.0 mm-40 -86.24 -47.48 0.55 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 79.3 Cg_exo -48.15 121.79 6.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.471 2.114 . . . . 0.0 112.402 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 107.63 15.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.4 mttp . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.966 -179.925 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.22 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -96.35 142.61 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.058 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.48 144.89 51.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -72.53 129.29 87.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.72 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.579 ' HB2' HG12 ' A' ' 42' ' ' VAL . 9.2 Cg_endo -51.91 149.64 19.88 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.4 ' O ' ' N ' ' B' ' 81' ' ' PHE . 75.4 m -120.37 -64.07 1.29 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -47.53 93.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 2.3 t80 -119.75 135.87 54.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.89 131.24 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.487 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.22 88.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.474 . . . . 0.0 110.397 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.572 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -56.11 -76.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.661 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -121.4 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.931 0.396 . . . . 0.0 111.788 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -105.31 97.48 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.907 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.5 t -77.62 145.38 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.707 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -146.31 167.49 27.94 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.227 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -92.19 126.82 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' B' ' 92' ' ' VAL . 37.1 t0 -135.82 135.14 39.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.758 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.42 1.72 18.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.009 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.619 HG13 ' OD1' ' B' ' 90' ' ' ASP . 11.5 m -45.5 -27.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.441 HG23 ' N ' ' B' ' 94' ' ' GLY . 12.8 t -153.41 -44.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.837 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' GLY . . . . . 0.441 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.57 35.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.367 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -144.66 -160.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.752 0.311 . . . . 0.0 110.598 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 1.052 ' CE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.56 147.3 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.437 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -90.71 178.49 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.74 32.28 32.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.633 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 1.8 tpt -44.1 101.92 0.27 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 0.0 111.423 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.454 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 82.7 Cg_exo -45.51 151.95 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.114 1.876 . . . . 0.0 112.077 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -43.97 -63.84 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.929 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -64.7 -61.29 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.747 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 67' ' ' LEU . 3.1 m0 -46.39 -50.62 16.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.633 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.14 -66.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.0 ptm180 -47.35 -27.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.915 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.648 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -63.05 -62.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.331 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -94.89 -59.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.679 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 109' ' ' THR . 4.7 tp-100 -77.82 -99.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.72 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -166.74 -52.17 0.03 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.891 0.377 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 99' ' ' MET . 0.3 OUTLIER -154.1 -176.5 5.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.434 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 99' ' ' MET . 26.7 t-20 -82.41 80.48 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.845 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.667 ' O ' HG23 ' B' ' 113' ' ' THR . 0.0 OUTLIER -57.14 88.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.701 0.762 . . . . 0.0 111.402 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.667 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.2 OUTLIER 164.63 -30.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.344 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.61 -66.48 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.671 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.4 t 45.06 95.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 174.32 145.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -109.37 146.26 34.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 tptt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.844 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.97 ' C6 ' HG21 ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.41 141.59 43.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 t -119.98 111.8 18.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -115.88 151.98 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -128.33 96.26 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.7 104.8 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 8' ' ' VAL . 25.7 t -84.71 158.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.72 HG23 ' CG2' ' A' ' 14' ' ' VAL . 34.4 m -140.76 150.71 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.405 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.8 m -145.12 135.2 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.335 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.72 146.08 4.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.69 152.58 39.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.58 0.228 . . . . 0.0 110.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 49.76 96.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.976 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 67.61 64.13 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.141 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 8' ' ' VAL . 7.6 p -48.56 -24.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.2 -32.84 2.6 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.919 ' HE3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.14 -73.45 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.637 0.256 . . . . 0.0 111.56 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.831 HG23 ' OD1' ' A' ' 57' ' ' ASP . 18.0 p -39.52 -61.31 0.82 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.775 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 6.1 p -46.43 -37.3 7.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 79' ' ' LEU . 5.9 tp -67.94 -71.46 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD12 ' CD2' ' B' ' 81' ' ' PHE . 1.7 mm? -38.18 -41.37 0.59 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.753 0.311 . . . . 0.0 111.604 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.719 HG21 ' HD3' ' A' ' 29' ' ' PRO . 4.4 mm -61.04 -45.05 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.449 ' HB3' " H2'" ' A' ' 185' ' ' GNP . 90.8 p -94.2 -64.02 1.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.74 ' CD1' HD12 ' A' ' 165' ' ' LEU . 27.1 t80 -49.38 -47.88 47.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.197 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' HD2' ' B' ' 81' ' ' PHE . 94.5 m -97.45 -95.76 0.21 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.93 HG21 ' CE ' ' A' ' 27' ' ' LYS . 5.0 t -41.23 -29.38 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 t30 68.13 24.25 7.74 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.93 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -112.41 -160.02 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.196 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.01 156.61 74.01 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.719 ' HD3' HG21 ' A' ' 21' ' ' ILE . 63.2 Cg_exo -36.68 142.33 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.071 2.514 . . . . 0.0 113.133 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.95 -83.32 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.537 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.94 97.31 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.377 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.38 106.45 1.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.098 0.475 . . . . 0.0 110.97 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 ' HD2' ' A' ' 34' ' ' PRO . 4.4 p -160.6 139.64 7.79 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.179 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.4 Cg_exo -37.66 100.2 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.764 2.31 . . . . 0.0 112.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.554 HG23 HG21 ' A' ' 17' ' ' THR . 4.9 m -47.0 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.257 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 34' ' ' PRO . 91.2 t -91.21 -43.67 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' B' ' 87' ' ' VAL . 84.0 t80 -172.57 106.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.746 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB2' HG22 ' A' ' 17' ' ' THR . 30.0 m-20 -107.52 127.36 53.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.65 ' HB3' HD12 ' B' ' 85' ' ' ILE . 31.4 t-20 -107.48 147.01 31.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.113 0.482 . . . . 0.0 111.309 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.695 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.27 161.11 43.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.187 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.82 116.75 29.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.182 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 55' ' ' LEU . 1.3 m -124.92 124.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 0.0 111.76 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -122.27 95.94 4.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.459 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.88 HG23 ' O ' ' B' ' 76' ' ' SER . 10.7 p -97.34 116.78 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.8 mtm -89.04 114.99 26.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.047 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.691 HG23 ' O ' ' B' ' 74' ' ' SER . 9.0 mt -115.8 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 73' ' ' GLY . . . 85.79 18.73 59.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.21 33.45 44.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.544 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -139.15 147.33 52.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.66 162.9 35.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.491 2.127 . . . . 0.0 112.207 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -154.34 167.53 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.5 m -131.87 97.04 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.214 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.75 158.94 16.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.29 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.92 103.72 0.26 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.054 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.39 103.32 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -83.71 102.95 12.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.172 179.423 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.831 ' OD1' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -71.38 -178.07 2.0 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.985 0.421 . . . . 0.0 111.111 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -170.53 172.81 5.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.701 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -87.39 -61.45 1.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.253 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.51 18.46 9.04 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 mt -94.33 -173.83 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.801 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.67 39.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -135.64 12.33 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.346 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.697 ' CE2' HG22 ' A' ' 58' ' ' THR . 1.3 m-85 -86.69 2.68 47.73 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.525 0.202 . . . . 0.0 111.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.3 p-10 -49.43 -25.63 2.7 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -39.07 12.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.94 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -96.84 26.32 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.538 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.568 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.49 -26.57 0.3 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 72.5 Cg_endo -76.72 -22.91 11.51 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.455 1.437 . . . . 0.0 111.667 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' B' ' 103' ' ' TRP . 7.4 mt -60.19 -18.27 47.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -94.38 -27.24 16.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.04 168.47 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.976 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 72' ' ' TYR . 14.1 Cg_endo -57.4 -17.62 27.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.422 2.081 . . . . 0.0 112.198 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -10.76 38.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.2 t -38.3 -30.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.03 -154.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 41.4 t -57.84 161.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -111.94 122.08 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.945 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.919 HD23 ' HE3' ' A' ' 16' ' ' LYS . 1.9 tp -103.83 121.51 43.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.291 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.734 ' N ' HD12 ' A' ' 79' ' ' LEU . 2.3 t -131.06 138.12 54.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.95 152.99 48.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HE1' HG12 ' A' ' 84' ' ' VAL . 26.9 p90 -138.65 176.13 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' A' ' 116' ' ' GLN . 91.5 p -89.69 120.03 30.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.537 HG12 ' HE1' ' A' ' 82' ' ' PHE . 32.3 m -93.06 40.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.786 HG12 ' N ' ' A' ' 120' ' ' ARG . 19.4 m -95.46 -45.77 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 85' ' ' VAL . 2.0 p -139.46 139.35 22.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.74 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 132' ' ' ASN . 42.6 Cg_endo -68.53 -17.81 43.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.579 2.186 . . . . 0.0 112.469 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -51.68 -23.73 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -93.32 -29.91 15.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.169 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 2.7 m-85 -46.44 -44.93 17.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.193 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.65 -58.26 8.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -63.17 -36.71 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 89' ' ' SER . 72.7 t -48.63 -65.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.435 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HD3' HD11 ' A' ' 145' ' ' LEU . 13.0 mtmm -73.33 -37.25 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.71 -12.39 61.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.9 tttm -119.03 -25.88 6.11 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.638 ' CZ3' HG13 ' A' ' 93' ' ' VAL . 31.2 m0 -93.29 -49.03 6.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.625 0.25 . . . . 0.0 111.313 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.8 t -47.6 -43.93 52.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.1 Cg_exo -67.38 -26.53 41.09 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.53 2.154 . . . . 0.0 112.589 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.05 -35.21 15.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.439 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -47.67 -27.58 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.367 . . . . 0.0 111.294 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -89.13 -33.23 17.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -51.92 -44.68 63.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.408 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -84.32 -46.59 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -97.34 104.23 19.12 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.746 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 95.9 Cg_exo -41.65 -51.12 4.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.554 2.17 . . . . 0.0 112.565 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -173.79 48.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.621 HG23 ' HD2' ' A' ' 109' ' ' PRO . 56.6 m -103.97 142.79 25.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.621 ' HD2' HG23 ' A' ' 108' ' ' THR . 78.7 Cg_exo -39.79 129.08 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.547 2.165 . . . . 0.0 112.086 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.6 p90 -102.53 173.75 6.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.164 0.507 . . . . 0.0 111.48 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.985 HD22 ' CE2' ' A' ' 154' ' ' TYR . 3.0 mt -151.74 126.25 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.876 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 4.1 tt -143.63 125.64 15.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.675 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 154' ' ' TYR . 7.1 p -157.05 134.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.326 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.629 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -105.94 158.62 15.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.555 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.492 ' CG2' ' C8 ' ' A' ' 185' ' ' GNP . 13.0 t -168.87 144.36 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.733 0.302 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.492 ' HG3' " C4'" ' A' ' 185' ' ' GNP . 2.3 mt-30 172.06 55.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.45 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 158' ' ' SER . 38.3 mt -52.88 -24.46 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.442 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 28.0 t70 -82.26 -55.22 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.231 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.47 ' C ' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -63.29 -40.76 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.786 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -66.25 71.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -174.97 53.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -98.45 161.24 25.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.99 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.12 -26.17 15.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.832 2.355 . . . . 0.0 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -28.71 16.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.98 -68.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.088 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.2 mp -45.36 -39.69 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.445 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -61.29 2.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.14 -35.38 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -49.7 -27.74 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 110.686 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.95 -20.36 62.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.404 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -89.92 -21.56 22.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.19 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.465 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 1.3 t-20 -88.21 -26.67 22.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.172 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 166.78 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 87.18 -175.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 1.4 tmmt? 63.22 129.03 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.5 140.18 62.0 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.429 2.086 . . . . 0.0 112.458 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG23 ' CB ' ' A' ' 141' ' ' THR . 5.9 mt -70.2 118.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.969 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.81 156.9 34.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.334 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.07 -29.46 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.293 2.662 . . . . 0.0 112.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.31 -43.74 73.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.412 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.412 ' CB ' HG23 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -46.58 -66.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.32 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.629 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -47.41 -47.69 26.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.246 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -56.39 -44.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -39.97 75.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.68 HD11 ' HD3' ' A' ' 94' ' ' LYS . 1.8 tm? -57.0 -52.34 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.599 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 112' ' ' LEU . . . -60.57 -26.45 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -81.37 -35.52 30.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.9 -52.13 8.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.254 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -94.34 30.82 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.242 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.03 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 149' ' ' LEU . . . 51.65 -176.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.156 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 152' ' ' VAL . 42.5 t -71.46 -8.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.81 152.1 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.52 0.328 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.985 ' CE2' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -153.16 151.8 30.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.088 0.471 . . . . 0.0 111.884 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.2 m -158.75 124.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.447 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.89 -178.46 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.349 0.595 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.7 p -141.77 -168.21 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -82.92 161.22 21.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 109.976 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.881 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -45.54 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.959 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -37.04 -42.72 0.43 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.057 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.6 p -86.77 171.71 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.154 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.39 89.01 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.166 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 -68.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.951 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.37 77.02 0.39 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.74 HD12 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -94.02 -32.81 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.138 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -65.66 -43.67 88.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 47.0 m-20 -51.72 -66.02 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 154' ' ' TYR . 2.1 p -42.92 -56.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.562 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 1.0 OUTLIER -52.12 -33.2 38.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 5.0 t0 -70.0 -31.14 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -88.99 -26.24 21.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.16 -24.53 21.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.988 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.643 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 15.8 mm -94.98 -57.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.1 tp -53.53 -24.67 14.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.77 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.62 -23.66 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.437 HD11 HD13 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -49.73 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.02 142.44 0.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.3 154.19 61.38 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.609 2.206 . . . . 0.0 112.243 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 171.42 16.31 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.23 151.52 81.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.22 124.42 12.9 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.197 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.23 87.21 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.932 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -60.85 -68.81 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 tt -144.03 151.43 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.8 t -136.03 130.12 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.68 HD11 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -47.17 139.47 7.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 67.6 Cg_exo -50.68 142.47 31.79 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.345 2.03 . . . . 0.0 112.189 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 166.78 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.724 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.51 110.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.762 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.5 p90 -81.08 172.73 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.305 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -130.04 135.98 48.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.9 95.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.181 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -72.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -125.24 138.88 52.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.024 0.44 . . . . 0.0 111.936 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.16 98.03 5.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.715 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 37' ' ' PHE . 61.2 t -77.65 152.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.881 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.415 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.39 177.88 24.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.152 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -77.16 124.59 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 110.788 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.595 ' CB ' HG23 ' B' ' 97' ' ' THR . 11.0 t0 -114.86 108.33 16.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.132 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.1 -19.35 62.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.2 -57.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.016 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 93' ' ' THR . 14.6 t -146.05 53.04 1.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.06 30.08 7.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' B' ' 93' ' ' THR . 17.1 pt-20 -118.21 -176.75 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.94 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -99.27 164.15 12.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.644 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.595 HG23 ' CB ' ' B' ' 90' ' ' ASP . 10.3 p -104.29 166.8 10.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 46.73 26.87 2.9 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.642 ' HE1' HD21 ' A' ' 67' ' ' LEU . 1.2 mtp -48.5 137.55 12.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.598 0.237 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.51 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 52.7 Cg_exo -53.8 151.39 26.15 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.238 1.959 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -44.63 -55.46 5.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.599 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.906 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.4 tm0? -70.84 -46.56 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.711 ' CG ' HD13 ' A' ' 70' ' ' LEU . 3.6 m0 -51.1 -57.91 7.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -53.1 -67.37 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.098 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.8 ptt85 -44.66 -40.98 6.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.397 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.906 HD23 ' OE1' ' B' ' 102' ' ' GLN . 0.1 OUTLIER -50.97 -55.08 19.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.83 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.64 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -94.46 -69.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.646 ' O ' HG23 ' B' ' 109' ' ' THR . 35.0 tt0 -79.47 -96.3 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.646 HG23 ' O ' ' B' ' 108' ' ' GLN . 16.8 p -164.07 -56.62 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.539 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.697 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -125.85 173.46 9.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.608 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' B' ' 99' ' ' MET . 0.8 OUTLIER -59.58 -55.76 30.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.563 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER -133.2 86.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.752 178.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 71.65 -62.37 0.46 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.563 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.54 38.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.408 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.2 OUTLIER 58.44 163.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.93 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.32 144.69 40.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.26 163.91 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 89.4 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.89 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.881 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.787 0.327 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.43 122.18 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.65 147.23 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.741 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.764 HD13 ' HB3' ' A' ' 176' ' ' ALA . 10.5 mt -131.46 104.18 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.274 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -102.72 96.48 6.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.744 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -80.81 122.07 26.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 71.8 t -97.69 154.05 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.5 t -120.17 166.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.389 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.759 HG11 ' HA ' ' A' ' 101' ' ' ILE . 7.4 p -157.51 121.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.45 169.28 27.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.289 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.473 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 4.0 m-20 -87.3 134.11 33.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -171.7 -45.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.95 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 77.31 -66.13 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 82' ' ' PHE . 23.4 m -48.07 -24.67 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.747 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -55.25 -91.09 0.01 OUTLIER Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.162 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 2.1 ttpm? -96.07 -72.84 0.62 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -40.51 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.95 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 69.6 m -49.52 -29.82 7.4 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.22 0.533 . . . . 0.0 110.833 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -53.0 -73.99 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.03 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.5 mt -48.46 -29.45 4.1 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.4 mm -53.69 -65.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.245 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -95.71 -17.96 20.85 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -179.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.608 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -97.24 -40.92 8.53 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.847 ' OG1' HD23 ' A' ' 20' ' ' LEU . 41.2 m -94.56 20.95 7.8 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.083 -0.386 . . . . 0.0 111.668 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.601 HG21 ' CD1' ' B' ' 81' ' ' PHE . 3.3 t -177.13 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.211 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 6.1 m120 81.2 51.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.903 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -133.93 -178.78 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.177 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -123.56 146.55 50.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.89 ' HD3' HG21 ' A' ' 21' ' ' ILE . 3.0 Cg_exo -35.62 146.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.661 2.908 . . . . 0.0 112.975 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -76.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.828 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.77 114.29 25.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.661 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.7 t80 -66.84 111.28 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.072 0.463 . . . . 0.0 111.121 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 87.8 t -159.51 131.3 4.1 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.2 Cg_exo -44.79 92.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.183 1.922 . . . . 0.0 111.451 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.871 HG23 ' CG ' ' A' ' 38' ' ' ASP . 97.8 m -50.72 88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.684 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.976 HG12 ' OH ' ' A' ' 64' ' ' TYR . 2.4 t -79.79 -42.84 22.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.8 t80 -124.76 -68.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.084 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.871 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.1 m-20 54.62 111.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.811 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.4 t-20 -106.99 160.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.038 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -148.29 162.36 39.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -178.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.09 148.06 30.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.9 m -151.61 158.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.259 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -154.93 87.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.2 m -99.49 168.22 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.418 ' HE2' ' CB ' ' B' ' 76' ' ' SER . 19.1 mtm -121.44 101.53 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' A' ' 51' ' ' TYR . 6.8 mm -93.32 90.1 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.41 20.35 60.49 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.38 34.43 8.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.558 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 21.5 mt-10 -138.62 138.65 22.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 52.8 Cg_exo -54.65 165.37 2.51 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.53 2.153 . . . . 0.0 112.297 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -152.91 136.93 16.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.6 m -135.4 97.82 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.5 pp -133.67 160.53 37.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.76 123.94 2.47 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.882 ' HB2' HD11 ' A' ' 20' ' ' LEU . 33.8 mt -75.73 117.49 17.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 3.6 m-85 -95.16 116.96 29.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 5.2 t70 -75.96 162.21 28.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.049 HG23 ' CD2' ' A' ' 64' ' ' TYR . 21.9 m -168.08 147.79 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.76 -83.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.079 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.631 ' C ' HD22 ' A' ' 61' ' ' LEU . . . 56.51 19.3 26.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.449 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 60' ' ' GLY . 1.4 mm? 63.73 51.93 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 63.47 28.43 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -125.17 22.38 7.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.049 ' CD2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -86.68 -2.55 58.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.525 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.59 -28.92 0.65 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 110.639 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -73.97 -45.36 50.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.892 HD23 HD21 ' B' ' 107' ' ' LEU . 52.4 mt -89.92 16.5 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -69.36 -59.36 5.03 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.473 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 10.5 Cg_endo -53.84 -19.64 15.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.466 2.11 . . . . 0.0 112.424 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -79.66 -27.44 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.455 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -103.83 -9.65 18.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.511 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 41.77 91.95 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.296 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.442 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 47.9 Cg_exo -55.85 -42.21 69.42 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -69.05 -10.91 59.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.59 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' TYR . 12.2 t -45.02 -48.47 11.59 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.666 0.27 . . . . 0.0 111.565 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -170.74 -159.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' LEU . 10.1 p -58.25 162.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.508 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -111.2 133.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.301 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' OH ' ' A' ' 154' ' ' TYR . 1.3 tp -104.21 116.07 31.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 58.9 t -103.34 154.59 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.416 . . . . 0.0 111.79 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 15' ' ' GLY . 23.8 p -115.2 117.69 31.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.811 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.936 ' CD1' HD21 ' A' ' 112' ' ' LEU . 9.9 t80 -99.12 165.71 11.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.608 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.588 ' HB3' HG21 ' A' ' 93' ' ' VAL . 1.5 t -83.26 136.85 34.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.473 0.654 . . . . 0.0 111.489 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 119' ' ' LEU . 98.8 t -51.68 -81.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.272 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -121.54 -96.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.734 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.732 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.1 t 39.91 93.29 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.532 ' HG3' HD12 ' A' ' 129' ' ' LEU . 84.4 Cg_exo -45.47 -26.78 2.94 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.553 2.168 . . . . 0.0 112.462 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -57.79 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.606 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -47.49 -43.05 24.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.459 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.722 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 t80 -48.13 -67.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.94 -42.43 65.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.112 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -61.39 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 90' ' ' PHE . 28.4 m -47.47 -26.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.666 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.95 -59.7 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.357 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 7.88 8.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -113.36 -41.01 3.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.629 0.252 . . . . 0.0 111.525 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.569 ' HE1' HG12 ' A' ' 93' ' ' VAL . 4.4 m95 -95.54 -43.34 8.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 101' ' ' ILE . 91.1 t -45.14 -58.23 6.01 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 13.9 Cg_endo -57.16 -17.93 27.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.437 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 -28.07 16.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -49.66 -35.6 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.3 -31.56 67.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.56 -43.3 93.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.64 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CE1' HG23 ' A' ' 9' ' ' VAL . 12.1 m80 -76.25 -64.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.207 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 24.4 p -68.32 112.73 11.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.701 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 34.0 Cg_exo -61.07 -66.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.584 2.189 . . . . 0.0 112.341 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -145.93 23.78 1.36 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.8 146.15 33.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.57 173.47 6.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.475 2.117 . . . . 0.0 111.894 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 4.8 p90 -150.28 -179.04 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 77' ' ' VAL . 2.2 mp -137.16 142.99 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.217 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD21 ' CD1' ' A' ' 82' ' ' PHE . 1.3 tp -112.86 125.98 54.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 111.473 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.841 HG13 ' OE2' ' A' ' 156' ' ' GLU . 3.5 t -106.31 135.71 43.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.413 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.04 143.55 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 84' ' ' VAL . 5.2 t -161.05 -169.79 2.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.677 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 172.49 72.57 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.773 0.32 . . . . 0.0 111.368 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 157' ' ' CYS . 14.8 mt -98.75 -67.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.941 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -42.18 18.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -53.56 -44.94 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.664 ' HD3' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -68.34 -19.94 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.37 -28.09 0.8 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.309 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.55 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -54.21 116.2 10.0 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.59 -56.17 3.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.512 2.141 . . . . 0.0 112.639 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -43.82 -39.17 3.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -57.98 -64.01 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.664 HD11 ' HD3' ' A' ' 120' ' ' ARG . 4.6 mp -57.27 -40.54 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -48.92 -38.55 23.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -89.94 -37.37 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.274 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.532 HD12 ' HG3' ' A' ' 87' ' ' PRO . 8.6 tp -48.95 -30.69 6.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.302 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.34 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.635 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -82.39 -25.77 33.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.53 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 7.3 m120 -85.1 -25.22 27.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.976 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 161.41 -23.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.567 0.542 . . . . 0.0 111.304 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 89.67 -43.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.978 0.511 . . . . 0.0 110.553 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.67 50.02 4.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.353 179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.496 ' HG2' HD11 ' A' ' 129' ' ' LEU . 73.2 Cg_endo -76.68 -47.37 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.622 2.214 . . . . 0.0 112.769 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.627 HD12 ' CD1' ' A' ' 90' ' ' PHE . 2.2 mm -106.82 136.67 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 111.211 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -159.74 155.37 22.51 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 5.2 Cg_endo -47.47 -25.29 4.97 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.708 2.272 . . . . 0.0 112.197 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 -35.36 14.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.27 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 136' ' ' PRO . 9.3 m -58.97 -50.21 74.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.007 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.58 11.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.699 ' HG3' HG13 ' A' ' 155' ' ' VAL . 1.4 tt0 -62.76 -39.04 92.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -58.93 -49.16 78.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.662 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 94' ' ' LYS . 5.1 tt -57.44 -36.1 70.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.622 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 112' ' ' LEU . . . -73.43 -23.98 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.73 -41.57 37.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -51.34 -47.3 62.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 149' ' ' LEU . 4.4 pp -70.69 -9.85 58.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.91 116.55 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.64 -176.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 111' ' ' LEU . 63.3 t -64.25 -14.51 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.571 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.638 ' O ' HD23 ' A' ' 111' ' ' LEU . 1.3 pttt 78.78 160.1 0.19 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 111.076 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.779 ' OH ' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -152.57 110.88 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.003 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.699 HG13 ' HG3' ' A' ' 143' ' ' GLU . 2.2 m -118.07 123.5 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.841 ' OE2' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -172.05 -178.33 2.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.532 ' HB2' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -130.5 166.97 19.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.251 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' HG21 ' A' ' 115' ' ' THR . 0.1 OUTLIER -88.6 99.94 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.517 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.697 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 46.22 -175.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.538 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 41.24 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.119 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 75.5 p 40.47 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.984 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.959 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 76.45 79.99 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.821 0.343 . . . . 0.0 110.991 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.67 -68.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.34 57.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.73 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.959 HD22 ' HG3' ' A' ' 162' ' ' GLN . 1.6 tp -93.74 -29.0 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -72.44 -57.4 4.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.434 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 72.4 m-80 -44.09 -56.71 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 111.12 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.42 HG13 ' HE2' ' A' ' 23' ' ' TYR . 2.4 p -55.07 -39.9 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.41 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.26 -25.62 59.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.739 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 4.4 t70 -85.14 -28.61 25.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.722 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 48.2 mm-40 -75.38 -39.58 58.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.89 -44.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.437 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 46' ' ' ILE . 28.7 mm -70.68 -62.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.362 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -54.67 -21.55 11.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.263 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -62.31 -45.52 92.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 111.265 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -75.34 -24.02 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.324 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.43 -29.08 5.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.966 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.66 142.87 46.25 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.22 148.84 69.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.568 2.179 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.7 143.59 68.95 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.554 2.169 . . . . 0.0 112.27 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 41.43 59.65 8.8 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.683 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.37 122.68 8.0 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.179 . . . . 0.0 112.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.93 119.27 32.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.5 -63.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tt -138.62 151.21 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' MET . 1.1 t -130.52 167.55 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.769 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -103.7 136.97 19.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.742 ' HG2' HG23 ' A' ' 24' ' ' THR . 51.0 Cg_exo -52.83 178.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.434 2.089 . . . . 0.0 112.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -150.75 -48.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.271 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -49.26 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 25' ' ' THR . 21.6 t80 59.5 119.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 111.04 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -153.23 127.52 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 92.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.282 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.473 ' OG1' HD12 ' B' ' 85' ' ' ILE . 70.1 p -77.22 -85.75 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.662 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -92.94 109.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.745 -179.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -98.11 96.86 8.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.924 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 59.3 t -83.18 143.23 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.652 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.57 177.82 24.65 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.069 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -99.2 125.31 44.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.467 ' CB ' HG23 ' B' ' 97' ' ' THR . 38.3 t0 -137.55 131.58 31.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.809 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 2.28 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.043 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.89 -28.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 120.892 0.377 . . . . 0.0 111.404 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.467 HG21 ' OE2' ' B' ' 95' ' ' GLU . 13.6 t -150.27 -44.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.851 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' GLY . . . . . 0.436 ' N ' HG23 ' B' ' 93' ' ' THR . . . 134.36 34.44 0.28 Allowed Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.448 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' B' ' 93' ' ' THR . 12.0 pt-20 -147.22 -166.6 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.285 . . . . 0.0 110.473 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 67' ' ' LEU . 9.0 m-85 -87.63 162.24 17.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.467 HG23 ' CB ' ' B' ' 90' ' ' ASP . 7.7 p -103.33 163.98 11.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 49.43 27.16 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.171 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -47.65 134.16 10.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.886 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.541 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 59.1 Cg_exo -53.32 142.64 56.62 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.367 2.045 . . . . 0.0 112.205 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' B' ' 102' ' ' GLN . 12.7 pt-20 -45.14 -47.89 12.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.919 0.39 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -69.54 -54.39 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.51 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 70' ' ' LEU . 18.7 m0 -53.15 -61.47 2.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -43.13 -67.69 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.594 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 17.4 mtt85 -48.1 -41.76 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.034 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.71 -56.68 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.78 -70.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.252 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.705 ' O ' HG23 ' B' ' 109' ' ' THR . 7.2 tt0 -79.05 -96.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.684 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.705 HG23 ' O ' ' B' ' 108' ' ' GLN . 9.3 p -165.68 -55.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.758 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 15.8 m -126.02 -179.32 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.429 ' ND2' ' HG3' ' B' ' 116' ' ' GLU . 0.7 OUTLIER -66.77 -59.66 3.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.875 HG22 ' O ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -138.74 86.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.554 177.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 112' ' ' ILE . 7.3 t 49.69 33.16 5.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.296 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 113' ' ' THR . 1.9 tttp 85.42 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.646 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.875 ' O ' HG22 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -165.56 117.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.006 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.429 ' HG3' ' ND2' ' B' ' 111' ' ' ASN . 3.4 tt0 -118.15 54.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.05 152.95 32.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.9 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.573 " H2'" ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.805 0.336 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -124.81 125.55 44.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 111.68 23.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' HB1' ' A' ' 176' ' ' ALA . 2.1 mt -129.22 132.23 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.265 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -113.57 157.46 22.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.397 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -128.74 112.97 14.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 73' ' ' PRO . 10.7 t -87.04 98.67 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 16' ' ' LYS . 22.5 m -114.4 145.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.597 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 58' ' ' THR . 32.8 m -137.94 121.34 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.54 167.41 38.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.852 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.09 -62.48 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.057 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.69 -137.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.597 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 187' ' ' HOH . . . -173.27 30.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.838 HG11 ' HA2' ' A' ' 114' ' ' GLY . 2.8 t -65.14 -12.52 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . -120.25 -24.84 2.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.644 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.643 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.21 -74.36 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.423 0.612 . . . . 0.0 112.159 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.909 HG21 ' O ' ' A' ' 188' ' ' HOH . 25.8 m -77.92 -63.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.706 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 13.0 m -49.09 -45.5 43.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.079 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.685 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.4 tm? -39.73 -72.65 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.213 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 19' ' ' LEU . 16.8 mt -61.99 -19.27 62.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.602 0.239 . . . . 0.0 111.205 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 25' ' ' THR . 1.0 OUTLIER -67.97 -48.22 75.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.357 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.463 ' OG ' ' C8 ' ' A' ' 185' ' ' GNP . 39.0 m -93.28 -20.54 20.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.662 0.268 . . . . 0.0 111.239 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.736 ' CE1' HD22 ' A' ' 165' ' ' LEU . 4.4 m-30 -84.0 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.83 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 42' ' ' VAL . 85.0 m -87.75 -83.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.238 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -49.12 -26.98 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.257 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 p-10 47.19 41.97 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 110.821 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -132.51 134.89 45.56 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -59.49 154.36 44.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 57.9 Cg_exo -34.9 145.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.18 2.587 . . . . 0.0 113.221 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.02 -83.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -100.93 115.67 30.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.92 103.5 4.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HD2' ' A' ' 34' ' ' PRO . 66.1 t -152.98 139.43 12.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD2' HG13 ' A' ' 33' ' ' VAL . 98.6 Cg_exo -42.02 92.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.5 2.133 . . . . 0.0 111.737 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.712 HG23 ' CG ' ' A' ' 38' ' ' ASP . 72.7 m -52.97 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.552 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.838 HG11 ' CD2' ' B' ' 96' ' ' PHE . 23.8 t -74.99 -32.74 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' HG21 ' B' ' 87' ' ' VAL . 3.2 t80 -144.96 -66.28 0.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.729 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.712 ' CG ' HG23 ' A' ' 35' ' ' THR . 4.4 m-20 55.18 108.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.391 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.513 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 46.9 t-20 -107.63 157.21 18.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.008 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.93 167.71 26.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.952 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 82' ' ' GLU . . . -123.12 156.98 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 53' ' ' LEU . 15.6 m -160.71 147.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.087 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.3 m -124.08 101.41 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.543 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 173' ' ' ILE . 15.8 m -98.61 141.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.5 mtm -105.18 100.19 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.738 HD13 ' CE1' ' A' ' 51' ' ' TYR . 5.1 mp -104.77 92.78 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.73 16.69 61.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.395 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.98 38.8 6.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.603 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 20.1 mt-10 -141.64 139.17 18.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.656 0.265 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.1 168.07 14.79 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.642 2.228 . . . . 0.0 112.387 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.738 ' CE1' HD13 ' A' ' 46' ' ' ILE . 4.9 m-85 -152.08 160.75 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.289 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -136.06 97.4 3.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.233 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 42' ' ' VAL . 7.7 tt -132.59 160.55 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.207 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.7 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -156.42 139.88 6.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 79' ' ' LEU . 1.1 mt -79.33 104.13 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.057 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' ' HD2' ' A' ' 5' ' ' LYS . 4.2 m-85 -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' OD2' HG21 ' A' ' 35' ' ' THR . 4.8 t0 -71.38 -169.46 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.746 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 9' ' ' VAL . 4.0 m -166.99 163.57 15.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . . . -92.79 -74.69 0.51 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.936 ' O ' HD13 ' A' ' 61' ' ' LEU . . . 131.74 61.57 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.851 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -132.31 -168.57 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.98 86.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 3.4 t0 76.03 43.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.041 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 5.0 t80 50.63 35.72 12.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.1 -152.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 18.8 mmt180 -87.52 -1.39 57.91 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.132 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.821 ' CG ' HD12 ' A' ' 70' ' ' LEU . 4.1 mp -81.97 58.28 3.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -63.59 -70.06 0.51 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.7 Cg_endo -68.23 -22.5 40.27 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.026 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.821 HD12 ' CG ' ' A' ' 67' ' ' LEU . 3.9 mt -57.48 -20.65 32.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.022 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.08 -34.12 6.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.541 ' CG ' ' HB ' ' A' ' 75' ' ' THR . 1.0 OUTLIER 66.04 76.33 0.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.673 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.926 ' HA ' HG21 ' A' ' 7' ' ' VAL . 77.8 Cg_exo -50.58 -55.18 4.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.854 2.369 . . . . 0.0 112.974 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -67.46 -8.04 30.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.774 HG22 HG23 ' A' ' 7' ' ' VAL . 8.8 t -33.05 -53.94 0.37 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER 170.47 -161.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.802 0.335 . . . . 0.0 111.024 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.92 HG22 ' HG2' ' A' ' 109' ' ' PRO . 66.2 t -58.98 150.28 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 39.1 p90 -139.93 128.74 23.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.901 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 55' ' ' LEU . 1.8 pt? -103.77 116.23 31.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 9' ' ' VAL . 10.1 t -94.24 154.53 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.482 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.7 p -67.08 171.84 5.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.355 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 t80 -163.78 105.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.81 0.338 . . . . 0.0 111.335 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -58.63 111.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.759 HG13 HG21 ' A' ' 137' ' ' ILE . 90.8 t -103.02 87.21 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 111.164 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.781 HG11 HD22 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 169.12 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.481 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.719 ' N ' HG22 ' A' ' 85' ' ' VAL . 68.2 m -46.99 103.59 0.37 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 111.025 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.62 -40.12 80.46 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.48 2.12 . . . . 0.0 112.363 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.8 t -53.6 -25.33 17.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.029 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 -36.7 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.025 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -49.35 -60.13 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.86 -31.9 73.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.6 m-20 -69.29 -61.9 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.744 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 29.9 m -48.73 -36.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.313 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -61.31 -63.07 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -82.68 8.01 13.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.895 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.9 tttt -117.23 -36.53 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.674 0.274 . . . . 0.0 111.338 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.744 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 28.5 m0 -93.38 -41.55 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.261 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.4 t -48.91 -57.96 9.86 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.3 Cg_endo -59.11 -18.04 41.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 112.305 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -84.76 -51.24 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.851 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 7.6 pt -51.29 -24.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.1 p -74.78 -28.99 60.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.362 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -70.87 -35.14 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.529 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.537 ' ND1' HG11 ' A' ' 9' ' ' VAL . 5.8 m80 -107.71 -2.43 20.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.739 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 3.5 m -149.62 58.03 3.09 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.63 55.9 5.07 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.747 2.298 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt 176.9 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.364 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 t -73.17 146.07 86.6 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.92 ' HG2' HG22 ' A' ' 77' ' ' VAL . 20.0 Cg_endo -60.29 178.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.644 2.229 . . . . 0.0 111.961 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 33.6 p90 -137.31 158.79 43.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD21 ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -135.14 127.53 30.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.475 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -104.31 101.38 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.064 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG12 ' OE1' ' A' ' 156' ' ' GLU . 3.5 m -107.43 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.838 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -168.74 159.13 32.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.805 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.873 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -167.89 -64.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 0.0 110.756 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 119' ' ' LEU . 0.2 OUTLIER 48.86 60.43 3.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.007 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 157' ' ' CYS . 9.1 mt -65.71 -31.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.821 ' HB3' HD23 ' A' ' 160' ' ' LEU . 11.9 p-10 -81.75 -49.15 10.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 85' ' ' VAL . 9.3 tt -49.65 -49.19 48.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.789 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.0 t0 75.96 31.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.668 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -93.73 157.32 38.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.35 -39.75 5.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -25.75 59.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.9 m -56.21 -68.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -46.81 -40.86 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.415 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -62.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.12 -34.83 68.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -50.3 -25.86 4.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.418 . . . . 0.0 110.706 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.76 46.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.39 26.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.082 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.411 ' HB3' ' HD3' ' A' ' 133' ' ' LYS . 11.4 m120 -93.02 -30.0 15.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -175.01 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 169.02 146.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 129' ' ' LEU . 5.8 mmmt 60.61 145.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 140.97 70.57 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 84' ' ' VAL . 4.3 mt -50.71 126.3 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -98.75 167.3 11.61 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.338 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' HG23 ' A' ' 115' ' ' THR . 52.1 Cg_exo -53.39 -22.98 22.57 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.827 2.351 . . . . 0.0 112.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.22 -35.67 14.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.488 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.479 ' CG2' HG23 ' A' ' 137' ' ' ILE . 22.9 m -46.45 -42.5 15.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.057 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -51.29 56.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 6.1 tm-20 -54.57 -38.79 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -52.12 -55.87 18.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.287 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 145' ' ' LEU . 3.9 tt -54.33 -32.67 57.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.069 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.929 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.51 -49.75 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.664 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.606 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -25.43 58.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.0 pp -122.65 19.89 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.21 -83.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 176.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 152' ' ' VAL . 78.7 t -76.02 -7.35 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.78 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.457 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER 82.85 141.35 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.694 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.929 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 5.8 p90 -153.21 153.4 32.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.799 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.0 m -158.56 123.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.413 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.429 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -165.75 157.97 14.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.993 0.425 . . . . 0.0 111.482 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.873 ' HA ' HG21 ' A' ' 115' ' ' THR . 1.8 m -119.01 -173.51 2.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.172 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.459 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -86.29 152.68 22.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.507 -179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.58 ' HB2' " H1'" ' A' ' 185' ' ' GNP . . . -40.48 -76.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.567 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -36.05 -33.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.652 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -82.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 63.41 97.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -65.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.06 75.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.685 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.736 HD22 ' CE1' ' A' ' 23' ' ' TYR . 4.5 pp -93.13 -10.15 36.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.771 0.32 . . . . 0.0 111.377 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -49.77 -26.33 3.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.851 0.358 . . . . 0.0 110.179 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.99 -51.28 68.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 155' ' ' VAL . 98.6 t -53.7 -49.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.31 -33.36 73.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.314 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.504 ' CG ' HG21 ' B' ' 75' ' ' ILE . 63.6 t0 -68.85 -36.94 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.76 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -44.83 27.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.59 62.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 44' ' ' VAL . 16.7 mt -82.62 -43.76 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.2 -52.78 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -51.46 -33.14 29.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -90.83 -26.96 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -49.94 -51.25 42.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 60.68 87.44 0.13 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 75.8 Cg_exo -49.68 143.14 23.08 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.532 2.155 . . . . 0.0 112.218 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 179' ' ' PRO . 53.4 Cg_exo -52.14 132.51 43.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 112.268 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.442 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 3.4 mt-10 -71.13 -51.37 10.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 69.5 Cg_exo -50.99 -175.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.61 2.206 . . . . 0.0 112.244 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 164.06 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.0 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.849 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 62.9 m -50.29 -80.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.625 HD11 ' CD1' ' A' ' 173' ' ' ILE . 5.9 tt -119.6 151.95 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.194 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -134.14 165.64 24.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -87.87 137.93 31.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 44' ' ' VAL . 38.4 Cg_endo -66.68 -167.46 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.613 2.209 . . . . 0.0 112.131 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.421 ' O ' ' N ' ' B' ' 81' ' ' PHE . 81.1 p -168.34 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.43 78.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 86.2 t80 -74.66 152.01 39.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.62 96.3 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.606 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -68.96 69.75 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.161 0.505 . . . . 0.0 109.662 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.554 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -43.79 -85.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.794 HG21 ' N ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -112.59 130.79 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -111.63 97.15 6.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.387 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 37' ' ' PHE . 16.6 t -77.84 157.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 112.047 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.27 177.89 24.32 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -112.16 123.01 49.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.526 ' CB ' HG21 ' B' ' 97' ' ' THR . 14.8 t0 -140.26 127.84 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.733 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.59 -5.8 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.793 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.803 HG13 HG23 ' B' ' 93' ' ' THR . 7.6 p -43.59 -29.09 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-O 120.802 0.334 . . . . 0.0 111.656 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.803 HG23 HG13 ' B' ' 92' ' ' VAL . 3.5 p -153.89 24.3 0.5 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.55 37.22 74.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.83 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.82 179.8 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.722 0.296 . . . . 0.0 110.878 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.838 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -74.76 164.13 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.526 HG21 ' CB ' ' B' ' 90' ' ' ASP . 27.1 p -126.6 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.163 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' B' ' 111' ' ' ASN . . . 51.72 29.67 26.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.58 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.73 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -74.4 164.77 58.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.081 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.794 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.0 Cg_exo -53.78 142.23 63.11 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.707 2.272 . . . . 0.0 112.343 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -45.71 -60.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -50.34 72.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.61 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.787 ' CE3' HD23 ' A' ' 67' ' ' LEU . 6.2 m0 -46.8 -63.38 1.04 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 110.411 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -51.01 -60.06 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 31.2 mtt-85 -48.77 -41.04 31.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.136 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.691 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.02 -56.73 8.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.47 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -95.06 -68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.062 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.742 ' O ' HG23 ' B' ' 109' ' ' THR . 4.8 tp-100 -77.87 -101.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.338 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.742 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.0 p -167.08 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.337 0.061 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.679 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 5.0 m -140.42 172.77 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.7 OUTLIER -56.96 -67.21 0.34 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.768 HG23 ' HB2' ' B' ' 115' ' ' SER . 0.5 OUTLIER -138.85 85.95 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 177.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' B' ' 114' ' ' LYS . 1.3 m 57.76 33.38 23.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.506 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' B' ' 113' ' ' THR . 15.1 ttmt 82.34 67.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.768 ' HB2' HG23 ' B' ' 112' ' ' ILE . 0.1 OUTLIER -141.12 124.69 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.32 -51.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -124.63 127.22 47.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.964 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.58 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.798 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.909 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -71.2 132.65 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 m -94.24 112.81 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' HB1' ' A' ' 176' ' ' ALA . 2.9 mt -114.92 133.09 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 104.34 7.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' HB3' HD23 ' A' ' 79' ' ' LEU . 14.3 m -77.33 99.06 5.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.665 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.73 HG11 ' CE1' ' A' ' 104' ' ' HIS . 10.8 t -84.61 159.45 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 79' ' ' LEU . 58.4 t -130.47 148.73 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 101' ' ' ILE . 12.6 p -138.41 132.64 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.92 146.11 17.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.631 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -72.05 126.22 29.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.89 -42.16 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.603 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.544 ' HB1' ' PB ' ' A' ' 185' ' ' GNP . . . 47.8 38.9 9.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 83' ' ' SER . 1.9 t -109.27 -14.01 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.77 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -135.67 -55.3 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -43.11 -66.26 0.39 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.171 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.742 HG21 ' O ' ' A' ' 187' ' ' HOH . 88.7 m -95.15 -50.53 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -50.5 -44.39 56.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.326 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 55' ' ' LEU . 18.1 tp -50.09 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.003 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.083 HD21 HD13 ' A' ' 55' ' ' LEU . 3.9 mt -51.14 -29.95 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 120.653 0.263 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -55.71 -69.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.353 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.529 ' HB3' HN22 ' A' ' 185' ' ' GNP . 0.3 OUTLIER -90.79 -10.49 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.757 ' CD2' HD12 ' A' ' 165' ' ' LEU . 7.7 t80 -95.37 -59.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.677 HG21 ' CG1' ' A' ' 42' ' ' VAL . 63.5 m -73.67 -45.61 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.333 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -113.97 3.83 15.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.5 p30 43.38 58.06 3.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 111.741 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.8 pttt -134.0 -164.74 1.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.511 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.528 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -134.21 166.45 29.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 46.5 Cg_exo -36.02 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.147 2.565 . . . . 0.0 113.47 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.64 -85.22 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.368 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.709 0.29 . . . . 0.0 110.286 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.1 t80 -80.91 106.39 12.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 111.623 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' THR . 12.7 m -158.99 145.3 12.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.093 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 36' ' ' VAL . 81.2 Cg_exo -44.73 88.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.825 HG23 ' CG ' ' A' ' 38' ' ' ASP . 66.0 m -55.19 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.386 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG11 ' CZ ' ' B' ' 96' ' ' PHE . 3.6 t -84.34 -21.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.651 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.2 t80 -147.96 -65.36 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.627 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.825 ' CG ' HG23 ' A' ' 35' ' ' THR . 7.4 m-20 54.33 109.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.271 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB3' HD12 ' B' ' 85' ' ' ILE . 28.0 t-20 -106.88 147.99 29.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.12 0.486 . . . . 0.0 110.968 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.629 ' CG ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -139.07 169.2 18.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.785 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -111.81 141.55 45.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.306 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.677 ' CG1' HG21 ' A' ' 24' ' ' THR . 2.4 m -162.83 159.57 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.35 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 51' ' ' TYR . 54.8 m -145.37 104.41 3.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.175 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.075 HG11 HD13 ' A' ' 173' ' ' ILE . 42.2 t -98.27 117.51 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.6 mtm -76.68 99.96 5.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.683 HD11 ' CG2' ' A' ' 173' ' ' ILE . 66.0 mt -92.96 89.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.0 70.12 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.572 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.53 -17.82 30.51 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.859 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -91.29 138.85 25.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.66 0.267 . . . . 0.0 111.112 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -68.73 166.49 25.95 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.625 2.217 . . . . 0.0 112.341 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 43' ' ' THR . 23.1 m-85 -153.94 173.73 15.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 97.26 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -101.68 161.31 13.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -159.82 118.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.425 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.083 HD13 HD21 ' A' ' 20' ' ' LEU . 5.5 mp -75.88 105.62 7.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.362 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -83.23 103.46 12.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.036 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.8 OUTLIER -75.67 172.68 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.739 HG23 ' CE1' ' A' ' 64' ' ' TYR . 2.2 m -167.05 171.37 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . . . -102.48 -161.07 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 61' ' ' LEU . . . -60.18 -16.08 39.98 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.75 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD13 HG23 ' A' ' 9' ' ' VAL . 1.5 tp 80.17 132.58 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 0.0 111.228 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 35.9 tt0 169.86 -34.91 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.593 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -116.21 -12.41 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.712 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.739 ' CE1' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -48.83 -33.96 11.54 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -47.49 -28.07 2.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.053 0.454 . . . . 0.0 110.424 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -82.04 -46.77 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.234 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.023 HD22 ' CE2' ' B' ' 96' ' ' PHE . 1.4 mp -92.49 49.56 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -99.65 -31.17 0.23 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 28.0 Cg_exo -37.14 -49.8 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.486 2.124 . . . . 0.0 114.025 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' B' ' 103' ' ' TRP . 0.1 OUTLIER -94.8 32.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 72' ' ' TYR . 4.4 p -134.04 -52.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.6 OUTLIER 41.56 98.89 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.805 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 105' ' ' CYS . 82.3 Cg_exo -45.62 -34.63 11.62 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.523 2.149 . . . . 0.0 112.579 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.93 -10.37 52.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.591 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 13.7 t -37.66 -49.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 165.79 -165.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.678 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 109' ' ' PRO . 10.9 p -64.84 125.69 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.766 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CD1' ' CB ' ' A' ' 105' ' ' CYS . 42.4 p90 -96.54 133.81 40.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.587 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 8' ' ' VAL . 2.2 pp -103.59 116.05 31.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.1 t -94.99 154.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 15' ' ' GLY . 5.8 p -111.5 160.0 17.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 111.385 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 82' ' ' PHE . 40.7 p90 -152.66 103.9 2.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 14' ' ' VAL . 22.8 t -54.5 118.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.001 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -88.74 81.86 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.223 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' HD22 ' A' ' 119' ' ' LEU . 1.6 m -131.68 79.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.456 ' C ' HD11 ' A' ' 137' ' ' ILE . 5.5 m 71.23 151.08 0.14 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' N ' HD11 ' A' ' 137' ' ' ILE . 55.1 Cg_exo -52.15 -22.03 14.18 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.541 2.161 . . . . 0.0 112.419 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -52.49 -32.43 40.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -91.09 -30.83 16.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.016 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -47.55 -65.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.17 -28.43 67.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 23.2 m-20 -69.84 -84.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 89' ' ' SER . 2.3 m -43.75 -29.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.693 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 12.6 tttt -70.57 -69.39 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -81.44 7.63 11.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.064 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.1 -42.59 3.92 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.413 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.743 ' CD1' HG12 ' A' ' 93' ' ' VAL . 12.7 m95 -95.27 -43.36 8.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 68.7 t -48.41 -44.36 64.23 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.57 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 48.0 Cg_exo -55.68 -23.43 40.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.017 1.811 . . . . 0.0 112.166 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -93.53 -30.01 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.854 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.882 ' HA ' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -49.43 -26.41 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.138 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.418 ' N ' HG13 ' A' ' 101' ' ' ILE . 19.6 p -77.4 -32.13 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -64.54 -49.6 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.73 ' CE1' HG11 ' A' ' 7' ' ' VAL . 55.4 t-80 -65.54 -66.94 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.53 ' CB ' ' CD1' ' A' ' 78' ' ' PHE . 1.2 m -104.5 90.83 3.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 42.9 Cg_endo -67.92 118.04 5.33 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.675 2.25 . . . . 0.0 112.572 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.3 51.99 15.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.235 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.709 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.3 OUTLIER -132.87 144.09 51.41 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.709 ' HD2' HG22 ' A' ' 108' ' ' THR . 99.2 Cg_exo -42.0 147.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.512 2.141 . . . . 0.0 112.102 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.7 p90 -139.41 139.38 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -126.93 119.81 27.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.42 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 1.8 mt -90.34 102.12 14.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.72 96.75 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 14' ' ' VAL . . . -117.61 -119.42 2.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.798 HG21 ' HA ' ' A' ' 157' ' ' CYS . 20.2 m 69.11 167.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 111.438 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.492 ' OE1' HD13 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 176.43 112.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.484 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 157' ' ' CYS . 54.4 mt -91.82 -22.61 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.411 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.83 -44.23 7.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.469 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.533 HD22 ' CG1' ' A' ' 85' ' ' VAL . 1.9 tt -74.7 -47.87 29.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -48.99 -29.39 4.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.107 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.96 51.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 126' ' ' ILE . 11.3 m-20 -114.23 142.06 27.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.39 -21.64 18.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.552 2.168 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -43.17 57.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 p -56.36 -62.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -48.54 -46.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.41 -58.78 3.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.24 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -36.12 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.906 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -26.43 3.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.39 64.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -85.32 -41.5 15.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -61.39 -23.37 65.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.99 64.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.19 -171.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 167.6 9.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.15 120.93 6.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.538 2.158 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 87' ' ' PRO . 7.8 mt -56.61 121.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.235 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -117.96 164.8 18.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.833 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 115' ' ' THR . 75.3 Cg_exo -49.16 -26.21 10.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.568 2.179 . . . . 0.0 112.311 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.78 -51.05 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.6 m -54.87 -55.79 26.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.11 -49.18 52.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' CD ' HG12 ' A' ' 155' ' ' VAL . 7.9 mt-10 -54.61 -42.09 70.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -46.85 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.689 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.832 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -55.98 -48.72 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.867 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.81 68.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -70.36 -43.59 69.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.769 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -59.44 -26.25 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.6 pp -103.15 -23.26 13.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.999 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 149' ' ' LEU . 26.4 tptt 60.25 116.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -162.08 -161.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.299 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 111' ' ' LEU . 9.2 p -44.93 -43.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.494 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 89.95 145.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.452 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.495 ' O ' HG13 ' A' ' 155' ' ' VAL . 48.8 p90 -153.05 150.97 29.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.885 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.604 HG12 ' CD ' ' A' ' 143' ' ' GLU . 8.4 m -158.36 122.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.434 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.671 ' CG ' HG11 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -172.04 124.74 0.53 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.553 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.798 ' HA ' HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -128.51 119.52 25.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.71 ' OG ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -156.99 175.19 14.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.386 0.612 . . . . 0.0 112.497 -177.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.823 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 136.15 88.93 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.899 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.823 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 58.73 26.01 14.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 p -147.85 -72.08 0.21 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.815 ' OE1' HD11 ' A' ' 165' ' ' LEU . 3.2 mt-30 75.51 114.12 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.248 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 3.4 tttt -105.9 -45.12 4.45 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.11 71.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.621 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.815 HD11 ' OE1' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -95.05 -16.91 22.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.973 0.416 . . . . 0.0 111.25 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.414 ' HA ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.32 -24.92 2.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 13.7 m120 -71.79 -61.38 1.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.478 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 156' ' ' GLU . 11.4 p -45.52 -32.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.781 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.1 t80 -77.04 -35.28 56.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.853 ' CG ' HD12 ' B' ' 75' ' ' ILE . 3.8 t70 -58.25 -35.52 71.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.357 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 6.7 mm-40 -76.14 -44.5 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.777 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.98 64.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.989 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 1.075 HD13 HG11 ' A' ' 44' ' ' VAL . 5.1 mt -93.63 -54.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -59.8 -29.73 68.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -54.87 -33.72 62.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.95 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 4' ' ' ILE . . . -80.23 -23.51 40.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.68 42.04 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 179' ' ' PRO . 4.3 pt-20 -55.9 110.73 2.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 178' ' ' GLU . 33.2 Cg_endo -64.21 157.01 56.17 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.96 171.21 11.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.76 112.57 5.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.32 114.11 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.44 2.093 . . . . 0.0 112.143 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.56 101.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.1 tttp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.965 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 75' ' ' ILE . 5.2 p 69.7 -62.19 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 170' ' ' ASP . 8.6 mt -144.1 137.21 23.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.55 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.4 m -131.59 152.48 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.99 145.92 99.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.745 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.471 ' HB2' HG23 ' A' ' 24' ' ' THR . 61.0 Cg_exo -52.65 -167.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.552 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 84.3 p -149.67 -79.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.85 119.7 12.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.62 ' HB2' HG22 ' A' ' 24' ' ' THR . 12.8 t80 -132.78 130.23 39.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.658 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.33 136.45 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 90.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -81.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.59 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.654 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.1 mp -115.59 110.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.78 0.324 . . . . 0.0 111.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 86' ' ' HIS . 8.7 p80 -85.4 96.84 9.69 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.0 t -87.83 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.225 0.536 . . . . 0.0 112.304 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' B' ' 96' ' ' PHE . . . -142.61 177.8 21.49 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.362 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 2.6 t80 -101.05 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.3 0.55 . . . . 0.0 111.141 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.855 ' HB2' HG23 ' B' ' 97' ' ' THR . 9.0 t0 -140.47 114.48 9.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.622 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.73 -5.17 31.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.973 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 1.076 HG13 HG22 ' B' ' 93' ' ' THR . 14.7 p -45.74 -28.24 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.859 0.362 . . . . 0.0 111.176 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' THR . . . . . 1.076 HG22 HG13 ' B' ' 92' ' ' VAL . 0.0 OUTLIER -149.25 18.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.08 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.59 17.44 64.61 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.901 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.887 ' HG2' HG23 ' B' ' 93' ' ' THR . 18.6 pt-20 -128.62 -163.28 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.719 0.295 . . . . 0.0 110.708 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 1.023 ' CE2' HD22 ' A' ' 67' ' ' LEU . 6.6 m-30 -96.04 164.62 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.855 HG23 ' HB2' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -95.69 136.39 36.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.437 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 49.12 36.91 22.46 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.995 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -77.56 165.63 49.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.243 0.544 . . . . 0.0 112.31 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.654 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.5 Cg_exo -54.69 141.6 75.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.116 2.544 . . . . 0.0 112.26 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -56.02 -22.25 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 110.399 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.786 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.77 -64.73 0.81 Allowed 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.995 ' CG ' HD11 ' A' ' 70' ' ' LEU . 4.7 m0 -51.44 -60.09 3.52 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.437 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.834 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -40.51 -65.25 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 21.7 mtp85 -62.68 -35.48 79.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.768 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.593 HD23 ' O ' ' B' ' 102' ' ' GLN . 0.9 OUTLIER -49.64 -55.49 13.5 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -96.43 -72.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.138 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.47 ' C ' HG22 ' B' ' 109' ' ' THR . 5.4 tp-100 -82.67 -105.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.565 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' B' ' 105' ' ' ARG . 1.4 t 156.03 58.77 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.194 0.598 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.834 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER 172.02 126.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.972 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 15.0 m120 -50.49 -70.49 0.08 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.611 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER -121.25 85.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' B' ' 114' ' ' LYS . 9.4 t 45.18 25.35 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.268 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' B' ' 113' ' ' THR . 2.4 mttp 157.36 74.23 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.635 0.374 . . . . 0.0 110.703 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' B' ' 110' ' ' SER . 3.9 p -37.64 135.15 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.804 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -165.64 69.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.32 138.88 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.574 HN21 ' CD1' ' A' ' 165' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.742 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.15 121.35 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.81 120.47 40.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.61 130.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' O ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -135.83 96.61 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.965 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 77' ' ' VAL . 8.2 m -80.35 147.01 31.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 8' ' ' VAL . 4.4 t -122.16 159.88 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.431 . . . . 0.0 111.669 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.749 HG11 ' HA3' ' A' ' 15' ' ' GLY . 6.5 m -123.0 169.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.795 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 58' ' ' THR . 11.1 m -157.51 120.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.014 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 145.17 -161.78 28.15 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.702 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -118.25 169.26 9.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.733 0.301 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 90.54 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.223 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.588 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . 53.47 71.7 0.48 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.742 0.306 . . . . 0.0 110.244 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.674 HG23 HG21 ' A' ' 8' ' ' VAL . 1.6 m -47.07 -25.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.749 ' HA3' HG11 ' A' ' 8' ' ' VAL . . . 140.85 -40.45 1.36 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.577 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -97.46 -74.23 0.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.919 ' O ' HD13 ' A' ' 21' ' ' ILE . 5.1 t -35.37 -51.81 0.61 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.687 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.26 -45.99 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.726 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.766 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -59.36 -68.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.48 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 55' ' ' LEU . 17.7 mt -40.71 -45.38 2.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.159 0.504 . . . . 0.0 111.148 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -46.26 -70.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.547 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.63 ' N ' HG22 ' A' ' 21' ' ' ILE . 14.5 t -95.2 -60.76 1.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.243 0.544 . . . . 0.0 111.564 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.766 ' CD1' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -44.43 -26.63 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.929 -178.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.612 HG21 HG11 ' A' ' 42' ' ' VAL . 99.1 m -109.16 -89.92 0.47 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.195 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 27' ' ' LYS . 1.4 t -64.14 -19.91 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.697 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.7 t30 70.41 32.75 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.355 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' A' ' 25' ' ' THR . 4.9 ttpt -127.9 138.04 52.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' CZ ' " O3'" ' A' ' 185' ' ' GNP . 1.6 m-85 -81.67 149.29 63.88 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.736 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.11 153.89 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.788 2.326 . . . . 0.0 112.723 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -108.06 -71.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.67 109.76 17.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.608 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.83 92.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 73.3 t -138.1 131.29 16.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.426 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 97.9 Cg_exo -42.26 93.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 111.837 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.932 HG23 ' HB2' ' A' ' 38' ' ' ASP . 81.5 m -51.48 87.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.38 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 96' ' ' PHE . 93.8 t -77.05 -37.43 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.755 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.7 t80 -136.38 -63.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.745 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.932 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.5 t0 56.25 114.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.596 ' HB3' HD12 ' B' ' 85' ' ' ILE . 10.5 t-20 -108.11 153.09 23.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.379 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.616 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -144.33 169.25 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 0.0 111.343 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.66 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -110.07 138.08 46.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 41' ' ' ALA . 2.3 m -162.37 139.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.302 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 51' ' ' TYR . 51.6 m -132.71 110.85 10.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.188 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 HD11 ' B' ' 75' ' ' ILE . 60.6 t -98.07 117.07 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mtm -94.42 100.28 12.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.129 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.77 HD11 ' CG2' ' A' ' 173' ' ' ILE . 8.6 mt -93.13 114.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 17.94 78.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.02 29.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.524 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.09 130.41 63.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.504 0.192 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.11 160.38 42.78 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.595 2.197 . . . . 0.0 112.405 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.927 ' O ' HG23 ' A' ' 43' ' ' THR . 36.2 m-85 -146.74 165.19 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.157 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -121.11 97.67 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.497 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.892 HD21 ' CD2' ' A' ' 55' ' ' LEU . 7.2 tt -113.79 157.23 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.732 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.9 113.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 20' ' ' LEU . 2.3 mt -90.32 117.19 28.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.389 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -89.27 144.53 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.063 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD2' HG21 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -104.44 -163.69 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.904 0.383 . . . . 0.0 111.536 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.56 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.2 m -153.53 161.04 42.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 58' ' ' THR . . . -61.45 -49.93 74.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.45 -22.85 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.366 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.672 HD13 ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -115.55 176.37 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.784 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 100' ' ' GLU . 1.8 mp0 -81.94 67.75 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.672 ' OD1' HD13 ' A' ' 61' ' ' LEU . 6.0 m-20 -132.08 19.4 4.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CD1' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -89.61 -10.37 46.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.253 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.15 -31.02 0.86 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.834 0.35 . . . . 0.0 111.022 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -71.9 -39.76 69.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.476 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.056 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 23.5 mt -90.09 6.54 42.01 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.299 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -47.74 -43.02 49.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_exo -60.5 -19.0 57.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.209 1.939 . . . . 0.0 112.021 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.938 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -106.5 -48.22 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.817 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 33.75 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -41.04 153.73 0.23 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.463 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' HIS . 97.7 Cg_endo -84.74 -25.27 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.743 2.295 . . . . 0.0 112.774 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -65.51 -11.19 41.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.739 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 5' ' ' LYS . 2.5 t -42.99 -54.18 4.39 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER 178.45 -152.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.774 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -57.42 158.22 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.681 0.277 . . . . 0.0 110.676 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 77' ' ' VAL . 1.4 m-85 -115.47 145.79 42.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.69 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 mm? -104.05 135.7 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.846 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 101' ' ' ILE . 3.0 t -115.56 153.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.981 0.419 . . . . 0.0 111.729 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 23.0 p -110.05 155.28 22.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.845 ' HA ' HG11 ' A' ' 93' ' ' VAL . 30.9 p90 -178.9 109.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -54.28 -170.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.563 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 85' ' ' VAL . 26.9 m -152.06 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.429 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -47.18 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.474 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.468 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.6 m -68.43 110.72 6.27 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.498 0.19 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' CG ' HD22 ' A' ' 129' ' ' LEU . 34.2 Cg_exo -57.79 -21.87 50.45 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.527 2.152 . . . . 0.0 112.389 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -30.62 46.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.162 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 m -92.98 -26.99 17.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -48.73 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.197 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.62 -43.64 36.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -54.87 -69.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 82' ' ' PHE . 93.2 t -39.66 -44.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.933 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.74 -69.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.673 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.74 8.23 8.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -116.76 -43.72 2.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.715 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.609 ' HD1' HG13 ' A' ' 93' ' ' VAL . 13.8 m95 -95.64 -39.09 10.08 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.5 t -51.63 -45.47 91.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.489 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.3 Cg_exo -46.45 -38.44 21.04 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.359 2.039 . . . . 0.0 112.359 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.977 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 80' ' ' VAL . 19.6 mm -49.28 -26.66 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 p -90.34 -22.4 21.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -69.14 -37.31 78.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.673 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 73' ' ' PRO . 32.7 m-70 -103.71 -70.6 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.662 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.78 108.73 1.51 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.43 -65.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.25 28.42 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.842 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -95.61 148.16 34.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . 53.1 Cg_exo -53.71 161.61 4.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.523 2.148 . . . . 0.0 112.157 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -128.0 126.14 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 111.073 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.603 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -105.08 120.57 41.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.496 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.864 HD12 ' OH ' ' A' ' 154' ' ' TYR . 2.8 mt -90.68 149.31 22.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.638 HG21 HD13 ' A' ' 19' ' ' LEU . 29.2 m -156.82 173.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.951 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.751 ' O ' HG22 ' A' ' 115' ' ' THR . . . 138.36 -125.94 3.33 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.634 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 114' ' ' GLY . 0.6 OUTLIER 77.59 148.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.308 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 119' ' ' LEU . 16.7 mp0 -137.38 128.49 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 157' ' ' CYS . 62.0 mt -98.65 -38.38 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.13 -23.46 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.444 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 85' ' ' VAL . 1.3 tt -73.02 -15.31 61.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.474 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -69.3 -163.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.727 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 22.95 13.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.127 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.556 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.2 m-20 -86.84 141.89 33.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.799 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.71 -46.97 29.79 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -69.06 -33.34 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.6 m -52.59 -66.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.97 -38.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.014 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.73 -61.52 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -35.77 77.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.675 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.534 HD22 ' CG ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -50.2 -26.21 4.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.488 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.02 -23.08 63.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -85.15 -24.6 27.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -95.1 29.27 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.6 34.8 2.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 52.33 -162.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt 65.88 89.23 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.4 ' HA ' HD11 ' A' ' 129' ' ' LEU . 50.1 Cg_exo -55.35 143.63 75.68 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.576 2.184 . . . . 0.0 112.319 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.543 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.0 mt -56.49 121.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.7 p -106.07 172.39 3.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 52.3 Cg_exo -55.62 -19.95 25.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.696 2.264 . . . . 0.0 112.318 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -85.53 -31.62 22.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 137' ' ' ILE . 85.6 m -59.93 -48.49 81.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.946 0.403 . . . . 0.0 110.676 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.566 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -50.6 -47.97 58.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.688 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.42 -41.73 73.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.304 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -47.22 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD21 ' HE2' ' A' ' 94' ' ' LYS . 6.6 tp -59.56 -35.83 75.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -65.18 -30.63 71.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.083 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -75.1 -51.25 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -52.42 -48.01 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.86 -26.88 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 65.19 122.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.975 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -165.03 -160.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.591 ' HB ' HD12 ' A' ' 111' ' ' LEU . 17.3 t -61.37 -16.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.546 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.31 144.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.567 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.891 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 37.5 p90 -152.15 144.09 23.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 124.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.03 -178.69 2.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HA ' HG21 ' A' ' 115' ' ' THR . 14.6 p -133.09 -173.18 3.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.36 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 t -87.48 159.66 18.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.787 0.327 . . . . 0.0 110.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.619 ' CB ' HD22 ' A' ' 160' ' ' LEU . . . -56.32 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 161' ' ' THR . 0.6 OUTLIER 51.6 33.89 11.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.253 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 160' ' ' LEU . 1.4 p -167.82 -84.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.197 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.55 ' OE1' HD22 ' A' ' 165' ' ' LEU . 2.2 mt-30 73.43 104.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.019 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 -68.53 0.86 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.963 0.411 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.53 77.5 0.39 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.928 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 23' ' ' TYR . 1.7 tp -92.19 -36.94 12.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.0 111.569 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -26.31 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.332 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -66.33 -73.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.0 p -44.59 -37.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.5 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.3 -44.2 97.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 0.0 110.653 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.412 ' HA ' HD13 ' B' ' 75' ' ' ILE . 1.4 t0 -59.28 -40.0 84.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HG2' ' CE ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -77.82 -47.38 19.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.24 66.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.3 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.804 HG13 HD11 ' B' ' 75' ' ' ILE . 34.7 mm -82.21 -57.0 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.04 -29.02 11.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.089 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.63 63.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.02 -14.53 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.495 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 tp -91.88 21.23 5.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.258 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.438 ' CB ' ' HD3' ' A' ' 179' ' ' PRO . 1.4 mm-40 -92.39 -52.66 0.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 178' ' ' GLU . 38.3 Cg_exo -56.96 154.77 31.08 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.609 2.206 . . . . 0.0 112.338 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.9 131.95 22.11 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 144.79 96.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.07 -167.78 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.613 2.208 . . . . 0.0 112.359 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -66.43 91.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.953 179.91 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.18 -64.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.804 HD11 HG13 ' A' ' 173' ' ' ILE . 5.8 tt -140.75 151.88 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 2.2 m -130.77 133.35 45.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.19 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -62.1 136.99 95.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.517 ' CB ' HG12 ' A' ' 42' ' ' VAL . 77.3 Cg_exo -48.68 144.05 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.401 2.067 . . . . 0.0 112.372 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -104.39 -54.71 2.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 33.2 m-20 -67.56 162.43 23.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.498 ' CE1' HG21 ' A' ' 25' ' ' THR . 6.1 t80 174.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 84' ' ' THR . 10.6 pt-20 -153.52 139.71 18.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.27 70.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLU . 0.0 OUTLIER -42.28 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.696 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.879 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.3 mp -109.65 108.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 111.654 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -87.79 96.87 10.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.052 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.755 HG21 ' HB3' ' A' ' 37' ' ' PHE . 17.2 t -81.13 145.26 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.553 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -145.08 174.7 25.03 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.232 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -108.98 117.64 34.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.52 ' HB2' HG21 ' B' ' 97' ' ' THR . 42.2 t0 -123.89 136.18 54.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.972 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.41 0.77 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.894 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 1.058 HG13 HG22 ' B' ' 93' ' ' THR . 7.7 p -48.22 -25.96 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.885 0.374 . . . . 0.0 111.304 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' THR . . . . . 1.058 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -155.79 -39.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.325 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.84 11.91 2.53 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' B' ' 93' ' ' THR . 0.7 OUTLIER -122.85 172.11 8.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.889 0.344 . . . . 0.0 110.553 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 67' ' ' LEU . 1.8 m-85 -67.73 158.06 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.365 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.63 HG22 HD13 ' B' ' 112' ' ' ILE . 29.2 p -119.71 165.88 13.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.539 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 48.91 27.62 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.909 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.661 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.1 OUTLIER -77.33 163.1 66.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.933 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.879 ' N ' HG21 ' B' ' 85' ' ' ILE . 72.1 Cg_exo -48.52 136.21 26.46 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.246 . . . . 0.0 112.409 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.18 -39.75 14.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.028 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -47.62 34.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 1.056 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 4.8 m0 -49.3 -59.97 3.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.546 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -52.49 -59.57 4.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.033 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.7 mtt180 -48.46 -42.18 31.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.871 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.14 -54.63 19.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.702 HD11 HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -94.63 -69.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.727 ' O ' HG23 ' B' ' 109' ' ' THR . 36.8 tt0 -79.53 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.586 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.727 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.7 p -166.03 -46.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.677 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.2 OUTLIER -131.59 167.21 19.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.965 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -56.28 -54.85 40.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.63 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER -134.87 86.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.879 178.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m 74.68 -60.38 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.817 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.434 ' HA ' ' CB ' ' B' ' 110' ' ' SER . 0.6 OUTLIER -152.98 42.52 0.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.188 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.3 OUTLIER 48.63 81.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.831 0.348 . . . . 0.0 111.029 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -109.38 117.19 33.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -119.96 89.35 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 pttt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.9 179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.509 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.465 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.88 171.42 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.62 139.19 54.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.673 HG21 ' HB1' ' A' ' 176' ' ' ALA . 1.1 mp -125.72 139.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.21 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -114.98 138.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.675 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.53 110.76 22.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' PRO . 16.4 t -87.59 145.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.649 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' A' ' 14' ' ' VAL . 19.6 m -137.79 167.07 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.665 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.894 HG21 ' CE1' ' A' ' 104' ' ' HIS . 9.1 p -163.76 136.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 139.44 148.93 5.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.821 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 160.68 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.638 0.256 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 46.84 86.28 0.01 OUTLIER Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.991 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.808 ' HB2' ' O1A' ' A' ' 185' ' ' GNP . . . 72.8 67.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.178 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.7 p -48.7 -24.99 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.18 -27.9 5.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.393 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -96.91 -73.46 0.6 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 111.443 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.825 HG23 ' OD2' ' A' ' 57' ' ' ASP . 3.3 p -45.82 -66.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.711 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 11.7 p -41.49 -48.12 3.83 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.792 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.9 -69.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.705 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.656 HD13 ' HZ ' ' B' ' 81' ' ' PHE . 83.6 mt -40.53 -59.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 17' ' ' THR . 1.1 mp -36.33 -55.65 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB2' " O2'" ' A' ' 185' ' ' GNP . 1.2 t -93.72 -67.1 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.381 0.61 . . . . 0.0 110.672 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.786 ' CD2' HD13 ' A' ' 165' ' ' LEU . 24.5 t80 -40.13 -66.68 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.835 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.3 m -85.95 -80.23 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 111.648 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.726 HG21 ' HE3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -36.04 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.296 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.41 55.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.468 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HE3' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -173.93 -174.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -101.13 166.46 12.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 80.0 Cg_exo -44.45 146.67 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.505 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.4 m -102.51 -82.25 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.709 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.54 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.519 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.38 92.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.7 t -136.31 138.74 27.84 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.768 ' O ' HG23 ' A' ' 36' ' ' VAL . 86.4 Cg_exo -42.93 106.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.352 2.035 . . . . 0.0 111.504 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 39.7 m -47.07 88.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 34' ' ' PRO . 89.7 t -98.03 -51.64 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' B' ' 87' ' ' VAL . 60.0 t80 -163.35 95.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.751 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 25.9 m-20 -96.99 123.02 40.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' HB3' HD12 ' B' ' 85' ' ' ILE . 9.1 t-20 -108.07 150.25 27.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.832 0.349 . . . . 0.0 110.636 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.36 169.18 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.201 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -107.1 140.57 39.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.643 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.6 m -159.14 157.57 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.032 0.444 . . . . 0.0 111.908 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 51' ' ' TYR . 53.8 m -155.95 108.33 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 76' ' ' SER . 3.4 m -98.35 119.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.3 mtm -74.95 104.91 5.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.884 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mm -94.78 111.44 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 20.67 71.35 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.561 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 41.57 8.18 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -140.59 147.82 50.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.792 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.9 153.09 77.77 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.565 2.177 . . . . 0.0 112.274 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -147.98 162.04 40.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -135.31 97.39 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.573 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 54' ' ' GLY . 7.4 tt -124.69 159.6 30.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -154.7 123.56 1.39 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 20' ' ' LEU . 6.2 mp -75.87 119.65 20.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 6.9 m-85 -108.18 120.52 42.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.4 t70 -67.77 174.74 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.338 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.63 ' OG1' HG13 ' A' ' 7' ' ' VAL . 15.4 m -169.97 166.13 9.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.422 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 58' ' ' THR . . . -136.28 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.472 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' HA2' ' CE1' ' A' ' 104' ' ' HIS . . . -78.32 -128.95 0.51 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.708 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? 62.33 152.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 mp0 -45.97 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.319 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 7.0 m-20 -90.69 57.04 3.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 1.5 t80 47.12 43.61 14.48 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' OD2' ' CD2' ' A' ' 61' ' ' LEU . 1.0 OUTLIER 71.22 -140.65 0.05 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -95.32 -1.93 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.192 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.035 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 68.1 mt -88.0 51.73 2.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.369 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -94.06 -43.48 0.3 Allowed Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 13.1 Cg_exo -69.8 -42.74 3.1 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.19 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -86.51 11.91 11.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.631 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.488 ' HB2' ' CZ2' ' B' ' 103' ' ' TRP . 3.3 t -166.21 32.04 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.57 0.224 . . . . 0.0 111.043 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.512 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 7.6 p90 -33.34 122.36 0.45 Allowed Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.068 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.78 ' HA ' HG21 ' A' ' 7' ' ' VAL . 26.7 Cg_exo -62.48 -27.3 76.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.536 2.157 . . . . 0.0 112.587 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.98 -10.03 45.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.86 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.626 ' CG2' HG23 ' A' ' 7' ' ' VAL . 3.5 t -36.01 -55.01 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.458 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER -172.41 -158.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.497 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.7 p -57.93 163.24 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG22 ' A' ' 77' ' ' VAL . 9.0 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.426 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 8' ' ' VAL . 10.3 tp -130.16 123.82 31.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.1 t -131.21 147.14 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.056 0.455 . . . . 0.0 111.943 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.499 ' SG ' HG23 ' A' ' 113' ' ' VAL . 17.8 m -139.63 155.27 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.408 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CD2' HG11 ' A' ' 93' ' ' VAL . 6.7 p90 -162.21 164.17 27.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.78 157.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.474 HG13 HG22 ' A' ' 137' ' ' ILE . 59.0 t -111.76 -75.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.09 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -47.14 -81.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -49.42 105.13 0.47 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.871 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 43.1 Cg_endo -67.48 -17.04 48.69 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.47 2.113 . . . . 0.0 112.473 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t -48.91 -27.3 3.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.2 t -96.12 -37.59 10.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -49.78 -62.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -50.23 -57.34 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.032 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 5.6 m-20 -51.34 -59.64 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 89' ' ' SER . 61.3 t -44.33 -38.95 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.671 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.9 -62.28 1.48 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.02 7.99 5.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -121.3 -43.89 2.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.652 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.0 m95 -95.59 -34.12 12.13 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 94' ' ' LYS . 94.7 t -49.58 -47.28 78.66 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.2 Cg_endo -74.94 -11.56 21.59 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.051 1.834 . . . . 0.0 112.459 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.61 -43.48 9.61 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.09 0.472 . . . . 0.0 110.68 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 9' ' ' VAL . 11.7 pt -51.11 -34.97 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.484 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 81.6 p -52.87 -47.6 67.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.513 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 15.6 t60 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.183 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.894 ' CE1' HG21 ' A' ' 9' ' ' VAL . 29.3 m80 -79.96 -31.47 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 28.1 p -111.88 94.52 24.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.953 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -51.73 -55.19 4.18 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.568 2.179 . . . . 0.0 112.412 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 31.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -114.89 139.94 24.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.947 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 152' ' ' VAL . 75.7 Cg_exo -51.27 -172.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.629 2.219 . . . . 0.0 112.259 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 15.3 p90 -161.3 129.65 4.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.563 ' CD1' HG21 ' A' ' 77' ' ' VAL . 7.5 mp -97.29 129.94 44.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 149' ' ' LEU . 1.2 pt? -131.8 133.38 44.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.561 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 154' ' ' TYR . 2.7 m -141.16 176.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.375 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 84' ' ' VAL . . . -131.8 142.92 14.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.143 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.674 HG21 ' C5 ' ' A' ' 185' ' ' GNP . 38.0 p -128.91 108.71 10.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.638 ' HB3' HG22 ' A' ' 85' ' ' VAL . 1.2 mt-30 170.7 66.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 157' ' ' CYS . 4.9 pt -98.64 -23.41 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.64 -36.99 11.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.73 -18.74 34.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.302 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.8 ' HA ' HG11 ' A' ' 85' ' ' VAL . 10.6 ptm180 -51.23 -23.79 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -44.73 -28.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.96 ' O ' HG22 ' A' ' 125' ' ' THR . 28.2 p-10 -66.53 116.72 37.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 126' ' ' ILE . 45.9 Cg_exo -56.23 -22.58 41.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.42 2.08 . . . . 0.0 112.275 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -56.07 -43.93 78.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 122' ' ' ASP . 10.1 t -50.95 -33.02 22.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.0 mp -81.23 -42.76 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -49.48 -48.68 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -78.88 -36.94 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.983 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 125' ' ' THR . 0.7 OUTLIER -49.89 -26.63 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 110.5 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.18 63.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -94.22 -37.5 11.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -56.14 -24.42 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.17 53.33 0.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.13 170.36 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' HD3' ' HD2' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -76.91 154.99 83.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 138' ' ' THR . 76.6 Cg_exo -49.98 122.1 8.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.231 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.4 mt -50.98 125.19 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -130.89 -179.8 1.14 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.551 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 76.9 Cg_exo -51.14 -22.69 11.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.438 2.092 . . . . 0.0 112.221 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.33 -42.5 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.53 ' CG2' HG23 ' A' ' 137' ' ' ILE . 57.2 m -49.92 -56.35 10.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.41 -38.09 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.9 tt0 -59.85 -48.43 81.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.08 62.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -56.69 -38.05 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.243 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.015 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.05 -45.27 83.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.768 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -58.1 -45.71 86.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -56.89 13.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.808 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.682 ' CD2' HD11 ' A' ' 112' ' ' LEU . 3.5 pp -62.17 -27.29 68.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 72.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.094 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -109.07 -179.6 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 109' ' ' PRO . 68.9 t -46.74 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 159.14 136.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.43 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 1.015 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 11.1 p90 -153.15 141.84 20.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 111.544 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -158.06 124.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.854 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.65 -178.81 2.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.733 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.47 ' HB2' HD13 ' A' ' 117' ' ' ILE . 28.3 p -136.19 -173.32 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.446 ' CB ' HG12 ' A' ' 117' ' ' ILE . 5.0 p -87.2 156.0 19.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.349 . . . . 0.0 110.527 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.547 ' HB2' " H1'" ' A' ' 185' ' ' GNP . . . -51.78 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.294 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 161' ' ' THR . 0.2 OUTLIER 55.0 24.03 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.422 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 169.9 128.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.442 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -126.31 121.73 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -101.2 -43.63 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.85 85.67 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 23' ' ' TYR . 7.0 mt -85.3 -37.25 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -52.99 -24.84 10.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 155' ' ' VAL . 49.5 m-20 -63.45 -69.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.123 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.27 -41.98 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -67.59 -49.08 64.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.606 ' HA ' HG21 ' B' ' 75' ' ' ILE . 56.3 t0 -47.14 -45.37 22.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -84.29 -47.68 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -53.95 -33.21 56.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.557 HG13 HD11 ' B' ' 75' ' ' ILE . 23.3 mm -87.84 -33.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.2 tp -53.17 -56.75 13.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.72 -32.49 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -77.03 -28.03 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.598 HD12 ' OH ' ' A' ' 51' ' ' TYR . 39.0 tp -54.3 -25.41 23.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 68.41 96.4 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.27 169.58 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.625 2.216 . . . . 0.0 112.384 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.89 146.79 60.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.586 2.19 . . . . 0.0 112.264 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 2.0 mm-40 -54.71 -51.98 74.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 80.0 Cg_exo -47.44 124.63 9.62 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.572 2.181 . . . . 0.0 112.326 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.76 159.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -51.33 -76.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.96 0.41 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 170' ' ' ASP . 5.1 tt -115.69 151.74 17.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -135.93 135.15 39.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.379 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.693 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -55.47 136.33 70.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.527 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.693 ' HD2' HD23 ' B' ' 77' ' ' LEU . 71.7 Cg_exo -50.7 143.69 28.34 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.479 2.12 . . . . 0.0 112.411 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.1 -70.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -58.08 88.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.656 ' HZ ' HD13 ' A' ' 20' ' ' LEU . 9.5 t80 -113.25 136.28 52.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.34 130.0 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.386 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 96.95 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.926 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -101.53 139.72 22.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.994 0.426 . . . . 0.0 111.979 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' B' ' 86' ' ' HIS . 52.1 p-80 -120.38 96.55 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.335 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 37' ' ' PHE . 46.9 t -83.47 152.54 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.86 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.42 177.85 24.49 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.503 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.53 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.635 ' OD2' HG21 ' B' ' 97' ' ' THR . 1.2 m-20 -132.68 134.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 1.11 20.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.909 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.526 HG13 HG22 ' B' ' 93' ' ' THR . 7.3 p -46.08 -27.84 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.526 HG22 HG13 ' B' ' 92' ' ' VAL . 6.2 t -148.58 -42.02 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.044 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.79 29.67 0.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.467 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -138.18 -159.47 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.704 0.288 . . . . 0.0 110.457 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' CG1' ' B' ' 87' ' ' VAL . 3.5 m-85 -98.99 164.24 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.758 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.635 HG21 ' OD2' ' B' ' 90' ' ' ASP . 34.3 p -109.41 171.76 7.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 44.26 28.12 1.32 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.773 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' B' ' 108' ' ' GLN . 0.9 OUTLIER -49.83 129.46 21.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.562 0.22 . . . . 0.0 110.883 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 50.3 Cg_exo -53.92 140.4 68.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.375 2.05 . . . . 0.0 111.884 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -42.67 -45.88 4.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.252 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -56.78 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.797 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 1.035 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.6 m0 -52.36 -58.74 5.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.143 0.496 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' B' ' 108' ' ' GLN . . . -45.58 -70.32 0.11 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.136 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -47.32 -38.56 13.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.041 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.82 -64.88 0.58 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.859 0.361 . . . . 0.0 110.12 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -70.25 0.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' B' ' 99' ' ' MET . 0.7 OUTLIER -80.71 -160.39 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -154.23 57.43 0.71 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.26 -0.275 . . . . 0.0 111.042 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.74 124.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.157 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 4.4 m120 -48.1 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.603 HD13 HG22 ' B' ' 97' ' ' THR . 0.7 OUTLIER -127.18 86.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.874 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.17 88.05 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.398 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' B' ' 116' ' ' GLU . 0.2 OUTLIER 58.0 37.25 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.974 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.479 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.2 OUTLIER 65.65 -71.59 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 114' ' ' LYS . 0.5 OUTLIER 68.05 -81.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 117' ' ' GLN . . . . . 0.425 ' HG2' HG21 ' B' ' 112' ' ' ILE . 3.6 pt20 -75.9 118.83 19.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.938 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 19.7 mttp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.945 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.808 ' O1A' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.54 136.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -102.31 142.25 33.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.23 138.76 52.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.216 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.52 96.33 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.566 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.48 107.93 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' CG2' HG21 ' A' ' 75' ' ' THR . 3.0 t -84.58 150.48 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LYS . 7.5 p -135.34 146.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 78' ' ' PHE . 5.5 m -133.75 121.03 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' A' ' 97' ' ' TRP . . . 147.97 -174.32 27.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.68 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.68 155.4 49.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.367 . . . . 0.0 111.178 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 88.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB2' " C5'" ' A' ' 185' ' ' GNP . . . 49.94 53.78 12.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.668 HG13 HG21 ' A' ' 8' ' ' VAL . 10.0 p -80.54 2.68 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.345 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 109.87 -29.62 9.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.663 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.815 ' HB3' HG11 ' A' ' 8' ' ' VAL . 9.5 pttt -51.42 -67.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.773 -0.251 . . . . 0.0 111.635 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.758 HG21 ' O ' ' A' ' 188' ' ' HOH . 0.2 OUTLIER -96.81 -26.37 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' O ' ' N7 ' ' A' ' 185' ' ' GNP . 35.2 t -61.24 -58.42 8.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.424 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.998 HD12 HD21 ' A' ' 79' ' ' LEU . 14.5 mt -50.99 -73.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.393 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 55' ' ' LEU . 15.1 mt -39.35 -40.34 0.78 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -51.96 -67.35 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 1.8 t -93.27 -53.36 4.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.24 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.893 ' O ' HD21 ' B' ' 77' ' ' LEU . 13.9 t80 -44.51 -30.03 0.81 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.061 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 25' ' ' THR . 93.7 m -125.33 -101.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.608 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 4.7 t -40.37 -34.8 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' ILE . 3.5 t-20 75.65 47.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -151.4 136.91 17.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' " O2'" ' A' ' 185' ' ' GNP . 1.0 OUTLIER -58.42 166.7 2.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 28' ' ' PHE . 11.8 Cg_endo -55.69 171.81 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.945 2.43 . . . . 0.0 112.858 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 t -116.24 -75.38 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.099 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 129.06 39.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -90.66 104.32 16.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.198 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.592 HG23 ' HD2' ' A' ' 34' ' ' PRO . 5.2 p -160.78 140.51 8.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.915 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD2' HG23 ' A' ' 33' ' ' VAL . 55.7 Cg_exo -35.38 91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.933 2.422 . . . . 0.0 112.291 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 57' ' ' ASP . 98.8 m -51.32 87.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.15 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' B' ' 96' ' ' PHE . 88.6 t -84.9 -33.74 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.521 ' CE1' ' HG3' ' B' ' 100' ' ' PRO . 16.9 t80 -173.61 128.81 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.877 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 m-20 -127.86 148.98 50.49 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.778 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HB2' HD12 ' B' ' 85' ' ' ILE . 2.8 t-20 -107.07 157.27 17.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 0.0 110.69 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.568 ' OH ' HG23 ' A' ' 17' ' ' THR . 4.2 m-85 -152.82 169.29 23.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.237 0.542 . . . . 0.0 112.006 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' B' ' 81' ' ' PHE . . . -127.6 115.56 18.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG12 ' CB ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -141.13 155.53 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.438 . . . . 0.0 111.557 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.2 m -156.33 95.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.099 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.666 HG21 HG21 ' A' ' 173' ' ' ILE . 27.4 m -98.42 178.35 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.427 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 2.7 mtt -115.07 157.26 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.766 HD12 ' CE1' ' A' ' 51' ' ' TYR . 18.0 mt -158.24 89.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.585 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.17 3.02 79.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.77 26.91 5.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.0 pt-20 -141.63 138.82 17.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.638 0.256 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 43.4 Cg_exo -56.44 174.38 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.578 2.185 . . . . 0.0 112.198 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.766 ' CE1' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.87 171.2 17.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.002 0.43 . . . . 0.0 111.155 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -136.3 97.02 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.337 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 11.3 tp -98.22 157.71 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.954 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -163.22 103.01 0.21 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.426 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.03 HD11 HD23 ' A' ' 79' ' ' LEU . 3.4 mm? -75.78 105.05 6.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.763 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.7 m-85 -83.26 107.48 15.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.178 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -67.84 130.4 42.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.323 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.839 HG22 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.45 163.74 32.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -103.34 -53.62 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.411 . . . . 0.0 111.004 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.23 -45.64 1.1 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.268 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -151.76 17.91 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 13.2 mt-10 -103.43 83.59 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.139 0.495 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 78.28 -3.49 2.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.604 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.839 ' CD2' HG22 ' A' ' 58' ' ' THR . 24.2 m-85 -85.26 -13.7 48.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.747 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -39.49 -47.13 1.81 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.013 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -54.06 37.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.758 ' CB ' HD11 ' A' ' 70' ' ' LEU . 2.3 mp -78.59 82.24 4.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.19 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 24.1 ptt180 -88.2 -35.02 0.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 2.5 Cg_endo -82.68 7.95 4.86 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.081 . . . . 0.0 112.73 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.955 HD22 ' CE2' ' B' ' 103' ' ' TRP . 39.0 mt -51.54 111.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.485 0.659 . . . . 0.0 111.471 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.636 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 70.18 4.78 5.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.433 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 59.97 154.7 0.1 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.466 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.93 -52.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.947 2.432 . . . . 0.0 112.932 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -8.2 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.986 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 76' ' ' ASP . 1.1 t -32.79 -73.52 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.729 ' H ' HG23 ' A' ' 75' ' ' THR . 3.7 m-20 -161.56 -155.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 78' ' ' PHE . 14.1 p -66.86 162.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -98.5 127.34 44.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.03 HD23 HD11 ' A' ' 55' ' ' LEU . 13.5 tp -103.69 115.47 30.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.274 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.515 HG13 ' CG2' ' A' ' 14' ' ' VAL . 2.5 t -131.9 153.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.446 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 14' ' ' VAL . 62.6 m -142.65 172.02 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.511 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.738 ' HB3' HG21 ' A' ' 93' ' ' VAL . 50.8 p90 -164.41 151.72 11.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.105 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.47 136.8 42.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 115' ' ' THR . 5.3 m -107.15 68.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.12 -85.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.13 163.8 55.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.803 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.432 ' CB ' ' HB2' ' A' ' 132' ' ' ASN . 51.7 Cg_endo -69.17 -22.53 34.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.58 2.187 . . . . 0.0 112.287 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 p -70.18 -33.83 72.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.2 p -51.89 -46.25 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -51.92 -69.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.067 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.93 -29.22 55.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.002 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.5 m-20 -62.47 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 82' ' ' PHE . 7.2 p -41.38 -31.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.14 -70.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.842 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.57 8.11 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 27.3 tttm -113.68 -40.62 3.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.676 ' HD1' HG23 ' A' ' 93' ' ' VAL . 11.0 m95 -95.96 -13.58 23.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 94' ' ' LYS . 2.5 m -53.02 -32.57 10.37 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.5 Cg_exo -68.78 -41.87 5.26 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.782 1.654 . . . . 0.0 112.217 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' CG ' HD12 ' A' ' 61' ' ' LEU . 19.0 mp0 -58.56 -43.67 89.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.841 HG21 ' CD2' ' A' ' 110' ' ' PHE . 71.3 mt -48.58 -26.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -84.67 -37.16 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.58 -34.56 51.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -102.94 -61.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 8.4 m -109.29 85.61 3.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.2 -11.66 29.1 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.632 2.221 . . . . 0.0 112.794 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -152.78 40.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 111.419 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.4 139.88 36.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.853 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.1 Cg_exo -49.18 143.96 17.82 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.542 2.161 . . . . 0.0 112.113 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.841 ' CD2' HG21 ' A' ' 101' ' ' ILE . 1.6 p90 -131.39 130.52 42.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.28 136.09 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.394 179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.2 pp -146.78 114.19 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.672 HG11 ' CD ' ' A' ' 156' ' ' GLU . 10.0 p -129.1 152.3 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.382 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.484 ' HA3' HG13 ' A' ' 84' ' ' VAL . . . -73.16 -176.92 32.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.305 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.858 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -174.14 172.36 3.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 111.426 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.906 ' OE1' HD22 ' A' ' 119' ' ' LEU . 14.1 mt-30 72.53 108.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' A' ' 139' ' ' PRO . 41.7 mt -98.48 -59.83 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 119' ' ' LEU . 24.9 p30 -55.02 -22.51 15.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.906 HD22 ' OE1' ' A' ' 116' ' ' GLN . 7.3 tp -61.93 -48.11 81.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.956 ' HA ' HG12 ' A' ' 85' ' ' VAL . 1.6 ptt180 -58.91 -22.89 60.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.72 -23.8 7.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 29.6 m-20 -54.22 135.6 59.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 43.3 Cg_exo -56.58 -42.55 64.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.522 2.148 . . . . 0.0 112.397 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -38.69 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 120' ' ' ARG . 19.7 p -59.05 -64.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.6 mp -48.65 -43.68 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.069 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD2' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.59 -32.93 68.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -50.81 -26.23 5.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.928 0.394 . . . . 0.0 110.295 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.35 -22.44 60.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.928 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.48 -22.51 37.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 87' ' ' PRO . 25.6 t30 -94.04 30.59 1.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.957 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 34.69 0.37 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.788 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.71 -160.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.45 95.65 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.773 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.416 ' HA ' HD22 ' A' ' 129' ' ' LEU . 42.0 Cg_endo -67.56 141.8 56.69 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.608 2.205 . . . . 0.0 112.363 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 90' ' ' PHE . 4.1 mt -67.47 125.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -124.43 177.73 1.68 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' A' ' 117' ' ' ILE . 51.1 Cg_exo -54.23 -24.7 35.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.691 2.26 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -86.36 -39.02 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.027 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.8 m -49.97 -48.29 52.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -49.91 61.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.04 -47.93 68.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.52 -40.62 59.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.593 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 145' ' ' LEU . 8.5 tt -61.38 -41.69 97.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.967 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -53.33 -54.93 29.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -55.05 -38.83 68.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -51.49 -32.67 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 151' ' ' ALA . 1.6 pp -125.39 21.86 7.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.142 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 58.1 -84.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.993 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 149' ' ' LEU . . . 58.07 175.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 6.1 t -61.52 -15.99 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.484 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.45 140.84 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 110.466 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.967 ' CE1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -153.39 151.57 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 155' ' ' VAL . 14.9 m -157.93 123.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.579 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.672 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.7 pt-20 -172.36 152.21 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.152 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.54 ' O ' ' N2 ' ' A' ' 185' ' ' GNP . 83.3 m -101.82 -177.53 3.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.513 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 30.8 t -86.77 156.6 19.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.049 0.452 . . . . 0.0 111.594 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.906 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.04 -169.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.029 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 50.87 24.89 1.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.549 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -174.17 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 57.66 115.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.338 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -64.07 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.28 92.98 0.11 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.419 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -93.79 -10.37 34.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.477 0.18 . . . . 0.0 111.455 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.16 -43.32 3.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.336 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.94 -67.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.732 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.685 HG13 ' OH ' ' A' ' 23' ' ' TYR . 7.3 p -50.27 -28.78 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.78 -51.26 70.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.146 179.427 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 2.5 p30 -63.13 -32.24 73.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.4 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 24.6 tp10 -70.14 -30.68 67.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.98 -29.36 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.717 HG22 HD11 ' A' ' 46' ' ' ILE . 44.5 mm -94.95 -66.36 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -49.94 -45.76 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.979 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -55.34 -25.56 35.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -61.33 -29.23 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.057 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -92.7 44.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -146.97 83.43 7.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.54 162.03 38.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.612 2.208 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 156.64 55.35 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.582 2.188 . . . . 0.0 112.324 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -50.69 106.14 0.61 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.98 91.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.48 2.12 . . . . 0.0 112.273 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.51 95.67 6.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 28.5 m -55.34 -42.56 74.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.6 149.19 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.22 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 176.1 8.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.893 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -94.88 140.37 22.49 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.655 ' CB ' HG12 ' A' ' 42' ' ' VAL . 52.9 Cg_exo -54.61 -164.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.437 2.091 . . . . 0.0 112.103 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -167.79 -65.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.59 95.59 2.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.985 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -129.02 148.93 51.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.141 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -153.22 140.45 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.93 0.395 . . . . 0.0 111.758 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -75.48 95.34 3.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.051 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -77.02 -42.49 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 39' ' ' ASN . 2.0 mt -129.07 147.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 111.558 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -141.12 97.16 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.484 ' CG2' ' HD3' ' B' ' 100' ' ' PRO . 63.3 t -78.25 125.07 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 111.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 172.92 15.91 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.869 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -98.62 111.23 23.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.444 ' CG ' HG21 ' B' ' 97' ' ' THR . 1.1 m-20 -129.29 128.78 43.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.36 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.15 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.918 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.938 HG13 HG22 ' B' ' 93' ' ' THR . 7.5 p -41.5 -30.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 111.591 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.938 HG22 HG13 ' B' ' 92' ' ' VAL . 1.1 t -151.61 21.1 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.151 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.96 25.27 67.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.852 ' CG ' HG23 ' B' ' 93' ' ' THR . 8.3 pt-20 -145.71 171.84 14.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -70.54 164.75 24.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.421 . . . . 0.0 110.745 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.444 HG21 ' CG ' ' B' ' 90' ' ' ASP . 66.1 p -110.45 176.68 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 43.05 28.54 0.76 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.87 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.712 ' CE ' HD21 ' A' ' 67' ' ' LEU . 3.0 mtp -57.74 124.63 69.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.252 . . . . 0.0 110.956 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.521 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 49.2 Cg_exo -38.86 152.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.792 2.328 . . . . 0.0 112.692 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' B' ' 105' ' ' ARG . 2.8 mt-10 -47.58 -43.24 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.065 0.459 . . . . 0.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.488 ' HG2' HD23 ' B' ' 106' ' ' LEU . 0.0 OUTLIER -72.56 -57.67 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.246 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.955 ' CE2' HD22 ' A' ' 70' ' ' LEU . 13.1 m0 -48.31 -60.26 2.8 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.601 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' C ' ' B' ' 110' ' ' SER . . . -47.47 -67.99 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.2 mtp85 -52.23 -34.4 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.032 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -45.75 -65.64 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.696 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -63.22 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.56 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.69 ' O ' HG23 ' B' ' 109' ' ' THR . 0.4 OUTLIER -78.8 -100.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.677 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.69 HG23 ' O ' ' B' ' 108' ' ' GLN . 11.7 p -164.94 -57.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.226 0 CA-C-O 120.788 0.327 . . . . 0.0 111.851 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.572 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -127.7 158.89 36.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.382 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 99' ' ' MET . 0.6 OUTLIER -45.15 -57.44 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.055 0.455 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.602 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER -136.88 86.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 177.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m 73.19 -61.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.684 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -147.76 48.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.7 OUTLIER 70.46 162.21 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.782 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.43 -27.5 11.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.24 135.88 57.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.54 ' N2 ' ' O ' ' A' ' 157' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.758 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.85 0.357 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -94.6 120.93 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.8 t -99.73 147.15 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.866 HG23 ' OD2' ' A' ' 76' ' ' ASP . 65.8 mt -135.66 103.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB2' HG21 ' A' ' 75' ' ' THR . 5.6 mmtp -95.67 98.31 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -77.77 112.35 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.113 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 59.6 t -91.09 150.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 79' ' ' LEU . 7.3 p -139.51 147.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.063 0.458 . . . . 0.0 111.529 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 60' ' ' GLY . 7.1 p -138.27 120.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.534 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.62 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.769 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -20.87 15.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.782 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -78.37 -45.17 10.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.69 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 73.47 3.0 4.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' HA2' ' A' ' 114' ' ' GLY . 5.4 t -57.78 -17.93 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.242 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -81.25 -124.32 0.65 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.422 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -34.06 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.604 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -50.91 -71.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' THR . 51.7 t -48.03 -46.45 33.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.126 0.489 . . . . 0.0 110.985 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.883 HD13 HG11 ' A' ' 113' ' ' VAL . 69.4 tp -46.14 -59.78 2.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.537 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 55' ' ' LEU . 21.8 mt -44.69 -49.15 10.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.708 0.29 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 27' ' ' LYS . 3.4 mm -42.58 -49.19 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.491 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.464 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -93.68 -61.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.453 0.644 . . . . 0.0 110.256 178.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.941 ' OH ' HG13 ' A' ' 168' ' ' VAL . 1.2 t80 -39.8 -66.85 0.26 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.249 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.839 HG23 ' HB2' ' B' ' 78' ' ' PRO . 50.6 m -96.57 -77.54 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.366 0.603 . . . . 0.0 111.151 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.775 HG23 ' CE2' ' B' ' 81' ' ' PHE . 0.2 OUTLIER -36.29 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.225 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t30 47.72 65.08 1.37 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 110.616 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.16 -169.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.316 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -111.91 157.89 38.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -51.2 143.05 34.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.669 2.246 . . . . 0.0 112.438 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 p -95.12 -80.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.22 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.89 109.33 21.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.02 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.6 t80 -66.11 107.73 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.103 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA2' ' B' ' 88' ' ' GLY . 59.2 t -157.89 131.89 5.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' VAL . 94.7 Cg_exo -41.86 92.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.379 2.053 . . . . 0.0 111.969 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 38' ' ' ASP . 40.4 m -53.11 87.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.268 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.808 HG13 ' OH ' ' A' ' 64' ' ' TYR . 12.2 t -73.41 -27.04 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 110.058 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.715 ' HE2' HD13 ' B' ' 85' ' ' ILE . 15.8 t80 -146.85 -79.78 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.312 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.831 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.0 OUTLIER 60.69 118.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.119 -179.089 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 t-20 -107.7 156.86 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -152.49 144.89 24.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.005 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.11 140.2 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.139 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 24' ' ' THR . 25.6 m -154.81 132.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 51' ' ' TYR . 61.4 m -125.39 95.31 4.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 ' O ' ' B' ' 76' ' ' SER . 2.9 m -98.13 123.75 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.403 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -72.8 100.18 2.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.923 HD11 HG21 ' A' ' 173' ' ' ILE . 24.7 mm -90.48 89.37 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.44 12.74 55.62 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 4.7 58.96 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.125 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.13 150.61 43.23 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.03 0.415 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.29 162.44 7.74 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.679 2.252 . . . . 0.0 112.126 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.628 ' H ' HG23 ' A' ' 43' ' ' THR . 7.0 t80 -154.11 153.28 31.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.952 0.406 . . . . 0.0 111.459 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 p -136.31 97.43 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.223 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 54' ' ' GLY . 5.8 tt -112.51 144.89 41.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.762 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -127.5 112.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.183 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 16' ' ' LYS . 5.6 mp -77.96 102.93 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.308 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 1.3 m-85 -88.86 103.01 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.01 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.667 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -73.57 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.94 0.4 . . . . 0.0 111.246 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.05 -171.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.965 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . . . -156.69 149.27 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' VAL . . . -109.01 99.49 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.36 -65.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 170.02 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.736 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -111.14 27.29 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.965 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -91.42 -23.05 20.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -27.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.603 ' O ' HD23 ' B' ' 107' ' ' LEU . 22.1 mtt180 -48.67 -40.27 27.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.877 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD22 ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -92.12 40.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.638 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tpt180 -81.59 -66.46 0.23 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.499 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 19.3 Cg_endo -58.91 -15.16 25.73 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.56 2.173 . . . . 0.0 112.626 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.762 HD12 ' CG ' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.41 -13.0 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.108 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 1.3 t -111.6 -19.49 12.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.319 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 39.01 95.86 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.801 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 37.9 Cg_endo -66.2 -45.58 5.42 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.609 2.206 . . . . 0.0 112.183 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -12.08 47.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 5' ' ' LYS . 6.6 t -40.56 -46.8 2.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -172.64 -160.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.749 0.309 . . . . 0.0 111.058 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -58.17 154.18 2.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.731 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -106.76 138.79 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.27 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -104.11 122.61 45.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.093 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 101' ' ' ILE . 4.0 t -106.9 153.77 8.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.065 0.46 . . . . 0.0 111.919 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.27 155.66 18.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CZ ' HG23 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -166.07 121.66 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.968 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.88 164.4 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.651 ' HA ' HG21 ' A' ' 137' ' ' ILE . 34.5 t -147.67 66.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.318 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 120' ' ' ARG . 70.8 t -151.27 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -82.76 137.71 43.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 57.9 Cg_endo -72.06 -19.47 26.42 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.556 2.171 . . . . 0.0 112.325 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.8 p -56.91 -52.23 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.81 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -29.82 63.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -50.3 -45.86 54.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -47.54 85.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -61.1 -66.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 28.7 m -43.53 -40.84 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.664 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.2 tttm -57.44 -68.03 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 5.1 mt-10 -82.53 8.4 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.138 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.02 -38.69 3.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.404 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.584 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 49.9 m0 -95.23 -40.89 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.511 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 101' ' ' ILE . 60.7 t -55.85 -44.09 99.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 39.5 Cg_exo -60.22 -19.65 58.31 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.33 2.02 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.71 -30.8 56.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.885 HG22 ' O ' ' A' ' 98' ' ' VAL . 8.4 tp -49.16 -31.4 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.198 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -77.71 -44.04 29.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -51.86 -37.76 53.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 5.3 m-70 -97.2 -61.72 1.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 4.7 t -74.42 108.89 5.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.501 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.49 -60.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.392 2.062 . . . . 0.0 112.419 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -154.68 36.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.727 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -107.29 153.98 40.83 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD2' HG22 ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.89 145.68 97.67 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.606 2.204 . . . . 0.0 111.97 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 20.1 p90 -123.1 127.48 48.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.314 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.649 HD12 ' CG1' ' A' ' 152' ' ' VAL . 6.8 tt -109.14 119.29 39.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.045 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 mp -90.99 155.14 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.229 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 19' ' ' LEU . 3.0 t -148.78 165.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.705 ' HA2' HG12 ' A' ' 14' ' ' VAL . . . 143.41 154.63 6.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.799 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -176.78 164.48 2.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.421 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -172.25 93.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.815 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -25.72 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.855 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -95.26 -30.91 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.795 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.421 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -78.41 -44.72 24.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HA ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -53.14 -23.49 8.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 55.89 2.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.9 ' O ' HD12 ' A' ' 126' ' ' ILE . 1.3 m-20 -111.11 150.04 41.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 -57.95 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.716 2.277 . . . . 0.0 112.374 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -34.57 75.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 120' ' ' ARG . 54.2 m -55.49 -72.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.818 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 122' ' ' ASP . 3.7 mp -52.03 -39.1 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -32.08 30.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.048 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.67 -39.34 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.524 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 136' ' ' PRO . 17.6 mt -49.9 -26.14 3.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.457 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.43 67.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -25.35 22.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' CB ' ' HG3' ' A' ' 87' ' ' PRO . 9.6 m120 -115.95 30.23 7.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 103.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.973 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 6.3 pt20 -42.69 150.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 10.1 mttt 47.94 48.43 5.88 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.842 ' HD2' HD13 ' A' ' 129' ' ' LEU . 73.8 Cg_endo -75.88 -46.15 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.561 2.174 . . . . 0.0 112.562 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 84' ' ' VAL . 5.7 mm -99.85 129.94 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -148.86 164.5 21.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 75.6 Cg_exo -49.78 -23.31 8.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.546 2.164 . . . . 0.0 112.315 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -90.64 -41.23 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.1 m -49.02 -57.69 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.89 -49.56 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.65 -38.11 80.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -50.36 73.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.1 tp -57.25 -37.93 73.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -71.57 -26.53 62.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ttt-85 -73.43 -40.7 64.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.21 -44.7 94.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.4 pp -71.77 -26.39 62.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.694 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.0 tptt 69.05 109.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.62 -161.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.649 ' CG1' HD12 ' A' ' 111' ' ' LEU . 91.2 t -56.82 -20.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.305 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 75.07 139.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.197 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 39.6 p90 -152.8 162.09 41.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.7 m -158.13 124.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.695 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.571 ' CD ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -170.62 167.55 7.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.104 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.799 ' HA ' HG21 ' A' ' 115' ' ' THR . 17.4 p -118.9 -173.24 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -87.68 165.04 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.973 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.575 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -51.43 -175.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 66.23 -69.29 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.276 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.93 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.732 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.76 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 68.61 108.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.667 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -68.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.35 96.57 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.76 HD11 ' OE1' ' A' ' 162' ' ' GLN . 19.2 mt -93.24 -17.62 23.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.68 0.276 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -62.92 -49.96 72.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.455 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 166' ' ' LYS . 7.2 m120 -48.8 -71.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.941 HG13 ' OH ' ' A' ' 23' ' ' TYR . 3.5 p -47.62 -30.06 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -64.42 -38.21 90.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.779 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.448 ' CB ' HG13 ' B' ' 75' ' ' ILE . 17.4 t0 -63.63 -35.54 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.127 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 3.1 mm-40 -81.79 -24.63 35.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.73 41.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 46' ' ' ILE . 21.2 mt -88.71 -48.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.46 -27.77 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -50.82 -37.14 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.74 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -94.52 -20.58 19.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.318 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -82.99 -24.58 32.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.017 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 179' ' ' PRO . 3.8 mm-40 -51.31 -54.41 38.81 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 178' ' ' GLU . 57.3 Cg_exo -51.74 110.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.53 2.153 . . . . 0.0 112.225 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.47 137.38 11.33 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.459 2.106 . . . . 0.0 112.38 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.02 63.75 19.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.63 102.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.599 2.199 . . . . 0.0 112.371 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -56.32 130.46 44.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.98 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.3 p -99.36 -39.55 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.448 HG13 ' CB ' ' A' ' 170' ' ' ASP . 6.7 mm -140.33 139.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.897 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 p -138.69 141.85 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.013 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -70.24 131.67 88.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.839 ' HB2' HG23 ' A' ' 24' ' ' THR . 53.1 Cg_exo -54.63 154.29 20.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.399 2.066 . . . . 0.0 112.273 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.86 -43.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.87 61.63 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.976 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.775 ' CE2' HG23 ' A' ' 25' ' ' THR . 23.7 t80 -74.39 149.8 40.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.65 101.72 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -72.34 69.31 0.81 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.803 ' OG1' HD12 ' B' ' 85' ' ' ILE . 44.8 p -52.43 -85.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.245 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.803 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.5 OUTLIER -96.95 145.32 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.096 0.474 . . . . 0.0 112.092 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.95 96.89 4.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.519 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.602 HG22 ' HD3' ' B' ' 100' ' ' PRO . 29.7 t -78.03 157.29 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.969 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.589 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.43 177.92 24.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -84.52 119.08 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.615 ' CB ' HG23 ' B' ' 97' ' ' THR . 13.8 t0 -111.01 98.32 7.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.23 61.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.562 HG13 HG22 ' B' ' 93' ' ' THR . 13.4 p -46.92 -33.47 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.308 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.562 HG22 HG13 ' B' ' 92' ' ' VAL . 7.8 t -148.16 23.72 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.17 25.39 72.25 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.622 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.412 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 17.4 pt-20 -119.84 -166.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.732 0.301 . . . . 0.0 110.791 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 1.02 ' CE2' HD11 ' A' ' 67' ' ' LEU . 2.2 m-85 -103.9 163.74 12.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.615 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.6 p -104.64 150.05 25.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.576 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' ND2' ' B' ' 111' ' ' ASN . . . 69.5 43.93 66.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' B' ' 104' ' ' ALA . 2.7 tpt -47.28 103.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.551 0.215 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.602 ' HD3' HG22 ' B' ' 87' ' ' VAL . 77.5 Cg_exo -50.3 147.44 16.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.487 2.125 . . . . 0.0 111.915 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -66.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -65.7 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.417 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 1.04 ' CE3' HD22 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -46.71 -56.85 5.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.201 0.524 . . . . 0.0 110.552 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.611 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -55.26 -60.91 2.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.653 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.784 ' O ' HG22 ' B' ' 109' ' ' THR . 6.1 mtt-85 -42.42 -36.23 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.368 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.759 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -60.81 -60.72 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.32 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.18 -64.36 1.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.703 ' O ' HG23 ' B' ' 109' ' ' THR . 3.6 tp-100 -76.93 -79.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.236 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.784 HG22 ' O ' ' B' ' 105' ' ' ARG . 6.0 p 96.78 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.366 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 171.26 93.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.958 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.467 ' CB ' ' HB2' ' B' ' 115' ' ' SER . 1.7 t30 -49.78 92.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.611 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.678 ' O ' HG23 ' B' ' 113' ' ' THR . 0.4 OUTLIER -58.64 86.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.187 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.678 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.7 OUTLIER 153.45 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.444 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 41.35 63.49 1.23 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.562 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.467 ' HB2' ' CB ' ' B' ' 111' ' ' ASN . 0.5 OUTLIER -41.34 138.56 1.21 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 111.314 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.7 -58.35 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.84 96.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 32.9 tttt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.977 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.507 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.769 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.58 167.57 11.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -91.83 132.63 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.647 HD13 ' CB ' ' A' ' 176' ' ' ALA . 25.1 mt -116.25 133.41 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.3 OUTLIER -123.27 149.44 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.722 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.97 96.05 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.82 HG21 ' O ' ' A' ' 71' ' ' SER . 56.4 t -100.79 128.01 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.867 ' HB ' HG12 ' A' ' 14' ' ' VAL . 18.5 m -106.73 169.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.2 p -158.28 121.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.98 -140.58 5.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB2' ' CE2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -126.5 -78.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -60.36 -147.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.912 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -60.81 78.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 110.78 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.5 t -73.81 -1.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.142 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . 95.62 -24.74 28.08 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -60.32 -64.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.852 HG23 ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -96.09 -34.35 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.912 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 3.3 p -66.39 -45.19 80.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 79' ' ' LEU . 8.1 tp -61.29 -73.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.959 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -43.86 -48.45 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.397 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -47.74 -69.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.01 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.1 t -93.2 -60.89 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.462 . . . . 0.0 111.971 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.56 ' CD2' HD11 ' A' ' 19' ' ' LEU . 8.2 t80 -47.6 -24.96 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.702 HG21 HG11 ' A' ' 42' ' ' VAL . 79.6 m -111.36 -96.25 0.42 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.562 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.463 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.6 t -60.07 -21.76 61.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 27.9 t-20 72.1 30.38 2.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.9 OUTLIER -125.78 134.75 51.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -69.21 160.12 80.17 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.042 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.2 Cg_endo -50.64 169.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.965 2.444 . . . . 0.0 112.409 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -74.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 134.11 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.21 110.06 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -154.78 138.85 11.27 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.497 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 36' ' ' VAL . 93.8 Cg_exo -41.18 109.07 0.1 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.46 2.107 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 16' ' ' LYS . 18.1 m -47.16 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.297 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 34' ' ' PRO . 61.3 t -103.78 -53.77 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.886 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' B' ' 85' ' ' ILE . 45.8 t80 -159.0 78.46 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 12.2 m-20 -80.59 121.52 25.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.656 ' HB3' HD12 ' B' ' 85' ' ' ILE . 26.6 t-20 -107.07 151.2 25.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.037 0.446 . . . . 0.0 111.272 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.2 160.03 43.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.216 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.25 116.97 29.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.906 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 24' ' ' THR . 1.4 m -146.08 132.07 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.059 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 51' ' ' TYR . 21.0 m -127.49 112.19 14.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.838 0.352 . . . . 0.0 110.215 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 76' ' ' SER . 92.6 t -97.73 117.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.215 0.531 . . . . 0.0 110.143 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.4 mtm -93.42 106.09 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.294 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.68 HG23 HD13 ' B' ' 75' ' ' ILE . 7.2 mt -85.82 100.97 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.845 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 74' ' ' SER . . . 86.25 19.86 56.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.361 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.33 -46.31 1.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.595 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.4 pt-20 -65.72 139.69 97.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.663 0.268 . . . . 0.0 111.031 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.0 158.71 49.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -154.13 150.03 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.4 p -86.63 97.8 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.718 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -133.76 137.31 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.865 ' N ' HD22 ' A' ' 53' ' ' LEU . . . -162.25 145.4 10.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.551 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 79' ' ' LEU . 3.1 mm? -75.88 114.34 14.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.636 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.646 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -83.2 103.72 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.062 0.458 . . . . 0.0 109.843 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.852 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 m-20 -67.51 137.12 55.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.685 HG21 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -176.07 135.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.806 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -76.52 -61.97 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.221 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.99 89.56 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -118.63 -38.5 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 166.81 -30.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.22 -24.21 27.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 18.7 m-85 -56.6 -20.19 19.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -41.77 -30.26 0.23 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.768 0.318 . . . . 0.0 111.446 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -70.01 -48.66 57.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.081 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -88.56 49.55 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.552 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -99.45 -43.39 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.0 Cg_exo -58.12 -14.63 19.93 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.63 2.22 . . . . 0.0 112.979 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.713 HD22 ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -104.07 -15.6 15.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.103 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.82 ' O ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -132.9 22.07 4.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 15.1 p90 -46.61 114.33 2.67 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.106 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HG2' ' HA ' ' A' ' 105' ' ' CYS . 37.8 Cg_endo -65.72 -21.42 58.61 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.562 2.175 . . . . 0.0 112.32 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -65.92 -11.79 49.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.231 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' ' 72' ' ' TYR . 8.9 t -41.47 -48.55 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 111.47 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 75' ' ' THR . 2.6 m-20 -164.54 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.608 HG21 ' CB ' ' A' ' 175' ' ' ALA . 24.9 t -132.14 156.7 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE2' HG23 ' A' ' 101' ' ' ILE . 36.2 p90 -144.57 140.96 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 111.462 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.65 150.0 24.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.5 t -131.34 154.62 40.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.186 0.517 . . . . 0.0 111.913 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.503 ' N ' ' HA ' ' A' ' 14' ' ' VAL . 10.1 p -68.15 172.93 5.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.815 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CZ ' ' CD2' ' A' ' 145' ' ' LEU . 0.9 OUTLIER 179.44 100.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.62 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 m -58.57 91.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.882 HG11 ' HB2' ' A' ' 142' ' ' ALA . 10.4 m -83.52 54.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.721 HG22 ' N ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -150.6 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.531 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.721 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.2 t -57.5 135.76 82.04 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.618 0.247 . . . . 0.0 110.64 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 98.4 Cg_endo -78.25 -39.42 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.548 2.165 . . . . 0.0 112.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.24 -24.02 6.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.18 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 93' ' ' VAL . 70.5 m -88.68 -40.34 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CZ ' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -42.32 -53.04 4.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.686 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -48.34 -55.41 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.364 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.0 m-20 -70.78 -37.89 73.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.189 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.944 HG23 ' O ' ' A' ' 89' ' ' SER . 98.6 t -44.09 -45.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.639 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -85.69 -47.79 9.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.38 7.67 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -128.56 -38.09 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.908 ' CE3' HG13 ' A' ' 93' ' ' VAL . 46.1 m0 -95.13 -26.54 15.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.61 HG23 ' HA ' ' A' ' 94' ' ' LYS . 59.7 t -67.35 -44.1 45.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.563 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 41.6 Cg_exo -56.87 -34.98 98.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.324 2.016 . . . . 0.0 112.308 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.16 -33.29 74.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.536 HG23 ' CE2' ' A' ' 78' ' ' PHE . 47.6 mt -49.17 -40.25 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.5 p -77.3 -21.44 53.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.328 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.45 -37.2 77.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.86 0.362 . . . . 0.0 110.678 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 73' ' ' PRO . 22.1 m-70 -106.51 -39.75 5.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.813 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 3.9 m -99.25 102.74 16.9 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 87.6 Cg_exo -42.99 -62.29 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.479 2.119 . . . . 0.0 112.403 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -171.67 40.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 155.76 41.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.646 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.91 118.21 2.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.457 2.104 . . . . 0.0 112.179 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.2 p90 -104.89 141.99 35.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.319 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 111' ' ' LEU . 3.5 mt -129.49 158.11 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.989 0.423 . . . . 0.0 111.244 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.8 m -156.56 155.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.44 39.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 158' ' ' SER . 73.0 p -146.29 160.04 42.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.699 0.285 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.42 35.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 157' ' ' CYS . 20.0 mt -97.04 -61.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.987 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.66 -35.88 11.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.79 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 119' ' ' LEU . 6.0 tt -70.52 -32.21 69.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HG3' HG23 ' A' ' 85' ' ' VAL . 7.0 ttm180 -76.63 59.38 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -129.21 37.29 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.87 141.64 22.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.44 -49.57 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.556 2.171 . . . . 0.0 112.265 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m -57.77 -22.98 49.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.547 HG22 HD12 ' A' ' 129' ' ' LEU . 5.2 m -48.83 -66.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.69 -45.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -50.19 52.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -81.37 -35.09 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 125' ' ' THR . 2.8 mt -50.91 -25.56 4.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.495 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.26 -21.41 56.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.081 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -83.38 -20.05 34.93 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.98 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.89 30.55 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 77.79 32.95 0.38 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.39 -161.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.14 93.25 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 37.5 Cg_endo -66.2 124.85 13.12 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.548 2.165 . . . . 0.0 112.064 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.508 HG21 ' CA ' ' A' ' 84' ' ' VAL . 3.7 mt -50.55 120.29 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -118.12 158.41 46.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 3.7 Cg_exo -40.3 -29.42 0.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.071 2.514 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -36.75 21.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' THR . 93.5 m -48.05 -47.61 33.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.882 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -49.31 -46.58 46.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -57.66 -42.95 84.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.42 -53.47 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 14.8 tp -57.26 -31.95 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.467 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.875 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -66.66 -31.59 72.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -70.34 -47.64 60.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -23.14 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 pp -106.3 -24.26 12.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.073 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 1.2 tttt 62.16 120.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.845 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.7 -161.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 5.1 t -67.37 -15.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.574 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.32 146.02 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.875 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 24.3 p90 -152.79 126.25 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.186 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.1 t -138.12 123.39 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -170.73 -179.63 2.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.469 ' HB2' HD11 ' A' ' 117' ' ' ILE . 17.6 p -130.62 -173.22 3.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 115' ' ' THR . 8.7 t -87.15 163.2 17.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.702 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.75 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.25 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.058 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.75 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 69.73 -63.25 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.64 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.2 p -89.51 -169.62 2.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.484 ' OE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -172.56 109.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -100.39 -38.75 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.44 88.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.304 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -91.98 -11.54 35.8 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -34.22 37.36 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -57.09 -45.43 83.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.283 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' VAL . 31.1 t -54.76 -52.96 37.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.472 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' CB ' ' HH ' ' A' ' 23' ' ' TYR . 1.4 m-30 -70.15 -28.25 65.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -53.93 -52.12 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.775 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 1.5 tp10 -89.9 -33.9 16.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -66.14 -38.38 88.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.858 HD12 ' HG ' ' A' ' 53' ' ' LEU . 42.3 mm -86.66 -44.17 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.4 tm? -64.43 -31.94 73.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 77' ' ' VAL . . . -51.75 -29.29 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.647 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -63.64 -20.98 66.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.18 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.71 38.3 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.475 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 12.1 tp10 -78.27 -46.65 2.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.286 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 178' ' ' GLU . 90.3 Cg_endo -81.3 145.99 15.39 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.401 2.068 . . . . 0.0 112.324 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.72 156.71 56.86 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.536 2.157 . . . . 0.0 112.273 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.484 ' HB2' ' CD ' ' A' ' 182' ' ' PRO . 1.4 mt-10 -160.12 -66.46 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.484 ' CD ' ' HB2' ' A' ' 181' ' ' GLU . 33.7 Cg_endo -63.95 82.99 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.486 2.124 . . . . 0.0 112.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.14 168.8 16.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -50.45 -27.49 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.339 . . . . 0.0 110.898 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -144.03 137.41 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.867 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -138.65 133.54 32.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.604 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -77.2 143.23 69.28 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.59 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 42' ' ' VAL . 51.3 Cg_exo -54.12 152.36 24.84 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.352 2.035 . . . . 0.0 112.062 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -117.19 -37.07 3.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.89 163.05 27.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 27.6 t80 -167.46 130.35 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.624 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -153.42 116.67 4.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 69.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.427 ' N ' ' O ' ' B' ' 82' ' ' GLU . 8.2 p -57.9 -77.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.247 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.783 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -103.76 139.44 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.499 . . . . 0.0 112.279 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -123.11 96.21 4.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.101 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' A' ' 36' ' ' VAL . 57.7 t -88.08 144.51 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.891 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.36 176.85 20.05 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.989 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -77.35 113.42 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.568 ' CB ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -107.99 108.05 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.66 -17.2 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.307 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' VAL . . . . . 0.529 HG12 ' CG ' ' B' ' 90' ' ' ASP . 10.2 p -43.01 -35.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.509 HG23 HG22 ' B' ' 92' ' ' VAL . 18.2 p -157.79 45.33 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.05 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.54 27.39 5.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.62 -168.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.719 0.295 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 1.081 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -106.0 164.49 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.829 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.568 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.9 p -99.45 165.31 11.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.964 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.419 ' CA ' ' OG1' ' B' ' 113' ' ' THR . . . 49.09 51.73 24.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.762 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -60.48 119.33 42.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.665 ' HG3' HG21 ' B' ' 85' ' ' ILE . 58.4 Cg_exo -49.56 156.46 2.9 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.291 1.994 . . . . 0.0 112.146 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.67 -57.1 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.455 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.422 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.1 tm0? -69.94 -52.52 23.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.225 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -50.1 -57.77 6.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.725 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.616 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -48.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.204 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 77.5 mtt180 -54.76 -34.29 62.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.242 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.659 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.05 -61.04 2.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.925 0.393 . . . . 0.0 109.978 179.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.681 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -70.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.15 178.324 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.556 ' C ' HG22 ' B' ' 109' ' ' THR . 4.0 pt20 -80.74 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.203 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.556 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.05 62.58 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.459 0.304 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 110' ' ' SER . . . . . 0.616 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.1 OUTLIER 168.41 108.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.384 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.8 OUTLIER -65.39 74.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.5 OUTLIER -57.48 87.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.196 0.522 . . . . 0.0 111.311 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.419 ' OG1' ' CA ' ' B' ' 98' ' ' GLY . 4.2 m 179.92 -50.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.173 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -36.69 2.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.757 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.77 108.18 13.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.51 -83.56 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -73.59 109.9 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.604 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 69.44 140.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.27 144.68 46.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 53' ' ' LEU . 9.1 pt -119.87 114.57 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 0.8 OUTLIER -135.11 100.05 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -77.93 130.21 36.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.803 HG13 HG21 ' A' ' 75' ' ' THR . 2.1 m -96.67 150.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 16' ' ' LYS . 17.9 t -125.63 154.29 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.362 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 59' ' ' ALA . 7.2 p -149.64 121.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.738 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . 130.6 -179.52 16.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.93 -179.53 5.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.48 77.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.379 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 81' ' ' CYS . . . 53.41 84.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.738 HG11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -109.23 4.26 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.286 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.865 ' CA ' HD12 ' A' ' 19' ' ' LEU . . . 97.09 -18.19 57.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.281 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.818 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -62.92 -74.19 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.773 0.321 . . . . 0.0 111.515 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.796 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -96.62 -25.88 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 19' ' ' LEU . 2.1 p -65.61 -48.11 73.38 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.705 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD12 ' CA ' ' A' ' 15' ' ' GLY . 4.3 mt -61.26 -73.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.349 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 40' ' ' TYR . 11.2 mt -40.8 -43.42 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.981 0.419 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.773 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -48.71 -69.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.806 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 1.8 t -93.79 -55.39 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CZ ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -51.96 -19.25 1.7 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.498 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.452 ' CB ' ' HA ' ' A' ' 20' ' ' LEU . 43.2 m -123.94 -86.23 0.64 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.232 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.453 ' CG2' ' HD3' ' A' ' 27' ' ' LYS . 4.7 t -65.83 -14.21 60.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' ILE . 36.0 t30 79.03 -56.28 0.44 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.908 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -47.74 145.74 2.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.996 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.773 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -88.48 167.01 20.32 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.7 Cg_endo -45.82 165.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.993 2.462 . . . . 0.0 112.688 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.8 t -119.56 -76.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.98 113.94 25.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.643 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.28 109.3 4.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 111.056 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' HD2' ' A' ' 34' ' ' PRO . 67.2 t -157.52 138.03 9.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.478 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 84.3 Cg_exo -43.81 92.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.314 2.009 . . . . 0.0 111.617 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.813 HG23 ' CG ' ' A' ' 38' ' ' ASP . 56.8 m -51.98 87.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 34' ' ' PRO . 20.9 t -79.54 -28.23 12.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 109.762 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' B' ' 85' ' ' ILE . 3.7 t80 -146.62 -68.76 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.813 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.2 m-20 60.47 131.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.389 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' HB2' HD12 ' B' ' 85' ' ' ILE . 5.6 t-20 -108.0 159.81 16.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.796 ' OH ' HG23 ' A' ' 17' ' ' THR . 3.7 m-85 -152.18 157.44 41.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -115.29 137.94 51.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.176 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 41' ' ' ALA . 3.2 m -162.2 164.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 51' ' ' TYR . 84.8 m -155.94 99.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.483 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 76' ' ' SER . 3.1 m -98.54 117.15 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.5 mtm -91.37 102.12 14.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.21 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 177' ' ' LEU . 1.7 mp -87.3 107.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 20.84 77.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.39 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -141.67 100.47 6.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.949 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.38 155.95 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.501 2.134 . . . . 0.0 112.196 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.67 ' H ' HG23 ' A' ' 43' ' ' THR . 2.3 m-85 -154.16 169.63 23.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 111.327 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 97.22 4.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.321 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -105.04 161.26 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 111.375 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.833 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -160.27 127.3 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.057 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.043 HD11 HD23 ' A' ' 79' ' ' LEU . 1.8 mm? -75.93 103.23 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.9 103.0 12.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.022 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 58' ' ' THR . 1.5 m-20 -78.19 142.57 37.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 57' ' ' ASP . 2.2 p -167.72 178.68 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . . . -127.17 -66.71 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . 104.06 54.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.757 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER 170.48 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.324 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' A' ' 61' ' ' LEU . 22.7 mt-10 -85.79 89.96 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.186 0.517 . . . . 0.0 111.886 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 61.71 13.66 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.02 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.838 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 93.7 m-85 -102.62 -29.07 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -49.21 -27.37 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -93.49 -31.54 14.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.699 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -94.02 24.16 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -85.31 -46.31 0.63 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.205 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.7 Cg_exo -50.16 -23.15 9.14 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.834 HD22 ' CG ' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -76.24 -26.05 55.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.339 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.447 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 2.3 m -92.62 -23.42 19.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 2.0 p90 46.29 102.7 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.501 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.81 -34.28 8.29 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.657 2.238 . . . . 0.0 112.663 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.83 -10.66 50.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.563 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 HG13 ' A' ' 7' ' ' VAL . 8.3 t -38.42 -51.66 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.2 OUTLIER 167.97 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.9 p -58.44 162.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.5 135.46 40.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.043 HD23 HD11 ' A' ' 55' ' ' LEU . 12.6 tp -109.95 115.78 30.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.059 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.482 ' HB ' HD23 ' A' ' 112' ' ' LEU . 2.1 t -131.23 145.86 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.434 ' HB3' ' CA ' ' A' ' 14' ' ' VAL . 11.4 t -139.17 158.66 43.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.913 ' HB3' HG11 ' A' ' 93' ' ' VAL . 7.6 p90 -152.37 149.52 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -51.36 160.77 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.802 HG13 HG22 ' A' ' 137' ' ' ILE . 73.0 t -109.09 -69.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 125' ' ' THR . 67.0 t -52.03 -73.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.88 106.16 0.61 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD3' HG23 ' A' ' 125' ' ' THR . 68.8 Cg_endo -74.3 -25.76 13.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.528 2.152 . . . . 0.0 112.551 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.69 -24.16 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.8 m -96.15 -30.69 13.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.158 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.95 -69.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.125 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -50.47 -48.29 56.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' CA ' ' HG3' ' A' ' 96' ' ' LYS . 1.5 m-80 -53.2 -69.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 82' ' ' PHE . 61.5 t -40.45 -30.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.925 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.61 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.38 8.42 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.953 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG3' ' CA ' ' A' ' 92' ' ' ASN . 21.8 mmtm -113.3 -44.79 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.611 ' HD1' HG13 ' A' ' 93' ' ' VAL . 10.4 m95 -95.55 -36.79 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 94.1 t -52.5 -44.74 95.2 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.511 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 52.9 Cg_exo -52.51 -28.47 36.35 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.288 1.992 . . . . 0.0 112.288 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -77.94 -22.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 80' ' ' VAL . 21.6 mm -49.17 -31.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -85.01 -24.87 28.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 60' ' ' GLY . 9.9 t60 -65.78 -37.22 85.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -103.71 -19.66 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.256 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 12.2 m -152.88 74.49 7.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.761 0.315 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -12.57 33.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.617 2.211 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.57 21.16 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.255 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 135.67 25.04 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.85 159.63 4.87 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.498 2.132 . . . . 0.0 112.148 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 16.5 p90 -135.76 134.93 39.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 154' ' ' TYR . 4.6 mt -111.85 122.03 46.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' CE2' ' A' ' 82' ' ' PHE . 12.4 mt -91.15 162.94 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' PHE . 49.0 t -152.79 141.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.1 104.45 0.35 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.392 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 157' ' ' CYS . 71.1 p -137.84 137.56 38.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER 177.32 71.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 pt -98.69 -22.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.7 -24.41 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 116' ' ' GLN . 5.9 tt -75.15 -27.91 59.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.62 ' CB ' HG21 ' A' ' 85' ' ' VAL . 1.1 ptp180 -50.22 139.66 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.65 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.023 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -54.16 120.94 27.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.2 -41.42 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t -49.53 -31.67 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 129' ' ' LEU . 85.7 m -56.83 -58.98 5.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -51.38 -45.34 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -42.53 61.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -37.27 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 125' ' ' THR . 4.4 mt -50.71 -25.51 4.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.496 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.62 -20.46 53.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.21 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -81.3 -27.03 35.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.8 -8.36 57.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.454 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 62.89 26.45 15.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -100.84 -26.33 13.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.77 168.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.27 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.802 HG22 HG13 ' A' ' 84' ' ' VAL . 5.6 mt -51.52 135.37 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.224 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -132.31 177.75 2.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -53.35 -21.15 16.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.64 -42.34 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.499 ' HB ' HG23 ' A' ' 137' ' ' ILE . 22.7 m -50.88 -46.75 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.27 -40.43 58.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -43.87 97.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -51.55 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.799 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.78 -44.42 77.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -60.47 -31.38 70.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.86 -44.11 86.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.53 -50.64 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -68.14 -27.32 66.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.5 OUTLIER 70.59 108.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.82 -162.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 152' ' ' VAL . 57.3 t -67.34 -11.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.678 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 73.87 139.77 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.703 0.287 . . . . 0.0 110.86 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 24.6 p90 -153.11 162.64 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 155' ' ' VAL . 26.9 m -158.32 124.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.624 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -171.06 166.37 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.574 ' O ' HG21 ' A' ' 115' ' ' THR . 18.2 p -113.82 -173.13 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.413 ' CA ' ' HB ' ' A' ' 115' ' ' THR . 8.4 t -87.61 166.81 14.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.898 0.38 . . . . 0.0 111.029 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.664 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.16 -174.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.412 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.664 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.4 mm? 67.72 -64.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 166.14 11.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.873 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -142.01 122.94 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -105.07 -37.33 6.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 165.44 79.87 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.873 HD11 ' NE2' ' A' ' 162' ' ' GLN . 4.0 mt -83.89 -25.14 30.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 111.029 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -52.78 -31.46 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 166' ' ' LYS . 12.1 m-80 -65.28 -65.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.74 -27.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -74.3 -35.13 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.272 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.444 ' CB ' HG13 ' B' ' 75' ' ' ILE . 5.1 t70 -63.26 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.516 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 -25.6 25.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.769 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.99 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.054 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 46' ' ' ILE . 31.6 mm -94.8 -23.71 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.8 tt -72.5 -45.96 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.87 71.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.553 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -90.63 -19.67 23.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -47.47 -41.54 20.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.151 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.06 -83.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 46' ' ' ILE . 8.4 mm -91.67 140.03 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.481 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.9 m -128.38 139.58 52.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -75.88 138.73 69.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.551 ' CB ' HG12 ' A' ' 42' ' ' VAL . 65.6 Cg_exo -51.3 146.85 22.98 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.461 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 30.8 t -108.41 -51.3 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 1.5 t0 -77.49 167.88 20.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 6.5 t80 171.41 124.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -153.19 132.38 12.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 111.382 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -68.91 95.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.472 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -74.51 -62.86 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.576 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.513 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -116.87 113.94 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.888 0.375 . . . . 0.0 111.499 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.08 96.91 7.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.198 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.463 HG22 ' HD3' ' B' ' 100' ' ' PRO . 39.4 t -79.31 137.77 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.445 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -133.14 177.56 18.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -77.26 136.48 38.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' B' ' 97' ' ' THR . 10.0 t0 -124.21 110.1 14.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.11 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.752 HG12 HG23 ' B' ' 93' ' ' THR . 48.9 t -40.98 -48.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.848 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.752 HG23 HG12 ' B' ' 92' ' ' VAL . 3.4 p -155.48 50.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 47.73 33.42 9.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.421 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' B' ' 90' ' ' ASP . 11.8 pt-20 -118.31 -178.01 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.325 . . . . 0.0 110.79 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.802 ' HE2' HD13 ' A' ' 67' ' ' LEU . 2.3 m-85 -101.95 164.23 11.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.503 HG22 HD13 ' B' ' 112' ' ' ILE . 19.4 p -109.78 168.86 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 48.71 27.58 6.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.568 ' CE ' HD21 ' A' ' 67' ' ' LEU . 2.7 mtp -52.64 131.11 46.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.593 0.235 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.483 ' CA ' HG21 ' B' ' 85' ' ' ILE . 81.3 Cg_exo -49.5 145.74 15.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.554 2.17 . . . . 0.0 112.19 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -45.59 -39.93 8.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -78.57 -51.12 10.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.525 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.555 ' HA ' HD13 ' A' ' 70' ' ' LEU . 2.6 m0 -53.76 -55.43 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 109.622 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.541 ' HB1' HE21 ' B' ' 108' ' ' GLN . . . -51.64 -62.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.841 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 15.9 ptt85 -55.95 -36.31 67.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.301 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.834 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -46.83 -63.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -96.2 -69.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.193 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.563 ' C ' HG22 ' B' ' 109' ' ' THR . 0.4 OUTLIER -80.4 -105.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.071 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.563 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.34 -24.14 0.0 OUTLIER 'General case' 0 C--N 1.351 0.653 0 C-N-CA 122.43 0.292 . . . . 0.0 111.361 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.432 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.0 OUTLIER -109.5 107.9 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.332 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -43.43 -50.81 6.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 110.847 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.542 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -103.15 132.43 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -103.49 153.22 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.002 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 3' ' ' THR . 5.4 pt -158.04 121.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.981 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 112.88 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -91.86 128.73 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.817 HG21 ' CB ' ' A' ' 71' ' ' SER . 59.1 t -107.24 159.06 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.994 0.426 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 79' ' ' LEU . 4.9 m -126.79 163.24 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 80' ' ' VAL . 3.5 t -153.68 123.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.212 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 14' ' ' VAL . . . 147.7 168.97 14.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.735 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -60.0 -152.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -40.73 141.48 0.92 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 55.89 62.48 2.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.182 0.515 . . . . 0.0 109.701 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.741 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.9 t -54.68 -19.62 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 132.6 -36.04 2.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.795 ' N ' HG11 ' A' ' 8' ' ' VAL . 7.5 mmtt -95.91 -73.71 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.237 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.619 HG22 ' OD2' ' A' ' 57' ' ' ASP . 4.7 t -36.09 -53.06 0.79 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 5.4 p -63.8 -48.6 76.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.785 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 15' ' ' GLY . 12.5 mt -55.71 -72.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 55' ' ' LEU . 8.6 mt -38.09 -43.05 0.71 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.588 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -49.4 -69.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -93.47 -54.16 3.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.157 0.503 . . . . 0.0 111.452 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.818 ' HA ' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -51.31 -21.82 2.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.411 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 77.2 m -120.63 -88.07 0.63 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.832 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.76 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 5.0 t -54.89 -30.46 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.219 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.6 OUTLIER 76.64 51.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -158.83 116.28 2.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.768 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -45.85 168.39 0.11 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.884 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 61.7 Cg_exo -53.05 158.32 6.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.743 2.295 . . . . 0.0 112.981 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.1 t -107.44 -76.25 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.779 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.45 108.04 19.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.377 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.8 100.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.45 . . . . 0.0 111.161 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 ' HD2' ' A' ' 34' ' ' PRO . 96.5 t -151.51 139.51 12.85 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.207 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 36' ' ' VAL . 98.1 Cg_exo -41.58 91.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.385 2.056 . . . . 0.0 112.04 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 38' ' ' ASP . 93.0 m -54.25 87.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 34' ' ' PRO . 59.5 t -85.99 -24.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.398 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.6 t80 -142.39 -66.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.907 ' CG ' HG23 ' A' ' 35' ' ' THR . 6.1 m-20 53.71 107.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 41.7 t30 -107.6 153.08 23.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.794 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CE1' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.47 168.82 22.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.71 115.62 28.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.712 HG22 HD11 ' A' ' 55' ' ' LEU . 12.3 m -134.38 137.68 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.658 HG23 ' H ' ' A' ' 51' ' ' TYR . 55.1 m -136.7 108.59 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG12 ' O ' ' B' ' 76' ' ' SER . 4.8 m -98.24 117.29 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.052 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 27.2 mtm -79.4 100.98 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 173' ' ' ILE . 5.6 mm -87.95 91.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.43 16.04 74.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.709 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.09 25.8 10.9 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.736 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.0 mt-10 -124.65 131.26 24.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.554 0.216 . . . . 0.0 110.793 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 159.07 28.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.466 2.111 . . . . 0.0 112.271 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.658 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -154.04 161.51 41.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -136.44 97.42 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.531 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 53' ' ' LEU . 9.0 tt -107.34 131.76 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.266 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -97.17 134.24 11.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.252 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.932 HD22 ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -113.19 103.1 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.945 0.402 . . . . 0.0 110.905 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 4.1 m-85 -102.11 111.28 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.619 ' OD2' HG22 ' A' ' 17' ' ' THR . 4.5 t70 -88.01 171.4 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.426 ' O ' HG21 ' A' ' 14' ' ' VAL . 8.4 p -139.56 -175.7 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.715 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -101.02 -23.44 14.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.071 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . . . 74.71 51.78 7.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.359 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.0 174.89 11.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.88 30.77 2.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.1 28.81 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.877 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.8 m-85 -101.14 -11.74 19.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -43.06 -28.51 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.675 0.274 . . . . 0.0 111.592 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 3.5 mtt85 -45.02 -62.82 1.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.763 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.3 mp -72.33 173.5 8.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 5.2 tpp180 -101.0 -72.66 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.5 Cg_endo -71.4 -58.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.036 1.824 . . . . 0.0 113.06 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 64' ' ' TYR . 63.4 mt 50.1 25.65 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.817 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER 164.17 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.02 175.25 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 111.072 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 34.3 Cg_exo -61.9 -24.41 77.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.645 2.23 . . . . 0.0 112.17 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -68.06 -10.12 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.608 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -36.94 -32.15 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t0 51.62 -151.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.537 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 175' ' ' ALA . 40.6 t -57.56 156.2 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.692 0.282 . . . . 0.0 110.478 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -113.34 134.51 54.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.808 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.93 122.22 44.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.08 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 t -130.35 101.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.0 t -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.669 ' CB ' HG11 ' A' ' 93' ' ' VAL . 38.2 p90 -137.34 124.68 21.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.008 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 p -52.96 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.2 86.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.666 HG12 ' OE1' ' A' ' 116' ' ' GLN . 30.3 m -122.92 75.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.79 148.48 0.12 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 51.9 Cg_exo -54.6 -19.34 17.88 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.749 2.299 . . . . 0.0 112.591 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 t -46.59 -73.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.39 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.3 m -61.28 -24.57 66.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -51.32 -58.96 4.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.035 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -49.65 -60.72 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -53.32 -63.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' SER . 72.9 t -41.14 -29.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.959 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.9 tttt -74.84 -69.51 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.664 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.73 7.98 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.39 -43.34 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.648 0.261 . . . . 0.0 111.553 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.663 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.1 m95 -95.3 -40.12 9.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.5 t -52.65 -44.2 94.64 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.512 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.4 Cg_exo -59.79 -28.82 88.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.278 1.985 . . . . 0.0 112.235 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -24.29 60.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.7 mt -49.48 -27.81 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -76.87 -28.15 55.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -70.81 -44.8 65.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CE1' ' CD2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -89.02 -33.72 17.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 2.7 m -107.6 129.63 23.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.654 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.61 -83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.444 2.096 . . . . 0.0 112.64 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -153.52 83.68 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.854 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -151.59 163.92 22.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.854 ' HD2' HG22 ' A' ' 108' ' ' THR . 59.4 Cg_exo -52.09 130.24 34.27 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.451 2.101 . . . . 0.0 112.037 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -102.6 125.77 49.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -106.69 121.4 44.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.687 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -114.1 162.59 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.087 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 114' ' ' GLY . 3.1 t -146.84 166.3 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -161.12 101.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.529 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' GLY . 41.2 p -158.48 142.23 15.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.431 . . . . 0.0 111.238 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.666 ' OE1' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -174.79 40.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.453 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 158' ' ' SER . 10.1 mt -37.83 -37.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.838 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.59 -43.82 96.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.741 HD23 ' OD2' ' A' ' 122' ' ' ASP . 2.0 mt -86.99 -45.55 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 5.1 tmm_? -48.93 -26.24 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.9 46.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' A' ' 119' ' ' LEU . 2.3 m-20 -107.23 156.09 38.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.05 -49.89 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.17 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -50.05 -47.71 53.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -51.99 -31.76 30.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.218 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 24.0 mm -63.56 -54.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.66 -40.91 13.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -84.86 -37.84 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -49.58 -32.73 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.337 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.01 65.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.103 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -24.02 19.67 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.314 . . . . 0.0 110.867 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 18.7 m120 -95.98 30.19 2.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 26.65 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 49.19 -166.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.58 86.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.876 ' HA ' HD21 ' A' ' 129' ' ' LEU . 74.0 Cg_exo -48.38 169.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.575 2.184 . . . . 0.0 112.317 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.1 mt -94.13 130.27 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -110.75 168.42 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.962 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 48.8 Cg_exo -56.58 -17.74 23.37 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.714 2.276 . . . . 0.0 112.562 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -82.55 -32.93 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.194 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.3 m -56.69 -62.78 1.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.971 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.95 -50.58 26.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 tt0 -55.38 -39.86 70.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -53.66 -54.73 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.645 HD13 ' CE1' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -54.57 -37.15 65.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.692 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.796 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.23 -46.78 82.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -57.76 -44.68 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.626 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -22.29 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.037 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.563 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 2.9 pp -121.38 21.27 11.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 43.9 tttm 56.16 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.07 174.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.044 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 60.9 t -59.49 -17.76 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.46 135.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.647 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.796 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 13.6 p90 -152.9 154.82 35.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.363 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 168' ' ' VAL . 35.0 m -155.07 123.67 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.23 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.6 pt-20 -170.88 -178.68 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 111.111 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.8 p -127.91 -170.37 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.018 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.544 ' HB3' HD12 ' A' ' 117' ' ' ILE . 1.7 t -85.35 174.52 9.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.755 0.312 . . . . 0.0 110.288 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.509 ' HB1' ' OG ' ' A' ' 22' ' ' SER . . . -34.36 -85.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.05 -171.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.499 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 162' ' ' GLN . 4.3 p 64.72 -67.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.836 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.1 OUTLIER 54.53 94.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 110.783 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -105.18 -67.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.1 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.96 77.84 0.38 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.793 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.818 HD21 ' HA ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -93.7 -29.05 15.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' B' ' 77' ' ' LEU . 4.6 mmtp -54.62 -60.25 3.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.294 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -43.31 -37.06 2.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 156' ' ' GLU . 23.9 t -59.37 -62.28 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.755 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.75 ' CE1' HD21 ' B' ' 77' ' ' LEU . 66.2 m-85 -52.08 -28.94 19.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.474 ' OD1' HG21 ' B' ' 75' ' ' ILE . 1.9 m-20 -63.07 -41.8 99.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -88.62 -45.55 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 110.908 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.7 70.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.682 HG21 HD11 ' A' ' 46' ' ' ILE . 50.0 mm -86.35 -52.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 174' ' ' LEU . 3.4 tm? -55.05 -39.65 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.477 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -53.64 -47.4 70.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.87 35.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.7 tp -50.85 -44.83 59.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.037 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -44.38 96.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.474 HG21 ' OD1' ' A' ' 170' ' ' ASP . 7.2 tt -143.98 151.94 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -134.7 154.72 51.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.025 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -89.09 137.45 29.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.446 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 50.7 Cg_exo -55.25 -63.6 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.45 2.1 . . . . 0.0 111.793 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.88 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.164 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.79 88.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.76 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -118.79 -173.12 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.02 128.97 10.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.6 85.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.433 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.493 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -53.87 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -120.73 154.18 24.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 96.75 4.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.531 HG12 ' HB ' ' A' ' 36' ' ' VAL . 86.0 t -80.18 121.65 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.462 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -125.87 177.27 17.16 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.127 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.3 138.52 39.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 111.004 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.856 ' HB2' HG23 ' B' ' 97' ' ' THR . 4.4 t0 -139.0 112.94 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.16 60.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.646 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.596 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -41.22 -33.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.606 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.596 HG22 HG13 ' B' ' 92' ' ' VAL . 3.8 t -140.09 -37.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.96 20.96 1.59 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.71 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.34 -158.63 0.9 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.6 0.238 . . . . 0.0 110.394 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.42 ' CD1' HG11 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -103.41 164.53 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.803 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.856 HG23 ' HB2' ' B' ' 90' ' ' ASP . 11.5 p -95.73 162.53 13.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.1 46.18 33.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.568 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -61.53 124.36 80.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.561 0.219 . . . . 0.0 110.862 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.54 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 63.7 Cg_exo -50.62 159.66 2.1 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.366 2.044 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.01 -57.26 3.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.276 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -72.51 -56.09 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.613 ' CE2' HD23 ' A' ' 70' ' ' LEU . 8.6 m0 -46.24 -55.34 7.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -54.76 -45.94 74.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.109 0.481 . . . . 0.0 110.447 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 55.0 mtp85 -58.52 -41.41 85.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.88 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -50.3 -55.88 13.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.253 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.32 -69.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.758 ' O ' HG23 ' B' ' 109' ' ' THR . 8.8 tp60 -79.14 -100.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -168.17 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 120.872 0.367 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.409 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -150.95 174.25 13.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.217 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.58 72.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.621 0.725 . . . . 0.0 111.608 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.824 0.345 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.1 124.08 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.21 141.03 28.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.467 HG23 ' OD2' ' A' ' 76' ' ' ASP . 3.9 mt -146.7 129.34 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -131.65 95.35 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.568 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.9 t -77.35 100.44 5.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.722 HG23 ' OG1' ' A' ' 75' ' ' THR . 94.0 t -84.4 113.25 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.656 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.965 HG12 ' HB3' ' A' ' 79' ' ' LEU . 27.4 m -85.04 140.0 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.549 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 80' ' ' VAL . 11.8 p -126.49 154.88 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.679 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . 147.6 -169.19 28.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.666 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.94 29.6 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -125.12 -41.57 0.36 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 85.64 -23.68 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 81' ' ' CYS . 28.7 m -48.7 -23.83 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.833 ' HA3' HG23 ' A' ' 113' ' ' VAL . . . -120.56 -33.78 0.99 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.603 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 10' ' ' GLY . 44.3 mtmt -63.82 -76.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 111.406 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.021 HG21 ' CG2' ' A' ' 35' ' ' THR . 17.4 p -98.24 -43.9 6.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.253 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 58.2 m -52.61 -23.82 7.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.757 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 23' ' ' TYR . 18.8 tp -61.8 -71.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 55' ' ' LEU . 14.2 mt -44.12 -29.13 0.57 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.8 mm -65.79 -45.12 92.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.369 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' LEU . 78.5 p -94.93 -13.15 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.81 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.003 ' CD1' HD13 ' A' ' 165' ' ' LEU . 2.9 m-30 -95.93 -67.45 0.85 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.612 HG22 ' HB2' ' B' ' 81' ' ' PHE . 58.6 m -82.74 -81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.647 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.702 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -47.23 -40.44 16.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.274 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t30 64.79 41.38 5.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.702 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -126.84 -159.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.38 155.66 76.21 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 65.1 Cg_exo -36.79 132.47 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.017 2.478 . . . . 0.0 113.118 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m -97.91 -82.83 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.556 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.78 108.77 20.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.45 109.29 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.294 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.4 p -160.63 133.23 4.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.383 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 36' ' ' VAL . 90.5 Cg_exo -41.26 93.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.353 2.035 . . . . 0.0 111.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 1.021 ' CG2' HG21 ' A' ' 17' ' ' THR . 23.8 m -53.07 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.328 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' B' ' 96' ' ' PHE . 2.2 t -77.48 -24.6 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -150.56 -75.49 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.699 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.748 ' CG ' HG23 ' A' ' 35' ' ' THR . 5.7 m-20 60.27 117.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.778 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.579 ' CB ' HD12 ' B' ' 85' ' ' ILE . 16.0 t-20 -107.13 156.66 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.557 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.06 168.97 22.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.258 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.31 138.76 53.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.0 m -147.04 131.45 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.2 m -116.66 103.12 10.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.883 HG22 ' HD3' ' B' ' 78' ' ' PRO . 40.6 t -98.91 121.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.041 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.3 mtm -87.05 100.09 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.011 HD12 ' CZ ' ' A' ' 51' ' ' TYR . 14.1 mt -98.3 93.82 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 17.34 79.93 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.364 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 35.52 5.43 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -141.19 128.33 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.483 0.182 . . . . 0.0 110.928 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 168.7 3.24 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.05 . . . . 0.0 112.232 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.011 ' CZ ' HD12 ' A' ' 46' ' ' ILE . 2.4 m-85 -147.96 156.08 42.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 p -130.52 99.93 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 54' ' ' GLY . 10.4 tt -133.53 160.56 37.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.783 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -153.4 149.27 20.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 20' ' ' LEU . 16.3 mt -99.14 104.11 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 111.214 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' A' ' 7' ' ' VAL . 5.5 m-85 -83.39 112.66 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 7.2 t70 -66.93 134.09 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 111.237 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -145.12 155.33 43.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.765 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.46 -176.37 4.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.212 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -110.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tp 50.29 -161.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.366 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -132.52 40.0 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -131.69 21.04 4.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 58' ' ' THR . 2.7 m-85 -111.34 -27.99 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.74 -41.28 22.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.825 ' HG3' HD12 ' A' ' 67' ' ' LEU . 4.1 ptp85 -69.06 -36.7 77.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.404 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -98.0 29.05 3.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.576 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 2.6 tpt180 -88.73 -66.12 0.16 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 87.5 Cg_exo -37.27 -31.28 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.844 2.363 . . . . 0.0 112.827 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -51.99 -31.53 29.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.722 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -91.8 -25.47 19.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.9 OUTLIER 50.47 170.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.748 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.2 Cg_exo -68.67 -20.78 40.04 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.075 2.517 . . . . 0.0 112.666 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.52 -10.95 39.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.512 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.5 t -48.71 -23.82 1.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 111.639 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 4' ' ' ILE . 4.2 m-20 77.25 -152.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.67 148.85 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 7' ' ' VAL . 4.6 m-85 -100.39 131.92 46.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.965 ' HB3' HG12 ' A' ' 8' ' ' VAL . 48.9 tp -103.74 115.97 31.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.137 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' VAL . 4.6 t -110.38 150.76 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 111.799 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 31.4 p -92.75 170.73 9.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -161.86 101.34 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.385 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.464 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 41.9 t -68.33 129.92 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 142' ' ' ALA . 27.4 m -121.51 49.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -115.68 -69.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -100.2 103.44 23.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.733 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 80.2 Cg_exo -44.8 -27.61 2.5 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.584 2.189 . . . . 0.0 112.504 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -64.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.8 m -58.33 -34.95 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -45.61 -41.35 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.263 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.77 -61.26 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.735 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.4 m-20 -59.63 -38.68 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 89' ' ' SER . 92.5 t -47.5 -52.75 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.2 tttm -65.16 -47.83 75.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.479 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -82.36 8.17 12.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.36 -37.41 2.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.67 0.271 . . . . 0.0 111.558 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.801 ' CE3' HG13 ' A' ' 93' ' ' VAL . 22.6 m0 -92.28 -28.93 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.67 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.804 ' O ' HG22 ' A' ' 101' ' ' ILE . 33.1 t -74.47 -44.09 5.62 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 27.0 Cg_exo -62.34 -23.11 74.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.321 2.014 . . . . 0.0 112.345 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.9 -14.9 27.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.618 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -46.62 -33.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.388 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 p -81.06 -34.19 32.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -61.9 -27.29 68.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.44 -24.58 9.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 101' ' ' ILE . 2.1 m -120.62 92.02 47.5 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 55.9 Cg_endo -70.18 99.33 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.634 2.223 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 44.29 41.55 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 109' ' ' PRO . 53.4 m -117.64 142.2 30.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 108' ' ' THR . 6.9 Cg_endo -49.28 133.86 30.58 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.852 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.8 p90 -115.45 149.54 37.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.996 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 148.03 46.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 tp -116.03 142.26 47.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.628 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.879 HG12 ' OE1' ' A' ' 156' ' ' GLU . 1.4 m -153.54 176.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.32 138.13 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.4 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.702 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -158.35 153.13 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.601 ' CB ' HG13 ' A' ' 85' ' ' VAL . 28.5 mm-40 -151.84 98.42 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.652 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.854 HD11 ' HB2' ' A' ' 157' ' ' CYS . 2.8 mt -90.44 -46.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -25.81 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.535 HD12 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -77.22 -43.09 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -52.2 -29.03 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.17 47.01 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.982 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -89.05 140.93 29.1 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.793 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.75 -36.56 33.38 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -82.63 -30.43 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.771 HG22 ' CD1' ' A' ' 129' ' ' LEU . 61.1 m -56.03 -63.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.7 mp -50.53 -39.16 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.1 -55.87 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.711 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.76 45.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.57 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.33 -26.28 4.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 110.368 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.69 -24.13 63.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.802 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -84.15 -22.76 30.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 9.1 m-80 -93.92 30.05 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt 70.58 28.21 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -160.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.44 82.57 0.17 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.809 ' HA ' HD21 ' A' ' 129' ' ' LEU . 54.1 Cg_exo -52.46 166.69 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 84' ' ' VAL . 4.8 mt -101.59 122.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.457 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.1 p -112.98 176.51 1.46 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.6 Cg_exo -54.56 -20.37 20.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.607 2.205 . . . . 0.0 112.371 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.72 -47.94 15.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.473 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.9 m -51.18 -49.83 60.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -53.2 -50.01 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.33 -35.63 77.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.809 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -59.09 4.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.8 tp -61.82 -27.29 68.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 154' ' ' TYR . . . -73.2 -31.89 64.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.47 -45.51 65.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -23.07 25.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.049 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.806 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.5 pp -108.48 -16.55 14.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt 75.12 -69.73 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 -172.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 152' ' ' VAL . 62.1 t -68.29 -8.95 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.748 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.49 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.977 0.417 . . . . 0.0 111.003 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CZ ' ' HB1' ' A' ' 146' ' ' ALA . 2.8 p90 -153.47 154.54 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.653 ' H ' HG22 ' A' ' 168' ' ' VAL . 2.6 m -158.2 124.47 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.769 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.879 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -171.18 166.65 7.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.412 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.7 p -123.48 -173.63 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.22 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 116' ' ' GLN . 3.6 p -88.2 162.86 16.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.91 -173.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER 52.14 30.14 7.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.02 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 -68.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.554 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.1 OUTLIER 60.82 105.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -102.3 -64.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.13 88.82 0.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.604 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.003 HD13 ' CD1' ' A' ' 23' ' ' TYR . 2.4 mt -93.95 -10.86 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.553 0.216 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -57.7 -41.13 81.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 110.332 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.402 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 4.0 m-80 -57.8 -50.97 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 155' ' ' VAL . 55.6 t -52.33 -66.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.179 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.402 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -49.15 -40.73 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.559 ' HA ' HD13 ' B' ' 75' ' ' ILE . 48.4 t0 -50.14 -55.49 14.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -48.81 66.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.83 -28.97 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.096 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 46' ' ' ILE . 26.0 mm -93.57 -27.67 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -26.4 62.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.12 5.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.29 52.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 177' ' ' LEU . 5.9 tt -48.97 -26.32 2.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.864 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.68 -85.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 44' ' ' VAL . 8.3 tt -135.12 151.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.088 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.611 ' O ' HG13 ' A' ' 44' ' ' VAL . 40.1 t -134.78 148.72 50.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.17 88.44 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.635 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.883 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.4 Cg_endo -52.42 -172.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.61 2.207 . . . . 0.0 112.004 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.406 ' O ' ' N ' ' B' ' 81' ' ' PHE . 34.4 p -165.93 -40.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.204 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 71.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.612 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.2 t80 -93.35 139.58 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -153.37 129.26 10.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 78.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 110.372 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.542 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.642 HG21 ' HA ' ' B' ' 100' ' ' PRO . 0.5 OUTLIER -131.16 101.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.561 0.219 . . . . 0.0 111.395 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . 0.456 ' O ' ' CD2' ' B' ' 86' ' ' HIS . 13.5 p-80 -85.4 96.78 9.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.51 HG12 ' N ' ' B' ' 88' ' ' GLY . 88.0 t -78.43 158.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.243 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.51 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -143.18 171.18 25.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.099 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.37 116.04 28.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.903 0.383 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.697 ' CB ' HG23 ' B' ' 97' ' ' THR . 49.9 t0 -136.51 124.06 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.23 0.72 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.976 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.848 HG13 HG23 ' B' ' 93' ' ' THR . 7.2 p -43.66 -29.09 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.861 0.362 . . . . 0.0 111.368 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.848 HG23 HG13 ' B' ' 92' ' ' VAL . 1.4 p -155.4 25.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.803 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.38 20.68 65.73 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.426 ' CD ' ' HG1' ' B' ' 93' ' ' THR . 17.5 pt-20 -125.29 -163.25 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.779 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -105.04 164.57 11.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.697 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.3 p -98.72 144.11 28.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.51 45.18 24.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.313 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.603 ' HE1' HD21 ' A' ' 67' ' ' LEU . 2.4 tpt -49.95 105.67 0.54 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.619 0.247 . . . . 0.0 110.998 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.642 ' HA ' HG21 ' B' ' 85' ' ' ILE . 74.2 Cg_exo -48.88 144.32 15.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.481 2.12 . . . . 0.0 112.22 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -46.87 -47.29 21.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.176 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.53 -65.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.812 ' CE3' HD23 ' A' ' 67' ' ' LEU . 4.0 m0 -49.51 -53.51 22.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.599 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.566 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -52.62 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.166 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 2.8 mtt-85 -51.24 -32.79 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.812 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.79 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -49.79 -57.64 6.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.685 HD21 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.54 -72.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.952 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.565 ' C ' HG22 ' B' ' 109' ' ' THR . 2.8 pt20 -81.98 -113.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.229 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.565 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 158.75 65.78 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.499 0.32 . . . . 0.0 111.071 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER 170.07 125.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 111.345 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.4 OUTLIER -84.98 75.34 10.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.332 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.604 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.25 121.31 15.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.26 151.83 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -144.55 120.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 143.18 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.1 m -136.04 155.3 50.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.795 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 71' ' ' SER . 41.9 t -138.19 158.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.633 HG13 ' OG1' ' A' ' 58' ' ' THR . 7.7 p -110.95 160.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.175 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.533 ' N ' HG22 ' A' ' 8' ' ' VAL . 7.4 p -151.53 133.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.57 177.25 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -76.98 117.82 18.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.56 178.69 16.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.342 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 18' ' ' CYS . . . -131.57 0.41 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 113' ' ' VAL . 3.8 t -54.81 -20.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.475 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.9 -109.3 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.452 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE2' HD23 ' A' ' 79' ' ' LEU . 3.9 mptp? -98.86 -53.88 3.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.577 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -43.85 -77.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.559 ' H ' HG23 ' A' ' 17' ' ' THR . 40.0 t -66.19 -24.72 66.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.953 0.406 . . . . 0.0 111.351 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 23' ' ' TYR . 15.4 tp -63.08 -72.78 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.357 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.995 HD11 HD23 ' A' ' 55' ' ' LEU . 1.3 mm? -41.59 -38.26 1.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.646 ' O ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -49.37 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.64 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -93.76 -50.21 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 112.001 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' A' ' 19' ' ' LEU . 2.6 t80 -53.75 -31.66 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 94.5 m -108.91 -87.7 0.5 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.551 -0.459 . . . . 0.0 112.119 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 21' ' ' ILE . 1.8 t -55.09 -24.75 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.558 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' SER . 17.6 t-20 72.21 51.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.806 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 21' ' ' ILE . 8.6 pttt -135.15 -167.48 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.512 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -124.72 154.33 70.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.794 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 88.0 Cg_exo -41.5 146.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.848 2.365 . . . . 0.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -103.01 -81.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.779 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.67 114.94 26.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.746 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.2 t80 -67.88 107.81 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 ' HD2' ' A' ' 34' ' ' PRO . 97.2 t -158.7 140.12 9.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.281 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.1 Cg_exo -43.51 91.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.381 2.054 . . . . 0.0 111.898 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.577 HG21 ' HB ' ' A' ' 17' ' ' THR . 23.3 m -52.5 89.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.271 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' PRO . 25.2 t -95.6 22.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.416 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.2 t80 168.04 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.178 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER 54.54 109.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.728 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.4 t30 -107.42 168.38 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD2' ' CE2' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -153.12 168.91 24.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.423 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.64 124.09 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.725 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 53' ' ' LEU . 27.4 m -150.15 138.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 51' ' ' TYR . 32.0 m -136.92 108.21 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.062 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 76' ' ' SER . 2.6 m -98.05 116.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 100.36 13.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.767 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 46' ' ' ILE . 2.9 mm -72.81 90.7 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.6 77.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 35.34 4.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.33 93.28 36.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.12 121.15 6.41 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.728 ' O ' HG23 ' A' ' 43' ' ' THR . 1.4 m-30 -117.34 162.62 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 52' ' ' THR . 2.7 t -112.88 97.24 6.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.572 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 54' ' ' GLY . 1.2 tt -107.72 160.1 15.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -155.12 100.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.365 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HD11 ' A' ' 20' ' ' LEU . 1.4 mm? -78.17 126.98 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 3.4 m-85 -108.7 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.607 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -74.27 -163.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.933 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.633 ' OG1' HG13 ' A' ' 8' ' ' VAL . 69.4 p -159.48 169.02 24.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . -73.45 -37.98 65.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 27.02 22.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -137.59 23.53 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 0.0 111.026 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 48.56 27.85 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.04 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.892 ' HB2' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -98.76 26.74 5.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.917 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -88.76 -22.26 23.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -43.94 -28.88 0.5 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -49.55 -60.48 2.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.848 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.9 mp -65.84 -176.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.383 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.55 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -100.85 -63.67 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 59.3 Cg_endo -95.42 -59.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.338 2.025 . . . . 0.0 113.001 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.917 HD13 ' CD2' ' A' ' 64' ' ' TYR . 23.3 mt 62.52 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 120.838 0.351 . . . . 0.0 110.761 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.861 ' CB ' HG21 ' A' ' 7' ' ' VAL . 25.6 p -90.98 -14.38 31.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.037 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 49.34 173.31 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.56 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.3 Cg_exo -68.0 -23.3 40.64 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.839 2.359 . . . . 0.0 112.282 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -11.95 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.1 t -47.49 -25.7 1.16 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.613 0.244 . . . . 0.0 111.506 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 47.33 -91.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.035 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 78' ' ' PHE . 44.9 t -95.37 161.23 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.553 0.216 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG12 ' A' ' 77' ' ' VAL . 9.4 m-85 -122.77 147.07 46.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 113' ' ' VAL . 1.9 mm? -103.91 147.15 27.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.065 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.32 97.18 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.09 100.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' A' ' 93' ' ' VAL . 38.6 p90 -116.84 144.02 45.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.14 164.4 24.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 115' ' ' THR . 32.2 m -131.63 42.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.993 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.45 72.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.99 153.65 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.045 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 90' ' ' PHE . 27.5 Cg_exo -61.51 -13.72 31.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.681 2.254 . . . . 0.0 112.58 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.6 t -43.41 -71.79 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.9 m -80.77 -26.91 36.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.546 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 1.7 t80 -47.67 -61.4 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.049 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -50.23 -54.44 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -54.26 -45.67 72.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 89' ' ' SER . 98.4 t -47.59 -50.04 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.414 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.3 mtmt -78.26 -44.42 25.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.422 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -77.84 5.32 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.48 -36.97 2.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.613 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -95.31 -41.96 8.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 94' ' ' LYS . 46.1 t -49.87 -44.49 78.41 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.359 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_exo -55.05 -31.08 73.26 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.284 1.989 . . . . 0.0 111.957 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.7 -17.33 26.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -45.33 -31.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.861 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.2 p -71.13 -42.91 68.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.444 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -52.21 -36.15 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.329 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.472 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m80 -89.95 -36.68 14.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 17.3 t -98.02 115.61 65.74 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.36 -63.78 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.428 2.086 . . . . 0.0 112.475 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.7 34.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.87 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -109.4 160.17 28.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.87 ' HD2' HG22 ' A' ' 108' ' ' THR . 50.0 Cg_exo -53.46 169.55 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.539 2.16 . . . . 0.0 112.392 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -127.39 143.28 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 124.29 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.949 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.32 162.56 14.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.712 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 79' ' ' LEU . 15.1 m -155.6 121.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.196 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.54 168.43 13.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.346 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.529 ' O ' HG21 ' A' ' 84' ' ' VAL . 12.8 t -172.51 -165.4 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.904 ' HG2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 66.73 94.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 157' ' ' CYS . 50.8 mt -98.61 -40.26 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.059 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.85 -27.84 66.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.904 HD12 ' HG2' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -62.22 -58.62 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.55 161.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.4 27.0 5.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -83.86 160.02 59.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.22 -38.37 61.17 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.535 2.157 . . . . 0.0 112.328 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -87.75 -29.76 20.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.0 m -53.17 -61.19 2.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -57.71 -37.66 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -58.42 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -33.87 62.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.562 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.703 HD21 ' N ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.48 -26.21 4.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.39 -24.01 66.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.798 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -94.1 -17.97 22.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -92.56 22.29 4.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.744 0.307 . . . . 0.0 111.093 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 10.7 mmmm 69.29 39.54 1.65 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.852 0.358 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 12.7 pt20 47.38 -163.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.088 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 64.65 84.56 0.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.703 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.5 Cg_endo -69.52 -177.62 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.637 2.225 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 3.9 mm -94.81 105.3 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.6 p -99.04 167.89 10.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 64.7 Cg_exo -51.77 -27.6 27.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.739 2.292 . . . . 0.0 112.179 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -91.15 -28.68 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.2 m -49.15 -48.63 44.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.14 -59.82 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -50.47 -36.05 31.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -51.04 67.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.522 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.529 HD21 ' HE2' ' A' ' 94' ' ' LYS . 16.5 tp -58.08 -34.22 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.491 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.881 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -58.06 -58.0 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -51.79 -41.23 61.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -51.26 -29.88 15.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.1 pp -126.69 21.92 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.75 -86.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 57.36 -178.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 152' ' ' VAL . 38.9 t -70.37 -7.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 77.03 151.02 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.853 0.358 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.949 ' OH ' HD12 ' A' ' 112' ' ' LEU . 8.2 p90 -152.63 148.49 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.08 124.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.289 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.31 172.3 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.747 ' HB3' HD11 ' A' ' 117' ' ' ILE . 2.3 m -131.57 -173.54 3.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -87.76 158.75 18.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 111.038 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.63 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -53.57 -172.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.5 mm? 67.14 -66.76 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.744 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 159' ' ' ALA . 10.0 p -76.13 -79.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.842 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.753 HE21 HD11 ' A' ' 165' ' ' LEU . 1.2 tt0 68.28 116.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -99.07 -67.96 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.71 96.04 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.455 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.753 HD11 HE21 ' A' ' 162' ' ' GLN . 0.2 OUTLIER -92.83 -10.77 35.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -54.88 -40.9 70.22 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.445 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 42.5 m-80 -55.51 -65.95 0.5 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 155' ' ' VAL . 7.4 p -51.41 -39.24 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CD2' ' HG ' ' B' ' 77' ' ' LEU . 0.1 OUTLIER -54.22 -43.27 70.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.492 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' HD13 ' B' ' 75' ' ' ILE . 22.9 t0 -62.56 -45.98 90.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 14.8 mm-40 -59.03 -26.07 64.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.33 -61.28 2.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.3 mp -67.65 -56.92 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.533 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 4.6 tp -50.92 -25.83 5.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.75 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -60.01 -60.91 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.92 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.9 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.4 m 63.73 -75.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 170' ' ' ASP . 6.2 tt -142.8 151.55 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 t -125.61 140.08 53.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -72.63 134.56 81.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.425 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 64.5 Cg_exo -50.56 148.01 16.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.393 2.062 . . . . 0.0 112.169 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 4.3 t -112.29 -34.73 5.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -77.21 164.66 25.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.503 ' CE2' ' CD2' ' A' ' 40' ' ' TYR . 8.0 t80 175.69 118.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.475 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -149.32 133.69 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.055 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' B' ' 86' ' ' HIS . 1.4 t-160 -68.98 86.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.643 ' OG1' HD12 ' B' ' 85' ' ' ILE . 38.9 p -69.39 -74.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.731 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -115.97 111.51 35.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . 0.438 ' HB3' ' NE2' ' B' ' 83' ' ' HIS . 5.2 p80 -98.92 96.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.865 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 22.1 t -83.39 132.5 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -132.69 177.91 18.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.487 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -76.82 115.89 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.886 ' OD1' HG23 ' B' ' 92' ' ' VAL . 24.5 t0 -107.41 117.64 34.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -10.37 59.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.886 HG23 ' OD1' ' B' ' 90' ' ' ASP . 58.5 t -45.73 -50.02 3.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.598 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 93' ' ' THR . 14.2 t -154.06 56.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.11 27.31 5.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.405 ' CD ' HG22 ' B' ' 93' ' ' THR . 20.9 pt-20 -118.75 -177.66 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.445 ' HB3' HG12 ' B' ' 87' ' ' VAL . 6.2 m-85 -97.24 164.79 12.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.545 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.0 OUTLIER -95.21 156.8 16.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.754 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.94 52.32 26.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.503 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.636 ' HE1' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -63.52 121.37 69.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 103' ' ' TRP . 79.4 Cg_exo -46.07 162.34 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.175 1.917 . . . . 0.0 111.794 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -42.7 -64.2 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -45.77 64.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.572 ' HB3' HD21 ' A' ' 67' ' ' LEU . 11.6 m0 -52.86 -46.49 67.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.35 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -61.48 -63.18 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.952 0.406 . . . . 0.0 110.666 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.6 mtp180 -51.24 -34.51 32.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.541 HD21 ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -50.05 -58.12 6.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.873 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.616 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.28 -69.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.56 ' O ' HG23 ' B' ' 109' ' ' THR . 5.1 tt0 -79.03 -98.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 108' ' ' GLN . 23.5 p -160.53 -35.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.415 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.5 OUTLIER -166.33 169.04 14.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 111.703 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' B' ' 99' ' ' MET . 8.0 p30 -68.2 67.89 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.646 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.528 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.869 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.507 ' OE1' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -78.71 158.26 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.792 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 m -136.3 118.15 15.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.507 HD11 ' OE1' ' A' ' 2' ' ' GLN . 1.3 mp -126.41 149.39 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 12.1 mmtp -135.81 95.42 3.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.568 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.0 m -77.45 154.57 32.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 56' ' ' PHE . 53.0 t -136.43 159.22 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.048 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 57' ' ' ASP . 12.5 p -100.86 159.12 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 8' ' ' VAL . 13.0 p -150.53 129.04 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.74 139.86 4.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.448 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.4 m-20 -69.98 71.72 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -156.73 -148.24 5.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.774 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . -148.91 -35.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.949 HG11 ' HA2' ' A' ' 114' ' ' GLY . 20.3 t -47.7 -23.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 113' ' ' VAL . . . -52.08 -105.22 0.01 OUTLIER Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.586 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.839 ' HG2' HD23 ' A' ' 55' ' ' LEU . 41.5 mttm -95.61 -56.05 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -44.26 -75.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.972 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.748 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 35.4 t -55.74 -39.68 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.538 HD11 ' CG ' ' A' ' 23' ' ' TYR . 5.1 tp -54.16 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.15 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.023 HD21 HD22 ' A' ' 55' ' ' LEU . 74.9 mt -39.89 -38.16 0.65 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -54.05 -69.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.149 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.495 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -91.31 -34.05 15.08 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.538 ' CG ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -72.6 -45.75 57.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.557 ' OG1' HD23 ' A' ' 20' ' ' LEU . 97.5 m -89.81 -85.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 3.3 t -54.56 -28.35 45.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.832 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 77.75 52.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 9.3 pttt -137.71 -166.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.537 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -127.72 170.54 10.06 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.577 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 81.9 Cg_exo -40.33 140.59 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.801 2.334 . . . . 0.0 112.706 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.61 -84.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE1' ' CG ' ' B' ' 86' ' ' HIS . 13.2 pt-20 -96.31 119.43 34.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.19 109.26 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.167 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -159.84 139.0 8.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 36' ' ' VAL . 95.4 Cg_exo -41.73 96.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.43 2.087 . . . . 0.0 111.904 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 17' ' ' THR . 3.1 m -47.1 89.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.273 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 34' ' ' PRO . 58.2 t -95.18 -47.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' B' ' 87' ' ' VAL . 49.2 t80 -162.5 82.19 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.232 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 19.8 m-20 -83.01 124.91 30.86 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' B' ' 85' ' ' ILE . 44.7 t30 -107.89 154.28 21.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.845 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.38 168.91 23.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.225 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.21 115.28 29.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.51 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.4 m -139.8 130.04 30.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.303 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 51' ' ' TYR . 93.5 m -125.79 112.4 15.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.078 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 173' ' ' ILE . 2.6 m -97.66 116.94 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.07 0.462 . . . . 0.0 110.333 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.8 mtm -89.48 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.275 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG23 ' O ' ' B' ' 74' ' ' SER . 1.8 mp -87.03 133.39 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.23 63.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.388 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 -24.35 26.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.648 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.6 151.9 59.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.56 169.71 18.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.651 2.234 . . . . 0.0 112.297 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER -154.06 168.47 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.9 97.12 4.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.5 tt -134.06 158.7 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.661 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -152.62 136.44 5.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.594 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.023 HD22 HD21 ' A' ' 20' ' ' LEU . 8.6 mp -93.42 103.02 15.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.83 0.348 . . . . 0.0 110.814 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.657 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 m-85 -84.62 128.34 34.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.718 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -91.22 174.43 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 111.222 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.766 HG21 ' CE1' ' A' ' 104' ' ' HIS . 3.6 m -162.39 146.45 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -27.62 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.64 -22.49 33.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.4 174.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -103.51 25.39 9.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.79 22.41 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -87.2 -4.95 59.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.345 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.11 -30.41 0.75 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' C ' HD21 ' B' ' 107' ' ' LEU . 1.0 OUTLIER -76.72 -42.25 42.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.381 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.5 OUTLIER -93.53 21.79 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.799 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -83.73 -45.65 0.79 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.298 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 78.4 Cg_exo -46.91 -25.98 4.38 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.372 2.048 . . . . 0.0 112.115 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.966 HD13 ' CD1' ' B' ' 103' ' ' TRP . 2.6 mt -75.03 -28.43 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 3.6 p -86.77 -29.83 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.764 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CG ' ' O ' ' A' ' 71' ' ' SER . 2.4 p90 51.3 161.55 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.946 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 55.7 Cg_endo -70.39 -22.53 29.08 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.125 . . . . 0.0 112.158 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -10.65 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.454 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.653 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.1 t -44.68 -26.74 0.41 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.78 0.324 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 75.43 -154.08 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.593 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.8 p -57.64 156.71 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 1.1 p90 -129.39 161.57 30.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.8 HD22 ' HB2' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -103.97 160.4 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.329 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.667 HG21 HD23 ' A' ' 112' ' ' LEU . 3.7 t -128.55 150.7 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 1.8 m -111.77 142.96 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.383 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB2' HG11 ' A' ' 93' ' ' VAL . 51.1 p90 178.12 112.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.849 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.7 p -57.23 165.77 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 115' ' ' THR . 27.8 m -132.83 29.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.316 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.942 HG13 ' HA ' ' A' ' 120' ' ' ARG . 96.4 t -89.49 -78.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.05 117.83 67.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 52.3 Cg_exo -54.35 -21.93 25.04 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.449 2.099 . . . . 0.0 112.475 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.16 -35.19 16.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.958 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.7 t -80.26 -35.68 35.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.164 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -45.89 -43.7 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.86 -61.43 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.4 m-80 -63.86 -42.06 97.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 89' ' ' SER . 97.9 t -41.38 -48.2 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.903 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 tppt? -83.59 -52.33 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 8.02 5.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.9 tttp -128.26 -39.39 1.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.592 ' CE3' HG13 ' A' ' 93' ' ' VAL . 52.2 m0 -94.92 -28.61 15.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.7 t -65.47 -44.44 66.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.728 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.4 Cg_exo -49.82 -35.11 38.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.153 1.902 . . . . 0.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -11.9 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 98' ' ' VAL . 16.7 tt -45.74 -31.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.746 0.307 . . . . 0.0 111.548 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 p -81.77 -27.44 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -64.41 -37.72 88.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.766 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -80.26 -51.09 9.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 15.9 p -82.93 141.6 43.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.16 -45.83 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.629 2.219 . . . . 0.0 112.214 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 172.61 56.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -136.09 163.78 47.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.469 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 52.1 Cg_exo -52.33 164.22 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.609 2.206 . . . . 0.0 112.326 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 14.1 p90 -132.37 137.23 47.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.8 ' HB2' HD22 ' A' ' 79' ' ' LEU . 4.9 mt -110.23 121.39 45.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -106.41 128.93 54.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.515 HG12 ' OE1' ' A' ' 156' ' ' GLU . 16.3 m -128.05 147.71 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.116 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.949 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -167.21 122.58 1.06 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.275 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 84' ' ' VAL . 78.1 p -157.66 153.53 26.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 111.439 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER 178.16 99.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.67 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.424 ' CG1' ' OG ' ' A' ' 158' ' ' SER . 33.1 mt -99.99 -29.79 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.13 -30.28 34.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -92.16 -46.04 7.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 111.562 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.942 ' HA ' HG13 ' A' ' 85' ' ' VAL . 34.4 ptt180 -45.65 -34.0 3.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 111.164 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.75 55.98 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.704 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -107.87 156.16 38.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.07 -56.25 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 m -64.03 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 129' ' ' LEU . 94.8 m -49.15 -62.25 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.043 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.4 -41.25 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.37 -62.59 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -34.52 76.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.5 OUTLIER -50.82 -26.0 5.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.358 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.6 59.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.867 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -78.76 -23.19 45.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 4.5 m120 -94.08 30.08 1.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 70.53 19.41 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.242 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.87 112.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 83.6 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 129' ' ' LEU . 28.4 Cg_endo -62.71 96.26 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.592 2.195 . . . . 0.0 112.12 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 5.6 mt -47.74 122.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.404 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -104.21 171.02 5.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 51.2 Cg_exo -56.07 -22.45 39.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.725 2.283 . . . . 0.0 112.514 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -91.0 -28.65 17.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.462 ' CG2' HG23 ' A' ' 137' ' ' ILE . 25.3 m -49.49 -59.39 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.054 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.18 -46.9 46.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.14 79.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -54.4 -46.71 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' CD2' HD23 ' A' ' 149' ' ' LEU . 3.0 tt -59.29 -49.24 78.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 149' ' ' LEU . . . -64.86 -29.58 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -73.58 -40.54 63.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.94 -37.69 86.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 146' ' ' ALA . 4.5 pp -82.12 -21.16 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.5 tttt 68.6 126.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 179.59 -159.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.138 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 153' ' ' LYS . 12.1 p -44.36 -45.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 111.443 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.42 142.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.673 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 168' ' ' VAL . 40.3 p90 -153.07 160.74 42.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.372 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 167' ' ' ASN . 2.8 m -158.01 123.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -170.68 153.01 3.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.424 ' CB ' ' HD2' ' A' ' 163' ' ' LYS . 10.2 p -101.86 -173.83 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.968 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 1.6 p -88.44 174.4 8.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -47.94 178.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.907 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 160' ' ' LEU . 3.6 mm? 59.01 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.967 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 159' ' ' ALA . 6.7 p -56.03 176.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.594 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -163.22 103.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.036 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HD2' ' CB ' ' A' ' 157' ' ' CYS . 1.8 mtpp -95.35 -24.69 16.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.49 79.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.532 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.594 HD11 ' NE2' ' A' ' 162' ' ' GLN . 12.9 mt -71.06 -41.68 70.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' B' ' 76' ' ' SER . 0.1 OUTLIER -45.43 -27.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.543 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 155' ' ' VAL . 5.5 m120 -60.64 -72.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.474 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.641 HG21 ' OE1' ' A' ' 156' ' ' GLU . 13.2 p -47.49 -35.13 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.734 0.302 . . . . 0.0 111.087 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.68 ' O ' HD12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -73.23 -38.93 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -54.01 -42.05 68.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.208 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -80.46 -34.49 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.463 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.85 82.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.798 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.4 mt -90.12 -27.24 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.914 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.65 -49.03 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.578 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.16 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.8 -21.92 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -92.1 41.67 1.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.3 p -51.43 -36.26 43.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 23.1 mm -144.1 142.59 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -138.45 134.52 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -74.74 133.67 76.25 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.618 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.794 ' HB2' HG12 ' A' ' 42' ' ' VAL . 49.3 Cg_exo -55.46 -53.06 6.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.447 2.098 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 45.3 m 59.71 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.026 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -56.13 108.67 0.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.689 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.693 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -141.84 -175.84 4.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.346 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -153.28 138.25 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.64 99.28 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.344 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.534 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -69.73 -77.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.485 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.624 HG21 ' CD ' ' B' ' 100' ' ' PRO . 1.2 mp -122.25 128.58 75.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . 0.446 ' CG ' ' OE1' ' A' ' 31' ' ' GLU . 3.0 p-80 -105.26 96.14 6.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.945 HG22 ' HA ' ' B' ' 99' ' ' MET . 24.6 t -84.59 149.45 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.674 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.05 178.07 24.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -108.7 129.14 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 41.6 t0 -140.29 130.84 25.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.85 20.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.015 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.939 HG13 HG22 ' B' ' 93' ' ' THR . 13.7 p -45.87 -27.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.352 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.939 HG22 HG13 ' B' ' 92' ' ' VAL . 1.2 t -152.11 -39.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.41 7.64 2.15 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.291 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.58 -170.99 2.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.013 0.406 . . . . 0.0 110.688 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.9 m-85 -86.8 162.4 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 3.1 p -109.93 153.99 23.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.68 27.59 13.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.375 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.945 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -77.15 141.36 66.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.295 . . . . 0.0 111.452 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.624 ' CD ' HG21 ' B' ' 85' ' ' ILE . 81.5 Cg_exo -39.56 138.46 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.848 2.365 . . . . 0.0 112.693 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.22 -60.38 2.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.161 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.93 -50.29 27.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.966 ' CD1' HD13 ' A' ' 70' ' ' LEU . 1.7 m0 -55.22 -55.21 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.223 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -55.7 -55.01 37.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.321 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 7.9 mtt-85 -49.61 -45.0 47.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.043 0.449 . . . . 0.0 110.649 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.59 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.92 -54.99 16.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.97 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.62 -69.26 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.347 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.638 HE22 HG23 ' B' ' 112' ' ' ILE . 0.0 OUTLIER -78.61 -94.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.383 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.6 HG23 ' O ' ' B' ' 108' ' ' GLN . 17.6 p -160.78 -45.84 0.04 OUTLIER 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER -159.27 166.92 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.94 0.4 . . . . 0.0 111.876 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' B' ' 99' ' ' MET . 27.4 t-20 -63.79 75.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.638 HG23 HE22 ' B' ' 108' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -89.12 140.63 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -107.14 128.81 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.869 HG23 ' OD2' ' A' ' 76' ' ' ASP . 5.3 mm -120.14 118.0 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.663 ' O ' HG21 ' A' ' 75' ' ' THR . 8.2 mmtt -116.67 96.03 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.518 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.45 108.45 10.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 71' ' ' SER . 3.3 t -84.44 158.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.663 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.878 HG11 ' N ' ' A' ' 16' ' ' LYS . 29.7 t -136.51 141.58 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.979 0.418 . . . . 0.0 111.828 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 80' ' ' VAL . 22.0 t -144.69 121.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.76 42.41 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.866 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -89.14 -48.36 7.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -160.23 1.71 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.176 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 18' ' ' CYS . . . -136.57 4.63 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' N ' ' HB3' ' A' ' 81' ' ' CYS . 61.9 t -47.76 -23.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.706 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . -115.55 -61.59 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.753 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.878 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -51.25 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.408 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 85.3 m -96.56 -68.98 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.705 ' H ' ' HB1' ' A' ' 13' ' ' ALA . 8.2 m -48.02 -21.0 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 23' ' ' TYR . 3.3 tm? -56.88 -74.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.651 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 HG11 ' A' ' 42' ' ' VAL . 27.7 mt -63.49 -26.6 68.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.618 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.69 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -66.28 -44.34 91.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.865 179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 m -94.81 -11.82 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.862 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.04 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.9 m-30 -95.54 -67.67 0.84 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 112.112 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' HA ' ' B' ' 79' ' ' SER . 46.5 m -83.85 -81.22 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.22 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.793 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -48.84 -35.63 15.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.184 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 10.0 t-20 51.31 65.21 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.254 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -147.95 -175.35 4.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.464 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -102.78 157.98 32.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.644 0.259 . . . . 0.0 110.609 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 79.2 Cg_exo -39.55 145.82 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.732 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -99.57 -82.27 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HG3' ' ND1' ' B' ' 86' ' ' HIS . 8.0 pt-20 -102.06 118.29 36.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.4 t80 -70.05 110.49 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.0 t -158.96 138.34 8.35 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 85.1 Cg_exo -44.85 91.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.307 2.005 . . . . 0.0 111.684 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.926 HG23 ' HB2' ' A' ' 38' ' ' ASP . 88.2 m -51.92 87.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.505 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' B' ' 96' ' ' PHE . 45.8 t -82.32 -28.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 1.8 t80 -141.87 -64.37 0.43 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.926 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.3 t0 52.75 104.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.17 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 25.0 t30 -107.21 156.59 18.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -151.04 169.01 22.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.746 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -114.03 141.96 46.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -160.82 126.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.5 m -109.44 110.95 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.787 HG22 ' HD3' ' B' ' 78' ' ' PRO . 24.5 t -98.6 119.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 39.6 mtm -84.96 99.79 11.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 51' ' ' TYR . 4.8 mt -103.17 89.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.703 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.74 17.01 55.62 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.212 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.94 35.07 8.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.9 mm-40 -136.22 137.84 25.69 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.81 157.7 60.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.545 2.163 . . . . 0.0 112.336 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.757 ' H ' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -147.05 167.1 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.176 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 52' ' ' THR . 4.9 t -129.2 97.24 4.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.375 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.603 ' HB3' HG23 ' A' ' 42' ' ' VAL . 28.6 tp -112.87 155.98 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.333 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -158.34 121.65 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.312 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' HG ' ' A' ' 20' ' ' LEU . 3.7 mm? -75.94 105.63 7.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.881 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 7.4 m-85 -84.11 103.23 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -72.35 120.9 18.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.702 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.416 ' HB ' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -136.66 170.39 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . . . -124.1 -40.51 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.73 47.94 88.47 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.501 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -40.13 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 165.78 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.546 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 64' ' ' TYR . 52.6 p30 -86.99 -22.59 25.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.771 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 28.3 m-85 -67.02 -21.37 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.168 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.6 m-20 -48.02 -26.05 1.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.244 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 3.6 ptp180 -93.98 -27.87 16.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.034 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -103.21 18.1 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -93.05 -30.21 0.3 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -55.62 -20.81 28.82 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.53 1.487 . . . . 0.0 111.899 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.8 OUTLIER -72.81 -25.98 61.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 18.8 m -101.58 -21.46 14.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.665 ' O ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER 55.31 104.87 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.51 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 34.1 Cg_endo -64.69 -23.66 63.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -88.0 -9.92 51.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.345 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 72' ' ' TYR . 7.7 t -37.53 -53.69 1.17 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.869 ' OD2' HG23 ' A' ' 4' ' ' ILE . 3.3 m-20 -169.92 -88.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.735 HG21 ' CD1' ' A' ' 111' ' ' LEU . 9.9 p -128.21 163.72 31.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.683 0.278 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 77' ' ' VAL . 5.6 m-85 -111.85 138.52 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.823 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.03 143.17 33.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.522 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.9 t -132.3 153.05 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.797 0.332 . . . . 0.0 111.268 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -144.4 132.57 21.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.427 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.468 ' CB ' HG11 ' A' ' 93' ' ' VAL . 33.3 p90 -152.28 164.89 36.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.6 t -62.83 180.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.805 HG21 ' HA ' ' A' ' 115' ' ' THR . 4.9 m -156.35 43.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.288 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CB ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -154.13 -86.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.448 ' H ' HG23 ' A' ' 85' ' ' VAL . 1.5 m -52.64 110.13 1.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 22.4 Cg_endo -61.49 -15.95 44.5 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.024 . . . . 0.0 112.476 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.7 p -64.8 -23.65 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.5 p -95.95 -42.94 8.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -39.69 21.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 1.1 mm-40 -58.63 -55.56 33.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.8 m-20 -64.9 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 89' ' ' SER . 63.4 t -48.3 -67.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.719 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.69 -37.43 76.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.419 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 91' ' ' GLU . 28.7 mm-40 -74.05 -2.53 24.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -127.98 -35.02 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 60.4 m95 -88.7 -36.73 16.02 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 101' ' ' ILE . 58.6 t -57.8 -46.3 99.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 85.9 Cg_endo -79.49 -21.5 8.73 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.558 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.58 -36.57 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.7 tt -50.62 -28.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.813 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -73.61 -38.46 65.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.573 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -56.63 -44.04 80.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.492 ' CE1' ' HB3' ' A' ' 68' ' ' ARG . 1.7 t60 -88.87 -32.32 17.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.429 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 3.3 m -111.7 87.94 8.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.604 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 -78.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.46 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -126.78 48.1 2.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -126.85 139.51 35.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.748 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.7 Cg_exo -49.61 165.26 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.7 p90 -148.29 151.23 35.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.061 0.458 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.051 HD23 ' CD1' ' A' ' 154' ' ' TYR . 1.1 mp -125.6 119.73 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 149' ' ' LEU . 1.4 pt? -135.14 119.58 17.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.645 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.873 HG12 ' CZ ' ' A' ' 154' ' ' TYR . 10.1 p -156.57 111.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.885 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.68 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -86.47 169.12 40.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.668 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.805 ' HA ' HG21 ' A' ' 84' ' ' VAL . 13.9 t -174.82 137.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.863 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.45 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -166.72 84.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.741 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 157' ' ' CYS . 4.3 mt -77.39 -32.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -87.0 -23.68 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.45 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -95.86 -0.79 50.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.682 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.708 ' CB ' HG11 ' A' ' 85' ' ' VAL . 1.3 ptt85 -94.56 26.02 3.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.919 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.6 41.19 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.981 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.54 127.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.07 -44.18 49.37 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -57.45 -27.91 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 129' ' ' LEU . 2.4 m -57.86 -68.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.52 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -49.42 -37.43 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.69 -66.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -70.42 -34.16 72.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.876 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 125' ' ' THR . 3.4 mt -50.15 -26.17 4.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.03 61.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.921 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -18.65 36.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.214 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.83 30.1 1.91 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.179 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt 73.77 29.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 58.93 -161.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.48 90.14 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.32 118.57 5.76 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.587 2.191 . . . . 0.0 112.312 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.478 HG23 ' CG2' ' A' ' 141' ' ' THR . 7.2 mt -49.85 123.78 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -118.91 176.44 1.7 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.0 Cg_exo -54.17 -22.01 24.24 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.201 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -84.42 -36.27 22.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.478 ' CG2' HG23 ' A' ' 137' ' ' ILE . 19.7 m -51.51 -61.81 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.68 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -48.63 -45.72 38.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 155' ' ' VAL . 2.4 tm-20 -57.39 -40.48 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.562 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -58.9 -34.34 71.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.536 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.647 HD11 ' HD2' ' A' ' 94' ' ' LYS . 1.2 tt -71.84 -32.23 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.738 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.65 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -83.96 -35.22 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 43.0 m-20 -54.5 -61.51 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 112' ' ' LEU . 3.4 pp -58.89 -18.1 30.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.304 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.91 80.84 0.07 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.939 0.4 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -134.39 -173.72 3.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 88.9 t -47.54 -29.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 58.33 124.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.243 0.544 . . . . 0.0 111.686 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 1.051 ' CD1' HD23 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -153.79 126.09 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 143' ' ' GLU . 19.8 m -97.23 131.88 43.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.766 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.743 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.5 pm0 -162.73 138.68 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.794 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.641 ' HB3' HD11 ' A' ' 117' ' ' ILE . 6.7 m -102.3 -174.59 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 p -88.47 165.29 15.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.012 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -59.53 -159.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER 49.57 25.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -173.28 -72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.723 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 69.63 115.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.771 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -103.49 -68.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.09 96.08 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.04 HD13 ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -93.61 -10.65 33.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.527 0.203 . . . . 0.0 111.371 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -34.29 54.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 110.065 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -66.44 -33.09 74.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 156' ' ' GLU . 66.7 t -64.81 -63.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CZ ' ' CG ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -51.35 -32.29 25.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.524 ' HA ' HD13 ' B' ' 75' ' ' ILE . 61.9 t0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.9 -52.39 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.12 -28.31 4.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.586 HD11 HD22 ' A' ' 53' ' ' LEU . 16.4 mm -94.78 -38.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.757 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 174' ' ' LEU . 3.6 tt -54.96 -34.24 63.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -74.59 -25.43 59.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mp -94.5 46.51 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.887 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.6 m -64.44 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.329 . . . . 0.0 110.802 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 170' ' ' ASP . 5.9 tt -104.01 148.83 8.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -138.2 138.72 38.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.56 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -60.18 126.81 84.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.622 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.787 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.0 Cg_endo -51.9 171.26 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.9 t -136.65 -67.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -51.49 95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.473 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.4 t80 -114.3 141.22 47.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.43 131.86 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 91.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.192 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.499 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -62.3 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.65 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.56 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -127.02 120.17 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . 0.453 ' ND1' ' HG3' ' A' ' 31' ' ' GLU . 3.5 t-160 -103.98 96.56 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.484 HG22 ' HD3' ' B' ' 100' ' ' PRO . 44.6 t -79.86 155.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.04 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.46 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.48 178.26 24.27 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.236 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -85.97 112.76 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.667 ' CB ' HG23 ' B' ' 97' ' ' THR . 10.8 t0 -103.76 98.24 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -0.08 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.029 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.772 HG13 HG22 ' B' ' 93' ' ' THR . 12.3 p -57.47 -47.89 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.772 HG22 HG13 ' B' ' 92' ' ' VAL . 0.8 OUTLIER -120.99 -21.81 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.433 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.25 12.73 6.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.554 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.546 ' HG2' HG23 ' B' ' 93' ' ' THR . 16.7 pt-20 -121.83 -175.94 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.8 0.333 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 1.034 ' CE2' HD13 ' A' ' 67' ' ' LEU . 4.1 m-85 -82.05 164.6 21.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.667 HG23 ' CB ' ' B' ' 90' ' ' ASP . 0.3 OUTLIER -95.14 150.87 19.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.66 28.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.705 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -57.77 125.6 73.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.549 0.214 . . . . 0.0 110.974 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.484 ' HD3' HG22 ' B' ' 87' ' ' VAL . 69.6 Cg_exo -49.85 152.95 6.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.04 1.826 . . . . 0.0 111.595 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 8.4 pt-20 -43.32 -48.46 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 111.517 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -78.95 -52.95 7.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.866 ' CG ' HD13 ' A' ' 70' ' ' LEU . 4.9 m0 -50.12 -51.06 46.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.419 0.628 . . . . 0.0 110.052 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.705 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.93 -55.57 28.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.78 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 76.0 mtt180 -53.76 -44.44 70.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -48.85 -57.5 6.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -95.23 -68.86 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.295 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.75 ' O ' HG23 ' B' ' 109' ' ' THR . 7.9 tp60 -77.71 -101.6 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.353 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.75 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.1 p -168.16 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.684 0.278 . . . . 0.0 111.447 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.51 174.2 11.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.129 0.49 . . . . 0.0 111.836 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' B' ' 99' ' ' MET . 3.8 p30 -68.56 84.98 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 112' ' ' ILE . 3.6 tp . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.096 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.24 126.8 54.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.752 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 m -94.1 150.9 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.967 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 3' ' ' THR . 3.0 pt -155.87 147.07 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.83 115.38 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' HB3' HD23 ' A' ' 55' ' ' LEU . 54.0 t -78.09 154.36 31.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 56' ' ' PHE . 6.6 t -145.31 144.95 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.421 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 57' ' ' ASP . 7.2 p -118.78 136.02 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 9' ' ' VAL . 13.5 p -127.08 122.88 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.95 168.81 12.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.86 129.89 55.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.89 -27.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . 84.76 -41.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.702 HG11 ' HA2' ' A' ' 114' ' ' GLY . 16.0 t -48.42 -23.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.67 0.271 . . . . 0.0 111.667 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -56.71 -114.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.11 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.61 ' CG ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -96.15 -65.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -34.2 -73.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.788 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -52.67 -36.56 57.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.39 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -49.7 -70.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.549 HD13 ' OG1' ' A' ' 24' ' ' THR . 1.3 mm? -40.61 -37.21 0.69 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 25' ' ' THR . 6.6 mm -52.37 -69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.533 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 5.7 t -88.33 -50.71 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.471 0.653 . . . . 0.0 110.448 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CD2' ' CD1' ' A' ' 165' ' ' LEU . 21.9 t80 -46.13 -49.86 16.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.548 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 42' ' ' VAL . 52.3 m -96.71 -89.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.871 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -55.28 -26.16 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.2 t-20 70.59 58.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.871 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.1 pttt -134.84 -161.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.44 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -132.57 148.83 71.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.286 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 75.4 Cg_exo -39.34 133.72 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.758 2.306 . . . . 0.0 112.72 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -84.88 0.51 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.64 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.316 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -66.49 97.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.158 0.504 . . . . 0.0 111.041 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.5 p -154.33 137.34 10.22 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.815 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.6 Cg_exo -36.55 89.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.876 2.384 . . . . 0.0 112.645 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.863 HG23 ' CG ' ' A' ' 38' ' ' ASP . 58.4 m -53.54 89.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.013 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.818 HG11 ' CG ' ' B' ' 96' ' ' PHE . 3.3 t -79.14 -25.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 5.1 t80 -149.14 -70.85 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.863 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.7 m-20 63.28 130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.47 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 6.6 t-20 -108.01 157.77 17.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.104 0.478 . . . . 0.0 111.359 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 m-85 -152.78 160.31 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.078 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' B' ' 81' ' ' PHE . . . -121.22 126.67 50.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.49 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.725 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.5 m -148.94 140.05 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.101 0.477 . . . . 0.0 111.895 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.2 m -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.894 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.862 HG13 ' O ' ' B' ' 76' ' ' SER . 40.4 t -98.21 123.13 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.212 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtm -90.7 100.08 12.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.17 105.27 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.93 15.11 76.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 38.41 4.82 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.775 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.3 mm-40 -141.69 124.2 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.496 0.189 . . . . 0.0 110.817 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.96 161.54 15.44 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.624 2.216 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.617 ' H ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -146.23 165.15 30.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.6 112.56 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 54' ' ' GLY . 4.6 tt -119.86 138.46 53.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -126.33 102.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.214 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -83.98 149.69 26.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.411 . . . . 0.0 111.4 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.3 m-85 -138.93 116.79 11.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.679 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.577 ' HA ' HG12 ' A' ' 8' ' ' VAL . 4.2 t70 -69.91 152.75 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 64' ' ' TYR . 1.6 m -157.54 128.85 6.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.33 33.84 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.409 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 48.18 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.27 -169.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.894 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.88 -25.77 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.15 -23.4 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.755 ' CE2' HD23 ' A' ' 67' ' ' LEU . 4.3 m-85 -64.47 -12.6 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -40.3 -44.97 2.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.788 0.328 . . . . 0.0 111.586 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HG3' HD22 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -73.41 -35.56 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.498 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.085 HD21 ' CZ3' ' B' ' 103' ' ' TRP . 11.1 tp -90.38 10.53 24.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.117 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 1.6 tmt_? -82.93 -63.82 0.26 Allowed Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 68' ' ' ARG . 4.2 Cg_endo -46.59 -26.73 4.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.412 2.075 . . . . 0.0 111.756 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.908 HD22 HD12 ' A' ' 67' ' ' LEU . 8.5 mp -54.28 -39.51 66.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.581 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.491 ' HB2' HG21 ' A' ' 7' ' ' VAL . 88.3 p -92.49 -15.28 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 61.26 139.93 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.696 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 97.0 Cg_endo -80.66 -45.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -10.27 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.549 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 76' ' ' ASP . 10.3 t -40.4 -48.45 2.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 171.51 -167.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.784 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.9 p -58.26 162.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.517 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' N ' HG22 ' A' ' 77' ' ' VAL . 16.4 m-85 -112.01 143.2 43.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -103.5 145.88 29.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.101 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 112' ' ' LEU . 3.9 t -131.65 151.35 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.944 0.402 . . . . 0.0 111.482 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -121.28 103.55 9.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.697 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.972 ' CB ' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -128.87 123.01 31.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.443 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.885 ' O ' HD12 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -130.73 -74.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.268 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.53 HG12 ' CG2' ' A' ' 125' ' ' THR . 22.6 t -50.5 -70.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.02 100.86 0.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.954 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.6 -21.74 65.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.642 2.228 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -48.15 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 p -77.84 -37.45 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 84' ' ' VAL . 2.3 t80 -50.97 -66.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -41.52 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -60.99 -65.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 82' ' ' PHE . 93.0 t -40.68 -41.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.906 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -60.78 -69.69 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.48 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -80.9 8.34 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.59 -43.03 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.604 ' HD1' HG13 ' A' ' 93' ' ' VAL . 17.5 m95 -95.41 -37.1 11.09 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.2 t -50.02 -58.3 9.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 21.1 Cg_endo -60.67 -22.04 71.49 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.171 1.914 . . . . 0.0 112.031 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -32.05 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG21 ' CG ' ' A' ' 110' ' ' PHE . 22.1 mt -49.84 -26.51 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 p -74.55 -36.87 63.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -63.74 -38.42 91.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.776 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 6.5 m-70 -95.76 -24.38 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 2.9 m -121.53 97.77 46.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.749 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 87.4 Cg_exo -46.49 -61.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.585 2.19 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.24 32.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 161.31 26.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.87 129.35 24.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.53 2.153 . . . . 0.0 112.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' HG21 ' A' ' 101' ' ' ILE . 12.8 p90 -118.1 124.74 48.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.609 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -96.85 119.5 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.447 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.603 HD12 ' HB ' ' A' ' 80' ' ' VAL . 38.6 tp -97.94 102.05 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 15' ' ' GLY . 26.8 m -106.77 139.1 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 111.271 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.702 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -165.31 144.08 8.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.837 HG21 ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER 173.17 151.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.58 ' H ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -167.76 94.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.81 -27.4 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.724 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.774 ' CB ' HD13 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -96.36 -48.07 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 111.45 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.63 HD13 ' C ' ' A' ' 119' ' ' LEU . 2.4 tm? -66.28 -59.33 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.084 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' N ' HD13 ' A' ' 119' ' ' LEU . 33.5 mmt180 -66.97 -174.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 5.7 m-20 81.9 39.49 0.05 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.706 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -96.58 169.68 8.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.716 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.71 -19.41 24.25 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.5 t -84.38 -46.69 11.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.53 ' CG2' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -48.83 -60.84 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.031 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.83 -40.62 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.15 -46.03 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -83.76 -35.98 23.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 135' ' ' LYS . 1.6 tp -49.95 -26.51 4.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.51 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.52 65.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -78.41 -47.39 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.52 -26.33 68.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.99 52.37 9.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 1.4 tt0 -128.55 -86.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.75 ' C ' HD21 ' A' ' 129' ' ' LEU . 2.5 mtmt 166.72 161.34 0.11 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.686 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.687 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 Cg_exo -52.33 100.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.468 2.112 . . . . 0.0 112.159 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 84' ' ' VAL . 5.8 mt -48.67 119.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.458 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -111.08 177.08 1.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -55.13 -20.52 24.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.434 2.089 . . . . 0.0 112.219 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -80.06 -45.4 18.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.462 ' HB ' HG23 ' A' ' 137' ' ' ILE . 97.8 m -53.38 -45.54 69.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.93 -42.68 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.61 -37.22 86.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.724 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -53.98 47.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.96 -42.38 84.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.814 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.43 -41.96 66.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.092 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -45.43 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.99 -42.48 99.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -80.09 -26.48 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.718 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.8 OUTLIER 67.04 118.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.984 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.03 -161.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 152' ' ' VAL . 15.7 t -70.62 -7.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.19 140.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 110.791 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.814 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 p90 -152.71 148.29 27.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 111.454 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 154' ' ' TYR . 2.8 m -158.47 124.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.832 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.837 ' O ' HG21 ' A' ' 115' ' ' THR . 2.0 pt-20 -171.87 149.62 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 2.6 p -108.27 -174.58 2.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -86.16 159.6 19.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.21 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.474 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 68.78 -62.67 0.38 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.126 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -85.47 -68.83 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.277 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.87 118.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.711 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -105.53 -68.27 0.88 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.075 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.08 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.661 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -86.44 -10.19 54.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.643 0.259 . . . . 0.0 111.196 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.822 ' HD3' HD12 ' B' ' 77' ' ' LEU . 0.1 OUTLIER -47.87 -45.63 30.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.735 0.302 . . . . 0.0 111.162 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -58.8 -62.88 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.4 p -47.75 -26.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.19 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.552 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -76.61 -50.43 13.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.372 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 174' ' ' LEU . 5.3 t0 -49.96 -29.28 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.15 -39.76 22.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.048 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.72 -22.31 43.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 38.5 mm -91.96 -30.17 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.175 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 170' ' ' ASP . 1.7 tt -80.74 -26.09 37.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.69 65.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.413 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -87.89 -27.2 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.63 -30.66 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -50.73 63.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 44' ' ' VAL . 7.3 tt -143.96 151.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.862 ' O ' HG13 ' A' ' 44' ' ' VAL . 16.1 t -135.09 137.62 43.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.822 HD12 ' HD3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -67.48 141.5 95.59 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.806 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.761 ' HD2' HD23 ' B' ' 77' ' ' LEU . 53.7 Cg_exo -51.64 166.41 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.177 . . . . 0.0 112.28 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 81' ' ' PHE . 0.4 OUTLIER -139.56 -66.57 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.68 86.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 9.1 t80 -108.61 134.26 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.66 111.98 3.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.486 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 83' ' ' HIS . 27.2 p-80 -68.37 109.4 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.059 0.457 . . . . 0.0 109.943 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.563 ' OG1' HD12 ' B' ' 85' ' ' ILE . 1.5 p -77.17 -62.57 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.786 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.563 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.7 OUTLIER -121.9 143.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.764 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.65 96.57 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.464 HG13 ' O ' ' B' ' 97' ' ' THR . 25.1 t -78.21 149.08 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.24 177.63 24.47 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.352 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.22 129.62 47.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.408 ' CB ' HG23 ' B' ' 97' ' ' THR . 68.3 t0 -137.89 132.19 32.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 1.37 19.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.142 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -45.44 -27.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 120.912 0.387 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.422 HG23 ' N ' ' B' ' 94' ' ' GLY . 13.2 t -153.41 -42.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . 0.422 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.58 34.26 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.418 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.424 ' OE2' HD11 ' B' ' 112' ' ' ILE . 0.2 OUTLIER -147.28 175.44 10.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.935 ' CE2' HD22 ' A' ' 67' ' ' LEU . 2.2 m-85 -71.98 160.48 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.561 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.464 ' O ' HG13 ' B' ' 87' ' ' VAL . 16.9 p -104.76 156.27 18.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.166 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.53 39.57 74.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.704 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -51.14 123.34 19.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.537 0.208 . . . . 0.0 110.675 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.472 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 84.7 Cg_exo -46.75 154.54 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.275 1.983 . . . . 0.0 112.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -45.57 -48.27 14.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.282 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.39 -55.7 5.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 1.085 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.2 m0 -48.54 -53.36 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.704 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -57.68 -61.93 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.239 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 43.4 mtt85 -48.04 -45.23 31.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -48.33 -57.88 5.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.687 HD12 ' O ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -94.81 -67.73 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.107 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.725 ' O ' HG23 ' B' ' 109' ' ' THR . 7.9 tp60 -77.39 -99.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.725 HG23 ' O ' ' B' ' 108' ' ' GLN . 2.9 p -166.58 -40.22 0.02 OUTLIER 'General case' 0 C--N 1.338 0.084 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.66 176.51 11.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.993 0.425 . . . . 0.0 111.473 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.73 72.73 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.81 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 111.178 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 68.68 129.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.09 149.63 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.419 HD13 ' HB1' ' A' ' 176' ' ' ALA . 21.5 mt -140.48 153.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -129.56 96.22 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 37.4 t -81.36 107.96 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 8' ' ' VAL . 58.2 t -84.27 154.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 15' ' ' GLY . 2.4 t -140.5 139.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 104' ' ' HIS . 3.0 m -133.02 156.12 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.068 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . 147.63 178.54 22.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.647 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -25.46 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.71 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -84.01 -24.13 49.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.355 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 70.02 7.58 6.29 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.673 ' HB ' HG23 ' A' ' 113' ' ' VAL . 16.1 t -49.04 -24.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 111.251 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.869 ' C ' HG11 ' A' ' 8' ' ' VAL . . . -107.77 -43.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.541 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.652 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -67.35 -74.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.776 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.533 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -97.68 -52.94 3.58 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -55.29 -25.59 35.09 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.6 tm? -56.47 -73.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.423 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.732 ' HG ' HD22 ' A' ' 55' ' ' LEU . 18.7 mt -63.24 -25.36 68.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 110.553 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 27' ' ' LYS . 1.1 mp -62.9 -47.29 93.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.858 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 82.8 p -94.13 -17.32 22.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.558 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.7 m-30 -88.22 -66.8 0.88 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.002 0.429 . . . . 0.0 112.047 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -89.04 -83.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.182 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -42.77 -44.32 4.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.433 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 16.6 t-20 64.42 41.65 5.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -131.99 141.42 49.27 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.475 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -63.63 164.33 16.47 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 70.9 Cg_exo -38.21 150.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.952 2.434 . . . . 0.0 113.078 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 t -108.96 -83.1 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.24 114.59 26.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.637 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.33 107.88 5.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 34' ' ' PRO . 6.5 p -160.63 139.44 7.65 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.29 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 Cg_exo -39.45 93.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.568 2.179 . . . . 0.0 111.874 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 m -48.09 87.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.781 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 34' ' ' PRO . 92.2 t -89.77 -35.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 60.8 t80 -170.86 119.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.777 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 3.2 m-20 -119.44 138.27 53.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' HD12 ' B' ' 85' ' ' ILE . 8.7 t-20 -106.65 157.6 17.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.173 0.511 . . . . 0.0 111.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CG ' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -152.89 161.9 41.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 80' ' ' ASP . . . -117.64 117.75 30.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.48 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' CB ' ' B' ' 78' ' ' PRO . 23.8 m -136.6 167.75 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.393 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 41.8 m -156.39 85.98 1.0 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.874 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.578 HG21 HG12 ' A' ' 173' ' ' ILE . 28.1 m -98.6 176.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.435 ' C ' HD13 ' A' ' 46' ' ' ILE . 5.7 mtm -140.46 157.34 45.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.183 0.516 . . . . 0.0 111.565 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.947 HD11 ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -129.82 88.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.139 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.4 74.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.483 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.93 -34.37 3.29 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.025 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.88 133.28 76.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.662 0.231 . . . . 0.0 111.202 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 174.57 4.87 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.594 2.196 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.947 ' CD1' HD11 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -153.5 155.06 35.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.6 97.06 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 53' ' ' LEU . 2.4 pp -134.17 161.03 36.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.66 138.06 8.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.732 HD22 ' HG ' ' A' ' 20' ' ' LEU . 3.8 mp -75.7 107.18 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.09 102.99 12.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -73.4 144.11 46.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.302 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.805 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.51 179.42 9.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.596 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -138.32 163.36 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 43.7 1.62 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? -70.72 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.622 0.249 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 174.48 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.791 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.66 42.82 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.805 ' CE2' HG22 ' A' ' 58' ' ' THR . 4.4 m-85 -106.42 -24.62 12.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.673 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -45.76 -34.39 3.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.048 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.491 ' O ' HD21 ' B' ' 107' ' ' LEU . 4.3 mtt85 -51.94 -36.05 47.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.988 0.423 . . . . 0.0 110.483 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 70' ' ' LEU . 2.5 mt -96.01 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.386 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.3 mtt180 -56.76 -71.15 0.28 Allowed Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.563 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 33.9 Cg_endo -64.18 -29.42 64.74 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.059 1.839 . . . . 0.0 110.649 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 67' ' ' LEU . 9.8 mp -52.43 -24.79 8.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -155.72 33.18 0.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.455 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -35.23 151.03 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.985 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 2.8 Cg_exo -75.67 -32.01 4.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.895 2.397 . . . . 0.0 112.606 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -57.6 -17.84 16.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.701 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 76' ' ' ASP . 6.3 t -46.74 -52.89 12.95 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.592 0.234 . . . . 0.0 111.396 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 75' ' ' THR . 1.0 OUTLIER 176.99 -159.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.062 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.3 p -57.98 163.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 6.0 m-85 -115.62 132.69 56.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 0.0 110.863 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.3 tp -103.66 143.54 32.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.115 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.823 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.6 t -133.75 150.66 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -125.06 153.38 42.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.529 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 p90 -162.24 158.72 24.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.93 164.26 25.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 137' ' ' ILE . 60.6 t -147.08 55.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 120' ' ' ARG . 68.9 t -151.9 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 125' ' ' THR . 5.8 m -66.77 150.16 97.83 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 0.0 110.73 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 72.1 Cg_endo -77.39 -36.63 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.588 2.192 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 p -53.13 -38.9 63.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 -24.92 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.576 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.2 t80 -69.91 -61.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -26.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.2 m-20 -75.58 -60.96 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 90' ' ' PHE . 12.7 m -47.55 -27.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.669 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HE3' HD11 ' A' ' 145' ' ' LEU . 23.3 tttt -78.47 -61.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -82.44 8.37 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.995 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 6.7 ttpt -114.37 -37.82 4.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.635 0.255 . . . . 0.0 111.34 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.537 ' HE1' HG12 ' A' ' 93' ' ' VAL . 19.0 m95 -95.3 -42.12 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.604 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.887 ' O ' HG22 ' A' ' 101' ' ' ILE . 63.2 t -53.57 -43.63 96.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.8 Cg_exo -73.88 -31.4 8.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 112.499 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.11 -33.07 24.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 98' ' ' VAL . 12.9 tt -48.61 -29.31 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -66.62 -42.69 86.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.652 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -63.18 -33.0 74.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.413 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 12.4 m80 -79.76 -31.33 40.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.449 ' HB2' ' CG2' ' A' ' 108' ' ' THR . 18.6 p -130.68 122.39 19.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 48.0 Cg_exo -55.63 -64.92 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.489 2.126 . . . . 0.0 112.351 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -156.7 31.46 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 105' ' ' CYS . 1.8 t -97.25 150.03 36.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.05 144.65 27.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.802 2.335 . . . . 0.0 112.14 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 101' ' ' ILE . 4.5 p90 -121.92 157.33 31.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.1 mt -127.66 145.25 50.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.55 HD23 ' HB ' ' A' ' 80' ' ' VAL . 5.7 mt -120.34 159.4 25.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.512 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.8 m -156.11 106.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.909 0.385 . . . . 0.0 111.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.673 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -123.5 128.15 6.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.39 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 158' ' ' SER . 48.3 p -153.79 142.91 21.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 111.192 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.745 ' HG2' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -178.84 36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.868 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.464 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 5.4 pt -56.24 -21.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.266 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.735 ' CB ' HD13 ' A' ' 160' ' ' LEU . 9.9 t0 -96.09 -26.04 15.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.745 HD13 ' HG2' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -65.72 -56.53 11.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.597 ' HB2' HG22 ' A' ' 85' ' ' VAL . 7.0 tmm_? -46.68 100.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.84 -44.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -54.86 132.12 66.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 47.5 Cg_exo -56.07 -36.57 96.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.422 2.082 . . . . 0.0 112.231 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.9 m -49.24 -45.04 44.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.987 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.841 HG22 ' OG ' ' A' ' 86' ' ' SER . 68.3 p -53.77 -59.86 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 3.4 mp -60.16 -40.61 84.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.58 -61.67 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 2.0 ttpp -73.05 -36.01 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 136' ' ' PRO . 10.5 mt -50.29 -25.92 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.88 -20.75 57.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -91.22 -37.08 13.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.0 -27.66 66.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -78.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 179.14 -46.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 150.15 65.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.636 ' HA ' HD13 ' A' ' 129' ' ' LEU . 50.7 Cg_exo -53.58 174.38 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.615 2.21 . . . . 0.0 112.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.746 HG22 HG13 ' A' ' 84' ' ' VAL . 5.9 mt -92.5 122.62 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.2 p -110.81 167.71 8.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 81.9 Cg_exo -47.84 -25.44 6.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -46.72 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.511 ' HB ' HG23 ' A' ' 137' ' ' ILE . 7.2 m -52.16 -51.35 58.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -49.89 -41.02 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.022 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.7 -35.29 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.73 94.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.615 HD11 ' HE3' ' A' ' 94' ' ' LYS . 12.8 tp -65.12 -45.52 84.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -25.59 66.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.37 -64.04 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 150' ' ' LYS . 3.9 pp -51.32 -25.19 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.778 ' N ' HD12 ' A' ' 149' ' ' LEU . 11.0 mttp 65.59 108.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -145.64 -161.01 1.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 92.8 t -60.93 -20.11 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.316 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 78.25 137.99 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.166 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 50.0 p90 -153.2 166.27 33.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.25 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 155' ' ' VAL . 28.2 m -158.36 124.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.818 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.77 152.52 3.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.8 p -111.18 -173.64 2.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.464 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 11.1 t -87.79 156.49 19.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.524 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -56.73 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.207 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 53.36 25.09 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.95 -65.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 1.016 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.3 OUTLIER 64.74 122.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.35 -67.96 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 100.17 0.16 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.396 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.016 HD11 ' NE2' ' A' ' 162' ' ' GLN . 4.8 mt -93.68 -10.68 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.542 0.211 . . . . 0.0 111.539 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.44 -28.05 1.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.383 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -78.4 -60.9 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.045 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.7 p -50.01 -41.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.463 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -69.49 -40.84 76.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -50.27 -53.03 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.07 -51.54 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.05 -30.69 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.237 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.578 HG12 HG21 ' A' ' 44' ' ' VAL . 5.9 mt -91.76 -24.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.9 tp -80.33 -52.58 7.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -31.29 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.306 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -66.54 -23.26 66.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.271 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 46' ' ' ILE . 2.2 mp -90.34 48.28 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -117.6 -53.91 2.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' MET . 18.8 mm -104.02 144.23 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.69 153.08 48.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.202 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -90.91 135.79 28.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.639 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' B' ' 77' ' ' LEU . 52.5 Cg_exo -54.21 -172.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.562 2.174 . . . . 0.0 112.205 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 60.4 p -162.56 -53.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.548 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . 0.667 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.2 m-20 -67.5 62.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.403 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.0 t80 -81.32 131.02 35.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -153.59 120.06 5.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.18 102.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.507 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.6 OUTLIER -77.53 -60.77 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.592 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.507 HD12 ' OG1' ' B' ' 84' ' ' THR . 1.0 OUTLIER -120.69 134.61 63.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.934 0.397 . . . . 0.0 111.971 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -120.88 96.5 5.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.623 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.547 HG22 ' HD3' ' B' ' 100' ' ' PRO . 47.1 t -79.95 148.05 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.752 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.77 177.76 23.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.288 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -95.94 131.93 41.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.718 ' CG ' HG23 ' B' ' 97' ' ' THR . 3.1 p-10 -140.41 120.18 13.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.32 -0.66 26.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.613 HG13 HG22 ' B' ' 93' ' ' THR . 13.9 p -47.72 -26.51 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.282 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.613 HG22 HG13 ' B' ' 92' ' ' VAL . 3.9 t -149.05 -41.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.082 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.97 25.98 0.87 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.672 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.76 -162.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.74 0.305 . . . . 0.0 110.546 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.2 m-85 -100.25 164.2 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.718 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -100.22 167.12 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.11 33.61 22.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.432 ' O ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -47.21 109.04 0.98 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.501 0.191 . . . . 0.0 110.709 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.547 ' HD3' HG22 ' B' ' 87' ' ' VAL . 97.0 Cg_exo -40.19 153.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.7 2.266 . . . . 0.0 112.811 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -45.34 -57.9 3.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.194 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.49 -54.19 36.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.536 ' CE3' ' CD1' ' A' ' 67' ' ' LEU . 4.7 m0 -49.21 -63.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 0.0 110.788 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.49 -70.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.765 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 3.9 mtp180 -44.62 -37.07 3.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -50.37 -56.18 12.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.134 179.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.917 HD11 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.42 -70.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.539 ' O ' HG23 ' B' ' 109' ' ' THR . 4.8 tt0 -79.98 -99.06 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 108' ' ' GLN . 29.9 p -160.35 -35.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.565 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -161.66 -173.42 3.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.018 0.437 . . . . 0.0 111.951 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' B' ' 100' ' ' PRO . 0.3 OUTLIER -84.79 81.86 8.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.83 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 121.614 0.721 . . . . 0.0 111.349 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.824 0.345 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 63.31 117.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.42 169.34 8.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 176' ' ' ALA . 2.5 pt -160.23 134.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' ASP . 2.7 mptt -125.53 147.79 49.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLY . 20.7 m -133.48 134.48 43.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.841 HG12 ' HG1' ' A' ' 58' ' ' THR . 3.0 t -115.21 151.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 9' ' ' VAL . 9.2 p -93.24 160.87 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.542 HG23 ' CD2' ' A' ' 104' ' ' HIS . 7.3 p -152.61 129.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 174.21 17.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.78 84.66 2.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 81' ' ' CYS . . . -171.9 -147.21 5.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 17' ' ' THR . . . -178.95 32.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.954 HG13 HD12 ' A' ' 79' ' ' LEU . 3.3 p -81.32 4.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -84.04 -103.89 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.286 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HE2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 ttpm? -97.38 -13.2 21.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.775 HG23 ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.32 -74.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -74.16 -34.88 63.98 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.089 -0.382 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.731 HD23 ' CG2' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.11 -74.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.584 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD21 HD12 ' A' ' 55' ' ' LEU . 18.2 mt -47.93 -42.27 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.876 0.37 . . . . 0.0 111.067 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -49.13 -68.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.517 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -93.18 -56.99 2.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.646 ' CD1' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -50.12 -26.8 4.85 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 84.9 m -113.82 -91.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.925 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 21' ' ' ILE . 4.1 t -51.87 -24.22 5.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.964 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 65.94 52.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' CE1' ' B' ' 81' ' ' PHE . 0.0 OUTLIER -132.5 -166.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.647 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -130.78 147.08 64.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.04 151.97 5.31 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.752 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 t -105.81 -80.54 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -75.7 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.51 105.95 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 3.4 p -160.55 138.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 33' ' ' VAL . 72.3 Cg_exo -39.21 92.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.689 2.26 . . . . 0.0 112.272 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.548 HG22 ' OD2' ' A' ' 57' ' ' ASP . 1.4 m -50.25 91.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.197 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' HG11 ' B' ' 87' ' ' VAL . 1.9 t -81.86 -26.35 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HE2' HD13 ' B' ' 85' ' ' ILE . 9.3 t80 -148.63 -77.01 0.16 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.804 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 40' ' ' TYR . 59.0 t0 58.27 112.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 16.4 t-20 -106.33 159.62 15.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.005 0.431 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -152.12 168.85 23.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.063 -178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.653 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -104.97 133.14 50.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.704 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.2 m -162.51 133.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.479 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 51' ' ' TYR . 88.0 m -131.34 116.27 17.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.13 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 78' ' ' PRO . 4.0 m -98.08 117.19 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.052 0.453 . . . . 0.0 110.581 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -91.31 102.0 14.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 173' ' ' ILE . 9.7 mm -82.34 121.22 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.186 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.79 25.38 61.34 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.62 19.62 67.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.62 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -115.82 151.31 46.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.662 0.268 . . . . 0.0 110.795 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.56 139.55 64.64 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.584 2.189 . . . . 0.0 112.357 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.519 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -151.58 174.52 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.657 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.78 111.32 9.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.235 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 55' ' ' LEU . 4.9 tt -73.31 129.7 38.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -112.39 103.41 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.005 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 53' ' ' LEU . 23.6 mt -125.83 154.46 42.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -144.56 125.94 14.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD2' HG22 ' A' ' 35' ' ' THR . 15.0 t0 -67.66 161.83 24.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.841 ' HG1' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -168.73 157.73 8.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 64' ' ' TYR . . . -119.79 -175.26 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.46 -145.72 4.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 mt 51.77 -162.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.91 52.4 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.18 28.25 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.553 ' HE1' ' HB3' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -99.34 -19.33 17.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -44.05 -29.21 0.57 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.789 0.328 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -56.72 -46.64 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.584 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.954 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 40.5 mt -94.25 23.31 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 tmt_? -57.02 -57.86 21.75 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.99 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.8 Cg_endo -47.95 -22.3 3.32 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.641 2.227 . . . . 0.0 113.053 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HB3' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -88.68 -15.02 35.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 7' ' ' VAL . 17.3 m -108.04 -31.37 7.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 47.76 94.35 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 73.7 Cg_exo -49.51 -36.8 40.81 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.668 2.245 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.36 59.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.592 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 76' ' ' ASP . 14.7 t -41.32 -50.65 3.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.7 0.286 . . . . 0.0 111.629 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.81 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.6 OUTLIER 171.72 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.685 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' PHE . 9.9 p -58.0 154.84 2.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 105' ' ' CYS . 0.7 OUTLIER -104.26 163.69 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.156 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HG13 ' A' ' 14' ' ' VAL . 1.2 mm? -114.48 139.01 49.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 110' ' ' PHE . 4.1 t -131.09 134.44 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.556 ' HB2' HG12 ' A' ' 14' ' ' VAL . 42.3 t -134.49 154.63 51.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 112.05 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 2.8 p90 -124.03 108.33 12.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.589 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.2 p -37.39 102.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.177 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.043 HG12 HG22 ' A' ' 85' ' ' VAL . 98.6 t 56.86 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.386 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.043 HG22 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.04 -81.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.562 0.22 . . . . 0.0 111.511 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.505 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 m 54.27 102.25 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.18 -30.25 64.79 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.393 2.062 . . . . 0.0 112.322 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 p -71.72 -23.6 61.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -93.11 -22.6 19.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.154 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -48.92 -69.81 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.353 . . . . 0.0 111.032 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -51.74 -36.84 48.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 51.0 m-20 -64.04 -63.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 89' ' ' SER . 61.1 t -43.06 -32.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.0 -69.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.847 0.356 . . . . 0.0 111.417 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -80.25 8.04 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 15.3 tttt -115.09 -45.3 2.96 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.651 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.7 m95 -95.42 -38.46 10.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.2 t -51.64 -44.51 90.24 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.631 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.6 Cg_exo -55.92 -21.6 34.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 112.256 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.92 -31.18 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.125 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.519 HG23 HG11 ' A' ' 9' ' ' VAL . 56.0 mt -48.14 -31.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.3 p -64.05 -34.84 78.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.633 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -72.78 -33.18 66.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 9' ' ' VAL . 1.3 m-70 -79.17 -43.87 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 17.8 p -103.64 134.01 19.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_endo -83.86 72.91 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.386 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.0 26.38 15.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 1.6 m -107.85 142.15 24.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 63.0 Cg_exo -51.46 172.23 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 80' ' ' VAL . 6.7 p90 -148.57 138.7 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -95.26 119.51 33.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.7 HD12 ' HE2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -97.9 121.84 40.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.933 HG23 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.4 137.36 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.405 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.513 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -174.67 156.45 22.94 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.759 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 1.4 t 173.45 177.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.113 0.482 . . . . 0.0 111.297 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.705 HE22 HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -174.59 52.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.292 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 158' ' ' SER . 28.9 mt -37.11 -31.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -58.49 -64.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.614 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.705 HD23 HE22 ' A' ' 116' ' ' GLN . 3.7 mm? -95.97 -23.97 16.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.688 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.808 ' HG2' HG21 ' A' ' 85' ' ' VAL . 7.3 tmm_? -41.9 -30.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.447 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 61.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -109.04 157.6 36.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.979 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.5 -34.79 34.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.679 2.253 . . . . 0.0 112.272 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.7 m -69.79 -45.82 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.654 HG21 ' O ' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -55.13 -57.05 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 122' ' ' ASP . 5.1 mp -61.19 -32.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -69.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -50.34 -25.98 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.92 57.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.226 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 4.5 mmtp -87.1 -28.4 22.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.883 0.373 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.4 -18.2 57.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.236 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER 63.15 26.73 15.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.79 122.45 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -50.25 153.07 2.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.66 136.75 27.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 141' ' ' THR . 5.2 mp -72.42 99.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.031 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -90.27 179.79 1.41 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.711 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 51.7 Cg_exo -53.11 -21.6 16.97 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.487 2.125 . . . . 0.0 112.326 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -38.09 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.621 ' HB ' HG23 ' A' ' 137' ' ' ILE . 19.3 m -52.35 -48.81 65.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.98 -60.07 3.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -52.53 -27.4 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.29 13.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.731 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 tp -54.77 -36.89 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.952 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -64.68 -39.74 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -58.74 -42.8 89.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -23.98 66.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.794 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.684 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.7 pp -119.08 19.18 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.74 -85.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.684 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.79 179.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 43.0 t -67.83 -14.87 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.443 ' CG ' ' HG2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 80.17 141.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.719 0.295 . . . . 0.0 110.492 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.952 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 7.9 p90 -152.8 157.42 40.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.1 122.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.476 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.546 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.9 pt-20 -172.42 150.65 2.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.4 ' SG ' ' CD ' ' A' ' 163' ' ' LYS . 72.1 m -102.15 -173.46 2.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.864 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.483 ' HB3' HD12 ' A' ' 117' ' ' ILE . 16.1 t -87.85 174.14 8.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 111.35 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.543 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -61.64 -175.87 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 65.03 -71.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.022 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' ALA . 35.8 p -69.11 -83.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.673 ' CG ' HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER 69.77 113.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.489 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.4 ' CD ' ' SG ' ' A' ' 157' ' ' CYS . 5.7 mttp -101.4 -67.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 111.222 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.77 88.18 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -93.84 -15.24 25.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.546 0.212 . . . . 0.0 111.288 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -42.78 73.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.867 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -52.77 -64.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.9 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -49.32 -29.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.74 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -59.01 -44.86 91.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.801 179.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.933 ' HA ' HD13 ' B' ' 75' ' ' ILE . 36.3 t0 -61.18 -37.5 83.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.019 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.2 OUTLIER -71.15 -22.27 62.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.576 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.44 -54.05 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.064 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 46' ' ' ILE . 10.4 mt -63.46 -39.12 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 177' ' ' LEU . 13.1 tp -76.5 -36.08 58.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.05 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -53.61 -46.46 70.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.81 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -75.91 -28.24 57.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.069 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -53.97 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.022 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.799 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.8 m -50.53 -44.72 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 170' ' ' ASP . 0.7 OUTLIER -144.16 133.64 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.03 142.79 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -70.53 136.77 85.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.704 ' HB2' HG12 ' A' ' 42' ' ' VAL . 51.0 Cg_exo -54.43 154.4 19.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.516 2.144 . . . . 0.0 112.019 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.7 m -116.88 -83.29 0.64 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.394 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.79 99.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 13.8 t80 -123.19 129.46 51.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.23 142.31 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.0 102.51 1.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.613 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -86.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.438 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.609 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -104.35 127.47 58.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 111.191 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -105.79 99.18 8.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 36' ' ' VAL . 74.1 t -85.56 151.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.33 165.58 28.23 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.054 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.63 106.75 18.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.601 ' HB2' HG23 ' B' ' 97' ' ' THR . 16.0 t0 -124.08 118.24 26.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.71 21.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 1.063 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -47.34 -27.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-O 121.027 0.441 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 1.063 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -152.11 20.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.981 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.92 68.45 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.038 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.908 ' HG2' HG23 ' B' ' 93' ' ' THR . 10.2 pt-20 -132.41 164.89 25.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.079 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.609 ' HD2' ' HE1' ' B' ' 99' ' ' MET . 7.4 m-85 -79.11 154.65 29.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.811 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.601 HG23 ' HB2' ' B' ' 90' ' ' ASP . 19.1 p -93.5 169.47 10.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.21 23.54 8.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.418 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.609 ' HE1' ' HD2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -49.82 106.16 0.6 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.492 0.186 . . . . 0.0 110.959 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 67.2 Cg_exo -36.0 152.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 112.906 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -66.69 0.28 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.716 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.28 -52.0 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.075 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.954 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.5 m0 -48.27 -62.5 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.127 0.489 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.57 -69.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.546 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 0.6 OUTLIER -46.64 -38.5 9.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.421 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -49.48 -57.11 7.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.37 . . . . 0.0 110.568 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.77 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.3 -69.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.751 ' O ' HG23 ' B' ' 109' ' ' THR . 8.3 tp60 -79.18 -100.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.785 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.751 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.3 p -168.62 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.034 0.445 . . . . 0.0 110.736 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.519 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -134.23 170.58 15.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.212 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 99' ' ' MET . 10.9 m120 -54.31 -63.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.722 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 121.557 0.694 . . . . 0.0 109.37 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.8 91.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -89.86 159.51 16.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.25 136.96 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.262 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 4.4 mptt -118.91 96.41 5.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.22 97.36 4.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 75' ' ' THR . 12.7 t -84.45 111.26 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.77 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 55' ' ' LEU . 10.7 m -105.43 129.57 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.39 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.784 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.1 p -126.49 138.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.078 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.98 120.52 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.649 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.86 -31.23 70.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.029 0.442 . . . . 0.0 110.488 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.12 83.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.96 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 54.01 23.49 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.889 0.376 . . . . 0.0 111.032 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' CG1' ' OG1' ' A' ' 115' ' ' THR . 45.3 t -91.19 -17.89 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . -130.2 -8.82 3.18 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.263 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.623 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.8 pttt -94.9 -57.59 2.4 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.96 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 5.2 t -96.59 -41.8 8.36 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.013 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 2.8 m -64.28 -25.93 68.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -42.75 -72.74 0.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.585 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' HB2' ' A' ' 40' ' ' TYR . 16.4 mt -63.45 -33.81 76.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.152 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -55.29 -43.72 72.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.146 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 -26.68 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.806 ' HB3' HD21 ' B' ' 77' ' ' LEU . 3.7 m-30 -80.73 -67.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 81' ' ' PHE . 55.0 m -79.65 -83.03 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.487 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.53 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -50.53 -24.86 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.187 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.28 38.71 2.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -114.24 -165.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.981 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -122.37 141.84 35.68 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.953 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 51.7 Cg_exo -34.86 136.44 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.209 2.606 . . . . 0.0 113.267 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -105.78 -84.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.442 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 95.34 5.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.203 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.48 105.91 1.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.229 0.537 . . . . 0.0 111.378 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.6 p -160.63 134.06 4.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.541 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.22 89.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.435 2.09 . . . . 0.0 112.221 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.474 HG21 ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -72.98 86.65 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.113 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.792 HG21 ' CD2' ' B' ' 96' ' ' PHE . 22.9 m -68.09 -22.54 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.244 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 2.9 t80 -129.21 -76.2 0.55 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.569 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' HG21 ' A' ' 35' ' ' THR . 32.8 t0 61.39 118.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.599 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' CB ' HD12 ' B' ' 85' ' ' ILE . 12.0 t-20 -107.49 148.98 28.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.576 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.567 ' HB2' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -141.49 143.1 33.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.213 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.99 131.54 40.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.592 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.2 m -150.53 163.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.122 0.487 . . . . 0.0 111.618 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 51' ' ' TYR . 93.3 m -155.73 101.41 2.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.001 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.945 HG13 ' O ' ' B' ' 76' ' ' SER . 11.9 t -98.41 130.96 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.211 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.5 mtm -91.06 99.92 12.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 177' ' ' LEU . 19.8 mt -101.48 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.67 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.01 12.94 72.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.355 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.21 34.22 6.85 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.706 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 45' ' ' MET . 24.4 mt-10 -141.78 134.81 14.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.582 0.23 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.35 167.96 10.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.113 . . . . 0.0 112.287 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' H ' HG23 ' A' ' 43' ' ' THR . 2.9 m-85 -153.81 168.49 26.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.288 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.8 p -135.24 97.4 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.505 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.8 tt -115.82 160.92 19.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.812 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -161.11 120.81 0.97 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 16' ' ' LYS . 10.0 mp -77.04 102.82 6.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.918 0.39 . . . . 0.0 110.927 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 9.8 m-85 -84.1 104.95 14.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 58' ' ' THR . 40.0 m-20 -66.84 175.85 2.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.716 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 57' ' ' ASP . 23.1 p -161.43 128.95 4.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -58.49 170.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.51 66.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.538 HD22 ' H ' ' A' ' 61' ' ' LEU . 2.6 mm? -63.35 150.45 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.314 . . . . 0.0 110.918 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 34.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -116.7 20.54 13.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -78.38 -10.48 59.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.382 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -42.54 -30.64 0.37 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -79.55 -45.56 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 70' ' ' LEU . 1.4 mp -95.18 25.27 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -98.02 -49.61 0.22 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.675 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 60.1 Cg_exo -51.41 -43.1 51.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 121.965 1.776 . . . . 0.0 111.838 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.846 HD22 ' CG ' ' B' ' 103' ' ' TRP . 1.0 OUTLIER -49.08 -24.57 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.246 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.812 ' N ' HD12 ' A' ' 70' ' ' LEU . 1.3 p -104.52 -20.65 13.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.336 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.572 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 60.38 139.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.895 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . 96.9 Cg_endo -82.7 -47.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.584 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -69.23 -10.69 58.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.537 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 HG23 ' A' ' 7' ' ' VAL . 6.2 t -40.89 -52.21 3.09 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -173.17 -167.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.036 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.1 p -65.4 162.41 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 77' ' ' VAL . 15.0 m-85 -110.48 134.61 52.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.503 ' CB ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -104.31 120.33 40.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.5 t -131.16 153.76 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.5 ' HB2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -144.64 175.89 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 111.672 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG11 ' A' ' 93' ' ' VAL . 11.0 p90 -167.21 -176.05 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.703 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.9 t -135.07 44.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.38 -70.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 59.3 m -44.48 100.6 0.23 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.194 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.91 -36.4 83.53 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.667 2.245 . . . . 0.0 112.296 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 t -49.95 -32.37 14.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 t -96.0 -33.08 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 1.4 t80 -55.76 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -48.86 -26.13 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 17.9 m-20 -73.2 -65.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.083 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.648 HG13 ' HD1' ' A' ' 97' ' ' TRP . 61.1 t -41.71 -33.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.829 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HD3' HD11 ' A' ' 145' ' ' LEU . 9.2 ttpt -79.09 -62.38 1.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.17 7.79 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -117.8 -41.57 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.821 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.648 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.2 m95 -95.23 -39.58 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 98.1 t -47.57 -43.31 49.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.632 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.8 Cg_exo -67.76 -31.85 31.25 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.525 2.15 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -93.13 -22.76 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 10.2 tt -47.05 -27.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 p -74.94 -40.14 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.25 -39.12 81.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 110.407 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 7.2 m-70 -93.73 -26.18 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -123.86 66.54 39.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 73' ' ' PRO . 36.3 Cg_endo -65.44 111.56 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.66 2.24 . . . . 0.0 112.472 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.96 48.7 22.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.014 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 109' ' ' PRO . 69.9 m -140.89 140.59 21.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.833 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 108' ' ' THR . 19.5 Cg_endo -58.4 169.98 2.7 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 0.0 111.914 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.404 ' CB ' HD11 ' A' ' 101' ' ' ILE . 3.1 p90 -159.84 137.72 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.411 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 mp -100.96 124.29 46.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.154 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CZ ' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -134.71 102.12 5.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.626 HG23 ' CB ' ' A' ' 142' ' ' ALA . 4.0 p -145.3 108.0 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 155.47 42.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 156' ' ' GLU . 1.2 p -148.16 115.76 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -169.97 72.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 157' ' ' CYS . 24.9 mt -64.87 -62.52 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -50.93 -60.0 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -48.64 -48.37 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.592 ' HG3' HG11 ' A' ' 85' ' ' VAL . 22.0 ttp85 -50.34 -28.23 7.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.61 -15.46 61.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.485 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.54 ' O ' HD12 ' A' ' 126' ' ' ILE . 4.3 m-20 -53.84 143.83 38.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.757 0.313 . . . . 0.0 110.967 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.74 -45.02 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.0 m -49.25 -40.2 33.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -53.6 -63.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.8 mp -50.97 -39.51 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.92 -63.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.09 -34.6 66.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 136' ' ' PRO . 1.2 mt -50.15 -26.28 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.959 0.409 . . . . 0.0 110.459 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.42 61.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.908 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.54 -16.66 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -93.63 29.59 1.98 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.16 33.64 2.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 50.04 -163.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.28 75.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.629 ' HB3' HD13 ' A' ' 129' ' ' LEU . 57.2 Cg_endo -70.69 169.14 20.83 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.697 2.265 . . . . 0.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.643 HG23 ' CG2' ' A' ' 141' ' ' THR . 4.0 mp -97.95 131.9 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.117 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.478 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -129.57 -179.24 0.96 Allowed Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.266 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 61.2 Cg_exo -52.14 -21.26 12.41 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.442 2.095 . . . . 0.0 112.496 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.0 -40.79 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.643 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.8 m -48.37 -47.24 37.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.184 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.626 ' CB ' HG23 ' A' ' 113' ' ' VAL . . . -49.2 -50.89 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.835 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -32.0 73.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.414 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -55.43 -49.61 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.481 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 149' ' ' LEU . 6.5 tt -66.12 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.501 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -68.53 -49.07 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -63.46 -35.14 79.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -31.01 71.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.735 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 145' ' ' LEU . 4.1 pp -98.66 -20.12 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.664 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mmtm 63.13 93.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.556 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -136.55 -173.43 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 153' ' ' LYS . 9.2 p -41.72 -45.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.606 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 112.81 139.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.589 1.18 . . . . 0.0 109.959 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.879 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -153.65 140.57 19.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.687 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 155' ' ' VAL . 34.7 m -158.47 125.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.666 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.4 pt-20 -161.02 174.15 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.652 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.944 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.9 p -135.23 -170.73 2.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.995 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 164.44 17.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.815 0.34 . . . . 0.0 110.506 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -40.72 -90.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.067 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.07 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.699 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 170.04 -66.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.647 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.535 ' NE2' HD22 ' A' ' 165' ' ' LEU . 4.0 mm-40 43.73 96.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.604 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.84 -49.47 3.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.74 68.52 0.35 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.973 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.694 HD21 ' CD1' ' A' ' 23' ' ' TYR . 2.6 tp -93.02 -22.27 19.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 111.408 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -41.93 75.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.01 -65.21 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 169' ' ' PHE . 7.5 p -46.67 -49.1 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.466 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 39.8 t80 -55.09 -43.79 74.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.639 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' B' ' 75' ' ' ILE . 45.5 m-20 -53.09 -43.16 66.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.42 -44.82 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.83 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.925 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 169' ' ' PHE . 19.6 mm -94.95 -30.2 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.36 -46.18 80.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.87 -26.24 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.216 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -65.93 -50.56 63.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' HD13 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -90.69 65.96 6.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.944 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 60.23 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 170' ' ' ASP . 8.5 tt -127.13 145.87 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.945 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.39 132.19 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.74 145.32 83.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' B' ' 77' ' ' LEU . 73.9 Cg_exo -50.49 -175.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.733 2.288 . . . . 0.0 112.545 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 73.4 m -153.72 -63.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.504 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 2.2 t80 -98.44 139.71 33.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.81 124.76 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.783 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.453 ' CD2' ' OD1' ' A' ' 38' ' ' ASP . 2.9 t-160 -68.21 78.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.98 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.572 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -119.33 110.34 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -91.22 96.54 10.62 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 36' ' ' VAL . 60.3 t -78.1 137.27 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.562 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.61 177.74 17.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.191 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -78.11 123.86 27.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 111.034 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.566 ' CG ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -114.95 97.87 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.08 -18.68 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.585 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.536 HG13 ' N ' ' B' ' 93' ' ' THR . 13.3 p -45.37 -46.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 111.493 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.536 ' N ' HG13 ' B' ' 92' ' ' VAL . 6.6 t -121.94 -10.74 8.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.687 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.58 18.92 21.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.309 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.406 ' CD ' HG21 ' B' ' 93' ' ' THR . 14.1 pt-20 -124.47 -160.73 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.648 0.261 . . . . 0.0 110.708 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.792 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -98.34 164.32 12.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.566 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -101.46 167.94 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 47.84 33.83 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.373 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.595 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.99 117.86 5.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.46 0.171 . . . . 0.0 111.179 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.458 ' HD3' HG22 ' B' ' 87' ' ' VAL . 92.4 Cg_exo -42.88 155.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.054 . . . . 0.0 112.294 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -47.77 -54.05 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -55.85 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.846 ' CG ' HD22 ' A' ' 70' ' ' LEU . 6.0 m0 -47.83 -57.54 5.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -49.73 -65.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.346 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' B' ' 109' ' ' THR . 3.7 mtt-85 -49.11 -44.52 42.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.43 -61.24 1.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.3 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.656 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -94.75 -68.79 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.273 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.561 ' O ' HG23 ' B' ' 109' ' ' THR . 0.1 OUTLIER -78.45 -97.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.89 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.561 HG23 ' O ' ' B' ' 108' ' ' GLN . 22.5 p -160.48 -55.06 0.05 Allowed 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -151.63 172.44 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 112.121 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' B' ' 99' ' ' MET . 7.2 p30 -64.37 75.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.537 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.483 0.658 . . . . 0.0 111.004 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.819 0.342 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.9 -171.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 135.63 36.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.982 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.675 HG22 ' HB1' ' A' ' 176' ' ' ALA . 4.8 pt -149.63 111.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -134.26 99.73 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.432 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 6.0 m -77.27 152.4 34.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 56' ' ' PHE . 17.4 t -136.9 143.9 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.285 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 9' ' ' VAL . 6.5 p -85.01 160.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' HG22 ' A' ' 8' ' ' VAL . 3.9 m -138.09 121.18 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.22 173.9 31.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.22 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.409 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.3 m-20 -89.54 110.42 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.0 110.769 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -161.15 -39.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.786 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 83.45 -47.99 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.482 ' O ' HD13 ' A' ' 19' ' ' LEU . 18.5 m -47.07 -25.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.33 -94.44 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.477 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HZ1' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.83 -71.57 0.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.923 ' O ' HD13 ' A' ' 21' ' ' ILE . 1.1 t -36.0 -58.42 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.786 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 10.9 m -68.94 -26.86 65.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.964 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 15' ' ' GLY . 3.0 tp -58.38 -76.85 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.819 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 42' ' ' VAL . 12.9 mt -48.91 -33.35 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.856 -0.528 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 17' ' ' THR . 1.2 mp -51.16 -68.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 t -93.33 -57.19 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.593 ' O ' HD21 ' B' ' 77' ' ' LEU . 10.4 t80 -39.28 -39.89 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.661 HG21 HG12 ' A' ' 42' ' ' VAL . 62.7 m -104.72 -75.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -71.22 -15.33 62.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 9.5 t-20 65.59 36.92 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 111.165 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 1.5 tttp 176.6 164.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -134.22 60.97 47.64 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.69 0.281 . . . . 0.0 111.748 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 80.9 Cg_endo -91.63 126.56 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.064 2.51 . . . . 0.0 112.516 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.7 p 171.82 -88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.991 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.96 153.04 13.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.0 t80 -91.02 111.92 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 110.835 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 34' ' ' PRO . 95.0 t -158.67 140.38 9.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' A' ' 33' ' ' VAL . 82.0 Cg_exo -46.61 91.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.262 1.975 . . . . 0.0 111.446 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.809 HG23 ' CG ' ' A' ' 38' ' ' ASP . 54.5 m -52.9 87.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.544 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.504 HG11 ' CG ' ' B' ' 96' ' ' PHE . 37.2 t -75.4 -25.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 109.898 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.557 ' HE2' HD13 ' B' ' 85' ' ' ILE . 4.2 t80 -148.29 -68.82 0.23 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.247 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.809 ' CG ' HG23 ' A' ' 35' ' ' THR . 3.0 m-20 57.97 111.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.331 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.587 ' HB3' HD12 ' B' ' 85' ' ' ILE . 11.2 t-20 -107.96 148.82 29.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.08 142.15 25.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.599 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -83.22 152.17 25.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 24' ' ' THR . 1.2 m -162.43 148.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -132.09 104.81 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 173' ' ' ILE . 4.0 t -97.31 117.23 41.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.5 . . . . 0.0 110.58 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.8 mtm -100.23 100.01 10.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.947 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 46' ' ' ILE . 12.3 tt -109.85 109.54 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.25 15.81 61.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.545 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.68 -43.01 1.94 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.616 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.61 142.91 66.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.293 . . . . 0.0 111.057 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.81 173.98 11.85 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.322 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -153.28 146.46 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -99.72 97.42 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.033 HD21 HD12 ' A' ' 55' ' ' LEU . 7.9 tt -112.33 156.5 22.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.994 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.99 112.33 0.53 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.033 HD12 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -85.5 103.34 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.927 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.4 m-85 -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.35 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 14.2 t70 -72.17 166.36 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 64' ' ' TYR . 43.7 m -169.32 128.59 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.544 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -77.94 -73.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.69 -137.67 6.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 mt 71.73 -174.23 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -96.08 -16.89 21.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.393 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 71.5 m-20 -76.34 -19.27 58.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.4 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -70.33 -16.79 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.542 0.21 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -48.04 -25.73 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 5.7 ptp180 -91.99 -40.95 10.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.052 HD22 ' CE2' ' B' ' 96' ' ' PHE . 27.3 tp -86.78 1.13 53.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.51 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.01 -47.28 0.39 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.838 -0.164 . . . . 0.0 111.282 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 76.3 Cg_exo -49.08 -25.21 8.78 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.19 1.927 . . . . 0.0 111.411 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.77 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -65.02 -28.15 69.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.497 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 22.5 m -100.15 -14.89 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.262 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 54.58 141.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 123.252 0.621 . . . . 0.0 112.03 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.99 -34.51 2.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -10.71 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.322 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.495 HG21 HG23 ' A' ' 7' ' ' VAL . 9.0 t -40.6 -47.88 2.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.572 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 4' ' ' ILE . 1.3 m-20 169.06 -168.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 111' ' ' LEU . 12.2 p -58.29 141.97 14.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.448 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 105' ' ' CYS . 10.3 m-85 -92.9 143.7 26.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.627 HD23 ' HZ1' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.68 115.94 31.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.219 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 101' ' ' ILE . 2.7 t -89.26 93.69 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.962 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.455 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 28.1 p -67.62 110.38 3.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.744 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 93' ' ' VAL . 2.6 t80 -131.92 105.8 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.42 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -50.66 156.83 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.914 HG13 HG22 ' A' ' 137' ' ' ILE . 63.0 t -83.49 -75.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 120' ' ' ARG . 97.9 t -69.26 -101.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.522 ' N ' HG12 ' A' ' 85' ' ' VAL . 17.7 m 33.72 57.59 1.76 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.605 ' HD3' HG12 ' A' ' 85' ' ' VAL . 2.7 Cg_endo -46.06 -25.65 3.04 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.9 2.4 . . . . 0.0 112.362 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.39 -26.04 26.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.1 m -96.28 -38.78 9.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.254 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -45.17 -66.99 0.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.238 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 -55.55 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -54.17 -64.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.914 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 89' ' ' SER . 48.0 t -41.37 -36.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.813 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HD3' HD21 ' A' ' 145' ' ' LEU . 25.1 tptp -63.2 -69.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 2.4 mp0 -82.78 8.62 11.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tptp -117.43 -44.93 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' HD1' HG13 ' A' ' 93' ' ' VAL . 14.4 m95 -95.12 -28.19 15.2 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.825 ' O ' HG22 ' A' ' 101' ' ' ILE . 24.5 t -70.03 -44.56 21.5 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.704 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.5 Cg_exo -51.06 -29.31 27.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.23 1.953 . . . . 0.0 112.57 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -93.11 -17.51 23.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.666 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.894 HD11 HG22 ' A' ' 80' ' ' VAL . 9.6 tt -47.5 -35.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.805 0.336 . . . . 0.0 111.29 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 p -65.62 -38.33 89.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -61.67 -29.46 70.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.179 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -87.06 -48.96 7.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 28.9 p -104.04 96.55 9.66 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 111.005 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.56 100.45 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.573 2.182 . . . . 0.0 112.334 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.82 5.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 m -117.32 131.17 24.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.55 175.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.483 2.122 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 149' ' ' LEU . 3.9 p90 -163.15 159.42 22.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.7 mp -111.96 120.08 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.847 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.513 HD13 ' C ' ' A' ' 112' ' ' LEU . 1.3 tm? -95.19 102.49 14.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.69 160.39 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.373 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -147.45 137.3 6.51 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.364 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.5 p -130.26 -155.62 0.71 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.1 tp60 82.4 77.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.415 HG13 ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -100.12 -34.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -78.04 -51.72 9.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.268 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -51.54 -40.37 59.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.873 ' HB2' HG21 ' A' ' 85' ' ' VAL . 7.6 ptt85 -72.44 61.93 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -137.72 46.7 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.022 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.32 145.89 34.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.62 -45.21 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.317 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -49.96 -45.93 51.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.79 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -29.62 20.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.8 mm -66.09 -57.35 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.054 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -48.43 -38.19 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.056 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -39.09 17.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.976 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.482 HD13 ' HG3' ' A' ' 136' ' ' PRO . 6.2 mt -51.18 -25.54 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.409 . . . . 0.0 110.436 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.82 -19.18 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -31.9 33.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -67.62 -19.46 65.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.13 46.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.49 133.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.5 168.18 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.54 129.22 32.73 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.914 HG22 HG13 ' A' ' 84' ' ' VAL . 8.5 mt -60.41 129.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.471 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -128.09 179.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.948 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 73.0 Cg_exo -51.75 -21.67 11.9 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.674 2.25 . . . . 0.0 112.508 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.58 -53.37 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.547 ' CG2' HG23 ' A' ' 137' ' ' ILE . 54.4 m -46.21 -47.52 17.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.34 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -33.79 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.577 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -58.51 -56.62 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.506 HD21 ' HD3' ' A' ' 94' ' ' LYS . 17.9 tp -59.09 -52.94 63.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.434 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.642 ' CA ' HD23 ' A' ' 149' ' ' LEU . . . -57.91 -41.01 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.408 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.401 ' HA ' ' OH ' ' A' ' 154' ' ' TYR . 48.4 ttt-85 -50.16 -41.56 49.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.44 -21.74 64.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.935 HD13 ' CE1' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -74.84 -28.47 60.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 tttt 66.83 58.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.648 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -107.28 -177.97 3.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.412 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 66.3 t -48.86 -64.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 178.97 160.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.756 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.802 ' HE2' ' HB3' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -154.34 111.23 3.35 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 168' ' ' VAL . 23.6 m -158.27 120.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.859 0.362 . . . . 0.0 110.412 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -173.18 -178.63 1.79 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.61 -173.42 4.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.89 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.415 ' OG ' HG13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -87.2 155.94 19.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.267 0.556 . . . . 0.0 111.301 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 22' ' ' SER . . . -57.18 -158.85 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER 47.86 26.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.802 179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.499 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.62 121.46 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -105.42 -68.28 0.87 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.178 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.428 ' C ' HD23 ' A' ' 165' ' ' LEU . . . -162.86 85.19 0.11 Allowed Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.375 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -94.05 -10.11 34.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.728 0.299 . . . . 0.0 111.669 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -43.74 -29.44 0.52 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.925 0.393 . . . . 0.0 111.135 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 155' ' ' VAL . 16.1 m-20 -64.37 -47.4 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.557 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 155' ' ' VAL . 86.1 t -54.45 -47.62 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.571 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -69.97 -38.76 76.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.746 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.37 -42.34 66.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.269 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.436 ' CB ' ' HG2' ' A' ' 153' ' ' LYS . 1.6 tp10 -90.03 -41.53 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.72 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -60.48 -35.73 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 44' ' ' VAL . 29.6 mm -86.11 -44.65 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.37 -41.13 85.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -52.3 -40.03 61.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.675 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -84.56 -23.83 29.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 46' ' ' ILE . 4.0 tp -48.91 -64.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.22 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -96.35 142.61 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.058 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.48 144.89 51.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -72.53 129.29 87.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.72 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.579 ' HB2' HG12 ' A' ' 42' ' ' VAL . 9.2 Cg_endo -51.91 149.64 19.88 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.4 ' O ' ' N ' ' B' ' 81' ' ' PHE . 75.4 m -120.37 -64.07 1.29 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -47.53 93.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 2.3 t80 -119.75 135.87 54.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.89 131.24 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.487 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.22 88.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.474 . . . . 0.0 110.397 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.572 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -56.11 -76.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.661 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -121.4 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.931 0.396 . . . . 0.0 111.788 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -105.31 97.48 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.907 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.5 t -77.62 145.38 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.707 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -146.31 167.49 27.94 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.227 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -92.19 126.82 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' B' ' 92' ' ' VAL . 37.1 t0 -135.82 135.14 39.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.758 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.42 1.72 18.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.009 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.619 HG13 ' OD1' ' B' ' 90' ' ' ASP . 11.5 m -45.5 -27.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.441 HG23 ' N ' ' B' ' 94' ' ' GLY . 12.8 t -153.41 -44.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.837 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . 0.441 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.57 35.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.367 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -144.66 -160.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.752 0.311 . . . . 0.0 110.598 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 1.052 ' CE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.56 147.3 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.437 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -90.71 178.49 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.74 32.28 32.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.633 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 1.8 tpt -44.1 101.92 0.27 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 0.0 111.423 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.454 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 82.7 Cg_exo -45.51 151.95 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.114 1.876 . . . . 0.0 112.077 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -43.97 -63.84 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.929 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -64.7 -61.29 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.747 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 67' ' ' LEU . 3.1 m0 -46.39 -50.62 16.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.633 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.14 -66.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.0 ptm180 -47.35 -27.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.915 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.648 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -63.05 -62.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.331 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -94.89 -59.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.679 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 109' ' ' THR . 6.8 tp60 -77.82 -99.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.72 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -166.74 -52.17 0.03 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.891 0.377 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 99' ' ' MET . 0.3 OUTLIER -154.1 -176.5 5.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.434 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 99' ' ' MET . 26.7 t-20 -82.41 80.48 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.845 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.701 0.762 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.41 141.59 43.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 t -119.98 111.8 18.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -115.88 151.98 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -128.33 96.26 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.7 104.8 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 8' ' ' VAL . 25.7 t -84.71 158.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.72 HG23 ' CG2' ' A' ' 14' ' ' VAL . 34.4 m -140.76 150.71 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.405 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.8 m -145.12 135.2 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.335 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.72 146.08 4.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.69 152.58 39.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.58 0.228 . . . . 0.0 110.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 49.76 96.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.976 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 67.61 64.13 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.141 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 8' ' ' VAL . 7.6 p -48.56 -24.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.2 -32.84 2.6 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.919 ' HE3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.14 -73.45 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.637 0.256 . . . . 0.0 111.56 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.831 HG23 ' OD1' ' A' ' 57' ' ' ASP . 18.0 p -39.52 -61.31 0.82 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.775 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 6.1 p -46.43 -37.3 7.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 79' ' ' LEU . 5.9 tp -67.94 -71.46 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD12 ' CD2' ' B' ' 81' ' ' PHE . 1.7 mm? -38.18 -41.37 0.59 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.753 0.311 . . . . 0.0 111.604 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.719 HG21 ' HD3' ' A' ' 29' ' ' PRO . 4.4 mm -61.04 -45.05 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' LEU . 90.8 p -94.2 -64.02 1.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.74 ' CD1' HD12 ' A' ' 165' ' ' LEU . 27.1 t80 -49.38 -47.88 47.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.197 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' HD2' ' B' ' 81' ' ' PHE . 94.5 m -97.45 -95.76 0.21 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.93 HG21 ' CE ' ' A' ' 27' ' ' LYS . 5.0 t -41.23 -29.38 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 t30 68.13 24.25 7.74 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.93 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -112.41 -160.02 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.196 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.01 156.61 74.01 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.719 ' HD3' HG21 ' A' ' 21' ' ' ILE . 63.2 Cg_exo -36.68 142.33 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.071 2.514 . . . . 0.0 113.133 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.95 -83.32 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.537 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.94 97.31 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.377 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.38 106.45 1.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.098 0.475 . . . . 0.0 110.97 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 ' HD2' ' A' ' 34' ' ' PRO . 4.4 p -160.6 139.64 7.79 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.179 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.4 Cg_exo -37.66 100.2 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.764 2.31 . . . . 0.0 112.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.554 HG23 HG21 ' A' ' 17' ' ' THR . 4.9 m -47.0 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.257 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 34' ' ' PRO . 91.2 t -91.21 -43.67 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' B' ' 87' ' ' VAL . 84.0 t80 -172.57 106.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.746 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB2' HG22 ' A' ' 17' ' ' THR . 30.0 m-20 -107.52 127.36 53.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.65 ' HB3' HD12 ' B' ' 85' ' ' ILE . 31.4 t-20 -107.48 147.01 31.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.113 0.482 . . . . 0.0 111.309 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.695 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.27 161.11 43.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.187 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.82 116.75 29.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.182 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 55' ' ' LEU . 1.3 m -124.92 124.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 0.0 111.76 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -122.27 95.94 4.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.459 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.88 HG23 ' O ' ' B' ' 76' ' ' SER . 10.7 p -97.34 116.78 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.8 mtm -89.04 114.99 26.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.047 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.691 HG23 ' O ' ' B' ' 74' ' ' SER . 9.0 mt -115.8 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 73' ' ' GLY . . . 85.79 18.73 59.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.21 33.45 44.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.544 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -139.15 147.33 52.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.66 162.9 35.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.491 2.127 . . . . 0.0 112.207 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -154.34 167.53 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.5 m -131.87 97.04 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.214 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.75 158.94 16.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.29 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.92 103.72 0.26 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.054 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.39 103.32 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -83.71 102.95 12.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.172 179.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.831 ' OD1' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -71.38 -178.07 2.0 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.985 0.421 . . . . 0.0 111.111 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -170.53 172.81 5.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.701 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -87.39 -61.45 1.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.253 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.51 18.46 9.04 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 mt -94.33 -173.83 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.801 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.67 39.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -135.64 12.33 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.346 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.697 ' CE2' HG22 ' A' ' 58' ' ' THR . 1.3 m-85 -86.69 2.68 47.73 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.525 0.202 . . . . 0.0 111.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.3 p-10 -49.43 -25.63 2.7 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -39.07 12.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.94 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -96.84 26.32 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.538 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.568 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.49 -26.57 0.3 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 72.5 Cg_endo -76.72 -22.91 11.51 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.455 1.437 . . . . 0.0 111.667 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' B' ' 103' ' ' TRP . 7.4 mt -60.19 -18.27 47.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -94.38 -27.24 16.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.04 168.47 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.976 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 72' ' ' TYR . 14.1 Cg_endo -57.4 -17.62 27.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.422 2.081 . . . . 0.0 112.198 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -10.76 38.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.2 t -38.3 -30.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.03 -154.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 41.4 t -57.84 161.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -111.94 122.08 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.945 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.919 HD23 ' HE3' ' A' ' 16' ' ' LYS . 1.9 tp -103.83 121.51 43.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.291 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.734 ' N ' HD12 ' A' ' 79' ' ' LEU . 2.3 t -131.06 138.12 54.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.95 152.99 48.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HE1' HG12 ' A' ' 84' ' ' VAL . 26.9 p90 -138.65 176.13 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' A' ' 116' ' ' GLN . 91.5 p -89.69 120.03 30.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.537 HG12 ' HE1' ' A' ' 82' ' ' PHE . 32.3 m -93.06 40.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.786 HG12 ' N ' ' A' ' 120' ' ' ARG . 19.4 m -95.46 -45.77 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 85' ' ' VAL . 2.0 p -139.46 139.35 22.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.74 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 132' ' ' ASN . 42.6 Cg_endo -68.53 -17.81 43.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.579 2.186 . . . . 0.0 112.469 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -51.68 -23.73 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -93.32 -29.91 15.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.169 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 2.7 m-85 -46.44 -44.93 17.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.193 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.65 -58.26 8.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -63.17 -36.71 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 89' ' ' SER . 72.7 t -48.63 -65.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.435 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HD3' HD11 ' A' ' 145' ' ' LEU . 13.0 mtmm -73.33 -37.25 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.71 -12.39 61.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.9 tttm -119.03 -25.88 6.11 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.638 ' CZ3' HG13 ' A' ' 93' ' ' VAL . 31.2 m0 -93.29 -49.03 6.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.625 0.25 . . . . 0.0 111.313 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.8 t -47.6 -43.93 52.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.1 Cg_exo -67.38 -26.53 41.09 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.53 2.154 . . . . 0.0 112.589 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.05 -35.21 15.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.439 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -47.67 -27.58 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.367 . . . . 0.0 111.294 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -89.13 -33.23 17.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -51.92 -44.68 63.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.408 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -84.32 -46.59 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -97.34 104.23 19.12 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.746 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 95.9 Cg_exo -41.65 -51.12 4.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.554 2.17 . . . . 0.0 112.565 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -173.79 48.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.621 HG23 ' HD2' ' A' ' 109' ' ' PRO . 56.6 m -103.97 142.79 25.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.621 ' HD2' HG23 ' A' ' 108' ' ' THR . 78.7 Cg_exo -39.79 129.08 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.547 2.165 . . . . 0.0 112.086 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.6 p90 -102.53 173.75 6.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.164 0.507 . . . . 0.0 111.48 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.985 HD22 ' CE2' ' A' ' 154' ' ' TYR . 3.0 mt -151.74 126.25 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.876 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 4.1 tt -143.63 125.64 15.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.675 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 154' ' ' TYR . 7.1 p -157.05 134.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.326 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.629 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -105.94 158.62 15.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.555 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.0 t -168.87 144.36 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.733 0.302 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 2.3 mt-30 172.06 55.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.45 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 158' ' ' SER . 38.3 mt -52.88 -24.46 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.442 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 28.0 t70 -82.26 -55.22 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.231 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.47 ' C ' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -63.29 -40.76 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.786 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -66.25 71.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -174.97 53.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -98.45 161.24 25.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.99 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.12 -26.17 15.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.832 2.355 . . . . 0.0 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -28.71 16.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.98 -68.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.088 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.2 mp -45.36 -39.69 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.445 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -61.29 2.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.14 -35.38 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -49.7 -27.74 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 110.686 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.95 -20.36 62.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.404 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -89.92 -21.56 22.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.19 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.465 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 1.3 t-20 -88.21 -26.67 22.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.172 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 166.78 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 87.18 -175.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 1.4 tmmt? 63.22 129.03 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.5 140.18 62.0 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.429 2.086 . . . . 0.0 112.458 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG23 ' CB ' ' A' ' 141' ' ' THR . 5.9 mt -70.2 118.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.969 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.81 156.9 34.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.334 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.07 -29.46 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.293 2.662 . . . . 0.0 112.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.31 -43.74 73.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.412 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.412 ' CB ' HG23 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -46.58 -66.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.32 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.629 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -47.41 -47.69 26.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.246 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -56.39 -44.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -39.97 75.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.68 HD11 ' HD3' ' A' ' 94' ' ' LYS . 1.8 tm? -57.0 -52.34 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.599 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 112' ' ' LEU . . . -60.57 -26.45 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -81.37 -35.52 30.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.9 -52.13 8.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.254 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -94.34 30.82 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.242 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.03 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 149' ' ' LEU . . . 51.65 -176.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.156 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 152' ' ' VAL . 42.5 t -71.46 -8.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.81 152.1 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.52 0.328 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.985 ' CE2' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -153.16 151.8 30.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.088 0.471 . . . . 0.0 111.884 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.2 m -158.75 124.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.447 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.89 -178.46 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.349 0.595 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.7 p -141.77 -168.21 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -82.92 161.22 21.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 109.976 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -45.54 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.959 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -37.04 -42.72 0.43 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.057 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.6 p -86.77 171.71 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.154 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.499 HE21 HD23 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -163.39 89.01 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.166 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 -68.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.951 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.37 77.02 0.39 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.74 HD12 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -94.02 -32.81 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.138 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -65.66 -43.67 88.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 47.0 m-20 -51.72 -66.02 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 154' ' ' TYR . 2.1 p -42.92 -56.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.562 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 1.0 OUTLIER -52.12 -33.2 38.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 5.0 t0 -70.0 -31.14 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -88.99 -26.24 21.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.16 -24.53 21.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.988 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.643 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 15.8 mm -94.98 -57.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.1 tp -53.53 -24.67 14.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.77 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.62 -23.66 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.437 HD11 HD13 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -49.73 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -60.85 -68.81 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 tt -144.03 151.43 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.8 t -136.03 130.12 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.68 HD11 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -47.17 139.47 7.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 67.6 Cg_exo -50.68 142.47 31.79 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.345 2.03 . . . . 0.0 112.189 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 166.78 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.724 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.51 110.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.762 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.5 p90 -81.08 172.73 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.305 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -130.04 135.98 48.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.9 95.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.181 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -72.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -125.24 138.88 52.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.024 0.44 . . . . 0.0 111.936 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.16 98.03 5.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.715 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 37' ' ' PHE . 61.2 t -77.65 152.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.881 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.415 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.39 177.88 24.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.152 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -77.16 124.59 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 110.788 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.595 ' CB ' HG23 ' B' ' 97' ' ' THR . 11.0 t0 -114.86 108.33 16.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.132 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.1 -19.35 62.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.2 -57.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.016 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 93' ' ' THR . 14.6 t -146.05 53.04 1.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.06 30.08 7.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' B' ' 93' ' ' THR . 17.1 pt-20 -118.21 -176.75 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.94 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -99.27 164.15 12.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.644 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.595 HG23 ' CB ' ' B' ' 90' ' ' ASP . 10.3 p -104.29 166.8 10.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 46.73 26.87 2.9 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.642 ' HE1' HD21 ' A' ' 67' ' ' LEU . 1.2 mtp -48.5 137.55 12.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.598 0.237 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.51 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 52.7 Cg_exo -53.8 151.39 26.15 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.238 1.959 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -44.63 -55.46 5.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.599 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.906 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.4 tm0? -70.84 -46.56 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.711 ' CG ' HD13 ' A' ' 70' ' ' LEU . 3.6 m0 -51.1 -57.91 7.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -53.1 -67.37 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.098 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.8 ptt85 -44.66 -40.98 6.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.397 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.906 HD23 ' OE1' ' B' ' 102' ' ' GLN . 0.1 OUTLIER -50.97 -55.08 19.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.83 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.64 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -94.46 -69.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.646 ' O ' HG23 ' B' ' 109' ' ' THR . 7.3 tt0 -79.47 -96.3 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.646 HG23 ' O ' ' B' ' 108' ' ' GLN . 16.8 p -164.07 -56.62 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.539 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.697 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -125.85 173.46 9.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.608 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' B' ' 99' ' ' MET . 0.8 OUTLIER -59.58 -55.76 30.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.563 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.752 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.787 0.327 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.43 122.18 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.65 147.23 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.741 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.764 HD13 ' HB3' ' A' ' 176' ' ' ALA . 10.5 mt -131.46 104.18 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.274 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -102.72 96.48 6.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.744 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -80.81 122.07 26.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 71.8 t -97.69 154.05 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.5 t -120.17 166.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.389 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.759 HG11 ' HA ' ' A' ' 101' ' ' ILE . 7.4 p -157.51 121.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.45 169.28 27.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.289 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.473 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 4.0 m-20 -87.3 134.11 33.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -171.7 -45.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.95 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 77.31 -66.13 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 82' ' ' PHE . 23.4 m -48.07 -24.67 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.747 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -55.25 -91.09 0.01 OUTLIER Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.162 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 2.1 ttpm? -96.07 -72.84 0.62 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -40.51 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.95 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 69.6 m -49.52 -29.82 7.4 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.22 0.533 . . . . 0.0 110.833 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -53.0 -73.99 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.03 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.5 mt -48.46 -29.45 4.1 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.4 mm -53.69 -65.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.245 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -95.71 -17.96 20.85 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -179.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.608 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -97.24 -40.92 8.53 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.847 ' OG1' HD23 ' A' ' 20' ' ' LEU . 41.2 m -94.56 20.95 7.8 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.083 -0.386 . . . . 0.0 111.668 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.601 HG21 ' CD1' ' B' ' 81' ' ' PHE . 3.3 t -177.13 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.211 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 9.8 m-80 81.2 51.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.903 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -133.93 -178.78 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.177 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -123.56 146.55 50.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.89 ' HD3' HG21 ' A' ' 21' ' ' ILE . 3.0 Cg_exo -35.62 146.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.661 2.908 . . . . 0.0 112.975 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -76.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.828 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.77 114.29 25.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.661 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.7 t80 -66.84 111.28 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.072 0.463 . . . . 0.0 111.121 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 87.8 t -159.51 131.3 4.1 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.2 Cg_exo -44.79 92.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.183 1.922 . . . . 0.0 111.451 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.871 HG23 ' CG ' ' A' ' 38' ' ' ASP . 97.8 m -50.72 88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.684 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.976 HG12 ' OH ' ' A' ' 64' ' ' TYR . 2.4 t -79.79 -42.84 22.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.8 t80 -124.76 -68.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.084 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.871 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.1 m-20 54.62 111.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.811 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.4 t-20 -106.99 160.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.038 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -148.29 162.36 39.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -178.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.09 148.06 30.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.9 m -151.61 158.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.259 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -154.93 87.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.2 m -99.49 168.22 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.418 ' HE2' ' CB ' ' B' ' 76' ' ' SER . 19.1 mtm -121.44 101.53 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' A' ' 51' ' ' TYR . 6.8 mm -93.32 90.1 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.41 20.35 60.49 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.38 34.43 8.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.558 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 21.5 mt-10 -138.62 138.65 22.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 52.8 Cg_exo -54.65 165.37 2.51 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.53 2.153 . . . . 0.0 112.297 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -152.91 136.93 16.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.6 m -135.4 97.82 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.5 pp -133.67 160.53 37.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.76 123.94 2.47 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.882 ' HB2' HD11 ' A' ' 20' ' ' LEU . 33.8 mt -75.73 117.49 17.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 3.6 m-85 -95.16 116.96 29.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 5.2 t70 -75.96 162.21 28.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.049 HG23 ' CD2' ' A' ' 64' ' ' TYR . 21.9 m -168.08 147.79 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.76 -83.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.079 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.631 ' C ' HD22 ' A' ' 61' ' ' LEU . . . 56.51 19.3 26.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.449 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 60' ' ' GLY . 1.4 mm? 63.73 51.93 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 63.47 28.43 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -125.17 22.38 7.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.049 ' CD2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -86.68 -2.55 58.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.525 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.59 -28.92 0.65 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 110.639 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -73.97 -45.36 50.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.892 HD23 HD21 ' B' ' 107' ' ' LEU . 52.4 mt -89.92 16.5 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -69.36 -59.36 5.03 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.473 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 10.5 Cg_endo -53.84 -19.64 15.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.466 2.11 . . . . 0.0 112.424 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -79.66 -27.44 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.455 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -103.83 -9.65 18.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.511 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 41.77 91.95 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.296 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.442 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 47.9 Cg_exo -55.85 -42.21 69.42 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -69.05 -10.91 59.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.59 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' TYR . 12.2 t -45.02 -48.47 11.59 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.666 0.27 . . . . 0.0 111.565 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -170.74 -159.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' LEU . 10.1 p -58.25 162.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.508 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -111.2 133.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.301 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' OH ' ' A' ' 154' ' ' TYR . 1.3 tp -104.21 116.07 31.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 58.9 t -103.34 154.59 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.416 . . . . 0.0 111.79 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 15' ' ' GLY . 23.8 p -115.2 117.69 31.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.811 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.936 ' CD1' HD21 ' A' ' 112' ' ' LEU . 9.9 t80 -99.12 165.71 11.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.608 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.588 ' HB3' HG21 ' A' ' 93' ' ' VAL . 1.5 t -83.26 136.85 34.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.473 0.654 . . . . 0.0 111.489 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 119' ' ' LEU . 98.8 t -51.68 -81.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.272 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -121.54 -96.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.734 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.732 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.1 t 39.91 93.29 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.532 ' HG3' HD12 ' A' ' 129' ' ' LEU . 84.4 Cg_exo -45.47 -26.78 2.94 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.553 2.168 . . . . 0.0 112.462 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -57.79 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.606 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -47.49 -43.05 24.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.459 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.722 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 t80 -48.13 -67.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.94 -42.43 65.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.112 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -61.39 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 90' ' ' PHE . 28.4 m -47.47 -26.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.666 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.95 -59.7 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.357 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 7.88 8.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -113.36 -41.01 3.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.629 0.252 . . . . 0.0 111.525 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.569 ' HE1' HG12 ' A' ' 93' ' ' VAL . 4.4 m95 -95.54 -43.34 8.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 101' ' ' ILE . 91.1 t -45.14 -58.23 6.01 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 13.9 Cg_endo -57.16 -17.93 27.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.437 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 -28.07 16.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -49.66 -35.6 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.3 -31.56 67.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.56 -43.3 93.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.64 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CE1' HG23 ' A' ' 9' ' ' VAL . 12.1 m80 -76.25 -64.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.207 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 24.4 p -68.32 112.73 11.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.701 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 34.0 Cg_exo -61.07 -66.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.584 2.189 . . . . 0.0 112.341 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -145.93 23.78 1.36 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.8 146.15 33.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.57 173.47 6.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.475 2.117 . . . . 0.0 111.894 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 4.8 p90 -150.28 -179.04 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 77' ' ' VAL . 2.2 mp -137.16 142.99 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.217 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD21 ' CD1' ' A' ' 82' ' ' PHE . 1.3 tp -112.86 125.98 54.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 111.473 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.841 HG13 ' OE2' ' A' ' 156' ' ' GLU . 3.5 t -106.31 135.71 43.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.413 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.04 143.55 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 84' ' ' VAL . 5.2 t -161.05 -169.79 2.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.677 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 172.49 72.57 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.773 0.32 . . . . 0.0 111.368 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 157' ' ' CYS . 14.8 mt -98.75 -67.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.941 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -42.18 18.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -53.56 -44.94 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.664 ' HD3' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -68.34 -19.94 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.37 -28.09 0.8 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.309 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.55 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -54.21 116.2 10.0 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.59 -56.17 3.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.512 2.141 . . . . 0.0 112.639 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -43.82 -39.17 3.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -57.98 -64.01 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.664 HD11 ' HD3' ' A' ' 120' ' ' ARG . 4.6 mp -57.27 -40.54 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -48.92 -38.55 23.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -89.94 -37.37 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.274 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.532 HD12 ' HG3' ' A' ' 87' ' ' PRO . 8.6 tp -48.95 -30.69 6.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.302 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.34 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.635 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -82.39 -25.77 33.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.53 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 7.3 m120 -85.1 -25.22 27.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.976 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 161.41 -23.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.567 0.542 . . . . 0.0 111.304 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 89.67 -43.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.978 0.511 . . . . 0.0 110.553 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.67 50.02 4.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.353 179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.496 ' HG2' HD11 ' A' ' 129' ' ' LEU . 73.2 Cg_endo -76.68 -47.37 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.622 2.214 . . . . 0.0 112.769 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.627 HD12 ' CD1' ' A' ' 90' ' ' PHE . 2.2 mm -106.82 136.67 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 111.211 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -159.74 155.37 22.51 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 5.2 Cg_endo -47.47 -25.29 4.97 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.708 2.272 . . . . 0.0 112.197 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 -35.36 14.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.27 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 136' ' ' PRO . 9.3 m -58.97 -50.21 74.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.007 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.58 11.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.699 ' HG3' HG13 ' A' ' 155' ' ' VAL . 1.4 tt0 -62.76 -39.04 92.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -58.93 -49.16 78.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.662 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 94' ' ' LYS . 5.1 tt -57.44 -36.1 70.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.622 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 112' ' ' LEU . . . -73.43 -23.98 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.73 -41.57 37.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -51.34 -47.3 62.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 149' ' ' LEU . 4.4 pp -70.69 -9.85 58.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.91 116.55 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.64 -176.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 111' ' ' LEU . 63.3 t -64.25 -14.51 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.571 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.638 ' O ' HD23 ' A' ' 111' ' ' LEU . 1.3 pttt 78.78 160.1 0.19 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 111.076 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.779 ' OH ' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -152.57 110.88 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.003 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.699 HG13 ' HG3' ' A' ' 143' ' ' GLU . 2.2 m -118.07 123.5 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.841 ' OE2' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -172.05 -178.33 2.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.532 ' HB2' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -130.5 166.97 19.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.251 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' HG21 ' A' ' 115' ' ' THR . 0.1 OUTLIER -88.6 99.94 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.517 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.697 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 46.22 -175.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.538 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 41.24 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.119 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 75.5 p 40.47 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.984 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.959 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 76.45 79.99 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.821 0.343 . . . . 0.0 110.991 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.67 -68.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.34 57.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.73 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.959 HD22 ' HG3' ' A' ' 162' ' ' GLN . 1.6 tp -93.74 -29.0 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -72.44 -57.4 4.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.434 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 72.4 m-80 -44.09 -56.71 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 111.12 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.42 HG13 ' HE2' ' A' ' 23' ' ' TYR . 2.4 p -55.07 -39.9 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.41 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.26 -25.62 59.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.739 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 4.4 t70 -85.14 -28.61 25.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.722 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 48.2 mm-40 -75.38 -39.58 58.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.89 -44.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.437 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 46' ' ' ILE . 28.7 mm -70.68 -62.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.362 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -54.67 -21.55 11.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.263 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -62.31 -45.52 92.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 111.265 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -75.34 -24.02 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.324 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.43 -29.08 5.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.966 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.5 -63.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tt -138.62 151.21 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' MET . 1.1 t -130.52 167.55 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.769 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -103.7 136.97 19.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.742 ' HG2' HG23 ' A' ' 24' ' ' THR . 51.0 Cg_exo -52.83 178.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.434 2.089 . . . . 0.0 112.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -150.75 -48.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.271 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -49.26 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 25' ' ' THR . 21.6 t80 59.5 119.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 111.04 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -153.23 127.52 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 92.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.282 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.473 ' OG1' HD12 ' B' ' 85' ' ' ILE . 70.1 p -77.22 -85.75 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.662 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -92.94 109.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.745 -179.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -98.11 96.86 8.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.924 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 59.3 t -83.18 143.23 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.652 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.57 177.82 24.65 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.069 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -99.2 125.31 44.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.467 ' CB ' HG23 ' B' ' 97' ' ' THR . 38.3 t0 -137.55 131.58 31.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.809 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 2.28 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.043 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.89 -28.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 120.892 0.377 . . . . 0.0 111.404 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.467 HG21 ' OE2' ' B' ' 95' ' ' GLU . 13.6 t -150.27 -44.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.851 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . 0.436 ' N ' HG23 ' B' ' 93' ' ' THR . . . 134.36 34.44 0.28 Allowed Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.448 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' B' ' 93' ' ' THR . 12.0 pt-20 -147.22 -166.6 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.285 . . . . 0.0 110.473 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 67' ' ' LEU . 9.0 m-85 -87.63 162.24 17.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.467 HG23 ' CB ' ' B' ' 90' ' ' ASP . 7.7 p -103.33 163.98 11.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 49.43 27.16 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.171 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -47.65 134.16 10.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.886 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.541 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 59.1 Cg_exo -53.32 142.64 56.62 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.367 2.045 . . . . 0.0 112.205 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' B' ' 102' ' ' GLN . 12.7 pt-20 -45.14 -47.89 12.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.919 0.39 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -69.54 -54.39 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.51 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 70' ' ' LEU . 18.7 m0 -53.15 -61.47 2.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -43.13 -67.69 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.594 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 17.4 mtt85 -48.1 -41.76 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.034 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.71 -56.68 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.78 -70.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.252 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.705 ' O ' HG23 ' B' ' 109' ' ' THR . 7.2 tt0 -79.05 -96.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.684 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.705 HG23 ' O ' ' B' ' 108' ' ' GLN . 9.3 p -165.68 -55.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.758 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 15.8 m -126.02 -179.32 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' B' ' 99' ' ' MET . 0.7 OUTLIER -66.77 -59.66 3.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.698 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.554 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.805 0.336 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -124.81 125.55 44.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 111.68 23.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' HB1' ' A' ' 176' ' ' ALA . 2.1 mt -129.22 132.23 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.265 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -113.57 157.46 22.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.397 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -128.74 112.97 14.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 73' ' ' PRO . 10.7 t -87.04 98.67 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 16' ' ' LYS . 22.5 m -114.4 145.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.597 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 58' ' ' THR . 32.8 m -137.94 121.34 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.54 167.41 38.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.852 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.09 -62.48 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.057 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.69 -137.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.597 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . . . -173.27 30.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.838 HG11 ' HA2' ' A' ' 114' ' ' GLY . 2.8 t -65.14 -12.52 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . -120.25 -24.84 2.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.644 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.643 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.21 -74.36 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.423 0.612 . . . . 0.0 112.159 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.465 ' O ' HD13 ' A' ' 21' ' ' ILE . 25.8 m -77.92 -63.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.706 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 13.0 m -49.09 -45.5 43.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.079 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.685 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.4 tm? -39.73 -72.65 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.213 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 19' ' ' LEU . 16.8 mt -61.99 -19.27 62.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.602 0.239 . . . . 0.0 111.205 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 25' ' ' THR . 1.0 OUTLIER -67.97 -48.22 75.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.357 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 m -93.28 -20.54 20.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.662 0.268 . . . . 0.0 111.239 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.736 ' CE1' HD22 ' A' ' 165' ' ' LEU . 4.4 m-30 -84.0 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.83 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 42' ' ' VAL . 85.0 m -87.75 -83.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.238 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -49.12 -26.98 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.257 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 p-10 47.19 41.97 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 110.821 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -132.51 134.89 45.56 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -59.49 154.36 44.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.498 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 57.9 Cg_exo -34.9 145.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.18 2.587 . . . . 0.0 113.221 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.02 -83.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -100.93 115.67 30.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.92 103.5 4.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HD2' ' A' ' 34' ' ' PRO . 66.1 t -152.98 139.43 12.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD2' HG13 ' A' ' 33' ' ' VAL . 98.6 Cg_exo -42.02 92.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.5 2.133 . . . . 0.0 111.737 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.712 HG23 ' CG ' ' A' ' 38' ' ' ASP . 72.7 m -52.97 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.552 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.838 HG11 ' CD2' ' B' ' 96' ' ' PHE . 23.8 t -74.99 -32.74 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' HG21 ' B' ' 87' ' ' VAL . 3.2 t80 -144.96 -66.28 0.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.729 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.712 ' CG ' HG23 ' A' ' 35' ' ' THR . 4.4 m-20 55.18 108.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.391 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.513 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 46.9 t-20 -107.63 157.21 18.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.008 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.93 167.71 26.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.952 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 82' ' ' GLU . . . -123.12 156.98 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 53' ' ' LEU . 15.6 m -160.71 147.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.087 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.3 m -124.08 101.41 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.543 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 173' ' ' ILE . 15.8 m -98.61 141.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.5 mtm -105.18 100.19 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.738 HD13 ' CE1' ' A' ' 51' ' ' TYR . 5.1 mp -104.77 92.78 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.73 16.69 61.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.395 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.98 38.8 6.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.603 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 20.1 mt-10 -141.64 139.17 18.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.656 0.265 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.1 168.07 14.79 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.642 2.228 . . . . 0.0 112.387 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.738 ' CE1' HD13 ' A' ' 46' ' ' ILE . 4.9 m-85 -152.08 160.75 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.289 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -136.06 97.4 3.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.233 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 42' ' ' VAL . 7.7 tt -132.59 160.55 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.207 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.7 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -156.42 139.88 6.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 79' ' ' LEU . 1.1 mt -79.33 104.13 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.057 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' ' HD2' ' A' ' 5' ' ' LYS . 4.2 m-85 -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' OD2' HG21 ' A' ' 35' ' ' THR . 4.8 t0 -71.38 -169.46 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.746 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 9' ' ' VAL . 4.0 m -166.99 163.57 15.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . . . -92.79 -74.69 0.51 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.936 ' O ' HD13 ' A' ' 61' ' ' LEU . . . 131.74 61.57 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.851 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -132.31 -168.57 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.98 86.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 3.4 t0 76.03 43.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.041 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 5.0 t80 50.63 35.72 12.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.1 -152.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 18.8 mmt180 -87.52 -1.39 57.91 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.132 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.821 ' CG ' HD12 ' A' ' 70' ' ' LEU . 4.1 mp -81.97 58.28 3.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -63.59 -70.06 0.51 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.7 Cg_endo -68.23 -22.5 40.27 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.026 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.821 HD12 ' CG ' ' A' ' 67' ' ' LEU . 3.9 mt -57.48 -20.65 32.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.022 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.08 -34.12 6.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.541 ' CG ' ' HB ' ' A' ' 75' ' ' THR . 1.0 OUTLIER 66.04 76.33 0.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.673 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.926 ' HA ' HG21 ' A' ' 7' ' ' VAL . 77.8 Cg_exo -50.58 -55.18 4.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.854 2.369 . . . . 0.0 112.974 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -67.46 -8.04 30.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.774 HG22 HG23 ' A' ' 7' ' ' VAL . 8.8 t -33.05 -53.94 0.37 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER 170.47 -161.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.802 0.335 . . . . 0.0 111.024 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.92 HG22 ' HG2' ' A' ' 109' ' ' PRO . 66.2 t -58.98 150.28 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 39.1 p90 -139.93 128.74 23.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.901 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 55' ' ' LEU . 1.8 pt? -103.77 116.23 31.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 9' ' ' VAL . 10.1 t -94.24 154.53 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.482 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.7 p -67.08 171.84 5.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.355 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 t80 -163.78 105.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.81 0.338 . . . . 0.0 111.335 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -58.63 111.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.759 HG13 HG21 ' A' ' 137' ' ' ILE . 90.8 t -103.02 87.21 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 111.164 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.781 HG11 HD22 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 169.12 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.481 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.719 ' N ' HG22 ' A' ' 85' ' ' VAL . 68.2 m -46.99 103.59 0.37 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 111.025 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.62 -40.12 80.46 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.48 2.12 . . . . 0.0 112.363 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.8 t -53.6 -25.33 17.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.029 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 -36.7 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.025 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -49.35 -60.13 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.86 -31.9 73.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.6 m-20 -69.29 -61.9 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.744 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 29.9 m -48.73 -36.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.313 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -61.31 -63.07 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -82.68 8.01 13.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.895 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.9 tttt -117.23 -36.53 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.674 0.274 . . . . 0.0 111.338 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.744 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 28.5 m0 -93.38 -41.55 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.261 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.4 t -48.91 -57.96 9.86 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.3 Cg_endo -59.11 -18.04 41.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 112.305 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -84.76 -51.24 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.851 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 7.6 pt -51.29 -24.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.1 p -74.78 -28.99 60.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.362 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -70.87 -35.14 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.529 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.732 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.4 m-70 -107.71 -2.43 20.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.739 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 3.5 m -149.62 58.03 3.09 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.63 55.9 5.07 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.747 2.298 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt 176.9 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.364 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 t -73.17 146.07 86.6 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.92 ' HG2' HG22 ' A' ' 77' ' ' VAL . 20.0 Cg_endo -60.29 178.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.644 2.229 . . . . 0.0 111.961 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 33.6 p90 -137.31 158.79 43.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD21 ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -135.14 127.53 30.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.475 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -104.31 101.38 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.064 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG12 ' OE1' ' A' ' 156' ' ' GLU . 3.5 m -107.43 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.838 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -168.74 159.13 32.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.805 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.873 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -167.89 -64.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 0.0 110.756 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.545 ' NE2' HD13 ' A' ' 119' ' ' LEU . 0.8 OUTLIER 48.86 60.43 3.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.007 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 157' ' ' CYS . 9.1 mt -65.71 -31.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.821 ' HB3' HD23 ' A' ' 160' ' ' LEU . 11.9 p-10 -81.75 -49.15 10.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 85' ' ' VAL . 9.3 tt -49.65 -49.19 48.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.789 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.0 t0 75.96 31.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.668 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -93.73 157.32 38.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.35 -39.75 5.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -25.75 59.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.9 m -56.21 -68.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -46.81 -40.86 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.415 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -62.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.12 -34.83 68.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -50.3 -25.86 4.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.418 . . . . 0.0 110.706 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.76 46.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.39 26.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.082 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.411 ' HB3' ' HD3' ' A' ' 133' ' ' LYS . 9.8 m-80 -93.02 -30.0 15.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -175.01 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 169.02 146.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 129' ' ' LEU . 5.8 mmmt 60.61 145.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 140.97 70.57 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 84' ' ' VAL . 4.3 mt -50.71 126.3 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -98.75 167.3 11.61 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.338 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' HG23 ' A' ' 115' ' ' THR . 52.1 Cg_exo -53.39 -22.98 22.57 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.827 2.351 . . . . 0.0 112.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.22 -35.67 14.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.488 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.479 ' CG2' HG23 ' A' ' 137' ' ' ILE . 22.9 m -46.45 -42.5 15.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.057 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -51.29 56.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 6.1 tm-20 -54.57 -38.79 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -52.12 -55.87 18.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.287 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 145' ' ' LEU . 3.9 tt -54.33 -32.67 57.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.069 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.929 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.51 -49.75 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.664 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.606 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -25.43 58.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.0 pp -122.65 19.89 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.21 -83.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 176.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 152' ' ' VAL . 78.7 t -76.02 -7.35 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.78 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.457 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER 82.85 141.35 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.694 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.929 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 5.8 p90 -153.21 153.4 32.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.799 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.0 m -158.56 123.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.413 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.429 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -165.75 157.97 14.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.993 0.425 . . . . 0.0 111.482 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.873 ' HA ' HG21 ' A' ' 115' ' ' THR . 1.8 m -119.01 -173.51 2.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.172 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.29 152.68 22.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.507 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -40.48 -76.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.567 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -36.05 -33.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.652 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -82.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.536 ' NE2' HD21 ' A' ' 165' ' ' LEU . 0.9 OUTLIER 63.41 97.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -65.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.06 75.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.685 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.736 HD22 ' CE1' ' A' ' 23' ' ' TYR . 4.5 pp -93.13 -10.15 36.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.771 0.32 . . . . 0.0 111.377 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -49.77 -26.33 3.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.851 0.358 . . . . 0.0 110.179 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.99 -51.28 68.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 155' ' ' VAL . 98.6 t -53.7 -49.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.31 -33.36 73.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.314 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.504 ' CG ' HG21 ' B' ' 75' ' ' ILE . 63.6 t0 -68.85 -36.94 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.76 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -44.83 27.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.59 62.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 44' ' ' VAL . 16.7 mt -82.62 -43.76 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.2 -52.78 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -51.46 -33.14 29.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -90.83 -26.96 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -49.94 -51.25 42.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 62.9 m -50.29 -80.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.625 HD11 ' CD1' ' A' ' 173' ' ' ILE . 5.9 tt -119.6 151.95 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.194 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -134.14 165.64 24.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -87.87 137.93 31.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 44' ' ' VAL . 38.4 Cg_endo -66.68 -167.46 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.613 2.209 . . . . 0.0 112.131 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.421 ' O ' ' N ' ' B' ' 81' ' ' PHE . 81.1 p -168.34 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.43 78.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 86.2 t80 -74.66 152.01 39.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.62 96.3 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.606 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -68.96 69.75 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.161 0.505 . . . . 0.0 109.662 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.554 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -43.79 -85.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.794 HG21 ' N ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -112.59 130.79 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -111.63 97.15 6.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.387 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 37' ' ' PHE . 16.6 t -77.84 157.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 112.047 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.27 177.89 24.32 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -112.16 123.01 49.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.526 ' CB ' HG21 ' B' ' 97' ' ' THR . 14.8 t0 -140.26 127.84 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.733 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.59 -5.8 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.793 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.803 HG13 HG23 ' B' ' 93' ' ' THR . 7.6 p -43.59 -29.09 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-O 120.802 0.334 . . . . 0.0 111.656 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.803 HG23 HG13 ' B' ' 92' ' ' VAL . 3.5 p -153.89 24.3 0.5 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.55 37.22 74.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.83 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.82 179.8 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.722 0.296 . . . . 0.0 110.878 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.838 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -74.76 164.13 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.526 HG21 ' CB ' ' B' ' 90' ' ' ASP . 27.1 p -126.6 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.163 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' B' ' 111' ' ' ASN . . . 51.72 29.67 26.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.58 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.73 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -74.4 164.77 58.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.081 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.794 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.0 Cg_exo -53.78 142.23 63.11 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.707 2.272 . . . . 0.0 112.343 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -45.71 -60.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -50.34 72.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.61 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.787 ' CE3' HD23 ' A' ' 67' ' ' LEU . 6.2 m0 -46.8 -63.38 1.04 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 110.411 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -51.01 -60.06 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 31.2 mtt-85 -48.77 -41.04 31.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.136 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.691 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.02 -56.73 8.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.47 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -95.06 -68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.062 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.742 ' O ' HG23 ' B' ' 109' ' ' THR . 7.0 tp60 -77.87 -101.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.338 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.742 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.0 p -167.08 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.337 0.061 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.679 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 5.0 m -140.42 172.77 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.7 OUTLIER -56.96 -67.21 0.34 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -71.2 132.65 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 m -94.24 112.81 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' HB1' ' A' ' 176' ' ' ALA . 2.9 mt -114.92 133.09 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 104.34 7.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' HB3' HD23 ' A' ' 79' ' ' LEU . 14.3 m -77.33 99.06 5.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.665 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.73 HG11 ' CE1' ' A' ' 104' ' ' HIS . 10.8 t -84.61 159.45 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 79' ' ' LEU . 58.4 t -130.47 148.73 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 101' ' ' ILE . 12.6 p -138.41 132.64 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.92 146.11 17.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.631 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -72.05 126.22 29.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.89 -42.16 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.603 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 18' ' ' CYS . . . 47.8 38.9 9.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 83' ' ' SER . 1.9 t -109.27 -14.01 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.77 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -135.67 -55.3 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -43.11 -66.26 0.39 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.171 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.736 ' O ' HD13 ' A' ' 21' ' ' ILE . 88.7 m -95.15 -50.53 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -50.5 -44.39 56.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.326 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 55' ' ' LEU . 18.1 tp -50.09 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.003 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.083 HD21 HD13 ' A' ' 55' ' ' LEU . 3.9 mt -51.14 -29.95 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 120.653 0.263 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -55.71 -69.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.353 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.519 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -90.79 -10.49 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.757 ' CD2' HD12 ' A' ' 165' ' ' LEU . 7.7 t80 -95.37 -59.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.677 HG21 ' CG1' ' A' ' 42' ' ' VAL . 63.5 m -73.67 -45.61 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.333 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -113.97 3.83 15.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.5 p30 43.38 58.06 3.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 111.741 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.8 pttt -134.0 -164.74 1.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.511 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.528 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -134.21 166.45 29.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 46.5 Cg_exo -36.02 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.147 2.565 . . . . 0.0 113.47 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.64 -85.22 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.368 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.709 0.29 . . . . 0.0 110.286 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.1 t80 -80.91 106.39 12.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 111.623 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' THR . 12.7 m -158.99 145.3 12.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.093 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 36' ' ' VAL . 81.2 Cg_exo -44.73 88.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.825 HG23 ' CG ' ' A' ' 38' ' ' ASP . 66.0 m -55.19 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.386 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG11 ' CZ ' ' B' ' 96' ' ' PHE . 3.6 t -84.34 -21.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.651 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.2 t80 -147.96 -65.36 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.627 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.825 ' CG ' HG23 ' A' ' 35' ' ' THR . 7.4 m-20 54.33 109.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.271 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB3' HD12 ' B' ' 85' ' ' ILE . 28.0 t-20 -106.88 147.99 29.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.12 0.486 . . . . 0.0 110.968 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.629 ' CG ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -139.07 169.2 18.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.785 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -111.81 141.55 45.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.306 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.677 ' CG1' HG21 ' A' ' 24' ' ' THR . 2.4 m -162.83 159.57 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.35 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 51' ' ' TYR . 54.8 m -145.37 104.41 3.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.175 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.075 HG11 HD13 ' A' ' 173' ' ' ILE . 42.2 t -98.27 117.51 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.6 mtm -76.68 99.96 5.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.683 HD11 ' CG2' ' A' ' 173' ' ' ILE . 66.0 mt -92.96 89.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.0 70.12 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.572 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.53 -17.82 30.51 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.859 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -91.29 138.85 25.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.66 0.267 . . . . 0.0 111.112 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -68.73 166.49 25.95 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.625 2.217 . . . . 0.0 112.341 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 43' ' ' THR . 23.1 m-85 -153.94 173.73 15.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 97.26 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -101.68 161.31 13.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -159.82 118.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.425 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.083 HD13 HD21 ' A' ' 20' ' ' LEU . 5.5 mp -75.88 105.62 7.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.362 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -83.23 103.46 12.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.036 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.8 OUTLIER -75.67 172.68 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.739 HG23 ' CE1' ' A' ' 64' ' ' TYR . 2.2 m -167.05 171.37 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . . . -102.48 -161.07 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 61' ' ' LEU . . . -60.18 -16.08 39.98 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.75 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD13 HG23 ' A' ' 9' ' ' VAL . 1.5 tp 80.17 132.58 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 0.0 111.228 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 35.9 tt0 169.86 -34.91 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.593 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -116.21 -12.41 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.712 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.739 ' CE1' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -48.83 -33.96 11.54 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -47.49 -28.07 2.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.053 0.454 . . . . 0.0 110.424 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -82.04 -46.77 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.234 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.023 HD22 ' CE2' ' B' ' 96' ' ' PHE . 1.4 mp -92.49 49.56 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -99.65 -31.17 0.23 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 28.0 Cg_exo -37.14 -49.8 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.486 2.124 . . . . 0.0 114.025 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' B' ' 103' ' ' TRP . 0.1 OUTLIER -94.8 32.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 72' ' ' TYR . 4.4 p -134.04 -52.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.6 OUTLIER 41.56 98.89 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.805 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 105' ' ' CYS . 82.3 Cg_exo -45.62 -34.63 11.62 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.523 2.149 . . . . 0.0 112.579 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.93 -10.37 52.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.591 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 13.7 t -37.66 -49.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 165.79 -165.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.678 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 109' ' ' PRO . 10.9 p -64.84 125.69 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.766 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CD1' ' CB ' ' A' ' 105' ' ' CYS . 42.4 p90 -96.54 133.81 40.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.587 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 8' ' ' VAL . 2.2 pp -103.59 116.05 31.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.1 t -94.99 154.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 15' ' ' GLY . 5.8 p -111.5 160.0 17.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 111.385 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 82' ' ' PHE . 40.7 p90 -152.66 103.9 2.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 14' ' ' VAL . 22.8 t -54.5 118.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.001 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -88.74 81.86 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.223 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' HD22 ' A' ' 119' ' ' LEU . 1.6 m -131.68 79.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.456 ' C ' HD11 ' A' ' 137' ' ' ILE . 5.5 m 71.23 151.08 0.14 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' N ' HD11 ' A' ' 137' ' ' ILE . 55.1 Cg_exo -52.15 -22.03 14.18 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.541 2.161 . . . . 0.0 112.419 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -52.49 -32.43 40.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -91.09 -30.83 16.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.016 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -47.55 -65.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.17 -28.43 67.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 23.2 m-20 -69.84 -84.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 89' ' ' SER . 2.3 m -43.75 -29.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.693 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 12.6 tttt -70.57 -69.39 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -81.44 7.63 11.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.064 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.1 -42.59 3.92 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.413 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.743 ' CD1' HG12 ' A' ' 93' ' ' VAL . 12.7 m95 -95.27 -43.36 8.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 68.7 t -48.41 -44.36 64.23 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.57 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 48.0 Cg_exo -55.68 -23.43 40.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.017 1.811 . . . . 0.0 112.166 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -93.53 -30.01 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.854 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.882 ' HA ' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -49.43 -26.41 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.138 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.418 ' N ' HG13 ' A' ' 101' ' ' ILE . 19.6 p -77.4 -32.13 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -64.54 -49.6 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.73 ' CE1' HG11 ' A' ' 7' ' ' VAL . 55.4 t-80 -65.54 -66.94 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.53 ' CB ' ' CD1' ' A' ' 78' ' ' PHE . 1.2 m -104.5 90.83 3.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 42.9 Cg_endo -67.92 118.04 5.33 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.675 2.25 . . . . 0.0 112.572 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.3 51.99 15.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.235 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.709 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.3 OUTLIER -132.87 144.09 51.41 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.709 ' HD2' HG22 ' A' ' 108' ' ' THR . 99.2 Cg_exo -42.0 147.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.512 2.141 . . . . 0.0 112.102 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.7 p90 -139.41 139.38 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -126.93 119.81 27.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.42 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 1.8 mt -90.34 102.12 14.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.72 96.75 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 14' ' ' VAL . . . -117.61 -119.42 2.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.798 HG21 ' HA ' ' A' ' 157' ' ' CYS . 20.2 m 69.11 167.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 111.438 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.492 ' OE1' HD13 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 176.43 112.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.484 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 157' ' ' CYS . 54.4 mt -91.82 -22.61 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.411 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.83 -44.23 7.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.469 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.533 HD22 ' CG1' ' A' ' 85' ' ' VAL . 1.9 tt -74.7 -47.87 29.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -48.99 -29.39 4.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.107 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.96 51.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 126' ' ' ILE . 11.3 m-20 -114.23 142.06 27.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.39 -21.64 18.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.552 2.168 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -43.17 57.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 p -56.36 -62.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -48.54 -46.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.41 -58.78 3.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.24 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -36.12 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.906 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -26.43 3.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.39 64.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -85.32 -41.5 15.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -61.39 -23.37 65.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.99 64.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.19 -171.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 167.6 9.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.15 120.93 6.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.538 2.158 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 87' ' ' PRO . 7.8 mt -56.61 121.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.235 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -117.96 164.8 18.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.833 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 115' ' ' THR . 75.3 Cg_exo -49.16 -26.21 10.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.568 2.179 . . . . 0.0 112.311 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.78 -51.05 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.6 m -54.87 -55.79 26.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.11 -49.18 52.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' CD ' HG12 ' A' ' 155' ' ' VAL . 7.9 mt-10 -54.61 -42.09 70.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -46.85 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.689 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.832 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -55.98 -48.72 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.867 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.81 68.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -70.36 -43.59 69.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.769 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -59.44 -26.25 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.6 pp -103.15 -23.26 13.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.999 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 149' ' ' LEU . 26.4 tptt 60.25 116.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -162.08 -161.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.299 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 111' ' ' LEU . 9.2 p -44.93 -43.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.494 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 89.95 145.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.452 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.495 ' O ' HG13 ' A' ' 155' ' ' VAL . 48.8 p90 -153.05 150.97 29.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.885 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.604 HG12 ' CD ' ' A' ' 143' ' ' GLU . 8.4 m -158.36 122.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.434 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.671 ' CG ' HG11 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -172.04 124.74 0.53 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.553 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.798 ' HA ' HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -128.51 119.52 25.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.71 ' OG ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -156.99 175.19 14.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.386 0.612 . . . . 0.0 112.497 -177.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.823 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 136.15 88.93 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.899 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.823 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 58.73 26.01 14.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 p -147.85 -72.08 0.21 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.965 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 75.51 114.12 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.248 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 3.4 tttt -105.9 -45.12 4.45 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.11 71.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.621 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.965 HD11 ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -95.05 -16.91 22.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.973 0.416 . . . . 0.0 111.25 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.414 ' HA ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.32 -24.92 2.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 18.4 m-80 -71.79 -61.38 1.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.478 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 156' ' ' GLU . 11.4 p -45.52 -32.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.781 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.1 t80 -77.04 -35.28 56.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.853 ' CG ' HD12 ' B' ' 75' ' ' ILE . 3.8 t70 -58.25 -35.52 71.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.357 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 6.7 mm-40 -76.14 -44.5 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.777 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.98 64.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.989 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 1.075 HD13 HG11 ' A' ' 44' ' ' VAL . 5.1 mt -93.63 -54.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -59.8 -29.73 68.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -54.87 -33.72 62.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.95 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 4' ' ' ILE . . . -80.23 -23.51 40.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.68 42.04 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 75' ' ' ILE . 5.2 p 69.7 -62.19 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 170' ' ' ASP . 8.6 mt -144.1 137.21 23.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.55 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.4 m -131.59 152.48 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.99 145.92 99.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.745 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.471 ' HB2' HG23 ' A' ' 24' ' ' THR . 61.0 Cg_exo -52.65 -167.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.552 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 84.3 p -149.67 -79.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.85 119.7 12.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.62 ' HB2' HG22 ' A' ' 24' ' ' THR . 12.8 t80 -132.78 130.23 39.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.658 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.33 136.45 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 90.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -81.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.59 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.654 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.1 mp -115.59 110.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.78 0.324 . . . . 0.0 111.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 86' ' ' HIS . 8.7 p80 -85.4 96.84 9.69 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.0 t -87.83 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.225 0.536 . . . . 0.0 112.304 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' B' ' 96' ' ' PHE . . . -142.61 177.8 21.49 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.362 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 2.6 t80 -101.05 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.3 0.55 . . . . 0.0 111.141 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.855 ' HB2' HG23 ' B' ' 97' ' ' THR . 9.0 t0 -140.47 114.48 9.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.622 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.73 -5.17 31.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.973 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 1.076 HG13 HG22 ' B' ' 93' ' ' THR . 14.7 p -45.74 -28.24 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.859 0.362 . . . . 0.0 111.176 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 1.076 HG22 HG13 ' B' ' 92' ' ' VAL . 0.0 OUTLIER -149.25 18.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.08 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.59 17.44 64.61 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.901 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.887 ' HG2' HG23 ' B' ' 93' ' ' THR . 18.6 pt-20 -128.62 -163.28 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.719 0.295 . . . . 0.0 110.708 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 1.023 ' CE2' HD22 ' A' ' 67' ' ' LEU . 6.6 m-30 -96.04 164.62 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.855 HG23 ' HB2' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -95.69 136.39 36.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.437 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 49.12 36.91 22.46 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.995 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -77.56 165.63 49.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.243 0.544 . . . . 0.0 112.31 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.654 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.5 Cg_exo -54.69 141.6 75.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.116 2.544 . . . . 0.0 112.26 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -56.02 -22.25 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 110.399 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.786 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.77 -64.73 0.81 Allowed 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.995 ' CG ' HD11 ' A' ' 70' ' ' LEU . 4.7 m0 -51.44 -60.09 3.52 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.437 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.834 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -40.51 -65.25 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 21.7 mtp85 -62.68 -35.48 79.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.768 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.593 HD23 ' O ' ' B' ' 102' ' ' GLN . 0.9 OUTLIER -49.64 -55.49 13.5 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -96.43 -72.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.138 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.807 HE21 HG22 ' B' ' 109' ' ' THR . 9.0 tp60 -82.67 -105.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.565 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.807 HG22 HE21 ' B' ' 108' ' ' GLN . 1.4 t 156.03 58.77 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.194 0.598 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.834 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER 172.02 126.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.972 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 15.0 m120 -50.49 -70.49 0.08 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.611 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.15 121.35 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.81 120.47 40.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.61 130.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' O ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -135.83 96.61 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.965 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 77' ' ' VAL . 8.2 m -80.35 147.01 31.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 8' ' ' VAL . 4.4 t -122.16 159.88 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.431 . . . . 0.0 111.669 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.749 HG11 ' HA3' ' A' ' 15' ' ' GLY . 6.5 m -123.0 169.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.795 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 58' ' ' THR . 11.1 m -157.51 120.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.014 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 145.17 -161.78 28.15 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.702 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -118.25 169.26 9.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.733 0.301 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 90.54 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.223 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.588 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . 53.47 71.7 0.48 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.742 0.306 . . . . 0.0 110.244 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.674 HG23 HG21 ' A' ' 8' ' ' VAL . 1.6 m -47.07 -25.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.749 ' HA3' HG11 ' A' ' 8' ' ' VAL . . . 140.85 -40.45 1.36 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.577 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -97.46 -74.23 0.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.919 ' O ' HD13 ' A' ' 21' ' ' ILE . 5.1 t -35.37 -51.81 0.61 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.687 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.26 -45.99 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.726 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.766 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -59.36 -68.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.48 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 55' ' ' LEU . 17.7 mt -40.71 -45.38 2.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.159 0.504 . . . . 0.0 111.148 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -46.26 -70.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.547 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.63 ' N ' HG22 ' A' ' 21' ' ' ILE . 14.5 t -95.2 -60.76 1.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.243 0.544 . . . . 0.0 111.564 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.766 ' CD1' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -44.43 -26.63 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.929 -178.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.612 HG21 HG11 ' A' ' 42' ' ' VAL . 99.1 m -109.16 -89.92 0.47 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.195 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 27' ' ' LYS . 1.4 t -64.14 -19.91 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.697 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.7 t30 70.41 32.75 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.355 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' A' ' 25' ' ' THR . 4.9 ttpt -127.9 138.04 52.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' HA ' HG23 ' A' ' 21' ' ' ILE . 1.6 m-85 -81.67 149.29 63.88 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.736 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.11 153.89 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.788 2.326 . . . . 0.0 112.723 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -108.06 -71.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.67 109.76 17.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.608 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.83 92.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 73.3 t -138.1 131.29 16.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.426 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 97.9 Cg_exo -42.26 93.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 111.837 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.932 HG23 ' HB2' ' A' ' 38' ' ' ASP . 81.5 m -51.48 87.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.38 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 96' ' ' PHE . 93.8 t -77.05 -37.43 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.755 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.7 t80 -136.38 -63.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.745 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.932 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.5 t0 56.25 114.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.596 ' HB3' HD12 ' B' ' 85' ' ' ILE . 10.5 t-20 -108.11 153.09 23.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.379 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.616 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -144.33 169.25 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 0.0 111.343 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.66 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -110.07 138.08 46.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 41' ' ' ALA . 2.3 m -162.37 139.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.302 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 51' ' ' TYR . 51.6 m -132.71 110.85 10.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.188 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 HD11 ' B' ' 75' ' ' ILE . 60.6 t -98.07 117.07 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mtm -94.42 100.28 12.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.129 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.77 HD11 ' CG2' ' A' ' 173' ' ' ILE . 8.6 mt -93.13 114.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 17.94 78.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.02 29.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.524 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.09 130.41 63.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.504 0.192 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.11 160.38 42.78 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.595 2.197 . . . . 0.0 112.405 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.927 ' O ' HG23 ' A' ' 43' ' ' THR . 36.2 m-85 -146.74 165.19 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.157 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -121.11 97.67 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.497 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.892 HD21 ' CD2' ' A' ' 55' ' ' LEU . 7.2 tt -113.79 157.23 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.732 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.9 113.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 20' ' ' LEU . 2.3 mt -90.32 117.19 28.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.389 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -89.27 144.53 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.063 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD2' HG21 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -104.44 -163.69 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.904 0.383 . . . . 0.0 111.536 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.56 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.2 m -153.53 161.04 42.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 58' ' ' THR . . . -61.45 -49.93 74.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.45 -22.85 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.366 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.672 HD13 ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -115.55 176.37 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.784 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 100' ' ' GLU . 1.8 mp0 -81.94 67.75 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.672 ' OD1' HD13 ' A' ' 61' ' ' LEU . 6.0 m-20 -132.08 19.4 4.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CD1' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -89.61 -10.37 46.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.253 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.15 -31.02 0.86 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.834 0.35 . . . . 0.0 111.022 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -71.9 -39.76 69.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.476 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.056 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 23.5 mt -90.09 6.54 42.01 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.299 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -47.74 -43.02 49.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_exo -60.5 -19.0 57.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.209 1.939 . . . . 0.0 112.021 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.938 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -106.5 -48.22 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.817 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 33.75 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -41.04 153.73 0.23 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.463 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' HIS . 97.7 Cg_endo -84.74 -25.27 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.743 2.295 . . . . 0.0 112.774 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -65.51 -11.19 41.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.739 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 5' ' ' LYS . 2.5 t -42.99 -54.18 4.39 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER 178.45 -152.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.774 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -57.42 158.22 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.681 0.277 . . . . 0.0 110.676 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 77' ' ' VAL . 1.4 m-85 -115.47 145.79 42.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.69 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 mm? -104.05 135.7 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.846 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 101' ' ' ILE . 3.0 t -115.56 153.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.981 0.419 . . . . 0.0 111.729 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 23.0 p -110.05 155.28 22.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.845 ' HA ' HG11 ' A' ' 93' ' ' VAL . 30.9 p90 -178.9 109.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -54.28 -170.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.563 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 85' ' ' VAL . 26.9 m -152.06 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.429 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -47.18 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.474 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.468 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.6 m -68.43 110.72 6.27 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.498 0.19 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.534 ' CG ' HD22 ' A' ' 129' ' ' LEU . 34.2 Cg_exo -57.79 -21.87 50.45 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.527 2.152 . . . . 0.0 112.389 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -30.62 46.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.162 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 m -92.98 -26.99 17.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -48.73 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.197 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.62 -43.64 36.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -54.87 -69.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 82' ' ' PHE . 93.2 t -39.66 -44.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.933 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.74 -69.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.673 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.74 8.23 8.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -116.76 -43.72 2.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.715 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.609 ' HD1' HG13 ' A' ' 93' ' ' VAL . 13.8 m95 -95.64 -39.09 10.08 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.5 t -51.63 -45.47 91.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.489 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.3 Cg_exo -46.45 -38.44 21.04 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.359 2.039 . . . . 0.0 112.359 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.977 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 80' ' ' VAL . 19.6 mm -49.28 -26.66 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 p -90.34 -22.4 21.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -69.14 -37.31 78.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.673 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 73' ' ' PRO . 32.7 m-70 -103.71 -70.6 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.662 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.78 108.73 1.51 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.43 -65.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.25 28.42 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.842 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -95.61 148.16 34.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . 53.1 Cg_exo -53.71 161.61 4.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.523 2.148 . . . . 0.0 112.157 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -128.0 126.14 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 111.073 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.603 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -105.08 120.57 41.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.496 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.864 HD12 ' OH ' ' A' ' 154' ' ' TYR . 2.8 mt -90.68 149.31 22.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.638 HG21 HD13 ' A' ' 19' ' ' LEU . 29.2 m -156.82 173.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.951 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.751 ' O ' HG22 ' A' ' 115' ' ' THR . . . 138.36 -125.94 3.33 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.634 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 114' ' ' GLY . 0.6 OUTLIER 77.59 148.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.308 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 119' ' ' LEU . 16.7 mp0 -137.38 128.49 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 157' ' ' CYS . 62.0 mt -98.65 -38.38 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.13 -23.46 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.444 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 85' ' ' VAL . 1.3 tt -73.02 -15.31 61.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.474 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -69.3 -163.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.727 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 22.95 13.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.127 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.556 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.2 m-20 -86.84 141.89 33.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.799 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.71 -46.97 29.79 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -69.06 -33.34 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.6 m -52.59 -66.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.97 -38.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.014 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.73 -61.52 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -35.77 77.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.675 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.534 HD22 ' CG ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -50.2 -26.21 4.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.488 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.02 -23.08 63.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -85.15 -24.6 27.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -95.1 29.27 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.6 34.8 2.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 52.33 -162.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt 65.88 89.23 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.4 ' HA ' HD11 ' A' ' 129' ' ' LEU . 50.1 Cg_exo -55.35 143.63 75.68 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.576 2.184 . . . . 0.0 112.319 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.543 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.0 mt -56.49 121.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.7 p -106.07 172.39 3.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 52.3 Cg_exo -55.62 -19.95 25.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.696 2.264 . . . . 0.0 112.318 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -85.53 -31.62 22.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 137' ' ' ILE . 85.6 m -59.93 -48.49 81.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.946 0.403 . . . . 0.0 110.676 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.566 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -50.6 -47.97 58.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.688 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.42 -41.73 73.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.304 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -47.22 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD21 ' HE2' ' A' ' 94' ' ' LYS . 6.6 tp -59.56 -35.83 75.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -65.18 -30.63 71.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.083 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -75.1 -51.25 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -52.42 -48.01 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.86 -26.88 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 65.19 122.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.975 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -165.03 -160.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.591 ' HB ' HD12 ' A' ' 111' ' ' LEU . 17.3 t -61.37 -16.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.546 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.31 144.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.567 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.891 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 37.5 p90 -152.15 144.09 23.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 124.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.03 -178.69 2.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HA ' HG21 ' A' ' 115' ' ' THR . 14.6 p -133.09 -173.18 3.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.36 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 t -87.48 159.66 18.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.787 0.327 . . . . 0.0 110.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.619 ' CB ' HD22 ' A' ' 160' ' ' LEU . . . -56.32 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 161' ' ' THR . 0.6 OUTLIER 51.6 33.89 11.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.253 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 160' ' ' LEU . 1.4 p -167.82 -84.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.197 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.7 ' NE2' HD22 ' A' ' 165' ' ' LEU . 0.8 OUTLIER 73.43 104.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.019 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 -68.53 0.86 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.963 0.411 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.53 77.5 0.39 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.928 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.7 HD22 ' NE2' ' A' ' 162' ' ' GLN . 1.7 tp -92.19 -36.94 12.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.0 111.569 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -26.31 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.332 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -66.33 -73.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.0 p -44.59 -37.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.5 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.3 -44.2 97.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 0.0 110.653 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.412 ' HA ' HD13 ' B' ' 75' ' ' ILE . 1.4 t0 -59.28 -40.0 84.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HG2' ' CE ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -77.82 -47.38 19.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.24 66.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.3 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.804 HG13 HD11 ' B' ' 75' ' ' ILE . 34.7 mm -82.21 -57.0 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.04 -29.02 11.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.089 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.63 63.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.02 -14.53 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.495 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 tp -91.88 21.23 5.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.258 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.882 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.18 -64.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.804 HD11 HG13 ' A' ' 173' ' ' ILE . 5.8 tt -140.75 151.88 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 2.2 m -130.77 133.35 45.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.19 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -62.1 136.99 95.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.517 ' CB ' HG12 ' A' ' 42' ' ' VAL . 77.3 Cg_exo -48.68 144.05 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.401 2.067 . . . . 0.0 112.372 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -104.39 -54.71 2.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 33.2 m-20 -67.56 162.43 23.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.498 ' CE1' HG21 ' A' ' 25' ' ' THR . 6.1 t80 174.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 84' ' ' THR . 10.6 pt-20 -153.52 139.71 18.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.27 70.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLU . 0.0 OUTLIER -42.28 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.696 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.879 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.3 mp -109.65 108.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 111.654 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -87.79 96.87 10.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.052 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.755 HG21 ' HB3' ' A' ' 37' ' ' PHE . 17.2 t -81.13 145.26 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.553 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -145.08 174.7 25.03 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.232 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -108.98 117.64 34.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.52 ' HB2' HG21 ' B' ' 97' ' ' THR . 42.2 t0 -123.89 136.18 54.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.972 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.41 0.77 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.894 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 1.058 HG13 HG22 ' B' ' 93' ' ' THR . 7.7 p -48.22 -25.96 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.885 0.374 . . . . 0.0 111.304 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 1.058 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -155.79 -39.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.325 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.84 11.91 2.53 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' B' ' 93' ' ' THR . 0.7 OUTLIER -122.85 172.11 8.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.889 0.344 . . . . 0.0 110.553 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 67' ' ' LEU . 1.8 m-85 -67.73 158.06 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.365 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.63 HG22 HD13 ' B' ' 112' ' ' ILE . 29.2 p -119.71 165.88 13.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.539 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 48.91 27.62 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.909 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.661 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.1 OUTLIER -77.33 163.1 66.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.933 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.879 ' N ' HG21 ' B' ' 85' ' ' ILE . 72.1 Cg_exo -48.52 136.21 26.46 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.246 . . . . 0.0 112.409 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.18 -39.75 14.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.028 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -47.62 34.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 1.056 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 4.8 m0 -49.3 -59.97 3.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.546 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -52.49 -59.57 4.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.033 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.7 mtt180 -48.46 -42.18 31.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.871 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.14 -54.63 19.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.702 HD11 HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -94.63 -69.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.727 ' O ' HG23 ' B' ' 109' ' ' THR . 6.2 tt0 -79.53 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.586 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.727 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.7 p -166.03 -46.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.677 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.2 OUTLIER -131.59 167.21 19.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.965 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -56.28 -54.85 40.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.63 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.879 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.88 171.42 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.62 139.19 54.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.673 HG21 ' HB1' ' A' ' 176' ' ' ALA . 1.1 mp -125.72 139.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.21 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -114.98 138.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.675 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.53 110.76 22.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' PRO . 16.4 t -87.59 145.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.649 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' A' ' 14' ' ' VAL . 19.6 m -137.79 167.07 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.665 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.75 HG11 ' HD2' ' A' ' 104' ' ' HIS . 9.1 p -163.76 136.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 139.44 148.93 5.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.821 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 160.68 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.638 0.256 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 46.84 86.28 0.01 OUTLIER Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.991 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 72.8 67.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.178 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.7 p -48.7 -24.99 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.18 -27.9 5.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.393 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -96.91 -73.46 0.6 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 111.443 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.825 HG23 ' OD2' ' A' ' 57' ' ' ASP . 3.3 p -45.82 -66.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.711 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 11.7 p -41.49 -48.12 3.83 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.792 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.9 -69.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.705 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.656 HD13 ' HZ ' ' B' ' 81' ' ' PHE . 83.6 mt -40.53 -59.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 17' ' ' THR . 1.1 mp -36.33 -55.65 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 t -93.72 -67.1 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.381 0.61 . . . . 0.0 110.672 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.786 ' CD2' HD13 ' A' ' 165' ' ' LEU . 24.5 t80 -40.13 -66.68 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.835 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.3 m -85.95 -80.23 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 111.648 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.726 HG21 ' HE3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -36.04 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.296 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.41 55.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.468 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HE3' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -173.93 -174.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -101.13 166.46 12.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 80.0 Cg_exo -44.45 146.67 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.505 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.4 m -102.51 -82.25 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.709 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.54 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.519 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.38 92.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.7 t -136.31 138.74 27.84 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.768 ' O ' HG23 ' A' ' 36' ' ' VAL . 86.4 Cg_exo -42.93 106.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.352 2.035 . . . . 0.0 111.504 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 39.7 m -47.07 88.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 34' ' ' PRO . 89.7 t -98.03 -51.64 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' B' ' 87' ' ' VAL . 60.0 t80 -163.35 95.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.751 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 25.9 m-20 -96.99 123.02 40.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.556 ' HB3' HD12 ' B' ' 85' ' ' ILE . 9.1 t-20 -108.07 150.25 27.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.832 0.349 . . . . 0.0 110.636 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.36 169.18 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.201 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -107.1 140.57 39.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.643 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.6 m -159.14 157.57 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.032 0.444 . . . . 0.0 111.908 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 51' ' ' TYR . 53.8 m -155.95 108.33 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 76' ' ' SER . 3.4 m -98.35 119.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.3 mtm -74.95 104.91 5.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.884 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mm -94.78 111.44 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 20.67 71.35 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.561 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 41.57 8.18 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -140.59 147.82 50.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.792 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.9 153.09 77.77 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.565 2.177 . . . . 0.0 112.274 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -147.98 162.04 40.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -135.31 97.39 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.573 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 54' ' ' GLY . 7.4 tt -124.69 159.6 30.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -154.7 123.56 1.39 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 20' ' ' LEU . 6.2 mp -75.87 119.65 20.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 6.9 m-85 -108.18 120.52 42.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.4 t70 -67.77 174.74 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.338 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.63 ' OG1' HG13 ' A' ' 7' ' ' VAL . 15.4 m -169.97 166.13 9.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.422 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 104' ' ' HIS . . . -136.28 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.472 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 104' ' ' HIS . . . -78.32 -128.95 0.51 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.708 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? 62.33 152.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 mp0 -45.97 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.319 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 7.0 m-20 -90.69 57.04 3.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 1.5 t80 47.12 43.61 14.48 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' OD2' ' CD2' ' A' ' 61' ' ' LEU . 1.0 OUTLIER 71.22 -140.65 0.05 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -95.32 -1.93 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.192 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.035 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 68.1 mt -88.0 51.73 2.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.369 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -94.06 -43.48 0.3 Allowed Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 13.1 Cg_exo -69.8 -42.74 3.1 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.19 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -86.51 11.91 11.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.631 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.488 ' HB2' ' CZ2' ' B' ' 103' ' ' TRP . 3.3 t -166.21 32.04 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.57 0.224 . . . . 0.0 111.043 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.512 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 7.6 p90 -33.34 122.36 0.45 Allowed Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.068 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.78 ' HA ' HG21 ' A' ' 7' ' ' VAL . 26.7 Cg_exo -62.48 -27.3 76.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.536 2.157 . . . . 0.0 112.587 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.98 -10.03 45.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.86 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.626 ' CG2' HG23 ' A' ' 7' ' ' VAL . 3.5 t -36.01 -55.01 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.458 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER -172.41 -158.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.497 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.7 p -57.93 163.24 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG22 ' A' ' 77' ' ' VAL . 9.0 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.426 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 8' ' ' VAL . 10.3 tp -130.16 123.82 31.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.1 t -131.21 147.14 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.056 0.455 . . . . 0.0 111.943 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.499 ' SG ' HG23 ' A' ' 113' ' ' VAL . 17.8 m -139.63 155.27 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.408 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CD2' HG11 ' A' ' 93' ' ' VAL . 6.7 p90 -162.21 164.17 27.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.78 157.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.474 HG13 HG22 ' A' ' 137' ' ' ILE . 59.0 t -111.76 -75.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.09 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -47.14 -81.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -49.42 105.13 0.47 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.871 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 43.1 Cg_endo -67.48 -17.04 48.69 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.47 2.113 . . . . 0.0 112.473 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t -48.91 -27.3 3.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.2 t -96.12 -37.59 10.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -49.78 -62.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -50.23 -57.34 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.032 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 5.6 m-20 -51.34 -59.64 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 89' ' ' SER . 61.3 t -44.33 -38.95 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.671 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.9 -62.28 1.48 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.02 7.99 5.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -121.3 -43.89 2.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.652 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.0 m95 -95.59 -34.12 12.13 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 94' ' ' LYS . 94.7 t -49.58 -47.28 78.66 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.2 Cg_endo -74.94 -11.56 21.59 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.051 1.834 . . . . 0.0 112.459 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.61 -43.48 9.61 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.09 0.472 . . . . 0.0 110.68 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 9' ' ' VAL . 11.7 pt -51.11 -34.97 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.484 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 81.6 p -52.87 -47.6 67.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.513 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 15.6 t60 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.183 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.75 ' HD2' HG11 ' A' ' 9' ' ' VAL . 66.5 m-70 -79.96 -31.47 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 28.1 p -111.88 94.52 24.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.953 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -51.73 -55.19 4.18 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.568 2.179 . . . . 0.0 112.412 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 31.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -114.89 139.94 24.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.947 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 152' ' ' VAL . 75.7 Cg_exo -51.27 -172.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.629 2.219 . . . . 0.0 112.259 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 15.3 p90 -161.3 129.65 4.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.563 ' CD1' HG21 ' A' ' 77' ' ' VAL . 7.5 mp -97.29 129.94 44.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 149' ' ' LEU . 1.2 pt? -131.8 133.38 44.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.561 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 154' ' ' TYR . 2.7 m -141.16 176.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.375 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 84' ' ' VAL . . . -131.8 142.92 14.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.143 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.0 p -128.91 108.71 10.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 111.238 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.638 ' HB3' HG22 ' A' ' 85' ' ' VAL . 1.2 mt-30 170.7 66.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 157' ' ' CYS . 4.9 pt -98.64 -23.41 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.64 -36.99 11.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.73 -18.74 34.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.302 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.8 ' HA ' HG11 ' A' ' 85' ' ' VAL . 10.6 ptm180 -51.23 -23.79 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -44.73 -28.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.96 ' O ' HG22 ' A' ' 125' ' ' THR . 28.2 p-10 -66.53 116.72 37.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 126' ' ' ILE . 45.9 Cg_exo -56.23 -22.58 41.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.42 2.08 . . . . 0.0 112.275 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -56.07 -43.93 78.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 122' ' ' ASP . 10.1 t -50.95 -33.02 22.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.0 mp -81.23 -42.76 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -49.48 -48.68 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -78.88 -36.94 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.983 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 125' ' ' THR . 0.7 OUTLIER -49.89 -26.63 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 110.5 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.18 63.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -94.22 -37.5 11.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -56.14 -24.42 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.17 53.33 0.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.13 170.36 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.433 ' HD3' ' HD2' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -76.91 154.99 83.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 138' ' ' THR . 76.6 Cg_exo -49.98 122.1 8.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.231 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.4 mt -50.98 125.19 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -130.89 -179.8 1.14 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.551 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 76.9 Cg_exo -51.14 -22.69 11.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.438 2.092 . . . . 0.0 112.221 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.33 -42.5 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.53 ' CG2' HG23 ' A' ' 137' ' ' ILE . 57.2 m -49.92 -56.35 10.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.41 -38.09 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.9 tt0 -59.85 -48.43 81.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.08 62.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -56.69 -38.05 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.243 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.015 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.05 -45.27 83.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.768 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -58.1 -45.71 86.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -56.89 13.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.808 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.682 ' CD2' HD11 ' A' ' 112' ' ' LEU . 3.5 pp -62.17 -27.29 68.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 72.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.094 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -109.07 -179.6 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 109' ' ' PRO . 68.9 t -46.74 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 159.14 136.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.43 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 1.015 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 11.1 p90 -153.15 141.84 20.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 111.544 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -158.06 124.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.854 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.65 -178.81 2.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.733 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.47 ' HB2' HD13 ' A' ' 117' ' ' ILE . 28.3 p -136.19 -173.32 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.446 ' CB ' HG12 ' A' ' 117' ' ' ILE . 5.0 p -87.2 156.0 19.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.349 . . . . 0.0 110.527 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.478 ' C ' HD12 ' A' ' 160' ' ' LEU . . . -51.78 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.294 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 161' ' ' THR . 0.2 OUTLIER 55.0 24.03 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.422 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 169.9 128.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.715 HE22 HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -126.31 121.73 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -101.2 -43.63 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.85 85.67 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 23' ' ' TYR . 7.0 mt -85.3 -37.25 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -52.99 -24.84 10.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 155' ' ' VAL . 49.5 m-20 -63.45 -69.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.123 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.27 -41.98 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -67.59 -49.08 64.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.606 ' HA ' HG21 ' B' ' 75' ' ' ILE . 56.3 t0 -47.14 -45.37 22.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -84.29 -47.68 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -53.95 -33.21 56.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.557 HG13 HD11 ' B' ' 75' ' ' ILE . 23.3 mm -87.84 -33.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.2 tp -53.17 -56.75 13.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.72 -32.49 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -77.03 -28.03 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.598 HD12 ' OH ' ' A' ' 51' ' ' TYR . 39.0 tp -54.3 -25.41 23.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -51.33 -76.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.96 0.41 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 170' ' ' ASP . 5.1 tt -115.69 151.74 17.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -135.93 135.15 39.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.379 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.693 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -55.47 136.33 70.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.527 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.693 ' HD2' HD23 ' B' ' 77' ' ' LEU . 71.7 Cg_exo -50.7 143.69 28.34 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.479 2.12 . . . . 0.0 112.411 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.1 -70.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -58.08 88.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.656 ' HZ ' HD13 ' A' ' 20' ' ' LEU . 9.5 t80 -113.25 136.28 52.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.34 130.0 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.386 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 96.95 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.926 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -101.53 139.72 22.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.994 0.426 . . . . 0.0 111.979 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' B' ' 86' ' ' HIS . 52.1 p-80 -120.38 96.55 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.335 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 37' ' ' PHE . 46.9 t -83.47 152.54 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.86 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.42 177.85 24.49 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.503 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.53 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.635 ' OD2' HG21 ' B' ' 97' ' ' THR . 1.2 m-20 -132.68 134.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 1.11 20.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.909 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.526 HG13 HG22 ' B' ' 93' ' ' THR . 7.3 p -46.08 -27.84 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.526 HG22 HG13 ' B' ' 92' ' ' VAL . 6.2 t -148.58 -42.02 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.044 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.79 29.67 0.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.467 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -138.18 -159.47 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.704 0.288 . . . . 0.0 110.457 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' CG1' ' B' ' 87' ' ' VAL . 3.5 m-85 -98.99 164.24 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.758 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.635 HG21 ' OD2' ' B' ' 90' ' ' ASP . 34.3 p -109.41 171.76 7.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 44.26 28.12 1.32 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.773 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.83 129.46 21.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.562 0.22 . . . . 0.0 110.883 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 50.3 Cg_exo -53.92 140.4 68.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.375 2.05 . . . . 0.0 111.884 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -42.67 -45.88 4.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.252 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -56.78 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.797 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 1.035 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.6 m0 -52.36 -58.74 5.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.143 0.496 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.516 ' HB1' HE21 ' B' ' 108' ' ' GLN . . . -45.58 -70.32 0.11 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.136 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -47.32 -38.56 13.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.041 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.82 -64.88 0.58 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.859 0.361 . . . . 0.0 110.12 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -70.25 0.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.516 HE21 ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -80.71 -160.39 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -154.23 57.43 0.71 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.26 -0.275 . . . . 0.0 111.042 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.435 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.4 OUTLIER 167.74 124.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.157 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 4.4 m120 -48.1 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.603 HD13 HG22 ' B' ' 97' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.874 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.54 136.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -102.31 142.25 33.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.23 138.76 52.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.216 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.52 96.33 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.566 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.48 107.93 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' CG2' HG21 ' A' ' 75' ' ' THR . 3.0 t -84.58 150.48 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LYS . 7.5 p -135.34 146.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 78' ' ' PHE . 5.5 m -133.75 121.03 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' A' ' 97' ' ' TRP . . . 147.97 -174.32 27.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.68 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.68 155.4 49.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.367 . . . . 0.0 111.178 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 88.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . 49.94 53.78 12.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.668 HG13 HG21 ' A' ' 8' ' ' VAL . 10.0 p -80.54 2.68 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.345 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 109.87 -29.62 9.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.663 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.815 ' HB3' HG11 ' A' ' 8' ' ' VAL . 9.5 pttt -51.42 -67.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.773 -0.251 . . . . 0.0 111.635 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.735 ' O ' HD13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.81 -26.37 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 21' ' ' ILE . 35.2 t -61.24 -58.42 8.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.424 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.998 HD12 HD21 ' A' ' 79' ' ' LEU . 14.5 mt -50.99 -73.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.393 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 55' ' ' LEU . 15.1 mt -39.35 -40.34 0.78 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -51.96 -67.35 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 1.8 t -93.27 -53.36 4.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.24 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.893 ' O ' HD21 ' B' ' 77' ' ' LEU . 13.9 t80 -44.51 -30.03 0.81 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.061 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 25' ' ' THR . 93.7 m -125.33 -101.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.608 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 4.7 t -40.37 -34.8 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 75.65 47.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -151.4 136.91 17.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -58.42 166.7 2.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 28' ' ' PHE . 11.8 Cg_endo -55.69 171.81 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.945 2.43 . . . . 0.0 112.858 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 t -116.24 -75.38 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.099 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 129.06 39.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -90.66 104.32 16.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.198 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.592 HG23 ' HD2' ' A' ' 34' ' ' PRO . 5.2 p -160.78 140.51 8.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.915 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD2' HG23 ' A' ' 33' ' ' VAL . 55.7 Cg_exo -35.38 91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.933 2.422 . . . . 0.0 112.291 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 57' ' ' ASP . 98.8 m -51.32 87.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.15 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' B' ' 96' ' ' PHE . 88.6 t -84.9 -33.74 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.521 ' CE1' ' HG3' ' B' ' 100' ' ' PRO . 16.9 t80 -173.61 128.81 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.877 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 m-20 -127.86 148.98 50.49 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.778 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HB2' HD12 ' B' ' 85' ' ' ILE . 2.8 t-20 -107.07 157.27 17.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 0.0 110.69 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.568 ' OH ' HG23 ' A' ' 17' ' ' THR . 4.2 m-85 -152.82 169.29 23.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.237 0.542 . . . . 0.0 112.006 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' B' ' 81' ' ' PHE . . . -127.6 115.56 18.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG12 ' CB ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -141.13 155.53 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.438 . . . . 0.0 111.557 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.2 m -156.33 95.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.099 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.666 HG21 HG21 ' A' ' 173' ' ' ILE . 27.4 m -98.42 178.35 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.427 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 2.7 mtt -115.07 157.26 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.766 HD12 ' CE1' ' A' ' 51' ' ' TYR . 18.0 mt -158.24 89.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.585 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.17 3.02 79.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.77 26.91 5.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.0 pt-20 -141.63 138.82 17.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.638 0.256 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 43.4 Cg_exo -56.44 174.38 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.578 2.185 . . . . 0.0 112.198 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.766 ' CE1' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.87 171.2 17.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.002 0.43 . . . . 0.0 111.155 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -136.3 97.02 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.337 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 11.3 tp -98.22 157.71 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.954 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -163.22 103.01 0.21 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.426 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.03 HD11 HD23 ' A' ' 79' ' ' LEU . 3.4 mm? -75.78 105.05 6.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.763 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.7 m-85 -83.26 107.48 15.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.178 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -67.84 130.4 42.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.323 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.839 HG22 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.45 163.74 32.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -103.34 -53.62 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.411 . . . . 0.0 111.004 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.23 -45.64 1.1 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.268 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -151.76 17.91 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 13.2 mt-10 -103.43 83.59 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.139 0.495 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 78.28 -3.49 2.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.604 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.839 ' CD2' HG22 ' A' ' 58' ' ' THR . 24.2 m-85 -85.26 -13.7 48.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.747 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -39.49 -47.13 1.81 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.013 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -54.06 37.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.758 ' CB ' HD11 ' A' ' 70' ' ' LEU . 2.3 mp -78.59 82.24 4.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.19 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 24.1 ptt180 -88.2 -35.02 0.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 2.5 Cg_endo -82.68 7.95 4.86 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.081 . . . . 0.0 112.73 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.955 HD22 ' CE2' ' B' ' 103' ' ' TRP . 39.0 mt -51.54 111.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.485 0.659 . . . . 0.0 111.471 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.636 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 70.18 4.78 5.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.433 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 59.97 154.7 0.1 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.466 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.93 -52.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.947 2.432 . . . . 0.0 112.932 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -69.86 -8.2 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.986 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 76' ' ' ASP . 1.1 t -32.79 -73.52 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.729 ' H ' HG23 ' A' ' 75' ' ' THR . 3.7 m-20 -161.56 -155.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 78' ' ' PHE . 14.1 p -66.86 162.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -98.5 127.34 44.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.03 HD23 HD11 ' A' ' 55' ' ' LEU . 13.5 tp -103.69 115.47 30.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.274 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.515 HG13 ' CG2' ' A' ' 14' ' ' VAL . 2.5 t -131.9 153.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.446 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 14' ' ' VAL . 62.6 m -142.65 172.02 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.511 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.738 ' HB3' HG21 ' A' ' 93' ' ' VAL . 50.8 p90 -164.41 151.72 11.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.105 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.47 136.8 42.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 115' ' ' THR . 5.3 m -107.15 68.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.12 -85.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.13 163.8 55.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.803 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.432 ' CB ' ' HB2' ' A' ' 132' ' ' ASN . 51.7 Cg_endo -69.17 -22.53 34.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.58 2.187 . . . . 0.0 112.287 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 p -70.18 -33.83 72.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.2 p -51.89 -46.25 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -51.92 -69.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.067 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.93 -29.22 55.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.002 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.5 m-20 -62.47 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 82' ' ' PHE . 7.2 p -41.38 -31.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.14 -70.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.842 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.57 8.11 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 27.3 tttm -113.68 -40.62 3.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.676 ' HD1' HG23 ' A' ' 93' ' ' VAL . 11.0 m95 -95.96 -13.58 23.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 94' ' ' LYS . 2.5 m -53.02 -32.57 10.37 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.5 Cg_exo -68.78 -41.87 5.26 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.782 1.654 . . . . 0.0 112.217 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' CG ' HD12 ' A' ' 61' ' ' LEU . 19.0 mp0 -58.56 -43.67 89.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.841 HG21 ' CD2' ' A' ' 110' ' ' PHE . 71.3 mt -48.58 -26.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -84.67 -37.16 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.58 -34.56 51.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -102.94 -61.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 8.4 m -109.29 85.61 3.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.2 -11.66 29.1 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.632 2.221 . . . . 0.0 112.794 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -152.78 40.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 111.419 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.4 139.88 36.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.853 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.1 Cg_exo -49.18 143.96 17.82 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.542 2.161 . . . . 0.0 112.113 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.841 ' CD2' HG21 ' A' ' 101' ' ' ILE . 1.6 p90 -131.39 130.52 42.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.28 136.09 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.394 179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.2 pp -146.78 114.19 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.672 HG11 ' CD ' ' A' ' 156' ' ' GLU . 10.0 p -129.1 152.3 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.382 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.484 ' HA3' HG13 ' A' ' 84' ' ' VAL . . . -73.16 -176.92 32.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.305 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.858 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -174.14 172.36 3.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 111.426 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.906 ' OE1' HD22 ' A' ' 119' ' ' LEU . 14.1 mt-30 72.53 108.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' A' ' 139' ' ' PRO . 41.7 mt -98.48 -59.83 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 119' ' ' LEU . 24.9 p30 -55.02 -22.51 15.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.906 HD22 ' OE1' ' A' ' 116' ' ' GLN . 7.3 tp -61.93 -48.11 81.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.956 ' HA ' HG12 ' A' ' 85' ' ' VAL . 1.6 ptt180 -58.91 -22.89 60.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.72 -23.8 7.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 29.6 m-20 -54.22 135.6 59.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 43.3 Cg_exo -56.58 -42.55 64.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.522 2.148 . . . . 0.0 112.397 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -38.69 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 120' ' ' ARG . 19.7 p -59.05 -64.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.6 mp -48.65 -43.68 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.069 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD2' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.59 -32.93 68.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -50.81 -26.23 5.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.928 0.394 . . . . 0.0 110.295 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.35 -22.44 60.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.928 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.48 -22.51 37.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 87' ' ' PRO . 25.6 t30 -94.04 30.59 1.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.957 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 34.69 0.37 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.788 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.71 -160.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.45 95.65 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.773 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.416 ' HA ' HD22 ' A' ' 129' ' ' LEU . 42.0 Cg_endo -67.56 141.8 56.69 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.608 2.205 . . . . 0.0 112.363 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 90' ' ' PHE . 4.1 mt -67.47 125.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -124.43 177.73 1.68 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' A' ' 117' ' ' ILE . 51.1 Cg_exo -54.23 -24.7 35.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.691 2.26 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -86.36 -39.02 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.027 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.8 m -49.97 -48.29 52.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -49.91 61.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.04 -47.93 68.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.52 -40.62 59.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.593 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 145' ' ' LEU . 8.5 tt -61.38 -41.69 97.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.967 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -53.33 -54.93 29.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -55.05 -38.83 68.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -51.49 -32.67 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 151' ' ' ALA . 1.6 pp -125.39 21.86 7.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.142 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 58.1 -84.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.993 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 149' ' ' LEU . . . 58.07 175.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 6.1 t -61.52 -15.99 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.484 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.45 140.84 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 110.466 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.967 ' CE1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -153.39 151.57 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 155' ' ' VAL . 14.9 m -157.93 123.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.579 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.672 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.7 pt-20 -172.36 152.21 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.152 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 83.3 m -101.82 -177.53 3.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.485 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 30.8 t -86.77 156.6 19.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.049 0.452 . . . . 0.0 111.594 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.906 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.04 -169.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.029 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 50.87 24.89 1.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.549 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -174.17 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 57.66 115.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.338 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -64.07 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.28 92.98 0.11 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.419 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -93.79 -10.37 34.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.477 0.18 . . . . 0.0 111.455 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.16 -43.32 3.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.336 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.94 -67.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.732 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.685 HG13 ' OH ' ' A' ' 23' ' ' TYR . 7.3 p -50.27 -28.78 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.78 -51.26 70.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.146 179.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 2.5 p30 -63.13 -32.24 73.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.4 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 24.6 tp10 -70.14 -30.68 67.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.98 -29.36 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.717 HG22 HD11 ' A' ' 46' ' ' ILE . 44.5 mm -94.95 -66.36 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -49.94 -45.76 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.979 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -55.34 -25.56 35.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -61.33 -29.23 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.057 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -92.7 44.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 28.5 m -55.34 -42.56 74.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.6 149.19 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.22 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 176.1 8.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.893 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -94.88 140.37 22.49 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.655 ' CB ' HG12 ' A' ' 42' ' ' VAL . 52.9 Cg_exo -54.61 -164.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.437 2.091 . . . . 0.0 112.103 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -167.79 -65.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.59 95.59 2.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.985 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -129.02 148.93 51.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.141 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -153.22 140.45 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.93 0.395 . . . . 0.0 111.758 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -75.48 95.34 3.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.051 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -77.02 -42.49 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 39' ' ' ASN . 2.0 mt -129.07 147.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 111.558 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -141.12 97.16 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.484 ' CG2' ' HD3' ' B' ' 100' ' ' PRO . 63.3 t -78.25 125.07 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 111.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 172.92 15.91 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.869 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -98.62 111.23 23.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.444 ' CG ' HG21 ' B' ' 97' ' ' THR . 1.1 m-20 -129.29 128.78 43.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.36 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.15 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.918 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.938 HG13 HG22 ' B' ' 93' ' ' THR . 7.5 p -41.5 -30.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 111.591 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.938 HG22 HG13 ' B' ' 92' ' ' VAL . 1.1 t -151.61 21.1 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.151 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.96 25.27 67.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.852 ' CG ' HG23 ' B' ' 93' ' ' THR . 8.3 pt-20 -145.71 171.84 14.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -70.54 164.75 24.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.421 . . . . 0.0 110.745 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.444 HG21 ' CG ' ' B' ' 90' ' ' ASP . 66.1 p -110.45 176.68 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 43.05 28.54 0.76 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.87 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.712 ' CE ' HD21 ' A' ' 67' ' ' LEU . 3.0 mtp -57.74 124.63 69.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.252 . . . . 0.0 110.956 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.521 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 49.2 Cg_exo -38.86 152.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.792 2.328 . . . . 0.0 112.692 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' B' ' 105' ' ' ARG . 2.8 mt-10 -47.58 -43.24 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.065 0.459 . . . . 0.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.488 ' HG2' HD23 ' B' ' 106' ' ' LEU . 0.0 OUTLIER -72.56 -57.67 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.246 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.955 ' CE2' HD22 ' A' ' 70' ' ' LEU . 13.1 m0 -48.31 -60.26 2.8 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.601 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' C ' ' B' ' 110' ' ' SER . . . -47.47 -67.99 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.2 mtp85 -52.23 -34.4 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.032 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -45.75 -65.64 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.696 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -63.22 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.56 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.69 ' O ' HG23 ' B' ' 109' ' ' THR . 0.4 OUTLIER -78.8 -100.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.677 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.69 HG23 ' O ' ' B' ' 108' ' ' GLN . 11.7 p -164.94 -57.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.226 0 CA-C-O 120.788 0.327 . . . . 0.0 111.851 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.572 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -127.7 158.89 36.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.382 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 99' ' ' MET . 0.6 OUTLIER -45.15 -57.44 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.055 0.455 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.602 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.85 0.357 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -94.6 120.93 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.8 t -99.73 147.15 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.866 HG23 ' OD2' ' A' ' 76' ' ' ASP . 65.8 mt -135.66 103.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB2' HG21 ' A' ' 75' ' ' THR . 5.6 mmtp -95.67 98.31 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -77.77 112.35 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.113 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 59.6 t -91.09 150.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 79' ' ' LEU . 7.3 p -139.51 147.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.063 0.458 . . . . 0.0 111.529 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 60' ' ' GLY . 7.1 p -138.27 120.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.534 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.62 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.769 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -20.87 15.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.782 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -78.37 -45.17 10.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.69 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 73.47 3.0 4.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' HA2' ' A' ' 114' ' ' GLY . 5.4 t -57.78 -17.93 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.242 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -81.25 -124.32 0.65 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.422 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -34.06 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.604 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -50.91 -71.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' THR . 51.7 t -48.03 -46.45 33.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.126 0.489 . . . . 0.0 110.985 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.883 HD13 HG11 ' A' ' 113' ' ' VAL . 69.4 tp -46.14 -59.78 2.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.537 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 55' ' ' LEU . 21.8 mt -44.69 -49.15 10.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.708 0.29 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 27' ' ' LYS . 3.4 mm -42.58 -49.19 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.491 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.68 -61.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.453 0.644 . . . . 0.0 110.256 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.941 ' OH ' HG13 ' A' ' 168' ' ' VAL . 1.2 t80 -39.8 -66.85 0.26 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.249 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.839 HG23 ' HB2' ' B' ' 78' ' ' PRO . 50.6 m -96.57 -77.54 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.366 0.603 . . . . 0.0 111.151 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.775 HG23 ' CE2' ' B' ' 81' ' ' PHE . 0.2 OUTLIER -36.29 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.225 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t30 47.72 65.08 1.37 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 110.616 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.16 -169.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.316 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -111.91 157.89 38.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -51.2 143.05 34.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.669 2.246 . . . . 0.0 112.438 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 p -95.12 -80.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.22 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.89 109.33 21.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.02 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.6 t80 -66.11 107.73 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.103 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA2' ' B' ' 88' ' ' GLY . 59.2 t -157.89 131.89 5.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' VAL . 94.7 Cg_exo -41.86 92.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.379 2.053 . . . . 0.0 111.969 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 38' ' ' ASP . 40.4 m -53.11 87.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.268 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.808 HG13 ' OH ' ' A' ' 64' ' ' TYR . 12.2 t -73.41 -27.04 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 110.058 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.715 ' HE2' HD13 ' B' ' 85' ' ' ILE . 15.8 t80 -146.85 -79.78 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.312 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.831 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.0 OUTLIER 60.69 118.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.119 -179.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 t-20 -107.7 156.86 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -152.49 144.89 24.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.005 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.11 140.2 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.139 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 24' ' ' THR . 25.6 m -154.81 132.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 51' ' ' TYR . 61.4 m -125.39 95.31 4.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 ' O ' ' B' ' 76' ' ' SER . 2.9 m -98.13 123.75 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.403 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -72.8 100.18 2.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.923 HD11 HG21 ' A' ' 173' ' ' ILE . 24.7 mm -90.48 89.37 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.44 12.74 55.62 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 4.7 58.96 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.125 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.13 150.61 43.23 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.03 0.415 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.29 162.44 7.74 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.679 2.252 . . . . 0.0 112.126 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.628 ' H ' HG23 ' A' ' 43' ' ' THR . 7.0 t80 -154.11 153.28 31.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.952 0.406 . . . . 0.0 111.459 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 p -136.31 97.43 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.223 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 54' ' ' GLY . 5.8 tt -112.51 144.89 41.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.762 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -127.5 112.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.183 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 16' ' ' LYS . 5.6 mp -77.96 102.93 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.308 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 1.3 m-85 -88.86 103.01 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.01 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.667 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -73.57 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.94 0.4 . . . . 0.0 111.246 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.05 -171.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.965 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . . . -156.69 149.27 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' VAL . . . -109.01 99.49 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.36 -65.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 170.02 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.736 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -111.14 27.29 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.965 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -91.42 -23.05 20.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -27.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.603 ' O ' HD23 ' B' ' 107' ' ' LEU . 22.1 mtt180 -48.67 -40.27 27.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.877 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD22 ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -92.12 40.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.638 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tpt180 -81.59 -66.46 0.23 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.499 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 19.3 Cg_endo -58.91 -15.16 25.73 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.56 2.173 . . . . 0.0 112.626 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.762 HD12 ' CG ' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.41 -13.0 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.108 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 1.3 t -111.6 -19.49 12.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.319 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 39.01 95.86 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.801 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 37.9 Cg_endo -66.2 -45.58 5.42 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.609 2.206 . . . . 0.0 112.183 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -12.08 47.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 5' ' ' LYS . 6.6 t -40.56 -46.8 2.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -172.64 -160.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.749 0.309 . . . . 0.0 111.058 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -58.17 154.18 2.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.731 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -106.76 138.79 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.27 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -104.11 122.61 45.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.093 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 101' ' ' ILE . 4.0 t -106.9 153.77 8.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.065 0.46 . . . . 0.0 111.919 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.27 155.66 18.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CZ ' HG23 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -166.07 121.66 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.968 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.88 164.4 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.651 ' HA ' HG21 ' A' ' 137' ' ' ILE . 34.5 t -147.67 66.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.318 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 120' ' ' ARG . 70.8 t -151.27 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -82.76 137.71 43.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 57.9 Cg_endo -72.06 -19.47 26.42 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.556 2.171 . . . . 0.0 112.325 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.8 p -56.91 -52.23 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.81 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -29.82 63.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -50.3 -45.86 54.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -47.54 85.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -61.1 -66.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 28.7 m -43.53 -40.84 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.664 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.2 tttm -57.44 -68.03 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 5.1 mt-10 -82.53 8.4 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.138 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.02 -38.69 3.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.404 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.584 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 49.9 m0 -95.23 -40.89 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.511 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 101' ' ' ILE . 60.7 t -55.85 -44.09 99.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 39.5 Cg_exo -60.22 -19.65 58.31 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.33 2.02 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.71 -30.8 56.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.885 HG22 ' O ' ' A' ' 98' ' ' VAL . 8.4 tp -49.16 -31.4 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.198 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -77.71 -44.04 29.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -51.86 -37.76 53.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 5.3 m-70 -97.2 -61.72 1.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 4.7 t -74.42 108.89 5.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.501 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.49 -60.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.392 2.062 . . . . 0.0 112.419 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -154.68 36.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.727 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -107.29 153.98 40.83 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD2' HG22 ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.89 145.68 97.67 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.606 2.204 . . . . 0.0 111.97 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 20.1 p90 -123.1 127.48 48.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.314 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.649 HD12 ' CG1' ' A' ' 152' ' ' VAL . 6.8 tt -109.14 119.29 39.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.045 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 mp -90.99 155.14 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.229 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 19' ' ' LEU . 3.0 t -148.78 165.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.705 ' HA2' HG12 ' A' ' 14' ' ' VAL . . . 143.41 154.63 6.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.799 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -176.78 164.48 2.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.421 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -172.25 93.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.815 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -25.72 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.855 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -95.26 -30.91 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.795 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.421 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -78.41 -44.72 24.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HA ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -53.14 -23.49 8.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 55.89 2.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.9 ' O ' HD12 ' A' ' 126' ' ' ILE . 1.3 m-20 -111.11 150.04 41.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 -57.95 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.716 2.277 . . . . 0.0 112.374 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -34.57 75.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 120' ' ' ARG . 54.2 m -55.49 -72.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.818 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 122' ' ' ASP . 3.7 mp -52.03 -39.1 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -32.08 30.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.048 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.67 -39.34 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.524 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 136' ' ' PRO . 17.6 mt -49.9 -26.14 3.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.457 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.43 67.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -25.35 22.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.454 ' CB ' ' HG3' ' A' ' 87' ' ' PRO . 9.6 m120 -115.95 30.23 7.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 103.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.973 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 6.3 pt20 -42.69 150.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 10.1 mttt 47.94 48.43 5.88 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.842 ' HD2' HD13 ' A' ' 129' ' ' LEU . 73.8 Cg_endo -75.88 -46.15 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.561 2.174 . . . . 0.0 112.562 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 84' ' ' VAL . 5.7 mm -99.85 129.94 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -148.86 164.5 21.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 75.6 Cg_exo -49.78 -23.31 8.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.546 2.164 . . . . 0.0 112.315 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -90.64 -41.23 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.1 m -49.02 -57.69 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.89 -49.56 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.65 -38.11 80.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -50.36 73.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.1 tp -57.25 -37.93 73.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -71.57 -26.53 62.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ttt-85 -73.43 -40.7 64.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.21 -44.7 94.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.4 pp -71.77 -26.39 62.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.694 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.0 tptt 69.05 109.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.62 -161.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.649 ' CG1' HD12 ' A' ' 111' ' ' LEU . 91.2 t -56.82 -20.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.305 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 75.07 139.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.197 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 39.6 p90 -152.8 162.09 41.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.7 m -158.13 124.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.695 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.571 ' CD ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -170.62 167.55 7.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.104 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.799 ' HA ' HG21 ' A' ' 115' ' ' THR . 17.4 p -118.9 -173.24 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -87.68 165.04 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.973 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.575 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -51.43 -175.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 66.23 -69.29 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.276 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.93 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.91 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 68.61 108.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.667 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -68.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.35 96.57 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.91 HD11 ' NE2' ' A' ' 162' ' ' GLN . 19.2 mt -93.24 -17.62 23.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.68 0.276 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -62.92 -49.96 72.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.455 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 166' ' ' LYS . 23.1 m-80 -48.8 -71.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.941 HG13 ' OH ' ' A' ' 23' ' ' TYR . 3.5 p -47.62 -30.06 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -64.42 -38.21 90.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.779 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.448 ' CB ' HG13 ' B' ' 75' ' ' ILE . 17.4 t0 -63.63 -35.54 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.127 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 3.1 mm-40 -81.79 -24.63 35.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.73 41.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 46' ' ' ILE . 21.2 mt -88.71 -48.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.46 -27.77 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -50.82 -37.14 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.74 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -94.52 -20.58 19.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.318 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -82.99 -24.58 32.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.017 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.876 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.3 p -99.36 -39.55 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.448 HG13 ' CB ' ' A' ' 170' ' ' ASP . 6.7 mm -140.33 139.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.897 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 p -138.69 141.85 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.013 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -70.24 131.67 88.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.839 ' HB2' HG23 ' A' ' 24' ' ' THR . 53.1 Cg_exo -54.63 154.29 20.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.399 2.066 . . . . 0.0 112.273 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.86 -43.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.87 61.63 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.976 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.775 ' CE2' HG23 ' A' ' 25' ' ' THR . 23.7 t80 -74.39 149.8 40.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.65 101.72 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -72.34 69.31 0.81 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.803 ' OG1' HD12 ' B' ' 85' ' ' ILE . 44.8 p -52.43 -85.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.245 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.803 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.5 OUTLIER -96.95 145.32 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.096 0.474 . . . . 0.0 112.092 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.95 96.89 4.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.519 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.602 HG22 ' HD3' ' B' ' 100' ' ' PRO . 29.7 t -78.03 157.29 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.969 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.589 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.43 177.92 24.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -84.52 119.08 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.615 ' CB ' HG23 ' B' ' 97' ' ' THR . 13.8 t0 -111.01 98.32 7.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.23 61.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.562 HG13 HG22 ' B' ' 93' ' ' THR . 13.4 p -46.92 -33.47 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.308 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.562 HG22 HG13 ' B' ' 92' ' ' VAL . 7.8 t -148.16 23.72 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.17 25.39 72.25 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.622 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.412 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 17.4 pt-20 -119.84 -166.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.732 0.301 . . . . 0.0 110.791 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 1.02 ' CE2' HD11 ' A' ' 67' ' ' LEU . 2.2 m-85 -103.9 163.74 12.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.615 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.6 p -104.64 150.05 25.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.576 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' ND2' ' B' ' 111' ' ' ASN . . . 69.5 43.93 66.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' B' ' 104' ' ' ALA . 2.7 tpt -47.28 103.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.551 0.215 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.602 ' HD3' HG22 ' B' ' 87' ' ' VAL . 77.5 Cg_exo -50.3 147.44 16.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.487 2.125 . . . . 0.0 111.915 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -66.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -65.7 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.417 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 1.04 ' CE3' HD22 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -46.71 -56.85 5.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.201 0.524 . . . . 0.0 110.552 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.611 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -55.26 -60.91 2.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.653 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.784 ' O ' HG22 ' B' ' 109' ' ' THR . 6.1 mtt-85 -42.42 -36.23 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.368 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.759 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -60.81 -60.72 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.32 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.18 -64.36 1.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.703 ' O ' HG23 ' B' ' 109' ' ' THR . 5.5 tp60 -76.93 -79.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.236 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.784 HG22 ' O ' ' B' ' 105' ' ' ARG . 6.0 p 96.78 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.366 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 171.26 93.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.958 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.425 ' ND2' ' HA2' ' B' ' 98' ' ' GLY . 1.7 t30 -49.78 92.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.611 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.187 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.769 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.58 167.57 11.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -91.83 132.63 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.647 HD13 ' CB ' ' A' ' 176' ' ' ALA . 25.1 mt -116.25 133.41 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.3 OUTLIER -123.27 149.44 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.722 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.97 96.05 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.82 HG21 ' O ' ' A' ' 71' ' ' SER . 56.4 t -100.79 128.01 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.867 ' HB ' HG12 ' A' ' 14' ' ' VAL . 18.5 m -106.73 169.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.2 p -158.28 121.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.98 -140.58 5.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB2' ' CE2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -126.5 -78.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -60.36 -147.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.912 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -60.81 78.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 110.78 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.5 t -73.81 -1.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.142 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . 95.62 -24.74 28.08 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -60.32 -64.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.852 HG23 ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -96.09 -34.35 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.912 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 3.3 p -66.39 -45.19 80.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 79' ' ' LEU . 8.1 tp -61.29 -73.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.959 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -43.86 -48.45 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.397 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -47.74 -69.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.01 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.1 t -93.2 -60.89 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.462 . . . . 0.0 111.971 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.56 ' CD2' HD11 ' A' ' 19' ' ' LEU . 8.2 t80 -47.6 -24.96 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.702 HG21 HG11 ' A' ' 42' ' ' VAL . 79.6 m -111.36 -96.25 0.42 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.562 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.463 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.6 t -60.07 -21.76 61.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 27.9 t-20 72.1 30.38 2.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.9 OUTLIER -125.78 134.75 51.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -69.21 160.12 80.17 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.042 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.2 Cg_endo -50.64 169.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.965 2.444 . . . . 0.0 112.409 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -74.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 134.11 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.21 110.06 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -154.78 138.85 11.27 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.497 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 36' ' ' VAL . 93.8 Cg_exo -41.18 109.07 0.1 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.46 2.107 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 16' ' ' LYS . 18.1 m -47.16 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.297 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 34' ' ' PRO . 61.3 t -103.78 -53.77 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.886 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' B' ' 85' ' ' ILE . 45.8 t80 -159.0 78.46 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 12.2 m-20 -80.59 121.52 25.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.656 ' HB3' HD12 ' B' ' 85' ' ' ILE . 26.6 t-20 -107.07 151.2 25.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.037 0.446 . . . . 0.0 111.272 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.2 160.03 43.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.216 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.25 116.97 29.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.906 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 24' ' ' THR . 1.4 m -146.08 132.07 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.059 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 51' ' ' TYR . 21.0 m -127.49 112.19 14.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.838 0.352 . . . . 0.0 110.215 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 76' ' ' SER . 92.6 t -97.73 117.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.215 0.531 . . . . 0.0 110.143 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.4 mtm -93.42 106.09 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.294 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.68 HG23 HD13 ' B' ' 75' ' ' ILE . 7.2 mt -85.82 100.97 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.845 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 74' ' ' SER . . . 86.25 19.86 56.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.361 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.33 -46.31 1.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.595 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.4 pt-20 -65.72 139.69 97.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.663 0.268 . . . . 0.0 111.031 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.0 158.71 49.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -154.13 150.03 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.4 p -86.63 97.8 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.718 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -133.76 137.31 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.865 ' N ' HD22 ' A' ' 53' ' ' LEU . . . -162.25 145.4 10.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.551 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 79' ' ' LEU . 3.1 mm? -75.88 114.34 14.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.636 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.646 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -83.2 103.72 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.062 0.458 . . . . 0.0 109.843 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.852 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 m-20 -67.51 137.12 55.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.685 HG21 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -176.07 135.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.806 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -76.52 -61.97 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.221 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.99 89.56 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -118.63 -38.5 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 166.81 -30.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.22 -24.21 27.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 18.7 m-85 -56.6 -20.19 19.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -41.77 -30.26 0.23 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.768 0.318 . . . . 0.0 111.446 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -70.01 -48.66 57.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.081 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -88.56 49.55 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.552 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -99.45 -43.39 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.0 Cg_exo -58.12 -14.63 19.93 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.63 2.22 . . . . 0.0 112.979 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.713 HD22 ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -104.07 -15.6 15.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.103 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.82 ' O ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -132.9 22.07 4.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 15.1 p90 -46.61 114.33 2.67 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.106 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HG2' ' HA ' ' A' ' 105' ' ' CYS . 37.8 Cg_endo -65.72 -21.42 58.61 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.562 2.175 . . . . 0.0 112.32 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -65.92 -11.79 49.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.231 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' ' 72' ' ' TYR . 8.9 t -41.47 -48.55 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 111.47 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 75' ' ' THR . 2.6 m-20 -164.54 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.608 HG21 ' CB ' ' A' ' 175' ' ' ALA . 24.9 t -132.14 156.7 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE2' HG23 ' A' ' 101' ' ' ILE . 36.2 p90 -144.57 140.96 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 111.462 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.65 150.0 24.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.5 t -131.34 154.62 40.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.186 0.517 . . . . 0.0 111.913 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.503 ' N ' ' HA ' ' A' ' 14' ' ' VAL . 10.1 p -68.15 172.93 5.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.815 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CZ ' ' CD2' ' A' ' 145' ' ' LEU . 0.9 OUTLIER 179.44 100.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.62 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 m -58.57 91.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.882 HG11 ' HB2' ' A' ' 142' ' ' ALA . 10.4 m -83.52 54.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.721 HG22 ' N ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -150.6 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.531 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.721 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.2 t -57.5 135.76 82.04 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.618 0.247 . . . . 0.0 110.64 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 98.4 Cg_endo -78.25 -39.42 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.548 2.165 . . . . 0.0 112.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.24 -24.02 6.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.18 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 93' ' ' VAL . 70.5 m -88.68 -40.34 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CZ ' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -42.32 -53.04 4.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.686 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -48.34 -55.41 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.364 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.0 m-20 -70.78 -37.89 73.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.189 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.944 HG23 ' O ' ' A' ' 89' ' ' SER . 98.6 t -44.09 -45.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.639 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -85.69 -47.79 9.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.38 7.67 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -128.56 -38.09 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.908 ' CE3' HG13 ' A' ' 93' ' ' VAL . 46.1 m0 -95.13 -26.54 15.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.61 HG23 ' HA ' ' A' ' 94' ' ' LYS . 59.7 t -67.35 -44.1 45.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.563 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 41.6 Cg_exo -56.87 -34.98 98.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.324 2.016 . . . . 0.0 112.308 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.16 -33.29 74.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.536 HG23 ' CE2' ' A' ' 78' ' ' PHE . 47.6 mt -49.17 -40.25 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.5 p -77.3 -21.44 53.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.328 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.45 -37.2 77.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.86 0.362 . . . . 0.0 110.678 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 73' ' ' PRO . 22.1 m-70 -106.51 -39.75 5.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.813 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 3.9 m -99.25 102.74 16.9 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 87.6 Cg_exo -42.99 -62.29 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.479 2.119 . . . . 0.0 112.403 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -171.67 40.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 155.76 41.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.646 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.91 118.21 2.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.457 2.104 . . . . 0.0 112.179 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.2 p90 -104.89 141.99 35.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.319 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 111' ' ' LEU . 3.5 mt -129.49 158.11 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.989 0.423 . . . . 0.0 111.244 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.8 m -156.56 155.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.44 39.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 158' ' ' SER . 73.0 p -146.29 160.04 42.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.699 0.285 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.42 35.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 157' ' ' CYS . 20.0 mt -97.04 -61.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.987 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.66 -35.88 11.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.79 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 119' ' ' LEU . 6.0 tt -70.52 -32.21 69.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HG3' HG23 ' A' ' 85' ' ' VAL . 7.0 ttm180 -76.63 59.38 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -129.21 37.29 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.87 141.64 22.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.44 -49.57 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.556 2.171 . . . . 0.0 112.265 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m -57.77 -22.98 49.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.547 HG22 HD12 ' A' ' 129' ' ' LEU . 5.2 m -48.83 -66.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.69 -45.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -50.19 52.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -81.37 -35.09 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 125' ' ' THR . 2.8 mt -50.91 -25.56 4.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.495 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.26 -21.41 56.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.081 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -83.38 -20.05 34.93 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.98 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.89 30.55 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 77.79 32.95 0.38 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.39 -161.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.14 93.25 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 37.5 Cg_endo -66.2 124.85 13.12 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.548 2.165 . . . . 0.0 112.064 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.508 HG21 ' CA ' ' A' ' 84' ' ' VAL . 3.7 mt -50.55 120.29 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -118.12 158.41 46.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 3.7 Cg_exo -40.3 -29.42 0.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.071 2.514 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -36.75 21.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' THR . 93.5 m -48.05 -47.61 33.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.882 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -49.31 -46.58 46.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -57.66 -42.95 84.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.42 -53.47 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 14.8 tp -57.26 -31.95 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.467 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.875 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -66.66 -31.59 72.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -70.34 -47.64 60.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -23.14 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 pp -106.3 -24.26 12.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.073 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 1.2 tttt 62.16 120.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.845 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.7 -161.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 5.1 t -67.37 -15.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.574 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.32 146.02 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.875 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 24.3 p90 -152.79 126.25 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.186 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.1 t -138.12 123.39 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -170.73 -179.63 2.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.469 ' HB2' HD11 ' A' ' 117' ' ' ILE . 17.6 p -130.62 -173.22 3.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 115' ' ' THR . 8.7 t -87.15 163.2 17.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.702 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.75 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.25 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.058 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.75 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 69.73 -63.25 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.64 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.2 p -89.51 -169.62 2.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.634 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -172.56 109.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -100.39 -38.75 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.44 88.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.304 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.67 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -91.98 -11.54 35.8 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -34.22 37.36 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -57.09 -45.43 83.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.283 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' VAL . 31.1 t -54.76 -52.96 37.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.472 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' CB ' ' HH ' ' A' ' 23' ' ' TYR . 1.4 m-30 -70.15 -28.25 65.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -53.93 -52.12 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.775 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 1.5 tp10 -89.9 -33.9 16.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -66.14 -38.38 88.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.858 HD12 ' HG ' ' A' ' 53' ' ' LEU . 42.3 mm -86.66 -44.17 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.4 tm? -64.43 -31.94 73.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 77' ' ' VAL . . . -51.75 -29.29 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.647 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -63.64 -20.98 66.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.18 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.71 38.3 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.286 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -50.45 -27.49 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.339 . . . . 0.0 110.898 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -144.03 137.41 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.867 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -138.65 133.54 32.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.604 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -77.2 143.23 69.28 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.59 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 42' ' ' VAL . 51.3 Cg_exo -54.12 152.36 24.84 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.352 2.035 . . . . 0.0 112.062 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -117.19 -37.07 3.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.89 163.05 27.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 27.6 t80 -167.46 130.35 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.624 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -153.42 116.67 4.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 69.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.427 ' N ' ' O ' ' B' ' 82' ' ' GLU . 8.2 p -57.9 -77.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.247 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.783 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -103.76 139.44 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.499 . . . . 0.0 112.279 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -123.11 96.21 4.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.101 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' A' ' 36' ' ' VAL . 57.7 t -88.08 144.51 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.891 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.36 176.85 20.05 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.989 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -77.35 113.42 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.568 ' CB ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -107.99 108.05 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.66 -17.2 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.307 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' VAL . . . . . 0.529 HG12 ' CG ' ' B' ' 90' ' ' ASP . 10.2 p -43.01 -35.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.509 HG23 HG22 ' B' ' 92' ' ' VAL . 18.2 p -157.79 45.33 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.05 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.54 27.39 5.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.62 -168.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.719 0.295 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 1.081 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -106.0 164.49 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.829 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.568 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.9 p -99.45 165.31 11.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.964 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.09 51.73 24.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.762 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -60.48 119.33 42.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.665 ' HG3' HG21 ' B' ' 85' ' ' ILE . 58.4 Cg_exo -49.56 156.46 2.9 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.291 1.994 . . . . 0.0 112.146 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.67 -57.1 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.455 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.422 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.1 tm0? -69.94 -52.52 23.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.225 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -50.1 -57.77 6.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.725 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.616 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -48.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.204 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 77.5 mtt180 -54.76 -34.29 62.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.242 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.659 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.05 -61.04 2.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.925 0.393 . . . . 0.0 109.978 179.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.681 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -70.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.15 178.324 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' GLN . . . . . 0.556 ' C ' HG22 ' B' ' 109' ' ' THR . 4.0 pt20 -80.74 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.203 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.556 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.05 62.58 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.459 0.304 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' SER . . . . . 0.616 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.1 OUTLIER 168.41 108.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.384 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.8 OUTLIER -65.39 74.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 121.196 0.522 . . . . 0.0 111.311 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 69.44 140.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.27 144.68 46.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 53' ' ' LEU . 9.1 pt -119.87 114.57 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 0.8 OUTLIER -135.11 100.05 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -77.93 130.21 36.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.803 HG13 HG21 ' A' ' 75' ' ' THR . 2.1 m -96.67 150.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 16' ' ' LYS . 17.9 t -125.63 154.29 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.362 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 59' ' ' ALA . 7.2 p -149.64 121.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.738 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . 130.6 -179.52 16.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.93 -179.53 5.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.48 77.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.379 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB2' " C5'" ' A' ' 185' ' ' GNP . . . 53.41 84.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.871 0.367 . . . . 0.0 110.925 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.738 HG11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -109.23 4.26 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.286 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.865 ' CA ' HD12 ' A' ' 19' ' ' LEU . . . 97.09 -18.19 57.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.281 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.818 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -62.92 -74.19 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.773 0.321 . . . . 0.0 111.515 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.796 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -96.62 -25.88 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' SG ' ' C8 ' ' A' ' 185' ' ' GNP . 2.1 p -65.61 -48.11 73.38 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.705 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD12 ' CA ' ' A' ' 15' ' ' GLY . 4.3 mt -61.26 -73.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.349 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 40' ' ' TYR . 11.2 mt -40.8 -43.42 2.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.981 0.419 . . . . 0.0 111.558 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.773 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -48.71 -69.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.806 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 1.8 t -93.79 -55.39 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.0 111.507 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CZ ' ' CE2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -51.96 -19.25 1.7 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.498 -178.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.452 ' CB ' ' HA ' ' A' ' 20' ' ' LEU . 43.2 m -123.94 -86.23 0.64 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.232 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.453 ' CG2' ' HD3' ' A' ' 27' ' ' LYS . 4.7 t -65.83 -14.21 60.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' ILE . 36.0 t30 79.03 -56.28 0.44 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.908 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HD3' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -47.74 145.74 2.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.996 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.773 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -88.48 167.01 20.32 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 3.7 Cg_endo -45.82 165.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.993 2.462 . . . . 0.0 112.688 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.8 t -119.56 -76.44 0.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.98 113.94 25.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.643 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.28 109.3 4.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 0.0 111.056 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' HD2' ' A' ' 34' ' ' PRO . 67.2 t -157.52 138.03 9.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.478 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 36' ' ' VAL . 84.3 Cg_exo -43.81 92.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.314 2.009 . . . . 0.0 111.617 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.813 HG23 ' CG ' ' A' ' 38' ' ' ASP . 56.8 m -51.98 87.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 34' ' ' PRO . 20.9 t -79.54 -28.23 12.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 109.762 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HE2' HD13 ' B' ' 85' ' ' ILE . 3.7 t80 -146.62 -68.76 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.813 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.2 m-20 60.47 131.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.389 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' HB2' HD12 ' B' ' 85' ' ' ILE . 5.6 t-20 -108.0 159.81 16.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.924 0.392 . . . . 0.0 110.867 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.796 ' OH ' HG23 ' A' ' 17' ' ' THR . 3.7 m-85 -152.18 157.44 41.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -115.29 137.94 51.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.176 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 41' ' ' ALA . 3.2 m -162.2 164.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 51' ' ' TYR . 84.8 m -155.94 99.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.483 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 76' ' ' SER . 3.1 m -98.54 117.15 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 13.5 mtm -91.37 102.12 14.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.21 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 177' ' ' LEU . 1.7 mp -87.3 107.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.5 20.84 77.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.39 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -141.67 100.47 6.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.949 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.38 155.95 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.501 2.134 . . . . 0.0 112.196 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.67 ' H ' HG23 ' A' ' 43' ' ' THR . 2.3 m-85 -154.16 169.63 23.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 111.327 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.05 97.22 4.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.321 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -105.04 161.26 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.045 0.45 . . . . 0.0 111.375 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.833 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -160.27 127.3 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.057 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.043 HD11 HD23 ' A' ' 79' ' ' LEU . 1.8 mm? -75.93 103.23 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.9 103.0 12.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.022 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 58' ' ' THR . 1.5 m-20 -78.19 142.57 37.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 57' ' ' ASP . 2.2 p -167.72 178.68 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . . . -127.17 -66.71 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . 104.06 54.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.757 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.668 HD12 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER 170.48 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 111.324 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HG3' HD12 ' A' ' 61' ' ' LEU . 22.7 mt-10 -85.79 89.96 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.186 0.517 . . . . 0.0 111.886 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 61.71 13.66 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.02 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.838 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 93.7 m-85 -102.62 -29.07 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.186 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -49.21 -27.37 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -93.49 -31.54 14.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.699 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -94.02 24.16 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.803 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -85.31 -46.31 0.63 Allowed Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.205 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.7 Cg_exo -50.16 -23.15 9.14 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.834 HD22 ' CG ' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -76.24 -26.05 55.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.339 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.447 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 2.3 m -92.62 -23.42 19.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.086 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 2.0 p90 46.29 102.7 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.501 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.81 -34.28 8.29 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.657 2.238 . . . . 0.0 112.663 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.83 -10.66 50.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.563 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.803 HG21 HG13 ' A' ' 7' ' ' VAL . 8.3 t -38.42 -51.66 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.2 OUTLIER 167.97 -165.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.942 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.9 p -58.44 162.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.5 135.46 40.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.043 HD23 HD11 ' A' ' 55' ' ' LEU . 12.6 tp -109.95 115.78 30.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.059 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 ' HB ' HD23 ' A' ' 112' ' ' LEU . 2.1 t -131.23 145.86 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.252 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.434 ' HB3' ' CA ' ' A' ' 14' ' ' VAL . 11.4 t -139.17 158.66 43.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.913 ' HB3' HG11 ' A' ' 93' ' ' VAL . 7.6 p90 -152.37 149.52 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -51.36 160.77 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.802 HG13 HG22 ' A' ' 137' ' ' ILE . 73.0 t -109.09 -69.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 125' ' ' THR . 67.0 t -52.03 -73.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.804 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.88 106.16 0.61 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD3' HG23 ' A' ' 125' ' ' THR . 68.8 Cg_endo -74.3 -25.76 13.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.528 2.152 . . . . 0.0 112.551 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.69 -24.16 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.8 m -96.15 -30.69 13.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.158 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.95 -69.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.125 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -50.47 -48.29 56.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' CA ' ' HG3' ' A' ' 96' ' ' LYS . 1.5 m-80 -53.2 -69.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.913 HG11 ' HB3' ' A' ' 82' ' ' PHE . 61.5 t -40.45 -30.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.925 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.61 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.286 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.38 8.42 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.953 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG3' ' CA ' ' A' ' 92' ' ' ASN . 21.8 mmtm -113.3 -44.79 3.2 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.611 ' HD1' HG13 ' A' ' 93' ' ' VAL . 10.4 m95 -95.55 -36.79 11.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.506 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 94.1 t -52.5 -44.74 95.2 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.511 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 52.9 Cg_exo -52.51 -28.47 36.35 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.288 1.992 . . . . 0.0 112.288 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -77.94 -22.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.173 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 80' ' ' VAL . 21.6 mm -49.17 -31.29 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -85.01 -24.87 28.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 60' ' ' GLY . 9.9 t60 -65.78 -37.22 85.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -103.71 -19.66 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.256 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 12.2 m -152.88 74.49 7.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.761 0.315 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -12.57 33.29 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.617 2.211 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.57 21.16 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.255 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 135.67 25.04 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.81 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.85 159.63 4.87 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.498 2.132 . . . . 0.0 112.148 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 16.5 p90 -135.76 134.93 39.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 154' ' ' TYR . 4.6 mt -111.85 122.03 46.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' CE2' ' A' ' 82' ' ' PHE . 12.4 mt -91.15 162.94 14.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' PHE . 49.0 t -152.79 141.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.1 104.45 0.35 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.392 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 157' ' ' CYS . 71.1 p -137.84 137.56 38.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER 177.32 71.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 pt -98.69 -22.65 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -94.7 -24.41 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 116' ' ' GLN . 5.9 tt -75.15 -27.91 59.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.62 ' CB ' HG21 ' A' ' 85' ' ' VAL . 1.1 ptp180 -50.22 139.66 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.65 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.023 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -54.16 120.94 27.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.2 -41.42 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 t -49.53 -31.67 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD12 ' A' ' 129' ' ' LEU . 85.7 m -56.83 -58.98 5.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -51.38 -45.34 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -42.53 61.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.37 -37.27 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 125' ' ' THR . 4.4 mt -50.71 -25.51 4.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.496 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.62 -20.46 53.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.21 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -81.3 -27.03 35.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -86.8 -8.36 57.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.454 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? 62.89 26.45 15.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -100.84 -26.33 13.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.77 168.39 0.12 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.27 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.555 2.17 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.802 HG22 HG13 ' A' ' 84' ' ' VAL . 5.6 mt -51.52 135.37 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.224 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -132.31 177.75 2.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -53.35 -21.15 16.94 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -88.64 -42.34 12.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.499 ' HB ' HG23 ' A' ' 137' ' ' ILE . 22.7 m -50.88 -46.75 60.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.27 -40.43 58.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -43.87 97.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.768 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -51.55 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.799 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.78 -44.42 77.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -60.47 -31.38 70.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.86 -44.11 86.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.753 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.53 -50.64 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.886 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -68.14 -27.32 66.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.5 OUTLIER 70.59 108.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.0 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.82 -162.04 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 152' ' ' VAL . 57.3 t -67.34 -11.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.678 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 73.87 139.77 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.703 0.287 . . . . 0.0 110.86 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 24.6 p90 -153.11 162.64 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 155' ' ' VAL . 26.9 m -158.32 124.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.624 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -171.06 166.37 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.574 ' O ' HG21 ' A' ' 115' ' ' THR . 18.2 p -113.82 -173.13 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.217 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.413 ' CA ' ' HB ' ' A' ' 115' ' ' THR . 8.4 t -87.61 166.81 14.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.898 0.38 . . . . 0.0 111.029 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.664 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.16 -174.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.412 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.664 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.4 mm? 67.72 -64.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 166.14 11.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.873 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -142.01 122.94 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -105.07 -37.33 6.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 165.44 79.87 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.873 HD11 ' NE2' ' A' ' 162' ' ' GLN . 4.0 mt -83.89 -25.14 30.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 111.029 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -52.78 -31.46 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 166' ' ' LYS . 12.1 m-80 -65.28 -65.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.74 -27.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CE2' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -74.3 -35.13 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.272 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.444 ' CB ' HG13 ' B' ' 75' ' ' ILE . 5.1 t70 -63.26 -37.93 89.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.516 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 -25.6 25.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.769 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.52 -32.99 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.054 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 46' ' ' ILE . 31.6 mm -94.8 -23.71 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 3.8 tt -72.5 -45.96 56.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.38 -32.87 71.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.553 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -90.63 -19.67 23.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -47.47 -41.54 20.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.151 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 50.51 81.83 0.25 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.84 102.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.73 135.75 71.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.588 2.192 . . . . 0.0 112.262 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.08 145.86 31.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.29 74.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.557 2.171 . . . . 0.0 112.257 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.26 129.53 54.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.881 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.06 -83.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 46' ' ' ILE . 8.4 mm -91.67 140.03 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.481 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.9 m -128.38 139.58 52.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -75.88 138.73 69.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.551 ' CB ' HG12 ' A' ' 42' ' ' VAL . 65.6 Cg_exo -51.3 146.85 22.98 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.54 2.16 . . . . 0.0 112.461 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 30.8 t -108.41 -51.3 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 1.5 t0 -77.49 167.88 20.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 6.5 t80 171.41 124.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -153.19 132.38 12.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 111.382 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -68.91 95.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.472 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -74.51 -62.86 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.576 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.513 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -116.87 113.94 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.888 0.375 . . . . 0.0 111.499 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.08 96.91 7.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.198 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.463 HG22 ' HD3' ' B' ' 100' ' ' PRO . 39.4 t -79.31 137.77 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.445 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -133.14 177.56 18.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.329 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -77.26 136.48 38.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' B' ' 97' ' ' THR . 10.0 t0 -124.21 110.1 14.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.11 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.752 HG12 HG23 ' B' ' 93' ' ' THR . 48.9 t -40.98 -48.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.848 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.752 HG23 HG12 ' B' ' 92' ' ' VAL . 3.4 p -155.48 50.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 47.73 33.42 9.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.421 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' B' ' 90' ' ' ASP . 11.8 pt-20 -118.31 -178.01 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.784 0.325 . . . . 0.0 110.79 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.802 ' HE2' HD13 ' A' ' 67' ' ' LEU . 2.3 m-85 -101.95 164.23 11.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.503 HG22 HD13 ' B' ' 112' ' ' ILE . 19.4 p -109.78 168.86 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.92 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.423 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 48.71 27.58 6.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.568 ' CE ' HD21 ' A' ' 67' ' ' LEU . 2.7 mtp -52.64 131.11 46.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.593 0.235 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.483 ' CA ' HG21 ' B' ' 85' ' ' ILE . 81.3 Cg_exo -49.5 145.74 15.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.554 2.17 . . . . 0.0 112.19 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -45.59 -39.93 8.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.166 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -78.57 -51.12 10.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.525 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.555 ' HA ' HD13 ' A' ' 70' ' ' LEU . 2.6 m0 -53.76 -55.43 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 109.622 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.541 ' HB1' HE21 ' B' ' 108' ' ' GLN . . . -51.64 -62.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.841 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 15.9 ptt85 -55.95 -36.31 67.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.301 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.834 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -46.83 -63.27 1.07 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.625 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -96.2 -69.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.193 178.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.563 ' C ' HG22 ' B' ' 109' ' ' THR . 0.4 OUTLIER -80.4 -105.1 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.071 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.563 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.34 -24.14 0.0 OUTLIER 'General case' 0 C--N 1.351 0.653 0 C-N-CA 122.43 0.292 . . . . 0.0 111.361 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.432 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.0 OUTLIER -109.5 107.9 18.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.332 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -43.43 -50.81 6.85 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 110.847 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.542 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.7 OUTLIER -130.4 87.09 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 7.0 m 68.99 -63.52 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.064 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' B' ' 116' ' ' GLU . 9.4 mtpt -132.05 39.67 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.985 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m 60.8 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 114' ' ' LYS . 0.6 OUTLIER -177.89 153.98 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -93.34 97.93 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.876 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.534 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.713 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -103.15 132.43 49.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -103.49 153.22 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.002 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 3' ' ' THR . 5.4 pt -158.04 121.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.981 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 112.88 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -91.86 128.73 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.817 HG21 ' CB ' ' A' ' 71' ' ' SER . 59.1 t -107.24 159.06 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.994 0.426 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 79' ' ' LEU . 4.9 m -126.79 163.24 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 80' ' ' VAL . 3.5 t -153.68 123.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.212 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 14' ' ' VAL . . . 147.7 168.97 14.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.735 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -60.0 -152.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -40.73 141.48 0.92 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 55.89 62.48 2.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.182 0.515 . . . . 0.0 109.701 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.741 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.9 t -54.68 -19.62 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 132.6 -36.04 2.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.795 ' N ' HG11 ' A' ' 8' ' ' VAL . 7.5 mmtt -95.91 -73.71 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.237 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 188' ' ' HOH . 4.7 t -36.09 -53.06 0.79 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 5.4 p -63.8 -48.6 76.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 110.785 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 15' ' ' GLY . 12.5 mt -55.71 -72.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 55' ' ' LEU . 8.6 mt -38.09 -43.05 0.71 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.066 0.46 . . . . 0.0 111.588 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG22 ' N ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -49.4 -69.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.657 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -93.47 -54.16 3.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.157 0.503 . . . . 0.0 111.452 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.818 ' HA ' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -51.31 -21.82 2.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.411 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 77.2 m -120.63 -88.07 0.63 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.832 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.76 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 5.0 t -54.89 -30.46 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 111.219 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.6 OUTLIER 76.64 51.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.369 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -158.83 116.28 2.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.768 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -45.85 168.39 0.11 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.884 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 61.7 Cg_exo -53.05 158.32 6.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.743 2.295 . . . . 0.0 112.981 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.1 t -107.44 -76.25 0.62 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.779 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.45 108.04 19.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.377 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.8 100.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.45 . . . . 0.0 111.161 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 ' HD2' ' A' ' 34' ' ' PRO . 96.5 t -151.51 139.51 12.85 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.207 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 36' ' ' VAL . 98.1 Cg_exo -41.58 91.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.385 2.056 . . . . 0.0 112.04 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.907 HG23 ' CG ' ' A' ' 38' ' ' ASP . 93.0 m -54.25 87.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.131 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 34' ' ' PRO . 59.5 t -85.99 -24.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.398 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.6 t80 -142.39 -66.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.608 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.907 ' CG ' HG23 ' A' ' 35' ' ' THR . 6.1 m-20 53.71 107.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 41.7 t30 -107.6 153.08 23.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.794 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CE1' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.47 168.82 22.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.04 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.71 115.62 28.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.712 HG22 HD11 ' A' ' 55' ' ' LEU . 12.3 m -134.38 137.68 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.658 HG23 ' H ' ' A' ' 51' ' ' TYR . 55.1 m -136.7 108.59 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.079 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG12 ' O ' ' B' ' 76' ' ' SER . 4.8 m -98.24 117.29 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.052 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 27.2 mtm -79.4 100.98 7.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.034 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 173' ' ' ILE . 5.6 mm -87.95 91.72 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.43 16.04 74.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.709 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.09 25.8 10.9 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.736 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.0 mt-10 -124.65 131.26 24.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.554 0.216 . . . . 0.0 110.793 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 159.07 28.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.466 2.111 . . . . 0.0 112.271 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.658 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -154.04 161.51 41.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -136.44 97.42 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.531 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 53' ' ' LEU . 9.0 tt -107.34 131.76 53.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.266 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -97.17 134.24 11.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.252 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.932 HD22 ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -113.19 103.1 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.945 0.402 . . . . 0.0 110.905 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 4.1 m-85 -102.11 111.28 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.619 ' OD2' HG22 ' A' ' 17' ' ' THR . 4.5 t70 -88.01 171.4 10.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.188 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.426 ' O ' HG21 ' A' ' 14' ' ' VAL . 8.4 p -139.56 -175.7 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.715 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -101.02 -23.44 14.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.071 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . . . 74.71 51.78 7.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.359 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.0 174.89 11.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.88 30.77 2.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.1 28.81 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.877 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.8 m-85 -101.14 -11.74 19.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -43.06 -28.51 0.28 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.675 0.274 . . . . 0.0 111.592 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 3.5 mtt85 -45.02 -62.82 1.09 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.763 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.3 mp -72.33 173.5 8.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.97 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 5.2 tpp180 -101.0 -72.66 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.5 Cg_endo -71.4 -58.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.036 1.824 . . . . 0.0 113.06 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 64' ' ' TYR . 63.4 mt 50.1 25.65 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.844 0.354 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.817 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER 164.17 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.204 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.02 175.25 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 111.072 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 34.3 Cg_exo -61.9 -24.41 77.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.645 2.23 . . . . 0.0 112.17 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -68.06 -10.12 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.608 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -36.94 -32.15 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t0 51.62 -151.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.537 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 175' ' ' ALA . 40.6 t -57.56 156.2 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.692 0.282 . . . . 0.0 110.478 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -113.34 134.51 54.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.808 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.93 122.22 44.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.08 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 t -130.35 101.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.872 0.368 . . . . 0.0 111.623 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.0 t -102.99 148.1 26.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.669 ' CB ' HG11 ' A' ' 93' ' ' VAL . 38.2 p90 -137.34 124.68 21.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.008 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 p -52.96 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.2 86.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.666 HG12 ' OE1' ' A' ' 116' ' ' GLN . 30.3 m -122.92 75.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.975 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.79 148.48 0.12 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 51.9 Cg_exo -54.6 -19.34 17.88 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.749 2.299 . . . . 0.0 112.591 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 t -46.59 -73.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.39 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 93' ' ' VAL . 74.3 m -61.28 -24.57 66.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.645 ' CE1' HD13 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -51.32 -58.96 4.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.035 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -49.65 -60.72 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -53.32 -63.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' SER . 72.9 t -41.14 -29.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.959 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.9 tttt -74.84 -69.51 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.664 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.73 7.98 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.39 -43.34 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.648 0.261 . . . . 0.0 111.553 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.663 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.1 m95 -95.3 -40.12 9.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 63.5 t -52.65 -44.2 94.64 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.512 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.4 Cg_exo -59.79 -28.82 88.14 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.278 1.985 . . . . 0.0 112.235 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -24.29 60.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.7 mt -49.48 -27.81 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -76.87 -28.15 55.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -70.81 -44.8 65.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CE1' ' CD2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -89.02 -33.72 17.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 2.7 m -107.6 129.63 23.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.654 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.61 -83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.444 2.096 . . . . 0.0 112.64 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -153.52 83.68 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.854 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -151.59 163.92 22.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.854 ' HD2' HG22 ' A' ' 108' ' ' THR . 59.4 Cg_exo -52.09 130.24 34.27 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.451 2.101 . . . . 0.0 112.037 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -102.6 125.77 49.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -106.69 121.4 44.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.687 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -114.1 162.59 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.087 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 114' ' ' GLY . 3.1 t -146.84 166.3 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -161.12 101.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.529 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' GLY . 41.2 p -158.48 142.23 15.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.431 . . . . 0.0 111.238 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.666 ' OE1' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -174.79 40.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.453 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 158' ' ' SER . 10.1 mt -37.83 -37.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.838 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.59 -43.82 96.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.741 HD23 ' OD2' ' A' ' 122' ' ' ASP . 2.0 mt -86.99 -45.55 10.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 5.1 tmm_? -48.93 -26.24 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.001 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.9 46.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' A' ' 119' ' ' LEU . 2.3 m-20 -107.23 156.09 38.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.05 -49.89 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.17 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -50.05 -47.71 53.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -51.99 -31.76 30.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.218 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 24.0 mm -63.56 -54.6 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.66 -40.91 13.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.829 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -84.86 -37.84 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -49.58 -32.73 13.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.337 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.01 65.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.103 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -24.02 19.67 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.314 . . . . 0.0 110.867 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 18.7 m120 -95.98 30.19 2.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 26.65 3.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 49.19 -166.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.58 86.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.876 ' HA ' HD21 ' A' ' 129' ' ' LEU . 74.0 Cg_exo -48.38 169.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.575 2.184 . . . . 0.0 112.317 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.1 mt -94.13 130.27 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -110.75 168.42 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.962 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 48.8 Cg_exo -56.58 -17.74 23.37 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.714 2.276 . . . . 0.0 112.562 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -82.55 -32.93 28.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.194 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.3 m -56.69 -62.78 1.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.971 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.95 -50.58 26.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.2 tt0 -55.38 -39.86 70.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -53.66 -54.73 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.645 HD13 ' CE1' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -54.57 -37.15 65.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.692 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.796 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.23 -46.78 82.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -57.76 -44.68 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.626 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -22.29 14.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.037 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.563 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 2.9 pp -121.38 21.27 11.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.258 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 43.9 tttm 56.16 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.07 174.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.044 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 60.9 t -59.49 -17.76 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.46 135.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.647 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.796 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 13.6 p90 -152.9 154.82 35.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.363 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 168' ' ' VAL . 35.0 m -155.07 123.67 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.23 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.67 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.6 pt-20 -170.88 -178.68 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 111.111 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.428 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 4.8 p -127.91 -170.37 2.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.018 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.544 ' HB3' HD12 ' A' ' 117' ' ' ILE . 1.7 t -85.35 174.52 9.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.755 0.312 . . . . 0.0 110.288 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.531 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -34.36 -85.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.152 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.714 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.05 -171.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.499 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 162' ' ' GLN . 4.3 p 64.72 -67.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.836 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.1 OUTLIER 54.53 94.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 110.783 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -105.18 -67.8 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.1 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.96 77.84 0.38 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.793 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.818 HD21 ' HA ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -93.7 -29.05 15.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' B' ' 77' ' ' LEU . 4.6 mmtp -54.62 -60.25 3.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.294 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -43.31 -37.06 2.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.67 HG21 ' HB3' ' A' ' 156' ' ' GLU . 23.9 t -59.37 -62.28 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.755 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.75 ' CE1' HD21 ' B' ' 77' ' ' LEU . 66.2 m-85 -52.08 -28.94 19.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.416 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' OD1' HG21 ' B' ' 75' ' ' ILE . 1.9 m-20 -63.07 -41.8 99.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.404 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -88.62 -45.55 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 110.908 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.7 70.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.682 HG21 HD11 ' A' ' 46' ' ' ILE . 50.0 mm -86.35 -52.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.114 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 174' ' ' LEU . 3.4 tm? -55.05 -39.65 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.477 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -53.64 -47.4 70.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -81.43 -25.87 35.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.7 tp -50.85 -44.83 59.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.037 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 58.88 61.44 4.76 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.554 ' HG3' HD21 ' A' ' 174' ' ' LEU . 44.0 Cg_endo -68.18 154.54 72.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.21 152.34 61.62 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.656 2.237 . . . . 0.0 112.349 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.84 159.96 58.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.25 138.77 37.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.633 2.222 . . . . 0.0 112.306 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -56.05 160.67 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -44.38 96.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.474 HG21 ' OD1' ' A' ' 170' ' ' ASP . 7.2 tt -143.98 151.94 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -134.7 154.72 51.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.025 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.75 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -89.09 137.45 29.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.446 ' CG ' ' HB ' ' A' ' 42' ' ' VAL . 50.7 Cg_exo -55.25 -63.6 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.45 2.1 . . . . 0.0 111.793 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.88 -79.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.164 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.79 88.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.76 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -118.79 -173.12 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.02 128.97 10.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.6 85.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 110.433 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.493 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -53.87 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.515 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -120.73 154.18 24.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.4 96.75 4.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.091 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.531 HG12 ' HB ' ' A' ' 36' ' ' VAL . 86.0 t -80.18 121.65 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.462 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -125.87 177.27 17.16 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.127 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.3 138.52 39.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 111.004 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.856 ' HB2' HG23 ' B' ' 97' ' ' THR . 4.4 t0 -139.0 112.94 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.26 -14.16 60.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.646 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.596 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -41.22 -33.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.606 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.596 HG22 HG13 ' B' ' 92' ' ' VAL . 3.8 t -140.09 -37.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.445 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.96 20.96 1.59 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.71 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.34 -158.63 0.9 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.6 0.238 . . . . 0.0 110.394 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.42 ' CD1' HG11 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -103.41 164.53 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.803 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.856 HG23 ' HB2' ' B' ' 90' ' ' ASP . 11.5 p -95.73 162.53 13.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 49.1 46.18 33.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.568 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -61.53 124.36 80.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.561 0.219 . . . . 0.0 110.862 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.54 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 63.7 Cg_exo -50.62 159.66 2.1 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.366 2.044 . . . . 0.0 112.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.01 -57.26 3.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.276 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -72.51 -56.09 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.992 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.613 ' CE2' HD23 ' A' ' 70' ' ' LEU . 8.6 m0 -46.24 -55.34 7.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -54.76 -45.94 74.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.109 0.481 . . . . 0.0 110.447 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 55.0 mtp85 -58.52 -41.41 85.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.88 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -50.3 -55.88 13.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.253 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.32 -69.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.758 ' O ' HG23 ' B' ' 109' ' ' THR . 8.8 tp60 -79.14 -100.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.758 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -168.17 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.341 0.206 0 CA-C-O 120.872 0.367 . . . . 0.0 110.715 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.409 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -150.95 174.25 13.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.217 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.58 72.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.691 ' O ' HG23 ' B' ' 113' ' ' THR . 0.0 OUTLIER -57.63 88.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.621 0.725 . . . . 0.0 111.608 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.691 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 169.19 -56.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -110.33 -32.41 6.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -94.82 45.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -155.91 27.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 133.82 44.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.906 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.531 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.722 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.824 0.345 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.1 124.08 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.21 141.03 28.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.467 HG23 ' OD2' ' A' ' 76' ' ' ASP . 3.9 mt -146.7 129.34 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -131.65 95.35 3.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.568 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 3.9 t -77.35 100.44 5.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.722 HG23 ' OG1' ' A' ' 75' ' ' THR . 94.0 t -84.4 113.25 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.656 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.965 HG12 ' HB3' ' A' ' 79' ' ' LEU . 27.4 m -85.04 140.0 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.549 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 80' ' ' VAL . 11.8 p -126.49 154.88 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.679 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . 147.6 -169.19 28.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.666 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.94 29.6 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -125.12 -41.57 0.36 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 85.64 -23.68 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 81' ' ' CYS . 28.7 m -48.7 -23.83 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 111.222 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.833 ' HA3' HG23 ' A' ' 113' ' ' VAL . . . -120.56 -33.78 0.99 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.603 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 10' ' ' GLY . 44.3 mtmt -63.82 -76.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.348 . . . . 0.0 111.406 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.021 HG21 ' CG2' ' A' ' 35' ' ' THR . 17.4 p -98.24 -43.9 6.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.253 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' SG ' ' PB ' ' A' ' 185' ' ' GNP . 58.2 m -52.61 -23.82 7.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.757 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD11 ' CZ ' ' A' ' 23' ' ' TYR . 18.8 tp -61.8 -71.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.822 ' HG ' HD12 ' A' ' 55' ' ' LEU . 14.2 mt -44.12 -29.13 0.57 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.808 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.8 mm -65.79 -45.12 92.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.11 0.481 . . . . 0.0 110.369 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.535 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 78.5 p -94.93 -13.15 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.81 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.003 ' CD1' HD13 ' A' ' 165' ' ' LEU . 2.9 m-30 -95.93 -67.45 0.85 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.612 HG22 ' HB2' ' B' ' 81' ' ' PHE . 58.6 m -82.74 -81.81 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.647 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.702 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -47.23 -40.44 16.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.274 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t30 64.79 41.38 5.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.702 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -126.84 -159.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.51 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.38 155.66 76.21 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.291 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 65.1 Cg_exo -36.79 132.47 0.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.017 2.478 . . . . 0.0 113.118 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m -97.91 -82.83 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.556 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.78 108.77 20.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.265 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HA ' ' O3G' ' A' ' 185' ' ' GNP . 1.4 t80 -66.45 109.29 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.294 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.4 p -160.63 133.23 4.47 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.383 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 36' ' ' VAL . 90.5 Cg_exo -41.26 93.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.353 2.035 . . . . 0.0 111.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 1.021 ' CG2' HG21 ' A' ' 17' ' ' THR . 23.8 m -53.07 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.328 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' B' ' 96' ' ' PHE . 2.2 t -77.48 -24.6 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 39' ' ' ASN . 4.2 t80 -150.56 -75.49 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.699 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.748 ' CG ' HG23 ' A' ' 35' ' ' THR . 5.7 m-20 60.27 117.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.778 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.579 ' CB ' HD12 ' B' ' 85' ' ' ILE . 16.0 t-20 -107.13 156.66 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.557 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.06 168.97 22.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.258 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.31 138.76 53.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.0 m -147.04 131.45 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.2 m -116.66 103.12 10.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.708 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.883 HG22 ' HD3' ' B' ' 78' ' ' PRO . 40.6 t -98.91 121.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.041 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 37.3 mtm -87.05 100.09 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.011 HD12 ' CZ ' ' A' ' 51' ' ' TYR . 14.1 mt -98.3 93.82 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 17.34 79.93 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.364 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 35.52 5.43 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.655 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -141.19 128.33 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.483 0.182 . . . . 0.0 110.928 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 168.7 3.24 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.05 . . . . 0.0 112.232 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.011 ' CZ ' HD12 ' A' ' 46' ' ' ILE . 2.4 m-85 -147.96 156.08 42.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 p -130.52 99.93 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 54' ' ' GLY . 10.4 tt -133.53 160.56 37.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.783 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -153.4 149.27 20.76 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HG ' ' A' ' 20' ' ' LEU . 16.3 mt -99.14 104.11 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.767 0.318 . . . . 0.0 111.214 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' A' ' 7' ' ' VAL . 5.5 m-85 -83.39 112.66 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB3' ' CA ' ' A' ' 37' ' ' PHE . 7.2 t70 -66.93 134.09 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 111.237 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -145.12 155.33 43.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.765 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.46 -176.37 4.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.212 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.54 -110.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tp 50.29 -161.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.366 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -132.52 40.0 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -131.69 21.04 4.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 58' ' ' THR . 2.7 m-85 -111.34 -27.99 8.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.866 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.74 -41.28 22.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.692 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.825 ' HG3' HD12 ' A' ' 67' ' ' LEU . 4.1 ptp85 -69.06 -36.7 77.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.404 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD12 ' HG3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -98.0 29.05 3.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.576 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 2.6 tpt180 -88.73 -66.12 0.16 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 87.5 Cg_exo -37.27 -31.28 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.844 2.363 . . . . 0.0 112.827 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -51.99 -31.53 29.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.722 ' CB ' HG21 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -91.8 -25.47 19.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.9 OUTLIER 50.47 170.45 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.748 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.2 Cg_exo -68.67 -20.78 40.04 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.075 2.517 . . . . 0.0 112.666 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -65.52 -10.95 39.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.512 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.5 t -48.71 -23.82 1.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.661 0.267 . . . . 0.0 111.639 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' OD2' HG23 ' A' ' 4' ' ' ILE . 4.2 m-20 77.25 -152.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.67 148.85 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-O 120.757 0.313 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 7' ' ' VAL . 4.6 m-85 -100.39 131.92 46.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.965 ' HB3' HG12 ' A' ' 8' ' ' VAL . 48.9 tp -103.74 115.97 31.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.137 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' VAL . 4.6 t -110.38 150.76 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 111.799 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 31.4 p -92.75 170.73 9.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -161.86 101.34 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.385 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.464 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 41.9 t -68.33 129.92 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 142' ' ' ALA . 27.4 m -121.51 49.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.299 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -115.68 -69.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.953 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -100.2 103.44 23.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.733 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 80.2 Cg_exo -44.8 -27.61 2.5 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.584 2.189 . . . . 0.0 112.504 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -64.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.8 m -58.33 -34.95 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CE1' ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -45.61 -41.35 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.263 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.77 -61.26 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.735 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.4 m-20 -59.63 -38.68 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 89' ' ' SER . 92.5 t -47.5 -52.75 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.461 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.2 tttm -65.16 -47.83 75.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.479 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -82.36 8.17 12.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.36 -37.41 2.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.67 0.271 . . . . 0.0 111.558 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.801 ' CE3' HG13 ' A' ' 93' ' ' VAL . 22.6 m0 -92.28 -28.93 16.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.67 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.804 ' O ' HG22 ' A' ' 101' ' ' ILE . 33.1 t -74.47 -44.09 5.62 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 27.0 Cg_exo -62.34 -23.11 74.98 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.321 2.014 . . . . 0.0 112.345 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.9 -14.9 27.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.618 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -46.62 -33.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 111.388 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.7 p -81.06 -34.19 32.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -61.9 -27.29 68.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.44 -24.58 9.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 101' ' ' ILE . 2.1 m -120.62 92.02 47.5 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 55.9 Cg_endo -70.18 99.33 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.634 2.223 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 44.29 41.55 4.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.559 HG23 ' HD2' ' A' ' 109' ' ' PRO . 53.4 m -117.64 142.2 30.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.742 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 108' ' ' THR . 6.9 Cg_endo -49.28 133.86 30.58 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.109 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.852 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.8 p90 -115.45 149.54 37.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.996 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.07 148.03 46.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.044 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 tp -116.03 142.26 47.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.628 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.879 HG12 ' OE1' ' A' ' 156' ' ' GLU . 1.4 m -153.54 176.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.32 138.13 6.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.4 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.702 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -158.35 153.13 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.039 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.601 ' CB ' HG13 ' A' ' 85' ' ' VAL . 28.5 mm-40 -151.84 98.42 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.652 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.854 HD11 ' HB2' ' A' ' 157' ' ' CYS . 2.8 mt -90.44 -46.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -25.81 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.535 HD12 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -77.22 -43.09 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -52.2 -29.03 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.864 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.17 47.01 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.982 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -89.05 140.93 29.1 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.793 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.75 -36.56 33.38 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -82.63 -30.43 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.771 HG22 ' CD1' ' A' ' 129' ' ' LEU . 61.1 m -56.03 -63.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.7 mp -50.53 -39.16 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.1 -55.87 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.711 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.76 45.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.57 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.809 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.33 -26.28 4.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 110.368 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.69 -24.13 63.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.802 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -84.15 -22.76 30.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 9.1 m-80 -93.92 30.05 1.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.042 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt 70.58 28.21 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -160.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.44 82.57 0.17 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.809 ' HA ' HD21 ' A' ' 129' ' ' LEU . 54.1 Cg_exo -52.46 166.69 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 84' ' ' VAL . 4.8 mt -101.59 122.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.457 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.1 p -112.98 176.51 1.46 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.6 Cg_exo -54.56 -20.37 20.89 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.607 2.205 . . . . 0.0 112.371 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.72 -47.94 15.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.0 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.473 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.9 m -51.18 -49.83 60.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -53.2 -50.01 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.33 -35.63 77.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.809 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.02 -59.09 4.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.767 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.8 tp -61.82 -27.29 68.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 154' ' ' TYR . . . -73.2 -31.89 64.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.47 -45.51 65.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -23.07 25.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.049 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.806 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 4.5 pp -108.48 -16.55 14.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt 75.12 -69.73 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.757 0.313 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 -172.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 152' ' ' VAL . 62.1 t -68.29 -8.95 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.748 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.49 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.977 0.417 . . . . 0.0 111.003 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CZ ' ' HB1' ' A' ' 146' ' ' ALA . 2.8 p90 -153.47 154.54 34.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.332 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.653 ' H ' HG22 ' A' ' 168' ' ' VAL . 2.6 m -158.2 124.47 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.769 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.879 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -171.18 166.65 7.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.413 . . . . 0.0 111.412 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.854 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.7 p -123.48 -173.63 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.22 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 116' ' ' GLN . 3.6 p -88.2 162.86 16.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.91 -173.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER 52.14 30.14 7.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.02 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.04 -68.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.554 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.1 OUTLIER 60.82 105.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -102.3 -64.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.11 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.13 88.82 0.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.604 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.003 HD13 ' CD1' ' A' ' 23' ' ' TYR . 2.4 mt -93.95 -10.86 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.553 0.216 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -57.7 -41.13 81.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 110.332 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.402 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 4.0 m-80 -57.8 -50.97 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 155' ' ' VAL . 55.6 t -52.33 -66.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.179 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.402 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -49.15 -40.73 33.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.559 ' HA ' HD13 ' B' ' 75' ' ' ILE . 48.4 t0 -50.14 -55.49 14.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -48.81 66.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.83 -28.97 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.096 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 46' ' ' ILE . 26.0 mm -93.57 -27.67 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -26.4 62.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -59.12 5.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.29 52.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 177' ' ' LEU . 5.9 tt -48.97 -26.32 2.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.86 143.01 23.78 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.94 158.04 3.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.562 2.175 . . . . 0.0 112.404 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.73 176.57 4.98 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.178 . . . . 0.0 112.223 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 182' ' ' PRO . 3.9 mt-10 -72.0 -62.82 1.45 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 181' ' ' GLU . 59.4 Cg_endo -72.19 61.9 3.33 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.571 2.18 . . . . 0.0 112.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 146.37 21.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.4 tptp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.918 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.68 -85.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.754 HD11 HG11 ' A' ' 44' ' ' VAL . 8.3 tt -135.12 151.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.088 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.611 ' O ' HG13 ' A' ' 44' ' ' VAL . 40.1 t -134.78 148.72 50.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.159 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.17 88.44 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.635 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.883 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.4 Cg_endo -52.42 -172.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.61 2.207 . . . . 0.0 112.004 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.406 ' O ' ' N ' ' B' ' 81' ' ' PHE . 34.4 p -165.93 -40.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.204 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 71.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.612 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.2 t80 -93.35 139.58 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -153.37 129.26 10.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 78.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 110.372 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.542 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.642 HG21 ' HA ' ' B' ' 100' ' ' PRO . 0.5 OUTLIER -131.16 101.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.561 0.219 . . . . 0.0 111.395 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . 0.456 ' O ' ' CD2' ' B' ' 86' ' ' HIS . 13.5 p-80 -85.4 96.78 9.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 110.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.51 HG12 ' N ' ' B' ' 88' ' ' GLY . 88.0 t -78.43 158.69 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.243 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.51 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -143.18 171.18 25.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.099 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -97.37 116.04 28.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.903 0.383 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.697 ' CB ' HG23 ' B' ' 97' ' ' THR . 49.9 t0 -136.51 124.06 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.23 0.72 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.976 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.848 HG13 HG23 ' B' ' 93' ' ' THR . 7.2 p -43.66 -29.09 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.861 0.362 . . . . 0.0 111.368 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.848 HG23 HG13 ' B' ' 92' ' ' VAL . 1.4 p -155.4 25.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.803 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.38 20.68 65.73 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.426 ' CD ' ' HG1' ' B' ' 93' ' ' THR . 17.5 pt-20 -125.29 -163.25 1.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.779 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.1 m-85 -105.04 164.57 11.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.697 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.3 p -98.72 144.11 28.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' HB ' ' B' ' 113' ' ' THR . . . 74.51 45.18 24.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.603 ' HE1' HD21 ' A' ' 67' ' ' LEU . 2.4 tpt -49.95 105.67 0.54 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.619 0.247 . . . . 0.0 110.998 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.642 ' HA ' HG21 ' B' ' 85' ' ' ILE . 74.2 Cg_exo -48.88 144.32 15.47 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.481 2.12 . . . . 0.0 112.22 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -46.87 -47.29 21.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.176 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.53 -65.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.066 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.812 ' CE3' HD23 ' A' ' 67' ' ' LEU . 4.0 m0 -49.51 -53.51 22.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.599 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.566 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -52.62 -67.81 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.166 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 2.8 mtt-85 -51.24 -32.79 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.812 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.79 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -49.79 -57.64 6.95 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.685 HD21 ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -95.54 -72.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.952 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.565 ' C ' HG22 ' B' ' 109' ' ' THR . 2.8 pt20 -81.98 -113.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.229 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.565 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 158.75 65.78 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.499 0.32 . . . . 0.0 111.071 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.443 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER 170.07 125.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 111.345 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.4 OUTLIER -84.98 75.34 10.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.332 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -57.96 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.604 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 1.2 m 158.76 -46.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.819 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -98.05 -27.74 14.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.5 t -50.2 160.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.6 -170.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -74.58 152.1 39.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.899 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.555 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -67.25 121.31 15.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.26 151.83 18.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -144.55 120.44 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.9 143.18 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.1 m -136.04 155.3 50.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.795 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.861 HG21 ' CB ' ' A' ' 71' ' ' SER . 41.9 t -138.19 158.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.633 HG13 ' OG1' ' A' ' 58' ' ' THR . 7.7 p -110.95 160.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.175 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' N ' HG22 ' A' ' 8' ' ' VAL . 7.4 p -151.53 133.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.57 177.25 16.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -76.98 117.82 18.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.56 178.69 16.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.342 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 18' ' ' CYS . . . -131.57 0.41 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 113' ' ' VAL . 3.8 t -54.81 -20.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.475 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.9 -109.3 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.452 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HE2' HD23 ' A' ' 79' ' ' LEU . 3.9 mptp? -98.86 -53.88 3.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.577 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -43.85 -77.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.559 ' H ' HG23 ' A' ' 17' ' ' THR . 40.0 t -66.19 -24.72 66.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.953 0.406 . . . . 0.0 111.351 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 23' ' ' TYR . 15.4 tp -63.08 -72.78 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.357 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.995 HD11 HD23 ' A' ' 55' ' ' LEU . 1.3 mm? -41.59 -38.26 1.32 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 110.944 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.646 ' O ' HG22 ' A' ' 25' ' ' THR . 0.4 OUTLIER -49.37 -68.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.64 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -93.76 -50.21 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 112.001 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' A' ' 19' ' ' LEU . 2.6 t80 -53.75 -31.66 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 94.5 m -108.91 -87.7 0.5 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.551 -0.459 . . . . 0.0 112.119 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 21' ' ' ILE . 1.8 t -55.09 -24.75 27.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.558 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' SER . 17.6 t-20 72.21 51.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.806 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 21' ' ' ILE . 8.6 pttt -135.15 -167.48 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.512 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -124.72 154.33 70.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.794 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 88.0 Cg_exo -41.5 146.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.848 2.365 . . . . 0.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -103.01 -81.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.779 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.67 114.94 26.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.746 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.2 t80 -67.88 107.81 2.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.027 0.441 . . . . 0.0 110.959 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG13 ' HD2' ' A' ' 34' ' ' PRO . 97.2 t -158.7 140.12 9.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.281 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.1 Cg_exo -43.51 91.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.381 2.054 . . . . 0.0 111.898 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.577 HG21 ' HB ' ' A' ' 17' ' ' THR . 23.3 m -52.5 89.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.271 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' PRO . 25.2 t -95.6 22.39 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.416 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.2 t80 168.04 -80.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.178 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER 54.54 109.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.728 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.4 t30 -107.42 168.38 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD2' ' CE2' ' B' ' 81' ' ' PHE . 0.5 OUTLIER -153.12 168.91 24.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.423 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.64 124.09 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.725 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 53' ' ' LEU . 27.4 m -150.15 138.44 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.855 0.359 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 51' ' ' TYR . 32.0 m -136.92 108.21 6.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.062 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.713 HG12 ' O ' ' B' ' 76' ' ' SER . 2.6 m -98.05 116.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.148 0.499 . . . . 0.0 110.562 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 100.36 13.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.767 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 46' ' ' ILE . 2.9 mm -72.81 90.7 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.6 77.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 35.34 4.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.33 93.28 36.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.12 121.15 6.41 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.728 ' O ' HG23 ' A' ' 43' ' ' THR . 1.4 m-30 -117.34 162.62 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 52' ' ' THR . 2.7 t -112.88 97.24 6.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.572 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 54' ' ' GLY . 1.2 tt -107.72 160.1 15.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.063 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -155.12 100.89 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.365 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HD11 ' A' ' 20' ' ' LEU . 1.4 mm? -78.17 126.98 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' ' OH ' ' A' ' 72' ' ' TYR . 3.4 m-85 -108.7 111.06 22.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.607 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' CB ' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -74.27 -163.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.933 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.633 ' OG1' HG13 ' A' ' 8' ' ' VAL . 69.4 p -159.48 169.02 24.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . -73.45 -37.98 65.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 27.02 22.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -137.59 23.53 2.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.728 0.299 . . . . 0.0 111.026 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 48.56 27.85 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.04 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.892 ' HB2' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -98.76 26.74 5.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.917 ' CD2' HD13 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -88.76 -22.26 23.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -43.94 -28.88 0.5 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -49.55 -60.48 2.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.848 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 70' ' ' LEU . 1.9 mp -65.84 -176.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.383 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.55 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -100.85 -63.67 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 59.3 Cg_endo -95.42 -59.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.338 2.025 . . . . 0.0 113.001 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.917 HD13 ' CD2' ' A' ' 64' ' ' TYR . 23.3 mt 62.52 -76.41 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 120.838 0.351 . . . . 0.0 110.761 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.861 ' CB ' HG21 ' A' ' 7' ' ' VAL . 25.6 p -90.98 -14.38 31.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.037 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 49.34 173.31 0.02 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.56 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 72' ' ' TYR . 16.3 Cg_exo -68.0 -23.3 40.64 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.839 2.359 . . . . 0.0 112.282 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -11.95 50.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.1 t -47.49 -25.7 1.16 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.613 0.244 . . . . 0.0 111.506 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 47.33 -91.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.035 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 78' ' ' PHE . 44.9 t -95.37 161.23 2.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.553 0.216 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG12 ' A' ' 77' ' ' VAL . 9.4 m-85 -122.77 147.07 46.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 113' ' ' VAL . 1.9 mm? -103.91 147.15 27.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.065 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.32 97.18 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.899 0.38 . . . . 0.0 111.329 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.6 p -68.09 100.83 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.543 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' A' ' 93' ' ' VAL . 38.6 p90 -116.84 144.02 45.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 111.164 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.14 164.4 24.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 115' ' ' THR . 32.2 m -131.63 42.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.993 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 m -111.45 72.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.99 153.65 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.045 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 90' ' ' PHE . 27.5 Cg_exo -61.51 -13.72 31.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.681 2.254 . . . . 0.0 112.58 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.6 t -43.41 -71.79 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 93' ' ' VAL . 45.9 m -80.77 -26.91 36.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.546 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 1.7 t80 -47.67 -61.4 1.96 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.049 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -50.23 -54.44 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -54.26 -45.67 72.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 89' ' ' SER . 98.4 t -47.59 -50.04 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.414 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.3 mtmt -78.26 -44.42 25.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.422 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -77.84 5.32 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -126.48 -36.97 2.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.613 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -95.31 -41.96 8.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 94' ' ' LYS . 46.1 t -49.87 -44.49 78.41 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.359 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_exo -55.05 -31.08 73.26 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.284 1.989 . . . . 0.0 111.957 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.7 -17.33 26.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.102 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -45.33 -31.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.861 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.2 p -71.13 -42.91 68.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.444 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -52.21 -36.15 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.329 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.472 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m80 -89.95 -36.68 14.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 17.3 t -98.02 115.61 65.74 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.36 -63.78 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.428 2.086 . . . . 0.0 112.475 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.7 34.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.87 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -109.4 160.17 28.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.87 ' HD2' HG22 ' A' ' 108' ' ' THR . 50.0 Cg_exo -53.46 169.55 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.539 2.16 . . . . 0.0 112.392 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -127.39 143.28 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.12 124.29 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.949 HD12 ' OH ' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.32 162.56 14.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.712 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 79' ' ' LEU . 15.1 m -155.6 121.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.196 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.54 168.43 13.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.346 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.922 HG21 ' N7 ' ' A' ' 185' ' ' GNP . 12.8 t -172.51 -165.4 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.786 0.327 . . . . 0.0 110.984 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.904 ' HG2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 66.73 94.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.875 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 157' ' ' CYS . 50.8 mt -98.61 -40.26 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.059 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.85 -27.84 66.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.904 HD12 ' HG2' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -62.22 -58.62 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.55 161.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.4 27.0 5.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -83.86 160.02 59.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.22 -38.37 61.17 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.535 2.157 . . . . 0.0 112.328 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -87.75 -29.76 20.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.0 m -53.17 -61.19 2.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -57.71 -37.66 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -58.42 4.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.57 -33.87 62.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.562 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.703 HD21 ' N ' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -50.48 -26.21 4.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.512 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.39 -24.01 66.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.798 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -94.1 -17.97 22.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -92.56 22.29 4.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.744 0.307 . . . . 0.0 111.093 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 10.7 mmmm 69.29 39.54 1.65 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.852 0.358 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 12.7 pt20 47.38 -163.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.088 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt 64.65 84.56 0.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.703 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.5 Cg_endo -69.52 -177.62 1.88 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.637 2.225 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 3.9 mm -94.81 105.3 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.6 p -99.04 167.89 10.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 64.7 Cg_exo -51.77 -27.6 27.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.739 2.292 . . . . 0.0 112.179 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -91.15 -28.68 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 95.2 m -49.15 -48.63 44.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.14 -59.82 3.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.4 OUTLIER -50.47 -36.05 31.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -51.04 67.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.522 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.529 HD21 ' HE2' ' A' ' 94' ' ' LYS . 16.5 tp -58.08 -34.22 69.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.491 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.881 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -58.06 -58.0 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.975 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -51.79 -41.23 61.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.815 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -51.26 -29.88 15.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ALA . 1.1 pp -126.69 21.92 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.75 -86.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 149' ' ' LEU . . . 57.36 -178.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 152' ' ' VAL . 38.9 t -70.37 -7.67 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.76 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 77.03 151.02 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.853 0.358 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.949 ' OH ' HD12 ' A' ' 112' ' ' LEU . 8.2 p90 -152.63 148.49 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.08 124.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.289 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.31 172.3 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.747 ' HB3' HD11 ' A' ' 117' ' ' ILE . 2.3 m -131.57 -173.54 3.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -87.76 158.75 18.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.971 0.415 . . . . 0.0 111.038 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.63 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -53.57 -172.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.5 mm? 67.14 -66.76 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.744 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 159' ' ' ALA . 10.0 p -76.13 -79.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.842 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.753 HE21 HD11 ' A' ' 165' ' ' LEU . 1.2 tt0 68.28 116.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -99.07 -67.96 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.71 96.04 0.14 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.455 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.753 HD11 HE21 ' A' ' 162' ' ' GLN . 0.2 OUTLIER -92.83 -10.77 35.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.494 0.188 . . . . 0.0 111.315 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -54.88 -40.9 70.22 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.445 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 42.5 m-80 -55.51 -65.95 0.5 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 155' ' ' VAL . 7.4 p -51.41 -39.24 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CD2' ' HG ' ' B' ' 77' ' ' LEU . 0.1 OUTLIER -54.22 -43.27 70.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.492 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' HD13 ' B' ' 75' ' ' ILE . 22.9 t0 -62.56 -45.98 90.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 14.8 mm-40 -59.03 -26.07 64.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.878 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.33 -61.28 2.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 173' ' ' ILE . 1.3 mp -67.65 -56.92 11.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.533 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 4.6 tp -50.92 -25.83 5.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.951 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.75 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -60.01 -60.91 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.072 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.92 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.9 -26.97 60.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 57.01 88.71 0.12 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.15 152.53 72.48 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.526 2.15 . . . . 0.0 112.321 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.96 129.11 17.83 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.612 2.208 . . . . 0.0 112.36 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 4.0 pt-20 -108.91 98.32 29.16 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.47 119.76 6.7 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.491 2.127 . . . . 0.0 112.245 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -62.44 167.31 4.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.92 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 21.4 m 63.73 -75.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.856 0.36 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 170' ' ' ASP . 6.2 tt -142.8 151.55 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 t -125.61 140.08 53.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.219 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -72.63 134.56 81.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.425 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 64.5 Cg_exo -50.56 148.01 16.24 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.393 2.062 . . . . 0.0 112.169 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 4.3 t -112.29 -34.73 5.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -77.21 164.66 25.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.503 ' CE2' ' CD2' ' A' ' 40' ' ' TYR . 8.0 t80 175.69 118.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.475 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -149.32 133.69 17.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.055 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' B' ' 86' ' ' HIS . 1.4 t-160 -68.98 86.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.643 ' OG1' HD12 ' B' ' 85' ' ' ILE . 38.9 p -69.39 -74.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.468 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.757 HG23 ' OE2' ' B' ' 116' ' ' GLU . 0.9 OUTLIER -115.97 111.51 35.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.763 0.316 . . . . 0.0 111.74 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . 0.438 ' HB3' ' NE2' ' B' ' 83' ' ' HIS . 5.2 p80 -98.92 96.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.865 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 22.1 t -83.39 132.5 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -132.69 177.91 18.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.487 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -76.82 115.89 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.886 ' OD1' HG23 ' B' ' 92' ' ' VAL . 24.5 t0 -107.41 117.64 34.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -10.37 59.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.886 HG23 ' OD1' ' B' ' 90' ' ' ASP . 58.5 t -45.73 -50.02 3.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.664 0.269 . . . . 0.0 111.598 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 93' ' ' THR . 14.2 t -154.06 56.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.11 27.31 5.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.405 ' CD ' HG22 ' B' ' 93' ' ' THR . 20.9 pt-20 -118.75 -177.66 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.722 0.296 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.445 ' HB3' HG12 ' B' ' 87' ' ' VAL . 6.2 m-85 -97.24 164.79 12.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.545 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.0 OUTLIER -95.21 156.8 16.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.754 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.476 ' HA2' ' CG2' ' B' ' 113' ' ' THR . . . 49.94 52.32 26.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.503 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.636 ' HE1' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -63.52 121.37 69.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 103' ' ' TRP . 79.4 Cg_exo -46.07 162.34 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.175 1.917 . . . . 0.0 111.794 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -42.7 -64.2 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.822 0.344 . . . . 0.0 111.597 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -45.77 64.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.572 ' HB3' HD21 ' A' ' 67' ' ' LEU . 11.6 m0 -52.86 -46.49 67.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.35 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -61.48 -63.18 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.952 0.406 . . . . 0.0 110.666 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.6 mtp180 -51.24 -34.51 32.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.541 HD21 ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -50.05 -58.12 6.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.873 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.616 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.28 -69.82 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.56 ' O ' HG23 ' B' ' 109' ' ' THR . 5.1 tt0 -79.03 -98.5 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 108' ' ' GLN . 23.5 p -160.53 -35.57 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.415 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.5 OUTLIER -166.33 169.04 14.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 111.703 -178.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.43 ' ND2' ' OG ' ' B' ' 115' ' ' SER . 8.0 p30 -68.2 67.89 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.646 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.528 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.3 OUTLIER -56.71 87.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.869 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.476 ' CG2' ' HA2' ' B' ' 98' ' ' GLY . 1.8 t 160.78 42.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.94 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.43 ' OG ' ' ND2' ' B' ' 111' ' ' ASN . 1.0 OUTLIER 47.75 38.67 8.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 111.07 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.757 ' OE2' HG23 ' B' ' 85' ' ' ILE . 2.7 mp0 71.83 152.67 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -59.05 148.94 29.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.982 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 tttt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.878 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.922 ' N7 ' HG21 ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.824 0.345 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' OE1' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -78.71 158.26 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.792 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 m -136.3 118.15 15.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.507 HD11 ' OE1' ' A' ' 2' ' ' GLN . 1.3 mp -126.41 149.39 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 12.1 mmtp -135.81 95.42 3.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.568 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.0 m -77.45 154.57 32.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 56' ' ' PHE . 53.0 t -136.43 159.22 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.048 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 57' ' ' ASP . 12.5 p -100.86 159.12 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 8' ' ' VAL . 13.0 p -150.53 129.04 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.035 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.74 139.86 4.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.448 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.4 m-20 -69.98 71.72 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -156.73 -148.24 5.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.774 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . -148.91 -35.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.949 HG11 ' HA2' ' A' ' 114' ' ' GLY . 20.3 t -47.7 -23.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 113' ' ' VAL . . . -52.08 -105.22 0.01 OUTLIER Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.586 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.839 ' HG2' HD23 ' A' ' 55' ' ' LEU . 41.5 mttm -95.61 -56.05 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -44.26 -75.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.972 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.748 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 35.4 t -55.74 -39.68 71.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.538 HD11 ' CG ' ' A' ' 23' ' ' TYR . 5.1 tp -54.16 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.15 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.023 HD21 HD22 ' A' ' 55' ' ' LEU . 74.9 mt -39.89 -38.16 0.65 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -54.05 -69.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.149 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.495 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -91.31 -34.05 15.08 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.538 ' CG ' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -72.6 -45.75 57.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.557 ' OG1' HD23 ' A' ' 20' ' ' LEU . 97.5 m -89.81 -85.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 3.3 t -54.56 -28.35 45.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.832 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 77.75 52.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HG2' ' CG2' ' A' ' 25' ' ' THR . 9.3 pttt -137.71 -166.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.537 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -127.72 170.54 10.06 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.577 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 81.9 Cg_exo -40.33 140.59 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.801 2.334 . . . . 0.0 112.706 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.61 -84.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' OE1' ' CG ' ' B' ' 86' ' ' HIS . 13.2 pt-20 -96.31 119.43 34.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.717 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.19 109.26 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.167 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -159.84 139.0 8.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.779 ' O ' HG23 ' A' ' 36' ' ' VAL . 95.4 Cg_exo -41.73 96.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.43 2.087 . . . . 0.0 111.904 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 17' ' ' THR . 3.1 m -47.1 89.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.273 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 34' ' ' PRO . 58.2 t -95.18 -47.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' B' ' 87' ' ' VAL . 49.2 t80 -162.5 82.19 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.232 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 19.8 m-20 -83.01 124.91 30.86 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' B' ' 85' ' ' ILE . 44.7 t30 -107.89 154.28 21.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.845 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.38 168.91 23.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.225 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.21 115.28 29.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.51 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.4 m -139.8 130.04 30.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.303 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 51' ' ' TYR . 93.5 m -125.79 112.4 15.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.078 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 173' ' ' ILE . 2.6 m -97.66 116.94 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.07 0.462 . . . . 0.0 110.333 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 17.8 mtm -89.48 100.32 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.275 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG23 ' O ' ' B' ' 74' ' ' SER . 1.8 mp -87.03 133.39 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.23 63.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.388 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 -24.35 26.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.648 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.6 151.9 59.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.013 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.56 169.71 18.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.651 2.234 . . . . 0.0 112.297 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER -154.06 168.47 26.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.9 97.12 4.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.5 tt -134.06 158.7 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.661 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -152.62 136.44 5.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.594 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.023 HD22 HD21 ' A' ' 20' ' ' LEU . 8.6 mp -93.42 103.02 15.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.83 0.348 . . . . 0.0 110.814 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.657 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 m-85 -84.62 128.34 34.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.718 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -91.22 174.43 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 111.222 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.766 HG21 ' CE1' ' A' ' 104' ' ' HIS . 3.6 m -162.39 146.45 11.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -27.62 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.64 -22.49 33.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.4 174.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.821 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -103.51 25.39 9.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.79 22.41 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -87.2 -4.95 59.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.345 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -44.11 -30.41 0.75 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.848 0.356 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' C ' HD21 ' B' ' 107' ' ' LEU . 1.0 OUTLIER -76.72 -42.25 42.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.381 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.5 OUTLIER -93.53 21.79 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.799 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -83.73 -45.65 0.79 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.298 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 78.4 Cg_exo -46.91 -25.98 4.38 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.372 2.048 . . . . 0.0 112.115 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.966 HD13 ' CD1' ' B' ' 103' ' ' TRP . 2.6 mt -75.03 -28.43 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 3.6 p -86.77 -29.83 22.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.764 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.486 ' CG ' ' O ' ' A' ' 71' ' ' SER . 2.4 p90 51.3 161.55 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.946 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 55.7 Cg_endo -70.39 -22.53 29.08 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.125 . . . . 0.0 112.158 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -10.65 52.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.454 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.653 ' OG1' HG23 ' A' ' 7' ' ' VAL . 12.1 t -44.68 -26.74 0.41 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.78 0.324 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 75.43 -154.08 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.593 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.8 p -57.64 156.71 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 1.1 p90 -129.39 161.57 30.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.8 HD22 ' HB2' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -103.97 160.4 14.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.329 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.667 HG21 HD23 ' A' ' 112' ' ' LEU . 3.7 t -128.55 150.7 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 1.8 m -111.77 142.96 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.383 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HB2' HG11 ' A' ' 93' ' ' VAL . 51.1 p90 178.12 112.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.849 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.7 p -57.23 165.77 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 115' ' ' THR . 27.8 m -132.83 29.56 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.316 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.942 HG13 ' HA ' ' A' ' 120' ' ' ARG . 96.4 t -89.49 -78.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.712 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.05 117.83 67.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HB2' ' CB ' ' A' ' 132' ' ' ASN . 52.3 Cg_exo -54.35 -21.93 25.04 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.449 2.099 . . . . 0.0 112.475 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.16 -35.19 16.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.188 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.958 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.7 t -80.26 -35.68 35.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.164 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -45.89 -43.7 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.86 -61.43 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.098 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.4 m-80 -63.86 -42.06 97.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 89' ' ' SER . 97.9 t -41.38 -48.2 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.903 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HA ' HG23 ' A' ' 98' ' ' VAL . 1.2 tppt? -83.59 -52.33 6.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 8.02 5.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.9 tttp -128.26 -39.39 1.71 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.592 ' CE3' HG13 ' A' ' 93' ' ' VAL . 52.2 m0 -94.92 -28.61 15.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.8 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.7 t -65.47 -44.44 66.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.728 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.4 Cg_exo -49.82 -35.11 38.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.153 1.902 . . . . 0.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -11.9 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 98' ' ' VAL . 16.7 tt -45.74 -31.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.746 0.307 . . . . 0.0 111.548 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 p -81.77 -27.44 33.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -64.41 -37.72 88.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.766 ' CE1' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -80.26 -51.09 9.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 15.9 p -82.93 141.6 43.99 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.16 -45.83 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.629 2.219 . . . . 0.0 112.214 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm 172.61 56.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -136.09 163.78 47.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 52.1 Cg_exo -52.33 164.22 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.609 2.206 . . . . 0.0 112.326 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 14.1 p90 -132.37 137.23 47.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.8 ' HB2' HD22 ' A' ' 79' ' ' LEU . 4.9 mt -110.23 121.39 45.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -106.41 128.93 54.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.982 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.515 HG12 ' OE1' ' A' ' 156' ' ' GLU . 16.3 m -128.05 147.71 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.116 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.949 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -167.21 122.58 1.06 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.275 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 84' ' ' VAL . 78.1 p -157.66 153.53 26.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 111.439 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.753 ' OE1' H5'1 ' A' ' 185' ' ' GNP . 0.0 OUTLIER 178.16 99.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.67 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.424 ' CG1' ' OG ' ' A' ' 158' ' ' SER . 33.1 mt -99.99 -29.79 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.13 -30.28 34.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -92.16 -46.04 7.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 0.0 111.562 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.942 ' HA ' HG13 ' A' ' 85' ' ' VAL . 34.4 ptt180 -45.65 -34.0 3.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.864 0.364 . . . . 0.0 111.164 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.75 55.98 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.704 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -107.87 156.16 38.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.07 -56.25 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.623 2.215 . . . . 0.0 112.366 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 m -64.03 -29.02 70.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.61 HG22 HD13 ' A' ' 129' ' ' LEU . 94.8 m -49.15 -62.25 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.043 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.704 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.4 -41.25 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.37 -62.59 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -34.52 76.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 136' ' ' PRO . 0.5 OUTLIER -50.82 -26.0 5.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.358 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.6 -23.6 59.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.867 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -78.76 -23.19 45.48 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 87' ' ' PRO . 4.5 m120 -94.08 30.08 1.98 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 70.53 19.41 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.242 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.87 112.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 83.6 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 129' ' ' LEU . 28.4 Cg_endo -62.71 96.26 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.592 2.195 . . . . 0.0 112.12 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 5.6 mt -47.74 122.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.404 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -104.21 171.02 5.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 51.2 Cg_exo -56.07 -22.45 39.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.725 2.283 . . . . 0.0 112.514 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -91.0 -28.65 17.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.462 ' CG2' HG23 ' A' ' 137' ' ' ILE . 25.3 m -49.49 -59.39 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.054 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.18 -46.9 46.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.14 79.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -54.4 -46.71 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.799 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' CD2' HD23 ' A' ' 149' ' ' LEU . 3.0 tt -59.29 -49.24 78.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 149' ' ' LEU . . . -64.86 -29.58 70.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -73.58 -40.54 63.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -65.94 -37.69 86.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 146' ' ' ALA . 4.5 pp -82.12 -21.16 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.251 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.5 tttt 68.6 126.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 179.59 -159.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.138 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 153' ' ' LYS . 12.1 p -44.36 -45.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 111.443 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.42 142.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.673 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 168' ' ' VAL . 40.3 p90 -153.07 160.74 42.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.372 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 167' ' ' ASN . 2.8 m -158.01 123.84 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.686 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -170.68 153.01 3.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' CB ' ' HD2' ' A' ' 163' ' ' LYS . 10.2 p -101.86 -173.83 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.968 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 1.6 p -88.44 174.4 8.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.083 0.468 . . . . 0.0 111.311 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.874 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -47.94 178.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.907 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 160' ' ' LEU . 3.6 mm? 59.01 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.967 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 159' ' ' ALA . 6.7 p -56.03 176.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.594 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -163.22 103.33 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.036 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HD2' ' CB ' ' A' ' 157' ' ' CYS . 1.8 mtpp -95.35 -24.69 16.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.49 79.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.532 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.594 HD11 ' NE2' ' A' ' 162' ' ' GLN . 12.9 mt -71.06 -41.68 70.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.414 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' B' ' 76' ' ' SER . 0.1 OUTLIER -45.43 -27.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.543 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HB2' HG23 ' A' ' 155' ' ' VAL . 5.5 m120 -60.64 -72.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.474 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.641 HG21 ' OE1' ' A' ' 156' ' ' GLU . 13.2 p -47.49 -35.13 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.734 0.302 . . . . 0.0 111.087 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.68 ' O ' HD12 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -73.23 -38.93 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.355 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -54.01 -42.05 68.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.208 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -80.46 -34.49 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.463 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.85 82.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.798 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.4 mt -90.12 -27.24 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.914 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.65 -49.03 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.578 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.0 -42.16 72.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.8 -21.92 59.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER -92.1 41.67 1.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -135.62 68.66 66.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.853 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.72 151.61 5.07 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.489 2.126 . . . . 0.0 112.294 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.18 147.65 88.37 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.579 2.186 . . . . 0.0 112.224 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -71.09 137.57 84.67 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.14 -177.16 3.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.53 2.154 . . . . 0.0 112.341 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -54.03 129.03 32.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.3 p -51.43 -36.26 43.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 23.1 mm -144.1 142.59 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -138.45 134.52 34.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -74.74 133.67 76.25 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.618 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.794 ' HB2' HG12 ' A' ' 42' ' ' VAL . 49.3 Cg_exo -55.46 -53.06 6.3 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.447 2.098 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 45.3 m 59.71 -83.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.026 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -56.13 108.67 0.49 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.689 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.693 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -141.84 -175.84 4.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.346 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -153.28 138.25 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.64 99.28 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.344 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.534 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -69.73 -77.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.485 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.624 HG21 ' CD ' ' B' ' 100' ' ' PRO . 1.2 mp -122.25 128.58 75.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . 0.446 ' CG ' ' OE1' ' A' ' 31' ' ' GLU . 3.0 p-80 -105.26 96.14 6.32 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.945 HG22 ' HA ' ' B' ' 99' ' ' MET . 24.6 t -84.59 149.45 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.674 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.05 178.07 24.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -108.7 129.14 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 110.961 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' CG2' ' B' ' 97' ' ' THR . 41.6 t0 -140.29 130.84 25.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.85 20.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.015 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.939 HG13 HG22 ' B' ' 93' ' ' THR . 13.7 p -45.87 -27.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-O 120.84 0.352 . . . . 0.0 111.352 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.939 HG22 HG13 ' B' ' 92' ' ' VAL . 1.2 t -152.11 -39.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.41 7.64 2.15 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.291 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.58 -170.99 2.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.013 0.406 . . . . 0.0 110.688 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 67' ' ' LEU . 2.9 m-85 -86.8 162.4 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 3.1 p -109.93 153.99 23.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.68 27.59 13.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.375 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.945 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.0 OUTLIER -77.15 141.36 66.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.295 . . . . 0.0 111.452 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.624 ' CD ' HG21 ' B' ' 85' ' ' ILE . 81.5 Cg_exo -39.56 138.46 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.848 2.365 . . . . 0.0 112.693 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.22 -60.38 2.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.161 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.93 -50.29 27.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.966 ' CD1' HD13 ' A' ' 70' ' ' LEU . 1.7 m0 -55.22 -55.21 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.223 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' GLN . . . -55.7 -55.01 37.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.321 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' B' ' 109' ' ' THR . 7.9 mtt-85 -49.61 -45.0 47.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.043 0.449 . . . . 0.0 110.649 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.59 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.92 -54.99 16.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.97 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.763 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -94.62 -69.26 0.76 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.347 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.638 HE22 HG23 ' B' ' 112' ' ' ILE . 0.0 OUTLIER -78.61 -94.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.383 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.6 HG23 ' O ' ' B' ' 108' ' ' GLN . 17.6 p -160.78 -45.84 0.04 OUTLIER 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.438 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.1 OUTLIER -159.27 166.92 30.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.94 0.4 . . . . 0.0 111.876 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' B' ' 99' ' ' MET . 27.4 t-20 -63.79 75.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.638 HG23 HE22 ' B' ' 108' ' ' GLN . 0.0 OUTLIER -57.52 89.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.356 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.674 HG22 ' O ' ' B' ' 113' ' ' THR . 61.0 m 123.18 51.55 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.688 1.195 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.428 ' CB ' ' OD1' ' B' ' 111' ' ' ASN . 5.3 tttp 179.73 -63.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.646 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -65.64 138.85 58.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.64 115.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.12 158.52 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.874 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.494 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -89.12 140.63 29.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.5 t -107.14 128.81 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.869 HG23 ' OD2' ' A' ' 76' ' ' ASP . 5.3 mm -120.14 118.0 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.663 ' O ' HG21 ' A' ' 75' ' ' THR . 8.2 mmtt -116.67 96.03 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.518 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.45 108.45 10.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 71' ' ' SER . 3.3 t -84.44 158.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.663 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.878 HG11 ' N ' ' A' ' 16' ' ' LYS . 29.7 t -136.51 141.58 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.979 0.418 . . . . 0.0 111.828 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 80' ' ' VAL . 22.0 t -144.69 121.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.45 -175.76 42.41 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.866 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -89.14 -48.36 7.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -160.23 1.71 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.176 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' H ' ' A' ' 18' ' ' CYS . . . -136.57 4.63 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.894 HG13 ' O6 ' ' A' ' 185' ' ' GNP . 61.9 t -47.76 -23.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.706 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . -115.55 -61.59 0.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.753 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.878 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -51.25 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 187' ' ' HOH . 85.3 m -96.56 -68.98 0.77 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.705 ' H ' ' HB1' ' A' ' 13' ' ' ALA . 8.2 m -48.02 -21.0 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.747 HD21 ' CE2' ' A' ' 23' ' ' TYR . 3.3 tm? -56.88 -74.58 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.651 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 HG11 ' A' ' 42' ' ' VAL . 27.7 mt -63.49 -26.6 68.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.618 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.69 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -66.28 -44.34 91.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.865 179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.486 ' CB ' ' C2 ' ' A' ' 185' ' ' GNP . 1.1 m -94.81 -11.82 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.862 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.04 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.9 m-30 -95.54 -67.67 0.84 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 112.112 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' HA ' ' B' ' 79' ' ' SER . 46.5 m -83.85 -81.22 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.22 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.793 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -48.84 -35.63 15.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.184 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 10.0 t-20 51.31 65.21 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.254 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -147.95 -175.35 4.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.464 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.502 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -102.78 157.98 32.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.644 0.259 . . . . 0.0 110.609 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.502 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 79.2 Cg_exo -39.55 145.82 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.732 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -99.57 -82.27 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HG3' ' ND1' ' B' ' 86' ' ' HIS . 8.0 pt-20 -102.06 118.29 36.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.4 t80 -70.05 110.49 5.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.0 t -158.96 138.34 8.35 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.345 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' O ' HG23 ' A' ' 36' ' ' VAL . 85.1 Cg_exo -44.85 91.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.307 2.005 . . . . 0.0 111.684 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.926 HG23 ' HB2' ' A' ' 38' ' ' ASP . 88.2 m -51.92 87.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.505 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' B' ' 96' ' ' PHE . 45.8 t -82.32 -28.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 1.8 t80 -141.87 -64.37 0.43 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.926 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.3 t0 52.75 104.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.17 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 25.0 t30 -107.21 156.59 18.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.513 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -151.04 169.01 22.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.746 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -114.03 141.96 46.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -160.82 126.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.198 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.5 m -109.44 110.95 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.787 HG22 ' HD3' ' B' ' 78' ' ' PRO . 24.5 t -98.6 119.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 39.6 mtm -84.96 99.79 11.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 51' ' ' TYR . 4.8 mt -103.17 89.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.703 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.74 17.01 55.62 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.212 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.94 35.07 8.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.9 mm-40 -136.22 137.84 25.69 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.81 157.7 60.58 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.545 2.163 . . . . 0.0 112.336 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.757 ' H ' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -147.05 167.1 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.176 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 52' ' ' THR . 4.9 t -129.2 97.24 4.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.375 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.603 ' HB3' HG23 ' A' ' 42' ' ' VAL . 28.6 tp -112.87 155.98 23.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.333 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -158.34 121.65 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.312 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' HG ' ' A' ' 20' ' ' LEU . 3.7 mm? -75.94 105.63 7.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.81 0.338 . . . . 0.0 110.881 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 7.4 m-85 -84.11 103.23 13.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -72.35 120.9 18.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.702 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.416 ' HB ' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -136.66 170.39 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . . . -124.1 -40.51 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.73 47.94 88.47 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.501 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -40.13 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 165.78 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.546 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 64' ' ' TYR . 52.6 p30 -86.99 -22.59 25.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.164 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.771 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 28.3 m-85 -67.02 -21.37 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 111.168 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 5.6 m-20 -48.02 -26.05 1.64 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.244 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 3.6 ptp180 -93.98 -27.87 16.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.034 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -103.21 18.1 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -93.05 -30.21 0.3 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -55.62 -20.81 28.82 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.53 1.487 . . . . 0.0 111.899 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.8 OUTLIER -72.81 -25.98 61.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.916 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 18.8 m -101.58 -21.46 14.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.134 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.665 ' O ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER 55.31 104.87 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.51 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 34.1 Cg_endo -64.69 -23.66 63.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -88.0 -9.92 51.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.345 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 72' ' ' TYR . 7.7 t -37.53 -53.69 1.17 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.869 ' OD2' HG23 ' A' ' 4' ' ' ILE . 3.3 m-20 -169.92 -88.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.735 HG21 ' CD1' ' A' ' 111' ' ' LEU . 9.9 p -128.21 163.72 31.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.683 0.278 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' N ' HG22 ' A' ' 77' ' ' VAL . 5.6 m-85 -111.85 138.52 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.866 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.823 ' CB ' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.03 143.17 33.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.522 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.9 t -132.3 153.05 37.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.797 0.332 . . . . 0.0 111.268 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -144.4 132.57 21.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.427 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.468 ' CB ' HG11 ' A' ' 93' ' ' VAL . 33.3 p90 -152.28 164.89 36.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.6 t -62.83 180.0 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.805 HG21 ' HA ' ' A' ' 115' ' ' THR . 4.9 m -156.35 43.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.288 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.708 HG11 ' CB ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -154.13 -86.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.448 ' H ' HG23 ' A' ' 85' ' ' VAL . 1.5 m -52.64 110.13 1.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 22.4 Cg_endo -61.49 -15.95 44.5 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.024 . . . . 0.0 112.476 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.7 p -64.8 -23.65 67.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.5 p -95.95 -42.94 8.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -39.69 21.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 1.1 mm-40 -58.63 -55.56 33.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.8 m-20 -64.9 -38.17 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 89' ' ' SER . 63.4 t -48.3 -67.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.719 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -69.69 -37.43 76.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.419 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 91' ' ' GLU . 28.7 mm-40 -74.05 -2.53 24.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -127.98 -35.02 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 60.4 m95 -88.7 -36.73 16.02 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 101' ' ' ILE . 58.6 t -57.8 -46.3 99.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 85.9 Cg_endo -79.49 -21.5 8.73 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.558 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.58 -36.57 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 98' ' ' VAL . 15.7 tt -50.62 -28.49 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.813 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -73.61 -38.46 65.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.573 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -56.63 -44.04 80.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.492 ' CE1' ' HB3' ' A' ' 68' ' ' ARG . 1.7 t60 -88.87 -32.32 17.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.429 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 3.3 m -111.7 87.94 8.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.604 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.66 -78.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.46 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -126.78 48.1 2.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -126.85 139.51 35.16 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.748 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.7 Cg_exo -49.61 165.26 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.547 2.165 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CB ' HD11 ' A' ' 101' ' ' ILE . 6.7 p90 -148.29 151.23 35.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.061 0.458 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.051 HD23 ' CD1' ' A' ' 154' ' ' TYR . 1.1 mp -125.6 119.73 28.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.674 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 149' ' ' LEU . 1.4 pt? -135.14 119.58 17.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.645 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.873 HG12 ' CZ ' ' A' ' 154' ' ' TYR . 10.1 p -156.57 111.93 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.885 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.68 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -86.47 169.12 40.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.668 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.805 ' HA ' HG21 ' A' ' 84' ' ' VAL . 13.9 t -174.82 137.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.863 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.45 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -166.72 84.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.741 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 157' ' ' CYS . 4.3 mt -77.39 -32.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -87.0 -23.68 24.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.45 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -95.86 -0.79 50.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.682 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.708 ' CB ' HG11 ' A' ' 85' ' ' VAL . 1.3 ptt85 -94.56 26.02 3.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.919 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.6 41.19 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.981 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.54 127.29 29.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.07 -44.18 49.37 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -57.45 -27.91 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 129' ' ' LEU . 2.4 m -57.86 -68.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.52 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -49.42 -37.43 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -50.69 -66.73 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.424 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -70.42 -34.16 72.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.876 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 125' ' ' THR . 3.4 mt -50.15 -26.17 4.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.03 61.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.921 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.11 -18.65 36.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.214 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.83 30.1 1.91 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.179 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt 73.77 29.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.055 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 58.93 -161.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.48 90.14 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.32 118.57 5.76 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.587 2.191 . . . . 0.0 112.312 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.478 HG23 ' CG2' ' A' ' 141' ' ' THR . 7.2 mt -49.85 123.78 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -118.91 176.44 1.7 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 50.0 Cg_exo -54.17 -22.01 24.24 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.201 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -84.42 -36.27 22.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.478 ' CG2' HG23 ' A' ' 137' ' ' ILE . 19.7 m -51.51 -61.81 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.68 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -48.63 -45.72 38.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 155' ' ' VAL . 2.4 tm-20 -57.39 -40.48 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.562 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -58.9 -34.34 71.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.536 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.647 HD11 ' HD2' ' A' ' 94' ' ' LYS . 1.2 tt -71.84 -32.23 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.738 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.65 71.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -83.96 -35.22 24.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 43.0 m-20 -54.5 -61.51 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.826 HD21 HD21 ' A' ' 112' ' ' LEU . 3.4 pp -58.89 -18.1 30.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.304 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 77.91 80.84 0.07 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.939 0.4 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -134.39 -173.72 3.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 88.9 t -47.54 -29.84 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.118 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 58.33 124.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.243 0.544 . . . . 0.0 111.686 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 1.051 ' CD1' HD23 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -153.79 126.09 7.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 143' ' ' GLU . 19.8 m -97.23 131.88 43.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.766 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.743 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.5 pm0 -162.73 138.68 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.794 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.641 ' HB3' HD11 ' A' ' 117' ' ' ILE . 6.7 m -102.3 -174.59 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 p -88.47 165.29 15.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.012 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -59.53 -159.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER 49.57 25.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.777 0.322 . . . . 0.0 111.092 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -173.28 -72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.723 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 69.63 115.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.771 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -103.49 -68.19 0.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.09 96.08 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.04 HD13 ' CD1' ' A' ' 23' ' ' TYR . 1.8 mt -93.61 -10.65 33.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.527 0.203 . . . . 0.0 111.371 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -34.29 54.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 110.065 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -66.44 -33.09 74.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 156' ' ' GLU . 66.7 t -64.81 -63.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.902 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CZ ' ' CG ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -51.35 -32.29 25.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' HA ' HD13 ' B' ' 75' ' ' ILE . 61.9 t0 -63.6 -45.65 89.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.9 -52.39 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -49.12 -28.31 4.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.586 HD11 HD22 ' A' ' 53' ' ' LEU . 16.4 mm -94.78 -38.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.757 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 174' ' ' LEU . 3.6 tt -54.96 -34.24 63.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.91 -29.59 20.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -74.59 -25.43 59.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mp -94.5 46.51 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.47 ' CB ' ' CD ' ' A' ' 179' ' ' PRO . 1.8 mm-40 -60.35 -63.42 4.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 178' ' ' GLU . 55.6 Cg_endo -70.21 170.49 17.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.325 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.61 147.58 51.67 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.536 2.157 . . . . 0.0 112.201 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.36 151.24 77.5 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.55 90.81 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.594 2.196 . . . . 0.0 112.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -110.95 122.72 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.6 m -64.44 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.329 . . . . 0.0 110.802 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 170' ' ' ASP . 5.9 tt -104.01 148.83 8.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.5 t -138.2 138.72 38.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.56 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -60.18 126.81 84.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.622 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.787 ' HD3' HG22 ' A' ' 44' ' ' VAL . 9.0 Cg_endo -51.9 171.26 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 24' ' ' THR . 41.9 t -136.65 -67.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -51.49 95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.473 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 2.4 t80 -114.3 141.22 47.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.43 131.86 12.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 91.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.93 0.395 . . . . 0.0 110.192 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.499 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -62.3 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.65 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.56 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -127.02 120.17 54.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . 0.453 ' ND1' ' HG3' ' A' ' 31' ' ' GLU . 3.5 t-160 -103.98 96.56 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.484 HG22 ' HD3' ' B' ' 100' ' ' PRO . 44.6 t -79.86 155.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.04 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.46 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.48 178.26 24.27 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.236 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -85.97 112.76 21.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.667 ' CB ' HG23 ' B' ' 97' ' ' THR . 10.8 t0 -103.76 98.24 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -0.08 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.029 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.772 HG13 HG22 ' B' ' 93' ' ' THR . 12.3 p -57.47 -47.89 84.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.772 HG22 HG13 ' B' ' 92' ' ' VAL . 0.8 OUTLIER -120.99 -21.81 6.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.433 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.25 12.73 6.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.554 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.546 ' HG2' HG23 ' B' ' 93' ' ' THR . 16.7 pt-20 -121.83 -175.94 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.8 0.333 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 1.034 ' CE2' HD13 ' A' ' 67' ' ' LEU . 4.1 m-85 -82.05 164.6 21.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.826 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.667 HG23 ' CB ' ' B' ' 90' ' ' ASP . 0.3 OUTLIER -95.14 150.87 19.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.441 ' CA ' ' OG1' ' B' ' 113' ' ' THR . . . 48.54 48.66 28.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.705 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -57.77 125.6 73.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.549 0.214 . . . . 0.0 110.974 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.484 ' HD3' HG22 ' B' ' 87' ' ' VAL . 69.6 Cg_exo -49.85 152.95 6.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.04 1.826 . . . . 0.0 111.595 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 8.4 pt-20 -43.32 -48.46 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 111.517 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -78.95 -52.95 7.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.866 ' CG ' HD13 ' A' ' 70' ' ' LEU . 4.9 m0 -50.12 -51.06 46.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.419 0.628 . . . . 0.0 110.052 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.705 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.93 -55.57 28.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.78 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 76.0 mtt180 -53.76 -44.44 70.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.021 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -48.85 -57.5 6.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -95.23 -68.86 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.295 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.75 ' O ' HG23 ' B' ' 109' ' ' THR . 7.9 tp60 -77.71 -101.6 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.353 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.75 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.1 p -168.16 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.684 0.278 . . . . 0.0 111.447 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.51 174.2 11.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.129 0.49 . . . . 0.0 111.836 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' B' ' 99' ' ' MET . 3.8 p30 -68.56 84.98 0.29 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.696 ' O ' HG23 ' B' ' 113' ' ' THR . 3.6 tp -57.57 88.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.696 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 157.88 -25.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.488 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' B' ' 113' ' ' THR . 0.2 OUTLIER 82.81 47.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.589 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 75.1 m -53.01 -31.86 43.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -178.19 135.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -110.56 165.02 12.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 tttt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.002 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.894 ' O6 ' HG13 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.525 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.824 0.345 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.24 126.8 54.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.752 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 m -94.1 150.9 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.967 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 3' ' ' THR . 3.0 pt -155.87 147.07 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.83 115.38 17.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' HB3' HD23 ' A' ' 55' ' ' LEU . 54.0 t -78.09 154.36 31.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 56' ' ' PHE . 6.6 t -145.31 144.95 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.421 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 57' ' ' ASP . 7.2 p -118.78 136.02 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 9' ' ' VAL . 13.5 p -127.08 122.88 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.95 168.81 12.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.86 129.89 55.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.6 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.89 -27.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.492 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . 84.76 -41.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG11 ' HA2' ' A' ' 114' ' ' GLY . 16.0 t -48.42 -23.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.67 0.271 . . . . 0.0 111.667 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -56.71 -114.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.11 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.61 ' CG ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -96.15 -65.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -34.2 -73.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.788 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -52.67 -36.56 57.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.39 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -49.7 -70.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.549 HD13 ' OG1' ' A' ' 24' ' ' THR . 1.3 mm? -40.61 -37.21 0.69 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 25' ' ' THR . 6.6 mm -52.37 -69.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.533 ' CB ' ' HB2' ' A' ' 159' ' ' ALA . 5.7 t -88.33 -50.71 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.471 0.653 . . . . 0.0 110.448 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CD2' ' CD1' ' A' ' 165' ' ' LEU . 21.9 t80 -46.13 -49.86 16.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.548 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 42' ' ' VAL . 52.3 m -96.71 -89.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.871 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -55.28 -26.16 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.2 t-20 70.59 58.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.871 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.1 pttt -134.84 -161.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' " O3'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -132.57 148.83 71.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.286 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 75.4 Cg_exo -39.34 133.72 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.758 2.306 . . . . 0.0 112.72 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -84.88 0.51 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.443 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.64 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.316 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' O3G' ' A' ' 185' ' ' GNP . 1.2 t80 -66.49 97.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.158 0.504 . . . . 0.0 111.041 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 35' ' ' THR . 7.5 p -154.33 137.34 10.22 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.815 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.6 Cg_exo -36.55 89.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.876 2.384 . . . . 0.0 112.645 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.863 HG23 ' CG ' ' A' ' 38' ' ' ASP . 58.4 m -53.54 89.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.013 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.818 HG11 ' CG ' ' B' ' 96' ' ' PHE . 3.3 t -79.14 -25.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 110.402 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 5.1 t80 -149.14 -70.85 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.863 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.7 m-20 63.28 130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.47 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 6.6 t-20 -108.01 157.77 17.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.104 0.478 . . . . 0.0 111.359 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' HB3' ' CE2' ' B' ' 81' ' ' PHE . 1.7 m-85 -152.78 160.31 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.078 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' B' ' 81' ' ' PHE . . . -121.22 126.67 50.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.49 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.725 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.5 m -148.94 140.05 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.101 0.477 . . . . 0.0 111.895 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 51' ' ' TYR . 53.2 m -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.894 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.862 HG13 ' O ' ' B' ' 76' ' ' SER . 40.4 t -98.21 123.13 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.212 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtm -90.7 100.08 12.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.17 105.27 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.93 15.11 76.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.2 38.41 4.82 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.775 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.3 mm-40 -141.69 124.2 9.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.496 0.189 . . . . 0.0 110.817 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.96 161.54 15.44 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.624 2.216 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.617 ' H ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -146.23 165.15 30.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.6 112.56 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 54' ' ' GLY . 4.6 tt -119.86 138.46 53.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -126.33 102.63 0.65 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.214 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -83.98 149.69 26.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.411 . . . . 0.0 111.4 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.3 m-85 -138.93 116.79 11.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.679 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.577 ' HA ' HG12 ' A' ' 8' ' ' VAL . 4.2 t70 -69.91 152.75 44.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 64' ' ' TYR . 1.6 m -157.54 128.85 6.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.33 33.84 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.409 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 48.18 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.607 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.27 -169.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.894 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.88 -25.77 8.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -68.15 -23.4 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.755 ' CE2' HD23 ' A' ' 67' ' ' LEU . 4.3 m-85 -64.47 -12.6 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -40.3 -44.97 2.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.788 0.328 . . . . 0.0 111.586 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HG3' HD22 ' B' ' 107' ' ' LEU . 0.0 OUTLIER -73.41 -35.56 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.498 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.085 HD21 ' CZ3' ' B' ' 103' ' ' TRP . 11.1 tp -90.38 10.53 24.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.117 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 1.6 tmt_? -82.93 -63.82 0.26 Allowed Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 68' ' ' ARG . 4.2 Cg_endo -46.59 -26.73 4.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.412 2.075 . . . . 0.0 111.756 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.908 HD22 HD12 ' A' ' 67' ' ' LEU . 8.5 mp -54.28 -39.51 66.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.581 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.491 ' HB2' HG21 ' A' ' 7' ' ' VAL . 88.3 p -92.49 -15.28 27.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.0 OUTLIER 61.26 139.93 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.731 0.301 . . . . 0.0 110.696 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 97.0 Cg_endo -80.66 -45.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.652 2.235 . . . . 0.0 112.508 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -10.27 58.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.549 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 76' ' ' ASP . 10.3 t -40.4 -48.45 2.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 111.606 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 171.51 -167.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.784 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.609 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.9 p -58.26 162.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.517 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' N ' HG22 ' A' ' 77' ' ' VAL . 16.4 m-85 -112.01 143.2 43.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -103.5 145.88 29.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.101 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 112' ' ' LEU . 3.9 t -131.65 151.35 35.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.944 0.402 . . . . 0.0 111.482 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -121.28 103.55 9.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.697 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.972 ' CB ' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -128.87 123.01 31.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -178.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.443 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.885 ' O ' HD12 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -130.73 -74.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.268 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.53 HG12 ' CG2' ' A' ' 125' ' ' THR . 22.6 t -50.5 -70.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.02 100.86 0.24 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.954 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.6 -21.74 65.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.642 2.228 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -48.15 82.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.3 p -77.84 -37.45 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 84' ' ' VAL . 2.3 t80 -50.97 -66.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.85 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -41.52 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.713 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -60.99 -65.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.853 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 82' ' ' PHE . 93.0 t -40.68 -41.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.906 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -60.78 -69.69 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.48 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -80.9 8.34 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.59 -43.03 2.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.604 ' HD1' HG13 ' A' ' 93' ' ' VAL . 17.5 m95 -95.41 -37.1 11.09 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.2 t -50.02 -58.3 9.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 21.1 Cg_endo -60.67 -22.04 71.49 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.171 1.914 . . . . 0.0 112.031 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -32.05 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG21 ' CG ' ' A' ' 110' ' ' PHE . 22.1 mt -49.84 -26.51 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 p -74.55 -36.87 63.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -63.74 -38.42 91.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.776 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.456 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 6.5 m-70 -95.76 -24.38 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.434 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 2.9 m -121.53 97.77 46.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.749 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 87.4 Cg_exo -46.49 -61.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.585 2.19 . . . . 0.0 112.414 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.24 32.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 161.31 26.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.87 129.35 24.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.53 2.153 . . . . 0.0 112.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' HG21 ' A' ' 101' ' ' ILE . 12.8 p90 -118.1 124.74 48.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -96.85 119.5 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.447 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.603 HD12 ' HB ' ' A' ' 80' ' ' VAL . 38.6 tp -97.94 102.05 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 15' ' ' GLY . 26.8 m -106.77 139.1 29.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 111.271 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.702 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -165.31 144.08 8.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.371 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.837 HG21 ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER 173.17 151.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 111.063 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.58 ' H ' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -167.76 94.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.435 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.81 -27.4 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.724 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.774 ' CB ' HD13 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -96.36 -48.07 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 111.45 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.63 HD13 ' C ' ' A' ' 119' ' ' LEU . 2.4 tm? -66.28 -59.33 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.084 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' N ' HD13 ' A' ' 119' ' ' LEU . 33.5 mmt180 -66.97 -174.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 5.7 m-20 81.9 39.49 0.05 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -96.58 169.68 8.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.716 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.71 -19.41 24.25 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.591 2.194 . . . . 0.0 112.449 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.5 t -84.38 -46.69 11.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.53 ' CG2' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -48.83 -60.84 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.031 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.5 mp -50.83 -40.62 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.913 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.15 -46.03 53.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -83.76 -35.98 23.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.9 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.75 HD21 ' C ' ' A' ' 135' ' ' LYS . 1.6 tp -49.95 -26.51 4.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.51 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.52 65.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -78.41 -47.39 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.52 -26.33 68.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.99 52.37 9.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 1.4 tt0 -128.55 -86.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.75 ' C ' HD21 ' A' ' 129' ' ' LEU . 2.5 mtmt 166.72 161.34 0.11 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.686 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.687 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 Cg_exo -52.33 100.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.468 2.112 . . . . 0.0 112.159 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.885 HD12 ' O ' ' A' ' 84' ' ' VAL . 5.8 mt -48.67 119.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.458 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.2 p -111.08 177.08 1.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 52.1 Cg_exo -55.13 -20.52 24.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.434 2.089 . . . . 0.0 112.219 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -80.06 -45.4 18.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.462 ' HB ' HG23 ' A' ' 137' ' ' ILE . 97.8 m -53.38 -45.54 69.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.93 -42.68 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.61 -37.22 86.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.724 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -53.98 47.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.96 -42.38 84.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.729 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.814 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.43 -41.96 66.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.092 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -45.43 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.99 -42.48 99.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.3 pp -80.09 -26.48 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.718 ' N ' HD12 ' A' ' 149' ' ' LEU . 0.8 OUTLIER 67.04 118.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.984 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.03 -161.82 0.93 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 152' ' ' VAL . 15.7 t -70.62 -7.63 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 80.19 140.43 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 110.791 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.814 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 3.0 p90 -152.71 148.29 27.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 111.454 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 154' ' ' TYR . 2.8 m -158.47 124.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.832 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.837 ' O ' HG21 ' A' ' 115' ' ' THR . 2.0 pt-20 -171.87 149.62 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.539 ' O ' ' N2 ' ' A' ' 185' ' ' GNP . 2.6 p -108.27 -174.58 2.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.495 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.8 OUTLIER -86.16 159.6 19.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.821 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.21 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.474 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER 68.78 -62.67 0.38 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 111.126 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -85.47 -68.83 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.277 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 73.87 118.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.711 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -105.53 -68.27 0.88 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.37 . . . . 0.0 111.075 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.08 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.661 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -86.44 -10.19 54.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.643 0.259 . . . . 0.0 111.196 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.822 ' HD3' HD12 ' B' ' 77' ' ' LEU . 0.1 OUTLIER -47.87 -45.63 30.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.735 0.302 . . . . 0.0 111.162 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -58.8 -62.88 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.4 p -47.75 -26.52 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.19 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.552 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -76.61 -50.43 13.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.372 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 174' ' ' LEU . 5.3 t0 -49.96 -29.28 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.15 -39.76 22.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.048 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.72 -22.31 43.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 38.5 mm -91.96 -30.17 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.175 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 170' ' ' ASP . 1.7 tt -80.74 -26.09 37.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.762 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.66 -34.69 65.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.413 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -87.89 -27.2 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.63 -30.66 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.84 150.71 37.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.07 146.52 17.17 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.57 2.18 . . . . 0.0 112.383 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 161.45 45.92 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.571 2.181 . . . . 0.0 112.314 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.455 ' N ' ' HD2' ' A' ' 182' ' ' PRO . 1.3 tm-20 -49.71 -60.39 5.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.061 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 181' ' ' GLU . 39.4 Cg_endo -67.14 162.82 36.64 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.582 2.188 . . . . 0.0 112.335 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -115.71 116.39 27.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -50.73 63.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.415 HD11 HG11 ' A' ' 44' ' ' VAL . 7.3 tt -143.96 151.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.862 ' O ' HG13 ' A' ' 44' ' ' VAL . 16.1 t -135.09 137.62 43.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.822 HD12 ' HD3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -67.48 141.5 95.59 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.806 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.761 ' HD2' HD23 ' B' ' 77' ' ' LEU . 53.7 Cg_exo -51.64 166.41 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.565 2.177 . . . . 0.0 112.28 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 81' ' ' PHE . 0.4 OUTLIER -139.56 -66.57 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.68 86.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 9.1 t80 -108.61 134.26 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.66 111.98 3.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.486 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 83' ' ' HIS . 27.2 p-80 -68.37 109.4 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.059 0.457 . . . . 0.0 109.943 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.563 ' OG1' HD12 ' B' ' 85' ' ' ILE . 1.5 p -77.17 -62.57 1.61 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.786 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.563 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.7 OUTLIER -121.9 143.8 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 111.764 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.65 96.57 4.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.848 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.464 HG13 ' O ' ' B' ' 97' ' ' THR . 25.1 t -78.21 149.08 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.615 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.24 177.63 24.47 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.352 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -101.22 129.62 47.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.408 ' CB ' HG23 ' B' ' 97' ' ' THR . 68.3 t0 -137.89 132.19 32.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 1.37 19.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.142 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 p -45.44 -27.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-O 120.912 0.387 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.422 HG23 ' N ' ' B' ' 94' ' ' GLY . 13.2 t -153.41 -42.87 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.007 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . 0.422 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.58 34.26 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.418 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.424 ' OE2' HD11 ' B' ' 112' ' ' ILE . 0.2 OUTLIER -147.28 175.44 10.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.935 ' CE2' HD22 ' A' ' 67' ' ' LEU . 2.2 m-85 -71.98 160.48 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.561 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.464 ' O ' HG13 ' B' ' 87' ' ' VAL . 16.9 p -104.76 156.27 18.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.166 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.53 39.57 74.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.704 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -51.14 123.34 19.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.537 0.208 . . . . 0.0 110.675 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.472 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 84.7 Cg_exo -46.75 154.54 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.275 1.983 . . . . 0.0 112.241 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -45.57 -48.27 14.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.282 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.39 -55.7 5.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 1.085 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.2 m0 -48.54 -53.36 18.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.779 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.704 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -57.68 -61.93 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.239 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 43.4 mtt85 -48.04 -45.23 31.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -48.33 -57.88 5.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.687 HD12 ' O ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -94.81 -67.73 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.107 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.725 ' O ' HG23 ' B' ' 109' ' ' THR . 7.9 tp60 -77.39 -99.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.725 HG23 ' O ' ' B' ' 108' ' ' GLN . 2.9 p -166.58 -40.22 0.02 OUTLIER 'General case' 0 C--N 1.338 0.084 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.66 176.51 11.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.993 0.425 . . . . 0.0 111.473 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.73 72.73 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.81 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -57.72 87.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.549 0.69 . . . . 0.0 111.178 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m 178.27 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.665 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -130.1 -41.35 1.28 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 70.83 38.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.13 115.54 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -100.3 145.44 28.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.735 ' N2 ' HG23 ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 68.68 129.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.09 149.63 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.031 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.419 HD13 ' HB1' ' A' ' 176' ' ' ALA . 21.5 mt -140.48 153.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -129.56 96.22 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 37.4 t -81.36 107.96 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 8' ' ' VAL . 58.2 t -84.27 154.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.872 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 15' ' ' GLY . 2.4 t -140.5 139.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 104' ' ' HIS . 3.0 m -133.02 156.12 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.068 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . 147.63 178.54 22.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.647 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -25.46 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.71 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -84.01 -24.13 49.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.355 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 187' ' ' HOH . . . 70.02 7.58 6.29 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.747 HG13 ' N7 ' ' A' ' 185' ' ' GNP . 16.1 t -49.04 -24.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 111.251 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.869 ' C ' HG11 ' A' ' 8' ' ' VAL . . . -107.77 -43.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.541 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.652 ' N ' HG11 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -67.35 -74.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.776 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.533 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -97.68 -52.94 3.58 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 0.8 OUTLIER -55.29 -25.59 35.09 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.6 tm? -56.47 -73.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.423 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.732 ' HG ' HD22 ' A' ' 55' ' ' LEU . 18.7 mt -63.24 -25.36 68.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 110.553 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.817 HG23 ' O ' ' A' ' 27' ' ' LYS . 1.1 mp -62.9 -47.29 93.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.858 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.535 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 82.8 p -94.13 -17.32 22.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.558 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 165' ' ' LEU . 3.7 m-30 -88.22 -66.8 0.88 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.002 0.429 . . . . 0.0 112.047 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -89.04 -83.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.182 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.72 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -42.77 -44.32 4.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 16.6 t-20 64.42 41.65 5.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.817 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -131.99 141.42 49.27 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.475 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -63.63 164.33 16.47 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 70.9 Cg_exo -38.21 150.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.952 2.434 . . . . 0.0 113.078 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 t -108.96 -83.1 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.798 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.24 114.59 26.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.637 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -72.33 107.88 5.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 34' ' ' PRO . 6.5 p -160.63 139.44 7.65 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.29 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.657 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 Cg_exo -39.45 93.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.568 2.179 . . . . 0.0 111.874 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 m -48.09 87.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.781 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 34' ' ' PRO . 92.2 t -89.77 -35.43 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' CH2' ' B' ' 103' ' ' TRP . 60.8 t80 -170.86 119.45 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.777 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 3.2 m-20 -119.44 138.27 53.23 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' HB2' HD12 ' B' ' 85' ' ' ILE . 8.7 t-20 -106.65 157.6 17.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.173 0.511 . . . . 0.0 111.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.645 ' CG ' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -152.89 161.9 41.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.192 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 80' ' ' ASP . . . -117.64 117.75 30.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.48 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' CB ' ' B' ' 78' ' ' PRO . 23.8 m -136.6 167.75 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.061 0.458 . . . . 0.0 111.393 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 41.8 m -156.39 85.98 1.0 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.874 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.578 HG21 HG12 ' A' ' 173' ' ' ILE . 28.1 m -98.6 176.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.522 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.435 ' C ' HD13 ' A' ' 46' ' ' ILE . 5.7 mtm -140.46 157.34 45.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.183 0.516 . . . . 0.0 111.565 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.947 HD11 ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -129.82 88.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.139 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.35 8.4 74.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.483 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.93 -34.37 3.29 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.025 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.88 133.28 76.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.662 0.231 . . . . 0.0 111.202 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.24 174.57 4.87 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.594 2.196 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.947 ' CD1' HD11 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -153.5 155.06 35.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.6 97.06 3.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 53' ' ' LEU . 2.4 pp -134.17 161.03 36.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.66 138.06 8.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.732 HD22 ' HG ' ' A' ' 20' ' ' LEU . 3.8 mp -75.7 107.18 7.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.791 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.09 102.99 12.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -73.4 144.11 46.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.302 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.805 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -155.51 179.42 9.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.596 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -138.32 163.36 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.16 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 43.7 1.62 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.363 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? -70.72 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.622 0.249 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER 174.48 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.791 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.66 42.82 1.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.805 ' CE2' HG22 ' A' ' 58' ' ' THR . 4.4 m-85 -106.42 -24.62 12.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.673 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -45.76 -34.39 3.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.048 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.491 ' O ' HD21 ' B' ' 107' ' ' LEU . 4.3 mtt85 -51.94 -36.05 47.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.988 0.423 . . . . 0.0 110.483 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 70' ' ' LEU . 2.5 mt -96.01 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.386 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.3 mtt180 -56.76 -71.15 0.28 Allowed Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.563 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 33.9 Cg_endo -64.18 -29.42 64.74 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.059 1.839 . . . . 0.0 110.649 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.027 HD22 HD22 ' A' ' 67' ' ' LEU . 9.8 mp -52.43 -24.79 8.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.778 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.5 p -155.72 33.18 0.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.455 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -35.23 151.03 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.985 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 2.8 Cg_exo -75.67 -32.01 4.97 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.895 2.397 . . . . 0.0 112.606 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -57.6 -17.84 16.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.701 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 76' ' ' ASP . 6.3 t -46.74 -52.89 12.95 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.592 0.234 . . . . 0.0 111.396 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 75' ' ' THR . 1.0 OUTLIER 176.99 -159.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 111.062 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.3 p -57.98 163.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' N ' HG22 ' A' ' 77' ' ' VAL . 6.0 m-85 -115.62 132.69 56.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 0.0 110.863 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.3 tp -103.66 143.54 32.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.115 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.823 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.6 t -133.75 150.66 31.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB3' ' N ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -125.06 153.38 42.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.529 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 p90 -162.24 158.72 24.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.93 164.26 25.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 137' ' ' ILE . 60.6 t -147.08 55.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 120' ' ' ARG . 68.9 t -151.9 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 125' ' ' THR . 5.8 m -66.77 150.16 97.83 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 0.0 110.73 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 128' ' ' LYS . 72.1 Cg_endo -77.39 -36.63 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.588 2.192 . . . . 0.0 112.435 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.5 p -53.13 -38.9 63.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 -24.92 30.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.029 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.576 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.2 t80 -69.91 -61.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.091 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -26.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.2 m-20 -75.58 -60.96 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 90' ' ' PHE . 12.7 m -47.55 -27.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.669 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.615 ' HE3' HD11 ' A' ' 145' ' ' LEU . 23.3 tttt -78.47 -61.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -82.44 8.37 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.995 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 6.7 ttpt -114.37 -37.82 4.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.635 0.255 . . . . 0.0 111.34 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.537 ' HE1' HG12 ' A' ' 93' ' ' VAL . 19.0 m95 -95.3 -42.12 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.604 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.887 ' O ' HG22 ' A' ' 101' ' ' ILE . 63.2 t -53.57 -43.63 96.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.8 Cg_exo -73.88 -31.4 8.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 112.499 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.11 -33.07 24.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 98' ' ' VAL . 12.9 tt -48.61 -29.31 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -66.62 -42.69 86.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.652 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -63.18 -33.0 74.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.413 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 12.4 m80 -79.76 -31.33 40.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.449 ' HB2' ' CG2' ' A' ' 108' ' ' THR . 18.6 p -130.68 122.39 19.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 48.0 Cg_exo -55.63 -64.92 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.489 2.126 . . . . 0.0 112.351 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -156.7 31.46 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.449 ' CG2' ' HB2' ' A' ' 105' ' ' CYS . 1.8 t -97.25 150.03 36.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.05 144.65 27.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.802 2.335 . . . . 0.0 112.14 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 101' ' ' ILE . 4.5 p90 -121.92 157.33 31.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.1 mt -127.66 145.25 50.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.55 HD23 ' HB ' ' A' ' 80' ' ' VAL . 5.7 mt -120.34 159.4 25.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.512 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 80' ' ' VAL . 10.8 m -156.11 106.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.909 0.385 . . . . 0.0 111.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.673 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -123.5 128.15 6.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.39 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 158' ' ' SER . 48.3 p -153.79 142.91 21.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 111.192 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.745 ' HG2' HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -178.84 36.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.868 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.464 ' CG1' ' HB3' ' A' ' 158' ' ' SER . 5.4 pt -56.24 -21.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.266 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.735 ' CB ' HD13 ' A' ' 160' ' ' LEU . 9.9 t0 -96.09 -26.04 15.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.745 HD13 ' HG2' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -65.72 -56.53 11.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.597 ' HB2' HG22 ' A' ' 85' ' ' VAL . 7.0 tmm_? -46.68 100.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.84 -44.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -54.86 132.12 66.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 47.5 Cg_exo -56.07 -36.57 96.38 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.422 2.082 . . . . 0.0 112.231 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.9 m -49.24 -45.04 44.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.987 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.841 HG22 ' OG ' ' A' ' 86' ' ' SER . 68.3 p -53.77 -59.86 4.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 3.4 mp -60.16 -40.61 84.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.58 -61.67 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 2.0 ttpp -73.05 -36.01 66.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 136' ' ' PRO . 10.5 mt -50.29 -25.92 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.88 -20.75 57.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -91.22 -37.08 13.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.851 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.0 -27.66 66.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -78.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 179.14 -46.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 150.15 65.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.636 ' HA ' HD13 ' A' ' 129' ' ' LEU . 50.7 Cg_exo -53.58 174.38 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.615 2.21 . . . . 0.0 112.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.746 HG22 HG13 ' A' ' 84' ' ' VAL . 5.9 mt -92.5 122.62 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.2 p -110.81 167.71 8.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 81.9 Cg_exo -47.84 -25.44 6.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.668 2.245 . . . . 0.0 112.359 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -46.72 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.511 ' HB ' HG23 ' A' ' 137' ' ' ILE . 7.2 m -52.16 -51.35 58.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -49.89 -41.02 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.022 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.7 -35.29 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.73 94.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.615 HD11 ' HE3' ' A' ' 94' ' ' LYS . 12.8 tp -65.12 -45.52 84.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -25.59 66.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -41.06 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.37 -64.04 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 150' ' ' LYS . 3.9 pp -51.32 -25.19 5.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.778 ' N ' HD12 ' A' ' 149' ' ' LEU . 11.0 mttp 65.59 108.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -145.64 -161.01 1.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 92.8 t -60.93 -20.11 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.316 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 78.25 137.99 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 111.166 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 50.0 p90 -153.2 166.27 33.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.25 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 155' ' ' VAL . 28.2 m -158.36 124.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.818 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.77 152.52 3.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.433 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 13.8 p -111.18 -173.64 2.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.464 ' HB3' ' CG1' ' A' ' 117' ' ' ILE . 11.1 t -87.79 156.49 19.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.554 ' N ' ' N3 ' ' A' ' 185' ' ' GNP . . . -56.73 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.207 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 53.36 25.09 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.95 -65.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 1.016 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.3 OUTLIER 64.74 122.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.12 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.35 -67.96 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.33 100.17 0.16 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.396 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.016 HD11 ' NE2' ' A' ' 162' ' ' GLN . 4.8 mt -93.68 -10.68 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.542 0.211 . . . . 0.0 111.539 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.44 -28.05 1.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.383 . . . . 0.0 111.065 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -78.4 -60.9 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.045 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.7 p -50.01 -41.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.463 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -69.49 -40.84 76.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -50.27 -53.03 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.07 -51.54 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.05 -30.69 48.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.237 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.578 HG12 HG21 ' A' ' 44' ' ' VAL . 5.9 mt -91.76 -24.87 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.9 tp -80.33 -52.58 7.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.222 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -31.29 4.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.306 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -66.54 -23.26 66.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.271 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 HG13 ' A' ' 46' ' ' ILE . 2.2 mp -90.34 48.28 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB2' ' CD ' ' A' ' 179' ' ' PRO . 6.5 mt-10 -56.56 -62.17 5.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.451 ' CD ' ' HB2' ' A' ' 178' ' ' GLU . 36.3 Cg_endo -65.41 110.73 1.65 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.678 2.252 . . . . 0.0 112.466 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -51.76 178.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.521 2.147 . . . . 0.0 112.189 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.93 156.6 47.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.57 95.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.631 2.22 . . . . 0.0 112.401 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.12 175.87 6.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.999 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -117.6 -53.91 2.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.036 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' MET . 18.8 mm -104.02 144.23 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.69 153.08 48.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.202 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -90.91 135.79 28.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.639 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' B' ' 77' ' ' LEU . 52.5 Cg_exo -54.21 -172.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.562 2.174 . . . . 0.0 112.205 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 60.4 p -162.56 -53.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.548 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . 0.667 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.2 m-20 -67.5 62.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.403 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' HB ' ' A' ' 25' ' ' THR . 4.0 t80 -81.32 131.02 35.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -153.59 120.06 5.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.18 102.33 1.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.507 ' OG1' HD12 ' B' ' 85' ' ' ILE . 0.6 OUTLIER -77.53 -60.77 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.592 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.507 HD12 ' OG1' ' B' ' 84' ' ' THR . 1.0 OUTLIER -120.69 134.61 63.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.934 0.397 . . . . 0.0 111.971 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -120.88 96.5 5.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.623 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.547 HG22 ' HD3' ' B' ' 100' ' ' PRO . 47.1 t -79.95 148.05 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.752 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.77 177.76 23.06 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.288 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -95.94 131.93 41.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.718 ' CG ' HG23 ' B' ' 97' ' ' THR . 3.1 p-10 -140.41 120.18 13.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.32 -0.66 26.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.613 HG13 HG22 ' B' ' 93' ' ' THR . 13.9 p -47.72 -26.51 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.282 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.613 HG22 HG13 ' B' ' 92' ' ' VAL . 3.9 t -149.05 -41.39 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.082 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.97 25.98 0.87 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.672 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.76 -162.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.74 0.305 . . . . 0.0 110.546 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 36' ' ' VAL . 1.2 m-85 -100.25 164.2 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.718 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -100.22 167.12 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.11 33.61 22.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.545 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.432 ' O ' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -47.21 109.04 0.98 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.501 0.191 . . . . 0.0 110.709 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.547 ' HD3' HG22 ' B' ' 87' ' ' VAL . 97.0 Cg_exo -40.19 153.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.7 2.266 . . . . 0.0 112.811 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -45.34 -57.9 3.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.194 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.49 -54.19 36.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.536 ' CE3' ' CD1' ' A' ' 67' ' ' LEU . 4.7 m0 -49.21 -63.4 1.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 0.0 110.788 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.49 -70.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.765 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 3.9 mtp180 -44.62 -37.07 3.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.904 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -50.37 -56.18 12.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.134 179.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.917 HD11 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.42 -70.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.539 ' O ' HG23 ' B' ' 109' ' ' THR . 4.8 tt0 -79.98 -99.06 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 108' ' ' GLN . 29.9 p -160.35 -35.23 0.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.565 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -161.66 -173.42 3.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.018 0.437 . . . . 0.0 111.951 -178.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' B' ' 100' ' ' PRO . 0.3 OUTLIER -84.79 81.86 8.69 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.83 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.693 ' O ' HG23 ' B' ' 113' ' ' THR . 0.0 OUTLIER -56.59 88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.614 0.721 . . . . 0.0 111.349 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.693 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.1 OUTLIER 170.29 -57.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.703 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -113.07 -27.46 8.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.832 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' B' ' 111' ' ' ASN . 2.4 m -62.92 -74.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 60.24 109.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -66.86 151.27 47.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.995 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.9 mttm . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.82 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.747 ' N7 ' HG13 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.868 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.824 0.345 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 63.31 117.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.42 169.34 8.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.628 HD12 ' HB3' ' A' ' 176' ' ' ALA . 2.5 pt -160.23 134.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' ASP . 2.7 mptt -125.53 147.79 49.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLY . 20.7 m -133.48 134.48 43.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.841 HG12 ' HG1' ' A' ' 58' ' ' THR . 3.0 t -115.21 151.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 9' ' ' VAL . 9.2 p -93.24 160.87 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.955 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.542 HG23 ' CD2' ' A' ' 104' ' ' HIS . 7.3 p -152.61 129.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 174.21 17.33 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.78 84.66 2.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 81' ' ' CYS . . . -171.9 -147.21 5.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB1' HG23 ' A' ' 17' ' ' THR . . . -178.95 32.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.954 HG13 HD12 ' A' ' 79' ' ' LEU . 3.3 p -81.32 4.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.483 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -84.04 -103.89 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.286 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HE2' ' CD1' ' A' ' 40' ' ' TYR . 1.9 ttpm? -97.38 -13.2 21.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.775 HG23 ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.32 -74.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -74.16 -34.88 63.98 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.089 -0.382 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.731 HD23 ' CG2' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -57.11 -74.1 0.06 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.584 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD21 HD12 ' A' ' 55' ' ' LEU . 18.2 mt -47.93 -42.27 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.876 0.37 . . . . 0.0 111.067 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -49.13 -68.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.517 ' N ' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -93.18 -56.99 2.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.646 ' CD1' HD13 ' A' ' 19' ' ' LEU . 4.1 t80 -50.12 -26.8 4.85 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 84.9 m -113.82 -91.39 0.51 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.925 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 21' ' ' ILE . 4.1 t -51.87 -24.22 5.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 110.964 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 65.94 52.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' CE1' ' B' ' 81' ' ' PHE . 0.0 OUTLIER -132.5 -166.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.647 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -130.78 147.08 64.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.04 151.97 5.31 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.684 2.256 . . . . 0.0 112.752 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 t -105.81 -80.54 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.7 tt0 -75.7 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.51 105.95 1.64 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG23 ' HD2' ' A' ' 34' ' ' PRO . 3.4 p -160.55 138.18 7.02 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.96 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' HG23 ' A' ' 33' ' ' VAL . 72.3 Cg_exo -39.21 92.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.689 2.26 . . . . 0.0 112.272 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.548 HG22 ' OD2' ' A' ' 57' ' ' ASP . 1.4 m -50.25 91.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.197 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' HG11 ' B' ' 87' ' ' VAL . 1.9 t -81.86 -26.35 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HE2' HD13 ' B' ' 85' ' ' ILE . 9.3 t80 -148.63 -77.01 0.16 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.804 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD1' ' CE2' ' A' ' 40' ' ' TYR . 59.0 t0 58.27 112.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 16.4 t-20 -106.33 159.62 15.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.005 0.431 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -152.12 168.85 23.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.063 -178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.653 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -104.97 133.14 50.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.704 HG12 ' HB2' ' B' ' 78' ' ' PRO . 1.2 m -162.51 133.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.479 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 51' ' ' TYR . 88.0 m -131.34 116.27 17.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.13 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.647 HG13 ' HG3' ' B' ' 78' ' ' PRO . 4.0 m -98.08 117.19 42.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.052 0.453 . . . . 0.0 110.581 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.7 mtm -91.31 102.0 14.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 173' ' ' ILE . 9.7 mm -82.34 121.22 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.186 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.79 25.38 61.34 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.62 19.62 67.95 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.62 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -115.82 151.31 46.21 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.662 0.268 . . . . 0.0 110.795 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.56 139.55 64.64 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.584 2.189 . . . . 0.0 112.357 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.519 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -151.58 174.52 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.657 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.78 111.32 9.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.235 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.716 HD21 HD12 ' A' ' 55' ' ' LEU . 4.9 tt -73.31 129.7 38.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.523 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -112.39 103.41 1.46 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.005 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 53' ' ' LEU . 23.6 mt -125.83 154.46 42.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -144.56 125.94 14.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD2' HG22 ' A' ' 35' ' ' THR . 15.0 t0 -67.66 161.83 24.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.841 ' HG1' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -168.73 157.73 8.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.785 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' ' HE1' ' A' ' 64' ' ' TYR . . . -119.79 -175.26 2.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.09 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -80.46 -145.72 4.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 mt 51.77 -162.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.91 52.4 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -126.18 28.25 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.042 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.553 ' HE1' ' HB3' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -99.34 -19.33 17.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.23 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -44.05 -29.21 0.57 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.789 0.328 . . . . 0.0 111.06 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -56.72 -46.64 81.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.584 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.954 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 40.5 mt -94.25 23.31 5.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 tmt_? -57.02 -57.86 21.75 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.99 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.8 Cg_endo -47.95 -22.3 3.32 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.641 2.227 . . . . 0.0 113.053 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HB3' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -88.68 -15.02 35.94 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 7' ' ' VAL . 17.3 m -108.04 -31.37 7.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 47.76 94.35 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 73.7 Cg_exo -49.51 -36.8 40.81 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.668 2.245 . . . . 0.0 112.501 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -10.36 59.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.592 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 76' ' ' ASP . 14.7 t -41.32 -50.65 3.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.7 0.286 . . . . 0.0 111.629 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.81 ' OD2' ' HB1' ' A' ' 176' ' ' ALA . 0.6 OUTLIER 171.72 -158.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.685 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 78' ' ' PHE . 9.9 p -58.0 154.84 2.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.825 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 105' ' ' CYS . 0.7 OUTLIER -104.26 163.69 12.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.156 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HG13 ' A' ' 14' ' ' VAL . 1.2 mm? -114.48 139.01 49.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 110' ' ' PHE . 4.1 t -131.09 134.44 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.556 ' HB2' HG12 ' A' ' 14' ' ' VAL . 42.3 t -134.49 154.63 51.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.161 0.505 . . . . 0.0 112.05 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CE1' ' N ' ' A' ' 114' ' ' GLY . 2.8 p90 -124.03 108.33 12.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.589 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.2 p -37.39 102.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.177 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.043 HG12 HG22 ' A' ' 85' ' ' VAL . 98.6 t 56.86 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.386 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.043 HG22 HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.04 -81.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.562 0.22 . . . . 0.0 111.511 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.505 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 m 54.27 102.25 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.18 -30.25 64.79 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.393 2.062 . . . . 0.0 112.322 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 p -71.72 -23.6 61.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -93.11 -22.6 19.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.154 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -48.92 -69.81 0.11 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.353 . . . . 0.0 111.032 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -51.74 -36.84 48.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 51.0 m-20 -64.04 -63.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 89' ' ' SER . 61.1 t -43.06 -32.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.0 -69.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.847 0.356 . . . . 0.0 111.417 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -80.25 8.04 8.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 15.3 tttt -115.09 -45.3 2.96 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.651 ' HD1' HG13 ' A' ' 93' ' ' VAL . 16.7 m95 -95.42 -38.46 10.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.2 t -51.64 -44.51 90.24 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.631 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.6 Cg_exo -55.92 -21.6 34.41 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 112.256 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.92 -31.18 15.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.125 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.519 HG23 HG11 ' A' ' 9' ' ' VAL . 56.0 mt -48.14 -31.8 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.122 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.3 p -64.05 -34.84 78.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.633 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -72.78 -33.18 66.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.58 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 9' ' ' VAL . 1.3 m-70 -79.17 -43.87 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 17.8 p -103.64 134.01 19.97 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_endo -83.86 72.91 5.16 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.667 2.245 . . . . 0.0 112.386 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.0 26.38 15.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 1.6 m -107.85 142.15 24.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 63.0 Cg_exo -51.46 172.23 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 80' ' ' VAL . 6.7 p90 -148.57 138.7 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -95.26 119.51 33.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.7 HD12 ' HE2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -97.9 121.84 40.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.933 HG23 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -155.4 137.36 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.003 0.43 . . . . 0.0 111.405 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.513 ' N ' ' CE1' ' A' ' 82' ' ' PHE . . . -174.67 156.45 22.94 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.759 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 1.4 t 173.45 177.66 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.113 0.482 . . . . 0.0 111.297 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.705 HE22 HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -174.59 52.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.292 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 158' ' ' SER . 28.9 mt -37.11 -31.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -58.49 -64.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.614 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.705 HD23 HE22 ' A' ' 116' ' ' GLN . 3.7 mm? -95.97 -23.97 16.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.688 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.808 ' HG2' HG21 ' A' ' 85' ' ' VAL . 7.3 tmm_? -41.9 -30.84 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 111.447 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 61.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -109.04 157.6 36.56 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.979 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.5 -34.79 34.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.679 2.253 . . . . 0.0 112.272 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.7 m -69.79 -45.82 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.654 HG21 ' O ' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -55.13 -57.05 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.854 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 122' ' ' ASP . 5.1 mp -61.19 -32.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -69.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.982 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -34.3 77.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -50.34 -25.98 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.92 57.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.226 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 4.5 mmtp -87.1 -28.4 22.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.883 0.373 . . . . 0.0 110.939 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.4 -18.2 57.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.236 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER 63.15 26.73 15.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.79 122.45 27.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -50.25 153.07 2.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.66 136.75 27.09 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.619 2.213 . . . . 0.0 112.359 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.621 HG23 ' HB ' ' A' ' 141' ' ' THR . 5.2 mp -72.42 99.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.031 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -90.27 179.79 1.41 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.711 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 138' ' ' THR . 51.7 Cg_exo -53.11 -21.6 16.97 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.487 2.125 . . . . 0.0 112.326 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -38.09 12.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.621 ' HB ' HG23 ' A' ' 137' ' ' ILE . 19.3 m -52.35 -48.81 65.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.925 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -49.98 -60.07 3.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -52.53 -27.4 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -57.29 13.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.731 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 tp -54.77 -36.89 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.952 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -64.68 -39.74 94.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -58.74 -42.8 89.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.684 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -23.98 66.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.794 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.684 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.7 pp -119.08 19.18 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.74 -85.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.684 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 59.79 179.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 43.0 t -67.83 -14.87 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.502 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.443 ' CG ' ' HG2' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 80.17 141.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.719 0.295 . . . . 0.0 110.492 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.952 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 7.9 p90 -152.8 157.42 40.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 154' ' ' TYR . 1.2 m -158.1 122.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.476 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.546 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.9 pt-20 -172.42 150.65 2.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.708 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 72.1 m -102.15 -173.46 2.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.864 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.483 ' HB3' HD12 ' A' ' 117' ' ' ILE . 16.1 t -87.85 174.14 8.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 111.35 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.634 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -61.64 -175.87 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.087 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 65.03 -71.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.022 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' ALA . 35.8 p -69.11 -83.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.673 ' CG ' HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER 69.77 113.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.489 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.4 ' CD ' ' SG ' ' A' ' 157' ' ' CYS . 5.7 mttp -101.4 -67.45 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.33 . . . . 0.0 111.222 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.77 88.18 0.14 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -93.84 -15.24 25.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.546 0.212 . . . . 0.0 111.288 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -42.78 73.24 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.867 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -52.77 -64.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.9 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -49.32 -29.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.74 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -59.01 -44.86 91.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.801 179.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.933 ' HA ' HD13 ' B' ' 75' ' ' ILE . 36.3 t0 -61.18 -37.5 83.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.019 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.2 OUTLIER -71.15 -22.27 62.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.576 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.44 -54.05 4.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.064 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 46' ' ' ILE . 10.4 mt -63.46 -39.12 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD12 HD22 ' A' ' 177' ' ' LEU . 13.1 tp -76.5 -36.08 58.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.05 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -53.61 -46.46 70.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.81 ' HB1' ' OD2' ' A' ' 76' ' ' ASP . . . -75.91 -28.24 57.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.069 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -53.97 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.022 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.25 68.11 3.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.799 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 38.4 Cg_endo -66.63 108.32 1.41 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.0 112.322 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 38.2 Cg_endo -66.67 101.34 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.461 2.107 . . . . 0.0 112.223 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.432 ' N ' ' HD2' ' A' ' 182' ' ' PRO . 4.2 mm-40 -67.76 -61.62 4.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 181' ' ' GLU . 36.3 Cg_endo -65.25 119.51 6.55 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.585 2.19 . . . . 0.0 112.366 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.67 175.47 10.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.895 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 46' ' ' ILE . 2.8 m -50.53 -44.72 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 170' ' ' ASP . 0.7 OUTLIER -144.16 133.64 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.03 142.79 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -70.53 136.77 85.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.704 ' HB2' HG12 ' A' ' 42' ' ' VAL . 51.0 Cg_exo -54.43 154.4 19.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.516 2.144 . . . . 0.0 112.019 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.7 m -116.88 -83.29 0.64 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.394 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.79 99.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 13.8 t80 -123.19 129.46 51.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.23 142.31 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.0 102.51 1.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.613 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -86.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.438 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.609 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -104.35 127.47 58.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 111.191 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -105.79 99.18 8.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 36' ' ' VAL . 74.1 t -85.56 151.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.33 165.58 28.23 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.054 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.63 106.75 18.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.005 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.601 ' HB2' HG23 ' B' ' 97' ' ' THR . 16.0 t0 -124.08 118.24 26.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.31 0.71 21.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 1.063 HG13 HG22 ' B' ' 93' ' ' THR . 12.7 p -47.34 -27.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-O 121.027 0.441 . . . . 0.0 110.967 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 1.063 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -152.11 20.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.981 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.92 68.45 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.038 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.908 ' HG2' HG23 ' B' ' 93' ' ' THR . 10.2 pt-20 -132.41 164.89 25.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.079 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.609 ' HD2' ' HE1' ' B' ' 99' ' ' MET . 7.4 m-85 -79.11 154.65 29.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.811 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.601 HG23 ' HB2' ' B' ' 90' ' ' ASP . 19.1 p -93.5 169.47 10.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.21 23.54 8.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.418 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.609 ' HE1' ' HD2' ' B' ' 96' ' ' PHE . 0.1 OUTLIER -49.82 106.16 0.6 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.492 0.186 . . . . 0.0 110.959 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 37' ' ' PHE . 67.2 Cg_exo -36.0 152.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.965 2.443 . . . . 0.0 112.906 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -66.69 0.28 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.716 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.28 -52.0 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.075 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.954 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.5 m0 -48.27 -62.5 1.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.127 0.489 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -47.57 -69.2 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.546 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 0.6 OUTLIER -46.64 -38.5 9.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.421 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -49.48 -57.11 7.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.37 . . . . 0.0 110.568 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.77 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.3 -69.28 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.751 ' O ' HG23 ' B' ' 109' ' ' THR . 8.3 tp60 -79.18 -100.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.785 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.751 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.3 p -168.62 -41.46 0.02 OUTLIER 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.034 0.445 . . . . 0.0 110.736 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.519 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -134.23 170.58 15.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.212 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 99' ' ' MET . 10.9 m120 -54.31 -63.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.966 0.413 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.722 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.0 OUTLIER -121.32 87.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.557 0.694 . . . . 0.0 109.37 178.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.445 ' OG1' HD13 ' B' ' 112' ' ' ILE . 7.5 m 69.66 -63.33 0.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' B' ' 110' ' ' SER . 1.8 mtpt -147.23 40.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.941 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.16 -67.88 0.2 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -86.45 145.74 26.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -92.13 143.83 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.938 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.634 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.8 91.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.808 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -89.86 159.51 16.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.25 136.96 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.262 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 4.4 mptt -118.91 96.41 5.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.22 97.36 4.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.994 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 75' ' ' THR . 12.7 t -84.45 111.26 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.77 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 55' ' ' LEU . 10.7 m -105.43 129.57 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.39 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.784 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.1 p -126.49 138.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.078 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.98 120.52 0.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.649 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.86 -31.23 70.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.029 0.442 . . . . 0.0 110.488 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.71 -32.12 83.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.446 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.96 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 54.01 23.49 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.889 0.376 . . . . 0.0 111.032 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG13 ' N7 ' ' A' ' 185' ' ' GNP . 45.3 t -91.19 -17.89 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' HB2' ' A' ' 81' ' ' CYS . . . -130.2 -8.82 3.18 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.263 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.623 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.8 pttt -94.9 -57.59 2.4 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.055 0.455 . . . . 0.0 110.201 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.96 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 5.2 t -96.59 -41.8 8.36 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.013 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' C8 ' ' A' ' 185' ' ' GNP . 2.8 m -64.28 -25.93 68.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.619 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -42.75 -72.74 0.06 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.585 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' HB2' ' A' ' 40' ' ' TYR . 16.4 mt -63.45 -33.81 76.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.152 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 25' ' ' THR . 0.8 OUTLIER -55.29 -43.72 72.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.146 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.521 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 15.0 m -95.96 -26.68 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.806 ' HB3' HD21 ' B' ' 77' ' ' LEU . 3.7 m-30 -80.73 -67.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 81' ' ' PHE . 55.0 m -79.65 -83.03 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.487 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.53 HG21 ' CE ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -50.53 -24.86 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.187 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.28 38.71 2.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.7 OUTLIER -114.24 -165.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.981 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -122.37 141.84 35.68 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.953 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 51.7 Cg_exo -34.86 136.44 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.209 2.606 . . . . 0.0 113.267 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 p -105.78 -84.37 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.442 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 95.34 5.94 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.203 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' CD1' ' O1G' ' A' ' 185' ' ' GNP . 1.3 t80 -66.48 105.91 1.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.229 0.537 . . . . 0.0 111.378 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' THR . 3.6 p -160.63 134.06 4.84 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.541 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.22 89.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.435 2.09 . . . . 0.0 112.221 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.474 HG21 ' OD2' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -72.98 86.65 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.113 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.792 HG21 ' CD2' ' B' ' 96' ' ' PHE . 22.9 m -68.09 -22.54 27.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.244 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 56' ' ' PHE . 2.9 t80 -129.21 -76.2 0.55 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.569 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' OD2' HG21 ' A' ' 35' ' ' THR . 32.8 t0 61.39 118.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.599 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' CB ' HD12 ' B' ' 85' ' ' ILE . 12.0 t-20 -107.49 148.98 28.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.576 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.567 ' HB2' HD12 ' A' ' 20' ' ' LEU . 1.2 m-85 -141.49 143.1 33.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.213 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.99 131.54 40.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.592 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.2 m -150.53 163.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.122 0.487 . . . . 0.0 111.618 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 51' ' ' TYR . 93.3 m -155.73 101.41 2.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.001 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.945 HG13 ' O ' ' B' ' 76' ' ' SER . 11.9 t -98.41 130.96 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.211 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 19.5 mtm -91.06 99.92 12.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 177' ' ' LEU . 19.8 mt -101.48 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.67 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.01 12.94 72.92 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.355 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.21 34.22 6.85 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.706 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 45' ' ' MET . 24.4 mt-10 -141.78 134.81 14.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.582 0.23 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.35 167.96 10.33 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.113 . . . . 0.0 112.287 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' H ' HG23 ' A' ' 43' ' ' THR . 2.9 m-85 -153.81 168.49 26.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.288 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.8 p -135.24 97.4 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.505 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.8 tt -115.82 160.92 19.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.812 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -161.11 120.81 0.97 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 16' ' ' LYS . 10.0 mp -77.04 102.82 6.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.918 0.39 . . . . 0.0 110.927 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 9.8 m-85 -84.1 104.95 14.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 58' ' ' THR . 40.0 m-20 -66.84 175.85 2.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.716 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 57' ' ' ASP . 23.1 p -161.43 128.95 4.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.906 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -58.49 170.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.34 -18.51 66.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.538 HD22 ' H ' ' A' ' 61' ' ' LEU . 2.6 mm? -63.35 150.45 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.314 . . . . 0.0 110.918 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.53 34.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -116.7 20.54 13.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -78.38 -10.48 59.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.382 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -42.54 -30.64 0.37 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -79.55 -45.56 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 70' ' ' LEU . 1.4 mp -95.18 25.27 4.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.453 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -98.02 -49.61 0.22 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.675 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 60.1 Cg_exo -51.41 -43.1 51.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 121.965 1.776 . . . . 0.0 111.838 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.846 HD22 ' CG ' ' B' ' 103' ' ' TRP . 1.0 OUTLIER -49.08 -24.57 1.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.246 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.812 ' N ' HD12 ' A' ' 70' ' ' LEU . 1.3 p -104.52 -20.65 13.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.336 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.572 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 60.38 139.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.895 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' ' HG2' ' A' ' 106' ' ' PRO . 96.9 Cg_endo -82.7 -47.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.656 2.237 . . . . 0.0 112.584 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -69.23 -10.69 58.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.537 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 HG23 ' A' ' 7' ' ' VAL . 6.2 t -40.89 -52.21 3.09 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' N ' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -173.17 -167.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.374 . . . . 0.0 111.036 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 78' ' ' PHE . 11.1 p -65.4 162.41 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 77' ' ' VAL . 15.0 m-85 -110.48 134.61 52.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.929 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 ' CB ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -104.31 120.33 40.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.5 t -131.16 153.76 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.5 ' HB2' ' N ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER -144.64 175.89 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 111.672 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG11 ' A' ' 93' ' ' VAL . 11.0 p90 -167.21 -176.05 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.703 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.789 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.9 t -135.07 44.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 177.38 -70.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.484 ' H ' HG23 ' A' ' 85' ' ' VAL . 59.3 m -44.48 100.6 0.23 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.194 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.91 -36.4 83.53 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.667 2.245 . . . . 0.0 112.296 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 t -49.95 -32.37 14.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 t -96.0 -33.08 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 137' ' ' ILE . 1.4 t80 -55.76 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -48.86 -26.13 2.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 17.9 m-20 -73.2 -65.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.083 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.648 HG13 ' HD1' ' A' ' 97' ' ' TRP . 61.1 t -41.71 -33.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.829 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.617 ' HD3' HD11 ' A' ' 145' ' ' LEU . 9.2 ttpt -79.09 -62.38 1.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.17 7.79 6.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -117.8 -41.57 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.821 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.648 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.2 m95 -95.23 -39.58 10.0 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 98.1 t -47.57 -43.31 49.14 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.632 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.8 Cg_exo -67.76 -31.85 31.25 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.525 2.15 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -93.13 -22.76 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.79 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 10.2 tt -47.05 -27.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 p -74.94 -40.14 60.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -59.25 -39.12 81.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 0.0 110.407 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 7.2 m-70 -93.73 -26.18 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.557 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -123.86 66.54 39.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.731 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 73' ' ' PRO . 36.3 Cg_endo -65.44 111.56 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.66 2.24 . . . . 0.0 112.472 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.96 48.7 22.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.014 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 109' ' ' PRO . 69.9 m -140.89 140.59 21.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.833 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 108' ' ' THR . 19.5 Cg_endo -58.4 169.98 2.7 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 0.0 111.914 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' CB ' HD11 ' A' ' 101' ' ' ILE . 3.1 p90 -159.84 137.72 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.411 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 mp -100.96 124.29 46.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.154 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' HG ' ' CZ ' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -134.71 102.12 5.16 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.626 HG23 ' CB ' ' A' ' 142' ' ' ALA . 4.0 p -145.3 108.0 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 155.47 42.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.539 HG22 ' HG3' ' A' ' 156' ' ' GLU . 1.2 p -148.16 115.76 6.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -169.97 72.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 157' ' ' CYS . 24.9 mt -64.87 -62.52 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -50.93 -60.0 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -48.64 -48.37 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.064 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.592 ' HG3' HG11 ' A' ' 85' ' ' VAL . 22.0 ttp85 -50.34 -28.23 7.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.61 -15.46 61.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.485 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.54 ' O ' HD12 ' A' ' 126' ' ' ILE . 4.3 m-20 -53.84 143.83 38.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.757 0.313 . . . . 0.0 110.967 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.74 -45.02 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.0 m -49.25 -40.2 33.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.6 p -53.6 -63.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.61 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.8 mp -50.97 -39.51 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.92 -63.26 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.09 -34.6 66.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 136' ' ' PRO . 1.2 mt -50.15 -26.28 4.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.959 0.409 . . . . 0.0 110.459 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.42 61.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.908 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -84.54 -16.66 41.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -93.63 29.59 1.98 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.16 33.64 2.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 50.04 -163.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.28 75.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.629 ' HB3' HD13 ' A' ' 129' ' ' LEU . 57.2 Cg_endo -70.69 169.14 20.83 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.697 2.265 . . . . 0.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.643 HG23 ' CG2' ' A' ' 141' ' ' THR . 4.0 mp -97.95 131.9 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.062 0.458 . . . . 0.0 111.117 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.478 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -129.57 -179.24 0.96 Allowed Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.266 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 61.2 Cg_exo -52.14 -21.26 12.41 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.442 2.095 . . . . 0.0 112.496 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.0 -40.79 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.643 ' CG2' HG23 ' A' ' 137' ' ' ILE . 96.8 m -48.37 -47.24 37.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.184 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.626 ' CB ' HG23 ' A' ' 113' ' ' VAL . . . -49.2 -50.89 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.835 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -32.0 73.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.414 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -55.43 -49.61 71.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.481 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 149' ' ' LEU . 6.5 tt -66.12 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.501 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.879 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -68.53 -49.07 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.902 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -63.46 -35.14 79.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -31.01 71.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.735 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 145' ' ' LEU . 4.1 pp -98.66 -20.12 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.143 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.664 ' N ' HD12 ' A' ' 149' ' ' LEU . 5.4 mmtm 63.13 93.68 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.556 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -136.55 -173.43 3.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 153' ' ' LYS . 9.2 p -41.72 -45.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.606 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 112.81 139.26 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.589 1.18 . . . . 0.0 109.959 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.879 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -153.65 140.57 19.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.971 0.415 . . . . 0.0 111.687 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 155' ' ' VAL . 34.7 m -158.47 125.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.666 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.4 pt-20 -161.02 174.15 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.652 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.944 ' HB2' HD11 ' A' ' 117' ' ' ILE . 16.9 p -135.23 -170.73 2.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.995 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 164.44 17.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.815 0.34 . . . . 0.0 110.506 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -40.72 -90.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.067 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -54.07 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.699 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 170.04 -66.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.647 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.535 ' NE2' HD22 ' A' ' 165' ' ' LEU . 4.0 mm-40 43.73 96.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.604 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.84 -49.47 3.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.74 68.52 0.35 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.973 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.694 HD21 ' CD1' ' A' ' 23' ' ' TYR . 2.6 tp -93.02 -22.27 19.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 0.0 111.408 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -41.93 75.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.01 -65.21 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 169' ' ' PHE . 7.5 p -46.67 -49.1 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.466 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 39.8 t80 -55.09 -43.79 74.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.016 0.436 . . . . 0.0 110.639 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' B' ' 75' ' ' ILE . 45.5 m-20 -53.09 -43.16 66.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.474 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.42 -44.82 23.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.83 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.925 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.466 HG13 ' CE2' ' A' ' 169' ' ' PHE . 19.6 mm -94.95 -30.2 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.36 -46.18 80.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.87 -26.24 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.216 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . . . -65.93 -50.56 63.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' HD13 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -90.69 65.96 6.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.944 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -71.96 -61.01 2.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 178' ' ' GLU . 54.6 Cg_endo -69.79 158.64 56.24 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.611 2.207 . . . . 0.0 112.403 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.36 175.92 9.36 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 108.39 1.22 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.44 151.83 9.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.449 2.099 . . . . 0.0 112.275 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 -178.82 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 75' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 60.23 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.338 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 170' ' ' ASP . 8.5 tt -127.13 145.87 33.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.945 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -138.39 132.19 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -59.74 145.32 83.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' B' ' 77' ' ' LEU . 73.9 Cg_exo -50.49 -175.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.733 2.288 . . . . 0.0 112.545 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 73.4 m -153.72 -63.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.504 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 2.2 t80 -98.44 139.71 33.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.81 124.76 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.783 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.453 ' CD2' ' OD1' ' A' ' 38' ' ' ASP . 2.9 t-160 -68.21 78.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.244 0.545 . . . . 0.0 110.129 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.98 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.572 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -119.33 110.34 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -91.22 96.54 10.62 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 36' ' ' VAL . 60.3 t -78.1 137.27 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.562 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.61 177.74 17.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.191 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -78.11 123.86 27.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 111.034 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.566 ' CG ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -114.95 97.87 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.08 -18.68 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.585 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.536 HG13 ' N ' ' B' ' 93' ' ' THR . 13.3 p -45.37 -46.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.747 0.308 . . . . 0.0 111.493 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.536 ' N ' HG13 ' B' ' 92' ' ' VAL . 6.6 t -121.94 -10.74 8.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.687 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.58 18.92 21.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.309 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.406 ' CD ' HG21 ' B' ' 93' ' ' THR . 14.1 pt-20 -124.47 -160.73 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.648 0.261 . . . . 0.0 110.708 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.792 ' CD2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -98.34 164.32 12.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.566 HG23 ' CG ' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -101.46 167.94 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.966 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 47.84 33.83 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.373 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.595 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.99 117.86 5.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.46 0.171 . . . . 0.0 111.179 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.458 ' HD3' HG22 ' B' ' 87' ' ' VAL . 92.4 Cg_exo -42.88 155.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.054 . . . . 0.0 112.294 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -47.77 -54.05 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -55.85 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.846 ' CG ' HD22 ' A' ' 70' ' ' LEU . 6.0 m0 -47.83 -57.54 5.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 99' ' ' MET . . . -49.73 -65.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.346 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.45 ' CG ' ' O ' ' B' ' 109' ' ' THR . 3.7 mtt-85 -49.11 -44.52 42.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.96 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.43 -61.24 1.42 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.3 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.656 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -94.75 -68.79 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.273 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.561 ' O ' HG23 ' B' ' 109' ' ' THR . 0.1 OUTLIER -78.45 -97.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.89 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.561 HG23 ' O ' ' B' ' 108' ' ' GLN . 22.5 p -160.48 -55.06 0.05 Allowed 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.423 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.3 OUTLIER -151.63 172.44 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 112.121 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' B' ' 99' ' ' MET . 7.2 p30 -64.37 75.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.537 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' B' ' 112' ' ' ILE . 0.0 OUTLIER -56.55 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.483 0.658 . . . . 0.0 111.004 -179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' B' ' 112' ' ' ILE . 1.2 m 160.27 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.63 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 116' ' ' GLU . 23.0 tttp 78.98 43.63 0.07 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.34 -64.0 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.812 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 114' ' ' LYS . 2.9 tt0 74.28 118.47 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -126.02 134.89 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.707 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.565 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.88 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.819 0.342 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.9 -171.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.92 135.63 36.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.982 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.675 HG22 ' HB1' ' A' ' 176' ' ' ALA . 4.8 pt -149.63 111.13 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -134.26 99.73 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.432 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 6.0 m -77.27 152.4 34.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 56' ' ' PHE . 17.4 t -136.9 143.9 33.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.285 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 9' ' ' VAL . 6.5 p -85.01 160.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' HG22 ' A' ' 8' ' ' VAL . 3.9 m -138.09 121.18 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.22 173.9 31.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.22 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.409 ' HB2' ' NE1' ' A' ' 97' ' ' TRP . 16.3 m-20 -89.54 110.42 21.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.739 0.304 . . . . 0.0 110.769 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -161.15 -39.36 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.786 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 83.45 -47.99 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG12 ' N7 ' ' A' ' 185' ' ' GNP . 18.5 m -47.07 -25.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -56.33 -94.44 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.477 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.627 ' HZ1' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.83 -71.57 0.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.923 ' O ' HD13 ' A' ' 21' ' ' ILE . 1.1 t -36.0 -58.42 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.786 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 10.9 m -68.94 -26.86 65.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.964 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 15' ' ' GLY . 3.0 tp -58.38 -76.85 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.819 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 42' ' ' VAL . 12.9 mt -48.91 -33.35 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.856 -0.528 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 17' ' ' THR . 1.2 mp -51.16 -68.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 3.6 t -93.33 -57.19 2.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.427 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.593 ' O ' HD21 ' B' ' 77' ' ' LEU . 10.4 t80 -39.28 -39.89 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.06 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.661 HG21 HG12 ' A' ' 42' ' ' VAL . 62.7 m -104.72 -75.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -71.22 -15.33 62.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 9.5 t-20 65.59 36.92 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.752 0.31 . . . . 0.0 111.165 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 1.5 tttp 176.6 164.92 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -134.22 60.97 47.64 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.69 0.281 . . . . 0.0 111.748 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 80.9 Cg_endo -91.63 126.56 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.064 2.51 . . . . 0.0 112.516 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.7 p 171.82 -88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.991 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.96 153.04 13.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 3.0 t80 -91.02 111.92 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.014 0.435 . . . . 0.0 110.835 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' A' ' 34' ' ' PRO . 95.0 t -158.67 140.38 9.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.677 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' A' ' 33' ' ' VAL . 82.0 Cg_exo -46.61 91.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.262 1.975 . . . . 0.0 111.446 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.809 HG23 ' CG ' ' A' ' 38' ' ' ASP . 54.5 m -52.9 87.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.544 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.504 HG11 ' CG ' ' B' ' 96' ' ' PHE . 37.2 t -75.4 -25.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 109.898 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.557 ' HE2' HD13 ' B' ' 85' ' ' ILE . 4.2 t80 -148.29 -68.82 0.23 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.247 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.809 ' CG ' HG23 ' A' ' 35' ' ' THR . 3.0 m-20 57.97 111.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.331 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.587 ' HB3' HD12 ' B' ' 85' ' ' ILE . 11.2 t-20 -107.96 148.82 29.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 110.877 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -148.08 142.15 25.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.599 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -83.22 152.17 25.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 24' ' ' THR . 1.2 m -162.43 148.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -132.09 104.81 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 173' ' ' ILE . 4.0 t -97.31 117.23 41.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.151 0.5 . . . . 0.0 110.58 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.8 mtm -100.23 100.01 10.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.947 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 46' ' ' ILE . 12.3 tt -109.85 109.54 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.982 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.25 15.81 61.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.545 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.68 -43.01 1.94 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.616 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.61 142.91 66.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.293 . . . . 0.0 111.057 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.81 173.98 11.85 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.322 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -153.28 146.46 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.8 m -99.72 97.42 8.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.033 HD21 HD12 ' A' ' 55' ' ' LEU . 7.9 tt -112.33 156.5 22.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.994 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.99 112.33 0.53 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.033 HD12 HD21 ' A' ' 53' ' ' LEU . 3.6 mp -85.5 103.34 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.927 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.4 m-85 -92.26 118.34 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.35 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 37' ' ' PHE . 14.2 t70 -72.17 166.36 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 64' ' ' TYR . 43.7 m -169.32 128.59 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.544 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -77.94 -73.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.69 -137.67 6.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.1 mt 71.73 -174.23 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -96.08 -16.89 21.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.393 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 71.5 m-20 -76.34 -19.27 58.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.4 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -70.33 -16.79 63.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.542 0.21 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -48.04 -25.73 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 5.7 ptp180 -91.99 -40.95 10.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.124 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.052 HD22 ' CE2' ' B' ' 96' ' ' PHE . 27.3 tp -86.78 1.13 53.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.51 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.01 -47.28 0.39 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.838 -0.164 . . . . 0.0 111.282 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 76.3 Cg_exo -49.08 -25.21 8.78 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.19 1.927 . . . . 0.0 111.411 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.77 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -65.02 -28.15 69.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.497 ' C ' ' CG ' ' A' ' 72' ' ' TYR . 22.5 m -100.15 -14.89 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.262 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CG ' ' C ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 54.58 141.34 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 123.252 0.621 . . . . 0.0 112.03 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.99 -34.51 2.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -10.71 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.322 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.495 HG21 HG23 ' A' ' 7' ' ' VAL . 9.0 t -40.6 -47.88 2.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.572 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 4' ' ' ILE . 1.3 m-20 169.06 -168.54 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 111' ' ' LEU . 12.2 p -58.29 141.97 14.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.448 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 105' ' ' CYS . 10.3 m-85 -92.9 143.7 26.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.627 HD23 ' HZ1' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.68 115.94 31.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.219 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 101' ' ' ILE . 2.7 t -89.26 93.69 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.962 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.455 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 28.1 p -67.62 110.38 3.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.744 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 93' ' ' VAL . 2.6 t80 -131.92 105.8 7.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.42 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 t -50.66 156.83 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.914 HG13 HG22 ' A' ' 137' ' ' ILE . 63.0 t -83.49 -75.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 120' ' ' ARG . 97.9 t -69.26 -101.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.522 ' N ' HG12 ' A' ' 85' ' ' VAL . 17.7 m 33.72 57.59 1.76 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.605 ' HD3' HG12 ' A' ' 85' ' ' VAL . 2.7 Cg_endo -46.06 -25.65 3.04 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.9 2.4 . . . . 0.0 112.362 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.39 -26.04 26.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.1 m -96.28 -38.78 9.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.254 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -45.17 -66.99 0.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.238 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 -55.55 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.6 OUTLIER -54.17 -64.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.914 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 89' ' ' SER . 48.0 t -41.37 -36.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.813 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HD3' HD21 ' A' ' 145' ' ' LEU . 25.1 tptp -63.2 -69.99 0.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.783 0.325 . . . . 0.0 111.322 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 2.4 mp0 -82.78 8.62 11.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tptp -117.43 -44.93 2.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' HD1' HG13 ' A' ' 93' ' ' VAL . 14.4 m95 -95.12 -28.19 15.2 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.825 ' O ' HG22 ' A' ' 101' ' ' ILE . 24.5 t -70.03 -44.56 21.5 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.704 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.5 Cg_exo -51.06 -29.31 27.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.23 1.953 . . . . 0.0 112.57 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -93.11 -17.51 23.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.666 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.894 HD11 HG22 ' A' ' 80' ' ' VAL . 9.6 tt -47.5 -35.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.805 0.336 . . . . 0.0 111.29 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 p -65.62 -38.33 89.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.546 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -61.67 -29.46 70.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.179 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -87.06 -48.96 7.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 28.9 p -104.04 96.55 9.66 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 111.005 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.56 100.45 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.573 2.182 . . . . 0.0 112.334 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.82 5.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 m -117.32 131.17 24.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.55 175.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.483 2.122 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 149' ' ' LEU . 3.9 p90 -163.15 159.42 22.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 77' ' ' VAL . 8.7 mp -111.96 120.08 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.847 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.513 HD13 ' C ' ' A' ' 112' ' ' LEU . 1.3 tm? -95.19 102.49 14.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.69 160.39 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.373 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -147.45 137.3 6.51 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.364 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.97 HG21 ' C6 ' ' A' ' 185' ' ' GNP . 6.5 p -130.26 -155.62 0.71 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.1 tp60 82.4 77.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.415 HG13 ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -100.12 -34.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -78.04 -51.72 9.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.268 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -51.54 -40.37 59.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 111.069 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.873 ' HB2' HG21 ' A' ' 85' ' ' VAL . 7.6 ptt85 -72.44 61.93 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.795 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -137.72 46.7 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.022 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.32 145.89 34.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.62 -45.21 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.317 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.9 t -49.96 -45.93 51.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.79 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -29.62 20.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.556 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.8 mm -66.09 -57.35 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.054 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -48.43 -38.19 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.056 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -39.09 17.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.976 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.482 HD13 ' HG3' ' A' ' 136' ' ' PRO . 6.2 mt -51.18 -25.54 5.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.409 . . . . 0.0 110.436 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.82 -19.18 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -31.9 33.78 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -67.62 -19.46 65.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.13 46.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.962 0.41 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.49 133.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.5 168.18 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HG3' HD13 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.54 129.22 32.73 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.59 2.193 . . . . 0.0 112.232 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.914 HG22 HG13 ' A' ' 84' ' ' VAL . 8.5 mt -60.41 129.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.471 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -128.09 179.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.948 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 73.0 Cg_exo -51.75 -21.67 11.9 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.674 2.25 . . . . 0.0 112.508 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.58 -53.37 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.547 ' CG2' HG23 ' A' ' 137' ' ' ILE . 54.4 m -46.21 -47.52 17.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.133 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.34 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -33.79 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.577 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -58.51 -56.62 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.506 HD21 ' HD3' ' A' ' 94' ' ' LYS . 17.9 tp -59.09 -52.94 63.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.434 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.642 ' CA ' HD23 ' A' ' 149' ' ' LEU . . . -57.91 -41.01 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.408 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.401 ' HA ' ' OH ' ' A' ' 154' ' ' TYR . 48.4 ttt-85 -50.16 -41.56 49.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.44 -21.74 64.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.935 HD13 ' CE1' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -74.84 -28.47 60.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.168 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 tttt 66.83 58.81 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.648 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -107.28 -177.97 3.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.412 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 66.3 t -48.86 -64.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER 178.97 160.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.756 179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.802 ' HE2' ' HB3' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -154.34 111.23 3.35 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 168' ' ' VAL . 23.6 m -158.27 120.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.859 0.362 . . . . 0.0 110.412 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -173.18 -178.63 1.79 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.61 -173.42 4.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.89 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.415 ' OG ' HG13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -87.2 155.94 19.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.267 0.556 . . . . 0.0 111.301 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' A' ' 22' ' ' SER . . . -57.18 -158.85 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER 47.86 26.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 110.802 179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.512 ' NE2' ' N2 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER 73.62 121.46 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.03 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -105.42 -68.28 0.87 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.178 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.428 ' C ' HD23 ' A' ' 165' ' ' LEU . . . -162.86 85.19 0.11 Allowed Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.375 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -94.05 -10.11 34.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.728 0.299 . . . . 0.0 111.669 -179.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -43.74 -29.44 0.52 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.925 0.393 . . . . 0.0 111.135 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 155' ' ' VAL . 16.1 m-20 -64.37 -47.4 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.557 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 155' ' ' VAL . 86.1 t -54.45 -47.62 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.571 ' CD1' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -69.97 -38.76 76.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.746 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.37 -42.34 66.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.945 0.402 . . . . 0.0 110.269 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.436 ' CB ' ' HG2' ' A' ' 153' ' ' LYS . 1.6 tp10 -90.03 -41.53 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.72 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -60.48 -35.73 76.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.992 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 44' ' ' VAL . 29.6 mm -86.11 -44.65 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.37 -41.13 85.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 171' ' ' GLU . . . -52.3 -40.03 61.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.675 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -84.56 -23.83 29.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 46' ' ' ILE . 4.0 tp -48.91 -64.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.06 80.7 5.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -51.37 104.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.59 137.94 58.22 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.593 2.195 . . . . 0.0 112.236 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 6.0 mm-40 -86.24 -47.48 0.55 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 79.3 Cg_exo -48.15 121.79 6.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.471 2.114 . . . . 0.0 112.402 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 107.63 15.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.4 mttp . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.966 -179.925 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.22 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -96.35 142.61 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.058 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.48 144.89 51.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -72.53 129.29 87.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.72 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.579 ' HB2' HG12 ' A' ' 42' ' ' VAL . 9.2 Cg_endo -51.91 149.64 19.88 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.4 ' O ' ' N ' ' B' ' 81' ' ' PHE . 75.4 m -120.37 -64.07 1.29 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.071 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -47.53 93.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.13 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 40' ' ' TYR . 2.3 t80 -119.75 135.87 54.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.89 131.24 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.487 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.22 88.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.474 . . . . 0.0 110.397 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.572 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -56.11 -76.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.661 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -121.4 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.931 0.396 . . . . 0.0 111.788 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -105.31 97.48 7.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.907 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.5 t -77.62 145.38 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 0.0 111.707 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -146.31 167.49 27.94 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.227 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -92.19 126.82 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 110.971 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' B' ' 92' ' ' VAL . 37.1 t0 -135.82 135.14 39.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.758 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.42 1.72 18.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.009 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.619 HG13 ' OD1' ' B' ' 90' ' ' ASP . 11.5 m -45.5 -27.9 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.441 HG23 ' N ' ' B' ' 94' ' ' GLY . 12.8 t -153.41 -44.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.837 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . 0.441 ' N ' HG23 ' B' ' 93' ' ' THR . . . 132.57 35.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.367 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -144.66 -160.52 1.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.752 0.311 . . . . 0.0 110.598 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 1.052 ' CE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.56 147.3 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.437 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' B' ' 90' ' ' ASP . 34.3 p -90.71 178.49 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.801 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 51.74 32.28 32.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.633 ' CB ' ' HB2' ' B' ' 104' ' ' ALA . 1.8 tpt -44.1 101.92 0.27 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 0.0 111.423 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.454 ' HB2' ' HB2' ' B' ' 103' ' ' TRP . 82.7 Cg_exo -45.51 151.95 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.114 1.876 . . . . 0.0 112.077 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -43.97 -63.84 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.929 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 105' ' ' ARG . 0.2 OUTLIER -64.7 -61.29 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.747 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 67' ' ' LEU . 3.1 m0 -46.39 -50.62 16.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.633 ' HB2' ' CB ' ' B' ' 99' ' ' MET . . . -61.14 -66.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.171 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.0 ptm180 -47.35 -27.52 1.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.915 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.648 ' CG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -63.05 -62.92 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.331 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -94.89 -59.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.679 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 109' ' ' THR . 6.8 tp60 -77.82 -99.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.72 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.2 p -166.74 -52.17 0.03 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.891 0.377 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 99' ' ' MET . 0.3 OUTLIER -154.1 -176.5 5.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.434 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 99' ' ' MET . 26.7 t-20 -82.41 80.48 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.845 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.667 ' O ' HG23 ' B' ' 113' ' ' THR . 0.0 OUTLIER -57.14 88.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.701 0.762 . . . . 0.0 111.402 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.667 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.2 OUTLIER 164.63 -30.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.344 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.61 -66.48 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.671 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.4 t 45.06 95.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 174.32 145.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -109.37 146.26 34.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 tptt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.844 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.97 ' C6 ' HG21 ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.41 141.59 43.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 t -119.98 111.8 18.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.003 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -115.88 151.98 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -128.33 96.26 4.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.7 104.8 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 8' ' ' VAL . 25.7 t -84.71 158.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.72 HG23 ' CG2' ' A' ' 14' ' ' VAL . 34.4 m -140.76 150.71 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.405 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.8 m -145.12 135.2 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.335 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.72 146.08 4.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.69 152.58 39.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.58 0.228 . . . . 0.0 110.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 49.76 96.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.976 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 67.61 64.13 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.141 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 8' ' ' VAL . 7.6 p -48.56 -24.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.2 -32.84 2.6 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.919 ' HE3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -96.14 -73.45 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.637 0.256 . . . . 0.0 111.56 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.831 HG23 ' OD1' ' A' ' 57' ' ' ASP . 18.0 p -39.52 -61.31 0.82 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.775 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 6.1 p -46.43 -37.3 7.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 111.087 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 79' ' ' LEU . 5.9 tp -67.94 -71.46 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD12 ' CD2' ' B' ' 81' ' ' PHE . 1.7 mm? -38.18 -41.37 0.59 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.753 0.311 . . . . 0.0 111.604 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.719 HG21 ' HD3' ' A' ' 29' ' ' PRO . 4.4 mm -61.04 -45.05 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.449 ' HB3' " H2'" ' A' ' 185' ' ' GNP . 90.8 p -94.2 -64.02 1.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.337 0.589 . . . . 0.0 111.327 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.74 ' CD1' HD12 ' A' ' 165' ' ' LEU . 27.1 t80 -49.38 -47.88 47.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.197 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' HD2' ' B' ' 81' ' ' PHE . 94.5 m -97.45 -95.76 0.21 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.93 HG21 ' CE ' ' A' ' 27' ' ' LYS . 5.0 t -41.23 -29.38 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 t30 68.13 24.25 7.74 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.93 ' CE ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -112.41 -160.02 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.196 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -127.01 156.61 74.01 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.719 ' HD3' HG21 ' A' ' 21' ' ' ILE . 63.2 Cg_exo -36.68 142.33 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.071 2.514 . . . . 0.0 113.133 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.95 -83.32 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.537 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.94 97.31 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.377 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.38 106.45 1.73 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.098 0.475 . . . . 0.0 110.97 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 ' HD2' ' A' ' 34' ' ' PRO . 4.4 p -160.6 139.64 7.79 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.179 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.4 Cg_exo -37.66 100.2 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.764 2.31 . . . . 0.0 112.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.554 HG23 HG21 ' A' ' 17' ' ' THR . 4.9 m -47.0 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.257 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 34' ' ' PRO . 91.2 t -91.21 -43.67 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.567 ' HB3' HG21 ' B' ' 87' ' ' VAL . 84.0 t80 -172.57 106.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.746 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.676 ' HB2' HG22 ' A' ' 17' ' ' THR . 30.0 m-20 -107.52 127.36 53.55 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.65 ' HB3' HD12 ' B' ' 85' ' ' ILE . 31.4 t-20 -107.48 147.01 31.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.113 0.482 . . . . 0.0 111.309 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.695 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.27 161.11 43.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.187 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.82 116.75 29.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.182 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 55' ' ' LEU . 1.3 m -124.92 124.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.947 0.403 . . . . 0.0 111.76 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -122.27 95.94 4.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.459 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.88 HG23 ' O ' ' B' ' 76' ' ' SER . 10.7 p -97.34 116.78 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.793 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.8 mtm -89.04 114.99 26.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.047 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.691 HG23 ' O ' ' B' ' 74' ' ' SER . 9.0 mt -115.8 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 73' ' ' GLY . . . 85.79 18.73 59.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.21 33.45 44.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.544 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -139.15 147.33 52.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.66 162.9 35.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.491 2.127 . . . . 0.0 112.207 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -154.34 167.53 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.5 m -131.87 97.04 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.214 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.75 158.94 16.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.29 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.92 103.72 0.26 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.054 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.39 103.32 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -83.71 102.95 12.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.172 179.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.831 ' OD1' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -71.38 -178.07 2.0 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.985 0.421 . . . . 0.0 111.111 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -170.53 172.81 5.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.701 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -87.39 -61.45 1.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.253 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.51 18.46 9.04 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 mt -94.33 -173.83 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.801 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.67 39.0 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -135.64 12.33 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.346 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.697 ' CE2' HG22 ' A' ' 58' ' ' THR . 1.3 m-85 -86.69 2.68 47.73 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.525 0.202 . . . . 0.0 111.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.3 p-10 -49.43 -25.63 2.7 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -39.07 12.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.374 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.94 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -96.84 26.32 4.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.538 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.568 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -90.49 -26.57 0.3 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 72.5 Cg_endo -76.72 -22.91 11.51 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.455 1.437 . . . . 0.0 111.667 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' B' ' 103' ' ' TRP . 7.4 mt -60.19 -18.27 47.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -94.38 -27.24 16.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 50.04 168.47 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.976 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 72' ' ' TYR . 14.1 Cg_endo -57.4 -17.62 27.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.422 2.081 . . . . 0.0 112.198 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.63 -10.76 38.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.364 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 7' ' ' VAL . 12.2 t -38.3 -30.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.03 -154.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.683 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 78' ' ' PHE . 41.4 t -57.84 161.14 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -111.94 122.08 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.945 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.919 HD23 ' HE3' ' A' ' 16' ' ' LYS . 1.9 tp -103.83 121.51 43.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.291 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.734 ' N ' HD12 ' A' ' 79' ' ' LEU . 2.3 t -131.06 138.12 54.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.439 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.7 m -129.95 152.99 48.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' HE1' HG12 ' A' ' 84' ' ' VAL . 26.9 p90 -138.65 176.13 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' A' ' 116' ' ' GLN . 91.5 p -89.69 120.03 30.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.537 HG12 ' HE1' ' A' ' 82' ' ' PHE . 32.3 m -93.06 40.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.002 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.786 HG12 ' N ' ' A' ' 120' ' ' ARG . 19.4 m -95.46 -45.77 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 85' ' ' VAL . 2.0 p -139.46 139.35 22.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.74 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 132' ' ' ASN . 42.6 Cg_endo -68.53 -17.81 43.34 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.579 2.186 . . . . 0.0 112.469 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 t -51.68 -23.73 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -93.32 -29.91 15.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.169 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 2.7 m-85 -46.44 -44.93 17.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.193 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -55.65 -58.26 8.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.081 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.7 m120 -63.17 -36.71 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.244 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 89' ' ' SER . 72.7 t -48.63 -65.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.435 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HD3' HD11 ' A' ' 145' ' ' LEU . 13.0 mtmm -73.33 -37.25 66.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.479 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.71 -12.39 61.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.9 tttm -119.03 -25.88 6.11 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.638 ' CZ3' HG13 ' A' ' 93' ' ' VAL . 31.2 m0 -93.29 -49.03 6.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.625 0.25 . . . . 0.0 111.313 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.919 ' O ' HG22 ' A' ' 101' ' ' ILE . 48.8 t -47.6 -43.93 52.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.1 Cg_exo -67.38 -26.53 41.09 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.53 2.154 . . . . 0.0 112.589 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.05 -35.21 15.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.439 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -47.67 -27.58 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.367 . . . . 0.0 111.294 -179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -89.13 -33.23 17.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -51.92 -44.68 63.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.408 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 0.1 OUTLIER -84.32 -46.59 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -97.34 104.23 19.12 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.746 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 95.9 Cg_exo -41.65 -51.12 4.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.554 2.17 . . . . 0.0 112.565 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -173.79 48.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.621 HG23 ' HD2' ' A' ' 109' ' ' PRO . 56.6 m -103.97 142.79 25.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.621 ' HD2' HG23 ' A' ' 108' ' ' THR . 78.7 Cg_exo -39.79 129.08 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.547 2.165 . . . . 0.0 112.086 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.6 p90 -102.53 173.75 6.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.164 0.507 . . . . 0.0 111.48 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.985 HD22 ' CE2' ' A' ' 154' ' ' TYR . 3.0 mt -151.74 126.25 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.876 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 146' ' ' ALA . 4.1 tt -143.63 125.64 15.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.675 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 154' ' ' TYR . 7.1 p -157.05 134.58 2.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.326 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.629 ' H ' ' HB1' ' A' ' 142' ' ' ALA . . . -105.94 158.62 15.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.555 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.492 ' CG2' ' C8 ' ' A' ' 185' ' ' GNP . 13.0 t -168.87 144.36 3.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.733 0.302 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.492 ' HG3' " C4'" ' A' ' 185' ' ' GNP . 2.3 mt-30 172.06 55.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.45 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 158' ' ' SER . 38.3 mt -52.88 -24.46 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.442 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 28.0 t70 -82.26 -55.22 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.231 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.47 ' C ' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -63.29 -40.76 98.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.195 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.786 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -66.25 71.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -174.97 53.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -98.45 161.24 25.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.99 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.12 -26.17 15.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.832 2.355 . . . . 0.0 112.255 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 -28.71 16.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -48.98 -68.27 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.088 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.2 mp -45.36 -39.69 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.445 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -61.29 2.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -75.14 -35.38 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -49.7 -27.74 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.407 . . . . 0.0 110.686 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.95 -20.36 62.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.404 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -89.92 -21.56 22.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.19 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.465 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 1.3 t-20 -88.21 -26.67 22.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.172 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 166.78 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 87.18 -175.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.643 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 1.4 tmmt? 63.22 129.03 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.476 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.5 140.18 62.0 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.429 2.086 . . . . 0.0 112.458 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG23 ' CB ' ' A' ' 141' ' ' THR . 5.9 mt -70.2 118.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.969 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.81 156.9 34.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.334 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -40.07 -29.46 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.293 2.662 . . . . 0.0 112.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.31 -43.74 73.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.412 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.412 ' CB ' HG23 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -46.58 -66.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.32 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.629 ' HB1' ' H ' ' A' ' 114' ' ' GLY . . . -47.41 -47.69 26.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.246 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -56.39 -44.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -39.97 75.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.631 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.68 HD11 ' HD3' ' A' ' 94' ' ' LYS . 1.8 tm? -57.0 -52.34 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.599 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 112' ' ' LEU . . . -60.57 -26.45 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -81.37 -35.52 30.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.9 -52.13 8.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.254 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -94.34 30.82 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.242 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.03 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 149' ' ' LEU . . . 51.65 -176.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.156 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 152' ' ' VAL . 42.5 t -71.46 -8.08 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.81 152.1 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.52 0.328 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.985 ' CE2' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -153.16 151.8 30.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.088 0.471 . . . . 0.0 111.884 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.2 m -158.75 124.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.447 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -168.89 -178.46 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.349 0.595 . . . . 0.0 111.749 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 13.7 p -141.77 -168.21 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.752 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -82.92 161.22 21.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 109.976 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.881 ' HB2' " O2'" ' A' ' 185' ' ' GNP . . . -45.54 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.959 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -37.04 -42.72 0.43 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.057 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.6 p -86.77 171.71 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.154 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.527 ' NE2' HN21 ' A' ' 185' ' ' GNP . 0.6 OUTLIER -163.39 89.01 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.166 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.1 -68.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.951 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.37 77.02 0.39 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.74 HD12 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -94.02 -32.81 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.138 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -65.66 -43.67 88.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 47.0 m-20 -51.72 -66.02 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 154' ' ' TYR . 2.1 p -42.92 -56.09 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.562 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 1.0 OUTLIER -52.12 -33.2 38.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 5.0 t0 -70.0 -31.14 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -88.99 -26.24 21.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.16 -24.53 21.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.988 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.643 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 15.8 mm -94.98 -57.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.1 tp -53.53 -24.67 14.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.77 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.034 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.62 -23.66 17.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.437 HD11 HD13 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -49.73 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.02 142.44 0.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.3 154.19 61.38 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.609 2.206 . . . . 0.0 112.243 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 171.42 16.31 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.23 151.52 81.26 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.22 124.42 12.9 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.197 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -76.23 87.21 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.932 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -60.85 -68.81 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 tt -144.03 151.43 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.103 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.88 ' O ' HG23 ' A' ' 44' ' ' VAL . 10.8 t -136.03 130.12 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.68 HD11 ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -47.17 139.47 7.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 169' ' ' PHE . 67.6 Cg_exo -50.68 142.47 31.79 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.345 2.03 . . . . 0.0 112.189 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 166.78 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.724 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.51 110.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.762 ' CD2' HD12 ' A' ' 20' ' ' LEU . 4.5 p90 -81.08 172.73 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.305 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -130.04 135.98 48.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.9 95.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.181 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -72.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -125.24 138.88 52.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.024 0.44 . . . . 0.0 111.936 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.16 98.03 5.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.715 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 37' ' ' PHE . 61.2 t -77.65 152.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.881 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.415 ' N ' HG12 ' B' ' 87' ' ' VAL . . . -146.39 177.88 24.44 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.152 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -77.16 124.59 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.803 0.335 . . . . 0.0 110.788 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.595 ' CB ' HG23 ' B' ' 97' ' ' THR . 11.0 t0 -114.86 108.33 16.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.132 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.1 -19.35 62.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.243 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.2 -57.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.016 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 93' ' ' THR . 14.6 t -146.05 53.04 1.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.06 30.08 7.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.536 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' B' ' 93' ' ' THR . 17.1 pt-20 -118.21 -176.75 3.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.94 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -99.27 164.15 12.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.644 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.595 HG23 ' CB ' ' B' ' 90' ' ' ASP . 10.3 p -104.29 166.8 10.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 46.73 26.87 2.9 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.642 ' HE1' HD21 ' A' ' 67' ' ' LEU . 1.2 mtp -48.5 137.55 12.08 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.598 0.237 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.51 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 52.7 Cg_exo -53.8 151.39 26.15 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.238 1.959 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -44.63 -55.46 5.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.599 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.906 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.4 tm0? -70.84 -46.56 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.711 ' CG ' HD13 ' A' ' 70' ' ' LEU . 3.6 m0 -51.1 -57.91 7.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -53.1 -67.37 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.098 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.8 ptt85 -44.66 -40.98 6.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.397 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.906 HD23 ' OE1' ' B' ' 102' ' ' GLN . 0.1 OUTLIER -50.97 -55.08 19.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.83 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.64 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -94.46 -69.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.191 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.646 ' O ' HG23 ' B' ' 109' ' ' THR . 7.3 tt0 -79.47 -96.3 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.49 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.646 HG23 ' O ' ' B' ' 108' ' ' GLN . 16.8 p -164.07 -56.62 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.926 0.393 . . . . 0.0 111.539 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.697 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -125.85 173.46 9.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.608 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' B' ' 99' ' ' MET . 0.8 OUTLIER -59.58 -55.76 30.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.563 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER -133.2 86.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.752 178.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 71.65 -62.37 0.46 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.563 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.54 38.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.408 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.2 OUTLIER 58.44 163.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.93 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -111.32 144.69 40.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.26 163.91 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 89.4 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.89 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.881 " O2'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.787 0.327 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.43 122.18 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.65 147.23 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.741 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.764 HD13 ' HB3' ' A' ' 176' ' ' ALA . 10.5 mt -131.46 104.18 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.274 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -102.72 96.48 6.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.744 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -80.81 122.07 26.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 71.8 t -97.69 154.05 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.5 t -120.17 166.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.389 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.759 HG11 ' HA ' ' A' ' 101' ' ' ILE . 7.4 p -157.51 121.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.45 169.28 27.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.289 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.473 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 4.0 m-20 -87.3 134.11 33.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -171.7 -45.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.95 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . 77.31 -66.13 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 82' ' ' PHE . 23.4 m -48.07 -24.67 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.747 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.727 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -55.25 -91.09 0.01 OUTLIER Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.162 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 2.1 ttpm? -96.07 -72.84 0.62 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -40.51 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.95 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 69.6 m -49.52 -29.82 7.4 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.22 0.533 . . . . 0.0 110.833 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -53.0 -73.99 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.03 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.5 mt -48.46 -29.45 4.1 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 27' ' ' LYS . 6.4 mm -53.69 -65.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.245 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -95.71 -17.96 20.85 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -179.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.608 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -97.24 -40.92 8.53 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.847 ' OG1' HD23 ' A' ' 20' ' ' LEU . 41.2 m -94.56 20.95 7.8 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.083 -0.386 . . . . 0.0 111.668 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.601 HG21 ' CD1' ' B' ' 81' ' ' PHE . 3.3 t -177.13 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.211 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 9.8 m-80 81.2 51.51 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.903 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -133.93 -178.78 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.177 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -123.56 146.55 50.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.89 ' HD3' HG21 ' A' ' 21' ' ' ILE . 3.0 Cg_exo -35.62 146.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.661 2.908 . . . . 0.0 112.975 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -76.16 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.828 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.77 114.29 25.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.661 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.7 t80 -66.84 111.28 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.072 0.463 . . . . 0.0 111.121 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 87.8 t -159.51 131.3 4.1 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 36' ' ' VAL . 82.2 Cg_exo -44.79 92.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.183 1.922 . . . . 0.0 111.451 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.871 HG23 ' CG ' ' A' ' 38' ' ' ASP . 97.8 m -50.72 88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.684 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.976 HG12 ' OH ' ' A' ' 64' ' ' TYR . 2.4 t -79.79 -42.84 22.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' B' ' 85' ' ' ILE . 2.8 t80 -124.76 -68.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.084 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.871 ' CG ' HG23 ' A' ' 35' ' ' THR . 2.1 m-20 54.62 111.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.811 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 8.4 t-20 -106.99 160.5 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.038 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.901 ' CD1' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -148.29 162.36 39.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -178.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.09 148.06 30.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.9 m -151.61 158.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.259 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -154.93 87.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.2 m -99.49 168.22 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.418 ' HE2' ' CB ' ' B' ' 76' ' ' SER . 19.1 mtm -121.44 101.53 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' A' ' 51' ' ' TYR . 6.8 mm -93.32 90.1 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.41 20.35 60.49 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.38 34.43 8.65 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.558 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 21.5 mt-10 -138.62 138.65 22.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.735 0.302 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 52.8 Cg_exo -54.65 165.37 2.51 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.53 2.153 . . . . 0.0 112.297 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CD2' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -152.91 136.93 16.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.6 m -135.4 97.82 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.5 pp -133.67 160.53 37.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -140.76 123.94 2.47 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.882 ' HB2' HD11 ' A' ' 20' ' ' LEU . 33.8 mt -75.73 117.49 17.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 3.6 m-85 -95.16 116.96 29.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.653 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 5.2 t70 -75.96 162.21 28.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.049 HG23 ' CD2' ' A' ' 64' ' ' TYR . 21.9 m -168.08 147.79 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.76 -83.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.079 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.631 ' C ' HD22 ' A' ' 61' ' ' LEU . . . 56.51 19.3 26.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.449 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 60' ' ' GLY . 1.4 mm? 63.73 51.93 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 63.47 28.43 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -125.17 22.38 7.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.768 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.049 ' CD2' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -86.68 -2.55 58.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.525 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.59 -28.92 0.65 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 110.639 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -73.97 -45.36 50.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.892 HD23 HD21 ' B' ' 107' ' ' LEU . 52.4 mt -89.92 16.5 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -69.36 -59.36 5.03 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.473 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 10.5 Cg_endo -53.84 -19.64 15.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.466 2.11 . . . . 0.0 112.424 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.805 HD22 ' HG ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -79.66 -27.44 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.455 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.7 OUTLIER -103.83 -9.65 18.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.511 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER 41.77 91.95 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.857 0.361 . . . . 0.0 111.296 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.442 ' CB ' ' HD3' ' A' ' 106' ' ' PRO . 47.9 Cg_exo -55.85 -42.21 69.42 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -69.05 -10.91 59.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.59 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' TYR . 12.2 t -45.02 -48.47 11.59 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.666 0.27 . . . . 0.0 111.565 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' THR . 0.6 OUTLIER -170.74 -159.37 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.082 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' LEU . 10.1 p -58.25 162.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.948 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.508 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -111.2 133.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.301 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' OH ' ' A' ' 154' ' ' TYR . 1.3 tp -104.21 116.07 31.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.114 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 58.9 t -103.34 154.59 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.416 . . . . 0.0 111.79 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 15' ' ' GLY . 23.8 p -115.2 117.69 31.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.811 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.936 ' CD1' HD21 ' A' ' 112' ' ' LEU . 9.9 t80 -99.12 165.71 11.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.608 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.588 ' HB3' HG21 ' A' ' 93' ' ' VAL . 1.5 t -83.26 136.85 34.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.473 0.654 . . . . 0.0 111.489 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 119' ' ' LEU . 98.8 t -51.68 -81.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.272 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -121.54 -96.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.734 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.732 ' N ' HG22 ' A' ' 85' ' ' VAL . 7.1 t 39.91 93.29 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.532 ' HG3' HD12 ' A' ' 129' ' ' LEU . 84.4 Cg_exo -45.47 -26.78 2.94 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.553 2.168 . . . . 0.0 112.462 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.35 -57.79 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.606 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -47.49 -43.05 24.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.459 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.722 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 t80 -48.13 -67.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.94 -42.43 65.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.112 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -61.39 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.177 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 90' ' ' PHE . 28.4 m -47.47 -26.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.666 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -74.95 -59.7 2.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.357 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 7.88 8.87 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -113.36 -41.01 3.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.629 0.252 . . . . 0.0 111.525 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.569 ' HE1' HG12 ' A' ' 93' ' ' VAL . 4.4 m95 -95.54 -43.34 8.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 101' ' ' ILE . 91.1 t -45.14 -58.23 6.01 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 13.9 Cg_endo -57.16 -17.93 27.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.437 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 -28.07 16.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -49.66 -35.6 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.3 -31.56 67.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.56 -43.3 93.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.64 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CE1' HG23 ' A' ' 9' ' ' VAL . 12.1 m80 -76.25 -64.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.207 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 24.4 p -68.32 112.73 11.84 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.701 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 73' ' ' PRO . 34.0 Cg_exo -61.07 -66.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.584 2.189 . . . . 0.0 112.341 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -145.93 23.78 1.36 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.8 146.15 33.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.57 173.47 6.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.475 2.117 . . . . 0.0 111.894 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 4.8 p90 -150.28 -179.04 6.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 77' ' ' VAL . 2.2 mp -137.16 142.99 42.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.217 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD21 ' CD1' ' A' ' 82' ' ' PHE . 1.3 tp -112.86 125.98 54.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 111.473 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.841 HG13 ' OE2' ' A' ' 156' ' ' GLU . 3.5 t -106.31 135.71 43.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.413 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -160.04 143.55 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 84' ' ' VAL . 5.2 t -161.05 -169.79 2.48 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.677 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.457 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER 172.49 72.57 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.773 0.32 . . . . 0.0 111.368 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 157' ' ' CYS . 14.8 mt -98.75 -67.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.941 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -42.18 18.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.539 HD13 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -53.56 -44.94 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.664 ' HD3' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -68.34 -19.94 64.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.37 -28.09 0.8 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.309 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.55 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -54.21 116.2 10.0 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.623 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.59 -56.17 3.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.512 2.141 . . . . 0.0 112.639 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -43.82 -39.17 3.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -57.98 -64.01 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.664 HD11 ' HD3' ' A' ' 120' ' ' ARG . 4.6 mp -57.27 -40.54 74.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -48.92 -38.55 23.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -89.94 -37.37 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.274 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.532 HD12 ' HG3' ' A' ' 87' ' ' PRO . 8.6 tp -48.95 -30.69 6.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.302 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.67 -26.34 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.635 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -82.39 -25.77 33.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.53 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 7.3 m120 -85.1 -25.22 27.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.976 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 161.41 -23.14 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.567 0.542 . . . . 0.0 111.304 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 89.67 -43.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.978 0.511 . . . . 0.0 110.553 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -126.67 50.02 4.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.353 179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.496 ' HG2' HD11 ' A' ' 129' ' ' LEU . 73.2 Cg_endo -76.68 -47.37 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.622 2.214 . . . . 0.0 112.769 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.627 HD12 ' CD1' ' A' ' 90' ' ' PHE . 2.2 mm -106.82 136.67 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.998 0.427 . . . . 0.0 111.211 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -159.74 155.37 22.51 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.435 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 5.2 Cg_endo -47.47 -25.29 4.97 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.708 2.272 . . . . 0.0 112.197 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.38 -35.36 14.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.27 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 136' ' ' PRO . 9.3 m -58.97 -50.21 74.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 111.007 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.58 11.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.699 ' HG3' HG13 ' A' ' 155' ' ' VAL . 1.4 tt0 -62.76 -39.04 92.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -58.93 -49.16 78.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.662 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 94' ' ' LYS . 5.1 tt -57.44 -36.1 70.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.622 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 112' ' ' LEU . . . -73.43 -23.98 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.73 -41.57 37.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.854 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -51.34 -47.3 62.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 149' ' ' LEU . 4.4 pp -70.69 -9.85 58.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.384 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.91 116.55 0.05 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -175.64 -176.28 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 111' ' ' LEU . 63.3 t -64.25 -14.51 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.571 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.638 ' O ' HD23 ' A' ' 111' ' ' LEU . 1.3 pttt 78.78 160.1 0.19 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 111.076 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.779 ' OH ' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -152.57 110.88 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.003 -179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.699 HG13 ' HG3' ' A' ' 143' ' ' GLU . 2.2 m -118.07 123.5 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.841 ' OE2' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -172.05 -178.33 2.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.049 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.532 ' HB2' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -130.5 166.97 19.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.251 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' HG21 ' A' ' 115' ' ' THR . 0.1 OUTLIER -88.6 99.94 12.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.517 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.697 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 46.22 -175.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.538 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.697 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 41.24 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.119 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 75.5 p 40.47 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.984 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.959 ' HG3' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 76.45 79.99 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.821 0.343 . . . . 0.0 110.991 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.67 -68.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.34 57.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.73 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.959 HD22 ' HG3' ' A' ' 162' ' ' GLN . 1.6 tp -93.74 -29.0 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -72.44 -57.4 4.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.792 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.434 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 72.4 m-80 -44.09 -56.71 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 111.12 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.42 HG13 ' HE2' ' A' ' 23' ' ' TYR . 2.4 p -55.07 -39.9 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.41 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CZ ' ' CE1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.26 -25.62 59.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.739 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 4.4 t70 -85.14 -28.61 25.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.019 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.722 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 48.2 mm-40 -75.38 -39.58 58.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.819 0.342 . . . . 0.0 111.042 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.89 -44.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.437 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 46' ' ' ILE . 28.7 mm -70.68 -62.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.362 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER -54.67 -21.55 11.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.263 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -62.31 -45.52 92.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.767 0.317 . . . . 0.0 111.265 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -75.34 -24.02 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.324 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.43 -29.08 5.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.966 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.66 142.87 46.25 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.22 148.84 69.46 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.568 2.179 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.7 143.59 68.95 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.554 2.169 . . . . 0.0 112.27 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 41.43 59.65 8.8 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.683 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.37 122.68 8.0 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.568 2.179 . . . . 0.0 112.278 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.93 119.27 32.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.5 -63.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tt -138.62 151.21 24.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' MET . 1.1 t -130.52 167.55 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.769 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.476 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -103.7 136.97 19.12 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.742 ' HG2' HG23 ' A' ' 24' ' ' THR . 51.0 Cg_exo -52.83 178.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.434 2.089 . . . . 0.0 112.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -150.75 -48.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.271 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -49.26 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.601 ' CD1' HG21 ' A' ' 25' ' ' THR . 21.6 t80 59.5 119.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.841 0.353 . . . . 0.0 111.04 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -153.23 127.52 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 92.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.282 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.473 ' OG1' HD12 ' B' ' 85' ' ' ILE . 70.1 p -77.22 -85.75 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.662 HD13 ' HE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -92.94 109.04 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.745 -179.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -98.11 96.86 8.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.924 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 96' ' ' PHE . 59.3 t -83.18 143.23 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.652 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.57 177.82 24.65 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.069 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -99.2 125.31 44.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.467 ' CB ' HG23 ' B' ' 97' ' ' THR . 38.3 t0 -137.55 131.58 31.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.809 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.54 2.28 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.043 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.89 -28.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 120.892 0.377 . . . . 0.0 111.404 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.467 HG21 ' OE2' ' B' ' 95' ' ' GLU . 13.6 t -150.27 -44.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.851 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . 0.436 ' N ' HG23 ' B' ' 93' ' ' THR . . . 134.36 34.44 0.28 Allowed Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.448 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.467 ' OE2' HG21 ' B' ' 93' ' ' THR . 12.0 pt-20 -147.22 -166.6 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.7 0.285 . . . . 0.0 110.473 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 67' ' ' LEU . 9.0 m-85 -87.63 162.24 17.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.467 HG23 ' CB ' ' B' ' 90' ' ' ASP . 7.7 p -103.33 163.98 11.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.985 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 49.43 27.16 7.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.171 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' B' ' 111' ' ' ASN . 0.1 OUTLIER -47.65 134.16 10.63 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.886 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.541 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 59.1 Cg_exo -53.32 142.64 56.62 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.367 2.045 . . . . 0.0 112.205 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' B' ' 102' ' ' GLN . 12.7 pt-20 -45.14 -47.89 12.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.919 0.39 . . . . 0.0 110.807 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' B' ' 101' ' ' GLU . 0.0 OUTLIER -69.54 -54.39 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.51 179.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.517 ' CD1' ' HB3' ' A' ' 70' ' ' LEU . 18.7 m0 -53.15 -61.47 2.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -43.13 -67.69 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.594 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 17.4 mtt85 -48.1 -41.76 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.034 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.805 ' HG ' HD22 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.71 -56.68 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.78 -70.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.252 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.705 ' O ' HG23 ' B' ' 109' ' ' THR . 7.2 tt0 -79.05 -96.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.684 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.705 HG23 ' O ' ' B' ' 108' ' ' GLN . 9.3 p -165.68 -55.46 0.03 OUTLIER 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.815 0.34 . . . . 0.0 111.461 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.758 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 15.8 m -126.02 -179.32 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.429 ' ND2' ' HG3' ' B' ' 116' ' ' GLU . 0.7 OUTLIER -66.77 -59.66 3.36 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.875 HG22 ' O ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -138.74 86.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.554 177.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 112' ' ' ILE . 7.3 t 49.69 33.16 5.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.296 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 113' ' ' THR . 1.9 tttp 85.42 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.646 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.875 ' O ' HG22 ' B' ' 112' ' ' ILE . 0.4 OUTLIER -165.56 117.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.006 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.429 ' HG3' ' ND2' ' B' ' 111' ' ' ASN . 3.4 tt0 -118.15 54.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.05 152.95 32.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.9 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.573 " H2'" ' O ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.805 0.336 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -124.81 125.55 44.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 111.68 23.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' HB1' ' A' ' 176' ' ' ALA . 2.1 mt -129.22 132.23 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.265 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -113.57 157.46 22.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.397 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.9 m -128.74 112.97 14.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.926 HG21 ' HA ' ' A' ' 73' ' ' PRO . 10.7 t -87.04 98.67 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.852 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 16' ' ' LYS . 22.5 m -114.4 145.88 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.597 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 58' ' ' THR . 32.8 m -137.94 121.34 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.833 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.54 167.41 38.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.852 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.09 -62.48 1.45 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.057 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.69 -137.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.597 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 187' ' ' HOH . . . -173.27 30.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.838 HG11 ' HA2' ' A' ' 114' ' ' GLY . 2.8 t -65.14 -12.52 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.046 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . . . -120.25 -24.84 2.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.644 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.643 ' HB3' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -96.21 -74.36 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.423 0.612 . . . . 0.0 112.159 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.909 HG21 ' O ' ' A' ' 188' ' ' HOH . 25.8 m -77.92 -63.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.706 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 13.0 m -49.09 -45.5 43.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.079 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.685 HD21 ' CE2' ' A' ' 23' ' ' TYR . 1.4 tm? -39.73 -72.65 0.06 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.213 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 19' ' ' LEU . 16.8 mt -61.99 -19.27 62.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.602 0.239 . . . . 0.0 111.205 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 25' ' ' THR . 1.0 OUTLIER -67.97 -48.22 75.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.357 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.463 ' OG ' ' C8 ' ' A' ' 185' ' ' GNP . 39.0 m -93.28 -20.54 20.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.662 0.268 . . . . 0.0 111.239 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.736 ' CE1' HD22 ' A' ' 165' ' ' LEU . 4.4 m-30 -84.0 -66.14 0.93 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.83 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 42' ' ' VAL . 85.0 m -87.75 -83.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.238 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 21' ' ' ILE . 0.5 OUTLIER -49.12 -26.98 3.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.257 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' CA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 p-10 47.19 41.97 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 110.821 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -132.51 134.89 45.56 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -59.49 154.36 44.59 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 57.9 Cg_exo -34.9 145.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.18 2.587 . . . . 0.0 113.221 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.02 -83.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.192 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -100.93 115.67 30.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.92 103.5 4.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HD2' ' A' ' 34' ' ' PRO . 66.1 t -152.98 139.43 12.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD2' HG13 ' A' ' 33' ' ' VAL . 98.6 Cg_exo -42.02 92.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.5 2.133 . . . . 0.0 111.737 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.712 HG23 ' CG ' ' A' ' 38' ' ' ASP . 72.7 m -52.97 88.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.552 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.838 HG11 ' CD2' ' B' ' 96' ' ' PHE . 23.8 t -74.99 -32.74 27.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' HG21 ' B' ' 87' ' ' VAL . 3.2 t80 -144.96 -66.28 0.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.729 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.712 ' CG ' HG23 ' A' ' 35' ' ' THR . 4.4 m-20 55.18 108.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.391 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.513 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 46.9 t-20 -107.63 157.21 18.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.008 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -150.93 167.71 26.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.952 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 82' ' ' GLU . . . -123.12 156.98 33.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.206 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 53' ' ' LEU . 15.6 m -160.71 147.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.087 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.3 m -124.08 101.41 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.543 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 173' ' ' ILE . 15.8 m -98.61 141.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.5 mtm -105.18 100.19 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.738 HD13 ' CE1' ' A' ' 51' ' ' TYR . 5.1 mp -104.77 92.78 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.73 16.69 61.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.395 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.98 38.8 6.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.603 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 20.1 mt-10 -141.64 139.17 18.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.656 0.265 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.1 168.07 14.79 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.642 2.228 . . . . 0.0 112.387 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.738 ' CE1' HD13 ' A' ' 46' ' ' ILE . 4.9 m-85 -152.08 160.75 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.289 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -136.06 97.4 3.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.233 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 42' ' ' VAL . 7.7 tt -132.59 160.55 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.207 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.7 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -156.42 139.88 6.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.34 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 79' ' ' LEU . 1.1 mt -79.33 104.13 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.057 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' ' HD2' ' A' ' 5' ' ' LYS . 4.2 m-85 -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' OD2' HG21 ' A' ' 35' ' ' THR . 4.8 t0 -71.38 -169.46 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.746 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.827 ' HB ' HG12 ' A' ' 9' ' ' VAL . 4.0 m -166.99 163.57 15.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . . . -92.79 -74.69 0.51 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.936 ' O ' HD13 ' A' ' 61' ' ' LEU . . . 131.74 61.57 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.851 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -132.31 -168.57 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -58.98 86.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 3.4 t0 76.03 43.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.041 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 5.0 t80 50.63 35.72 12.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.1 -152.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' B' ' 107' ' ' LEU . 18.8 mmt180 -87.52 -1.39 57.91 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.132 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.821 ' CG ' HD12 ' A' ' 70' ' ' LEU . 4.1 mp -81.97 58.28 3.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -63.59 -70.06 0.51 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 43.7 Cg_endo -68.23 -22.5 40.27 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.026 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.821 HD12 ' CG ' ' A' ' 67' ' ' LEU . 3.9 mt -57.48 -20.65 32.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.022 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.08 -34.12 6.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.541 ' CG ' ' HB ' ' A' ' 75' ' ' THR . 1.0 OUTLIER 66.04 76.33 0.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.865 0.364 . . . . 0.0 110.673 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.926 ' HA ' HG21 ' A' ' 7' ' ' VAL . 77.8 Cg_exo -50.58 -55.18 4.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.854 2.369 . . . . 0.0 112.974 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -67.46 -8.04 30.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.774 HG22 HG23 ' A' ' 7' ' ' VAL . 8.8 t -33.05 -53.94 0.37 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' N ' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER 170.47 -161.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.802 0.335 . . . . 0.0 111.024 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.92 HG22 ' HG2' ' A' ' 109' ' ' PRO . 66.2 t -58.98 150.28 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' CE1' ' CB ' ' A' ' 105' ' ' CYS . 39.1 p90 -139.93 128.74 23.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.901 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.069 HD21 HD21 ' A' ' 55' ' ' LEU . 1.8 pt? -103.77 116.23 31.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 9' ' ' VAL . 10.1 t -94.24 154.53 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.482 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.7 p -67.08 171.84 5.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.355 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 t80 -163.78 105.18 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.81 0.338 . . . . 0.0 111.335 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -58.63 111.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.759 HG13 HG21 ' A' ' 137' ' ' ILE . 90.8 t -103.02 87.21 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 111.164 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.781 HG11 HD22 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 169.12 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.481 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.719 ' N ' HG22 ' A' ' 85' ' ' VAL . 68.2 m -46.99 103.59 0.37 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.528 0.204 . . . . 0.0 111.025 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 129' ' ' LEU . 50.5 Cg_exo -53.62 -40.12 80.46 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.48 2.12 . . . . 0.0 112.363 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.8 t -53.6 -25.33 17.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.029 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 -36.7 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.025 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -49.35 -60.13 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.86 -31.9 73.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.6 m-20 -69.29 -61.9 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.925 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.744 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 29.9 m -48.73 -36.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.313 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -61.31 -63.07 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -82.68 8.01 13.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.895 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.9 tttt -117.23 -36.53 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.674 0.274 . . . . 0.0 111.338 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.744 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 28.5 m0 -93.38 -41.55 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.261 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.4 t -48.91 -57.96 9.86 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.105 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.3 Cg_endo -59.11 -18.04 41.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 112.305 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -84.76 -51.24 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.851 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 7.6 pt -51.29 -24.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.1 p -74.78 -28.99 60.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.362 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -70.87 -35.14 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.529 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.732 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.4 m-70 -107.71 -2.43 20.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.739 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 78' ' ' PHE . 3.5 m -149.62 58.03 3.09 Favored Pre-proline 0 C--N 1.333 -0.14 0 CA-C-O 120.709 0.29 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.63 55.9 5.07 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.747 2.298 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt 176.9 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.364 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.9 t -73.17 146.07 86.6 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.92 ' HG2' HG22 ' A' ' 77' ' ' VAL . 20.0 Cg_endo -60.29 178.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.644 2.229 . . . . 0.0 111.961 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 33.6 p90 -137.31 158.79 43.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD21 ' O ' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -135.14 127.53 30.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.475 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -104.31 101.38 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.064 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG12 ' OE1' ' A' ' 156' ' ' GLU . 3.5 m -107.43 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.838 ' HA2' HG11 ' A' ' 14' ' ' VAL . . . -168.74 159.13 32.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.805 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.873 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -167.89 -64.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 0.0 110.756 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.545 ' NE2' HD13 ' A' ' 119' ' ' LEU . 0.8 OUTLIER 48.86 60.43 3.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.007 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 157' ' ' CYS . 9.1 mt -65.71 -31.06 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.821 ' HB3' HD23 ' A' ' 160' ' ' LEU . 11.9 p-10 -81.75 -49.15 10.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 85' ' ' VAL . 9.3 tt -49.65 -49.19 48.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.789 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.0 t0 75.96 31.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.668 ' O ' HD12 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -93.73 157.32 38.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.805 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.35 -39.75 5.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -25.75 59.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.9 m -56.21 -68.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 122' ' ' ASP . 4.6 mp -46.81 -40.86 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.415 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.64 -62.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.12 -34.83 68.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -50.3 -25.86 4.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.418 . . . . 0.0 110.706 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.76 46.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.39 26.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.082 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.411 ' HB3' ' HD3' ' A' ' 133' ' ' LYS . 9.8 m-80 -93.02 -30.0 15.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -175.01 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 169.02 146.55 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 129' ' ' LEU . 5.8 mmmt 60.61 145.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.67 140.97 70.57 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 84' ' ' VAL . 4.3 mt -50.71 126.3 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -98.75 167.3 11.61 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.338 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' HG23 ' A' ' 115' ' ' THR . 52.1 Cg_exo -53.39 -22.98 22.57 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.827 2.351 . . . . 0.0 112.674 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.22 -35.67 14.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.488 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.479 ' CG2' HG23 ' A' ' 137' ' ' ILE . 22.9 m -46.45 -42.5 15.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.057 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -51.29 56.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 6.1 tm-20 -54.57 -38.79 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.303 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -52.12 -55.87 18.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.287 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 145' ' ' LEU . 3.9 tt -54.33 -32.67 57.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.069 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.929 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.51 -49.75 72.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.664 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -51.78 -42.11 62.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.606 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -25.43 58.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' A' ' 151' ' ' ALA . 3.0 pp -122.65 19.89 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.21 -83.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . 58.78 176.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 152' ' ' VAL . 78.7 t -76.02 -7.35 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.78 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.457 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER 82.85 141.35 0.07 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.694 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.929 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 5.8 p90 -153.21 153.4 32.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.799 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.0 m -158.56 123.99 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.413 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.429 ' OE1' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -165.75 157.97 14.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.993 0.425 . . . . 0.0 111.482 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.873 ' HA ' HG21 ' A' ' 115' ' ' THR . 1.8 m -119.01 -173.51 2.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.172 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.459 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -86.29 152.68 22.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.507 -179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.58 ' HB2' " H1'" ' A' ' 185' ' ' GNP . . . -40.48 -76.08 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.567 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -36.05 -33.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.652 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -82.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.749 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.536 ' NE2' HD21 ' A' ' 165' ' ' LEU . 0.9 OUTLIER 63.41 97.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.994 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -65.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.06 75.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.685 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.736 HD22 ' CE1' ' A' ' 23' ' ' TYR . 4.5 pp -93.13 -10.15 36.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.771 0.32 . . . . 0.0 111.377 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -49.77 -26.33 3.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.851 0.358 . . . . 0.0 110.179 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.99 -51.28 68.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 155' ' ' VAL . 98.6 t -53.7 -49.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.31 -33.36 73.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.314 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.504 ' CG ' HG21 ' B' ' 75' ' ' ILE . 63.6 t0 -68.85 -36.94 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.76 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -44.83 27.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.655 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.38 -37.59 62.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.781 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 44' ' ' VAL . 16.7 mt -82.62 -43.76 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.2 -52.78 64.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.556 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -51.46 -33.14 29.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.019 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.912 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -90.83 -26.96 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.125 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.2 tp -49.94 -51.25 42.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 60.68 87.44 0.13 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 75.8 Cg_exo -49.68 143.14 23.08 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.532 2.155 . . . . 0.0 112.218 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 179' ' ' PRO . 53.4 Cg_exo -52.14 132.51 43.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 112.268 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.442 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 3.4 mt-10 -71.13 -51.37 10.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 69.5 Cg_exo -50.99 -175.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.61 2.206 . . . . 0.0 112.244 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 164.06 20.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.0 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.849 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 62.9 m -50.29 -80.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.371 . . . . 0.0 110.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.625 HD11 ' CD1' ' A' ' 173' ' ' ILE . 5.9 tt -119.6 151.95 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.194 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -134.14 165.64 24.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.2 OUTLIER -87.87 137.93 31.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.751 ' HD3' HG12 ' A' ' 44' ' ' VAL . 38.4 Cg_endo -66.68 -167.46 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.613 2.209 . . . . 0.0 112.131 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.421 ' O ' ' N ' ' B' ' 81' ' ' PHE . 81.1 p -168.34 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.43 78.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 86.2 t80 -74.66 152.01 39.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.62 96.3 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.606 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -68.96 69.75 0.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.161 0.505 . . . . 0.0 109.662 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.554 ' HB ' HD12 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -43.79 -85.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.232 -178.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.794 HG21 ' N ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -112.59 130.79 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -111.63 97.15 6.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.387 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 37' ' ' PHE . 16.6 t -77.84 157.01 5.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 112.047 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.517 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.27 177.89 24.32 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.907 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -112.16 123.01 49.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.526 ' CB ' HG21 ' B' ' 97' ' ' THR . 14.8 t0 -140.26 127.84 21.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.733 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.59 -5.8 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.793 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.803 HG13 HG23 ' B' ' 93' ' ' THR . 7.6 p -43.59 -29.09 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.073 0 CA-C-O 120.802 0.334 . . . . 0.0 111.656 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.803 HG23 HG13 ' B' ' 92' ' ' VAL . 3.5 p -153.89 24.3 0.5 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.55 37.22 74.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.83 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.82 179.8 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.722 0.296 . . . . 0.0 110.878 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.838 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -74.76 164.13 26.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.526 HG21 ' CB ' ' B' ' 90' ' ' ASP . 27.1 p -126.6 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.163 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' B' ' 111' ' ' ASN . . . 51.72 29.67 26.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.58 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.73 ' CE ' HD21 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -74.4 164.77 58.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.871 0.367 . . . . 0.0 111.081 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.794 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.0 Cg_exo -53.78 142.23 63.11 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.707 2.272 . . . . 0.0 112.343 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -45.71 -60.33 2.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -50.34 72.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.61 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.787 ' CE3' HD23 ' A' ' 67' ' ' LEU . 6.2 m0 -46.8 -63.38 1.04 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.247 0.546 . . . . 0.0 110.411 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -51.01 -60.06 3.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 31.2 mtt-85 -48.77 -41.04 31.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.136 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.691 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -49.02 -56.73 8.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.47 179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -95.06 -68.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.062 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.742 ' O ' HG23 ' B' ' 109' ' ' THR . 7.0 tp60 -77.87 -101.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.338 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.742 HG23 ' O ' ' B' ' 108' ' ' GLN . 3.0 p -167.08 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.337 0.061 0 CA-C-O 120.988 0.423 . . . . 0.0 111.19 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.679 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 5.0 m -140.42 172.77 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.701 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.7 OUTLIER -56.96 -67.21 0.34 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.768 HG23 ' HB2' ' B' ' 115' ' ' SER . 0.5 OUTLIER -138.85 85.95 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 177.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' B' ' 114' ' ' LYS . 1.3 m 57.76 33.38 23.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.506 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' B' ' 113' ' ' THR . 15.1 ttmt 82.34 67.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.768 ' HB2' HG23 ' B' ' 112' ' ' ILE . 0.1 OUTLIER -141.12 124.69 16.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.32 -51.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -124.63 127.22 47.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.964 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.58 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.798 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.909 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -71.2 132.65 45.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.9 m -94.24 112.81 24.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG12 ' HB1' ' A' ' 176' ' ' ALA . 2.9 mt -114.92 133.09 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.98 104.34 7.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.946 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' HB3' HD23 ' A' ' 79' ' ' LEU . 14.3 m -77.33 99.06 5.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.665 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.73 HG11 ' CE1' ' A' ' 104' ' ' HIS . 10.8 t -84.61 159.45 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 79' ' ' LEU . 58.4 t -130.47 148.73 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 101' ' ' ILE . 12.6 p -138.41 132.64 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.92 146.11 17.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.631 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -72.05 126.22 29.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.89 -42.16 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.603 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.544 ' HB1' ' PB ' ' A' ' 185' ' ' GNP . . . 47.8 38.9 9.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 83' ' ' SER . 1.9 t -109.27 -14.01 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.77 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -135.67 -55.3 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.625 ' HG2' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -43.11 -66.26 0.39 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.006 0.431 . . . . 0.0 111.171 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.742 HG21 ' O ' ' A' ' 187' ' ' HOH . 88.7 m -95.15 -50.53 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -50.5 -44.39 56.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.326 -178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 55' ' ' LEU . 18.1 tp -50.09 -77.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.003 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.083 HD21 HD13 ' A' ' 55' ' ' LEU . 3.9 mt -51.14 -29.95 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 120.653 0.263 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.736 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -55.71 -69.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.353 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.529 ' HB3' HN22 ' A' ' 185' ' ' GNP . 0.3 OUTLIER -90.79 -10.49 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.757 ' CD2' HD12 ' A' ' 165' ' ' LEU . 7.7 t80 -95.37 -59.66 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.677 HG21 ' CG1' ' A' ' 42' ' ' VAL . 63.5 m -73.67 -45.61 51.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.333 -178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.693 HG21 ' HD3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -113.97 3.83 15.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.5 p30 43.38 58.06 3.58 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 111.741 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD3' HG21 ' A' ' 25' ' ' THR . 10.8 pttt -134.0 -164.74 1.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.511 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.528 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -134.21 166.45 29.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 46.5 Cg_exo -36.02 144.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.147 2.565 . . . . 0.0 113.47 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.64 -85.22 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.368 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.709 0.29 . . . . 0.0 110.286 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.1 t80 -80.91 106.39 12.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 111.623 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' THR . 12.7 m -158.99 145.3 12.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.093 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.638 ' O ' HG23 ' A' ' 36' ' ' VAL . 81.2 Cg_exo -44.73 88.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.825 HG23 ' CG ' ' A' ' 38' ' ' ASP . 66.0 m -55.19 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.386 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG11 ' CZ ' ' B' ' 96' ' ' PHE . 3.6 t -84.34 -21.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.651 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.2 t80 -147.96 -65.36 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.627 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.825 ' CG ' HG23 ' A' ' 35' ' ' THR . 7.4 m-20 54.33 109.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.271 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HB3' HD12 ' B' ' 85' ' ' ILE . 28.0 t-20 -106.88 147.99 29.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.12 0.486 . . . . 0.0 110.968 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.629 ' CG ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -139.07 169.2 18.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.785 -179.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -111.81 141.55 45.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.306 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.677 ' CG1' HG21 ' A' ' 24' ' ' THR . 2.4 m -162.83 159.57 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.35 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 51' ' ' TYR . 54.8 m -145.37 104.41 3.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.175 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.075 HG11 HD13 ' A' ' 173' ' ' ILE . 42.2 t -98.27 117.51 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.031 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 21.6 mtm -76.68 99.96 5.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.683 HD11 ' CG2' ' A' ' 173' ' ' ILE . 66.0 mt -92.96 89.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.0 70.12 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.572 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.53 -17.82 30.51 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.859 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.8 OUTLIER -91.29 138.85 25.43 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.66 0.267 . . . . 0.0 111.112 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -68.73 166.49 25.95 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.625 2.217 . . . . 0.0 112.341 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 43' ' ' THR . 23.1 m-85 -153.94 173.73 15.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 97.26 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.508 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 54' ' ' GLY . 9.6 tt -101.68 161.31 13.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -159.82 118.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.425 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.083 HD13 HD21 ' A' ' 20' ' ' LEU . 5.5 mp -75.88 105.62 7.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.859 0.362 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CE2' ' CE1' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -83.23 103.46 12.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.036 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.8 OUTLIER -75.67 172.68 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.739 HG23 ' CE1' ' A' ' 64' ' ' TYR . 2.2 m -167.05 171.37 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . . . -102.48 -161.07 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.277 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 61' ' ' LEU . . . -60.18 -16.08 39.98 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.75 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD13 HG23 ' A' ' 9' ' ' VAL . 1.5 tp 80.17 132.58 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.024 0.44 . . . . 0.0 111.228 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 35.9 tt0 169.86 -34.91 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.593 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -116.21 -12.41 11.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.712 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.739 ' CE1' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -48.83 -33.96 11.54 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -47.49 -28.07 2.04 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.053 0.454 . . . . 0.0 110.424 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -82.04 -46.77 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.234 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.023 HD22 ' CE2' ' B' ' 96' ' ' PHE . 1.4 mp -92.49 49.56 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -99.65 -31.17 0.23 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 28.0 Cg_exo -37.14 -49.8 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.486 2.124 . . . . 0.0 114.025 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.995 HD11 ' CG ' ' B' ' 103' ' ' TRP . 0.1 OUTLIER -94.8 32.48 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 72' ' ' TYR . 4.4 p -134.04 -52.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.6 OUTLIER 41.56 98.89 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.805 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 105' ' ' CYS . 82.3 Cg_exo -45.62 -34.63 11.62 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.523 2.149 . . . . 0.0 112.579 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.93 -10.37 52.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.591 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CD2' ' A' ' 72' ' ' TYR . 13.7 t -37.66 -49.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER 165.79 -165.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.678 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 109' ' ' PRO . 10.9 p -64.84 125.69 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.766 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CD1' ' CB ' ' A' ' 105' ' ' CYS . 42.4 p90 -96.54 133.81 40.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.587 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 8' ' ' VAL . 2.2 pp -103.59 116.05 31.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.1 t -94.99 154.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 15' ' ' GLY . 5.8 p -111.5 160.0 17.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 111.385 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 82' ' ' PHE . 40.7 p90 -152.66 103.9 2.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.515 ' N ' HG21 ' A' ' 14' ' ' VAL . 22.8 t -54.5 118.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.001 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -88.74 81.86 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.223 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' HD22 ' A' ' 119' ' ' LEU . 1.6 m -131.68 79.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.456 ' C ' HD11 ' A' ' 137' ' ' ILE . 5.5 m 71.23 151.08 0.14 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' N ' HD11 ' A' ' 137' ' ' ILE . 55.1 Cg_exo -52.15 -22.03 14.18 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.541 2.161 . . . . 0.0 112.419 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -52.49 -32.43 40.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -91.09 -30.83 16.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.016 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -47.55 -65.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.17 -28.43 67.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 23.2 m-20 -69.84 -84.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 89' ' ' SER . 2.3 m -43.75 -29.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.693 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 12.6 tttt -70.57 -69.39 0.36 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -81.44 7.63 11.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 112.064 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -111.1 -42.59 3.92 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.413 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.743 ' CD1' HG12 ' A' ' 93' ' ' VAL . 12.7 m95 -95.27 -43.36 8.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 68.7 t -48.41 -44.36 64.23 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.57 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 48.0 Cg_exo -55.68 -23.43 40.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.017 1.811 . . . . 0.0 112.166 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -93.53 -30.01 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.854 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.882 ' HA ' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -49.43 -26.41 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.138 -179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.418 ' N ' HG13 ' A' ' 101' ' ' ILE . 19.6 p -77.4 -32.13 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -64.54 -49.6 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.495 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.73 ' CE1' HG11 ' A' ' 7' ' ' VAL . 55.4 t-80 -65.54 -66.94 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.68 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.53 ' CB ' ' CD1' ' A' ' 78' ' ' PHE . 1.2 m -104.5 90.83 3.56 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.797 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 42.9 Cg_endo -67.92 118.04 5.33 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.675 2.25 . . . . 0.0 112.572 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.3 51.99 15.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.235 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.709 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.3 OUTLIER -132.87 144.09 51.41 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.518 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.709 ' HD2' HG22 ' A' ' 108' ' ' THR . 99.2 Cg_exo -42.0 147.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.512 2.141 . . . . 0.0 112.102 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.7 p90 -139.41 139.38 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -126.93 119.81 27.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.42 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . 1.8 mt -90.34 102.12 14.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.72 96.75 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 14' ' ' VAL . . . -117.61 -119.42 2.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.798 HG21 ' HA ' ' A' ' 157' ' ' CYS . 20.2 m 69.11 167.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 111.438 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.492 ' OE1' HD13 ' A' ' 119' ' ' LEU . 0.5 OUTLIER 176.43 112.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.484 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 157' ' ' CYS . 54.4 mt -91.82 -22.61 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.411 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -95.83 -44.23 7.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.469 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.533 HD22 ' CG1' ' A' ' 85' ' ' VAL . 1.9 tt -74.7 -47.87 29.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -48.99 -29.39 4.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.107 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.96 51.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 126' ' ' ILE . 11.3 m-20 -114.23 142.06 27.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.39 -21.64 18.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.552 2.168 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -43.17 57.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 p -56.36 -62.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -48.54 -46.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.41 -58.78 3.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.24 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -36.12 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.906 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.55 -26.43 3.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.39 64.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -85.32 -41.5 15.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -61.39 -23.37 65.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.99 64.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.19 -171.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 167.6 9.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.15 120.93 6.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.538 2.158 . . . . 0.0 112.307 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 87' ' ' PRO . 7.8 mt -56.61 121.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.235 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -117.96 164.8 18.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.833 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 115' ' ' THR . 75.3 Cg_exo -49.16 -26.21 10.59 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.568 2.179 . . . . 0.0 112.311 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -65.78 -51.05 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.6 m -54.87 -55.79 26.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.11 -49.18 52.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' CD ' HG12 ' A' ' 155' ' ' VAL . 7.9 mt-10 -54.61 -42.09 70.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -46.85 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.689 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.832 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -55.98 -48.72 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.867 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.81 68.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -70.36 -43.59 69.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.769 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -59.44 -26.25 65.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.6 pp -103.15 -23.26 13.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.999 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 149' ' ' LEU . 26.4 tptt 60.25 116.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -162.08 -161.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.299 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 111' ' ' LEU . 9.2 p -44.93 -43.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.494 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER 89.95 145.7 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.452 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.495 ' O ' HG13 ' A' ' 155' ' ' VAL . 48.8 p90 -153.05 150.97 29.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.885 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.604 HG12 ' CD ' ' A' ' 143' ' ' GLU . 8.4 m -158.36 122.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.434 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.671 ' CG ' HG11 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -172.04 124.74 0.53 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.222 0.534 . . . . 0.0 111.553 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.798 ' HA ' HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -128.51 119.52 25.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.71 ' OG ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -156.99 175.19 14.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.386 0.612 . . . . 0.0 112.497 -177.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.823 ' C ' HD22 ' A' ' 160' ' ' LEU . . . 136.15 88.93 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.899 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.823 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 58.73 26.01 14.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 p -147.85 -72.08 0.21 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.965 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 75.51 114.12 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.248 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 3.4 tttt -105.9 -45.12 4.45 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.114 0.483 . . . . 0.0 110.644 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.11 71.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.621 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.965 HD11 ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -95.05 -16.91 22.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.973 0.416 . . . . 0.0 111.25 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.414 ' HA ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.32 -24.92 2.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 111.086 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 18.4 m-80 -71.79 -61.38 1.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.478 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 156' ' ' GLU . 11.4 p -45.52 -32.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.781 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.1 t80 -77.04 -35.28 56.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.285 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.853 ' CG ' HD12 ' B' ' 75' ' ' ILE . 3.8 t70 -58.25 -35.52 71.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.357 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 6.7 mm-40 -76.14 -44.5 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.777 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.11 -25.98 64.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.989 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 1.075 HD13 HG11 ' A' ' 44' ' ' VAL . 5.1 mt -93.63 -54.4 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -59.8 -29.73 68.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -54.87 -33.72 62.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.95 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 4' ' ' ILE . . . -80.23 -23.51 40.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.68 42.04 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 179' ' ' PRO . 4.3 pt-20 -55.9 110.73 2.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 178' ' ' GLU . 33.2 Cg_endo -64.21 157.01 56.17 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.408 2.072 . . . . 0.0 112.245 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.96 171.21 11.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.76 112.57 5.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.32 114.11 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.44 2.093 . . . . 0.0 112.143 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.56 101.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.1 tttp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.965 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 75' ' ' ILE . 5.2 p 69.7 -62.19 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 170' ' ' ASP . 8.6 mt -144.1 137.21 23.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.55 ' O ' HG13 ' A' ' 44' ' ' VAL . 1.4 m -131.59 152.48 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.99 145.92 99.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.745 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.471 ' HB2' HG23 ' A' ' 24' ' ' THR . 61.0 Cg_exo -52.65 -167.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.65 2.233 . . . . 0.0 112.552 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 84.3 p -149.67 -79.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.85 119.7 12.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.62 ' HB2' HG22 ' A' ' 24' ' ' THR . 12.8 t80 -132.78 130.23 39.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.658 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -153.33 136.45 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 90.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -81.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.59 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.654 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.1 mp -115.59 110.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.78 0.324 . . . . 0.0 111.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 86' ' ' HIS . 8.7 p80 -85.4 96.84 9.69 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 37' ' ' PHE . 41.0 t -87.83 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.225 0.536 . . . . 0.0 112.304 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' B' ' 96' ' ' PHE . . . -142.61 177.8 21.49 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.362 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 2.6 t80 -101.05 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.3 0.55 . . . . 0.0 111.141 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.855 ' HB2' HG23 ' B' ' 97' ' ' THR . 9.0 t0 -140.47 114.48 9.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.622 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.73 -5.17 31.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.973 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 1.076 HG13 HG22 ' B' ' 93' ' ' THR . 14.7 p -45.74 -28.24 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.859 0.362 . . . . 0.0 111.176 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 1.076 HG22 HG13 ' B' ' 92' ' ' VAL . 0.0 OUTLIER -149.25 18.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.08 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.59 17.44 64.61 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.901 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.887 ' HG2' HG23 ' B' ' 93' ' ' THR . 18.6 pt-20 -128.62 -163.28 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.719 0.295 . . . . 0.0 110.708 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 1.023 ' CE2' HD22 ' A' ' 67' ' ' LEU . 6.6 m-30 -96.04 164.62 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.855 HG23 ' HB2' ' B' ' 90' ' ' ASP . 0.6 OUTLIER -95.69 136.39 36.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.843 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.437 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 49.12 36.91 22.46 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.995 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -77.56 165.63 49.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.243 0.544 . . . . 0.0 112.31 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.654 ' N ' HG21 ' B' ' 85' ' ' ILE . 51.5 Cg_exo -54.69 141.6 75.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.116 2.544 . . . . 0.0 112.26 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -56.02 -22.25 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 110.399 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.786 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -68.77 -64.73 0.81 Allowed 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.995 ' CG ' HD11 ' A' ' 70' ' ' LEU . 4.7 m0 -51.44 -60.09 3.52 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.437 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.834 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -40.51 -65.25 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 21.7 mtp85 -62.68 -35.48 79.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.768 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.593 HD23 ' O ' ' B' ' 102' ' ' GLN . 0.9 OUTLIER -49.64 -55.49 13.5 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' B' ' 106' ' ' LEU . 0.0 OUTLIER -96.43 -72.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.138 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.807 HE21 HG22 ' B' ' 109' ' ' THR . 9.0 tp60 -82.67 -105.48 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.565 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.807 HG22 HE21 ' B' ' 108' ' ' GLN . 1.4 t 156.03 58.77 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.194 0.598 . . . . 0.0 110.204 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.834 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER 172.02 126.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.972 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 15.0 m120 -50.49 -70.49 0.08 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.611 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER -121.25 85.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' B' ' 114' ' ' LYS . 9.4 t 45.18 25.35 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.268 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' B' ' 113' ' ' THR . 2.4 mttp 157.36 74.23 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.635 0.374 . . . . 0.0 110.703 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' B' ' 110' ' ' SER . 3.9 p -37.64 135.15 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.804 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -165.64 69.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.32 138.88 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.574 HN21 ' CD1' ' A' ' 165' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.742 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.15 121.35 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.81 120.47 40.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.61 130.53 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' O ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -135.83 96.61 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.965 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 77' ' ' VAL . 8.2 m -80.35 147.01 31.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 8' ' ' VAL . 4.4 t -122.16 159.88 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.431 . . . . 0.0 111.669 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.749 HG11 ' HA3' ' A' ' 15' ' ' GLY . 6.5 m -123.0 169.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.795 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 58' ' ' THR . 11.1 m -157.51 120.88 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.014 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 145.17 -161.78 28.15 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.702 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -118.25 169.26 9.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.733 0.301 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 90.54 0.01 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.223 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.588 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . 53.47 71.7 0.48 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.742 0.306 . . . . 0.0 110.244 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.674 HG23 HG21 ' A' ' 8' ' ' VAL . 1.6 m -47.07 -25.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.749 ' HA3' HG11 ' A' ' 8' ' ' VAL . . . 140.85 -40.45 1.36 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.577 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CG ' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -97.46 -74.23 0.58 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.919 ' O ' HD13 ' A' ' 21' ' ' ILE . 5.1 t -35.37 -51.81 0.61 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.687 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -66.26 -45.99 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.726 -179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.766 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -59.36 -68.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.48 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 55' ' ' LEU . 17.7 mt -40.71 -45.38 2.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.159 0.504 . . . . 0.0 111.148 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -46.26 -70.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.547 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.63 ' N ' HG22 ' A' ' 21' ' ' ILE . 14.5 t -95.2 -60.76 1.61 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.243 0.544 . . . . 0.0 111.564 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.766 ' CD1' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -44.43 -26.63 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.929 -178.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.612 HG21 HG11 ' A' ' 42' ' ' VAL . 99.1 m -109.16 -89.92 0.47 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.195 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 27' ' ' LYS . 1.4 t -64.14 -19.91 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.697 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 8.7 t30 70.41 32.75 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.355 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' A' ' 25' ' ' THR . 4.9 ttpt -127.9 138.04 52.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' CZ ' " O3'" ' A' ' 185' ' ' GNP . 1.6 m-85 -81.67 149.29 63.88 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.736 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.11 153.89 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.788 2.326 . . . . 0.0 112.723 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -108.06 -71.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.67 109.76 17.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.608 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -66.83 92.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' ' HA3' ' B' ' 88' ' ' GLY . 73.3 t -138.1 131.29 16.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.426 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 97.9 Cg_exo -42.26 93.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.381 2.054 . . . . 0.0 111.837 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.932 HG23 ' HB2' ' A' ' 38' ' ' ASP . 81.5 m -51.48 87.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.38 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG11 ' CG ' ' B' ' 96' ' ' PHE . 93.8 t -77.05 -37.43 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.755 ' HB3' HG21 ' B' ' 87' ' ' VAL . 2.7 t80 -136.38 -63.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.745 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.932 ' HB2' HG23 ' A' ' 35' ' ' THR . 11.5 t0 56.25 114.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.596 ' HB3' HD12 ' B' ' 85' ' ' ILE . 10.5 t-20 -108.11 153.09 23.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.379 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.616 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -144.33 169.25 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.075 0.464 . . . . 0.0 111.343 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.66 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -110.07 138.08 46.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 41' ' ' ALA . 2.3 m -162.37 139.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.302 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.927 HG23 ' O ' ' A' ' 51' ' ' TYR . 51.6 m -132.71 110.85 10.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.188 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 HD11 ' B' ' 75' ' ' ILE . 60.6 t -98.07 117.07 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.9 mtm -94.42 100.28 12.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.129 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.77 HD11 ' CG2' ' A' ' 173' ' ' ILE . 8.6 mt -93.13 114.12 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 17.94 78.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.02 29.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.524 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.09 130.41 63.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.504 0.192 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.11 160.38 42.78 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.595 2.197 . . . . 0.0 112.405 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.927 ' O ' HG23 ' A' ' 43' ' ' THR . 36.2 m-85 -146.74 165.19 30.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.157 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -121.11 97.67 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.497 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.892 HD21 ' CD2' ' A' ' 55' ' ' LEU . 7.2 tt -113.79 157.23 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.732 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -151.9 113.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 20' ' ' LEU . 2.3 mt -90.32 117.19 28.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 111.389 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -89.27 144.53 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.063 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD2' HG21 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -104.44 -163.69 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.904 0.383 . . . . 0.0 111.536 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.56 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.2 m -153.53 161.04 42.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 58' ' ' THR . . . -61.45 -49.93 74.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.45 -22.85 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.366 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.672 HD13 ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -115.55 176.37 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.784 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 100' ' ' GLU . 1.8 mp0 -81.94 67.75 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.718 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.672 ' OD1' HD13 ' A' ' 61' ' ' LEU . 6.0 m-20 -132.08 19.4 4.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.367 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.56 ' CD1' HG23 ' A' ' 58' ' ' THR . 0.2 OUTLIER -89.61 -10.37 46.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.253 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.15 -31.02 0.86 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.834 0.35 . . . . 0.0 111.022 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -71.9 -39.76 69.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.476 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.056 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 23.5 mt -90.09 6.54 42.01 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.299 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -47.74 -43.02 49.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_exo -60.5 -19.0 57.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.209 1.939 . . . . 0.0 112.021 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.938 HD13 ' CG ' ' B' ' 103' ' ' TRP . 0.0 OUTLIER -106.5 -48.22 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.817 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 33.75 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -41.04 153.73 0.23 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.463 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' HIS . 97.7 Cg_endo -84.74 -25.27 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.743 2.295 . . . . 0.0 112.774 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -65.51 -11.19 41.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.739 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 5' ' ' LYS . 2.5 t -42.99 -54.18 4.39 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER 178.45 -152.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.774 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -57.42 158.22 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.681 0.277 . . . . 0.0 110.676 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 77' ' ' VAL . 1.4 m-85 -115.47 145.79 42.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.69 ' O ' HG12 ' A' ' 8' ' ' VAL . 2.2 mm? -104.05 135.7 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.846 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.714 HG22 HD11 ' A' ' 101' ' ' ILE . 3.0 t -115.56 153.89 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.981 0.419 . . . . 0.0 111.729 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 23.0 p -110.05 155.28 22.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.845 ' HA ' HG11 ' A' ' 93' ' ' VAL . 30.9 p90 -178.9 109.53 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.3 t -54.28 -170.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.563 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 85' ' ' VAL . 26.9 m -152.06 -43.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.429 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -47.18 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.474 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.468 ' H ' HG23 ' A' ' 85' ' ' VAL . 14.6 m -68.43 110.72 6.27 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.498 0.19 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' CG ' HD22 ' A' ' 129' ' ' LEU . 34.2 Cg_exo -57.79 -21.87 50.45 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.527 2.152 . . . . 0.0 112.389 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -30.62 46.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.162 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.1 m -92.98 -26.99 17.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -48.73 -69.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.197 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.62 -43.64 36.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -54.87 -69.21 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.845 HG11 ' HA ' ' A' ' 82' ' ' PHE . 93.2 t -39.66 -44.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.933 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.74 -69.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.673 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.74 8.23 8.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -116.76 -43.72 2.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.715 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.609 ' HD1' HG13 ' A' ' 93' ' ' VAL . 13.8 m95 -95.64 -39.09 10.08 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.5 t -51.63 -45.47 91.27 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.489 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.3 Cg_exo -46.45 -38.44 21.04 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.359 2.039 . . . . 0.0 112.359 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.977 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.714 HD11 HG22 ' A' ' 80' ' ' VAL . 19.6 mm -49.28 -26.66 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 p -90.34 -22.4 21.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -69.14 -37.31 78.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.673 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 73' ' ' PRO . 32.7 m-70 -103.71 -70.6 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.662 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 t -59.78 108.73 1.51 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.817 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.43 -65.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.25 28.42 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.842 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.474 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -95.61 148.16 34.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . 53.1 Cg_exo -53.71 161.61 4.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.523 2.148 . . . . 0.0 112.157 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -128.0 126.14 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 111.073 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.603 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -105.08 120.57 41.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.496 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.864 HD12 ' OH ' ' A' ' 154' ' ' TYR . 2.8 mt -90.68 149.31 22.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.638 HG21 HD13 ' A' ' 19' ' ' LEU . 29.2 m -156.82 173.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.951 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.751 ' O ' HG22 ' A' ' 115' ' ' THR . . . 138.36 -125.94 3.33 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.634 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 114' ' ' GLY . 0.6 OUTLIER 77.59 148.46 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.308 179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 119' ' ' LEU . 16.7 mp0 -137.38 128.49 27.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.752 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 157' ' ' CYS . 62.0 mt -98.65 -38.38 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.336 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.13 -23.46 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.444 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 85' ' ' VAL . 1.3 tt -73.02 -15.31 61.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.474 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -69.3 -163.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.727 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 22.95 13.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.127 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.556 ' O ' HD12 ' A' ' 126' ' ' ILE . 2.2 m-20 -86.84 141.89 33.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.799 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.71 -46.97 29.79 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 m -69.06 -33.34 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.975 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.6 m -52.59 -66.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.97 -38.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.014 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.73 -61.52 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -35.77 77.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.675 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.534 HD22 ' CG ' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -50.2 -26.21 4.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.488 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.02 -23.08 63.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.037 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -85.15 -24.6 27.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -95.1 29.27 2.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.6 34.8 2.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 52.33 -162.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.002 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt 65.88 89.23 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.4 ' HA ' HD11 ' A' ' 129' ' ' LEU . 50.1 Cg_exo -55.35 143.63 75.68 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.576 2.184 . . . . 0.0 112.319 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.543 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.0 mt -56.49 121.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.7 p -106.07 172.39 3.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 52.3 Cg_exo -55.62 -19.95 25.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.696 2.264 . . . . 0.0 112.318 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -85.53 -31.62 22.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 137' ' ' ILE . 85.6 m -59.93 -48.49 81.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.946 0.403 . . . . 0.0 110.676 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.566 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -50.6 -47.97 58.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.688 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.42 -41.73 73.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.304 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -47.22 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD21 ' HE2' ' A' ' 94' ' ' LYS . 6.6 tp -59.56 -35.83 75.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.441 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB2' ' CE2' ' A' ' 154' ' ' TYR . . . -65.18 -30.63 71.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.083 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -75.1 -51.25 13.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -52.42 -48.01 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.86 -26.88 33.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 65.19 122.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.975 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -165.03 -160.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.591 ' HB ' HD12 ' A' ' 111' ' ' LEU . 17.3 t -61.37 -16.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.546 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 83.31 144.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.567 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.891 ' CE2' ' HB2' ' A' ' 146' ' ' ALA . 37.5 p90 -152.15 144.09 23.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 124.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.03 -178.69 2.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HA ' HG21 ' A' ' 115' ' ' THR . 14.6 p -133.09 -173.18 3.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.36 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 t -87.48 159.66 18.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.787 0.327 . . . . 0.0 110.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.619 ' CB ' HD22 ' A' ' 160' ' ' LEU . . . -56.32 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 161' ' ' THR . 0.6 OUTLIER 51.6 33.89 11.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.253 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 160' ' ' LEU . 1.4 p -167.82 -84.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.197 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.7 ' NE2' HD22 ' A' ' 165' ' ' LEU . 0.8 OUTLIER 73.43 104.47 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.019 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 -68.53 0.86 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.963 0.411 . . . . 0.0 110.924 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.53 77.5 0.39 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.928 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.7 HD22 ' NE2' ' A' ' 162' ' ' GLN . 1.7 tp -92.19 -36.94 12.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.0 111.569 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -26.31 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.332 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -66.33 -73.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.0 p -44.59 -37.2 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.5 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CE2' ' CE1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -61.3 -44.2 97.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 0.0 110.653 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.412 ' HA ' HD13 ' B' ' 75' ' ' ILE . 1.4 t0 -59.28 -40.0 84.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.688 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HG2' ' CE ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -77.82 -47.38 19.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.31 -39.24 66.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.3 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.804 HG13 HD11 ' B' ' 75' ' ' ILE . 34.7 mm -82.21 -57.0 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.9 tp -51.04 -29.02 11.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.089 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.63 63.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.903 0.382 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.02 -14.53 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.495 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 tp -91.88 21.23 5.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.643 0.258 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.438 ' CB ' ' HD3' ' A' ' 179' ' ' PRO . 1.4 mm-40 -92.39 -52.66 0.27 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 178' ' ' GLU . 38.3 Cg_exo -56.96 154.77 31.08 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.609 2.206 . . . . 0.0 112.338 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.9 131.95 22.11 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 144.79 96.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.07 -167.78 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.613 2.208 . . . . 0.0 112.359 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -66.43 91.12 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.953 179.91 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.18 -64.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.397 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.804 HD11 HG13 ' A' ' 173' ' ' ILE . 5.8 tt -140.75 151.88 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 2.2 m -130.77 133.35 45.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.19 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -62.1 136.99 95.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.517 ' CB ' HG12 ' A' ' 42' ' ' VAL . 77.3 Cg_exo -48.68 144.05 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.401 2.067 . . . . 0.0 112.372 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -104.39 -54.71 2.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' PHE . 33.2 m-20 -67.56 162.43 23.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.498 ' CE1' HG21 ' A' ' 25' ' ' THR . 6.1 t80 174.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.78 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 84' ' ' THR . 10.6 pt-20 -153.52 139.71 18.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -68.27 70.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLU . 0.0 OUTLIER -42.28 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.696 -179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.879 HG21 ' N ' ' B' ' 100' ' ' PRO . 1.3 mp -109.65 108.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 111.654 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -87.79 96.87 10.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.052 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.755 HG21 ' HB3' ' A' ' 37' ' ' PHE . 17.2 t -81.13 145.26 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.553 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -145.08 174.7 25.03 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.232 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -108.98 117.64 34.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 110.818 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.52 ' HB2' HG21 ' B' ' 97' ' ' THR . 42.2 t0 -123.89 136.18 54.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.972 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.41 0.77 21.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.894 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 1.058 HG13 HG22 ' B' ' 93' ' ' THR . 7.7 p -48.22 -25.96 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.885 0.374 . . . . 0.0 111.304 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 1.058 HG22 HG13 ' B' ' 92' ' ' VAL . 0.1 OUTLIER -155.79 -39.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.325 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.84 11.91 2.53 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.13 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' B' ' 93' ' ' THR . 0.7 OUTLIER -122.85 172.11 8.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.889 0.344 . . . . 0.0 110.553 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 67' ' ' LEU . 1.8 m-85 -67.73 158.06 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.365 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.63 HG22 HD13 ' B' ' 112' ' ' ILE . 29.2 p -119.71 165.88 13.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.539 ' O ' HG22 ' B' ' 85' ' ' ILE . . . 48.91 27.62 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.909 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.661 ' HA ' HG22 ' B' ' 87' ' ' VAL . 0.1 OUTLIER -77.33 163.1 66.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.933 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.879 ' N ' HG21 ' B' ' 85' ' ' ILE . 72.1 Cg_exo -48.52 136.21 26.46 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.246 . . . . 0.0 112.409 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.18 -39.75 14.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.028 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -47.62 34.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 1.056 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 4.8 m0 -49.3 -59.97 3.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.546 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 110' ' ' SER . . . -52.49 -59.57 4.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.033 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 8.7 mtt180 -48.46 -42.18 31.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.871 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -50.14 -54.63 19.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.789 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.702 HD11 HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -94.63 -69.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.727 ' O ' HG23 ' B' ' 109' ' ' THR . 6.2 tt0 -79.53 -98.59 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.586 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.727 HG23 ' O ' ' B' ' 108' ' ' GLN . 4.7 p -166.03 -46.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.677 ' O ' ' HB1' ' B' ' 104' ' ' ALA . 0.2 OUTLIER -131.59 167.21 19.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.965 -179.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.9 OUTLIER -56.28 -54.85 40.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.63 HD13 HG22 ' B' ' 97' ' ' THR . 0.6 OUTLIER -134.87 86.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.879 178.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m 74.68 -60.38 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.817 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.434 ' HA ' ' CB ' ' B' ' 110' ' ' SER . 0.6 OUTLIER -152.98 42.52 0.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.188 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.422 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.3 OUTLIER 48.63 81.39 0.05 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.831 0.348 . . . . 0.0 111.029 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -109.38 117.19 33.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -119.96 89.35 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 4.9 pttt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.9 179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.509 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.465 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -121.88 171.42 8.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.62 139.19 54.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.673 HG21 ' HB1' ' A' ' 176' ' ' ALA . 1.1 mp -125.72 139.45 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.21 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.465 ' HG3' ' CD1' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -114.98 138.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.675 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.53 110.76 22.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' PRO . 16.4 t -87.59 145.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.649 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' A' ' 14' ' ' VAL . 19.6 m -137.79 167.07 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.665 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG11 ' HD2' ' A' ' 104' ' ' HIS . 9.1 p -163.76 136.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.375 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 139.44 148.93 5.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.821 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 160.68 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.638 0.256 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 46.84 86.28 0.01 OUTLIER Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.991 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.808 ' HB2' ' O1A' ' A' ' 185' ' ' GNP . . . 72.8 67.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.178 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.7 p -48.7 -24.99 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.18 -27.9 5.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.393 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -96.91 -73.46 0.6 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.815 0.34 . . . . 0.0 111.443 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.825 HG23 ' OD2' ' A' ' 57' ' ' ASP . 3.3 p -45.82 -66.41 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.711 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 11.7 p -41.49 -48.12 3.83 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.792 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.9 -69.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.705 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.656 HD13 ' HZ ' ' B' ' 81' ' ' PHE . 83.6 mt -40.53 -59.27 1.38 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 17' ' ' THR . 1.1 mp -36.33 -55.65 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.467 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB2' " O2'" ' A' ' 185' ' ' GNP . 1.2 t -93.72 -67.1 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.381 0.61 . . . . 0.0 110.672 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.786 ' CD2' HD13 ' A' ' 165' ' ' LEU . 24.5 t80 -40.13 -66.68 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.835 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' A' ' 20' ' ' LEU . 79.3 m -85.95 -80.23 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.982 0.42 . . . . 0.0 111.648 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.726 HG21 ' HE3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -36.04 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.296 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.41 55.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.468 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HE3' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -173.93 -174.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.768 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -101.13 166.46 12.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 80.0 Cg_exo -44.45 146.67 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.505 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.4 m -102.51 -82.25 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.709 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.54 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.519 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.38 92.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG13 ' HD2' ' A' ' 34' ' ' PRO . 92.7 t -136.31 138.74 27.84 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.768 ' O ' HG23 ' A' ' 36' ' ' VAL . 86.4 Cg_exo -42.93 106.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.352 2.035 . . . . 0.0 111.504 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 57' ' ' ASP . 39.7 m -47.07 88.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 34' ' ' PRO . 89.7 t -98.03 -51.64 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' B' ' 87' ' ' VAL . 60.0 t80 -163.35 95.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.751 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 25.9 m-20 -96.99 123.02 40.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' HB3' HD12 ' B' ' 85' ' ' ILE . 9.1 t-20 -108.07 150.25 27.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.832 0.349 . . . . 0.0 110.636 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -152.36 169.18 23.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.201 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -107.1 140.57 39.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.643 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' B' ' 78' ' ' PRO . 3.6 m -159.14 157.57 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.032 0.444 . . . . 0.0 111.908 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 51' ' ' TYR . 53.8 m -155.95 108.33 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.197 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 76' ' ' SER . 3.4 m -98.35 119.23 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.3 mtm -74.95 104.91 5.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.884 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 mm -94.78 111.44 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 20.67 71.35 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.561 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.75 41.57 8.18 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -140.59 147.82 50.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.792 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.9 153.09 77.77 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.565 2.177 . . . . 0.0 112.274 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -147.98 162.04 40.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 p -135.31 97.39 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.573 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 54' ' ' GLY . 7.4 tt -124.69 159.6 30.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -154.7 123.56 1.39 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 20' ' ' LEU . 6.2 mp -75.87 119.65 20.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 5' ' ' LYS . 6.9 m-85 -108.18 120.52 42.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.4 t70 -67.77 174.74 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.338 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.63 ' OG1' HG13 ' A' ' 7' ' ' VAL . 15.4 m -169.97 166.13 9.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.422 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' O ' ' CE1' ' A' ' 104' ' ' HIS . . . -136.28 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.472 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' HA2' ' CE1' ' A' ' 104' ' ' HIS . . . -78.32 -128.95 0.51 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.708 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 61' ' ' LEU . 3.4 mm? 62.33 152.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 mp0 -45.97 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.319 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 68' ' ' ARG . 7.0 m-20 -90.69 57.04 3.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.66 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 1.5 t80 47.12 43.61 14.48 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' OD2' ' CD2' ' A' ' 61' ' ' LEU . 1.0 OUTLIER 71.22 -140.65 0.05 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -95.32 -1.93 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.192 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.035 HD13 ' CZ3' ' B' ' 103' ' ' TRP . 68.1 mt -88.0 51.73 2.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.369 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -94.06 -43.48 0.3 Allowed Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 13.1 Cg_exo -69.8 -42.74 3.1 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.552 2.168 . . . . 0.0 112.19 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.939 HD12 ' HA ' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -86.51 11.91 11.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.631 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.488 ' HB2' ' CZ2' ' B' ' 103' ' ' TRP . 3.3 t -166.21 32.04 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.57 0.224 . . . . 0.0 111.043 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.512 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 7.6 p90 -33.34 122.36 0.45 Allowed Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.068 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.78 ' HA ' HG21 ' A' ' 7' ' ' VAL . 26.7 Cg_exo -62.48 -27.3 76.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.536 2.157 . . . . 0.0 112.587 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.98 -10.03 45.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.86 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.626 ' CG2' HG23 ' A' ' 7' ' ' VAL . 3.5 t -36.01 -55.01 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.458 ' H ' HG23 ' A' ' 75' ' ' THR . 0.5 OUTLIER -172.41 -158.63 0.12 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.497 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 111' ' ' LEU . 11.7 p -57.93 163.24 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.523 ' N ' HG22 ' A' ' 77' ' ' VAL . 9.0 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.426 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 8' ' ' VAL . 10.3 tp -130.16 123.82 31.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.691 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.1 t -131.21 147.14 32.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.056 0.455 . . . . 0.0 111.943 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.499 ' SG ' HG23 ' A' ' 113' ' ' VAL . 17.8 m -139.63 155.27 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.408 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CD2' HG11 ' A' ' 93' ' ' VAL . 6.7 p90 -162.21 164.17 27.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.78 157.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.474 HG13 HG22 ' A' ' 137' ' ' ILE . 59.0 t -111.76 -75.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.09 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -47.14 -81.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -49.42 105.13 0.47 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.871 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 43.1 Cg_endo -67.48 -17.04 48.69 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.47 2.113 . . . . 0.0 112.473 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t -48.91 -27.3 3.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 93' ' ' VAL . 23.2 t -96.12 -37.59 10.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -49.78 -62.23 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -50.23 -57.34 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.032 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 5.6 m-20 -51.34 -59.64 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 89' ' ' SER . 61.3 t -44.33 -38.95 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.671 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.9 -62.28 1.48 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.582 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.02 7.99 5.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -121.3 -43.89 2.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.652 ' HD1' HG13 ' A' ' 93' ' ' VAL . 20.0 m95 -95.59 -34.12 12.13 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 94' ' ' LYS . 94.7 t -49.58 -47.28 78.66 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.2 Cg_endo -74.94 -11.56 21.59 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.051 1.834 . . . . 0.0 112.459 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.61 -43.48 9.61 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.09 0.472 . . . . 0.0 110.68 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 9' ' ' VAL . 11.7 pt -51.11 -34.97 14.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.484 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 81.6 p -52.87 -47.6 67.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.513 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 15.6 t60 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.183 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.75 ' HD2' HG11 ' A' ' 9' ' ' VAL . 66.5 m-70 -79.96 -31.47 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.171 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 28.1 p -111.88 94.52 24.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.953 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -51.73 -55.19 4.18 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.568 2.179 . . . . 0.0 112.412 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 31.06 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -114.89 139.94 24.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.947 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 152' ' ' VAL . 75.7 Cg_exo -51.27 -172.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.629 2.219 . . . . 0.0 112.259 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 15.3 p90 -161.3 129.65 4.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.563 ' CD1' HG21 ' A' ' 77' ' ' VAL . 7.5 mp -97.29 129.94 44.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.392 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 149' ' ' LEU . 1.2 pt? -131.8 133.38 44.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.561 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 154' ' ' TYR . 2.7 m -141.16 176.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.375 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 84' ' ' VAL . . . -131.8 142.92 14.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.143 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.674 HG21 ' C5 ' ' A' ' 185' ' ' GNP . 38.0 p -128.91 108.71 10.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.638 ' HB3' HG22 ' A' ' 85' ' ' VAL . 1.2 mt-30 170.7 66.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 157' ' ' CYS . 4.9 pt -98.64 -23.41 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.64 -36.99 11.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.73 -18.74 34.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.302 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.8 ' HA ' HG11 ' A' ' 85' ' ' VAL . 10.6 ptm180 -51.23 -23.79 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 111.15 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -44.73 -28.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.41 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.96 ' O ' HG22 ' A' ' 125' ' ' THR . 28.2 p-10 -66.53 116.72 37.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 126' ' ' ILE . 45.9 Cg_exo -56.23 -22.58 41.27 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.42 2.08 . . . . 0.0 112.275 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -56.07 -43.93 78.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 122' ' ' ASP . 10.1 t -50.95 -33.02 22.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 129' ' ' LEU . 4.0 mp -81.23 -42.76 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -49.48 -48.68 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -78.88 -36.94 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.983 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 125' ' ' THR . 0.7 OUTLIER -49.89 -26.63 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.016 0.436 . . . . 0.0 110.5 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.18 63.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.048 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -94.22 -37.5 11.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -56.14 -24.42 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.17 53.33 0.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.13 170.36 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' HD3' ' HD2' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -76.91 154.99 83.07 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 138' ' ' THR . 76.6 Cg_exo -49.98 122.1 8.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.565 2.177 . . . . 0.0 112.231 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 141' ' ' THR . 6.4 mt -50.98 125.19 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.7 OUTLIER -130.89 -179.8 1.14 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.551 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 76.9 Cg_exo -51.14 -22.69 11.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.438 2.092 . . . . 0.0 112.221 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.33 -42.5 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.53 ' CG2' HG23 ' A' ' 137' ' ' ILE . 57.2 m -49.92 -56.35 10.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -50.41 -38.09 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 2.9 tt0 -59.85 -48.43 81.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.517 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -47.08 62.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -56.69 -38.05 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.243 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.015 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -57.05 -45.27 83.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.768 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -58.1 -45.71 86.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.12 -56.89 13.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.808 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.682 ' CD2' HD11 ' A' ' 112' ' ' LEU . 3.5 pp -62.17 -27.29 68.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 72.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.094 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -109.07 -179.6 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 109' ' ' PRO . 68.9 t -46.74 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 159.14 136.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.43 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 1.015 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 11.1 p90 -153.15 141.84 20.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 111.544 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -158.06 124.72 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.854 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.65 -178.81 2.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.733 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.47 ' HB2' HD13 ' A' ' 117' ' ' ILE . 28.3 p -136.19 -173.32 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.64 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.446 ' CB ' HG12 ' A' ' 117' ' ' ILE . 5.0 p -87.2 156.0 19.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.349 . . . . 0.0 110.527 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.547 ' HB2' " H1'" ' A' ' 185' ' ' GNP . . . -51.78 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.294 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 161' ' ' THR . 0.2 OUTLIER 55.0 24.03 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.422 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER 169.9 128.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.715 HE22 HD11 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -126.31 121.73 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 111.056 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -101.2 -43.63 5.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.85 85.67 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 23' ' ' TYR . 7.0 mt -85.3 -37.25 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -52.99 -24.84 10.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 155' ' ' VAL . 49.5 m-20 -63.45 -69.74 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.123 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 165' ' ' LEU . 7.6 p -47.27 -41.98 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CE2' ' HD3' ' B' ' 78' ' ' PRO . 0.3 OUTLIER -67.59 -49.08 64.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.606 ' HA ' HG21 ' B' ' 75' ' ' ILE . 56.3 t0 -47.14 -45.37 22.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.999 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -84.29 -47.68 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.421 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -53.95 -33.21 56.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.557 HG13 HD11 ' B' ' 75' ' ' ILE . 23.3 mm -87.84 -33.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.881 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.2 tp -53.17 -56.75 13.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.72 -32.49 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -77.03 -28.03 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.598 HD12 ' OH ' ' A' ' 51' ' ' TYR . 39.0 tp -54.3 -25.41 23.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 68.41 96.4 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.27 169.58 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.625 2.216 . . . . 0.0 112.384 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.89 146.79 60.46 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.586 2.19 . . . . 0.0 112.264 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 182' ' ' PRO . 2.0 mm-40 -54.71 -51.98 74.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 181' ' ' GLU . 80.0 Cg_exo -47.44 124.63 9.62 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.572 2.181 . . . . 0.0 112.326 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.76 159.49 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -51.33 -76.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.96 0.41 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 170' ' ' ASP . 5.1 tt -115.69 151.74 17.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -135.93 135.15 39.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.379 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.693 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -55.47 136.33 70.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.527 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.693 ' HD2' HD23 ' B' ' 77' ' ' LEU . 71.7 Cg_exo -50.7 143.69 28.34 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.479 2.12 . . . . 0.0 112.411 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.1 -70.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.917 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -58.08 88.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.656 ' HZ ' HD13 ' A' ' 20' ' ' LEU . 9.5 t80 -113.25 136.28 52.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.34 130.0 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.386 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 96.95 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.405 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.926 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 39' ' ' ASN . 1.1 mp -101.53 139.72 22.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.994 0.426 . . . . 0.0 111.979 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . 0.435 ' CG ' ' O ' ' B' ' 86' ' ' HIS . 52.1 p-80 -120.38 96.55 5.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.335 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 37' ' ' PHE . 46.9 t -83.47 152.54 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.86 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.48 ' HA3' ' CG1' ' A' ' 33' ' ' VAL . . . -146.42 177.85 24.49 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.503 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.53 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.635 ' OD2' HG21 ' B' ' 97' ' ' THR . 1.2 m-20 -132.68 134.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.44 1.11 20.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.909 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.526 HG13 HG22 ' B' ' 93' ' ' THR . 7.3 p -46.08 -27.84 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.327 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.526 HG22 HG13 ' B' ' 92' ' ' VAL . 6.2 t -148.58 -42.02 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.044 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.79 29.67 0.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.467 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -138.18 -159.47 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.704 0.288 . . . . 0.0 110.457 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.468 ' HB3' ' CG1' ' B' ' 87' ' ' VAL . 3.5 m-85 -98.99 164.24 12.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 110.758 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.635 HG21 ' OD2' ' B' ' 90' ' ' ASP . 34.3 p -109.41 171.76 7.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 44.26 28.12 1.32 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.773 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.83 129.46 21.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.562 0.22 . . . . 0.0 110.883 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.433 ' HD3' ' CG2' ' B' ' 87' ' ' VAL . 50.3 Cg_exo -53.92 140.4 68.79 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.375 2.05 . . . . 0.0 111.884 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -42.67 -45.88 4.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.252 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -56.78 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.797 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 1.035 ' CZ3' HD13 ' A' ' 67' ' ' LEU . 3.6 m0 -52.36 -58.74 5.75 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.143 0.496 . . . . 0.0 110.45 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.516 ' HB1' HE21 ' B' ' 108' ' ' GLN . . . -45.58 -70.32 0.11 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.136 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -47.32 -38.56 13.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.041 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -43.82 -64.88 0.58 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.859 0.361 . . . . 0.0 110.12 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -70.25 0.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.516 HE21 ' HB1' ' B' ' 104' ' ' ALA . 0.6 OUTLIER -80.71 -160.39 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.973 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -154.23 57.43 0.71 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.26 -0.275 . . . . 0.0 111.042 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.435 ' O ' ' NE2' ' B' ' 108' ' ' GLN . 0.4 OUTLIER 167.74 124.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.157 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.4 ' HB3' ' HA2' ' B' ' 98' ' ' GLY . 4.4 m120 -48.1 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.603 HD13 HG22 ' B' ' 97' ' ' THR . 0.7 OUTLIER -127.18 86.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.874 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.17 88.05 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.398 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' B' ' 116' ' ' GLU . 0.2 OUTLIER 58.0 37.25 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.974 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.479 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.2 OUTLIER 65.65 -71.59 0.08 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 114' ' ' LYS . 0.5 OUTLIER 68.05 -81.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . 0.425 ' HG2' HG21 ' B' ' 112' ' ' ILE . 3.6 pt20 -75.9 118.83 19.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.938 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 19.7 mttp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.945 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.808 ' O1A' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.54 136.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.7 m -102.31 142.25 33.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.23 138.76 52.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.216 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -127.52 96.33 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.566 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.48 107.93 10.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.729 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' CG2' HG21 ' A' ' 75' ' ' THR . 3.0 t -84.58 150.48 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LYS . 7.5 p -135.34 146.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 78' ' ' PHE . 5.5 m -133.75 121.03 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' A' ' 97' ' ' TRP . . . 147.97 -174.32 27.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.68 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.68 155.4 49.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.367 . . . . 0.0 111.178 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 88.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB2' " C5'" ' A' ' 185' ' ' GNP . . . 49.94 53.78 12.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.668 HG13 HG21 ' A' ' 8' ' ' VAL . 10.0 p -80.54 2.68 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.345 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 19' ' ' LEU . . . 109.87 -29.62 9.18 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.663 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.815 ' HB3' HG11 ' A' ' 8' ' ' VAL . 9.5 pttt -51.42 -67.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.773 -0.251 . . . . 0.0 111.635 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.758 HG21 ' O ' ' A' ' 188' ' ' HOH . 0.2 OUTLIER -96.81 -26.37 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.747 0.308 . . . . 0.0 111.304 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' O ' ' N7 ' ' A' ' 185' ' ' GNP . 35.2 t -61.24 -58.42 8.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.424 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.998 HD12 HD21 ' A' ' 79' ' ' LEU . 14.5 mt -50.99 -73.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.393 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.794 HD11 ' HB2' ' A' ' 55' ' ' LEU . 15.1 mt -39.35 -40.34 0.78 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -51.96 -67.35 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 1.8 t -93.27 -53.36 4.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.347 0.594 . . . . 0.0 110.24 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.893 ' O ' HD21 ' B' ' 77' ' ' LEU . 13.9 t80 -44.51 -30.03 0.81 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.061 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 25' ' ' THR . 93.7 m -125.33 -101.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.608 HG21 ' CZ ' ' B' ' 81' ' ' PHE . 4.7 t -40.37 -34.8 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 75.65 47.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -151.4 136.91 17.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CE1' " O2'" ' A' ' 185' ' ' GNP . 1.0 OUTLIER -58.42 166.7 2.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 28' ' ' PHE . 11.8 Cg_endo -55.69 171.81 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.945 2.43 . . . . 0.0 112.858 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 t -116.24 -75.38 0.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.099 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.19 129.06 39.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -90.66 104.32 16.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.198 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.592 HG23 ' HD2' ' A' ' 34' ' ' PRO . 5.2 p -160.78 140.51 8.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.915 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD2' HG23 ' A' ' 33' ' ' VAL . 55.7 Cg_exo -35.38 91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.933 2.422 . . . . 0.0 112.291 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 57' ' ' ASP . 98.8 m -51.32 87.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.15 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.915 HG11 ' CD2' ' B' ' 96' ' ' PHE . 88.6 t -84.9 -33.74 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.521 ' CE1' ' HG3' ' B' ' 100' ' ' PRO . 16.9 t80 -173.61 128.81 0.42 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.877 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 2.3 m-20 -127.86 148.98 50.49 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.778 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' HB2' HD12 ' B' ' 85' ' ' ILE . 2.8 t-20 -107.07 157.27 17.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.863 0.363 . . . . 0.0 110.69 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.568 ' OH ' HG23 ' A' ' 17' ' ' THR . 4.2 m-85 -152.82 169.29 23.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.237 0.542 . . . . 0.0 112.006 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' B' ' 81' ' ' PHE . . . -127.6 115.56 18.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG12 ' CB ' ' B' ' 78' ' ' PRO . 0.7 OUTLIER -141.13 155.53 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.019 0.438 . . . . 0.0 111.557 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.2 m -156.33 95.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.099 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.666 HG21 HG21 ' A' ' 173' ' ' ILE . 27.4 m -98.42 178.35 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.427 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 2.7 mtt -115.07 157.26 23.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.766 HD12 ' CE1' ' A' ' 51' ' ' TYR . 18.0 mt -158.24 89.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.585 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.17 3.02 79.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.77 26.91 5.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 12.0 pt-20 -141.63 138.82 17.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.638 0.256 . . . . 0.0 111.127 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 43.4 Cg_exo -56.44 174.38 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.578 2.185 . . . . 0.0 112.198 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.766 ' CE1' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.87 171.2 17.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.002 0.43 . . . . 0.0 111.155 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -136.3 97.02 3.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.337 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 54' ' ' GLY . 11.3 tp -98.22 157.71 16.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.954 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' N ' ' HG ' ' A' ' 53' ' ' LEU . . . -163.22 103.01 0.21 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.426 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.03 HD11 HD23 ' A' ' 79' ' ' LEU . 3.4 mm? -75.78 105.05 6.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.763 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.7 m-85 -83.26 107.48 15.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.178 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -67.84 130.4 42.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.323 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.839 HG22 ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -160.45 163.74 32.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -103.34 -53.62 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.964 0.411 . . . . 0.0 111.004 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.23 -45.64 1.1 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.268 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -151.76 17.91 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 13.2 mt-10 -103.43 83.59 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.139 0.495 . . . . 0.0 110.957 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 78.28 -3.49 2.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.604 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.839 ' CD2' HG22 ' A' ' 58' ' ' THR . 24.2 m-85 -85.26 -13.7 48.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.747 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -39.49 -47.13 1.81 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.013 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -54.06 37.38 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.758 ' CB ' HD11 ' A' ' 70' ' ' LEU . 2.3 mp -78.59 82.24 4.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.19 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 24.1 ptt180 -88.2 -35.02 0.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 2.5 Cg_endo -82.68 7.95 4.86 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.422 2.081 . . . . 0.0 112.73 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.955 HD22 ' CE2' ' B' ' 103' ' ' TRP . 39.0 mt -51.54 111.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.485 0.659 . . . . 0.0 111.471 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.636 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 70.18 4.78 5.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.433 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER 59.97 154.7 0.1 OUTLIER Pre-proline 0 N--CA 1.462 0.17 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.466 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -89.93 -52.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.947 2.432 . . . . 0.0 112.932 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -69.86 -8.2 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.986 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 76' ' ' ASP . 1.1 t -32.79 -73.52 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.729 ' H ' HG23 ' A' ' 75' ' ' THR . 3.7 m-20 -161.56 -155.68 0.4 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 78' ' ' PHE . 14.1 p -66.86 162.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -98.5 127.34 44.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.03 HD23 HD11 ' A' ' 55' ' ' LEU . 13.5 tp -103.69 115.47 30.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.274 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.515 HG13 ' CG2' ' A' ' 14' ' ' VAL . 2.5 t -131.9 153.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.446 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 14' ' ' VAL . 62.6 m -142.65 172.02 13.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.511 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.738 ' HB3' HG21 ' A' ' 93' ' ' VAL . 50.8 p90 -164.41 151.72 11.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.105 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.47 136.8 42.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 115' ' ' THR . 5.3 m -107.15 68.09 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.12 -85.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.13 163.8 55.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.853 0.358 . . . . 0.0 110.803 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.432 ' CB ' ' HB2' ' A' ' 132' ' ' ASN . 51.7 Cg_endo -69.17 -22.53 34.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.58 2.187 . . . . 0.0 112.287 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 p -70.18 -33.83 72.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.2 p -51.89 -46.25 64.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -51.92 -69.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.067 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.93 -29.22 55.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.002 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.5 m-20 -62.47 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.951 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.738 HG21 ' HB3' ' A' ' 82' ' ' PHE . 7.2 p -41.38 -31.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.14 -70.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.842 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.57 8.11 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 27.3 tttm -113.68 -40.62 3.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.676 ' HD1' HG23 ' A' ' 93' ' ' VAL . 11.0 m95 -95.96 -13.58 23.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 94' ' ' LYS . 2.5 m -53.02 -32.57 10.37 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.5 Cg_exo -68.78 -41.87 5.26 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.782 1.654 . . . . 0.0 112.217 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' CG ' HD12 ' A' ' 61' ' ' LEU . 19.0 mp0 -58.56 -43.67 89.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.816 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.841 HG21 ' CD2' ' A' ' 110' ' ' PHE . 71.3 mt -48.58 -26.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.006 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -84.67 -37.16 21.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.58 -34.56 51.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.973 0.416 . . . . 0.0 110.353 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -102.94 -61.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.866 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 78' ' ' PHE . 8.4 m -109.29 85.61 3.62 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.2 -11.66 29.1 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.632 2.221 . . . . 0.0 112.794 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -152.78 40.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 111.419 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.4 139.88 36.73 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.853 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 108' ' ' THR . 75.1 Cg_exo -49.18 143.96 17.82 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.542 2.161 . . . . 0.0 112.113 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.841 ' CD2' HG21 ' A' ' 101' ' ' ILE . 1.6 p90 -131.39 130.52 42.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.28 136.09 41.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.394 179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.2 pp -146.78 114.19 6.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.475 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.672 HG11 ' CD ' ' A' ' 156' ' ' GLU . 10.0 p -129.1 152.3 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.382 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.484 ' HA3' HG13 ' A' ' 84' ' ' VAL . . . -73.16 -176.92 32.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.305 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.858 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -174.14 172.36 3.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 111.426 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.906 ' OE1' HD22 ' A' ' 119' ' ' LEU . 14.1 mt-30 72.53 108.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' A' ' 139' ' ' PRO . 41.7 mt -98.48 -59.83 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 119' ' ' LEU . 24.9 p30 -55.02 -22.51 15.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.906 HD22 ' OE1' ' A' ' 116' ' ' GLN . 7.3 tp -61.93 -48.11 81.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.956 ' HA ' HG12 ' A' ' 85' ' ' VAL . 1.6 ptt180 -58.91 -22.89 60.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -52.72 -23.8 7.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 29.6 m-20 -54.22 135.6 59.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 43.3 Cg_exo -56.58 -42.55 64.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.522 2.148 . . . . 0.0 112.397 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -38.69 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 120' ' ' ARG . 19.7 p -59.05 -64.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.6 mp -48.65 -43.68 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -64.57 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.069 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD2' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -71.59 -32.93 68.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.925 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -50.81 -26.23 5.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.928 0.394 . . . . 0.0 110.295 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.35 -22.44 60.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.928 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.48 -22.51 37.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 87' ' ' PRO . 25.6 t30 -94.04 30.59 1.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.957 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 34.69 0.37 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.788 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.71 -160.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.45 95.65 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.773 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.416 ' HA ' HD22 ' A' ' 129' ' ' LEU . 42.0 Cg_endo -67.56 141.8 56.69 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.608 2.205 . . . . 0.0 112.363 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 90' ' ' PHE . 4.1 mt -67.47 125.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 1.0 OUTLIER -124.43 177.73 1.68 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' A' ' 117' ' ' ILE . 51.1 Cg_exo -54.23 -24.7 35.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.691 2.26 . . . . 0.0 112.343 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -86.36 -39.02 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.027 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.8 m -49.97 -48.29 52.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.63 -49.91 61.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.04 -47.93 68.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.52 -40.62 59.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.593 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 145' ' ' LEU . 8.5 tt -61.38 -41.69 97.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.967 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -53.33 -54.93 29.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.859 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -55.05 -38.83 68.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -51.49 -32.67 28.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 151' ' ' ALA . 1.6 pp -125.39 21.86 7.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.142 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 58.1 -84.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.993 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 149' ' ' LEU . . . 58.07 175.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 153' ' ' LYS . 6.1 t -61.52 -15.99 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.484 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 86.45 140.84 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 110.466 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.967 ' CE1' ' HB2' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -153.39 151.57 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 155' ' ' VAL . 14.9 m -157.93 123.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.579 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.672 ' CD ' HG11 ' A' ' 113' ' ' VAL . 2.7 pt-20 -172.36 152.21 2.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.152 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.54 ' O ' ' N2 ' ' A' ' 185' ' ' GNP . 83.3 m -101.82 -177.53 3.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.513 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 30.8 t -86.77 156.6 19.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.049 0.452 . . . . 0.0 111.594 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.906 ' O ' HD12 ' A' ' 160' ' ' LEU . . . -55.04 -169.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.029 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER 50.87 24.89 1.94 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.549 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -174.17 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.452 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 57.66 115.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.338 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -64.07 1.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.28 92.98 0.11 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.419 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -93.79 -10.37 34.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.477 0.18 . . . . 0.0 111.455 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.16 -43.32 3.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 111.336 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.94 -67.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.732 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.685 HG13 ' OH ' ' A' ' 23' ' ' TYR . 7.3 p -50.27 -28.78 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -57.78 -51.26 70.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.146 179.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 2.5 p30 -63.13 -32.24 73.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.4 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 24.6 tp10 -70.14 -30.68 67.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.98 -29.36 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.717 HG22 HD11 ' A' ' 46' ' ' ILE . 44.5 mm -94.95 -66.36 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.995 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -49.94 -45.76 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.979 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 171' ' ' GLU . . . -55.34 -25.56 35.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -61.33 -29.23 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.057 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -92.7 44.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -146.97 83.43 7.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.54 162.03 38.78 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.612 2.208 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.13 156.64 55.35 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.582 2.188 . . . . 0.0 112.324 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -50.69 106.14 0.61 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.98 91.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.48 2.12 . . . . 0.0 112.273 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.51 95.67 6.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 28.5 m -55.34 -42.56 74.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.6 149.19 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.22 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.47 176.1 8.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.893 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -94.88 140.37 22.49 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.71 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.655 ' CB ' HG12 ' A' ' 42' ' ' VAL . 52.9 Cg_exo -54.61 -164.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.437 2.091 . . . . 0.0 112.103 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -167.79 -65.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.59 95.59 2.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.985 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -129.02 148.93 51.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.141 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -153.22 140.45 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.93 0.395 . . . . 0.0 111.758 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -75.48 95.34 3.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.051 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -77.02 -42.49 38.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 39' ' ' ASN . 2.0 mt -129.07 147.91 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 111.558 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -141.12 97.16 3.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.083 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.484 ' CG2' ' HD3' ' B' ' 100' ' ' PRO . 63.3 t -78.25 125.07 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 111.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.59 172.92 15.91 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.869 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -98.62 111.23 23.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.444 ' CG ' HG21 ' B' ' 97' ' ' THR . 1.1 m-20 -129.29 128.78 43.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.36 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.15 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.918 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.938 HG13 HG22 ' B' ' 93' ' ' THR . 7.5 p -41.5 -30.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 111.591 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.938 HG22 HG13 ' B' ' 92' ' ' VAL . 1.1 t -151.61 21.1 0.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.151 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.96 25.27 67.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.852 ' CG ' HG23 ' B' ' 93' ' ' THR . 8.3 pt-20 -145.71 171.84 14.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.915 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -70.54 164.75 24.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.421 . . . . 0.0 110.745 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.444 HG21 ' CG ' ' B' ' 90' ' ' ASP . 66.1 p -110.45 176.68 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.918 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' B' ' 85' ' ' ILE . . . 43.05 28.54 0.76 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.87 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.712 ' CE ' HD21 ' A' ' 67' ' ' LEU . 3.0 mtp -57.74 124.63 69.61 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.63 0.252 . . . . 0.0 110.956 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.521 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 49.2 Cg_exo -38.86 152.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.792 2.328 . . . . 0.0 112.692 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' B' ' 105' ' ' ARG . 2.8 mt-10 -47.58 -43.24 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.065 0.459 . . . . 0.0 110.413 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.488 ' HG2' HD23 ' B' ' 106' ' ' LEU . 0.0 OUTLIER -72.56 -57.67 3.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.246 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.955 ' CE2' HD22 ' A' ' 70' ' ' LEU . 13.1 m0 -48.31 -60.26 2.8 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.601 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' C ' ' B' ' 110' ' ' SER . . . -47.47 -67.99 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 10.2 mtp85 -52.23 -34.4 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.032 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -45.75 -65.64 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.034 0.445 . . . . 0.0 110.886 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.696 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -63.22 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.56 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.69 ' O ' HG23 ' B' ' 109' ' ' THR . 0.4 OUTLIER -78.8 -100.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.677 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.69 HG23 ' O ' ' B' ' 108' ' ' GLN . 11.7 p -164.94 -57.04 0.03 OUTLIER 'General case' 0 C--N 1.341 0.226 0 CA-C-O 120.788 0.327 . . . . 0.0 111.851 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.572 ' C ' ' HB1' ' B' ' 104' ' ' ALA . 0.3 OUTLIER -127.7 158.89 36.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.382 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 99' ' ' MET . 0.6 OUTLIER -45.15 -57.44 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.055 0.455 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.602 ' O ' HG23 ' B' ' 112' ' ' ILE . 0.5 OUTLIER -136.88 86.07 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 177.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m 73.19 -61.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.684 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -147.76 48.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' B' ' 110' ' ' SER . 0.7 OUTLIER 70.46 162.21 0.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.782 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.43 -27.5 11.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.24 135.88 57.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.54 ' N2 ' ' O ' ' A' ' 157' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.758 ' O ' HG21 ' A' ' 17' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.85 0.357 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -94.6 120.93 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.8 t -99.73 147.15 25.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.866 HG23 ' OD2' ' A' ' 76' ' ' ASP . 65.8 mt -135.66 103.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.218 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB2' HG21 ' A' ' 75' ' ' THR . 5.6 mmtp -95.67 98.31 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -77.77 112.35 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.113 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG1' ' CE2' ' A' ' 78' ' ' PHE . 59.6 t -91.09 150.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 79' ' ' LEU . 7.3 p -139.51 147.36 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.063 0.458 . . . . 0.0 111.529 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 60' ' ' GLY . 7.1 p -138.27 120.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.534 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.62 36.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.769 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -20.87 15.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.782 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -78.37 -45.17 10.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.69 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 17' ' ' THR . . . 73.47 3.0 4.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' HA2' ' A' ' 114' ' ' GLY . 5.4 t -57.78 -17.93 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 110.242 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . -81.25 -124.32 0.65 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.422 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -34.06 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.604 ' CG2' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -50.91 -71.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' THR . 51.7 t -48.03 -46.45 33.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.126 0.489 . . . . 0.0 110.985 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.883 HD13 HG11 ' A' ' 113' ' ' VAL . 69.4 tp -46.14 -59.78 2.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.537 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 55' ' ' LEU . 21.8 mt -44.69 -49.15 10.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.708 0.29 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 27' ' ' LYS . 3.4 mm -42.58 -49.19 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.491 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.464 ' CB ' ' N3 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -93.68 -61.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.453 0.644 . . . . 0.0 110.256 178.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.941 ' OH ' HG13 ' A' ' 168' ' ' VAL . 1.2 t80 -39.8 -66.85 0.26 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.249 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.839 HG23 ' HB2' ' B' ' 78' ' ' PRO . 50.6 m -96.57 -77.54 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.366 0.603 . . . . 0.0 111.151 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.775 HG23 ' CE2' ' B' ' 81' ' ' PHE . 0.2 OUTLIER -36.29 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.225 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t30 47.72 65.08 1.37 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 110.616 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -173.16 -169.57 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.316 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -111.91 157.89 38.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.251 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -51.2 143.05 34.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.669 2.246 . . . . 0.0 112.438 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 p -95.12 -80.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.22 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.89 109.33 21.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.02 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' C ' HG23 ' A' ' 33' ' ' VAL . 1.6 t80 -66.11 107.73 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.104 0.478 . . . . 0.0 111.103 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA2' ' B' ' 88' ' ' GLY . 59.2 t -157.89 131.89 5.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' VAL . 94.7 Cg_exo -41.86 92.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.379 2.053 . . . . 0.0 111.969 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.831 HG23 ' CG ' ' A' ' 38' ' ' ASP . 40.4 m -53.11 87.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.268 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.808 HG13 ' OH ' ' A' ' 64' ' ' TYR . 12.2 t -73.41 -27.04 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 110.058 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.715 ' HE2' HD13 ' B' ' 85' ' ' ILE . 15.8 t80 -146.85 -79.78 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.312 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.831 ' CG ' HG23 ' A' ' 35' ' ' THR . 1.0 OUTLIER 60.69 118.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.119 -179.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 t-20 -107.7 156.86 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -152.49 144.89 24.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.005 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.11 140.2 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.139 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 24' ' ' THR . 25.6 m -154.81 132.34 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 51' ' ' TYR . 61.4 m -125.39 95.31 4.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 ' O ' ' B' ' 76' ' ' SER . 2.9 m -98.13 123.75 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.403 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mtm -72.8 100.18 2.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.923 HD11 HG21 ' A' ' 173' ' ' ILE . 24.7 mm -90.48 89.37 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.44 12.74 55.62 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 4.7 58.96 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.125 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.13 150.61 43.23 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.03 0.415 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.29 162.44 7.74 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.679 2.252 . . . . 0.0 112.126 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.628 ' H ' HG23 ' A' ' 43' ' ' THR . 7.0 t80 -154.11 153.28 31.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.952 0.406 . . . . 0.0 111.459 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 p -136.31 97.43 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.223 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 54' ' ' GLY . 5.8 tt -112.51 144.89 41.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.762 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -127.5 112.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.183 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 16' ' ' LYS . 5.6 mp -77.96 102.93 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 111.308 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 1.3 m-85 -88.86 103.01 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.01 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.667 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -73.57 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.94 0.4 . . . . 0.0 111.246 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.05 -171.22 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.965 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . . . -156.69 149.27 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' VAL . . . -109.01 99.49 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.57 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.36 -65.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 170.02 -32.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.736 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -111.14 27.29 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.965 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -91.42 -23.05 20.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -27.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.603 ' O ' HD23 ' B' ' 107' ' ' LEU . 22.1 mtt180 -48.67 -40.27 27.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.877 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD22 ' CE3' ' B' ' 103' ' ' TRP . 0.5 OUTLIER -92.12 40.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.638 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tpt180 -81.59 -66.46 0.23 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.499 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 19.3 Cg_endo -58.91 -15.16 25.73 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.56 2.173 . . . . 0.0 112.626 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.762 HD12 ' CG ' ' B' ' 103' ' ' TRP . 0.2 OUTLIER -96.41 -13.0 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.108 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 1.3 t -111.6 -19.49 12.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.319 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 71' ' ' SER . 0.2 OUTLIER 39.01 95.86 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.801 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 37.9 Cg_endo -66.2 -45.58 5.42 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.609 2.206 . . . . 0.0 112.183 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -12.08 47.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 5' ' ' LYS . 6.6 t -40.56 -46.8 2.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -172.64 -160.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.749 0.309 . . . . 0.0 111.058 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -58.17 154.18 2.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.731 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CE2' ' CG1' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -106.76 138.79 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.27 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -104.11 122.61 45.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.093 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 101' ' ' ILE . 4.0 t -106.9 153.77 8.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.065 0.46 . . . . 0.0 111.919 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.27 155.66 18.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.714 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CZ ' HG23 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -166.07 121.66 1.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.968 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.88 164.4 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.678 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.651 ' HA ' HG21 ' A' ' 137' ' ' ILE . 34.5 t -147.67 66.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.318 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.829 HG13 ' HA ' ' A' ' 120' ' ' ARG . 70.8 t -151.27 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -82.76 137.71 43.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.841 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 57.9 Cg_endo -72.06 -19.47 26.42 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.556 2.171 . . . . 0.0 112.325 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.8 p -56.91 -52.23 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.81 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.75 -29.82 63.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.845 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -50.3 -45.86 54.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -47.54 85.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -61.1 -66.42 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' CZ2' ' A' ' 97' ' ' TRP . 28.7 m -43.53 -40.84 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.664 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.2 tttm -57.44 -68.03 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 5.1 mt-10 -82.53 8.4 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.138 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -116.02 -38.69 3.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.404 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.584 ' CZ2' HG12 ' A' ' 93' ' ' VAL . 49.9 m0 -95.23 -40.89 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.511 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 101' ' ' ILE . 60.7 t -55.85 -44.09 99.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 39.5 Cg_exo -60.22 -19.65 58.31 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.33 2.02 . . . . 0.0 112.339 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.71 -30.8 56.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.284 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.885 HG22 ' O ' ' A' ' 98' ' ' VAL . 8.4 tp -49.16 -31.4 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.198 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -77.71 -44.04 29.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -51.86 -37.76 53.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 5.3 m-70 -97.2 -61.72 1.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.444 ' SG ' ' CD1' ' A' ' 78' ' ' PHE . 4.7 t -74.42 108.89 5.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.501 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.49 -60.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.392 2.062 . . . . 0.0 112.419 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -154.68 36.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.727 HG22 ' HD2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -107.29 153.98 40.83 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD2' HG22 ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.89 145.68 97.67 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.606 2.204 . . . . 0.0 111.97 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 20.1 p90 -123.1 127.48 48.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.97 0.414 . . . . 0.0 111.314 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.649 HD12 ' CG1' ' A' ' 152' ' ' VAL . 6.8 tt -109.14 119.29 39.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.045 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . 1.4 mp -90.99 155.14 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.229 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 19' ' ' LEU . 3.0 t -148.78 165.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.118 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.705 ' HA2' HG12 ' A' ' 14' ' ' VAL . . . 143.41 154.63 6.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.513 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.799 HG21 ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -176.78 164.48 2.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.421 ' HG2' ' CB ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -172.25 93.85 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.815 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -25.72 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.855 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -95.26 -30.91 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.795 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.421 ' CB ' ' HG2' ' A' ' 116' ' ' GLN . 0.2 OUTLIER -78.41 -44.72 24.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HA ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -53.14 -23.49 8.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.04 55.89 2.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.9 ' O ' HD12 ' A' ' 126' ' ' ILE . 1.3 m-20 -111.11 150.04 41.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.779 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 -57.95 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.716 2.277 . . . . 0.0 112.374 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -34.57 75.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 120' ' ' ARG . 54.2 m -55.49 -72.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.818 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 122' ' ' ASP . 3.7 mp -52.03 -39.1 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.878 0.37 . . . . 0.0 110.6 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -32.08 30.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.048 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.67 -39.34 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.524 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.842 HD13 ' HD2' ' A' ' 136' ' ' PRO . 17.6 mt -49.9 -26.14 3.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.457 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.43 67.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -25.35 22.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.621 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' CB ' ' HG3' ' A' ' 87' ' ' PRO . 9.6 m120 -115.95 30.23 7.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 103.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.973 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 6.3 pt20 -42.69 150.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.489 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 10.1 mttt 47.94 48.43 5.88 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.842 ' HD2' HD13 ' A' ' 129' ' ' LEU . 73.8 Cg_endo -75.88 -46.15 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.561 2.174 . . . . 0.0 112.562 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 84' ' ' VAL . 5.7 mm -99.85 129.94 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -148.86 164.5 21.08 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 75.6 Cg_exo -49.78 -23.31 8.27 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.546 2.164 . . . . 0.0 112.315 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -90.64 -41.23 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.1 m -49.02 -57.69 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -46.89 -49.56 20.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.65 -38.11 80.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -50.36 73.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.1 tp -57.25 -37.93 73.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 154' ' ' TYR . . . -71.57 -26.53 62.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.936 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ttt-85 -73.43 -40.7 64.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.21 -44.7 94.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 150' ' ' LYS . 4.4 pp -71.77 -26.39 62.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.744 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.694 ' N ' HD12 ' A' ' 149' ' ' LEU . 9.0 tptt 69.05 109.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.62 -161.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.649 ' CG1' HD12 ' A' ' 111' ' ' LEU . 91.2 t -56.82 -20.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.305 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 75.07 139.53 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.197 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 39.6 p90 -152.8 162.09 41.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 111.295 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 155' ' ' VAL . 33.7 m -158.13 124.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.695 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.571 ' CD ' HG13 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -170.62 167.55 7.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.104 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.799 ' HA ' HG21 ' A' ' 115' ' ' THR . 17.4 p -118.9 -173.24 2.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.382 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -87.68 165.04 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 110.973 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.575 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -51.43 -175.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 159' ' ' ALA . 1.7 mm? 66.23 -69.29 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.276 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.93 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.91 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER 68.61 108.68 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.667 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 -68.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.35 96.57 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.91 HD11 ' NE2' ' A' ' 162' ' ' GLN . 19.2 mt -93.24 -17.62 23.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.68 0.276 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -62.92 -49.96 72.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.455 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 166' ' ' LYS . 23.1 m-80 -48.8 -71.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.941 HG13 ' OH ' ' A' ' 23' ' ' TYR . 3.5 p -47.62 -30.06 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.524 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -64.42 -38.21 90.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.779 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.448 ' CB ' HG13 ' B' ' 75' ' ' ILE . 17.4 t0 -63.63 -35.54 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.127 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 3.1 mm-40 -81.79 -24.63 35.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.851 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.73 41.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 46' ' ' ILE . 21.2 mt -88.71 -48.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.46 -27.77 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 171' ' ' GLU . . . -50.82 -37.14 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.74 ' HB3' HD13 ' A' ' 4' ' ' ILE . . . -94.52 -20.58 19.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.318 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -82.99 -24.58 32.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.017 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 179' ' ' PRO . 3.8 mm-40 -51.31 -54.41 38.81 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 178' ' ' GLU . 57.3 Cg_exo -51.74 110.22 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.53 2.153 . . . . 0.0 112.225 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.47 137.38 11.33 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.459 2.106 . . . . 0.0 112.38 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.02 63.75 19.14 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.63 102.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.599 2.199 . . . . 0.0 112.371 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -56.32 130.46 44.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.98 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 19.3 p -99.36 -39.55 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.448 HG13 ' CB ' ' A' ' 170' ' ' ASP . 6.7 mm -140.33 139.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.897 ' O ' HG12 ' A' ' 44' ' ' VAL . 3.5 p -138.69 141.85 38.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.013 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -70.24 131.67 88.49 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.839 ' HB2' HG23 ' A' ' 24' ' ' THR . 53.1 Cg_exo -54.63 154.29 20.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.399 2.066 . . . . 0.0 112.273 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.86 -43.31 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.971 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.87 61.63 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.976 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.775 ' CE2' HG23 ' A' ' 25' ' ' THR . 23.7 t80 -74.39 149.8 40.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.681 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.65 101.72 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -72.34 69.31 0.81 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.803 ' OG1' HD12 ' B' ' 85' ' ' ILE . 44.8 p -52.43 -85.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.245 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.803 HD12 ' OG1' ' B' ' 84' ' ' THR . 0.5 OUTLIER -96.95 145.32 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.096 0.474 . . . . 0.0 112.092 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.95 96.89 4.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.519 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.602 HG22 ' HD3' ' B' ' 100' ' ' PRO . 29.7 t -78.03 157.29 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.969 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.589 ' HA2' HG12 ' A' ' 33' ' ' VAL . . . -146.43 177.92 24.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -84.52 119.08 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.615 ' CB ' HG23 ' B' ' 97' ' ' THR . 13.8 t0 -111.01 98.32 7.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.13 -16.23 61.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.562 HG13 HG22 ' B' ' 93' ' ' THR . 13.4 p -46.92 -33.47 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.308 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.562 HG22 HG13 ' B' ' 92' ' ' VAL . 7.8 t -148.16 23.72 1.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.17 25.39 72.25 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.622 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.412 ' HG2' ' CG2' ' B' ' 93' ' ' THR . 17.4 pt-20 -119.84 -166.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.732 0.301 . . . . 0.0 110.791 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 1.02 ' CE2' HD11 ' A' ' 67' ' ' LEU . 2.2 m-85 -103.9 163.74 12.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.764 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.615 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.6 p -104.64 150.05 25.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.576 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' ND2' ' B' ' 111' ' ' ASN . . . 69.5 43.93 66.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.611 ' CG ' ' HB2' ' B' ' 104' ' ' ALA . 2.7 tpt -47.28 103.91 0.38 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.551 0.215 . . . . 0.0 110.962 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.602 ' HD3' HG22 ' B' ' 87' ' ' VAL . 77.5 Cg_exo -50.3 147.44 16.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.487 2.125 . . . . 0.0 111.915 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -66.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -65.7 0.53 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.417 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 1.04 ' CE3' HD22 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -46.71 -56.85 5.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.201 0.524 . . . . 0.0 110.552 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.611 ' HB2' ' CG ' ' B' ' 99' ' ' MET . . . -55.26 -60.91 2.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.653 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.784 ' O ' HG22 ' B' ' 109' ' ' THR . 6.1 mtt-85 -42.42 -36.23 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.368 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.759 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -60.81 -60.72 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.32 179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.18 -64.36 1.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.703 ' O ' HG23 ' B' ' 109' ' ' THR . 5.5 tp60 -76.93 -79.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.236 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.784 HG22 ' O ' ' B' ' 105' ' ' ARG . 6.0 p 96.78 54.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.366 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 112' ' ' ILE . 0.6 OUTLIER 171.26 93.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.958 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.467 ' CB ' ' HB2' ' B' ' 115' ' ' SER . 1.7 t30 -49.78 92.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.611 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.678 ' O ' HG23 ' B' ' 113' ' ' THR . 0.4 OUTLIER -58.64 86.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.187 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.678 HG23 ' O ' ' B' ' 112' ' ' ILE . 0.7 OUTLIER 153.45 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.444 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 41.35 63.49 1.23 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.562 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.467 ' HB2' ' CB ' ' B' ' 111' ' ' ASN . 0.5 OUTLIER -41.34 138.56 1.21 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.88 0.371 . . . . 0.0 111.314 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.7 -58.35 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -58.84 96.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 32.9 tttt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.977 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.507 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.769 0.319 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.58 167.57 11.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.849 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -91.83 132.63 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.647 HD13 ' CB ' ' A' ' 176' ' ' ALA . 25.1 mt -116.25 133.41 62.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.3 OUTLIER -123.27 149.44 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.722 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.97 96.05 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.689 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.82 HG21 ' O ' ' A' ' 71' ' ' SER . 56.4 t -100.79 128.01 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.867 ' HB ' HG12 ' A' ' 14' ' ' VAL . 18.5 m -106.73 169.44 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.2 p -158.28 121.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.98 -140.58 5.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB2' ' CE2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -126.5 -78.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -60.36 -147.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.912 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -60.81 78.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 110.78 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.867 HG12 ' HB ' ' A' ' 8' ' ' VAL . 2.5 t -73.81 -1.36 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.142 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 79' ' ' LEU . . . 95.62 -24.74 28.08 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HD2' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -60.32 -64.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.852 HG23 ' OD2' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -96.09 -34.35 11.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.912 ' SG ' ' HB1' ' A' ' 13' ' ' ALA . 3.3 p -66.39 -45.19 80.87 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.591 HD22 ' CD1' ' A' ' 79' ' ' LEU . 8.1 tp -61.29 -73.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.959 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -43.86 -48.45 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.397 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -47.74 -69.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.01 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.1 t -93.2 -60.89 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.462 . . . . 0.0 111.971 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.56 ' CD2' HD11 ' A' ' 19' ' ' LEU . 8.2 t80 -47.6 -24.96 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.702 HG21 HG11 ' A' ' 42' ' ' VAL . 79.6 m -111.36 -96.25 0.42 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.562 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.463 ' HB ' ' CD2' ' B' ' 81' ' ' PHE . 1.6 t -60.07 -21.76 61.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 27.9 t-20 72.1 30.38 2.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' CE1' ' B' ' 81' ' ' PHE . 0.9 OUTLIER -125.78 134.75 51.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -69.21 160.12 80.17 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.042 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD2' ' CD2' ' A' ' 28' ' ' PHE . 9.2 Cg_endo -50.64 169.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.965 2.444 . . . . 0.0 112.409 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -74.92 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 134.11 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.21 110.06 14.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.216 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.7 p -154.78 138.85 11.27 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.497 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 36' ' ' VAL . 93.8 Cg_exo -41.18 109.07 0.1 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.46 2.107 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 16' ' ' LYS . 18.1 m -47.16 91.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.297 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 34' ' ' PRO . 61.3 t -103.78 -53.77 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.886 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' B' ' 85' ' ' ILE . 45.8 t80 -159.0 78.46 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 12.2 m-20 -80.59 121.52 25.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.656 ' HB3' HD12 ' B' ' 85' ' ' ILE . 26.6 t-20 -107.07 151.2 25.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.037 0.446 . . . . 0.0 111.272 -178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -152.2 160.03 43.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.216 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.25 116.97 29.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.906 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 24' ' ' THR . 1.4 m -146.08 132.07 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.059 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 51' ' ' TYR . 21.0 m -127.49 112.19 14.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.838 0.352 . . . . 0.0 110.215 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.867 HG13 ' O ' ' B' ' 76' ' ' SER . 92.6 t -97.73 117.0 41.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.215 0.531 . . . . 0.0 110.143 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 11.4 mtm -93.42 106.09 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.294 -178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.68 HG23 HD13 ' B' ' 75' ' ' ILE . 7.2 mt -85.82 100.97 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.845 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 74' ' ' SER . . . 86.25 19.86 56.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.361 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.33 -46.31 1.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.595 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.4 pt-20 -65.72 139.69 97.08 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.663 0.268 . . . . 0.0 111.031 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.0 158.71 49.27 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -154.13 150.03 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.4 p -86.63 97.8 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.718 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -133.76 137.31 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.865 ' N ' HD22 ' A' ' 53' ' ' LEU . . . -162.25 145.4 10.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.551 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 79' ' ' LEU . 3.1 mm? -75.88 114.34 14.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.636 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.646 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -83.2 103.72 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.062 0.458 . . . . 0.0 109.843 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.852 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 m-20 -67.51 137.12 55.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.685 HG21 ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -176.07 135.23 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.806 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -76.52 -61.97 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.221 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.99 89.56 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -118.63 -38.5 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 166.81 -30.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.22 -24.21 27.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 18.7 m-85 -56.6 -20.19 19.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -41.77 -30.26 0.23 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.768 0.318 . . . . 0.0 111.446 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.8 mtt180 -70.01 -48.66 57.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.599 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.081 HD13 ' CE2' ' B' ' 96' ' ' PHE . 0.2 OUTLIER -88.56 49.55 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.552 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -99.45 -43.39 0.23 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.0 Cg_exo -58.12 -14.63 19.93 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.63 2.22 . . . . 0.0 112.979 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.713 HD22 ' CD1' ' B' ' 103' ' ' TRP . 0.3 OUTLIER -104.07 -15.6 15.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.103 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.82 ' O ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -132.9 22.07 4.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' CD1' ' HB ' ' A' ' 75' ' ' THR . 15.1 p90 -46.61 114.33 2.67 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.106 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HG2' ' HA ' ' A' ' 105' ' ' CYS . 37.8 Cg_endo -65.72 -21.42 58.61 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.562 2.175 . . . . 0.0 112.32 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -65.92 -11.79 49.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.231 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' ' 72' ' ' TYR . 8.9 t -41.47 -48.55 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 111.47 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.481 ' N ' HG23 ' A' ' 75' ' ' THR . 2.6 m-20 -164.54 -85.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.608 HG21 ' CB ' ' A' ' 175' ' ' ALA . 24.9 t -132.14 156.7 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.536 ' CE2' HG23 ' A' ' 101' ' ' ILE . 36.2 p90 -144.57 140.96 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 111.462 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.65 150.0 24.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' O ' HG22 ' A' ' 113' ' ' VAL . 2.5 t -131.34 154.62 40.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.186 0.517 . . . . 0.0 111.913 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.503 ' N ' ' HA ' ' A' ' 14' ' ' VAL . 10.1 p -68.15 172.93 5.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.815 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CZ ' ' CD2' ' A' ' 145' ' ' LEU . 0.9 OUTLIER 179.44 100.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.62 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 m -58.57 91.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.882 HG11 ' HB2' ' A' ' 142' ' ' ALA . 10.4 m -83.52 54.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.721 HG22 ' N ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -150.6 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.531 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.721 ' N ' HG22 ' A' ' 85' ' ' VAL . 4.2 t -57.5 135.76 82.04 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.618 0.247 . . . . 0.0 110.64 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HG2' ' HG2' ' A' ' 128' ' ' LYS . 98.4 Cg_endo -78.25 -39.42 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.548 2.165 . . . . 0.0 112.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.24 -24.02 6.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.18 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 93' ' ' VAL . 70.5 m -88.68 -40.34 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CZ ' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -42.32 -53.04 4.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.686 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -48.34 -55.41 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.364 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.0 m-20 -70.78 -37.89 73.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.189 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.944 HG23 ' O ' ' A' ' 89' ' ' SER . 98.6 t -44.09 -45.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.639 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HA ' HG23 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -85.69 -47.79 9.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.38 7.67 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -128.56 -38.09 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.908 ' CE3' HG13 ' A' ' 93' ' ' VAL . 46.1 m0 -95.13 -26.54 15.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.61 HG23 ' HA ' ' A' ' 94' ' ' LYS . 59.7 t -67.35 -44.1 45.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.563 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 41.6 Cg_exo -56.87 -34.98 98.1 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.324 2.016 . . . . 0.0 112.308 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -68.16 -33.29 74.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.536 HG23 ' CE2' ' A' ' 78' ' ' PHE . 47.6 mt -49.17 -40.25 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.5 p -77.3 -21.44 53.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.328 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -69.45 -37.2 77.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.86 0.362 . . . . 0.0 110.678 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 73' ' ' PRO . 22.1 m-70 -106.51 -39.75 5.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.813 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 3.9 m -99.25 102.74 16.9 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 104' ' ' HIS . 87.6 Cg_exo -42.99 -62.29 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.479 2.119 . . . . 0.0 112.403 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -171.67 40.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 155.76 41.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.646 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.91 118.21 2.59 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.457 2.104 . . . . 0.0 112.179 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . 6.2 p90 -104.89 141.99 35.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.319 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 111' ' ' LEU . 3.5 mt -129.49 158.11 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.989 0.423 . . . . 0.0 111.244 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.8 m -156.56 155.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.44 39.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.846 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 158' ' ' SER . 73.0 p -146.29 160.04 42.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.699 0.285 . . . . 0.0 110.714 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.42 35.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.21 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 157' ' ' CYS . 20.0 mt -97.04 -61.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.987 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -95.66 -35.88 11.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.79 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 119' ' ' LEU . 6.0 tt -70.52 -32.21 69.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.822 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HG3' HG23 ' A' ' 85' ' ' VAL . 7.0 ttm180 -76.63 59.38 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -129.21 37.29 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.87 141.64 22.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.44 -49.57 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.556 2.171 . . . . 0.0 112.265 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.7 m -57.77 -22.98 49.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.547 HG22 HD12 ' A' ' 129' ' ' LEU . 5.2 m -48.83 -66.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -57.69 -45.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -50.19 52.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.006 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HG2' ' HG2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -81.37 -35.09 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.959 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 125' ' ' THR . 2.8 mt -50.91 -25.56 4.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.495 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.26 -21.41 56.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.081 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -83.38 -20.05 34.93 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.98 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.89 30.55 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 77.79 32.95 0.38 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.39 -161.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.039 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.14 93.25 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 37.5 Cg_endo -66.2 124.85 13.12 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.548 2.165 . . . . 0.0 112.064 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.508 HG21 ' CA ' ' A' ' 84' ' ' VAL . 3.7 mt -50.55 120.29 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.0 p -118.12 158.41 46.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 3.7 Cg_exo -40.3 -29.42 0.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.071 2.514 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -36.75 21.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' THR . 93.5 m -48.05 -47.61 33.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.882 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -49.31 -46.58 46.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -57.66 -42.95 84.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.591 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.42 -53.47 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 14.8 tp -57.26 -31.95 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.467 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.875 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -66.66 -31.59 72.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -70.34 -47.64 60.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 -23.14 51.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.005 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 pp -106.3 -24.26 12.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.073 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' ALA . 1.2 tttt 62.16 120.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.845 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.7 -161.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 5.1 t -67.37 -15.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.574 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 85.32 146.02 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.875 ' CZ ' ' HB2' ' A' ' 146' ' ' ALA . 24.3 p90 -152.79 126.25 8.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.186 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.1 t -138.12 123.39 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -170.73 -179.63 2.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.761 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.469 ' HB2' HD11 ' A' ' 117' ' ' ILE . 17.6 p -130.62 -173.22 3.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.516 ' HA ' HG22 ' A' ' 115' ' ' THR . 8.7 t -87.15 163.2 17.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.702 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.75 ' C ' HD22 ' A' ' 160' ' ' LEU . . . -52.25 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.058 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.75 HD22 ' C ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 69.73 -63.25 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.64 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.2 p -89.51 -169.62 2.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.634 ' NE2' HD11 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -172.56 109.58 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -100.39 -38.75 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.44 88.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.304 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -91.98 -11.54 35.8 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -34.22 37.36 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -57.09 -45.43 83.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.283 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' VAL . 31.1 t -54.76 -52.96 37.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.472 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' CB ' ' HH ' ' A' ' 23' ' ' TYR . 1.4 m-30 -70.15 -28.25 65.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -53.93 -52.12 61.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.775 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 1.5 tp10 -89.9 -33.9 16.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 168' ' ' VAL . . . -66.14 -38.38 88.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.858 HD12 ' HG ' ' A' ' 53' ' ' LEU . 42.3 mm -86.66 -44.17 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.4 tm? -64.43 -31.94 73.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 77' ' ' VAL . . . -51.75 -29.29 18.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.647 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -63.64 -20.98 66.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.18 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.71 38.3 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.475 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 12.1 tp10 -78.27 -46.65 2.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.286 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 178' ' ' GLU . 90.3 Cg_endo -81.3 145.99 15.39 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.401 2.068 . . . . 0.0 112.324 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.72 156.71 56.86 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.536 2.157 . . . . 0.0 112.273 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.484 ' HB2' ' CD ' ' A' ' 182' ' ' PRO . 1.4 mt-10 -160.12 -66.46 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.325 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.484 ' CD ' ' HB2' ' A' ' 181' ' ' GLU . 33.7 Cg_endo -63.95 82.99 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.486 2.124 . . . . 0.0 112.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.14 168.8 16.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -50.45 -27.49 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.339 . . . . 0.0 110.898 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.68 HD13 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -144.03 137.41 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.071 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.867 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -138.65 133.54 32.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.604 HD23 ' HD2' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -77.2 143.23 69.28 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.59 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 42' ' ' VAL . 51.3 Cg_exo -54.12 152.36 24.84 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.352 2.035 . . . . 0.0 112.062 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -117.19 -37.07 3.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.244 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -75.89 163.05 27.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 27.6 t80 -167.46 130.35 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.624 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -153.42 116.67 4.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 69.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.427 ' N ' ' O ' ' B' ' 82' ' ' GLU . 8.2 p -57.9 -77.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.247 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.783 HD13 ' HE2' ' A' ' 37' ' ' PHE . 1.1 mp -103.76 139.44 24.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.499 . . . . 0.0 112.279 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -123.11 96.21 4.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.101 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' A' ' 36' ' ' VAL . 57.7 t -88.08 144.51 9.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.891 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.36 176.85 20.05 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.989 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -77.35 113.42 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.568 ' CB ' HG23 ' B' ' 97' ' ' THR . 12.0 t0 -107.99 108.05 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.66 -17.2 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.307 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' VAL . . . . . 0.529 HG12 ' CG ' ' B' ' 90' ' ' ASP . 10.2 p -43.01 -35.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.509 HG23 HG22 ' B' ' 92' ' ' VAL . 18.2 p -157.79 45.33 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.05 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.54 27.39 5.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.638 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.62 -168.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.719 0.295 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 1.081 ' CE2' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -106.0 164.49 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.829 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.568 HG23 ' CB ' ' B' ' 90' ' ' ASP . 1.9 p -99.45 165.31 11.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.964 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.419 ' CA ' ' OG1' ' B' ' 113' ' ' THR . . . 49.09 51.73 24.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.762 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' B' ' 104' ' ' ALA . 0.0 OUTLIER -60.48 119.33 42.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.665 ' HG3' HG21 ' B' ' 85' ' ' ILE . 58.4 Cg_exo -49.56 156.46 2.9 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.291 1.994 . . . . 0.0 112.146 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.67 -57.1 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.455 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.422 ' OE1' HD23 ' B' ' 106' ' ' LEU . 1.1 tm0? -69.94 -52.52 23.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.225 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -50.1 -57.77 6.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.725 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.616 ' HB1' ' H ' ' B' ' 110' ' ' SER . . . -48.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.204 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' B' ' 109' ' ' THR . 77.5 mtt180 -54.76 -34.29 62.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.242 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.659 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -47.05 -61.04 2.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.925 0.393 . . . . 0.0 109.978 179.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.681 HD11 ' HG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -95.41 -70.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.15 178.324 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.556 ' C ' HG22 ' B' ' 109' ' ' THR . 4.0 pt20 -80.74 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.203 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.556 HG22 ' C ' ' B' ' 108' ' ' GLN . 0.5 OUTLIER 159.05 62.58 0.0 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 122.459 0.304 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . 0.616 ' H ' ' HB1' ' B' ' 104' ' ' ALA . 0.1 OUTLIER 168.41 108.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.384 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' B' ' 111' ' ' ASN . 0.8 OUTLIER -65.39 74.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.449 ' N ' HD12 ' B' ' 112' ' ' ILE . 0.5 OUTLIER -57.48 87.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.196 0.522 . . . . 0.0 111.311 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.419 ' OG1' ' CA ' ' B' ' 98' ' ' GLY . 4.2 m 179.92 -50.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.173 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -36.69 2.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.757 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.77 108.18 13.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.51 -83.56 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -73.59 109.9 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.604 " H1'" ' HB2' ' A' ' 159' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_